|
4650 genotypes with 10208 annotations displayed
of selected term and subterms
|
|
Searched Term: muscle phenotype
|
\1700021F13Rikem1Smoc/\1700021F13Rikem1Smoc
(involves: C57BL/6JSmoc)
|
decreased cardiac muscle contractility
|
J:344873
|
| increased myocardial fiber size
|
J:344873
|
| myocardium hypertrophy
|
J:344873
|
| thin myocardium
|
J:344873
|
\2310039L15RikTg(Prnp-SNCA*A53T)23Mkle/\2310039L15Rik+
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
\2310065F04Rikem1Boet/\2310065F04Rikem1Boet
(involves: C57BL/6)
|
increased satellite cell number
|
J:306156
|
\2310065F04Riktm1.1Boet/\2310065F04Riktm1.1Boet
(involves: C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:306156
|
| abnormal skeletal muscle fiber morphology
|
J:306156
|
| abnormal skeletal muscle morphology
|
J:306156
|
| increased satellite cell number
|
J:306156
|
| increased skeletal muscle mass
|
J:306156
|
| increased skeletal muscle satellite cell proliferation
|
J:306156
|
| increased skeletal muscle weight
|
J:306156
|
| skeletal muscle hypertrophy
|
J:306156
|
\2310065F04Riktm1.1Boet/\2310065F04Riktm1.1Boet
\Ino80tm1.1Jland/\Ino80tm1.1Jland
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:306156
|
\2310065F04Riktm1.1Boet/\2310065F04Riktm1.1Boet
\Ino80tm1.1Jland/\Ino80tm1.1Jland
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl)
|
muscle phenotype
|
J:306156
|
\2610005L07RikGt(ROSA)73Sor/\2610005L07RikGt(ROSA)73Sor
\Pdgfratm1Sor/\Pdgfra+
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
\3425401B19Rikem1Liyu/\3425401B19Rik+
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:350467
|
\3425401B19Rikem1Liyu/\3425401B19Rikem1Liyu
(involves: C57BL/6J)
|
abnormal sarcomere morphology
|
J:350467
|
| decreased cardiac muscle contractility
|
J:350467
|
| dilated cardiomyopathy
|
J:350467
|
| increased myocardial fiber size
|
J:350467
|
| myocardial hypertrabeculation
|
J:350467
|
\4933430I17Riktm1b(EUCOMM)Wtsi/\4933430I17Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1b(EUCOMM)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
\4933434E20Riktm1a(EUCOMM)Wtsi/\4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
\5430431A17Rikem1Doca/\5430431A17Rikem1Doca
(C57BL/6-5430431A17Rikem1Doca)
|
abnormal skeletal muscle fiber morphology
|
J:266332
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:164749
|
| decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Ak2em1.1Dze/\Ak2em1.1Dze
(involves: 129 * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:305579
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Clk4em1Yihc/\Clk4em1Yihc
(B6(FVB)-Clk4em1Yihc A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
abnormal sarcomere morphology
|
J:327369
|
| decreased heart ventricle muscle contractility
|
J:327369
|
| diffuse Z line
|
J:327369
|
| increased myocardial fiber size
|
J:327369
|
| myocardium hypertrophy
|
J:327369
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Dusp12em1Zhzy/\Dusp12em1Zhzy
(involves: FVB/N)
|
cardiomyopathy
|
J:345360
|
| decreased cardiac muscle contractility
|
J:345360
|
| myocardium hypertrophy
|
J:345360
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Ppiftm1Jmol/\Ppiftm1Jmol
\Slc8b1tm1c(EUCOMM)Wtsi/\Slc8b1tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:325413
|
| decreased heart ventricle muscle contractility
|
J:325413
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Tg(CAG-cat,-Dusp14)4Lyg/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:263251
|
| increased myocardial fiber size
|
J:263251
|
| myocardium hypertrophy
|
J:263251
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:127391
|
| abnormal myocardial fiber morphology
|
J:127391
|
| decreased cardiac muscle contractility
|
J:127391
|
| dilated cardiomyopathy
|
J:127391
|
| increased myocardial fiber size
|
J:127391
|
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
abnormal intercalated disk morphology
|
J:128060
|
| abnormal myocardial fiber morphology
|
J:128060
|
| abnormal sarcolemma morphology
|
J:128060
|
| abnormal sarcomere morphology
|
J:128060
|
| abnormal Z line morphology
|
J:128060
|
| decreased heart left ventricle muscle contractility
|
J:128060
|
| dilated cardiomyopathy
|
J:128060
|
\Aars1sti/\Aars1tm1.1Slac
(involves: C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:216802
|
\Aars1sti/\Aars1tm1Slac
(involves: C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:216802
|
| abnormal myocardial fiber morphology
|
J:216802
|
| abnormal sarcoplasmic reticulum morphology
|
J:216802
|
| decreased heart left ventricle muscle contractility
|
J:216802
|
| myocardial fiber disarray
|
J:216802
|
\Abca1tm1Wpfl/\Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
| heart left ventricle hypertrophy
|
J:64390
|
| heart right ventricle hypertrophy
|
J:64390
|
\Abca1tm1Wpfl/\Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
| heart left ventricle hypertrophy
|
J:64390
|
| heart right ventricle hypertrophy
|
J:64390
|
\Abca5tm1Akya/\Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
dilated cardiomyopathy
|
J:99152
|
| myocardial fiber degeneration
|
J:99152
|
\Abca5tm1Akya/\Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
dilated cardiomyopathy
|
J:99152
|
| myocardial fiber degeneration
|
J:99152
|
\Abcb8tm1Hard/\Abcb8tm1Hard
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:182234
|
| abnormal myocardial fiber morphology
|
J:182234
|
| cardiomyopathy
|
J:182234
|
| decreased cardiac muscle contractility
|
J:182234
|
\Abcc9em1Nich/\Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
| increased vasodilation
|
J:281903
|
\Abcc9em1Nich/\Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
\Abcc9em2Nich/\Abcc9em2Nich
(involves: C57BL/6J * CBA/J)
|
decreased heart left ventricle muscle contractility
|
J:281630
|
| increased muscle fatigability
|
J:281630
|
\Abcc9em3Nich/\Abcc9+
(B6.Cg-Abcc9em3Nich)
|
abnormal myocardial fiber morphology
|
J:308986
|
\Abcc9em3Nich/\Abcc9em3Nich
(B6.Cg-Abcc9em3Nich)
|
abnormal aorta smooth muscle morphology
|
J:308986
|
| abnormal myocardial fiber morphology
|
J:308986
|
\Abcc9tm1.1Mcn/\Abcc9tm1.1Mcn
\Tg(Tagln-cre)1Her/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:216539
|
| cardiomyopathy
|
J:216539
|
| decreased cardiac muscle contractility
|
J:216539
|
\Abcc9tm1Cfb/\Abcc9tm1Cfb
(involves: CD-1)
|
increased skeletal muscle cell glucose uptake
|
J:71840
|
\Abcc9tm1Cfb/\Abcc9tm1Cfb
(Not Specified)
|
abnormal vascular smooth muscle physiology
|
J:78066
|
\Abcg5trac/\Abcg5trac
(A/J-Abcg5trac)
|
cardiomyopathy
|
J:157223
|
\Abcg8tm1b(KOMP)Wtsi/\Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Abhd5tm1Rze/\Abhd5tm1Rze
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:197835
|
| increased cardiac muscle cell glucose uptake
|
J:197835
|
| increased cardiac muscle triglyceride level
|
J:197835
|
| increased skeletal muscle triglyceride level
|
J:197835
|
| myocardium steatosis
|
J:197835
|
\Abhd6tm1a(EUCOMM)Hmgu/\Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
increased skeletal muscle cell glucose uptake
|
J:234876
|
\Abhd12tm1Crv/\Abhd12tm1Crv
(involves: C57BL/6)
|
muscle weakness
|
J:193716
|
\Abi1tm1Pen/\Abi1tm1Pen
(involves: CD-1)
|
disorganized myocardium
|
J:169009
|
\Abi3bptm1Tac/\Abi3bptm1Tac
(involves: 129S5/SvEvBrd)
|
decreased heart left ventricle muscle contractility
|
J:251000
|
\Abitramtm1b(EUCOMM)Wtsi/\Abitramtm1b(EUCOMM)Wtsi
(C57BL/6N-Abitramtm1b(EUCOMM)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
\Abl1tm1.1Gcos/\Abl1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:168843
|
\Abl1tm1.1Gcos/\Abl1tm1.1Gcos
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:168843
|
\Abl1tm1Gcos/\Abl1+
\Myf5tm2Tajb/\Myf5tm2Tajb
\Myf6tm1Tajb/\Myf6tm1Tajb
\Myod1tm2.1(icre)Glh/\Myod1+
(involves: 129S * 129X1/SvJ * C57BL/6J)
|
abnormal myogenesis
|
J:168843
|
\Abl1tm1Mlg/\Abl1tm1Mlg
(B6.129-Abl1tm1Mlg)
|
abnormal myocardial fiber morphology
|
J:156743
|
| abnormal myocardium compact layer morphology
|
J:156743
|
| abnormal trabecula carnea morphology
|
J:156743
|
| increased fetal cardiomyocyte proliferation
|
J:156743
|
| increased myocardial fiber number
|
J:156743
|
| myocardial fiber disarray
|
J:156743
|
\Acacbtm1.1Dejs/\Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs)
|
increased skeletal muscle glycogen level
|
J:157000
|
\Acad9tm1c(KOMP)Wtsi/\Acad9tm1c(KOMP)Wtsi
\Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
abnormal muscle morphology
|
J:326969
|
| centrally nucleated skeletal muscle fibers
|
J:326969
|
| muscle weakness
|
J:326969
|
\Acad9tm1c(KOMP)Wtsi/\Acad9tm1c(KOMP)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
cardiomyopathy
|
J:326969
|
| decreased cardiac muscle contractility
|
J:326969
|
| myocardial fiber disarray
|
J:326969
|
\Acadmtm1Uab/\Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:115759
|
| cardiomyopathy
|
J:115759
|
| myocardial fiber degeneration
|
J:115759
|
\Acadsdel-J/\Acadsdel-J
(involves: BALB/cByJ)
|
abnormal skeletal muscle morphology
|
J:14707
|
\Acadvltm1Vje/\Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98627
|
| abnormal skeletal muscle fiber morphology
|
J:98627
|
| cardiomyopathy
|
J:98627
|
| myocardial fiber degeneration
|
J:98627
|
\Acadvltm1Vje/\Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:106714
|
\Acadvltm1Zkhu/\Acadvltm1Zkhu
\Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
abnormal myocardial fiber morphology
|
J:208711
|
| decreased heart left ventricle muscle contractility
|
J:208711
|
| dilated cardiomyopathy
|
J:208711
|
\Acanb2b183Clo/\Acanb2b183Clo
(C57BL/6J-Acanb2b183Clo)
|
cardiomyopathy
|
J:175213
|
\Ace2tm1Hira/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:135766
|
\Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124548,
J:77232
|
| dilated cardiomyopathy
|
J:124548
|
\Ace2tm1Pngr/Y
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiac muscle contractility
|
J:124548
|
\Ace2tm1Pngr/\Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:77232
|
\Achetm1.1Pata/\Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6)
|
muscle weakness
|
J:132775
|
\Achetm2Pata/\Achetm2Pata
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
muscle weakness
|
J:132775
|
\Achetm4.1Pata/\Achetm4.1Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB * FVB/N)
|
muscle weakness
|
J:147855
|
\Achetm4Pata/\Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
|
muscle weakness
|
J:147855
|
\Ackr3tm1Jgo/\Ackr3+
(involves: 129S/SvEvBrd * C57BL/6)
|
myocardial fiber degeneration
|
J:136246
|
\Ackr3tm1Jgo/\Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6)
|
myocardial fiber degeneration
|
J:136246
|
\Ackr3tm1Twb/\Ackr3tm1.1Twb
\Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:167833
|
| heart left ventricle hypertrophy
|
J:167833
|
| increased myocardial fiber size
|
J:167833
|
| myocardial fiber disarray
|
J:167833
|
\Acot12em1(IMPC)Hmgu/\Acot12em1(IMPC)Hmgu
(C57BL/6NCrl-Acot12em1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Acp1Gt(RRK222)Byg/\Acp1Gt(RRK222)Byg
(C.129P2(B6)-Acp1Gt(RRK222)Byg)
|
decreased cardiomyocyte apoptosis
|
J:227733
|
\Acta1tm1Hrd/\Acta1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal sarcomere morphology
|
J:184588
|
| decreased muscle weight
|
J:184588
|
| facial muscle atrophy
|
J:184588
|
\Acta1tm1Hrd/\Acta1+
\Tg(ACTA1-FHL1)#Cmit/?
(either: (involves: 129S1/Sv * 129X1/SvJ * FVB/N) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc * FVB/N))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
\Acta1tm1Hrd/\Acta1+
\Tg(MSV-SKI)33Hugh/?
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
\Acta1tm1Hrd/\Acta1+
\Tg(Myl1-Igf1)1Nros/?
(either: (involves: 129S1/Sv * 129X1/SvJ * FVB/N) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc * FVB/N))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
\Acta1tm1Jll/\Acta1+
\Tg(ACTA1*D286G)#Kjno/\Tg(ACTA1*D286G)#Kjno
(involves: C57BL/6 * CBA)
|
abnormal muscle fiber morphology
|
J:209273
|
| abnormal skeletal muscle morphology
|
J:209273
|
| abnormal Z line morphology
|
J:209273
|
| increased variability of skeletal muscle fiber size
|
J:209273
|
\Acta1tm1Jll/\Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal muscle development
|
J:78070
|
| abnormal muscle physiology
|
J:78070
|
| abnormal skeletal muscle fiber morphology
|
J:78070
|
| decreased skeletal muscle fiber diameter
|
J:78070
|
| decreased skeletal muscle glycogen level
|
J:78070
|
| muscle weakness
|
J:78070
|
\Acta2tm1Rjs/\Acta2tm1Rjs
(involves: 129S7/SvEvBrd * C57)
|
decreased vasoconstriction
|
J:113261
|
\Actbem1Erv/\Actbem1Erv
(involves: C57BL/6)
|
muscle phenotype
|
J:265862
|
\Actbtm1(PyVT)Arge/\Actb+
\Waptm1(cre)Arge/\Wap+
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:87544
|
\Actbtm2(Tag)Arge/\Actb+
\Tg(Hsp70-1-cre)1Arge/0
(involves: 129S1/Sv * C57BL/6J * CBA)
|
abnormal smooth muscle morphology
|
J:87544
|
| increased leiomyosarcoma incidence
|
J:87544
|
\Actc1tm1Jll/\Actc1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal sarcomere morphology
|
J:40165
|
| disorganized myocardium
|
J:102007
|
| increased fetal cardiomyocyte apoptosis
|
J:102007
|
\Actc1tm1Jll/\Actc1tm1Jll
\Tg(Myh6-Actg2)1Jll/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:40165
|
| decreased cardiac muscle contractility
|
J:107848,
J:40165
|
| decreased heart ventricle muscle contractility
|
J:40165
|
| heart left ventricle hypertrophy
|
J:40165
|
\Actc1dttm1Kwan/\Actc1dttm1Kwan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased myocardial fiber size
|
J:297375
|
| increased myocardial fiber number
|
J:297375
|
\Actg1tm1.2Erv/\Actg1tm1.2Erv
\Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:112808
|
| abnormal Z line morphology
|
J:112808
|
| centrally nucleated skeletal muscle fibers
|
J:112808
|
| impaired skeletal muscle contractility
|
J:112808
|
| increased variability of skeletal muscle fiber size
|
J:112808
|
\Actg1tm1Erv/\Actg1tm1Erv
\Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:112808
|
| abnormal Z line morphology
|
J:112808
|
| centrally nucleated skeletal muscle fibers
|
J:112808
|
| impaired skeletal muscle contractility
|
J:112808
|
| increased variability of skeletal muscle fiber size
|
J:112808
|
\Actmapem1Nki/\Actmapem1Nki
(FVB/N-Actmapem1Nki)
|
abnormal skeletal muscle fiber morphology
|
J:331923
|
| centrally nucleated skeletal muscle fibers
|
J:331923
|
| impaired skeletal muscle contractility
|
J:331923
|
| muscle weakness
|
J:331923
|
\Actn2em1Kage/\Actn2+
(C57BL/6-Actn2em1Kage)
|
muscle phenotype
|
J:334092
|
\Actn2em1Kage/\Actn2em1Kage
(C57BL/6-Actn2em1Kage)
|
abnormal sarcomere morphology
|
J:334092
|
| abnormal Z line morphology
|
J:334092
|
| decreased fetal cardiomyocyte proliferation
|
J:334092
|
\Actn3tm1Knno/\Actn3tm1Knno
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:125639
|
| abnormal skeletal muscle morphology
|
J:125639
|
\Actn4tm1a(EUCOMM)Wtsi/\Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
\Acvr1tm1Emsh/\Acvr1+
(chimera involves: BALB/c * C57BL/6 * CD-1)
|
skeletal muscle degeneration
|
J:194134
|
\Acvr1tm1Mak/\Acvr1+
\Olig2tm1.1(cre)Wdr/\Olig2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle spasm
|
J:285841
|
\Acvr2btm1.1Zuk/\Acvr2btm1.1Zuk
\Tg(Myl1-cre)1Sjl/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL/J)
|
increased skeletal muscle weight
|
J:188599
|
\Acvrl1tm1Dgen/\Acvrl1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:186473
|
\Acvrl1tm1Dyl/\Acvrl1tm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:65521
|
| increased vasodilation
|
J:85366
|
\Acvrl1tm1Enl/\Acvrl1+
(involves: C57BL/6)
|
telangiectasia
|
J:82115
|
\Acvrl1tm1Enl/\Acvrl1tm1Enl
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:61177
|
| abnormal vascular smooth muscle morphology
|
J:61177
|
\Acvrl1tm2Spo/\Acvrl1tm2Spo
\Tg(Acvrl1-cre)L1Spo/0
(involves: 129 * 129S4/SvJae * C57BL/6 * FVB/N)
|
vascular smooth muscle hypotrophy
|
J:130020
|
\Adatm1Mw/\Adatm1Mw
(involves: 129S7/SvEvBrd)
|
heart right ventricle hypertrophy
|
J:231559
|
| increased vascular smooth muscle cell proliferation
|
J:231559
|
| vascular smooth muscle hypertrophy
|
J:231559
|
\Adam7em1(IMPC)Ccpcz/\Adam7em1(IMPC)Ccpcz
(C57BL/6NCrl-Adam7em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Adam12tm1Asf/\Adam12tm1Asf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:81009
|
| decreased skeletal muscle fiber density
|
J:81009
|
\Adam17tm1.1Rain/\Adam17tm1.2Rain
\Tg(Tek-cre)12Flv/0
(B6.Cg-Adam17tm1.1Rain Adam17tm1.2Rain Tg(Tek-cre)12Flv)
|
decreased cardiac muscle contractility
|
J:195050
|
\Adam17tm1.1Wesh/\Adam17tm1.1Wesh
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
abnormal myocardial trabeculae morphology
|
J:210193
|
| abnormal myocardium layer morphology
|
J:210193
|
| thin myocardium
|
J:210193
|
\Adam17tm1Imx/\Adam17tm1Imx
(involves: 129 * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:85547
|
| increased fetal cardiomyocyte proliferation
|
J:85547
|
\Adam17tm1Imx/\Adam17tm1Imx
\Adam19Gt(Betageo)1Bbl/\Adam19Gt(Betageo)1Bbl
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:99649
|
| absent myocardial trabeculae
|
J:99649
|
\Adam19Gt(Betageo)1Bbl/\Adam19Gt(Betageo)1Bbl
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:87592
|
\Adam19tm1Asf/\Adam19tm1Asf
(either: B6.129P2-Adam19tm1Asf or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:106261
|
| heart right ventricle hypertrophy
|
J:106261
|
| thin diaphragm muscle
|
J:106261
|
\Adamts2tm1Prc/\Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:271185
|
\Adamts6b2b1879.1Clo/\Adamts6b2b1879.1Clo
(C57BL/6J-Adamts6b2b1879.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2029Clo/\Adamts6b2b2029Clo
(C57BL/6J-Adamts6b2b2029Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2182Clo/\Adamts6b2b2182Clo
(C57BL/6J-Adamts6b2b2182Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2187.1Clo/\Adamts6b2b2187.1Clo
(C57BL/6J-Adamts6b2b2187.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2228Clo/\Adamts6b2b2228Clo
(C57BL/6J-Adamts6b2b2228Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2405Clo/\Adamts6b2b2405Clo
(C57BL/6J-Adamts6b2b2405Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2407Clo/\Adamts6b2b2407Clo
(C57BL/6J-Adamts6b2b2407Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts6b2b2744Clo/\Adamts6b2b2744Clo
(C57BL/6J-Adamts6b2b2744Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Adamts10em1Cbal/\Adamts10em1Cbal
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal skeletal muscle morphology
|
J:266801
|
| decreased skeletal muscle fiber size
|
J:266801
|
| increased skeletal muscle fiber number
|
J:266801
|
| increased skeletal muscle mass
|
J:266801
|
\Adamts14Gt(511E11)Cmhd/\Adamts14Gt(511E11)Cmhd
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:271185
|
\Adamts14Gt(511E11)Cmhd/\Adamts14Gt(511E11)Cmhd
\Adamts2tm1Prc/\Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:271185
|
\Adamtsl2tm1b(KOMP)Wtsi/\Adamtsl2tm1b(KOMP)Wtsi
(C57BL/6-Adamtsl2tm1b(KOMP)Wtsi)
|
muscle phenotype
|
J:221347
|
\Adamtsl2tm1c(KOMP)Wtsi/\Adamtsl2tm1c(KOMP)Wtsi
\Tg(Prrx1-cre)1Cjt/0
(B6.Cg-Adamtsl2tm1c(KOMP)Wtsi Tg(Prrx1-cre)1Cjt)
|
abnormal calcaneal tendon morphology
|
J:280264
|
| abnormal tendon cell morphology
|
J:280264
|
| abnormal tendon collagen fibril morphology
|
J:280264
|
\Adamtsl2tm1c(KOMP)Wtsi/\Adamtsl2tm1c(KOMP)Wtsi
\Tg(Scx-GFP/cre)1Stzr/0
(involves: C57BL/6 * C57BL/6N)
|
abnormal calcaneal tendon morphology
|
J:280264
|
\Adarb1tm1.1Skwa/\Adarb1tm1.1Skwa
\Tg(SLC18A3-cre)KMisa/0
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:164294
|
| centrally nucleated skeletal muscle fibers
|
J:164294
|
| skeletal muscle fiber atrophy
|
J:164294
|
\Adck2tm1(KOMP)Vlcg/\Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:280282
|
| increased variability of skeletal muscle fiber size
|
J:280282
|
\Adcy6tm1Hkh/\Adcy6tm1Hkh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart left ventricle muscle contractility
|
J:143138
|
\Adcyap1tm1Nms/\Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
|
abnormal skeletal muscle morphology
|
J:71968
|
\Adgbem1(IMPC)Mbp/\Adgbem1(IMPC)Mbp
(C57BL/6NCrl-Adgbem1(IMPC)Mbp/Mmucd)
|
increased skeletal muscle mass
|
J:211773
|
\Adgrg6em2Jlp/\Adgrg6em2Jlp
(C57BL/6-Adgrg6em2Jlp)
|
abnormal myocardial trabeculae morphology
|
J:315981
|
| thin myocardium compact layer
|
J:315981
|
\Adgrg6tm1Apr/\Adgrg6tm1Apr
(either: 129S/SvEv-Gpr126tm1Apr or B6.129S-Gpr126tm1Apr or (involves: 129S/SvEv * MF1))
|
thin myocardium
|
J:167309
|
\Adgrg6tm1Arte/\Adgrg6tm1Arte
\Tg(Scx-GFP/cre)1Stzr/0
(involves: 129S5/SvEvBrd)
|
abnormal tendon physiology
|
J:313834
|
\Adgrg6tm1Lex/\Adgrg6tm1Lex
(involves: 129S/SvEvBrd)
|
myocardial trabeculae hypoplasia
|
J:202002
|
\Adgrg6tm1Taki/\Adgrg6tm1Taki
(involves: C57BL/6)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:202002
|
| abnormal myocardial trabeculae morphology
|
J:202002
|
| increased cardiac muscle triglyceride level
|
J:202002
|
\Adgrg7tm1Wfro/\Adgrg7tm1Wfro
(129/Sv-Adgrg7tm1Wfro)
|
interstinal hyperperistalsis
|
J:243849
|
\Adipoqtm1Chan/\Adipoqtm1Chan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal skeletal muscle fiber morphology
|
J:138678
|
\Adipoqtm1Ish/\Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:103106
|
| decreased heart left ventricle muscle contractility
|
J:106599
|
| muscle phenotype
|
J:199264
|
\Adipor1tm2Tka/\Adipor1tm2Tka
\Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn)
|
abnormal skeletal muscle fiber type ratio
|
J:159462
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:159462
|
| increased skeletal muscle triglyceride level
|
J:159462
|
\Admtm1Hku/\Adm+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:106173
|
\Admtm1Unc/\Adm+
\Tg(Alb1-Ren)2Unc/?
(129S6/SvEvTac-Admtm1Unc Tg(Alb1-Ren)2Unc)
|
increased myocardial fiber size
|
J:125933
|
\Admtm1Unc/\Admtm1Unc
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:67044
|
| disorganized myocardium
|
J:67044
|
| increased cardiomyocyte apoptosis
|
J:106927
|
\Adora2atm1Jfc/\Adora2atm1Jfc
(B6.129S4-Adora2atm1Jfc)
|
heart right ventricle hypertrophy
|
J:194389
|
| vascular smooth muscle hypertrophy
|
J:194389
|
\Adra1atm1Pcs/\Adra1atm1Pcs
(involves: 129X1/SvJ * FVB/N)
|
decreased vasoconstriction
|
J:77732
|
\Adra1atm1Pcs/\Adra1atm1Pcs
\Adra1btm1Cta/\Adra1btm1Cta
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle contractility
|
J:102648
|
| decreased myocardial fiber size
|
J:83876
|
| increased heart left ventricle muscle contractility
|
J:83876
|
\Adra1atm1Pcs/\Adra1atm1Pcs
\Adra1btm1Cta/\Adra1btm1Cta
(B6.129-Adra1btm1Cta Adra1atm1Pcs)
|
decreased myocardial fiber size
|
J:83876
|
\Adra1btm1Cta/\Adra1btm1Cta
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:103581,
J:43591
|
| decreased vasoconstriction
|
J:103581
|
\Adra1btm1Cta/\Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:87718
|
\Adra1dtm1Gzt/\Adra1dtm1Gzt
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle tone
|
J:91151
|
\Adra2btm1Gsb/\Adra2btm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vasoconstriction
|
J:34819
|
\Adrb1tm1Bkk/\Adrb1tm1Bkk
\Adrb2tm1Bkk/\Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
|
decreased cardiac muscle contractility
|
J:55553
|
\Aebp2Gt(BC0681)Wtsi/\Aebp2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:177673
|
\Afg3l2Emv66/\Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66/TyJ)
|
abnormal skeletal muscle fiber morphology
|
J:132285
|
| centrally nucleated skeletal muscle fibers
|
J:132285
|
| decreased skeletal muscle fiber size
|
J:132285
|
| progressive muscle weakness
|
J:132285
|
\Afg3l2par/\Afg3l2par
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:132285
|
| centrally nucleated skeletal muscle fibers
|
J:132285
|
| decreased skeletal muscle fiber size
|
J:106411,
J:132285
|
| muscle weakness
|
J:34237
|
| muscular atrophy
|
J:106411,
J:34237
|
| progressive muscle weakness
|
J:13950,
J:132285
|
\Agertm1.1Arnd/\Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
| decreased vascular smooth muscle cell proliferation
|
J:82620
|
\Agltm1a(EUCOMM)Wtsi/\Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased cardiac muscle glycogen level
|
J:212003
|
| increased skeletal muscle glycogen level
|
J:212003
|
| muscle weakness
|
J:212003
|
\Agltm1Geno/\Agltm1Geno
(C57BL/6J-Agltm1Geno)
|
increased cardiac muscle glycogen level
|
J:218471
|
| increased skeletal muscle glycogen level
|
J:218471
|
\Agrnnmf380/\Agrnnmf380
(C57BL/6J-Agrnnmf380/J)
|
abnormal skeletal muscle fiber type ratio
|
J:176117
|
| muscle spasm
|
J:87349
|
| myopathy
|
J:87349
|
| skeletal muscle atrophy
|
J:176117
|
\Agrnnmf380/\Agrnnmf380
(involves: C57BL/6J * DBA)
|
skeletal muscle atrophy
|
J:176117
|
\Agrnnmf380/\Agrnnmf380
(involves: C57BL/6J * CAST)
|
muscle phenotype
|
J:176117
|
\Agrntm1Rwb/\Agrntm1Rwb
\Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:122821
|
\Agttm1Afu/\Agttm1Afu
(involves: C57BL/6 * CBA * ICR)
|
vascular smooth muscle hyperplasia
|
J:36820
|
\Agtpbp1pcd-6J/\Agtpbp1pcd-6J
(C57BL/6J-Agtpbp1pcd-6J/J)
|
decreased skeletal muscle fiber size
|
J:87349
|
\Agtr2tm1Gsb/Y
(FVB.129-Agtr2tm1Gsb)
|
abnormal vascular smooth muscle morphology
|
J:103237
|
| abnormal vasoconstriction
|
J:103237
|
| increased vasoconstriction
|
J:103376
|
| vascular smooth muscle hypertrophy
|
J:103376
|
\Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle triglyceride level
|
J:105210
|
\Agtr2tm1Tin/Y
(B6.129P2-Agtr2tm1Tin)
|
abnormal myocardial fiber morphology
|
J:63751
|
\Agtr2tm1Tin/Y
\Efemp2tm1.1Hiya/\Efemp2tm1.2Hiya
\Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:213282
|
\Agxt2tm1Lex/\Agxt2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vasodilation
|
J:207876
|
\Ahcyem1Cya/\Ahcy+
(C57BL/6N-Ahcyem1Cya/Cya)
|
abnormal vasodilation
|
J:298071
|
\Ahrtm1Gonz/\Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
vascular smooth muscle hypertrophy
|
J:44690
|
\Ahsgtm1Mbl/\Ahsgtm1Mbl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
calcified muscle
|
J:44632
|
\Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
| increased cardiomyocyte apoptosis
|
J:110278
|
\Aifm1Hq/\Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
| increased cardiomyocyte apoptosis
|
J:110278
|
\Aifm1tm2Pngr/Y
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
abnormal myocardial fiber morphology
|
J:113016
|
| abnormal skeletal muscle fiber morphology
|
J:113016
|
| decreased cardiac muscle contractility
|
J:113016
|
| decreased skeletal muscle mass
|
J:113016
|
| dilated cardiomyopathy
|
J:113016
|
| increased myocardial fiber size
|
J:113016
|
| increased skeletal muscle fiber diameter
|
J:113016
|
| muscle degeneration
|
J:113016
|
| muscular atrophy
|
J:113016
|
\Ak1tm1Bew/\Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:66101
|
\Ak1tm1Bew/\Ak1tm1Bew
\Ckmtm1Bew/\Ckmtm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:109659
|
\Akap6tm1.1Mskf/\Akap6tm1.1Mskf
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: C57BL/6 * FVB/N * SJL)
|
heart left ventricle hypertrophy
|
J:214288
|
| increased cardiomyocyte apoptosis
|
J:214288
|
| increased myocardial fiber size
|
J:214288
|
\Akap12Gt(XE450)Byg/\Akap12Gt(XE450)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:207542
|
| increased heart left ventricle muscle contractility
|
J:207542
|
\Akap13Gt(CSJ306)Byg/\Akap13Gt(CSJ306)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:231257
|
\Akap13tm1Segj/\Akap13tm1Segj
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:181087
|
| myocardial trabeculae hypoplasia
|
J:181087
|
| thin myocardium
|
J:181087
|
\Akt1tm1Mbb/\Akt1tm1Mbb
(involves: 129P2/OlaHsd)
|
decreased myocardial fiber size
|
J:96823
|
\Akt1tm1Nhy/\Akt1tm1Nhy
\Akt2tm1Rsg/\Akt2tm1Rsg
(involves: 129/Sv * C57BL/6 * DBA/1LacJ)
|
muscle hypoplasia
|
J:83741
|
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:71491
|
\Albtm1(cre/ERT2)Mtz/\Albtm1(cre/ERT2)Mtz
\Slc2a2tm2Thor/\Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:197607
|
\Aldh1a2tm1Dll/\Aldh1a2tm1Ipc
\Tg(Rarb-cre)1Mrc/0
(Not Specified)
|
muscle phenotype
|
J:97213
|
\Aldh1a2tm1Ipc/\Aldh1a2tm1Ipc
(Not Specified)
|
abnormal myocardium layer morphology
|
J:67816
|
| absent myocardial trabeculae
|
J:54067
|
| thick myocardium
|
J:67816
|
\Aldh2tm1Dmro/\Aldh2+
(B6.129-Aldh2tm1Dmro)
|
decreased cardiac muscle contractility
|
J:261952
|
\Aldh5a1tm1Kmg/\Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71949
|
\Alpk3Gt(OST149512)Lex/\Alpk3Gt(OST149512)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:222361
|
| abnormal myocardial fiber morphology
|
J:222361
|
| abnormal myocardium layer morphology
|
J:222361
|
| cardiomyopathy
|
J:222361
|
| decreased cardiac muscle contractility
|
J:222361
|
| decreased heart left ventricle muscle contractility
|
J:222361
|
| myocardium hypertrophy
|
J:222361
|
\Alpk3tm1b(EUCOMM)Hmgu/\Alpk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Alpk3tm1b(EUCOMM)Hmgu/H)
|
decreased cardiac muscle contractility
|
J:211773
|
\Alpltm1Jlm/\Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal muscle morphology
|
J:39015
|
\Als2tm1Jei/\Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:104446
|
| abnormal skeletal muscle fiber type ratio
|
J:104446
|
| centrally nucleated skeletal muscle fibers
|
J:104446
|
| skeletal muscle fiber atrophy
|
J:104446
|
\Alx4M1Yzcm/\Alx4M1Yzcm
(C57BL/6-Alx4M1Yzcm)
|
abnormal muscle morphology
|
J:199512
|
\Ampd1tm1Tm/\Ampd1tm1Tm
(B6.129S2-Ampd1tm1Tm)
|
muscle phenotype
|
J:260685
|
\Angpt1tm1Sato/\Angpt1tm1Sato
(involves: 129P2/OlaHsd * C57BL/6)
|
absent myocardial trabeculae
|
J:37459
|
\Angpt1tm2Sato/\Angpt1tm2Sato
(involves: 129P2/OlaHsd * C57BL/6)
|
absent myocardial trabeculae
|
J:37459
|
\Ank1tm1Vso/\Ank1tm1Vso
(B6J.129S4-Ank1tm1Vso)
|
abnormal diaphragm morphology
|
J:223673
|
| abnormal extensor digitorum longus morphology
|
J:223673
|
| abnormal muscle electrophysiology
|
J:223673
|
| abnormal sarcolemma morphology
|
J:223673
|
| abnormal sarcoplasmic reticulum morphology
|
J:223673
|
| abnormal skeletal muscle fiber triad morphology
|
J:223673
|
| impaired skeletal muscle contractility
|
J:223673
|
| myopathy
|
J:223673
|
| skeletal muscle fiber degeneration
|
J:223673
|
\Ank2em1Melr/\Ank2em1Melr
(B6.Cg-Ank2em1Melr)
|
decreased cardiac muscle contractility
|
J:338515
|
\Ank2tm2.1Bnt/\Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
|
muscle phenotype
|
J:222913
|
\Ank2tm3.1Bnt/\Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
decreased skeletal muscle cell glucose uptake
|
J:222913
|
| increased skeletal muscle cell glucose uptake
|
J:222913
|
\Ankank/\Ankank
(involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)
|
abnormal tendon morphology
|
J:6580
|
| calcified tendon
|
J:6580
|
\Ankrd1tm1Krc/\Ankrd1tm1Krc
\Ankrd2tm1Krc/\Ankrd2tm1Krc
\Ankrd23tm1Krc/\Ankrd23tm1Krc
(involves: 129 * Black Swiss)
|
abnormal muscle physiology
|
J:125819
|
| abnormal sarcomere morphology
|
J:125819
|
\Ankrd2tm1Krc/\Ankrd2tm1Krc
(involves: 129 * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:214867
|
\Ankrd17tm1.1Yty/\Ankrd17tm1.1Yty
(B6.129P2-Ankrd17tm1.1Yty)
|
abnormal vascular smooth muscle morphology
|
J:152840
|
| thin myocardium
|
J:152840
|
| trabecula carnea hypoplasia
|
J:152840
|
\Ano1tm1.1Cahb/\Ano1tm1.1Cahb
\Tg(Myh11-icre/ERT2)1Soff/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal vascular smooth muscle morphology
|
J:207993
|
| decreased vasoconstriction
|
J:207993
|
\Ano1tm1Bdh/\Ano1tm1Bdh
(involves: 129S1/Sv)
|
abnormal tracheal smooth muscle morphology
|
J:138613
|
\Ano5em1Huyi/\Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi)
|
abnormal skeletal muscle morphology
|
J:294237
|
\Ano5tm1.2Naga/\Ano5tm1.2Naga
(involves: C57BL/6)
|
muscle phenotype
|
J:236134
|
\Ano5tm1Lrk/\Ano5tm1Lrk
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:235810
|
| abnormal gastrocnemius morphology
|
J:235810
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:235810
|
| abnormal skeletal muscle morphology
|
J:235810
|
| abnormal tibialis anterior morphology
|
J:235810
|
| centrally nucleated skeletal muscle fibers
|
J:235810
|
| delayed skeletal muscle regeneration
|
J:235810
|
| impaired skeletal muscle regeneration
|
J:235810
|
| increased muscle fatigability
|
J:235810
|
| muscle phenotype
|
J:235810
|
| skeletal muscle fiber necrosis
|
J:235810
|
\Anpepem1(IMPC)Hmgu/\Anpepem1(IMPC)Hmgu
(C57BL/6N-Anpepem1(IMPC)Hmgu/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
\Anxa6tm1Moss/\Anxa6tm1Moss
(involves: 129P2/OlaHsd * C57BL/6)
|
increased heart ventricle muscle contractility
|
J:75832
|
\Ap2b1b2b2321Clo/\Ap2b1b2b2321Clo
(C57BL/6J-Ap2b1b2b2321Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Ap4e1tm1b(KOMP)Wtsi/\Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
\ApcMin/\Apc+
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
muscle phenotype
|
J:130429
|
\Apcdd1em1Jlp/\Apcdd1+
\Asxl3em1Jlp/\Asxl3+
\Mib1em1Jlp/\Mib1+
(C57BL/6-Apcdd1em1Jlp Asxl3em1Jlp Mib1em1Jlp)
|
thin ventricle myocardium compact layer
|
J:338889
|
\Apex1tm1Cur/\Apex1+
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle physiology
|
J:119957
|
| decreased vasoconstriction
|
J:102294
|
| decreased vasodilation
|
J:102294
|
| increased vasoconstriction
|
J:102294
|
\Aph1atm1.1Bdes/\Aph1atm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal dermomyotome development
|
J:96106
|
\Aplntm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:140286
|
\Aplntm1Pngr/\Aplntm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:140286
|
\Aplntm1Tq/Y
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
\Aplntm1Tq/\Aplntm1Tq
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
\Aplnrtm1.1Path/\Aplnrtm1.1Path
(Not Specified)
|
heart right ventricle hypertrophy
|
J:227456
|
\Aplnrtm1.1Tq/\Aplnrtm1.1Tq
(C57BL/6-Aplnrtm1.1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
\Aplnrtm1Path/\Aplnrtm1Path
\Tg(Kdr-cre)#Brei/0
(involves: C57BL/6)
|
heart right ventricle hypertrophy
|
J:227456
|
\Apobtm2Sgy/\Apobtm2Sgy
\Ldlrtm1Her/\Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:227165
|
\Apobtm2Sgy/\Apobtm2Sgy
\Ldlrtm1Her/\Ldlrtm1Her
\Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased cardiac muscle contractility
|
J:227165
|
| heart left ventricle hypertrophy
|
J:227165
|
\Apobec2tm1Msn/\Apobec2tm1Msn
(B6.129P2-Apobec2tm1Msn)
|
abnormal skeletal muscle fiber type ratio
|
J:221028
|
| abnormal soleus morphology
|
J:221028
|
| centrally nucleated skeletal muscle fibers
|
J:221028
|
| decreased soleus weight
|
J:221028
|
| decreased tibialis anterior weight
|
J:221028
|
| increased variability of skeletal muscle fiber size
|
J:221028
|
| myopathy
|
J:221028
|
\Apoetm1.1Mae/\Apoetm1.1Mae
\Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased cardiac muscle triglyceride level
|
J:219838
|
| decreased skeletal muscle triglyceride level
|
J:219838
|
\Apoetm1Bres/\Apoetm1Bres
\Cd59atm1Bpm/\Cd59atm1Bpm
(involves: 129 * 129P2/OlaHsd)
|
vascular smooth muscle hyperplasia
|
J:158457
|
| vascular smooth muscle hypoplasia
|
J:158457
|
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal vascular smooth muscle physiology
|
J:338121
|
| abnormal vasodilation
|
J:298071
|
| decreased vasodilation
|
J:101576
|
| impaired muscle relaxation
|
J:60364
|
\Apoetm1Unc/\Apoetm1Unc
(involves: 129P2/OlaHsd)
|
decreased vasodilation
|
J:154332
|
\Apoetm1Unc/\Apoetm1Unc
\Ccr5tm1Kuz/\Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128063
|
\Apoetm1Unc/\Apoetm1Unc
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj)
|
abnormal vascular smooth muscle physiology
|
J:125247
|
| increased vascular smooth muscle cell proliferation
|
J:125247
|
\Apoetm1Unc/\Apoetm1Unc
\Cst3tm1Karl/\Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6)
|
vascular smooth muscle hyperplasia
|
J:106879
|
\Apoetm1Unc/\Apoetm1Unc
\Il1r1tm1Imx/\Il1r1tm1Imx
(B6.129-Il1r1tm1Imx Apoetm1Unc)
|
increased vasoconstriction
|
J:148173
|
| increased vasodilation
|
J:148173
|
\Apoetm1Unc/\Apoetm1Unc
\Klf15tm2Jain/\Klf15tm2Jain
\Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N)
|
vascular smooth muscle hypoplasia
|
J:203920
|
\Apoetm1Unc/\Apoetm1Unc
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
vascular smooth muscle hypoplasia
|
J:110044
|
\Apoetm1Unc/\Apoetm1Unc
\Nos3tm1Plh/\Nos3tm1Plh
(B6.129-Nos3tm1Plh Apoetm1Unc)
|
decreased cardiac muscle contractility
|
J:103306
|
\Apoetm1Unc/\Apoetm1Unc
\Sprr3tm1.1Ppy/\Sprr3tm1.1Ppy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * SJL)
|
abnormal vascular smooth muscle physiology
|
J:230470
|
| vascular smooth muscle hypoplasia
|
J:230470
|
\Apptm2.1Ldad/\Apptm2.1Ldad
(involves: 129 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:166989
|
| increased variability of skeletal muscle fiber size
|
J:166989
|
| muscle degeneration
|
J:166989
|
| myositis
|
J:166989
|
\Appl1tm1Ymli/\Appl1tm1Ymli
(involves: 129S1/Sv * C57BL/6J)
|
decreased vasodilation
|
J:189487
|
| increased vasoconstriction
|
J:189487
|
\Appl2tm1Smoc/\Appl2tm1Smoc
\Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
increased skeletal muscle cell glucose uptake
|
J:230004
|
\Aqp5tm1Amn/\Aqp5tm1Amn
(involves: 129X1/SvJ * Black Swiss)
|
muscle phenotype
|
J:72954
|
\Artm1Chc/Y
\Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
increased skeletal muscle triglyceride level
|
J:98775
|
\Artm1Ska/Y
\Tg(CMV-cre)1Ipc/?
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:101049
|
| decreased heart left ventricle muscle contractility
|
J:101049
|
| decreased myocardial fiber size
|
J:101049
|
\Artm2Ska/\Artm2Ska
\Pax7tm2.1(cre/ERT2)Fan/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrl)
|
muscle phenotype
|
J:316008
|
\Artm3(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
muscle phenotype
|
J:114552
|
\Artm4(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:114552
|
| abnormal skeletal muscle fiber morphology
|
J:114552
|
| centrally nucleated skeletal muscle fibers
|
J:114552
|
| impaired muscle relaxation
|
J:114552
|
| increased variability of skeletal muscle fiber size
|
J:114552
|
| muscle weakness
|
J:114552
|
| myopathy
|
J:114552
|
| progressive muscle weakness
|
J:114552
|
| skeletal muscle fiber atrophy
|
J:114552
|
\Artm4(AR)Dmr/\Ar+
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:114552
|
\Araftm1Mmc/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:33951
|
\Araftm1Mmc/\Araftm1Mmc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:33951
|
\Arb2aTg(Tyr)TpNpln/\Arb2aTg(Tyr)TpNpln
(involves: FVB/N)
|
heart left ventricle hypertrophy
|
J:260599
|
\Arfgef3tm1Hong/\Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
decreased skeletal muscle cell glucose uptake
|
J:216529
|
\Arhgap1tm1Yizh/\Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
|
muscular atrophy
|
J:119516
|
\Arhgap18tm1a(KOMP)Wtsi/\Arhgap18tm1a(KOMP)Wtsi
(C57BL/6-Arhgap18tm1a(KOMP)Wtsi)
|
abnormal vascular smooth muscle physiology
|
J:267328
|
| decreased vasoconstriction
|
J:267328
|
\Arhgap26Gt(OST135790)Lex/\Arhgap26Gt(OST135790)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal myoblast fusion
|
J:215392
|
| decreased skeletal muscle fiber size
|
J:215392
|
| impaired skeletal muscle regeneration
|
J:215392
|
\Arhgap42Gt(CE0477)Wtsi/\Arhgap42Gt(CE0477)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:221301
|
\Arhgef1tm1Rmt/\Arhgef1tm1Rmt
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: C57BL/6 * FVB/N)
|
decreased vasoconstriction
|
J:157074
|
\Arhgef3em1Chej/\Arhgef3em1Chej
(involves: C57BL/6N)
|
abnormal muscle contractility
|
J:304135
|
| enhanced muscle regeneration
|
J:304135
|
| muscle phenotype
|
J:304135
|
\Arhgef9em1Frk/Y
(C57BL/6NJ-Arhgef9em1Frk/FrkJ)
|
myoclonus
|
J:364541
|
\Arhgef12tm1Soff/\Arhgef12tm1Soff
(Not Specified)
|
decreased vasoconstriction
|
J:141641
|
\Arid1am1Mag/\Arid1am1Mag
(involves: 129 * CD-1)
|
absent myocardial trabeculae
|
J:192829
|
\Arid1bem1Hzhu/\Arid1b+
(C57BL/6J-Arid1bem1Hzhu)
|
muscle weakness
|
J:256668
|
\Arid2tm1a(EUCOMM)Wtsi/\Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:223458
|
| thin myocardium compact layer
|
J:223458
|
\Arid3atm1Pwt/\Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
thin myocardium compact layer
|
J:169178
|
\Arid5bGt(ROSA)75Sor/\Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
\Ark2cGt(P9-3F)Sor/\Ark2c+
\Smad9tm1Rob/\Smad9tm1Rob
\Tg(Hlxb9-GFP)1Tmj/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
skeletal muscle atrophy
|
J:198828
|
\Ark2cGt(P9-3F)Sor/\Ark2cGt(P9-3F)Sor
\Tg(Hlxb9-GFP)1Tmj/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
skeletal muscle atrophy
|
J:198828
|
\Ark2nem1Wehi/\Ark2nem1Wehi
(C57BL/6J-8030462N17Rikem1Wehi)
|
abnormal muscle physiology
|
J:330717
|
| decreased skeletal muscle fiber size
|
J:330717
|
| impaired skeletal muscle contractility
|
J:330717
|
\Arl16em1(IMPC)Ccpcz/\Arl16em1(IMPC)Ccpcz
(C57BL/6NCrl-Arl16em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Arrb1tm1Jse/\Arrb1tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
increased heart left ventricle muscle contractility
|
J:44953
|
\Arsbm1J/\Arsbm1J
(C57BL/6J-Arsbm1J/GrsrJ)
|
skeletal muscle degeneration
|
J:149960
|
\Arsbtm1Cptr/\Arsbtm1Cptr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:102290
|
| decreased heart left ventricle muscle contractility
|
J:102290
|
\Arxtm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
muscle spasm
|
J:262482
|
\Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
\Arxtm1.1Jno/\Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
\Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
\Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
\Asah1tm1.2Geno/\Asah1tm1.2Geno
(involves: C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:285931
|
| dystrophic muscle
|
J:285931
|
| skeletal muscle fiber atrophy
|
J:285931
|
\Asb7em1(IMPC)Ccpcz/\Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Asic2tm1Wsh/\Asic2+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
\Asic2tm1Wsh/\Asic2tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
\Asltm1Brle/\Asltm1Brle
(involves: 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:180208
|
| decreased vasodilation
|
J:180208
|
\Asnsd1Gt(OST460318)Lex/\Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal limb muscle morphology
|
J:320329
|
| abnormal skeletal muscle fiber morphology
|
J:320329
|
| centrally nucleated skeletal muscle fibers
|
J:320329
|
| decreased skeletal muscle mass
|
J:320329
|
| enhanced skeletal muscle regeneration
|
J:320329
|
| muscle weakness
|
J:320329
|
| myopathy
|
J:320329
|
| skeletal muscle fiber degeneration
|
J:320329
|
| skeletal muscle fiber necrosis
|
J:320329
|
\Aspatm1a(EUCOMM)Wtsi/\Aspatm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle tone
|
J:172582
|
| muscle hypertonia
|
J:172582
|
| muscle weakness
|
J:172582
|
\Asphtm1Egk/\Asphtm1Egk
(Not Specified)
|
increased cardiac muscle contractility
|
J:130155
|
\Aspscr1tm1.1Jsbo/\Aspscr1tm1.1Jsbo
\Tg(Ckmm-cre)5Khn/0
(B6.Cg-Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn)
|
abnormal skeletal muscle morphology
|
J:308358
|
| increased skeletal muscle cell glucose uptake
|
J:308358
|
| increased skeletal muscle fiber mitochondrial size
|
J:308358
|
| increased skeletal muscle glycogen level
|
J:308358
|
| increased skeletal muscle triglyceride level
|
J:308358
|
\Asxl3tm1.1(ASXL3*P723R)Clia/\Asxl3tm2.1(ASXL3*P1817A)Clia
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:322485
|
| abnormal myocardial fiber morphology
|
J:322485
|
| abnormal myocardium layer morphology
|
J:322485
|
| decreased cardiac muscle contractility
|
J:322485
|
| myocardium hypertrophy
|
J:322485
|
\Atad3atm1c(KOMP)Wtsi/\Atad3atm1c(KOMP)Wtsi
\Myl1tm1(cre)Sjb/\Myl1+
(B6J.Cg-Myl1tm1(cre)Sjb Atad3atm1c(KOMP)Wtsi)
|
abnormal muscle fiber mitochondrial morphology
|
J:263681
|
| abnormal muscle fiber morphology
|
J:263681
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:263681
|
| decreased skeletal muscle weight
|
J:263681
|
| skeletal muscle fiber atrophy
|
J:263681
|
| skeletal muscle fiber degeneration
|
J:263681
|
\Atcayji-hes/\Atcayji-hes
(C3H/HeJ-Atcayji-hes)
|
dystonia
|
J:85793
|
\Atcayji/\Atcayji
(Not Specified)
|
dystonia
|
J:14903
|
| muscle spasm
|
J:14903
|
\Ate1tm1Akas/\Ate1tm1Akas
(Not Specified)
|
abnormal intercalated disk morphology
|
J:144625
|
| abnormal myocardial fiber morphology
|
J:144625
|
| decreased cardiac muscle contractility
|
J:144625
|
| thin myocardium
|
J:144625
|
\Ate1tm1Avar/\Ate1tm1Avar
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
ventricle myocardium hypoplasia
|
J:77750
|
\Atf4tm1.1Cmad/\Atf4tm1.1Cmad
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
decreased susceptibility to induced muscular atrophy
|
J:206503
|
| muscle phenotype
|
J:206503
|
\Atg5tm1Myok/\Atg5tm1Myok
\A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S/SvEv * FVB/N)
|
abnormal cardiac muscle contractility
|
J:121778
|
| increased myocardial fiber size
|
J:121778
|
\Atg5tm1Myok/\Atg5tm1Myok
\Cnot3tm1.1Kjkb/\Cnot3tm1.1Kjkb
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:260012
|
\Atg7tm1Tchi/\Atg7tm1Tchi
\Cnot1tm1Tya/\Cnot1tm1Tya
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
\Atg7tm1Tchi/\Atg7tm1Tchi
\Cnot3tm1.1Kjkb/\Cnot3tm1.1Kjkb
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
\Atg7tm1Tchi/\Atg7tm1Tchi
\Cnot3tm1.1Kjkb/\Cnot3tm1.1Kjkb
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cfTg(Myh6-cre/Esr1*)1Jmk
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
\Atg16l1tm1a(EUCOMM)Wtsi/\Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Atictm1c(EUCOMM)Hmgu/\Atictm1c(EUCOMM)Hmgu
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
\Atictm1c(EUCOMM)Hmgu/\Atictm1c(EUCOMM)Hmgu
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
\Atl1tm1.1Cbla/\Atl1tm1.1Cbla
\Reep1Gt(OST398247)Lex/\Reep1Gt(OST398247)Lex
(B6.Cg-Reep1Gt(OST398247)Lex Atl1tm1.1Cbla)
|
abnormal muscle morphology
|
J:334532
|
| skeletal muscle atrophy
|
J:334532
|
\Atp1a1em1(IMPC)Ccpcz/\Atp1a1+
(C57BL/6NCrl-Atp1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Atp1a1tm1Ling/\Atp1a1+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
\Atp1a1tm1Ling/\Atp1a1+
(involves: 129P2/OlaHsd)
|
impaired muscle contractility
|
J:114415
|
\Atp1a1tm2Ling/\Atp1a1tm2Ling
\Atp1a2tm3Ling/\Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
increased cardiac muscle contractility
|
J:95157
|
\Atp1a2tm2Ling/\Atp1a2+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
\Atp1a2tm2Ling/\Atp1a2+
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:114415
|
\Atp1a2tm3Ling/\Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:87082
|
\Atp1a3tm1.1Kwk/\Atp1a3+
(B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk)
|
dystonia
|
J:210870
|
\Atp1a3tm1Mika/\Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:264408
|
\Atp1a3tm1Ute/\Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dystonia
|
J:262419
|
\Atp1b1tm1.1Akra/\Atp1b1tm1.1Akra
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S/SvEv * 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:152596
|
| decreased heart ventricle muscle contractility
|
J:152596
|
\Atp2a1tm1Dhm/\Atp2a1tm1Dhm
(involves: CD-1)
|
abnormal diaphragm morphology
|
J:82947
|
| abnormal muscle physiology
|
J:82947
|
| impaired muscle relaxation
|
J:82947
|
| impaired skeletal muscle contractility
|
J:82947
|
| increased muscle fatigability
|
J:82947
|
\Atp2a2tm1.1Iemr/\Atp2a2tm1.1Iemr
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:157143
|
\Atp2a2tm1Fwuy/\Atp2a2tm1Fwuy
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal cardiac muscle relaxation
|
J:111247
|
| decreased cardiac muscle contractility
|
J:111247
|
| heart left ventricle hypertrophy
|
J:111247
|
| thin ventricle myocardium compact layer
|
J:111247
|
\Atp2a2tm1Fwuy/\Atp2a2tm1Fwuy
\Plntm1Egk/\Plntm1Egk
(involves: 129 * FVB/N * Swiss)
|
abnormal cardiac muscle relaxation
|
J:110974
|
| increased myocardial fiber size
|
J:110974
|
\Atp2a2tm1Ges/\Atp2a2+
(involves: 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:95608,
J:52186
|
| decreased heart left ventricle muscle contractility
|
J:66006
|
| decreased heart ventricle muscle contractility
|
J:95608,
J:52186
|
| heart left ventricle hypertrophy
|
J:95608
|
\Atp2a3tm1Ges/\Atp2a3tm1Ges
(involves: Black Swiss)
|
abnormal muscle relaxation
|
J:44333
|
\Atp2b1Tg(Thy1-CHMP2B*)1Rene/\Atp2b1+
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
| muscle fasciculation
|
J:237873
|
\Atp2b1Tg(Thy1-CHMP2B*)1Rene/\Atp2b1Tg(Thy1-CHMP2B*)1Rene
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
| muscle fasciculation
|
J:237873
|
\Atp2b1tm1.1Hiraw/\Atp2b1tm1.1Hiraw
\Tg(Tagln-cre)1Her/0
(B6J.Cg-Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her)
|
increased vasoconstriction
|
J:225010
|
\Atp2b1tm1Ges/\Atp2b1+
\Atp2b4tm1Ges/\Atp2b4tm1Ges
(Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
\Atp2b4tm1Ges/\Atp2b4tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
\Atp5if1tm1Ksuj/\Atp5if1tm1Ksuj
(involves: C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:256558
|
\Atp6ap2tm1.1Aich/Y
\Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6 * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:165020
|
\Atp6v0d1em1Nju/\Atp6v0d1em1Nju
\Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased cardiac muscle contractility
|
J:346448
|
| increased myocardial fiber size
|
J:346448
|
\Atp7aMo-dp2/\Atp7a+
(Not Specified)
|
calcified tendon
|
J:13104
|
\Atp7atm1.1Mjp/Y
\Mnx1tm4(cre)Tmj/\Mnx1+
(involves: 129S1/Sv * C57BL/6)
|
decreased skeletal muscle mass
|
J:221066
|
| muscular atrophy
|
J:221066
|
\Atp7atm1.2Mlke/Y
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:266704
|
| increased skeletal muscle fiber diameter
|
J:266704
|
\Atp7btx/\Atp7btx
(DL-Atp7btx)
|
abnormal muscle physiology
|
J:7102
|
\Atp7btx/\Atp7btx
(involves: C57BL/6 * DL)
|
abnormal muscle physiology
|
J:7102
|
\Atp11atm1a(KOMP)Wtsi/\Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
\Atp11atm1c(KOMP)Wtsi/\Atp11atm1c(KOMP)Wtsi
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6N)
|
abnormal myoblast differentiation
|
J:262981
|
| abnormal skeletal muscle regeneration
|
J:262981
|
| muscle phenotype
|
J:262981
|
\Atp13a3em2H/\Atp13a3+
(C57BL/6NTac-Atp13a3em2H/H)
|
abnormal myocardial fiber morphology
|
J:358006
|
| heart right ventricle hypertrophy
|
J:358006
|
\Atpaf1em1Cya/\Atpaf1em1Cya
(involves: C57BL/6N)
|
abnormal myocardial fiber mitochondrial morphology
|
J:347150
|
| decreased heart left ventricle muscle contractility
|
J:347150
|
| dilated cardiomyopathy
|
J:347150
|
| increased myocardial fiber apoptosis
|
J:347150
|
| increased myocardial fiber size
|
J:347150
|
\Atrnmg-3J/\Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J)
|
abnormal muscle physiology
|
J:80364
|
\Atrnmg-3J/\Atrnmg-3J
\Atrnl1tm1Gsb/\Atrnl1tm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C3H * C3HeB/FeJ)
|
cardiomyopathy
|
J:130463
|
\Atxn1tm1Hzo/\Atxn1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle degeneration
|
J:77225
|
\Atxn7tm1Hzo/\Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6)
|
myoclonus
|
J:82072
|
\avc3/\avc3
(involves: C57BL/6J * FVB/N)
|
abnormal myocardium compact layer morphology
|
J:163196
|
\Avpi1tm1b(EUCOMM)Hmgu/\Avpi1tm1b(EUCOMM)Hmgu
(C57BL/6N-Avpi1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased cardiac muscle contractility
|
J:211773
|
\Avpr1atm1Gzt/\Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal vasoconstriction
|
J:110099
|
\Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
\Awat2tm1.2Golc/\Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
\b2b227.2Clo/\b2b227.2Clo
(C57BL/6J-b2b227.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b227Clo/\b2b227Clo
(C57BL/6J-b2b227Clo)
|
cardiomyopathy
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b246Clo/\b2b246Clo
(C57BL/6J-b2b246Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b370Clo/\b2b370Clo
(C57BL/6J-b2b370Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b383Clo/\b2b383Clo
(C57BL/6J-b2b383Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b386.1Clo/\b2b386.1Clo
(C57BL/6J-b2b386.1Clo)
|
myocardial hypertrabeculation
|
J:175213
|
\b2b386Clo/\b2b386Clo
(C57BL/6J-b2b386Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
\b2b635Clo/\b2b635Clo
(C57BL/6J-b2b635Clo)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:242757
|
\b2b827Clo/\b2b827Clo
(C57BL/6J-b2b827Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
\b2b842Clo/\b2b842Clo
(C57BL/6J-b2b842Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b904.1Clo/\b2b904.1Clo
(C57BL/6J-b2b904.1Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
\b2b904.2Clo/\b2b904.2Clo
(C57BL/6J-b2b904.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b904Clo/\b2b904Clo
(C57BL/6J-b2b904Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b913Clo/\b2b913Clo
(C57BL/6J-b2b913Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b918Clo/\b2b918Clo
(C57BL/6J-b2b918Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b972Clo/\b2b972Clo
(C57BL/6J-b2b972Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
\b2b977Clo/\b2b977Clo
(C57BL/6J-b2b977Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
\b2b999Clo/\b2b999Clo
(C57BL/6J-b2b999Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1117.2Clo/\b2b1117.2Clo
(C57BL/6J-b2b1117.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1117Clo/\b2b1117Clo
(C57BL/6J-b2b1117Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1163.2Clo/\b2b1163.2Clo
(C57BL/6J-b2b1163.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1163Clo/\b2b1163Clo
(C57BL/6J-b2b1163Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1200.2Clo/\b2b1200.2Clo
(C57BL/6J-b2b1200.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1200Clo/\b2b1200Clo
(C57BL/6J-b2b1200Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1247Clo/\b2b1247Clo
(C57BL/6J-b2b1247Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
| abnormal ventricle myocardium morphology
|
J:175213
|
| ventricular cardiomyopathy
|
J:175213
|
\b2b1511.2Clo/\b2b1511.2Clo
(C57BL/6J-b2b1511.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1511Clo/\b2b1511Clo
(C57BL/6J-b2b1511Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1528Clo/\b2b1528Clo
(C57BL/6J-b2b1528Clo)
|
diaphragmatic hernia
|
J:175213
|
\b2b1594Clo/\b2b1594Clo
(C57BL/6J-b2b1594Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1639Clo/\b2b1639Clo
(C57BL/6J-b2b1639Clo)
|
heart right ventricle hypertrophy
|
J:175213
|
\b2b1714Clo/\b2b1714Clo
(C57BL/6J-b2b1714Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1723Clo/\b2b1723Clo
(C57BL/6J-b2b1723Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b1835Clo/\b2b1835Clo
(C57BL/6J-b2b1835Clo)
|
ventricular cardiomyopathy
|
J:175213
|
\b2b1876Clo/\b2b1876Clo
(C57BL/6J-b2b1876Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b1879Clo/\b2b1879Clo
(C57BL/6J-b2b1879Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2025.2Clo/\b2b2025.2Clo
(C57BL/6J-b2b2025.2Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b2025Clo/\b2b2025Clo
(C57BL/6J-b2b2025Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b2059Clo/\b2b2059Clo
(C57BL/6J-b2b2059Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2110.2Clo/\b2b2110.2Clo
(C57BL/6J-b2b2110.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2110Clo/\b2b2110Clo
(C57BL/6J-b2b2110Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2140Clo/\b2b2140Clo
(C57BL/6J-b2b2140Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2153.1Clo/\b2b2153.1Clo
(C57BL/6J-b2b2153.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2153.2Clo/\b2b2153.2Clo
(C57BL/6J-b2b2153.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2153Clo/\b2b2153Clo
(C57BL/6J-b2b2153Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2187.2Clo/\b2b2187.2Clo
(C57BL/6J-b2b2187.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2187Clo/\b2b2187Clo
(C57BL/6J-b2b2187Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2362.2Clo/\b2b2362.2Clo
(C57BL/6J-b2b2362.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2362Clo/\b2b2362Clo
(C57BL/6J-b2b2362Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
| myocardial hypertrabeculation
|
J:175213
|
\b2b2459Clo/\b2b2459Clo
(C57BL/6J-b2b2459Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b2696.2Clo/\b2b2696.2Clo
(C57BL/6J-b2b2696.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
\b2b2738Clo/\b2b2738Clo
(C57BL/6J-b2b2738Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\b2b2739Clo/\b2b2739Clo
(C57BL/6J-b2b2739Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b3260.2Clo/\b2b3260.2Clo
(C57BL/6J-b2b3260.2Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\b2b3260Clo/\b2b3260Clo
(C57BL/6J-b2b3260Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\B4gat1m1Ddg/\B4gat1m1Ddg
(involves: C3H/He * C57BL/6)
|
dystrophic muscle
|
J:194150
|
\B4gat1m1Ddg/\B4gat1tm1(KOMP)Vlcg
(involves: C3H/He * C57BL/6 * C57BL/6NTac)
|
dystrophic muscle
|
J:194150
|
| skeletal muscle atrophy
|
J:194150
|
\B9d1tm1a(EUCOMM)Wtsi/\B9d1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
thin myocardium
|
J:178421
|
\B9d2tm1a(EUCOMM)Wtsi/\B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
\Bace1tm1Cdi/\Bace1tm1Cdi
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:86936
|
\Bace1tm1Psa/\Bace1+
(involves: 129S2/SvPas * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
\Bace1tm1Psa/\Bace1tm1Psa
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
\Bace1tm1Psa/\Bace1tm1Psa
\Nrg1tm4.1Cbm/\Nrg1+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
\Bace1tm1Psa/\Bace1tm1Psa
\Tg(Thy1-Nrg1*I)1Kan/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
\Bach1tm1Igar/\Bach1tm1Igar
(B6.129P2-Bach1tm1Igar)
|
abnormal vascular smooth muscle morphology
|
J:123370
|
| decreased cardiomyocyte apoptosis
|
J:123370
|
\Bag3Gt(OST16086)Lex/\Bag3Gt(OST16086)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:112361
|
| abnormal Z line morphology
|
J:112361
|
| increased myocardial fiber apoptosis
|
J:112361
|
| myocardial fiber degeneration
|
J:112361
|
| skeletal muscle fiber degeneration
|
J:112361
|
\Bag3tm1c(EUCOMM)Hmgu/\Bag3tm1.1Chen
\Tg(Myhca-cre)1Abel/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
| dilated cardiomyopathy
|
J:246352
|
\Bag3tm1c(EUCOMM)Hmgu/\Bag3tm1c(EUCOMM)Hmgu
\Tg(Myhca-cre)1Abel/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
| dilated cardiomyopathy
|
J:246352
|
\Bag5em1Asay/\Bag5em1Asay
(C57BL/6JJcl-Bag5em1Asay)
|
abnormal myocardial fiber morphology
|
J:327046
|
| decreased heart left ventricle muscle contractility
|
J:327046
|
\Baiap2l2tm1a(EUCOMM)Hmgu/\Baiap2l2tm1a(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1a(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
\Bap1tm1.1Geno/\Bap1tm1.1Geno
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
cardiac muscle necrosis
|
J:187380
|
\Barx2tm1Rsd/\Barx2tm1Rsd
(involves: 129/Sv * C57BL/6)
|
abnormal muscle fiber morphology
|
J:187799
|
| abnormal skeletal muscle fiber morphology
|
J:187799
|
| abnormal skeletal muscle morphology
|
J:187799
|
| decreased skeletal muscle fiber diameter
|
J:187799
|
| decreased skeletal muscle mass
|
J:187799
|
| decreased skeletal muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| skeletal muscle fiber atrophy
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
\Barx2tm1Rsd/\Barx2tm1Rsd
\Dmdmdx/Y
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:187799
|
| decreased muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| progressive muscle weakness
|
J:187799
|
| skeletal muscle endomysial fibrosis
|
J:187799
|
| skeletal muscle fiber necrosis
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
\Barx2tm1Rsd/\Barx2tm1Rsd
\Dmdmdx/\Dmdmdx
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:187799
|
| decreased muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| progressive muscle weakness
|
J:187799
|
| skeletal muscle endomysial fibrosis
|
J:187799
|
| skeletal muscle fiber necrosis
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
\Baxtm1Sjk/\Baxtm1Sjk
\Lama2tm1Eeng/\Lama2tm1Eeng
(B6.129-Baxtm1Sjk Lama2tm1Eeng)
|
abnormal skeletal muscle fiber morphology
|
J:94431
|
| impaired skeletal muscle regeneration
|
J:94431
|
| increased skeletal muscle mass
|
J:94431
|
\Baxtm1Sjk/\Baxtm1Sjk
\Ntf3tm1Jae/\Ntf3tm1Jae
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
absent muscle spindles
|
J:83461
|
\Baxtm1Sjk/\Baxtm1Sjk
\Ntrk1tm2(Ntrk3)Apat/\Ntrk1tm2(Ntrk3)Apat
(involves: 129S1/Sv * 129X1/SvJ)
|
increased muscle spindle number
|
J:92099
|
\Baz1btm1Ska/\Baz1b+
(involves: C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:149990
|
\Baz1btm1Ska/\Baz1btm1Ska
(involves: C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:149990
|
| abnormal myocardium layer morphology
|
J:149990
|
\Bcar1tm1Hhi/\Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:48967
|
| abnormal Z line morphology
|
J:48967
|
| decreased cardiac muscle contractility
|
J:48967
|
| increased vasodilation
|
J:48967
|
| thin myocardium
|
J:48967
|
\Bcar1tm2.1Homy/\Bcar1tm2.1Homy
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:195063
|
\BckdkGt(VICT48)710Lex/\BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
|
decreased muscle weight
|
J:117564
|
\Bcl2tm1.1Sjk/\Bcl2tm1.1Sjk
\Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
decreased skeletal muscle cell glucose uptake
|
J:181308
|
| muscle phenotype
|
J:181308
|
\Bcl2tm1Sjk/\Bcl2tm1Sjk
(B6;129S2-Bcl2tm1Sjk/J)
|
abnormal skeletal muscle fiber type ratio
|
J:66494
|
\Bcl6tm1Gdba/\Bcl6tm1Gdba
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
increased skeletal muscle cell glucose uptake
|
J:271078
|
\Bcl6tm1Htno/\Bcl6tm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myocardial fiber degeneration
|
J:55952
|
\Bcl9tm1.1Agt/\Bcl9tm1.1Agt
\Bcl9ltm1.1Agt/\Bcl9ltm1.1Agt
\Myf5tm1(cre)Mrc/\Myf5+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal muscle development
|
J:154476
|
| decreased skeletal muscle fiber size
|
J:154476
|
| impaired skeletal muscle regeneration
|
J:154476
|
\Bdh1tm1c(EUCOMM)Wtsi/\Bdh1tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:274475
|
\bella/\bella
(involves: BALB/c * C3H/HeH)
|
centrally nucleated skeletal muscle fibers
|
J:177995
|
\Best3tm1.1Zhoj/\Best3tm1.1Zhoj
\Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:338981
|
\Bex1Gt(OST125186)Lex/\Bex1Gt(OST125186)Lex
(involves: 129S5/SvEvBrd)
|
abnormal skeletal muscle regeneration
|
J:127357
|
\Bgntm1Mfy/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:76203
|
\Bgntm1Mfy/Y
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal tendon collagen fibril morphology
|
J:91512
|
\Bgntm1Mfy/Y
\Fmodtm1Aol/\Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:76203
|
| abnormal tendon morphology
|
J:76203
|
| decreased tendon stiffness
|
J:76203
|
\Bicraem3Hzhg/\Bicraem3Hzhg
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C57BL/6J * CBA/J)
|
decreased heart right ventricle muscle contractility
|
J:335098
|
\Bidtm1Sjk/\Bidtm1Sjk
\Cstbtm1Rm/\Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
\Bin1tm1Gcp/\Bin1tm1Gcp
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal A band morphology
|
J:83753
|
| abnormal myocardial fiber morphology
|
J:83753
|
| abnormal sarcomere morphology
|
J:83753
|
| diffuse Z line
|
J:83753
|
| disorganized myocardium
|
J:83753
|
| ventricular cardiomyopathy
|
J:83753
|
\Birc2tm1.1Rbr/\Birc2tm1.1Rbr
\Birc3tm1.1Rbr/\Birc3tm1.1Rbr
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182515
|
\Birc2tm1.1Rbr/\Birc2tm1.1Rbr
\Xiaptm1Vdr/\Xiaptm1Vdr
(involves: 129S1/Sv * BALB/cJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:182515
|
\Bmal1tm1.1Shbi/\Bmal1tm1.1Shbi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle phenotype
|
J:177865
|
\Bmal1tm1.2Shbi/\Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
increased skeletal muscle triglyceride level
|
J:177865
|
\Bmal1tm1Bra/\Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
abnormal vascular smooth muscle physiology
|
J:191844
|
| calcified calcaneal tendon
|
J:116189,
J:97108
|
| calcified tendon
|
J:97108
|
| decreased muscle weight
|
J:110697
|
| decreased vasodilation
|
J:191844
|
| increased vasoconstriction
|
J:191844
|
| vascular smooth muscle hyperplasia
|
J:191844
|
\Bmal1tm1Bra/\Bmal1tm1Bra
\Tg(ACTA1-Arntl)1Jt/0
(involves: 129/Sv * C57BL/6J * CD-1)
|
calcified calcaneal tendon
|
J:116189
|
\Bmp1tm1.1Dgr/\Bmp1tm1.1Dgr
\Tll1tm2.1Dgr/\Tll1tm2.1Dgr
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal tendon collagen fibril morphology
|
J:210366
|
\Bmp2tm1Jfm/\Bmp2tm1Jfm
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal myocardium layer morphology
|
J:104417
|
\Bmp4tm2(tetO-Bmp4,lacZ)Jfm/?
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/?
\Tg(Mef2c-cre)2Blk/?
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
thick myocardium
|
J:169047
|
\Bmp4tm2Blh/\Bmp4+
(involves: 129S6/SvEvTac * ICR)
|
abnormal vascular smooth muscle morphology
|
J:112335
|
| heart right ventricle hypertrophy
|
J:112335
|
\Bmp10tm1.1(Gdf2)Minh/\Bmp10tm1.1(Gdf2)Minh
(C57BL/6N-Bmp10tm1.1(Gdf2)Minh)
|
decreased fetal cardiomyocyte proliferation
|
J:222016
|
\Bmp10tm1Shou/\Bmp10tm1Shou
(either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6J))
|
trabecula carnea hypoplasia
|
J:89476
|
\Bmpr1atm1Bhr/\Bmpr1atm2.1Bhr
\Tg(GATA6-cre)#Jbeb/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:111392
|
\Bmpr1atm2.1Bhr/\Bmpr1atm2.1Bhr
\Kdrtm1(cre)Sato/\Kdr+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
vascular smooth muscle hypoplasia
|
J:112269
|
\Bmpr1atm2.1Bhr/\Bmpr1atm2.2Bhr
\Isl1tm1(cre)Sev/\Isl1+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal fetal cardiomyocyte apoptosis
|
J:107396
|
| decreased fetal cardiomyocyte proliferation
|
J:107396
|
\Bmpr2b2b2556Clo/\Bmpr2b2b2556Clo
(C57BL/6J-Bmpr2b2b2556Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\Bmpr2tm1.1Enl/\Bmpr2tm1.1Enl
\Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
heart right ventricle hypertrophy
|
J:158116
|
| increased vascular smooth muscle cell proliferation
|
J:158116
|
\Bmpr2tm1Kmi/\Bmpr2+
(involves: 129S4/SvJae * C57BL/6J)
|
increased vasoconstriction
|
J:117167
|
\Bmpr2tm1Mmue/\Bmpr2+
\Smad1tm1Rjle/\Smad1+
(involves: 129S1/SvImJ * 129S6/SvEvTac * C57BL/6)
|
heart right ventricle hypertrophy
|
J:224752
|
\Bnip3tm1Gwd/\Bnip3tm1Gwd
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:127533
|
\Bnip3ltm1.1Gwd/\Bnip3ltm1.1Gwd
\Tg(Myh6-Gnaq)#Gwd/0
(involves: 129 * FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
\Bnip3ltm1Gwd/\Bnip3ltm1Gwd
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129 * 129S7/SvEvBrd)
|
decreased cardiomyocyte apoptosis
|
J:145086
|
| increased cardiac muscle contractility
|
J:145086
|
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased cardiac muscle contractility
|
J:170095
|
\Braftm1Tumg/\Braf+
\Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA)
|
abnormal myocardial trabeculae morphology
|
J:216228
|
| thin myocardium compact layer
|
J:216228
|
\Braftm1Tumg/\Braf+
\Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA * ICR)
|
abnormal myocardial fiber morphology
|
J:226977
|
| abnormal myocardial trabeculae morphology
|
J:226977
|
\Braftm2Cpri/\Braf+
\Tg(CMV-cre)1Cgn/0
(B6.Cg-Braftm2Cpri Tg(CMV-cre)1Cgn)
|
increased myocardial fiber size
|
J:187371
|
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
|
muscular atrophy
|
J:81559
|
\Brd2em1(IMPC)Wtsi/\Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
abnormal pectinate muscle morphology
|
J:239583
|
| absent eye muscles
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
\Bsgtm1Itl/\Bsgtm1Itl
\Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S/SvEv * C3H * C57BL/6)
|
muscle phenotype
|
J:288233
|
\Bsntm1Gund/\Bsntm1Gund
(Not Specified)
|
myoclonus
|
J:82241
|
\Btaf1m1Fme/\Btaf1m1Fme
(involves: C57BL/6J * FVB/NJ)
|
myocardial trabeculae hypoplasia
|
J:173663
|
\Btctm1Dcl/\Btctm1Dcl
\Hbegftm1Dcl/\Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:83820
|
\Btdtm1Bwol/\Btdtm1Bwol
(B6.Cg-Btdtm1Bwol)
|
hypotonia
|
J:168391
|
\Bub1btm1Jvd/\Bub1btm1Jvd
(involves: 129S6/SvEvTac)
|
muscular atrophy
|
J:91128
|
\Bub1btm1Jvd/\Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:293084
|
\Bub1btm1Jvd/\Bub1btm3.1Jvd
(involves: 129S6/SvEvTac * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:293084
|
\Bub1btm2.1Jvd/\Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:194926
|
| muscular atrophy
|
J:194926
|
\Bub3tm1Jvd/\Bub3+
\Rae1tm1Jvd/\Rae1+
(Not Specified)
|
muscle degeneration
|
J:105717
|
| muscular atrophy
|
J:105717
|
\Bud23em2Asil/\Bud23em2Asil
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
decreased cardiac muscle contractility
|
J:290738
|
| decreased myocardial fiber mitochondrial DNA content
|
J:290738
|
| dilated cardiomyopathy
|
J:290738
|
\C1qtnf9tm1(KOMP)Vlcg/\C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:212299
|
| abnormal skeletal muscle morphology
|
J:212299
|
\C2cd5Gt(IST12020E4)Tigm/\C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
decreased cardiac muscle cell glucose uptake
|
J:284780
|
| decreased skeletal muscle cell glucose uptake
|
J:284780
|
\C3tm1Crr/\C3tm1Crr
\Dysftm1Kcam/\Dysftm1Kcam
(B6.129-Dysftm1Kcam C3tm1Crr)
|
muscle weakness
|
J:171870
|
\C3tm1Hrc/\C3tm1Hrc
\Lama2dy/\Lama2dy
(either: (involves: 129S2/SvPas * 129P1/ReJ) or (involves: 129X1/SvJ * 129P1/ReJ))
|
abnormal skeletal muscle morphology
|
J:102959
|
| dystrophic muscle
|
J:102959
|
| skeletal muscle interstitial fibrosis
|
J:102959
|
\cab/\cab
(STOCK Cacna1smdg)
|
abnormal myocardium layer morphology
|
J:6195
|
\Cacna1atg-la/\Cacna1aWb
(involves: AKR/J * C3H/HeJ * C57BL/6J)
|
dystonia
|
J:119639
|
\Cacna1atg-rol/\Cacna1atg-rol
(involves: C57BL/6 * SIII)
|
abnormal muscle electrophysiology
|
J:164115
|
| muscle weakness
|
J:164115
|
\Cacna1atg/\Cacna1atg
(B6.D2-Cacna1atg/J)
|
abnormal muscle electrophysiology
|
J:233263
|
| dystonia
|
J:233263
|
\Cacna1atg/\Cacna1atm2.1Maag
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * FVB/N)
|
abnormal muscle electrophysiology
|
J:233263
|
| dystonia
|
J:233263
|
\Cacna1atg/\Cacna1atm2.1Maag
\Tg(Pcp2-cre)2Mpin/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J * FVB/N)
|
dystonia
|
J:233263
|
\Cacna1atm1(CACNA1A)Ttan/\Cacna1atm1(CACNA1A)Ttan
(involves: 129S4/SvJae)
|
dystonia
|
J:123243
|
\Cacna1atm1.1(CACNA1A)Ttan/\Cacna1atm1.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
\Cacna1atm1Hssh/\Cacna1atm1Hssh
(involves: 129 * C57BL/6J)
|
muscle spasm
|
J:59076
|
\Cacna1atm2.1(CACNA1A)Ttan/\Cacna1atm2.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
\Cacna1atm2.1Maag/\Cacna1atm2.2Maag
\Tg(EIIa-cre)C5379Lmgd/0
(involves: 129P2/OlaHsd * FVB/N)
|
dystonia
|
J:117062
|
\Cacna1aWb/\Cacna1aWb
(either: C3.B6-Cacna1aWb or (involves: C3H/HeJ * C57BL/6J))
|
dystonia
|
J:119639
|
\Cacna1ctm1.1Wac/\Cacna1ctm1.1Wac
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:203057
|
| abnormal muscle electrophysiology
|
J:203057
|
| decreased cardiac muscle contractility
|
J:203057
|
| increased myocardial fiber size
|
J:203057
|
\Cacna1ctm1Ggm/\Cacna1ctm1Ggm
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:189406
|
\Cacna1ctm1Itl/\Cacna1ctm1Itl
(B6.129S6-Cacna1ctm1Itl)
|
heart right ventricle hypertrophy
|
J:171162
|
| increased myocardial fiber size
|
J:171162
|
\Cacna1ctm2.1Wac/\Cacna1ctm2.1Wac
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:216746
|
\Cacna1ctm3Hfm/\Cacna1ctm4Hfm
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal muscle electrophysiology
|
J:175463
|
\Cacna1htm1Kcam/\Cacna1htm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:86616
|
| increased vasoconstriction
|
J:86616
|
\Cacna1smdg/\Cacna1smdg
(involves: STOCK T/t4)
|
abnormal diaphragm morphology
|
J:7295,
J:7296
|
| abnormal muscle development
|
J:14970,
J:5576
|
| abnormal muscle fiber morphology
|
J:7295,
J:7296
|
| abnormal muscle physiology
|
J:641
|
| abnormal sarcomere morphology
|
J:18533
|
| abnormal skeletal muscle fiber morphology
|
J:4724,
J:5283,
J:18533
|
| abnormal tongue muscle morphology
|
J:14970
|
| abnormal Z line morphology
|
J:5283,
J:18533
|
| absent skeletal muscle
|
J:4466
|
| decreased skeletal muscle mass
|
J:14970
|
| dilated sarcoplasmic reticulum
|
J:5283
|
| impaired skeletal muscle contractility
|
J:4724,
J:18533
|
| increased skeletal muscle fiber mitochondrial size
|
J:5283
|
| muscle degeneration
|
J:14970
|
| thin diaphragm muscle
|
J:4466
|
\Cacna1smdg/\Cacna1smdg
(involves: 129P1/ReJ * STOCK T/t4)
|
abnormal diaphragm morphology
|
J:6592
|
| abnormal muscle morphology
|
J:6592
|
| impaired skeletal muscle contractility
|
J:5371
|
\Cacna1smdg/\Cacna1smdg
(involves: 129 * STOCK T/t4)
|
abnormal muscle development
|
J:15029
|
| impaired muscle contractility
|
J:7390,
J:15029
|
\Cacna1stm1.1Arte/\Cacna1stm1.1Arte
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:235534
|
| abnormal muscle physiology
|
J:235534
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:235534
|
| abnormal skeletal muscle fiber type ratio
|
J:235534
|
| impaired skeletal muscle contractility
|
J:235534
|
| muscle phenotype
|
J:235534
|
\Cacna1stm1.1Cann/\Cacna1s+
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
| abnormal muscle physiology
|
J:193967
|
| dilated sarcoplasmic reticulum
|
J:193967
|
\Cacna1stm1.1Cann/\Cacna1stm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
| abnormal muscle physiology
|
J:193967
|
| centrally nucleated skeletal muscle fibers
|
J:193967
|
| dilated sarcoplasmic reticulum
|
J:193967
|
| myopathy
|
J:193967
|
\Cacna2d1tm1Aschw/\Cacna2d1tm1Aschw
(involves: Black Swiss)
|
abnormal muscle electrophysiology
|
J:151101
|
| decreased cardiac muscle contractility
|
J:151101
|
\Cacna2d2du-3J/\Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:82238
|
\Cacna2d2du/\Cacna2d2du
(TKDU)
|
skeletal muscle hypoplasia
|
J:152373
|
\Cacna2d2tm1Svi/\Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
myoclonus
|
J:92396
|
\Cacnb1tm1Rgg/\Cacnb1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:37052
|
| abnormal skeletal muscle fiber morphology
|
J:37052
|
| decreased skeletal muscle mass
|
J:37052
|
| impaired skeletal muscle contractility
|
J:37052
|
\Cacnb2tm1.1Mfre/\Cacnb2tm1.1Mfre
\Tg(CAG-Bgeo/GFP)21Lbe/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)
|
thin myocardium
|
J:126506
|
\Cacnb3tm1Acv/\Cacnb3tm1Acv
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle morphology
|
J:86381
|
| abnormal vascular smooth muscle physiology
|
J:86381
|
| vascular smooth muscle hypertrophy
|
J:86381
|
\Cacnb4lh/\Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi)
|
facial muscle spasm
|
J:79139
|
\Cacng1tm1Rgg/\Cacng1+
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
\Cacng1tm1Rgg/\Cacng1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
\Cacng1tm1Vfz/\Cacng1tm1Vfz
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle electrophysiology
|
J:62133
|
\Calb1em1(IMPC)Ccpcz/\Calb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Calb1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Calcrltm1Kmca/\Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca)
|
abnormal myocardium compact layer morphology
|
J:106927
|
| abnormal myocardium layer morphology
|
J:106927
|
| abnormal vascular smooth muscle morphology
|
J:106927
|
| decreased fetal cardiomyocyte proliferation
|
J:106927
|
| disorganized myocardium
|
J:106927
|
| increased fetal cardiomyocyte apoptosis
|
J:106927
|
| thin myocardium compact layer
|
J:106927
|
| vascular smooth muscle hypoplasia
|
J:106927
|
\Cald1tm1Chac/\Cald1+
(involves: C57BL/6 * C57BL/6J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:202998
|
\Calrtm1Mlk/\Calrtm1Mlk
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:119647
|
| abnormal myocardial fiber morphology
|
J:119647
|
| abnormal sarcomere morphology
|
J:119647
|
| abnormal Z line morphology
|
J:119647
|
| decreased myocardial fiber number
|
J:119647
|
| increased cardiac muscle glycogen level
|
J:119647
|
| thin myocardium compact layer
|
J:53466
|
| trabecula carnea hypoplasia
|
J:119647,
J:53466
|
\Calrtm1Star/\Calrtm1Star
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL))
|
increased cardiomyocyte apoptosis
|
J:61550
|
| trabecula carnea hypoplasia
|
J:61550
|
| ventricular cardiomyopathy
|
J:61550
|
\Camk2dtm1.1Jhb/\Camk2dtm1.1Jhb
(Not Specified)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
\Camkmttm1Rpav/\Camkmttm1Rpav
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased variability of skeletal muscle fiber size
|
J:228818
|
| myopathy
|
J:228818
|
\Camkmttm1Rpav/\Camkmttm1Rpav
(B6.129S7-Camkmttm1Rpav)
|
muscle phenotype
|
J:228818
|
\can/\can
(STOCK Tmc1dn)
|
abnormal neck muscle morphology
|
J:5194
|
| calcified muscle
|
J:5194
|
\Canxem1(IMPC)Ccpcz/\Canxem1(IMPC)Ccpcz
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Cap2tm1a(EUCOMM)Wtsi/\Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased heart left ventricle muscle contractility
|
J:234044
|
| dilated cardiomyopathy
|
J:234044
|
\Cap2tm1e(EUCOMM)Wtsi/\Cap2tm1e(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1e(EUCOMM)Wtsi)
|
abnormal I band morphology
|
J:226742
|
| abnormal M line morphology
|
J:226742
|
| abnormal myocardial fiber morphology
|
J:226742
|
| abnormal myocardium layer morphology
|
J:226742
|
| abnormal sarcomere morphology
|
J:226742
|
| abnormal ventricle myocardium morphology
|
J:226742
|
| decreased myocardial fiber number
|
J:226742
|
| dilated cardiomyopathy
|
J:226742
|
\Capn3Gt(OST141731)Lex/\Capn3Gt(OST141731)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal A band morphology
|
J:91206
|
| abnormal diaphragm morphology
|
J:91206
|
| abnormal gastrocnemius morphology
|
J:91206
|
| abnormal muscle morphology
|
J:91206
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:91206
|
| abnormal skeletal muscle fiber morphology
|
J:91206
|
| abnormal soleus morphology
|
J:91206
|
| abnormal tibialis anterior morphology
|
J:91206
|
| decreased skeletal muscle mass
|
J:91206
|
\Capn3tm1.1Hiso/\Capn3tm1.1Hiso
(B6.129P2-Capn3tm1.1Hiso)
|
abnormal skeletal muscle fiber morphology
|
J:163711
|
| centrally nucleated skeletal muscle fibers
|
J:163711
|
| decreased skeletal muscle fiber diameter
|
J:163711
|
| dystrophic muscle
|
J:163711
|
| skeletal muscle degeneration
|
J:163711
|
\Capn3tm1Jsb/\Capn3+
\Ttntm1.1Isrd/\Ttntm1.1Isrd
(involves: 129/Sv * 129S2/SvPas * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:165576
|
| dilated cardiomyopathy
|
J:165576
|
| dystrophic muscle
|
J:165576
|
\Capn3tm1Jsb/\Capn3tm1Jsb
(either: 129/Sv-Capn3tm1Jsb or (involves: 129/Sv * C57BL/6))
|
abnormal sarcolemma morphology
|
J:66862
|
| dystrophic muscle
|
J:66862
|
\Capn6tm1Hiso/Y
(B6.Cg-Capn6tm1Hiso)
|
abnormal myogenesis
|
J:200747
|
\Capn6tm1Hiso/\Capn6tm1Hiso
(B6.Cg-Capn6tm1Hiso)
|
abnormal tongue muscle morphology
|
J:200747
|
| enhanced skeletal muscle regeneration
|
J:200747
|
\Capns1tm1.1Otsu/\Capns1tm1.1Otsu
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:176736
|
\Car3tm1Gkim/\Car3tm1Gkim
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal muscle contractility
|
J:94222
|
\Carns1tm1.2Meck/\Carns1tm1.2Meck
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
muscle phenotype
|
J:298850
|
\Casp3tm1Flv/\Casp3tm1Flv
(B6N.129S1-Casp3tm1Flv/J)
|
increased cardiomyocyte apoptosis
|
J:189241
|
\Casp8tm1.1Yuan/\Casp8tm1.1Yuan
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * MF1)
|
abnormal myocardium layer morphology
|
J:49459
|
\Casp8tm1Syon/\Casp8tm1Syon
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased fetal cardiomyocyte apoptosis
|
J:103506
|
\Casp8tm1Syon/\Casp8tm1Syon
\Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)
|
increased fetal cardiomyocyte apoptosis
|
J:102279
|
\Casp8tm1Wll/\Casp8tm1.1Yuan
\Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
myocardium necrosis
|
J:92722
|
\Casp8tm1Yuan/\Casp8tm1Yuan
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
abnormal myocardial trabeculae morphology
|
J:49459
|
| abnormal myocardium layer morphology
|
J:49459
|
| thin myocardium
|
J:49459
|
\Casq1Gt(OST82566)Lex/\Casq1Gt(OST82566)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal muscle electrophysiology
|
J:140828
|
| abnormal muscle physiology
|
J:140828
|
| abnormal sarcomere morphology
|
J:140828
|
| abnormal sarcoplasmic reticulum morphology
|
J:140828
|
| abnormal skeletal muscle fiber morphology
|
J:140828
|
| impaired muscle relaxation
|
J:140828
|
| impaired skeletal muscle contractility
|
J:140828
|
| muscular atrophy
|
J:140828
|
\Casq2tm1.1Sgp/\Casq2tm1.1Sgp
(involves: 129X1/SvJ * C57BL/6NCrL)
|
abnormal myocardial fiber morphology
|
J:151367
|
\Casq2tm1Jse/\Casq2tm1Jse
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:124211
|
| heart left ventricle hypertrophy
|
J:124211
|
\Casq2tm2.1Sgp/\Casq2tm2.1Sgp
(involves: 129)
|
abnormal myocardial fiber morphology
|
J:212671
|
| abnormal sarcoplasmic reticulum morphology
|
J:212671
|
\Casq2tm2Jse/\Casq2tm2Jse
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:124211
|
| heart left ventricle hypertrophy
|
J:124211
|
\CasrNuf/\CasrNuf
(involves: 102/El * C3H/He)
|
calcified muscle
|
J:92612
|
\Casz1Gt(CJ0565)Wtsi/\Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:242127
|
| abnormal sarcomere morphology
|
J:242127
|
| abnormal Z line morphology
|
J:242127
|
| decreased fetal cardiomyocyte proliferation
|
J:242127
|
| myocardium hypoplasia
|
J:242127
|
| thin myocardium
|
J:242127
|
| ventricular myocardium compact layer hypoplasia
|
J:242127
|
\Casz1tm1.1Flc/\Casz1tm1.1Flc
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:221324
|
| thin myocardium
|
J:221324
|
| trabecula carnea hypoplasia
|
J:221324
|
\Cav1em2(IMPC)Ics/\Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
decreased cardiac muscle contractility
|
J:211773
|
\Cav1tm1Krc/\Cav1tm1Krc
(involves: 129S4/SvJae * Black Swiss)
|
decreased heart ventricle muscle contractility
|
J:78603
|
| dilated cardiomyopathy
|
J:78603
|
| heart right ventricle hypertrophy
|
J:78603
|
| increased heart right ventricle muscle contractility
|
J:78603
|
\Cav1tm1Kur/\Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasoconstriction
|
J:71760
|
| increased vasodilation
|
J:71760
|
\Cav1tm1Mls/\Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:87282
|
| abnormal skeletal muscle fiber morphology
|
J:117199
|
| abnormal vasoconstriction
|
J:75193
|
| abnormal vasodilation
|
J:75193
|
| decreased cardiac muscle contractility
|
J:87282
|
| heart left ventricle hypertrophy
|
J:87282
|
| myocardial fiber disarray
|
J:87282
|
\Cav1tm1Mls/\Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased vasoconstriction
|
J:120603
|
\Cav1tm1Mls/\Cav1tm1Mls
(STOCK Cav1tm1Mls/J)
|
decreased vasoconstriction
|
J:132392
|
| increased vasodilation
|
J:132392
|
\Cav1tm1Mls/\Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
|
abnormal skeletal muscle morphology
|
J:182288
|
\Cav1tm1Mls/\Cav1tm1Mls
\Cav3tm1Mls/\Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal myocardial fiber morphology
|
J:77372
|
| cardiomyopathy
|
J:77372
|
| decreased heart left ventricle muscle contractility
|
J:77372
|
| heart left ventricle hypertrophy
|
J:77372
|
| myocardial fiber disarray
|
J:77372
|
\Cav2tm1Mls/\Cav2tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal muscle regeneration
|
J:117199
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:117199
|
| abnormal skeletal muscle fiber morphology
|
J:117199
|
| increased satellite cell number
|
J:117199
|
| increased skeletal muscle fiber size
|
J:117199
|
\Cav3tm1Mls/\Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal myocardial fiber morphology
|
J:79453
|
| abnormal sarcolemma morphology
|
J:69965
|
| abnormal skeletal muscle fiber morphology
|
J:69965
|
| cardiomyopathy
|
J:79453
|
| decreased heart ventricle muscle contractility
|
J:79453
|
| dystrophic muscle
|
J:69965
|
| heart left ventricle hypertrophy
|
J:79453
|
| increased variability of skeletal muscle fiber size
|
J:69965
|
| muscle phenotype
|
J:117199
|
| myopathy
|
J:69965
|
| skeletal muscle fiber necrosis
|
J:69965
|
\Cav3tm1Ncnp/\Cav3+
\Dmdmdx/\Dmdmdx
(involves: 129S4/SvJae * C57BL/10 * C57BL/10ScSn)
|
abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle fiber morphology
|
J:150127
|
| centrally nucleated skeletal muscle fibers
|
J:150127
|
\Cav3tm1Ncnp/\Cav3tm1Ncnp
(involves: 129S4/SvJae * C57BL/6J)
|
muscle degeneration
|
J:66558
|
\Cav3tm1Ncnp/\Cav3tm1Ncnp
(involves: 129S4/SvJae * C57BL/10)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle fiber morphology
|
J:150127
|
| centrally nucleated skeletal muscle fibers
|
J:150127
|
| myocardial fiber disarray
|
J:150127
|
\Cavin1tm1Pfp/\Cavin1tm1Pfp
(B6.129S6-Cavin1tm1Pfp/J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:217273
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:217273
|
\Cbltm1Ddlb/\Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:94416
|
| increased skeletal muscle cell glucose uptake
|
J:94416
|
\Cbstm1Unc/\Cbs+
(B6.129P2-Cbstm1Unc/J)
|
abnormal vasodilation
|
J:64885
|
\Cbx6tm1a(EUCOMM)Wtsi/\Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
\Ccl2tm1Rol/\Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased vasodilation
|
J:155025
|
\Ccl2tm1Rol/\Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
abnormal skeletal muscle morphology
|
J:118606
|
| impaired skeletal muscle regeneration
|
J:118606
|
| increased muscle weight
|
J:118606
|
| skeletal muscle necrosis
|
J:118606
|
\Ccm2tm1Mlkn/\Ccm2tm1Mlkn
\Nfatc1tm1.1(cre)Bz/\Nfatc1+
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:238897
|
\Ccm2tm1Sbn/\Ccm2tm1Sbn
(involves: C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:174085
|
\Ccm2tm2.1Sbn/\Ccm2tm2.1Sbn
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:174085
|
\Ccm2ltm1Mlkn/\Ccm2ltm1Mlkn
\Heg1tm1Mlkn/\Heg1tm1Mlkn
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:187714
|
| decreased heart left ventricle muscle contractility
|
J:187714
|
| thin myocardium
|
J:187714
|
| trabecula carnea hypoplasia
|
J:187714
|
\Ccm2ltm1Mlkn/\Ccm2ltm1Mlkn
\Heg1tm1Mlkn/\Heg1tm2.1Mlkn
\Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * SJL)
|
thin myocardium
|
J:187714
|
\Ccn3tm1Cabo/\Ccn3+
(involves: 129S/SvEv)
|
ventricular cardiomyopathy
|
J:135676
|
\Ccn3tm1Cabo/\Ccn3tm1Cabo
(involves: 129S/SvEv)
|
muscular atrophy
|
J:135676
|
| ventricular cardiomyopathy
|
J:135676
|
\Ccn3tm1Hko/\Ccn3tm1Hko
(B6.129-Ccn3tm1Hko)
|
increased vascular smooth muscle cell proliferation
|
J:172144
|
\Ccr2em1(IMPC)H/\Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
increased cardiac muscle contractility
|
J:211773
|
\Ccr5tm1Kuz/\Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz/J)
|
decreased skeletal muscle glycogen level
|
J:264446
|
\Ccr10/Cntnap1tm1Bhat/\Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
\Ccr10/Cntnap1tm1Bhat/\Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
\Cd36tm1Mfe/\Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle glycogen level
|
J:83611
|
| decreased cardiac muscle triglyceride level
|
J:83611
|
| increased cardiac muscle cell glucose uptake
|
J:83611
|
\Cd36tm1Mfe/\Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:220343
|
| decreased skeletal muscle cell glucose uptake
|
J:220343
|
| decreased skeletal muscle glycogen level
|
J:220343
|
\Cd36tm2.1Mfe/\Cd36tm2.1Mfe
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
decreased cardiac muscle triglyceride level
|
J:225392
|
\Cd44tm1Mak/\Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
\Cd47tm1Fpl/\Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:139652
|
| muscle phenotype
|
J:139652
|
\Cd55tm1Song/\Cd55tm1Song
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm)
|
abnormal muscle morphology
|
J:113567
|
| myositis
|
J:113567
|
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
myositis
|
J:113567
|
\Cd86tm1Shr/\Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
muscular atrophy
|
J:71352
|
\Cd163tm1(KOMP)Vlcg/\Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal gastrocnemius morphology
|
J:224919
|
| abnormal skeletal muscle satellite cell proliferation
|
J:224919
|
| enhanced skeletal muscle regeneration
|
J:224919
|
\Cdc26tm1b(EUCOMM)Hmgu/\Cdc26+
(C57BL/6N-Cdc26tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
\Cdc42tm1.1Yizh/\Cdc42+
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:174208
|
\Cdc42tm1.1Yizh/\Cdc42+
\Nkx2-5tm1Siz/\Nkx2-5+
(involves: 129S4/SvJaeSor)
|
decreased heart ventricle muscle contractility
|
J:174208
|
\Cdc73tm1Btt/\Cdc73tm1Btt
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased skeletal muscle mass
|
J:135255
|
\Cdh2tm1Glr/\Cdh2Gt(OST49160)Lex
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:98828
|
| abnormal myocardial fiber morphology
|
J:98828
|
| decreased heart left ventricle muscle contractility
|
J:98828
|
\Cdh2tm1Glr/\Cdh2tm1Hyn
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:98828
|
| abnormal myocardial fiber morphology
|
J:98828
|
| decreased heart left ventricle muscle contractility
|
J:98828
|
\Cdh2tm1Hyn/\Cdh2tm1Hyn
(involves: 129S2/SvPas)
|
abnormal myocardial fiber morphology
|
J:37888
|
| abnormal myocardium layer morphology
|
J:37888
|
\Cdk2tm1Kald/\Cdk2tm1Kald
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:108720
|
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm1Bbd/\Cdk4tm1Bbd
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased myocardial fiber number
|
J:124678
|
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm2.1Bbd/\Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:125217
|
\Cdk5rap1tm1.2Tomik/\Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik)
|
decreased cardiac muscle contractility
|
J:220703
|
| increased skeletal muscle fiber mitochondrial DNA content
|
J:220703
|
\Cdk10tm1.2Kald/\Cdk10tm1.2Kald
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal muscle morphology
|
J:262333
|
\Cdk13tm1a(EUCOMM)Hmgu/\Cdk13tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal myocardium layer morphology
|
J:291583
|
| thin myocardium
|
J:291583
|
\Cdkal1Gt(6062)Tgen/\Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
decreased skeletal muscle triglyceride level
|
J:195460
|
| increased skeletal muscle triglyceride level
|
J:195460
|
\Cdkn1atm1Led/\Cdkn1atm1Led
\Cdkn1ctm1Sje/\Cdkn1c+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:52552
|
| increased skeletal muscle fiber size
|
J:52552
|
| thin diaphragm muscle
|
J:52552
|
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Foxk1tm1Djg/\Foxk1tm1Djg
(involves: 129S2/SvPas * 129S4/SvJae)
|
muscle phenotype
|
J:81688
|
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Rb1tm1Tyj/\Rb1tm1Tyj
\Tg(Rb1)1Blg/0
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
| abnormal myogenesis
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Zfpm2tm1.1Esv/\Zfpm2tm1.1Esv
(involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:216295
|
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL)
|
abnormal fetal cardiomyocyte proliferation
|
J:57380
|
| decreased myocardial fiber size
|
J:57380
|
| increased myocardial fiber number
|
J:57380
|
\Cdkn1btm1Mlf/\Cdkn1b+
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Cdkn2dtm1Maro/\Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:58522
|
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
\Cdkn1ctm1Sje/\Cdkn1ctm1Sje
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:40203
|
\Cdkn2atm1.1Brn/\Cdkn2a+
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
\Cdkn2atm1.1Brn/\Cdkn2atm1.1Brn
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
\Cdkn2atm1Cjs/\Cdkn2a+
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Pax7tm1Pgr/\Pax7+
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Pax7tm1Pgr/\Pax7tm1Pgr
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
| skeletal muscle hyperplasia
|
J:237183
|
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Pdgfratm12Sor/\Pdgfra+
(involves: 129 * C57BL/6J * SJL)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(Mt1-Hgf)19Lmb/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
abnormal myogenesis
|
J:79704
|
| increased rhabdomyosarcoma incidence
|
J:79704
|
| increased satellite cell number
|
J:79704
|
\Cdkn2atm2Brn/\Cdkn2a+
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased uterus leiomyoma incidence
|
J:132943
|
\Cdkn2atm2Brn/\Cdkn2atm2Brn
\Nf2tm2Gth/\Nf2+
(involves: 129P2/OlaHsd)
|
increased uterus leiomyoma incidence
|
J:132943
|
\Cdkn2atm2Brn/\Cdkn2atm2Brn
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
| increased uterus leiomyoma incidence
|
J:132943
|
\Cdkn2atm4Rdp/\Cdkn2atm4Rdp
\Myf6tm1(cre)Mrc/\Myf6+
\Pax3tm1Mrc/\Pax3tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
\Cdkn2atm4Rdp/\Cdkn2atm4Rdp
\Nf1tm1Par/\Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ)
|
increased rhabdomyosarcoma incidence
|
J:234760
|
\Ceacam2tm1Snaj/\Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:181979
|
| increased skeletal muscle triglyceride level
|
J:181979
|
\Cebpatm6Nerl/\Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:120098
|
\Cebpbtm1Kish/\Cebpb+
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle mass
|
J:237461
|
\Cebpbtm1Nerl/\Cebpbtm1Nerl
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
muscle phenotype
|
J:153686
|
\Cebpbtm1Vpo/\Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
increased skeletal muscle cell glucose uptake
|
J:62132
|
\Cebpbtm3Nerl/\Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
|
calcified muscle
|
J:153686
|
| decreased skeletal muscle fiber size
|
J:153686
|
| impaired skeletal muscle regeneration
|
J:153686
|
| myositis
|
J:153686
|
| skeletal muscle fibrosis
|
J:153686
|
\Celf4tm1a(EUCOMM)Wtsi/\Celf4tm1a(EUCOMM)Wtsi
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Cenpftm1Dbdr/\Cenpftm1Dbdr
\Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2 * ICR)
|
abnormal intercalated disk morphology
|
J:185133
|
| abnormal myocardial fiber morphology
|
J:185133
|
| decreased fetal cardiomyocyte proliferation
|
J:185133
|
| dilated cardiomyopathy
|
J:185133
|
| myocardial trabeculae hypoplasia
|
J:185133
|
\Cept1tm1.1Sem/\Cept1tm1.1Sem
\Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
muscle weakness
|
J:249456
|
\Cert1Gt(RRF047)Byg/\Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:146172
|
\Cert1tm1.1Jsau/\Cert1tm1.1Jsau
(involves: 129S/SvEv * BALB/cJ * C57BL/6)
|
abnormal muscle development
|
J:177789
|
\Cert1tm1a(KOMP)Wtsi/\Cert1tm1a(KOMP)Wtsi
(C57BL/6N-Cert1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal pectinate muscle morphology
|
J:239583
|
\Cfap57em1(IMPC)Mbp/\Cfap57em1(IMPC)Mbp
(C57BL/6NCrl-Cfap57em1(IMPC)Mbp/Mmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Cfap276em1Fuxi/\Cfap276+
(C57BL/6J-Cfap276em1Fuxi)
|
skeletal muscle atrophy
|
J:283448
|
\Cfap276em1Fuxi/\Cfap276em1Fuxi
(C57BL/6J-Cfap276em1Fuxi)
|
skeletal muscle atrophy
|
J:283448
|
\Cfap276em2.1Fuxi/\Cfap276+
(involves: C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:295996
|
\Cfap276em2.1Fuxi/\Cfap276em2.1Fuxi
(involves: C57BL/6J)
|
muscular atrophy
|
J:295996
|
| skeletal muscle fiber atrophy
|
J:295996
|
\Cfhtm1.1Song/\Cfhtm1.1Song
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:240426
|
\Cfl2tm1.1Itl/\Cfl2tm1.1Itl
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal sarcomere morphology
|
J:182571
|
| abnormal skeletal muscle fiber morphology
|
J:182571
|
| abnormal skeletal muscle fiber type ratio
|
J:182571
|
| abnormal skeletal muscle morphology
|
J:182571
|
| muscle weakness
|
J:182571
|
| skeletal muscle fiber degeneration
|
J:182571
|
\Cfl2tm1Itl/\Cfl2tm1Itl
\Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * C57BL/6NTac * SJL)
|
abnormal sarcomere morphology
|
J:182571
|
| abnormal skeletal muscle fiber morphology
|
J:182571
|
| abnormal skeletal muscle morphology
|
J:182571
|
\Cfl2tm1Itl/\Cfl2tm1Itl
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6NTac * FVB/N)
|
abnormal skeletal muscle morphology
|
J:182571
|
| abnormal Z line morphology
|
J:182571
|
| skeletal muscle fiber degeneration
|
J:182571
|
\Cfl2tm1Itl/\Cfl2tm1Itl
\Tg(Mef2c-cre)1Blk/0
(involves: C57BL/6NTac)
|
abnormal skeletal muscle morphology
|
J:182571
|
| abnormal Z line morphology
|
J:182571
|
\Cflartm1Mak/\Cflartm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal myocardial trabeculae morphology
|
J:63049
|
| thin myocardium
|
J:63049
|
\Chat/Slc18a3tm1.1Vpra/\Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:153908
|
| hypotonia
|
J:153908
|
| skeletal muscle atrophy
|
J:153908
|
| skeletal muscle fiber atrophy
|
J:153908
|
\Chat/Slc18a3tm1.1Vpra/\Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:153908
|
| hypotonia
|
J:153908
|
| skeletal muscle atrophy
|
J:153908
|
| skeletal muscle fiber atrophy
|
J:153908
|
\Chattm1.1Jrs/\Chattm1.1Jrs
(Not Specified)
|
abnormal muscle morphology
|
J:91066
|
| diaphragmatic hernia
|
J:91066
|
| thin diaphragm muscle
|
J:91066
|
\Chattm1Mlt/\Chattm1Mlt
\Tg(SLC18A3-cre)KMisa/0
(involves: 129 * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:212048
|
| abnormal muscle morphology
|
J:212048
|
| abnormal soleus morphology
|
J:212048
|
| muscle weakness
|
J:212048
|
| muscular atrophy
|
J:212048
|
| skeletal muscle endomysial fibrosis
|
J:212048
|
| skeletal muscle fibrosis
|
J:212048
|
\Chchd10em3Dpn/\Chchd10em3Dpn
(C57BL/6J-Chchd10em3Dpn)
|
abnormal tibialis anterior morphology
|
J:344465
|
| decreased myocardial fiber mitochondrial DNA content
|
J:344465
|
| decreased skeletal muscle fiber size
|
J:344465
|
| myopathy
|
J:344465
|
\Chchd10em3Dpn/\Chchd10em3Dpn
\Oma1tm1Otin/\Oma1+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal muscle fiber mitochondrial morphology
|
J:344465
|
\Chchd10em8Lutzy/\Chchd10+
(C57BL/6NJ-Chchd10em8Lutzy/J)
|
abnormal sarcomere morphology
|
J:272524
|
| abnormal skeletal muscle fiber morphology
|
J:272524
|
| centrally nucleated skeletal muscle fibers
|
J:272524
|
| decreased skeletal muscle mass
|
J:272524
|
\Chd2Gt(RRBO46)Byg/\Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
cardiomyopathy
|
J:146743
|
| myocardial fiber degeneration
|
J:146743
|
\Chd4em1Flc/\Chd4em1Flc
(C57BL/6J-Chd4em1Flc)
|
abnormal myocardial fiber morphology
|
J:338019
|
| abnormal myocardial trabeculae morphology
|
J:338019
|
| abnormal skeletal muscle fiber morphology
|
J:338019
|
| abnormal Z line morphology
|
J:338019
|
| decreased heart left ventricle muscle contractility
|
J:338019
|
| decreased skeletal muscle fiber number
|
J:338019
|
| increased fetal cardiomyocyte proliferation
|
J:338019
|
| increased skeletal muscle fiber size
|
J:338019
|
| thin myocardium compact layer
|
J:338019
|
\Chd7tm2a(EUCOMM)Wtsi/\Chd7tm2a(EUCOMM)Wtsi
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:207089
|
| increased cardiomyocyte apoptosis
|
J:207089
|
| thin myocardium
|
J:207089
|
\Chd7tm2a(EUCOMM)Wtsi/\Chd7tm2a(EUCOMM)Wtsi
\Mesp1tm2(cre)Ysa/\Mesp1+
(involves: C57BL/6J * C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardial trabeculae morphology
|
J:225736
|
| abnormal myocardium compact layer morphology
|
J:225736
|
| thin ventricle myocardium compact layer
|
J:225736
|
\Chd7tm2a(EUCOMM)Wtsi/\Chd7tm2a(EUCOMM)Wtsi
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal myocardium compact layer morphology
|
J:225736
|
\Chgatm1Skmt/\Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J)
|
heart left ventricle hypertrophy
|
J:99805
|
\Chkbrmd/\Chkbrmd
(involves: BALB/cByJ * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:108320
|
| abnormal muscle physiology
|
J:108320
|
| abnormal sarcolemma morphology
|
J:108320
|
| abnormal skeletal muscle fiber morphology
|
J:108320
|
| centrally nucleated skeletal muscle fibers
|
J:108320
|
| dystrophic muscle
|
J:108320
|
| muscle degeneration
|
J:108320
|
\Chn1Gt714Lex/\Chn1Gt714Lex
(involves: 129S5/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:128698
|
\Chrdtm1Emdr/\Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
heart right ventricle hypertrophy
|
J:83662
|
| increased vasodilation
|
J:83662
|
\Chrm2tm1Jwe/\Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
impaired smooth muscle contractility
|
J:60451,
J:125455
|
\Chrm2tm1Minm/\Chrm2tm1Minm
(involves: 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:99247
|
\Chrm2tm1Minm/\Chrm2tm1Minm
\Chrm3tm1Mmt/\Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
| impaired smooth muscle contractility
|
J:99247
|
\Chrm3tm1Jwe/\Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased vasodilation
|
J:102321
|
| impaired smooth muscle contractility
|
J:125455
|
\Chrm3tm1Jwe/\Chrm3tm1Jwe
(involves: 129S6/SvEvTac)
|
impaired smooth muscle contractility
|
J:113518
|
\Chrm3tm1Mmt/\Chrm3tm1Mmt
(involves: 129X1/SvJ)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
| impaired smooth muscle contractility
|
J:99247
|
\Chrm3tm1Mmt/\Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:64069
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:64069
|
\Chrm4tm1Jwe/\Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
impaired smooth muscle contractility
|
J:125455
|
| muscle phenotype
|
J:60451
|
\Chrm5tm1Jwe/\Chrm5tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal vasodilation
|
J:72953
|
\Chrna3tm1Bay/\Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle phenotype
|
J:54994
|
\Chrnb2tm1Mdb/\Chrnb2tm1Mdb
\Chrnb4tm1Mdb/\Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
intestinal hypoperistalsis
|
J:73590
|
| muscle phenotype
|
J:73590
|
\Chrnetm1Jrs/\Chrnetm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
skeletal muscle atrophy
|
J:74958
|
\Chrnetm1Vwi/\Chrnetm1Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:36557
|
| decreased muscle weight
|
J:36557
|
| impaired skeletal muscle contractility
|
J:36557
|
| skeletal muscle atrophy
|
J:36557
|
\Chrnetm2Vwi/\Chrnetm2Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:182046
|
| impaired skeletal muscle contractility
|
J:182046
|
\Chrngtm1(Chrne)Mknn/\Chrngtm1(Chrne)Mknn
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:105142
|
\Chrngtm1Mtak/\Chrngtm1Mtak
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:99894
|
| abnormal muscle physiology
|
J:99894
|
| abnormal skeletal muscle fiber morphology
|
J:99894
|
| increased variability of skeletal muscle fiber size
|
J:99894
|
\Chrngtm2(Chrne)Vwi/\Chrngtm2(Chrne)Vwi
(involves: C57BL/6)
|
thin diaphragm muscle
|
J:169541
|
\Chst11tm1a(KOMP)Wtsi/\Chst11tm1a(KOMP)Wtsi
(C57BL/6N-Chst11tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle topology
|
J:239583
|
\Chtoptm1a(EUCOMM)Wtsi/\Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal abdominal muscle morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
\Cibar1tm1b(KOMP)Wtsi/\Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
calcified tendon
|
J:274784
|
\Cir1tm3a(KOMP)Wtsi/\Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Cirbilem1Cya/\Cirbilem1Cya
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
| increased cardiomyocyte apoptosis
|
J:301260
|
\Cisd2Gt(XS0445)Wtsi/\Cisd2Gt(XS0445)Wtsi
(B6.129P2-Cisd2Gt(XS0445)Wtsi)
|
abnormal sarcomere morphology
|
J:183788
|
| abnormal skeletal muscle fiber morphology
|
J:183788
|
| abnormal skeletal muscle fiber type ratio
|
J:183788
|
| abnormal skeletal muscle morphology
|
J:183788
|
| dilated sarcoplasmic reticulum
|
J:183788
|
| impaired skeletal muscle contractility
|
J:183788
|
| muscle phenotype
|
J:183788
|
\Cisd2tm1Tfts/\Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
abnormal muscle fiber morphology
|
J:148467
|
| abnormal myocardium layer morphology
|
J:148467
|
| muscle degeneration
|
J:148467
|
\Cittm1Fdc/\Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
myoclonus
|
J:77297
|
\Ckmtm1Bew/\Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:76699
|
| decreased cardiac muscle contractility
|
J:76204
|
| impaired skeletal muscle contractility
|
J:76699,
J:20440
|
| increased skeletal muscle glycogen level
|
J:76699
|
\Ckmtm1Bew/\Ckmtm1Bew
\Ckmt2tm1Bew/\Ckmt2tm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:106327
|
| decreased skeletal muscle mass
|
J:106327
|
| heart left ventricle hypertrophy
|
J:101961
|
| impaired skeletal muscle contractility
|
J:106327
|
\Ckmtm1Bew/\Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
\Ckmtm2Bew/\Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
\Ckmt2tm1Bew/\Ckmt2tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:101961
|
| muscle phenotype
|
J:76886
|
\cl/\cl
(Not Specified)
|
decreased skeletal muscle mass
|
J:294
|
\Clcc1m1J/\Clcc1m1J
(B6.C3Sn(Cg)-Clcc1m1J/SlacJ)
|
decreased skeletal muscle fiber diameter
|
J:218443
|
| muscular atrophy
|
J:218443
|
| skeletal muscle atrophy
|
J:218443
|
| skeletal muscle fiber atrophy
|
J:218443
|
\Clcn1adr-mto2J/\Clcn1adr-mto2J
(BALB/cByJ-Clcn1adr-mto2J)
|
impaired muscle relaxation
|
J:112061
|
\Clcn1adr-mto7J/\Clcn1adr-mto7J
(C57BL/6J-Clcn1adr-mto7J/J)
|
muscle spasm
|
J:82238
|
\Clcn1adr-mto8J/\Clcn1adr-mto8J
(B6;C3Fe-Clcn1adr-mto8J/CxJ)
|
muscle spasm
|
J:120858
|
\Clcn1adr-mto9J/\Clcn1adr-mto9J
(C57BL/6J-Clcn1adr-mto9J/J)
|
impaired muscle relaxation
|
J:134519
|
\Clcn1adr-mto/\Clcn1adr-mto
(SWR/J-Clcn1adr-mto/J)
|
abnormal muscle electrophysiology
|
J:6814,
J:14251
|
| abnormal muscle physiology
|
J:6814
|
| impaired muscle relaxation
|
J:14251
|
| increased skeletal muscle mass
|
J:6814
|
| muscle phenotype
|
J:6814
|
\Clcn1adr/\Clcn1adr
(A2G-Clcn1adr)
|
abnormal muscle electrophysiology
|
J:25830
|
| abnormal muscle physiology
|
J:4480,
J:25830
|
| abnormal skeletal muscle morphology
|
J:25829
|
| impaired muscle relaxation
|
J:25830
|
| impaired skeletal muscle contractility
|
J:25830
|
| muscle twitch
|
J:7524
|
\Clcn1m1Anu/\Clcn1m1Anu
(involves: C57BL/6 * CBA/H)
|
muscle hypertonia
|
J:104190
|
\Clcn3tm1.1Jrhm/\Clcn3tm1.1Jrhm
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-cre)3Jig/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:222375
|
| dilated cardiomyopathy
|
J:222375
|
| myocardium hypertrophy
|
J:222375
|
\Cldn12tm1.1(KOMP)Vlcg/\Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:279934
|
\Clec9atm1b(KOMP)Wtsi/\Clec9atm1b(KOMP)Wtsi
(C57BL/6N-Clec9atm1b(KOMP)Wtsi/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
\Clip3tm1.1Ics/\Clip3tm1.1Ics
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:194894
|
| impaired muscle contractility
|
J:194894
|
\Clmptm1.1Fgr/\Clmptm1.1Fgr
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
| abnormal intestinal smooth muscle morphology
|
J:258315
|
| abnormal muscle tone
|
J:258315
|
| impaired ureteric peristalsis
|
J:258315
|
\Clmptm1Fgr/\Clmptm1Fgr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
| impaired ureteric peristalsis
|
J:258315
|
\Clnkem1(IMPC)Ccpcz/\Clnkem1(IMPC)Ccpcz
(C57BL/6NCrl-Clnkem1(IMPC)Ccpcz/Ccpcz)
|
decreased skeletal muscle mass
|
J:211773
|
\Clp1tm1.1Pngr/\Clp1tm1.1Pngr
(CBA.Cg-Clp1tm1.1Pngr)
|
progressive muscle weakness
|
J:196364
|
| skeletal muscle atrophy
|
J:196364
|
\Clp1tm1.1Pngr/\Clp1tm1.1Pngr
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J)
|
muscle phenotype
|
J:196364
|
\Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle physiology
|
J:148522
|
\Clutm1Jakh/\Clutm1Jakh
(involves: Black Swiss * FVB/N)
|
abnormal myocardial fiber morphology
|
J:65660
|
| abnormal myocardium layer morphology
|
J:65660
|
| decreased cardiac muscle contractility
|
J:65660
|
| decreased myocardial fiber number
|
J:65660
|
\Cmahtm1Avrk/\Cmahtm1Avrk
\Dmdmdx/\Dmdmdx
(involves: 129X1/SvJ * C57BL/10ScSn)
|
cardiac muscle necrosis
|
J:164594
|
| dystrophic muscle
|
J:164594
|
| muscle weakness
|
J:164594
|
| skeletal muscle fibrosis
|
J:164594
|
\Cmn1CAST/Ei/?
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\MnmC/\MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
\Cmn2CAST/Ei/?
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\MnmC/\MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
\Cmn3C57BL/6J/?
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\MnmC/\MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
\Cmn3CAST/Ei/?
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\MnmC/\MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
\Cmtm3em1Wlh/\Cmtm3em1Wlh
(involves: C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:338327
|
| decreased cardiac muscle contractility
|
J:338327
|
| increased cardiac muscle contractility
|
J:338327
|
| increased myocardial fiber size
|
J:338327
|
| myocardial fiber disarray
|
J:338327
|
| myocardium hypertrophy
|
J:338327
|
\cmy1/\cmy1
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
| dilated cardiomyopathy
|
J:149470
|
\cmy2/\cmy2
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
| dilated cardiomyopathy
|
J:149470
|
\Cmya5tm1Cap/\Cmya5tm1Cap
(129-Cmya5tm1Cap)
|
abnormal cardiac muscle tissue morphology
|
J:322761
|
| abnormal gastrocnemius morphology
|
J:322761
|
| abnormal intercalated disk morphology
|
J:322761
|
| abnormal sarcoplasmic reticulum morphology
|
J:322761
|
| abnormal soleus morphology
|
J:322761
|
| decreased heart ventricle muscle contractility
|
J:322761
|
\Cnot1tm1Tya/\Cnot1tm1Tya
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
\Cnot3tm1.1Kjkb/\Cnot3tm1.1Kjkb
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| cardiomyopathy
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
| decreased myocardial fiber number
|
J:260012
|
| muscle phenotype
|
J:260012
|
\Cnot3tm1Pngr/\Cnot3+
(B6.Cg-Cnot3tm1Pngr)
|
decreased cardiac muscle contractility
|
J:167954
|
| decreased heart left ventricle muscle contractility
|
J:167954
|
\Cnptm1(cre)Kan/\Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle weakness
|
J:91814
|
\Cntftm1Mpin/\Cntftm1Mpin
(involves: 129S2/SvPas)
|
muscle weakness
|
J:15313
|
\Cntn1m1J/\Cntn1m1J
(B6;C-Cntn1m1J/GrsrJ)
|
muscle phenotype
|
J:178817
|
\Cntnap1em1Bhat/\Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
\Cntnap1em2Bhat/\Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
\Cntnap1tm1Bhat/\Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:107653
|
\Coa8em1Zev/\Coa8em1Zev
(FVB/NJ-Coa8em1Zev)
|
muscle phenotype
|
J:277865
|
\Coasytm1.1Vtr/\Coasytm1.1Vtr
\Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6N * CBA)
|
dystonia
|
J:299154
|
\cod/\cod
(Not Specified)
|
decreased skeletal muscle fiber diameter
|
J:13460
|
\Col1a1Aga2/\Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
|
abnormal myocardium layer morphology
|
J:185988
|
| decreased heart left ventricle muscle contractility
|
J:185988
|
| heart right ventricle hypertrophy
|
J:185988
|
\Col1a1M1Jrt/\Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
|
abnormal tendon collagen fibril morphology
|
J:216423
|
| decreased tendon stiffness
|
J:216423
|
| myocardium hypertrophy
|
J:216423
|
\Col1a1tm2(CAG-IDH2*R172K)Kkw/\Col1a1+
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:209629
|
| abnormal myocardial fiber morphology
|
J:209629
|
| abnormal sarcomere morphology
|
J:209629
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:209629
|
| abnormal skeletal muscle morphology
|
J:209629
|
| abnormal Z line morphology
|
J:209629
|
| decreased cardiac muscle contractility
|
J:209629
|
| dilated cardiomyopathy
|
J:209629
|
| increased cardiac muscle glycogen level
|
J:209629
|
| increased cardiomyocyte apoptosis
|
J:209629
|
| increased skeletal muscle glycogen level
|
J:209629
|
| skeletal muscle endomysial fibrosis
|
J:209629
|
| skeletal muscle fiber degeneration
|
J:209629
|
| skeletal muscle fiber necrosis
|
J:209629
|
\Col1a1tm3(CAG-IDH2*R140Q)Kkw/\Col1a1+
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:209629
|
| abnormal myocardial fiber morphology
|
J:209629
|
| abnormal sarcomere morphology
|
J:209629
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:209629
|
| abnormal skeletal muscle morphology
|
J:209629
|
| abnormal Z line morphology
|
J:209629
|
| decreased cardiac muscle contractility
|
J:209629
|
| dilated cardiomyopathy
|
J:209629
|
| increased cardiomyocyte apoptosis
|
J:209629
|
| increased skeletal muscle glycogen level
|
J:209629
|
\Col1a2oim/\Col1a2oim
(involves: C3H/HeJ * C57BL/6JLe)
|
decreased tendon stiffness
|
J:41509
|
\Col1a2oim/\Col1a2oim
(B6C3Fe a/a-Col1a2oim/J)
|
abnormal tendon morphology
|
J:124000
|
\Col3a1m1Lsmi/\Col3a1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:180733
|
| increased vasoconstriction
|
J:180733
|
\Col3a1tm1Jae/\Col3a1tm1Jae
(involves: 129S4/SvJae)
|
muscle phenotype
|
J:39273
|
\Col4a1deltaex40/\Col4a1+
(involves: 129S/SvEv * C57BL/6J)
|
myopathy
|
J:172720
|
\Col4a1deltaex40/\Col4a1+
(involves: 129S/SvEv * C57BL/6J * CAST/EiJ)
|
myopathy
|
J:172720
|
\Col4a1tm1.1Ics/\Col4a1+
(involves: 129S2/SvPas * C57BL/6)
|
dystrophic muscle
|
J:240798
|
\Col4a1tm1.1Ics/\Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
dystrophic muscle
|
J:240798
|
\Col4a2em1(IMPC)Wtsi/\Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
abnormal eye muscle morphology
|
J:239583
|
\Col5a3tm1Dgr/\Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased skeletal muscle cell glucose uptake
|
J:171817
|
\Col6a1tm1Gmb/\Col6a1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:51410
|
| abnormal intercostal muscle morphology
|
J:51410
|
| centrally nucleated skeletal muscle fibers
|
J:51410
|
| myopathy
|
J:51410
|
| skeletal muscle necrosis
|
J:51410
|
\Col6a1tm1Gmb/\Col6a1tm1Gmb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:51410
|
| abnormal intercostal muscle morphology
|
J:51410
|
| abnormal muscle morphology
|
J:51410
|
| abnormal skeletal muscle morphology
|
J:86734
|
| impaired skeletal muscle contractility
|
J:86734
|
| muscle phenotype
|
J:51410
|
| myopathy
|
J:51410
|
| skeletal muscle necrosis
|
J:51410
|
\Col6a1tm1Sngi/\Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi)
|
abnormal muscle development
|
J:278926
|
| abnormal skeletal muscle fiber morphology
|
J:278926
|
| abnormal skeletal muscle morphology
|
J:278926
|
| decreased skeletal muscle fiber number
|
J:278926
|
| decreased skeletal muscle mass
|
J:278926
|
| decreased skeletal muscle size
|
J:278926
|
| impaired skeletal muscle contractility
|
J:278926
|
| increased variability of skeletal muscle fiber size
|
J:278926
|
| muscle weakness
|
J:278926
|
| skeletal muscle endomysial fibrosis
|
J:278926
|
\Col6a3tm1Chu/\Col6a3tm1Chu
(B6.129-Col6a3tm1Chu)
|
abnormal muscle physiology
|
J:198581
|
| abnormal skeletal muscle regeneration
|
J:198581
|
| abnormal tendon collagen fibril morphology
|
J:198581
|
| centrally nucleated skeletal muscle fibers
|
J:198581
|
| decreased skeletal muscle weight
|
J:198581
|
| increased collagen deposition in the muscles
|
J:198581
|
| increased variability of skeletal muscle fiber size
|
J:198581
|
| myopathy
|
J:198581
|
| skeletal muscle interstitial fibrosis
|
J:198581
|
\Col6a3tm2.1Chu/\Col6a3+
(B6.129(Cg)-Col6a3tm2.1Chu)
|
abnormal muscle fiber morphology
|
J:208903
|
| abnormal tendon cell morphology
|
J:208903
|
| abnormal tendon collagen fibril morphology
|
J:208903
|
| abnormal tendon morphology
|
J:208903
|
| centrally nucleated skeletal muscle fibers
|
J:208903
|
| dilated sarcoplasmic reticulum
|
J:208903
|
| impaired skeletal muscle contractility
|
J:208903
|
| increased variability of skeletal muscle fiber size
|
J:208903
|
| myopathy
|
J:208903
|
\Col6a3tm2.1Chu/\Col6a3tm2.1Chu
(B6.129(Cg)-Col6a3tm2.1Chu)
|
abnormal muscle fiber morphology
|
J:208903
|
| abnormal tendon cell morphology
|
J:208903
|
| abnormal tendon collagen fibril morphology
|
J:208903
|
| abnormal tendon morphology
|
J:208903
|
| centrally nucleated skeletal muscle fibers
|
J:208903
|
| dilated sarcoplasmic reticulum
|
J:208903
|
| increased variability of skeletal muscle fiber size
|
J:208903
|
| myopathy
|
J:208903
|
\Col12a1tm1Debi/\Col12a1tm1Debi
(Not Specified)
|
abnormal muscle physiology
|
J:209074
|
| abnormal quadriceps morphology
|
J:209074
|
| abnormal sarcolemma morphology
|
J:209074
|
| abnormal skeletal muscle morphology
|
J:209074
|
| decreased skeletal muscle weight
|
J:209074
|
\Col13a1tm1Pih/\Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
abnormal sarcolemma morphology
|
J:71939
|
| abnormal skeletal muscle fiber morphology
|
J:71939
|
| abnormal skeletal muscle morphology
|
J:71939
|
| abnormal Z line morphology
|
J:71939
|
| decreased skeletal muscle fiber diameter
|
J:71939
|
| muscle degeneration
|
J:71939
|
| myopathy
|
J:71939
|
| myositis
|
J:71939
|
\Col13a1tm3.1Pih/\Col13a1tm3.1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:242846
|
| abnormal skeletal muscle fiber morphology
|
J:242846
|
| abnormal skeletal muscle fiber type ratio
|
J:242846
|
| abnormal soleus morphology
|
J:242846
|
| centrally nucleated skeletal muscle fibers
|
J:242846
|
| decreased soleus weight
|
J:242846
|
| muscle weakness
|
J:242846
|
| skeletal muscle fiber atrophy
|
J:242846
|
\Col13a1tm4.1Pih/\Col13a1tm4.1Pih
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:242846
|
| abnormal skeletal muscle fiber morphology
|
J:242846
|
| centrally nucleated skeletal muscle fibers
|
J:242846
|
\Col14a1tm1Debi/\Col14a1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased tendon stiffness
|
J:148619
|
\Col14a1tm1Debi/\Col14a1tm1Debi
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:148619
|
| abnormal tendon morphology
|
J:148619
|
| decreased tendon stiffness
|
J:148619
|
\Col15a1tm1Pih/\Col15a1tm1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle fiber morphology
|
J:67212
|
| abnormal muscle morphology
|
J:67212
|
| enhanced skeletal muscle regeneration
|
J:67212
|
| myopathy
|
J:67212
|
\Col19a1tm1Rmz/\Col19a1tm1Rmz
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
abnormal esophageal smooth muscle morphology
|
J:92510
|
\Col19a1tm2Rmz/\Col19a1tm2Rmz
(involves: 129T2/SvEmsJ)
|
impaired muscle relaxation
|
J:92510
|
\Col25a1tm1.1Tiwa/\Col25a1tm1.1Tiwa
(B6.Cg-Col25a1tm1.1Tiwa)
|
abnormal skeletal muscle morphology
|
J:206855
|
| centrally nucleated skeletal muscle fibers
|
J:206855
|
| decreased skeletal muscle fiber diameter
|
J:206855
|
\Commd9Gt(AQ0362)Wtsi/\Commd9Gt(AQ0362)Wtsi
(involves: 129P2/OlaHsd)
|
myocardium necrosis
|
J:230747
|
\Comptm1Mbri/\Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal tendon morphology
|
J:154984
|
| centrally nucleated skeletal muscle fibers
|
J:154984
|
| decreased tendon stiffness
|
J:154984
|
| increased muscle fatigability
|
J:154984
|
| myopathy
|
J:154984
|
\Coq8atm1.1Ics/\Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
abnormal skeletal muscle morphology
|
J:249129
|
| skeletal muscle fiber degeneration
|
J:249129
|
\Coq9tm1.1Lcl/\Coq9tm1.1Lcl
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
myopathy
|
J:193288
|
\Corintm1Qwu/\Corintm1Qwu
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:96458
|
\Coro1ctm1a(KOMP)Wtsi/\Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Cox6a1tm1(KOMP)Wtsi/\Cox6a1tm1(KOMP)Wtsi
(involves: C57BL/6JJcl * C57BL/6N)
|
abnormal muscle morphology
|
J:230212
|
| muscular atrophy
|
J:230212
|
\Cox7a1tm1Hutt/\Cox7a1+
(B6.129-Cox7a1tm1Hutt)
|
decreased heart ventricle muscle contractility
|
J:192141
|
\Cox7a1tm1Hutt/\Cox7a1tm1Hutt
(B6.129-Cox7a1tm1Hutt)
|
decreased heart ventricle muscle contractility
|
J:192141
|
| dilated cardiomyopathy
|
J:192141
|
\Cox7a2lGt(OST241316)Lex/\Cox7a2lGt(OST241316)Lex
(B6.129S5-Cox7a2lGt(OST241316)Lex)
|
decreased quadriceps weight
|
J:215964
|
\Cox10tm1Ctm/\Cox10tm1Ctm
\Myl1tm1(cre)Sjb/\Myl1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:101747
|
| decreased skeletal muscle mass
|
J:101747
|
| increased muscle fatigability
|
J:101747
|
| increased variability of skeletal muscle fiber size
|
J:101747
|
| myopathy
|
J:101747
|
\Cox15tm1.1Zev/\Cox15tm1.1Zev
\Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle fiber mitochondrial morphology
|
J:176080
|
| centrally nucleated skeletal muscle fibers
|
J:176080
|
| increased variability of skeletal muscle fiber size
|
J:176080
|
| myopathy
|
J:176080
|
\Cpaptm1a(EUCOMM)Wtsi/\Cpaptm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cpaptm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal myocardial fiber morphology
|
J:194085
|
\Cpetm1Yplo/\Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:95741
|
\Cpeb4tm1a(EUCOMM)Wtsi/\Cpeb4tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6NTac)
|
muscle phenotype
|
J:236098
|
\Cpt1ctm1Dhwu/\Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:148205
|
\Crattm1.1Pbrc/\Crattm1.1Pbrc
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
abnormal muscle physiology
|
J:184778
|
\Creb1tm1.1Berd/\Creb1tm1.1Berd
(B6NHsd.129S4-Creb1tm1.1Berd)
|
abnormal myotube morphology
|
J:177923
|
| enhanced skeletal muscle regeneration
|
J:177923
|
| increased myoblast proliferation
|
J:177923
|
| muscle phenotype
|
J:177923
|
\Creb1tm1.1Berd/\Creb1tm1.1Berd
\Dmdmdx/Y
(B.Cg-Creb1tm1.1Berd Dmdmdx)
|
enhanced skeletal muscle regeneration
|
J:177923
|
| skeletal muscle degeneration
|
J:177923
|
\Creb3Gt1Mbac/\Creb3+
(B6NTac.Cg-Creb3Gt1Mbac)
|
decreased skeletal muscle triglyceride level
|
J:345514
|
\Crebbptm1Reck/\Crebbp+
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:85950
|
| thin ventricle myocardium compact layer
|
J:85949
|
\Creg1tm1Yal/\Creg1+
(involves: 129 * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:253911
|
| increased cardiomyocyte apoptosis
|
J:253911
|
\Creld1tm1c(EUCOMM)Wtsi/\Creld1tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:304446
|
| ventricle myocardium hypoplasia
|
J:304446
|
\Cremtm1Gsc/\Cremtm1Gsc
(involves: 129 * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:81241
|
\Crim1em1(IMPC)Wtsi/\Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
|
telangiectasia
|
J:239583
|
\Crim1Gt(KST264)Byg/\Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
impaired ureteric peristalsis
|
J:187026
|
\Crktm1.1Cur/\Crktm1.1Cur
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:111399
|
| increased vasodilation
|
J:111399
|
\cro/?
(involves: C57BL/6J * CBA/J)
|
muscle phenotype
|
J:104881
|
\Crppaem2Mbp/\Crppaem2Mbp
\Myf5tm3(cre)Sor/\Myf5+
(B6.Cg-Myf5tm3(cre)Sor Crppaem2Mbp)
|
abnormal skeletal muscle morphology
|
J:324289
|
| centrally nucleated skeletal muscle fibers
|
J:324289
|
| decreased skeletal muscle weight
|
J:324289
|
| dystrophic muscle
|
J:324289
|
| increased variability of skeletal muscle fiber size
|
J:324289
|
| skeletal muscle fiber necrosis
|
J:324289
|
| skeletal muscle fibrosis
|
J:324289
|
\Crtc3tm1Mmy/\Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle cell glucose uptake
|
J:167211
|
\Cry1tm1Asn/\Cry1tm1Asn
\Cry2tm1Hnos/\Cry2tm1Hnos
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasoconstriction
|
J:134129
|
\Cryabem1Mtc/\Cryabem1Mtc
(involves: C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:342762
|
| myocardium hypertrophy
|
J:342762
|
\Cryabtm1.1Ady/\Cryab+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:171679
|
| myopathy
|
J:171679
|
| skeletal muscle fiber necrosis
|
J:171679
|
| skeletal muscle fibrosis
|
J:171679
|
\Cryabtm1.1Ady/\Cryabtm1.1Ady
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:171679
|
| myopathy
|
J:171679
|
| skeletal muscle fiber necrosis
|
J:171679
|
| skeletal muscle fibrosis
|
J:171679
|
\Csde1tm1Fda/\Csde1tm1Fda
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:252972
|
\Csf1op/\Csf1op
(B6C3Fe a/a-Csf1op/J)
|
abnormal masseter muscle morphology
|
J:20589
|
\Csnk1a1tm1c(KOMP)Wtsi/\Csnk1a1tm1c(KOMP)Wtsi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal myocardium layer morphology
|
J:216977
|
\Csnk1g2tm1b(EUCOMM)Wtsi/\Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
\Csnk2a1tm1Dcs/\Csnk2a1tm1Dcs
(involves: 129S6/SvEvTac * C57BL/6)
|
trabecula carnea hypoplasia
|
J:129208
|
\Csrp1tm1Mbk/\Csrp1tm1Mbk
(B6.129-Csrp1tm1Mbk)
|
muscle phenotype
|
J:172149
|
\Csrp2tm1Rawe/\Csrp2tm1Rawe
(B6.129X1-Csrp2tm1Rawe)
|
abnormal intercalated disk morphology
|
J:138969
|
| increased myocardial fiber size
|
J:138969
|
\Csrp2tm1Sfy/\Csrp2tm1Sfy
(B6.129S2-Csrp2tm1Sfy)
|
abnormal vascular smooth muscle physiology
|
J:117557
|
\Csrp3tm1.1Kage/\Csrp3tm1.1Kage
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal cardiac muscle relaxation
|
J:307893
|
| decreased heart left ventricle muscle contractility
|
J:307893
|
\Csrp3tm1.1Rkn/\Csrp3+
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
cardiomyopathy
|
J:170878
|
| increased cardiac muscle contractility
|
J:170878
|
\Csrp3tm1.1Rkn/\Csrp3tm1.1Rkn
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
abnormal skeletal muscle fiber morphology
|
J:170878
|
| cardiomyopathy
|
J:170878
|
| increased cardiac muscle contractility
|
J:170878
|
| increased variability of skeletal muscle fiber size
|
J:170878
|
| myocardial fiber disarray
|
J:170878
|
| myopathy
|
J:170878
|
\Csrp3tm1Crni/\Csrp3tm1Crni
(Not Specified)
|
abnormal intercalated disk morphology
|
J:138969
|
| decreased cardiac muscle contractility
|
J:88510,
J:66250
|
| decreased heart ventricle muscle contractility
|
J:38213
|
| dilated cardiomyopathy
|
J:38213,
J:88510,
J:66250
|
| increased myocardial fiber size
|
J:138969
|
\Csrp3tm1Crni/\Csrp3tm1Crni
\Plntm1Egk/\Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:58299
|
\Csrp3tm1Crni/\Csrp3tm1Crni
\Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
decreased heart ventricle muscle contractility
|
J:48062
|
\Csrp3tm1Crni/\Csrp3tm1Crni
\Tg(WTbeta2)4Wjk/0
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:48062
|
| dilated cardiomyopathy
|
J:48062
|
\Cstbtm1Rm/\Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
facial muscle spasm
|
J:50587
|
| myoclonus
|
J:50587
|
\Cstbtm1Rm/\Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
\Ctbp1tm1Sor/\Ctbp1tm1Sor
\Ctbp2Gt(ROSA61)Sor/\Ctbp2+
(involves: 129S4/SvJaeSor)
|
abnormal diaphragm morphology
|
J:77905
|
| abnormal muscle development
|
J:77905
|
\Ctcfem1Hyao/\Ctcfem1Hyao
(C57BL/6N-Ctcfem1Hyao)
|
abnormal ventricle myocardium morphology
|
J:350502
|
| myocardial ventricular hypertrabeculation
|
J:350502
|
| thick myocardium
|
J:350502
|
\Cthtm1Iish/\Cthtm1Iish
(B6.129-Cthtm1Iish/Iish)
|
decreased skeletal muscle fiber diameter
|
J:166184
|
| increased susceptibility to induced muscular atrophy
|
J:166184
|
\Cthtm1Liwu/\Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased vasodilation
|
J:140705
|
\Cthrc1tm1Vli/\Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli)
|
increased skeletal muscle glycogen level
|
J:192096
|
\Ctnna1tm1Efu/\Ctnna1tm1Efu
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129X1/SvJ * FVB/N)
|
dilated cardiomyopathy
|
J:197814
|
\Ctnna3tm1.1Fvr/\Ctnna3tm1.1Fvr
(involves: 129S6/SvEvTac * BALB/cJ)
|
abnormal myocardial fiber morphology
|
J:197814
|
| decreased cardiac muscle contractility
|
J:197814
|
| dilated cardiomyopathy
|
J:197814
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal muscle development
|
J:124278
|
\Ctnnb1tm1Yy/\Ctnnb1tm1Yy
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:184918
|
\Ctnstm1Antc/\Ctnstm1Antc
(involves: 129/Sv * C57BL/6)
|
muscle degeneration
|
J:79610
|
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:76333
|
| abnormal myocardium layer morphology
|
J:76333
|
| decreased cardiac muscle contractility
|
J:76333
|
| decreased heart left ventricle muscle contractility
|
J:76333
|
| dilated cardiomyopathy
|
J:76333
|
| heart left ventricle hypertrophy
|
J:76333
|
\Ctsstm1Hap/\Ctsstm1Hap
\Dmdmdx/\Dmdmdx
(involves: 129S2/SvPas * C57BL/10ScSn)
|
abnormal skeletal muscle fiber morphology
|
J:230788
|
| centrally nucleated skeletal muscle fibers
|
J:230788
|
| dystrophic muscle
|
J:230788
|
| skeletal muscle fiber necrosis
|
J:230788
|
| skeletal muscle fibrosis
|
J:230788
|
\Ctsstm1Hap/\Ctsstm1Hap
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her)
|
vascular smooth muscle hypoplasia
|
J:82520
|
\Cul3tm1.1Arte/\Cul3+
(involves: C57BL/6J * C57BL/6N)
|
increased vasoconstriction
|
J:229424
|
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
decreased vascular smooth muscle cell proliferation
|
J:124722
|
\Cxadrtm1.1Ics/\Cxadrtm1.1Ics
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal intercalated disk morphology
|
J:174138
|
\Cxadrtm1.1Mds/\Cxadrtm1.1Mds
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:121400
|
| increased fetal cardiomyocyte proliferation
|
J:121400
|
\Cxadrtm1Dvst/\Cxadrtm1Dvst
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:100174
|
| abnormal sarcomere morphology
|
J:100174
|
| decreased myocardial fiber size
|
J:100174
|
| increased cardiac muscle glycogen level
|
J:100174
|
\Cxadrtm1Know/\Cxadrtm1Know
\Tg(Myh6-cre)2182Mds/0
(involves: 129 * Black Swiss * FVB/N)
|
abnormal intercalated disk morphology
|
J:140870
|
| decreased cardiac muscle contractility
|
J:140870
|
\Cxadrtm1Mgot/\Cxadrtm1Mgot
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: FVB)
|
abnormal atrioventricular node morphology
|
J:140109
|
\Cxadrtm1Rwf/\Cxadrtm1Rwf
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:99585
|
| thin myocardium
|
J:99585
|
\Cxcl12tm1Tng/\Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
\Cxcr4tm1Qma/\Cxcr4tm1Qma
(B6.129X-Cxcr4tm1Qma/J)
|
abnormal muscle precursor cell migration
|
J:100909
|
| abnormal myogenesis
|
J:100909
|
\Cxcr4tm1Qma/\Cxcr4tm1Qma
\Gab1tm1Wbm/\Gab1tm1Wbm
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal intrinsic tongue muscle morphology
|
J:100909
|
| abnormal muscle precursor cell migration
|
J:100909
|
| abnormal myogenesis
|
J:100909
|
| hypaxial muscle hypoplasia
|
J:100909
|
\Cxcr4tm1Tng/\Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
\Cxcr4tm1Tng/\Cxcr4tm2Tng
\Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
\Cxcr4tm2Yzo/\Cxcr4tm2Yzo
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:289614
|
| cardiomyopathy
|
J:289614
|
| decreased heart left ventricle muscle contractility
|
J:289614
|
| decreased heart ventricle muscle contractility
|
J:289614
|
\Cyb5r3tm1c(KOMP)Wtsi/\Cyb5r3tm1c(KOMP)Wtsi
\Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:280543
|
| increased vasoconstriction
|
J:280543
|
| increased vasodilation
|
J:280543
|
\Cybbtm1Din/Y
(B6.129S-Cybbtm1Din)
|
abnormal myocardial fiber morphology
|
J:135786
|
\Cybbtm1Din/Y
\Tg(SOD1*G93A)dl1Gur/0
(B6.Cg-Cybbtm1Din Tg(SOD1*G93A)dl1Gur)
|
increased skeletal muscle fiber size
|
J:111782
|
\Cygbtm1Ppam/\Cygbtm1Ppam
\Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell physiology
|
J:206378
|
| abnormal myoblast differentiation
|
J:206378
|
| impaired muscle regeneration
|
J:206378
|
| skeletal muscle degeneration
|
J:206378
|
\Cyp2j5tm1Dcz/\Cyp2j5tm1Dcz
(129S/SvEv-Cyp2j5tm1Dcz)
|
increased vasoconstriction
|
J:146047
|
\Cyp11a1tm1Bcc/\Cyp11a1tm1Bcc
(involves: 129 * C57BL/6)
|
muscular atrophy
|
J:78062
|
\Cyp11b2tm2Hsk/\Cyp11b2tm2Hsk
(involves: 129S6/SvEvTac)
|
increased myocardial fiber size
|
J:147672
|
\Cyp19a1tm1Esi/\Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiac muscle contractility
|
J:105620
|
\Cyp51tm1.1Bfro/\Cyp51tm1.1Bfro
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:173366
|
\Cyth1tm1Jya/\Cyth1tm1Jya
(B6JJms.129-Cyth1tm1Jya)
|
muscle phenotype
|
J:357385
|
\D930028M14Riktm1a(EUCOMM)Wtsi/\D930028M14Riktm1a(EUCOMM)Wtsi
(C57BL/6N-D930028M14Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\d-58H/\d-58H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Daam1Gt(RRT390)Byg/\Daam1Gt(RRT390)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:167714
|
| abnormal sarcomere morphology
|
J:167714
|
\Daam1tm1.1Tpy/\Daam1tm1.1Tpy
\Daam2tm1Tpy/\Daam2tm1Tpy
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal A band morphology
|
J:228507
|
| abnormal H zone morphology
|
J:228507
|
| abnormal I band morphology
|
J:228507
|
| abnormal intercalated disk morphology
|
J:228507
|
| abnormal myocardial fiber morphology
|
J:228507
|
| abnormal myocardial trabeculae morphology
|
J:228507
|
| absent M line
|
J:228507
|
| absent Z line
|
J:228507
|
| diffuse Z line
|
J:228507
|
\Daam1tm1.1Tpy/\Daam1tm1.1Tpy
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal cardiac muscle tissue morphology
|
J:228507
|
\Daam1tm1.1Tpy/\Daam1tm1.1Tpy
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| thin ventricle myocardium compact layer
|
J:228507
|
\Daam1tm1.1Tpy/\Daam1tm1.1Tpy
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
\Wnt5atm1Amc/\Wnt5a+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| thick myocardium compact layer
|
J:228507
|
\Daam1tm1.1Tpy/\Daam1tm1.1Tpy
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
\Wnt5atm1Amc/\Wnt5atm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| abnormal myocardium compact layer morphology
|
J:228507
|
\Dag1tm1.1Sabl/\Dag1tm1.1Sabl
(involves: C57BL/6 * CD-1)
|
abnormal muscle physiology
|
J:350439
|
| abnormal skeletal muscle fiber morphology
|
J:350439
|
\Dag1tm1.1Swin/\Dag1tm1.1Swin
\Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
centrally nucleated skeletal muscle fibers
|
J:187750
|
\Dag1tm1.1Swin/\Dag1tm1.1Swin
\Dmdmdx/\Dmdmdx
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
centrally nucleated skeletal muscle fibers
|
J:187750
|
\Dag1tm2Kcam/\Dag1tm2Kcam
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal cardiac muscle contractility
|
J:169951
|
| dilated cardiomyopathy
|
J:169951
|
| myocardial fiber degeneration
|
J:169951
|
\Dag1tm2Kcam/\Dag1tm2Kcam
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal skeletal muscle morphology
|
J:78838
|
| centrally nucleated skeletal muscle fibers
|
J:78838
|
| dystrophic muscle
|
J:78838
|
| increased skeletal muscle fiber diameter
|
J:78838
|
| increased skeletal muscle fiber size
|
J:78838
|
| increased skeletal muscle weight
|
J:78838
|
| increased variability of skeletal muscle fiber size
|
J:78838
|
| skeletal muscle necrosis
|
J:78838
|
\Dag1tm4.1Kcam/\Dag1tm4.1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
centrally nucleated skeletal muscle fibers
|
J:169291
|
| dystrophic muscle
|
J:169291
|
\Dcaf6tm1.1Ntuy/\Dcaf6tm1.1Ntuy
(B6JNarl.Cg-Dcaf6tm1.1Ntuy)
|
abnormal muscle physiology
|
J:233771
|
| delayed skeletal muscle regeneration
|
J:233771
|
| impaired skeletal muscle regeneration
|
J:233771
|
\Dcntm1Ioz/\Dcntm1Ioz
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal tendon morphology
|
J:39212
|
\Dcntm1Ioz/\Dcntm1Ioz
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal tendon morphology
|
J:91512
|
\Dctn1tm2.1Cai/\Dctn1tm2.1Cai
\Tg(Thy1-cre)1Vln/?
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased gastrocnemius weight
|
J:264431
|
| skeletal muscle atrophy
|
J:264431
|
\Ddah1tm1Pval/\Ddah1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasodilation
|
J:121719
|
| increased vasoconstriction
|
J:121719
|
\Ddah1tm1Yjch/\Ddah1tm1Yjch
\Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:168130
|
\Ddr2tm1.1(cre/Esr1*)Rcow/\Ddr2tm1.1(cre/Esr1*)Rcow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:214642
|
| decreased cardiac muscle contractility
|
J:214642
|
| decreased myocardial fiber size
|
J:214642
|
\Ddttm1Lhy/\Ddttm1Lhy
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
cardiac muscle necrosis
|
J:213776
|
| decreased heart left ventricle muscle contractility
|
J:213776
|
\Ddx3xtm1.1Lyou/Y
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129 * C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:231798
|
\Degs1Gt(OST368559)Lex/\Degs1+
(involves: 129S5/SvEvBrd)
|
increased muscle cell glucose uptake
|
J:203554
|
\Del(1Aim2-Ifi205)1Stsn/\+
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
\Del(1Aim2-Ifi205)1Stsn/\Del(1Aim2-Ifi205)1Stsn
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
\Del(2Hoxd4-Hoxd13)30Ddu/\Del(2Hoxd4-Hoxd13)30Ddu
(involves: 129S2/SvPas)
|
abnormal smooth muscle morphology
|
J:92363
|
\Del(2Hoxd8,Hoxd9-Hoxd13)1Cx/\Del(2Hoxd8,Hoxd9-Hoxd13)1Cx
(involves: NZW/LacJ)
|
muscular atrophy
|
J:103924
|
\Del(2Hoxd8-Hoxd13)9Ddu/\Del(2Hoxd8-Hoxd13)9Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
\Del(2Hoxd9-Hoxd13)8Ddu/\Del(2Hoxd9-Hoxd13)8Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
\Del(2Hoxd10-Hoxd13)7Ddu/\Del(2Hoxd10-Hoxd13)7Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
\Del(4C4-C5)1Lap/\Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:158126
|
| increased vascular smooth muscle cell proliferation
|
J:158126
|
\Del(4Cyp2j13-Cyp2j5)1Brs/\Del(4Cyp2j13-Cyp2j5)1Brs
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:223128
|
\Del(7Hmx3-Hmx2)2Tlu/\Del(7Hmx3-Hmx2)2Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
muscle spasm
|
J:92940
|
\Del(7Ube3a-Snrpn)1Alb/\+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hypotonia
|
J:56617
|
\Del(9Hspb2-Cryab)1Wawr/\Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
|
abnormal skeletal muscle fiber morphology
|
J:72926
|
| abnormal tongue muscle morphology
|
J:72926
|
| dystrophic muscle
|
J:72926
|
| muscle degeneration
|
J:72926
|
| progressive muscle weakness
|
J:72926
|
\Del(11Irf1-D11Mit23)1Rub/\Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
increased cardiac muscle triglyceride level
|
J:60187
|
\Del(16Hspa13-App)3Yah/\+
(B6J.129P2-Del(16Hspa13-App)3Yah)
|
abnormal muscle physiology
|
J:223518
|
| abnormal skeletal muscle fiber type ratio
|
J:223518
|
| abnormal skeletal muscle morphology
|
J:223518
|
| decreased skeletal muscle mass
|
J:223518
|
\Del(18Pcdhg)1Xzw/\Del(18Pcdhg)1Xzw
(Not Specified)
|
muscle hypertonia
|
J:188341
|
\Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
myopathy
|
J:115155
|
\Destm1.1Ccrs/\Des+
(involves: 129 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:219616
|
| cardiomyopathy
|
J:219616
|
| decreased cardiac muscle contractility
|
J:219616
|
| dilated cardiomyopathy
|
J:219616
|
| muscle phenotype
|
J:219616
|
\Destm1.1Ccrs/\Destm1.1Ccrs
(involves: 129 * C57BL/6J)
|
abnormal skeletal muscle fiber mitochondrial morphology
|
J:219616
|
| abnormal skeletal muscle fiber morphology
|
J:219616
|
| abnormal soleus morphology
|
J:219616
|
| abnormal Z line morphology
|
J:219616
|
| cardiomyopathy
|
J:219616
|
| centrally nucleated skeletal muscle fibers
|
J:219616
|
| decreased cardiac muscle contractility
|
J:219616
|
| dilated cardiomyopathy
|
J:219616
|
| dystrophic muscle
|
J:219616
|
| impaired skeletal muscle contractility
|
J:219616
|
| increased variability of skeletal muscle fiber size
|
J:219616
|
| myopathy
|
J:219616
|
| progressive muscle weakness
|
J:219616
|
| skeletal muscle degeneration
|
J:219616
|
| skeletal muscle endomysial fibrosis
|
J:219616
|
| skeletal muscle fiber degeneration
|
J:219616
|
\Destm1Cap/\Destm1Cap
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59831
|
| abnormal myocardial fiber morphology
|
J:59831,
J:35123
|
| abnormal myocardium layer morphology
|
J:35123
|
| abnormal skeletal muscle morphology
|
J:35123
|
| abnormal smooth muscle morphology
|
J:35123
|
| cardiomyopathy
|
J:35123
|
| decreased heart ventricle muscle contractility
|
J:59831
|
| disorganized myocardium
|
J:59831,
J:35123
|
| muscle degeneration
|
J:35123
|
| thin myocardium
|
J:59831
|
\Destm1Cap/\Destm1Cap
(involves: 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:88267
|
| decreased heart ventricle muscle contractility
|
J:88267
|
| dilated cardiomyopathy
|
J:88267
|
\Destm1Cap/\Destm1Cap
\Tg(Bcl2)BCap/\Tg(Bcl2)BCap
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:88267
|
\Destm1Cba/\Destm1Cba
(involves: 129S2/SvPas)
|
abnormal diaphragm morphology
|
J:32928
|
| abnormal myocardial fiber morphology
|
J:32928
|
| abnormal myocardium layer morphology
|
J:32928
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal vascular smooth muscle morphology
|
J:32928
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| myocardium necrosis
|
J:32928
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
| thin diaphragm muscle
|
J:32928
|
\Destm1Cba/\Destm1Cba
(involves: 129S2/SvPas * C57BL/6J)
|
cardiomyopathy
|
J:130557
|
| decreased cardiac muscle contractility
|
J:130557
|
\Destm1Cba/\Destm1Cba
\Synmtm1.1Ics/\Synmtm1.1Ics
(involves: 129S2/SvPas)
|
abnormal myoblast differentiation
|
J:268425
|
| muscle phenotype
|
J:268425
|
\Destm1Ltho/\Destm1Ltho
(involves: 129S2/SvPas * C57BL/6J * CBA)
|
abnormal intercalated disk morphology
|
J:127515
|
| abnormal myocardial fiber morphology
|
J:127515
|
| abnormal ventricle papillary muscle morphology
|
J:127515
|
| decreased myocardial fiber number
|
J:127515
|
| myocardial fiber degeneration
|
J:127515
|
\Dgcr8tm1.1Blel/\Dgcr8tm1.1Blel
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased heart ventricle muscle contractility
|
J:161342
|
\Dguoktm1.1Anka/\Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
decreased myocardial fiber mitochondrial DNA content
|
J:294620
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:294620
|
\Dhcr7tm1Gst/\Dhcr7tm1Gst
\Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
|
hypotonia
|
J:141730
|
\Dhfrorana/\Dhfr+
(involves: C57BL/6JAnu)
|
decreased vasodilation
|
J:236197
|
\Dhrs7bGt(OST255410)Lex/\Dhrs7bGt(OST255410)Lex
(B6;129S5-Dhrs7bGt(OST255410)Lex/Mmucd)
|
muscle degeneration
|
J:171883
|
\Dhtkd1tm1Mmgu/\Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:288186
|
\Dhtkd1tm1Zgwg/\Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
abnormal sarcomere morphology
|
J:267178
|
| muscular atrophy
|
J:267178
|
| progressive muscle weakness
|
J:267178
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129 * 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:211548
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129 * 129S1/Sv)
|
thin ventricle myocardium compact layer
|
J:156467
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
impaired skeletal muscle regeneration
|
J:292144
|
\Dicer1tm1Smr/\Dicer1tm1Smr
\Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:131962
|
| abnormal sarcomere morphology
|
J:131962
|
| decreased heart ventricle muscle contractility
|
J:131962
|
| dilated cardiomyopathy
|
J:131962
|
| disorganized myocardium
|
J:131962
|
| increased cardiomyocyte apoptosis
|
J:131962
|
\Disp1tm1Ptch/\Disp1tm1Ptch
(involves: 129P2/OlaHsd)
|
abnormal dermomyotome development
|
J:79831
|
\Dlg1tm1Jhm/\Dlg1tm1Jhm
(involves: 129 * C57BL/6J)
|
impaired smooth muscle contractility
|
J:118250
|
| impaired ureteric peristalsis
|
J:118250
|
\Dlk1tm1.1Jvs/\Dlk1+
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber number
|
J:167124
|
| impaired skeletal muscle regeneration
|
J:167124
|
| increased skeletal muscle fiber diameter
|
J:167124
|
| increased skeletal muscle fiber size
|
J:167124
|
| skeletal muscle fibrosis
|
J:167124
|
\Dll1tm1Gos/\Dll1tm2Gos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myoblast differentiation
|
J:119082
|
| abnormal myotube differentiation
|
J:119082
|
| decreased skeletal muscle mass
|
J:119082
|
\Dll1tm1Gos/\Dll1tm2Gos
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:148902
|
| abnormal myogenesis
|
J:148902
|
| decreased skeletal muscle mass
|
J:148902
|
\Dll1tm3.1Gos/\Dll1tm3.1Gos
(Not Specified)
|
muscle phenotype
|
J:213529
|
\Dll3pu/\Dll3pu
(involves: 101/Rl * C3H/Rl)
|
abnormal dermomyotome development
|
J:14975
|
| abnormal multifidus muscle morphology
|
J:324821
|
\Dll3tm1Rbe/\Dll3tm1Rbe
(B6.129P2-Dll3tm1Rbe)
|
abnormal multifidus muscle morphology
|
J:324821
|
\Dll4tm1Jrt/\Dll4tm1Jrt
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
trabecula carnea hypoplasia
|
J:93157
|
\Dll4tm1Nwg/\Dll4+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal vascular smooth muscle morphology
|
J:94740
|
\Dlx2tm1Jlr/\Dlx2tm1Jlr
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * CD-1))
|
intestinal hypoperistalsis
|
J:29443
|
\Dlx2tm1Jlr/\Dlx2tm1Jlr
(involves: 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:40427
|
\Dlx5tm1Jlr/\Dlx5tm1Jlr
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal intrinsic tongue muscle morphology
|
J:56559
|
| abnormal mylohyoid muscle morphology
|
J:56559
|
| abnormal pterygoid muscle morphology
|
J:56559
|
| abnormal tongue muscle morphology
|
J:56559
|
\Dmdem1Cmusr/Y
(BALB/c-Dmdem1Cmusr)
|
abnormal extensor digitorum longus morphology
|
J:353371
|
| abnormal muscle contractility
|
J:353371
|
| abnormal muscle physiology
|
J:353371
|
| abnormal skeletal muscle fiber type ratio
|
J:353371
|
| abnormal skeletal muscle morphology
|
J:353371
|
| calcified muscle
|
J:353371
|
| centrally nucleated skeletal muscle fibers
|
J:353371
|
| dystrophic muscle
|
J:353371
|
| increased skeletal muscle fiber size
|
J:353371
|
| increased skeletal muscle weight
|
J:353371
|
| increased variability of skeletal muscle fiber size
|
J:353371
|
| skeletal muscle fibrosis
|
J:353371
|
| skeletal muscle hypertrophy
|
J:353371
|
\Dmdem1Eno/Y
(involves: C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:253191
|
| dystrophic muscle
|
J:253191
|
| increased variability of skeletal muscle fiber size
|
J:253191
|
| myositis
|
J:253191
|
| skeletal muscle necrosis
|
J:253191
|
\Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
|
centrally nucleated skeletal muscle fibers
|
J:285447
|
| dystrophic muscle
|
J:285447
|
| muscle weakness
|
J:285447
|
| myositis
|
J:285447
|
| skeletal muscle fiber degeneration
|
J:285447
|
| skeletal muscle fibrosis
|
J:285447
|
\Dmdem4Eno/\Dmdem4Eno
(C57BL/6-Dmdem4Eno)
|
centrally nucleated skeletal muscle fibers
|
J:285447
|
| dystrophic muscle
|
J:285447
|
| muscle weakness
|
J:285447
|
| myositis
|
J:285447
|
| skeletal muscle fiber degeneration
|
J:285447
|
| skeletal muscle fibrosis
|
J:285447
|
\Dmdem#Tve/Y
(involves: C57BL/6 * CBA)
|
abnormal sarcolemma morphology
|
J:275476
|
| centrally nucleated skeletal muscle fibers
|
J:275476
|
| decreased skeletal muscle fiber diameter
|
J:275476
|
| dystrophic muscle
|
J:275476
|
| muscle weakness
|
J:275476
|
| skeletal muscle fiber degeneration
|
J:275476
|
| skeletal muscle fiber necrosis
|
J:275476
|
| skeletal muscle fibrosis
|
J:275476
|
\DmdGt(ROSABetageo)1Mpd/Y
(involves: 129S1/Sv)
|
abnormal muscle morphology
|
J:47968
|
| abnormal muscle physiology
|
J:47968
|
\DmdGt(ROSABetageo)1Mpd/\DmdGt(ROSABetageo)1Mpd
(involves: 129S1/Sv)
|
abnormal muscle morphology
|
J:47968
|
| abnormal muscle physiology
|
J:47968
|
\Dmdmdx-2Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle fiber morphology
|
J:9638
|
| impaired muscle relaxation
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
\Dmdmdx-2Cv/Y
(B6Ros.Cg-Dmdmdx-2Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-2Cv/\Dmdmdx-2Cv
(B6Ros.Cg-Dmdmdx-2Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-3Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
impaired muscle relaxation
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
\Dmdmdx-3Cv/Y
(B6Ros.Cg-Dmdmdx-3Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| centrally nucleated skeletal muscle fibers
|
J:23502
|
| increased variability of skeletal muscle fiber size
|
J:12150
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-3Cv/Y
(B6.Cg-Dmdmdx-3Cv/J)
|
abnormal muscle contractility
|
J:134272
|
| abnormal skeletal muscle morphology
|
J:134272
|
| centrally nucleated skeletal muscle fibers
|
J:134272
|
| increased variability of skeletal muscle fiber size
|
J:134272
|
\Dmdmdx-3Cv/Y
\Utrntm1Ked/\Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle morphology
|
J:116348
|
\Dmdmdx-3Cv/\Dmdmdx-3Cv
(B6Ros.Cg-Dmdmdx-3Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| centrally nucleated skeletal muscle fibers
|
J:23502
|
| increased variability of skeletal muscle fiber size
|
J:12150
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-3Cv/\Dmdmdx-3Cv
\Utrntm1Ked/\Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle morphology
|
J:116348
|
\Dmdmdx-4Cv/Y
(B6Ros.Cg-Dmdmdx-4Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-4Cv/Y
(B6Ros.Cg-Dmdmdx-4Cv/J)
|
abnormal muscle contractility
|
J:134272
|
| abnormal skeletal muscle morphology
|
J:134272
|
| centrally nucleated skeletal muscle fibers
|
J:134272
|
| increased variability of skeletal muscle fiber size
|
J:134272
|
\Dmdmdx-4Cv/\Dmdmdx-4Cv
(B6Ros.Cg-Dmdmdx-4Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-4Cv/\Dmdmdx-4Cv
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle fiber morphology
|
J:128921
|
| centrally nucleated skeletal muscle fibers
|
J:128921
|
| increased satellite cell number
|
J:128921
|
| skeletal muscle fiber necrosis
|
J:128921
|
\Dmdmdx-4Cv/\Dmdmdx-4Cv
\Myf5tm2Tajb/\Myf5tm2Tajb
(involves: 129S2/SvPas * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
increased skeletal muscle fiber diameter
|
J:128921
|
| skeletal muscle fiber necrosis
|
J:128921
|
\Dmdmdx-4Cv/\Dmdmdx-4Cv
\Terctm1Rdp/\Terctm1Rdp
(B6.Cg-Terctm1Rdp Dmdmdx-4Cv)
|
abnormal myocardial fiber morphology
|
J:200365
|
| decreased heart ventricle muscle contractility
|
J:200365
|
| dilated cardiomyopathy
|
J:200365
|
| ventricular cardiomyopathy
|
J:200365
|
\Dmdmdx-5Cv/Y
(B6Ros.Cg-Dmdmdx-5Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| impaired skeletal muscle contractility
|
J:177391
|
| increased muscle fatigability
|
J:177391
|
| muscle phenotype
|
J:177391
|
| skeletal muscle fibrosis
|
J:177391,
J:23502
|
\Dmdmdx-5Cv/\Dmdmdx-5Cv
(B6Ros.Cg-Dmdmdx-5Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
\Dmdmdx-5Cv/\Dmdmdx-5Cv
(B6Ros.Cg-Dmdmdx-5Cv/J)
|
abnormal muscle contractility
|
J:164891
|
| centrally nucleated skeletal muscle fibers
|
J:164891
|
| increased satellite cell number
|
J:164891
|
| increased variability of skeletal muscle fiber size
|
J:164891
|
\Dmdmdx-5Cv/\Dmdmdx-5Cv
\Flt1tm1Jrt/\Flt1+
(involves: C3HA * C57BL/6Ros)
|
abnormal muscle contractility
|
J:164891
|
| abnormal muscle development
|
J:164891
|
| abnormal skeletal muscle fiber morphology
|
J:164891
|
| abnormal skeletal muscle fiber size
|
J:164891
|
| increased satellite cell number
|
J:164891
|
| muscle phenotype
|
J:164891
|
\Dmdmdx-5Cv/\Dmdmdx-5Cv
\Flt1tm1Jrt/\Flt1+
\Utrntm1Jrs/\Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C3HA * C57BL/6Ros)
|
centrally nucleated skeletal muscle fibers
|
J:164891
|
\Dmdmdx/?
(B6.B10ScSn-Dmdmdx)
|
abnormal skeletal muscle fiber morphology
|
J:85088
|
| abnormal skeletal muscle morphology
|
J:85088
|
| dystrophic muscle
|
J:85088
|
\Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle morphology
|
J:7361
|
| abnormal muscle physiology
|
J:3666
|
| abnormal skeletal muscle fiber morphology
|
J:7361
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscular atrophy
|
J:7361
|
| myopathy
|
J:7361
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle necrosis
|
J:7361
|
\Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle contractility
|
J:152525
|
| abnormal muscle development
|
J:150127
|
| abnormal myocardial fiber morphology
|
J:150127
|
| abnormal myotube morphology
|
J:150127
|
| abnormal skeletal muscle fiber morphology
|
J:152525
|
| centrally nucleated skeletal muscle fibers
|
J:150127,
J:152525
|
| impaired muscle relaxation
|
J:9638
|
| impaired skeletal muscle contractility
|
J:177391
|
| muscle phenotype
|
J:177391
|
| myocardial fiber degeneration
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
| skeletal muscle fiber necrosis
|
J:152525
|
| skeletal muscle fibrosis
|
J:177391
|
\Dmdmdx/Y
(involves: C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:152891,
J:95776
|
| abnormal intercostal muscle morphology
|
J:152891
|
| abnormal muscle electrophysiology
|
J:142492
|
| abnormal muscle tone
|
J:152749
|
| abnormal skeletal muscle fiber morphology
|
J:152749
|
| centrally nucleated skeletal muscle fibers
|
J:19034
|
| diaphragmitis
|
J:140282
|
| increased skeletal muscle fiber diameter
|
J:19034,
J:152749
|
| increased skeletal muscle mass
|
J:19034
|
| myositis
|
J:140282
|
| skeletal muscle endomysial fibrosis
|
J:19034,
J:140282
|
| skeletal muscle fiber necrosis
|
J:19034
|
| skeletal muscle hypertrophy
|
J:19034
|
| skeletal muscle necrosis
|
J:95776
|
\Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
\Dmdmdx/Y
\Dtnatm1Jrs/\Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
\Dmdmdx/Y
\Dtnatm1Jrs/\Dtnatm1Jrs
\Utrntm1Jrs/\Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
| skeletal muscle necrosis
|
J:59675
|
\Dmdmdx/?
\Fgf2tm1Zllr/\Fgf2tm1Zllr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn)
|
dystrophic muscle
|
J:85088
|
\Dmdmdx/?
\Fgf2tm1Zllr/\Fgf2tm1Zllr
\Fgf6tm1Thbr/\Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:85088
|
| abnormal skeletal muscle fiber morphology
|
J:85088
|
| abnormal skeletal muscle morphology
|
J:85088
|
| decreased satellite cell number
|
J:85088
|
| dystrophic muscle
|
J:85088
|
| increased variability of skeletal muscle fiber size
|
J:85088
|
| muscle phenotype
|
J:85088
|
| skeletal muscle fiber necrosis
|
J:85088
|
\Dmdmdx/?
\Fgf6tm1Thbr/\Fgf6tm1Thbr
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:42574
|
| abnormal epaxial muscle morphology
|
J:42574
|
| abnormal hypaxial muscle morphology
|
J:42574
|
| dystrophic muscle
|
J:85088
|
| muscle phenotype
|
J:42574
|
| myopathy
|
J:42574
|
\Dmdmdx/Y
\Foxk1tm1Djg/\Foxk1tm1Djg
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle fibrosis
|
J:62225
|
| skeletal muscle necrosis
|
J:62225
|
\Dmdmdx/Y
\Foxn1nu/\Foxn1nu
(involves: C57BL/10ScSn)
|
abnormal muscle morphology
|
J:95776
|
| decreased skeletal muscle fiber size
|
J:95776
|
| increased skeletal muscle fiber size
|
J:95776
|
\Dmdmdx/Y
\Mirc37tm1Boet/\Mirc37tm1Boet
(involves: C57BL/10ScSn)
|
dystrophic muscle
|
J:241493
|
\Dmdmdx/?
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dilated cardiomyopathy
|
J:52248
|
| increased myocardial fiber size
|
J:52248
|
| myocardium necrosis
|
J:52248
|
\Dmdmdx/Y
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
\Dmdmdx/Y
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
\Dmdmdx/Y
\Terctm1Rdp/\Terc+
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal diaphragm morphology
|
J:167294
|
| abnormal muscle physiology
|
J:167294
|
| centrally nucleated skeletal muscle fibers
|
J:167294
|
\Dmdmdx/Y
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal diaphragm morphology
|
J:167294
|
| abnormal muscle electrophysiology
|
J:167294
|
| abnormal muscle physiology
|
J:167294
|
| abnormal skeletal muscle morphology
|
J:167294
|
| calcified muscle
|
J:167294
|
| centrally nucleated skeletal muscle fibers
|
J:167294
|
| decreased satellite cell number
|
J:167294
|
| dystrophic muscle
|
J:167294
|
| increased variability of skeletal muscle fiber size
|
J:167294
|
| muscle weakness
|
J:167294
|
| muscular atrophy
|
J:167294
|
| myositis
|
J:167294
|
| skeletal muscle degeneration
|
J:167294
|
| skeletal muscle fibrosis
|
J:167294
|
| skeletal muscle necrosis
|
J:167294
|
\Dmdmdx/Y
\Tg(DMD*)#Spc/0
(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2)
|
dystrophic muscle
|
J:280218
|
| myositis
|
J:280218
|
| skeletal muscle fibrosis
|
J:280218
|
\Dmdmdx/Y
\Utrntm1Jrs/\Utrn+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
diaphragmitis
|
J:140282
|
| myositis
|
J:140282
|
| skeletal muscle endomysial fibrosis
|
J:140282
|
\Dmdmdx/\Dmd+
(involves: C57BL/10ScSn)
|
abnormal skeletal muscle fiber morphology
|
J:121251
|
\Dmdmdx/\Dmd+
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
\Dmdmdx/\Dmd+
\Foxk1tm1Djg/\Foxk1+
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle necrosis
|
J:62225
|
\Dmdmdx/\Dmd+
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
\Dmdmdx/\Dmdmdx
(involves: C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:152891
|
| abnormal intercostal muscle morphology
|
J:152891
|
| abnormal muscle contractility
|
J:152525
|
| abnormal muscle electrophysiology
|
J:142492
|
| abnormal muscle physiology
|
J:152750
|
| abnormal muscle tone
|
J:152749
|
| abnormal scalene muscle morphology
|
J:152891
|
| abnormal skeletal muscle fiber morphology
|
J:152892,
J:152525,
J:152749
|
| abnormal skeletal muscle morphology
|
J:152892
|
| abnormal skeletal muscle satellite cell proliferation
|
J:152892
|
| centrally nucleated skeletal muscle fibers
|
J:19034,
J:152525
|
| dilated sarcoplasmic reticulum
|
J:152892
|
| increased skeletal muscle fiber diameter
|
J:19034,
J:152749
|
| increased skeletal muscle mass
|
J:19034
|
| skeletal muscle endomysial fibrosis
|
J:19034
|
| skeletal muscle fiber necrosis
|
J:152892,
J:19034,
J:152525
|
| skeletal muscle hypertrophy
|
J:19034
|
| skeletal muscle necrosis
|
J:152892
|
\Dmdmdx/\Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle morphology
|
J:7361
|
| abnormal muscle physiology
|
J:3666
|
| abnormal skeletal muscle fiber morphology
|
J:7361
|
| abnormal skeletal muscle regeneration
|
J:226314
|
| calcified muscle
|
J:226314
|
| cardiomyopathy
|
J:226314
|
| centrally nucleated skeletal muscle fibers
|
J:226314
|
| decreased cardiac muscle contractility
|
J:226314
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361,
J:226314
|
| impaired skeletal muscle contractility
|
J:226314
|
| increased skeletal muscle fiber diameter
|
J:226314
|
| increased skeletal muscle mass
|
J:226314
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscular atrophy
|
J:7361
|
| myopathy
|
J:7361
|
| myositis
|
J:226314
|
| skeletal muscle degeneration
|
J:226314
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle hypertrophy
|
J:226314
|
| skeletal muscle necrosis
|
J:7361
|
\Dmdmdx/\Dmdmdx
(C57BL/10ScSn-Dmdmdx)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle morphology
|
J:7361
|
| abnormal myotube morphology
|
J:150127
|
| abnormal skeletal muscle fiber morphology
|
J:7361,
J:152524
|
| centrally nucleated skeletal muscle fibers
|
J:150127,
J:152524
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361
|
| increased quadriceps weight
|
J:160773
|
| increased skeletal muscle fiber number
|
J:160773
|
| increased skeletal muscle mass
|
J:160773
|
| increased skeletal muscle weight
|
J:160773
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscle phenotype
|
J:160773
|
| muscular atrophy
|
J:7361
|
| myocardial fiber disarray
|
J:150127
|
| myocardium necrosis
|
J:152524
|
| myopathy
|
J:7361
|
| skeletal muscle fiber necrosis
|
J:152524
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle necrosis
|
J:7361
|
\Dmdmdx/\Dmdmdx
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
centrally nucleated skeletal muscle fibers
|
J:125527
|
| impaired skeletal muscle contractility
|
J:125527
|
| increased skeletal muscle fiber diameter
|
J:125527
|
| skeletal muscle fiber degeneration
|
J:125527
|
| skeletal muscle fibrosis
|
J:125527
|
\Dmdmdx/\Dmdmdx
(D2.B10-Dmdmdx)
|
decreased quadriceps weight
|
J:160773
|
| decreased skeletal muscle fiber number
|
J:160773
|
| decreased skeletal muscle mass
|
J:160773
|
| decreased skeletal muscle weight
|
J:160773
|
| muscle weakness
|
J:160773
|
| skeletal muscle fibrosis
|
J:160773
|
\Dmdmdx/\Dmdmdx
(D2.B10-Dmdmdx/J)
|
abnormal skeletal muscle fiber morphology
|
J:226314
|
| abnormal skeletal muscle regeneration
|
J:226314
|
| calcified muscle
|
J:226314
|
| cardiac muscle degeneration
|
J:226314
|
| cardiomyopathy
|
J:226314
|
| centrally nucleated skeletal muscle fibers
|
J:226314
|
| decreased cardiac muscle contractility
|
J:226314
|
| decreased skeletal muscle fiber diameter
|
J:226314
|
| decreased skeletal muscle fiber size
|
J:226314
|
| decreased skeletal muscle mass
|
J:226314
|
| dystrophic muscle
|
J:226314
|
| impaired skeletal muscle contractility
|
J:226314
|
| myositis
|
J:226314
|
| skeletal muscle atrophy
|
J:226314
|
| skeletal muscle degeneration
|
J:226314
|
| skeletal muscle fiber atrophy
|
J:226314
|
\Dmdmdx/\Dmdmdx
\Dusp1tm1Brv/\Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)
|
decreased skeletal muscle fiber diameter
|
J:162340
|
| decreased skeletal muscle fiber size
|
J:162340
|
| decreased skeletal muscle weight
|
J:162340
|
| dystrophic muscle
|
J:162340
|
| myositis
|
J:162340
|
| skeletal muscle fiber degeneration
|
J:162340
|
\Dmdmdx/\Dmdmdx
\Foxk1tm1Djg/\Foxk1tm1Djg
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle fibrosis
|
J:62225
|
| skeletal muscle necrosis
|
J:62225
|
\Dmdmdx/\Dmdmdx
\Mamstrtm1.2Eno/\Mamstrtm1.2Eno
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
| decreased skeletal muscle weight
|
J:179880
|
| muscle degeneration
|
J:179880
|
| skeletal muscle fibrosis
|
J:179880
|
\Dmdmdx/\Dmdmdx
\Mmp9tm1Tvu/\Mmp9+
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
abnormal muscle morphology
|
J:150030
|
| abnormal muscle physiology
|
J:150030
|
| enhanced skeletal muscle regeneration
|
J:150030
|
\Dmdmdx/\Dmdmdx
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
abnormal muscle morphology
|
J:150030
|
| enhanced skeletal muscle regeneration
|
J:150030
|
\Dmdmdx/\Dmdmdx
\Prkdcscid/\Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
centrally nucleated skeletal muscle fibers
|
J:125527
|
| impaired skeletal muscle contractility
|
J:125527
|
| increased skeletal muscle fiber diameter
|
J:125527
|
| skeletal muscle fiber degeneration
|
J:125527
|
| skeletal muscle fibrosis
|
J:125527
|
\Dmdmdx/\Dmdmdx
\Selenostm1.1Sfa/\Selenos+
(involves: C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle fiber type ratio
|
J:266872
|
| muscle phenotype
|
J:266872
|
\Dmdmdx/\Dmdmdx
\Snhg15tm1Nju/\Snhg15tm1Nju
(involves: C57BL/6J * C57BL/10ScSn)
|
impaired skeletal muscle regeneration
|
J:291983
|
| increased variability of skeletal muscle fiber size
|
J:291983
|
| muscle phenotype
|
J:291983
|
| skeletal muscle fibrosis
|
J:291983
|
\Dmdmdx/\Dmdmdx
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
\Dmdmdx/\Dmdmdx
\Tg(ACTA1-SSPN)3.0Rcros/0
(involves: C57BL/10ScSn)
|
abnormal sarcolemma morphology
|
J:185346
|
| centrally nucleated skeletal muscle fibers
|
J:185346
|
| dystrophic muscle
|
J:185346
|
\Dmdmdx/\Dmdmdx
\Utrntm1Jrs/\Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:42389
|
| abnormal muscle relaxation
|
J:42389
|
| cardiomyopathy
|
J:59675,
J:42389
|
| dystrophic muscle
|
J:59675,
J:42389
|
| muscle degeneration
|
J:42389
|
| muscle weakness
|
J:42389
|
| myocardium necrosis
|
J:42389
|
| skeletal muscle interstitial fibrosis
|
J:42389
|
| skeletal muscle necrosis
|
J:42389
|
\Dmdmdx/\Dmdmdx
\Utrntm1Ked/\Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn * DBA)
|
abnormal skeletal muscle fiber morphology
|
J:42388
|
| abnormal skeletal muscle fiber size
|
J:42388
|
| centrally nucleated skeletal muscle fibers
|
J:42388
|
| dystrophic muscle
|
J:42388
|
| progressive muscle weakness
|
J:42388
|
| skeletal muscle interstitial fibrosis
|
J:42388
|
| skeletal muscle necrosis
|
J:42388
|
\Dmdtm1.1Khan/Y
(involves: C57BL/6 * CBA)
|
increased skeletal muscle fiber size
|
J:96210
|
| skeletal muscle fiber degeneration
|
J:96210
|
| skeletal muscle fiber necrosis
|
J:96210
|
\Dmdtm1.1Know/\Dmdtm1.1Know
(involves: C3H)
|
abnormal sarcolemma morphology
|
J:207775
|
\Dmdtm1.1Know/\Dmdtm1.1Know
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
\Tg(Myh6-2A)#Know/0
(involves: BALB/c * C3H * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:207775
|
| increased cardiac muscle contractility
|
J:207775
|
\Dmdtm1Kmf/Y
(involves: C57BL/6)
|
dystrophic muscle
|
J:233298
|
| muscle degeneration
|
J:233298
|
| myositis
|
J:233298
|
| skeletal muscle fiber necrosis
|
J:233298
|
| skeletal muscle fibrosis
|
J:233298
|
\Dmdtm1Mok/Y
(involves: 129S/SvEv)
|
abnormal diaphragm morphology
|
J:43164
|
| muscle degeneration
|
J:43164
|
\Dmpkem1Sws/\Dmpkem1Sws
(C57BL/6J-Dmpkem1Sws)
|
muscle phenotype
|
J:284198
|
\Dmpkem2Sws/\Dmpkem2Sws
(involves: C57BL/6J * FVB/NJ)
|
muscle phenotype
|
J:284198
|
\Dmpktm1Bew/\Dmpktm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:43052,
J:33711
|
\Dmpktm1Rdd/\Dmpk+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal sarcomere morphology
|
J:53077
|
| decreased skeletal muscle fiber diameter
|
J:33714
|
| enhanced skeletal muscle regeneration
|
J:33714
|
| impaired skeletal muscle contractility
|
J:33714
|
| myopathy
|
J:33714
|
\Dmpktm1Rdd/\Dmpktm1Rdd
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal sarcomere morphology
|
J:33714
|
| absent Z line
|
J:33714
|
| dilated sarcoplasmic reticulum
|
J:33714
|
| enhanced skeletal muscle regeneration
|
J:33714
|
| impaired skeletal muscle contractility
|
J:33714
|
| increased variability of skeletal muscle fiber size
|
J:33714
|
| myopathy
|
J:33714
|
| progressive muscle weakness
|
J:33714
|
\Dmrt2tm1Rjo/\Dmrt2tm1Rjo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal dermomyotome development
|
J:104893
|
| abnormal myotome development
|
J:104893
|
| abnormal myotome morphology
|
J:104893
|
\Dnah5b2b2395Clo/\Dnah5b2b2395Clo
(C57BL/6J-Dnah5b2b2395Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Dnah11b2b1279Clo/\Dnah11b2b1279Clo
(C57BL/6J-Dnah11b2b1279Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
\Dnah11b2b1289Clo/\Dnah11b2b1289Clo
(C57BL/6J-Dnah11b2b1289Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Dnaja3tm1.1Jdl/\Dnaja3tm1.1Jdl
\Tg(Myhca-cre)1Abel/0
(involves: 129X1/SvJ * C57BL/6J * FVB)
|
abnormal myocardial fiber morphology
|
J:104462
|
| abnormal sarcomere morphology
|
J:104462
|
| decreased heart ventricle muscle contractility
|
J:104462
|
| decreased myocardial fiber mitochondrial DNA content
|
J:104462
|
| dilated cardiomyopathy
|
J:104462
|
| increased cardiomyocyte apoptosis
|
J:104462
|
| trabecula carnea hypoplasia
|
J:104462
|
\Dnajb4em1Sngi/\Dnajb4+
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:333950
|
| abnormal skeletal muscle morphology
|
J:333950
|
| decreased skeletal muscle fiber size
|
J:333950
|
| impaired skeletal muscle contractility
|
J:333950
|
| increased variability of skeletal muscle fiber size
|
J:333950
|
| muscle weakness
|
J:333950
|
| skeletal muscle atrophy
|
J:333950
|
| skeletal muscle fibrosis
|
J:333950
|
\Dnajb4em1Sngi/\Dnajb4em1Sngi
(involves: C57BL/6J)
|
abnormal diaphragm morphology
|
J:333950
|
| abnormal sarcomere morphology
|
J:333950
|
| abnormal skeletal muscle fiber morphology
|
J:333950
|
| abnormal skeletal muscle morphology
|
J:333950
|
\Dnajb4em2Sngi/\Dnajb4em2Sngi
(involves: C57BL/6J)
|
abnormal diaphragm morphology
|
J:333950
|
| abnormal sarcomere morphology
|
J:333950
|
| abnormal skeletal muscle fiber morphology
|
J:333950
|
| decreased skeletal muscle mass
|
J:333950
|
| impaired skeletal muscle contractility
|
J:333950
|
| increased variability of skeletal muscle fiber size
|
J:333950
|
| muscle weakness
|
J:333950
|
| skeletal muscle fibrosis
|
J:333950
|
\Dnajc5tm1Sud/\Dnajc5tm1Sud
(involves: 129S6/SvEvTac)
|
decreased skeletal muscle mass
|
J:91702
|
| progressive muscle weakness
|
J:91702
|
\Dnajc11spc/\Dnajc11spc
(B6.Cg-Dnajc11spc)
|
progressive muscle weakness
|
J:221543
|
\Dnase2atm1Aea/\Dnase2atm1Aea
(involves: 129 * C57BL/6)
|
diaphragmatic hernia
|
J:89469
|
| thin diaphragm muscle
|
J:89469
|
\Dnm1lPy/\Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal cardiac muscle relaxation
|
J:161510
|
| abnormal myocardial fiber mitochondrial morphology
|
J:161510
|
| decreased heart ventricle muscle contractility
|
J:161510
|
| increased myocardial fiber size
|
J:161510
|
| thin myocardium
|
J:161510
|
\Dnm2tm1.1Ics/\Dnm2+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle contractility
|
J:237196
|
| abnormal skeletal muscle fiber morphology
|
J:166364
|
| decreased skeletal muscle fiber diameter
|
J:166364
|
| decreased skeletal muscle fiber size
|
J:166364
|
| decreased skeletal muscle mass
|
J:166364
|
| increased skeletal muscle fiber size
|
J:166364
|
| increased skeletal muscle mass
|
J:166364
|
| muscle weakness
|
J:166364
|
| muscular atrophy
|
J:166364
|
\Dnm2tm1.1Ics/\Dnm2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:166364
|
| centrally nucleated skeletal muscle fibers
|
J:166364
|
| decreased skeletal muscle fiber size
|
J:166364
|
\Dnm2tm2.1Ics/\Dnm2+
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288372
|
| abnormal skeletal muscle fiber morphology
|
J:288372
|
| abnormal skeletal muscle fiber type ratio
|
J:288372
|
| decreased skeletal muscle fiber diameter
|
J:288372
|
| decreased skeletal muscle weight
|
J:288372
|
| myopathy
|
J:288372
|
\Dnm2tm4.1Ics/\Dnm2+
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:329580
|
| decreased skeletal muscle fiber size
|
J:329580
|
\Dnm2tm4.1Ics/\Dnm2tm4.1Ics
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:329580
|
\Dnm3ostm1Tkk/\Dnm3ostm1Tkk
(involves: 129 * C57BL/6 * ICR)
|
abnormal muscle morphology
|
J:143209
|
\Dnmt3atm1Jae/\Dnmt3atm1Jae
\Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:121563
|
\Dock1tm1.1Ysfk/\Dock1tm1.1Ysfk
(B6(Cg)-Dock1tm1.1Ysfk)
|
abnormal myogenesis
|
J:178190
|
\Dock1tm1Jfco/\Dock1+
\Dock5Gt(AN0268)Wtsi/\Dock5+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:143342
|
\Dock1tm1Jfco/\Dock1+
\Dock5Gt(AN0268)Wtsi/\Dock5Gt(AN0268)Wtsi
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:143342
|
\Dock1tm1Jfco/\Dock1tm1Jfco
(involves: 129/Sv * C57BL/6)
|
abnormal diaphragm morphology
|
J:143342
|
| abnormal intercostal muscle morphology
|
J:143342
|
| abnormal muscle development
|
J:143342
|
| abnormal muscle physiology
|
J:143342
|
| decreased skeletal muscle fiber diameter
|
J:143342
|
| decreased skeletal muscle mass
|
J:143342
|
| thin diaphragm muscle
|
J:143342
|
\Dock1tm1Jfco/\Dock1tm1Jfco
(involves: 129)
|
abnormal myogenesis
|
J:178190
|
\Dock3tm1Dasc/\Dock3tm1Dasc
(B6.Cg-Dock3tm1Dasc)
|
muscular atrophy
|
J:144341
|
\Dock5Gt(AN0268)Wtsi/\Dock5Gt(AN0268)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:143342
|
\Dok7tm2Yyam/\Dok7tm2Yyam
(involves: 129P2/OlaHsd * C57BL/6J)
|
muscle weakness
|
J:213767
|
\Dot1ltm1Tche/\Dot1ltm1.1Tche
\Tg(Myhca-cre)1Abel/0
(Not Specified)
|
abnormal muscle physiology
|
J:168140
|
| dilated cardiomyopathy
|
J:168140
|
| increased cardiomyocyte apoptosis
|
J:168140
|
| increased fetal cardiomyocyte proliferation
|
J:168140
|
\Dp(16Hspa13-App)2Yah/0
(B6J.129P2-Dp(16Hspa13-App)2Yah)
|
abnormal skeletal muscle fiber type ratio
|
J:223518
|
| abnormal skeletal muscle morphology
|
J:223518
|
| decreased muscle fiber mitochondrial DNA content
|
J:223518
|
| increased skeletal muscle mass
|
J:223518
|
\Dpmy/\Dpmy+
(B6NJ;CBA-Dpmy/GrsrJ)
|
muscular atrophy
|
J:226382
|
\Dpp9tm1.1Npa/\Dpp9tm1.1Npa
(involves: C57BL/6)
|
abnormal tongue muscle morphology
|
J:251322
|
\Drd1tm1Jcd/\Drd1tm1Jcd
\Drd2tm1Ebo/\Drd2tm1Ebo
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:91781
|
\Drd1tm2Jcd/\Drd1+
\Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N)
|
dystonia
|
J:120070
|
\Drd1tm2Jcd/\Drd1+
\Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N)
|
dystonia
|
J:120582
|
| myoclonus
|
J:120582
|
\Droshatm1Litt/\Droshatm1.1Litt
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased skeletal muscle mass
|
J:138683
|
\Dsc2tm1.2Leu/\Dsc2tm1.2Leu
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:302593
|
| heart left ventricle hypertrophy
|
J:302593
|
\Dscam3J/\Dscam3J
(involves: BALB/c * C3H/HeSnSmn * C57BL/Ka)
|
muscle hypertonia
|
J:195831
|
\Dsg2em1Spin/\Dsg2+
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:342765
|
\Dsg2em1Spin/\Dsg2em1Spin
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:342765
|
| decreased heart ventricle muscle contractility
|
J:342765
|
\Dsg2tm1a(EUCOMM)Wtsi/\Dsg2tm1a(EUCOMM)Wtsi
(C57BL/6-Dsg2tm1a(EUCOMM)Wtsi)
|
cardiomyopathy
|
J:235770
|
\Dsg2tm1b(EUCOMM)Wtsi/\Dsg2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dsg2tm1b(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
\Dsg2tm1d(EUCOMM)Wtsi/\Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cardiomyopathy
|
J:235770
|
| decreased cardiac muscle contractility
|
J:235770
|
| increased cardiomyocyte apoptosis
|
J:235770
|
\Dsg2tm1d(EUCOMM)Wtsi/\Dsg2tm1d(EUCOMM)Wtsi
\Gsk3btm1Dral/\Gsk3b+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
\Dsg2tm1d(EUCOMM)Wtsi/\Dsg2tm1d(EUCOMM)Wtsi
\Gsk3btm1Dral/\Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
\Dsptm1Efu/\Dsptm1Efu
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal intercalated disk morphology
|
J:205990
|
| abnormal myocardial fiber morphology
|
J:205990
|
| abnormal myocardium layer morphology
|
J:205990
|
| abnormal Z line morphology
|
J:205990
|
| decreased heart ventricle muscle contractility
|
J:205990
|
| ventricular cardiomyopathy
|
J:205990
|
\Dstdt-23Rbrc/\Dstdt-23Rbrc
(involves: C3H/HeN * C57BL/6)
|
abnormal muscle physiology
|
J:251779
|
| dystonia
|
J:251779
|
| muscular atrophy
|
J:251779
|
\Dstdt-30J/\Dstdt-30J
(C57BL/6J-Dstdt-30J/J)
|
dystonia
|
J:155853
|
\Dstdt-31J/\Dstdt-31J
(involves: DBA/1LacJ)
|
dystonia
|
J:155854
|
\Dstdt-37J/\Dstdt-37J
(C57BL/6J-Dstdt-37J/J)
|
decreased skeletal muscle fiber size
|
J:82238
|
| dystonia
|
J:82238
|
\Dstdt-38J/\Dstdt-38J
(involves: BALB/cByJ * C57BL/6J)
|
muscle spasm
|
J:82238
|
\Dstdt-39J/\Dstdt-39J
(involves: NOD)
|
dystonia
|
J:157224
|
\Dstdt-alb/\Dstdt-alb
(BALB/cByJ-Dstdt-alb)
|
dystonia
|
J:64441
|
\Dstdt/\Dstdt
(Q-Dstdt)
|
dystonia
|
J:64095
|
\Dstdt/\Dstdt
(involves: Q)
|
dystonia
|
J:5674
|
\DstGt(E182H05)Wrst/\DstGt(E182H05)Wrst
(B6NCrj.129P2-DstGt(E182H05)Wrst)
|
dystonia
|
J:228781,
J:251779
|
\DstGt(E182H05)Wrst/\DstGt(E182H05)Wrst
(involves: 129P2/OlaHsd * ICR)
|
abnormal muscle electrophysiology
|
J:228781,
J:251779
|
\DstTg4/\DstTg4
(involves: CD-1)
|
abnormal muscle physiology
|
J:55704
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:55704
|
| abnormal skeletal muscle fiber morphology
|
J:55704
|
| abnormal Z line morphology
|
J:55704
|
| impaired skeletal muscle contractility
|
J:55704
|
| muscle weakness
|
J:55704
|
\DstTg4/\DstTg4
(involves: C57BL/6 * CD-1)
|
abnormal muscle spindle morphology
|
J:209161
|
\Dsttm1Efu/\Dsttm1Efu
(involves: C57BL/6)
|
dystonia
|
J:24974
|
| muscular atrophy
|
J:24974
|
\Dtnatm1Jrs/\Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:60776,
J:59675
|
| myocardial fiber degeneration
|
J:59675
|
\Dtnatm1Jrs/\Dtnatm1Jrs
\Utrntm1Jrs/\Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
\Dtnbp1sdy/\Dtnbp1sdy
(involves: DBA/2J)
|
muscle phenotype
|
J:85123
|
\Dusp1tm1Brv/\Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle development
|
J:162340
|
| abnormal muscle regeneration
|
J:162340
|
| abnormal myoblast differentiation
|
J:162340
|
| decreased myoblast proliferation
|
J:162340
|
| decreased skeletal muscle fiber diameter
|
J:162340
|
| decreased skeletal muscle fiber size
|
J:162340
|
\Dusp6tm1Jmol/\Dusp6tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:190460
|
| increased satellite cell number
|
J:190460
|
| muscle phenotype
|
J:190460
|
\Dusp8tm1Jmol/\Dusp8tm1Jmol
(involves: 129/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:233947
|
| abnormal myocardial fiber morphology
|
J:233947
|
| increased cardiac muscle contractility
|
J:233947
|
\Dusp14em1Lyg/\Dusp14em1Lyg
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263251
|
| increased myocardial fiber size
|
J:263251
|
| myocardium hypertrophy
|
J:263251
|
\Dync1h1Cra1/\Dync1h1+
(C3HeB/FeJ-Dync1h1Cra1)
|
muscle spasm
|
J:83128
|
\Dync1h1Cra1/\Dync1h1+
(involves: C3HeB/FeJ * C57BL/6)
|
muscle spasm
|
J:83128
|
\Dync1h1Loa/\Dync1h1+
(C3H/HeH-Dync1h1Loa)
|
muscle spasm
|
J:83128
|
\Dync1h1Loa/\Dync1h1+
(involves: C3H/HeH * C57BL/6)
|
muscle spasm
|
J:83128
|
\Dync1h1tm1.1Sjki/\Dync1h1+
(involves: 129 * 129S1/SvImJ * C57BL/6 * C57BL/6J)
|
muscle phenotype
|
J:264493
|
\Dysfim/\Dysf+
\Fktntm1Ttd/\Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
muscle phenotype
|
J:221523
|
\Dysfim/\Dysf+
\Large1myd/\Large1myd
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| increased variability of skeletal muscle fiber size
|
J:221523
|
| myositis
|
J:221523
|
| skeletal muscle fiber degeneration
|
J:221523
|
| skeletal muscle fiber necrosis
|
J:221523
|
\Dysfim/\Dysfim
(involves: SJL)
|
dystrophic muscle
|
J:57764
|
| progressive muscle weakness
|
J:57764
|
\Dysfim/\Dysfim
\Fktntm1Ttd/\Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| abnormal skeletal muscle morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| myositis
|
J:221523
|
| skeletal muscle fiber degeneration
|
J:221523
|
| skeletal muscle fibrosis
|
J:221523
|
\Dysfim/\Dysfim
\Fktntm2(FCMD)Ttd/\Fktn+
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| skeletal muscle fiber necrosis
|
J:221523
|
\Dysfim/\Dysfim
\Large1myd/\Large1myd
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| increased variability of skeletal muscle fiber size
|
J:221523
|
| myositis
|
J:221523
|
\Dysfprmd/\Dysfprmd
(A/J)
|
abnormal skeletal muscle fiber morphology
|
J:92838
|
| abnormal skeletal muscle morphology
|
J:92838
|
| centrally nucleated skeletal muscle fibers
|
J:92838
|
| skeletal muscle endomysial fibrosis
|
J:92838
|
| skeletal muscle fiber degeneration
|
J:92838
|
| skeletal muscle fiber necrosis
|
J:92838
|
\Dysfprmd/\Dysfprmd
(involves: 129 * A/J * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:331473
|
\Dysfprmd/\Dysfprmd
\Elmo2tm2.1Jfco/\Elmo2tm2.1Jfco
(involves: 129 * A/J * C57BL/6)
|
muscle phenotype
|
J:331473
|
\Dysfprmd/\Dysfprmd
\Hprt1tm2(CAG-Myof)Isrd/Y
(involves: 129 * A/J * C57BL/6)
|
dystrophic muscle
|
J:187293
|
| muscle phenotype
|
J:187293
|
\Dysfprmd/\Dysfprmd
\Hprt1tm2(CAG-Myof)Isrd/\Hprt1tm2(CAG-Myof)Isrd
(involves: 129 * A/J * C57BL/6)
|
dystrophic muscle
|
J:187293
|
| muscle phenotype
|
J:187293
|
\Dysftm1.1Mdcb/\Dysftm1.1Mdcb
(B6.129P2(Cg)-Dysftm1.1Mdcb)
|
abnormal muscle physiology
|
J:302056
|
| dystrophic muscle
|
J:302056
|
| skeletal muscle fiber necrosis
|
J:302056
|
| skeletal muscle fibrosis
|
J:302056
|
\Dysftm1Kcam/\Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal sarcolemma morphology
|
J:83126
|
| centrally nucleated skeletal muscle fibers
|
J:83126,
J:171870
|
| dystrophic muscle
|
J:83126
|
| impaired skeletal muscle regeneration
|
J:83126
|
| increased variability of skeletal muscle fiber size
|
J:83126,
J:171870
|
| myositis
|
J:171870
|
| skeletal muscle fiber degeneration
|
J:83126
|
| skeletal muscle fiber necrosis
|
J:83126
|
| skeletal muscle fibrosis
|
J:171870
|
| skeletal muscle necrosis
|
J:171870
|
\Dysftm1Meho/\Dysftm1Meho
(involves: 129S4/SvJae * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:92838
|
| abnormal skeletal muscle morphology
|
J:92838
|
| centrally nucleated skeletal muscle fibers
|
J:92838
|
| increased skeletal muscle fiber size
|
J:92838
|
| skeletal muscle endomysial fibrosis
|
J:92838
|
| skeletal muscle fiber necrosis
|
J:92838
|
\E2f1tm1Meg/\E2f1tm1Meg
\Rb1tm1Tyj/\Rb1tm1Tyj
\Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
\Ece1tm1Reh/\Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:46640
|
\Ecel1tm1Hiki/\Ecel1tm1Hiki
(B6.129-Ecel1tm1Hiki)
|
thin diaphragm muscle
|
J:160510
|
\Ecsitmpc178H/\Ecsitmpc178H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
\Edn1tm1Utj/\Edn1tm1Utj
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * ICR))
|
abnormal neck muscle morphology
|
J:17694
|
| abnormal tongue muscle morphology
|
J:17694
|
\Ednratm1Ywa/\Ednratm1Ywa
(129S/SvEv-Ednratm1Ywa)
|
abnormal muscle morphology
|
J:46639
|
\Ednratm6(Edn1)Hku/\Ednra+
(involves: 129 * C57BL/6 * ICR)
|
abnormal masseter muscle morphology
|
J:224515
|
\Ednrbs-1Acrg/\Ednrbs-9ThW
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
abnormal diaphragm morphology
|
J:87686
|
\Ednrbs-1Acrg/\Ednrbs-48UThc
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
muscle phenotype
|
J:87686
|
\Ednrbs-15DttMb/\Ednrbs-15DttMb
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
abnormal diaphragm morphology
|
J:87686
|
\Ednrbtm1.1Nrd/\Ednrb+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased heart ventricle muscle contractility
|
J:226561
|
\Ednrbtm1.1Yko/\Ednrbtm1.1Yko
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
\Ednrbtm1Yko/\Ednrbtm1Yko
\Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
\Eef1a2em#Abb/\Eef1a2+
(C57BL/6JCrl-Eef1a2em#Abb)
|
decreased skeletal muscle mass
|
J:296080
|
\Eef1a2wst/\Eef1a2wst
(involves: HRS/J)
|
abnormal muscle morphology
|
J:104855
|
\Efemp1tm2Lmar/\Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle weight
|
J:132043
|
\Efemp2tm1.1Chu/\Efemp2tm1.1Chu
(B6(SJL)-Efemp2tm1.1Chu)
|
abnormal aorta smooth muscle morphology
|
J:223792
|
| abnormal hypodermis muscle layer morphology
|
J:223792
|
| abnormal tendon collagen fibril morphology
|
J:223792
|
\Efemp2tm1.1Hiya/\Efemp2tm1.2Hiya
\Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:213282
|
| abnormal vascular smooth muscle morphology
|
J:170883
|
\Efemp2tm1.1Tynk/\Efemp2tm1.2Tynk
\Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
heart left ventricle hypertrophy
|
J:154659
|
\Efemp2tm1.2Hiya/\Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:170883
|
| abnormal vascular smooth muscle physiology
|
J:170883
|
| increased vascular smooth muscle cell proliferation
|
J:170883
|
| vascular smooth muscle hyperplasia
|
J:170883
|
\Efemp2tm1.2Tynk/\Efemp2tm1.2Tynk
(involves: C57BL/6)
|
diaphragmatic hernia
|
J:154659
|
\Efemp2tm1Dgen/\Efemp2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:106902
|
\Efhc1tm1Kzy/\Efhc1+
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
\Efhc1tm1Kzy/\Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
\Efna1tm1Jinc/\Efna1tm1Jinc
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:166527
|
\Efnb2tm1And/\Efnb2tm1And
(involves: 129S7/SvEvBrd)
|
abnormal myocardium layer morphology
|
J:119151
|
| absent myocardial trabeculae
|
J:75288
|
\Efnb2tm1And/\Efnb2tm1And
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:74909
|
\Efnb2tm1And/\Efnb2tm2And
\Tg(Tek-cre)12Flv/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:74909
|
\Eftud2tm1b(KOMP)Wtsi/\Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
\Egfrtm2(EGFR)Wag/\Egfrtm2(EGFR)Wag
(involves: 129/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:84870
|
\Egfrwa2/\Egfrwa2
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:241813
|
| decreased heart left ventricle muscle contractility
|
J:241813
|
| decreased heart right ventricle muscle contractility
|
J:241813
|
| decreased heart ventricle muscle contractility
|
J:241813
|
| heart left ventricle hypertrophy
|
J:241813
|
\Egfrwa2/\Egfrwa2
\Ptpn11tm1Paw/\Ptpn11+
(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6)
|
abnormal muscle morphology
|
J:75413
|
| intestinal hypoperistalsis
|
J:75413
|
\Egfrwa2/\Egfrwa2
\Ptpn11tm1Rbn/\Ptpn11+
(involves: 129 * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt)
|
myocardium hypertrophy
|
J:60750
|
\Egln1tm1.1Brei/\Egln1tm1.1Brei
\Myl2tm1(cre)Krc/\Myl2+
(B6.Cg-Myl2tm1(cre)Krc Egln1tm1.1Brei)
|
decreased cardiomyocyte apoptosis
|
J:170943
|
\Egln1tm1Fong/\Egln1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:132630
|
\Egln1tm1Fong/\Egln1tm1Fong
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:114669
|
| thin ventricle myocardium compact layer
|
J:114669
|
\Egln1tm1Kael/\Egln1tm1Kael
\Egln3tm1Vlcg/\Egln3tm1Vlcg
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
cardiomyopathy
|
J:179490
|
| decreased heart ventricle muscle contractility
|
J:179490
|
| myocardial fiber degeneration
|
J:179490
|
\Egln1tm1Kael/\Egln1tm1Kael
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myocardium layer morphology
|
J:132718
|
| dilated cardiomyopathy
|
J:132718
|
| increased myocardial fiber size
|
J:132718
|
\Egln1tm1Kael/\Egln1tm1Kael
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:179490
|
| increased myocardial fiber size
|
J:179490
|
| myocardial fiber degeneration
|
J:179490
|
\Egln2tm1Pec/\Egln2tm1Pec
(involves: 129S/SvEv * Swiss)
|
abnormal muscle physiology
|
J:132630
|
| skeletal muscle necrosis
|
J:132630
|
\Egln2tm1Pec/\Egln2tm1Pec
\Epas1tm1Pec/\Epas1+
(involves: 129S/SvEv * Swiss)
|
muscle phenotype
|
J:132630
|
\Egln2tm1Pec/\Egln2tm1Pec
\Hif1atm1Pec/\Hif1a+
(involves: 129S/SvEv * Swiss)
|
muscle phenotype
|
J:132630
|
\Egln3tm1Fong/\Egln3tm1Fong
(involves: 129S6/SvEvTac * C57BL/6)
|
muscle phenotype
|
J:132630
|
\Egr2tm3Pch/\Egr2tm3Pch
\Tg(Tek-cre)1Ywa/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
heart left ventricle hypertrophy
|
J:230306
|
\Egr3tm1Jmi/\Egr3tm1Jmi
(Not Specified)
|
abnormal muscle spindle morphology
|
J:76256
|
| absent muscle spindles
|
J:49575
|
\Ehbp1l1tm1a(EUCOMM)Wtsi/\Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| thin myocardium
|
J:239583
|
\Ehhadhtm1Jkr/\Ehhadhtm1Jkr
\Hsd17b4tm1Baes/\Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:104835
|
\Eif2ak4tm1Drc/\Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle mass
|
J:92545
|
\Eif2ak4tm1Drc/\Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc)
|
decreased skeletal muscle mass
|
J:92545
|
\Eif3ftm1(KOMP)Vlcg/\Eif3f+
(B6J.B6N-Eif3ftm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:294674
|
| decreased skeletal muscle fiber size
|
J:294674
|
| decreased skeletal muscle mass
|
J:294674
|
| increased susceptibility to induced muscular atrophy
|
J:294674
|
\Eif4ebp1tm1Nso/\Eif4ebp1tm1Nso
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiac muscle contractility
|
J:163763
|
\Eif4ebp1tm1Nso/\Eif4ebp1tm1Nso
\Mtortm1.1Gcon/\Mtortm1.1Gcon
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:163763
|
\Eif4hGt(Ex279)Byg/\Eif4hGt(Ex279)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:181945
|
| increased muscle fatigability
|
J:181945
|
\Elac2tm1c(EUCOMM)Wtsi/\Elac2tm1c(EUCOMM)Wtsi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
decreased cardiac muscle contractility
|
J:265839
|
| dilated cardiomyopathy
|
J:265839
|
\Elavl1tm1.1Dkon/\Elavl1tm1.1Dkon
\Tg(MYOD1-cre)M23Glh/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:279284
|
| abnormal skeletal muscle fiber type ratio
|
J:279284
|
| decreased susceptibility to induced muscular atrophy
|
J:279284
|
\Elmo1tm1.2Ravi/\Elmo1tm1.2Ravi
\Elmo2tm1.1Jfco/\Elmo2tm1.1Jfco
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:331473
|
| decreased skeletal muscle fiber size
|
J:331473
|
| impaired skeletal muscle regeneration
|
J:331473
|
\Elmo1tm1.2Ravi/\Elmo1tm1.2Ravi
\Elmo2tm1c(EUCOMM)Hmgu/\Elmo2tm1c(EUCOMM)Hmgu
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal muscle development
|
J:331473
|
\Elmo1tm1.2Ravi/\Elmo1tm1.2Ravi
\Elmo2tm1c(EUCOMM)Hmgu/\Elmo2tm1c(EUCOMM)Hmgu
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal diaphragm development
|
J:331473
|
| abnormal muscle development
|
J:331473
|
\Elmo2tm2.1Jfco/\Elmo2tm2.1Jfco
(involves: 129 * C57BL/6)
|
enhanced skeletal muscle regeneration
|
J:331473
|
| increased skeletal muscle fiber size
|
J:331473
|
\Elntm1Dyl/\Eln+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:51109
|
\Elntm1Dyl/\Elntm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:47771
|
\Elp1tm1.1Gilas/\Elp1tm1.1Gilas
\Tg(Dct-cre)1Apdn/0
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:237480
|
\Elp1tm1.2Id/\Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
abnormal muscle spindle morphology
|
J:188923
|
\Elp2em2Bjw/\Elp2em2Bjw
(involves: C57BL/6)
|
hypotonia
|
J:306113
|
\Elp2em2Bjw/\Elp2em2Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
\Elp2em2Bjw/\Elp2em3Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
\Emdtm1.1Stw/Y
(involves: 129S1/Sv * FVB/N)
|
abnormal gastrocnemius morphology
|
J:106760
|
\Emdtm1.1Stw/Y
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:218095
|
| decreased heart left ventricle muscle contractility
|
J:218095
|
| decreased heart right ventricle muscle contractility
|
J:218095
|
| decreased heart ventricle muscle contractility
|
J:218095
|
| decreased myocardial fiber size
|
J:218095
|
| increased myocardial fiber number
|
J:218095
|
\Emdtm1.1Stw/\Emdtm1.1Stw
(involves: 129S1/Sv * FVB/N)
|
muscle phenotype
|
J:106760
|
\Emdtm1Ykh/Y
(B6.129X1-Emdtm1Ykh)
|
abnormal myocardial fiber morphology
|
J:106563
|
| abnormal skeletal muscle fiber morphology
|
J:106563
|
\Emdtm1Ykh/\Emdtm1Ykh
(B6.129X1-Emdtm1Ykh)
|
abnormal myocardial fiber morphology
|
J:106563
|
| abnormal skeletal muscle fiber morphology
|
J:106563
|
\Eml1heco/\Eml1heco
(involves: NOR)
|
myoclonus
|
J:208031
|
\En1tm2(cre)Wrst/\En1+
\Tor1atm1Wtd/\Tor1atm3.1Wtd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:213785
|
\En1tm2(cre)Wrst/\En1+
\Tor1atm2Wtd/\Tor1atm3.1Wtd
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
\Engtm1Dyl/\Engtm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:55403
|
\Engtm1Hma/\Eng+
(129P2/OlaHsd-Engtm1Hma)
|
abnormal vascular smooth muscle morphology
|
J:73415
|
\Engtm1Hma/\Engtm1Hma
(involves: 129P2/OlaHsd * C57BL/6J)
|
thin myocardium
|
J:73415
|
\Engtm1Hma/\Engtm1Hma
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:98373
|
\Engtm1Mle/\Eng+
(involves: 129P2/OlaHsd * C57BL/6)
|
ear telangiectasia
|
J:58502
|
| neck telangiectasia
|
J:58502
|
| tail telangiectasia
|
J:58502
|
\Engtm1Mle/\Eng+
(129P2/OlaHsd-Engtm1Mle)
|
ear telangiectasia
|
J:58502
|
| tail telangiectasia
|
J:58502
|
\Enhotm1.1Butl/\Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
decreased skeletal muscle cell glucose uptake
|
J:225402
|
\Enpp1m1Amgn/\Enpp1m1Amgn
(involves: C3H/HeSnJ * C57BL/6J * Swiss)
|
calcified calcaneal tendon
|
J:168664
|
| calcified tendon
|
J:168664
|
\Enpp1tm1Gdg/\Enpp1tm1Gdg
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:110028
|
\Enpp1tm1Gdg/\Enpp1tm1Gdg
(involves: 129S1/Sv)
|
calcified calcaneal tendon
|
J:111462
|
\Enpp1ttw/\Enpp1ttw
(involves: ICR)
|
calcified calcaneal tendon
|
J:37369
|
\Entpd1tm1Djp/\Entpd1tm1Djp
(B6.129-Entpd1tm1Djp)
|
abnormal muscle electrophysiology
|
J:143010
|
| impaired smooth muscle contractility
|
J:143010
|
\Ep300tm1Dli/\Ep300tm1Dli
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
absent trabeculae carneae
|
J:47301
|
| decreased cardiac muscle contractility
|
J:47301
|
\Ep300tm1Reck/\Ep300+
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber morphology
|
J:85950
|
| abnormal muscle morphology
|
J:85950
|
| abnormal myogenesis
|
J:85950
|
| decreased skeletal muscle fiber size
|
J:85950
|
| myocardium hypoplasia
|
J:85949
|
| thin myocardium
|
J:85949
|
| thin ventricle myocardium compact layer
|
J:85949
|
\Epas1tm1Mcs/\Epas1tm1.1Mcs
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
heart left ventricle hypertrophy
|
J:302384
|
\Epc1Gt(XB645)Byg/\Epc1+
(B6.129P2-Epc1Gt(XB645)Byg)
|
abnormal muscle development
|
J:151355
|
\epf/\epf
(Not Specified)
|
emprosthotonos
|
J:6309
|
\Epg5tm1Ygz/\Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal muscle fiber morphology
|
J:196603
|
| abnormal Z line morphology
|
J:196603
|
| centrally nucleated skeletal muscle fibers
|
J:196603
|
| decreased skeletal muscle fiber size
|
J:196603
|
| muscular atrophy
|
J:196603
|
| skeletal muscle fiber degeneration
|
J:196603
|
\Ephb4tm1And/\Ephb4tm1And
(involves: 129S7/SvEvBrd * C57BL/6J)
|
absent myocardial trabeculae
|
J:57908
|
\Epm2atm1Kzy/\Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cardiac muscle cell glucose uptake
|
J:173769
|
| increased cardiac muscle glycogen level
|
J:173769
|
| muscle weakness
|
J:76688
|
| myoclonus
|
J:76688
|
\Epm2aip1Gt(BA0314)Wtsi/\Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:204966
|
\EpoTg(TAg/Epo)134.3LCPjr/\EpoTg(TAg/Epo)134.3LCPjr
(involves: C57BL/6 * CBA)
|
increased myocardial fiber size
|
J:79374
|
\Eportm1Lizon/\Eportm1Lizon
\Tg(Gata1-Epor)AMym/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
heart right ventricle hypertrophy
|
J:121500
|
\Erbb2l11Jus8/\Erbb2l11Jus8
(129S5.B6(129S7)-Erbb2l11Jus8)
|
abnormal atrium myocardium morphology
|
J:222460
|
\Erbb2tm1Cbm/\Erbb2tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
absent trabeculae carneae
|
J:48515
|
\Erbb2tm1Cbm/\Erbb2tm2.1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
absent trabeculae carneae
|
J:75421
|
\Erbb2tm1Cbm/\Erbb2tm2Cbm
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:77347
|
| decreased heart left ventricle muscle contractility
|
J:77347
|
| decreased heart ventricle muscle contractility
|
J:77347
|
| dilated cardiomyopathy
|
J:77347
|
\Erbb2tm1Gne/\Erbb2tm1Gne
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6J))
|
absent myocardial trabeculae
|
J:45302
|
\Erbb2tm1Haus/\Erbb2tm1Haus
(involves: 129S4/SvJae * C57BL/6)
|
absent myocardial trabeculae
|
J:29973
|
\Erbb2tm1Haus/\Erbb2tm1Klee
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle spindle morphology
|
J:147957
|
| decreased muscle spindle number
|
J:147957
|
\Erbb2tm1Klee/\Erbb2tm1Klee
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S4/SvJae)
|
abnormal cardiac muscle relaxation
|
J:76196
|
| abnormal myocardial fiber morphology
|
J:76196
|
| decreased heart ventricle muscle contractility
|
J:76196
|
| dilated cardiomyopathy
|
J:76196
|
\Erbb2tm1Klee/\Erbb2tm1Klee
\Tg(Ckmm-cre)1Lrsn/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:76196
|
| abnormal myocardial fiber morphology
|
J:76196
|
| decreased heart left ventricle muscle contractility
|
J:76196
|
| dilated cardiomyopathy
|
J:76196
|
\Erbb2tm1Mul/\Erbb2tm1Mul
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
absent trabeculae carneae
|
J:74283
|
\Erbb2tm3(Erbb2)Mul/\Erbb2tm1Mll
\Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle spindle morphology
|
J:82801
|
| absent muscle spindles
|
J:82801
|
\Erbb2tm3(Erbb2)Mul/\Erbb2tm3(Erbb2)Mul
(involves: 129S1/Sv * 129X1/SvJ)
|
absent primary muscle spindle
|
J:81565
|
| partial loss of secondary muscle spindle
|
J:81565
|
\Erbb2tm3(Erbb2)Mul/\Erbb2tm3(Erbb2)Mul
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB)
|
absent primary muscle spindle
|
J:81565
|
| absent secondary muscle spindle
|
J:81565
|
| impaired skeletal muscle regeneration
|
J:81565
|
| increased myoblast apoptosis
|
J:81565
|
\Erbb2tm8.1(Erbb2)Mul/\Erbb2tm8.1(Erbb2)Mul
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:89255
|
\Erbb3tm1Gne/\Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:45302
|
| abnormal myocardium layer morphology
|
J:45302
|
\Erbb4tm1Grl/\Erbb4tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
absent trabeculae carneae
|
J:29972
|
\Erbb4tm1Htig/\Erbb4tm1Htig
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal intercalated disk morphology
|
J:101252
|
| abnormal myocardial fiber morphology
|
J:101252
|
| decreased heart left ventricle muscle contractility
|
J:101252
|
| decreased myocardial fiber number
|
J:101252
|
| dilated cardiomyopathy
|
J:101252
|
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased skeletal muscle mass
|
J:117488
|
| dystonia
|
J:117488
|
\Ercc3tm2Jhjh/\Ercc3tm2Jhjh
\Xpatm1Hvs/\Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle hypertonia
|
J:145759
|
\Ercc6tm1Gvh/\Ercc6tm1Gvh
\Xpatm1Hvs/\Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
|
dystonia
|
J:122013
|
\Ergtm1.1Path/\Ergtm1.1Path
(Not Specified)
|
heart right ventricle hypertrophy
|
J:227456
|
\Ergic2tm1.1Bcgen/\Ergic2tm1.1Bcgen
(Not Specified)
|
abnormal ventricle myocardium morphology
|
J:345070
|
| decreased cardiac muscle contractility
|
J:345070
|
| decreased heart ventricle muscle contractility
|
J:345070
|
\Ergic3tm1.1Bcgen/\Ergic3tm1.1Bcgen
(Not Specified)
|
abnormal ventricle myocardium morphology
|
J:345070
|
| decreased cardiac muscle contractility
|
J:345070
|
| decreased heart ventricle muscle contractility
|
J:345070
|
\Esr1tm1.1Ics/\Esr1tm1.1Ics
(involves: C57BL/6NTac)
|
abnormal vasodilation
|
J:206373
|
\Esr1tm1.1Mma/\Esr1tm1.1Mma
(involves: 129S2/SvPas)
|
abnormal vasodilation
|
J:206373
|
\Esr1tm1Ksk/\Esr1+
(involves: 129P2/OlaHsd)
|
abnormal cremaster muscle morphology
|
J:112350
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
abnormal cremaster muscle morphology
|
J:112350
|
\Esr1tm4.2Ksk/\Esr1tm4.2Ksk
\Mir22tm1Boet/\Mir22tm1Boet
\Tg(Ckmm-cre)5Khn/0
(involves: 129S2/SvPas * C57BL/6 * FVB)
|
muscle phenotype
|
J:266382
|
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:73898
|
| abnormal vascular smooth muscle morphology
|
J:73898
|
| abnormal vascular smooth muscle physiology
|
J:73898
|
| increased vasoconstriction
|
J:73898
|
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal intercalated disk morphology
|
J:93438
|
| abnormal muscle contractility
|
J:95398
|
| abnormal myocardial fiber morphology
|
J:93438
|
| increased myocardial fiber size
|
J:93438
|
| increased vasodilation
|
J:64165
|
\Esrrbtm1.1Nat/\Esrrbtm1.1Nat
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:241078
|
| decreased cardiac muscle contractility
|
J:241078
|
| decreased heart ventricle muscle contractility
|
J:241078
|
| dilated cardiomyopathy
|
J:241078
|
\Etfdhtm1c(EUCOMM)Hmgu/\Etfdhtm1c(EUCOMM)Hmgu
\Tg(ACTA1-rtTA,tetO-cre)102Monk/0
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal muscle physiology
|
J:345923
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:345923
|
| increased skeletal muscle fiber mitochondrial size
|
J:345923
|
| myopathy
|
J:345923
|
\Etv1tm1Tmj/\Etv1+
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| increased muscle spindle number
|
J:75311
|
\Etv1tm1Tmj/\Etv1tm1Tmj
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle spindle morphology
|
J:78232
|
\Etv1tm1Tmj/\Etv1tm1Tmj
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| abnormal muscle spindle morphology
|
J:75311
|
| absent golgi tendon organ
|
J:75311
|
\Etv1tm1Tmj/\Etv1tm1Tmj
\Etv4tm1Arbr/\Etv4+
(involves: 129S1/Sv)
|
decreased muscle spindle number
|
J:197913
|
\Etv1tm1Tmj/\Etv1tm1Tmj
\Ntf3tm1Lfr/\Ntf3tm1Lfr
(involves: 129S1/Sv * 129S2/SvPas)
|
absent golgi tendon organ
|
J:75311
|
| absent muscle spindles
|
J:75311
|
\Etv1tm1Tmj/\Etv1tm2Tmj
\Tg(EGR3-WGA)1Tmj/0
(involves: 129S1/Sv)
|
decreased muscle spindle number
|
J:197913
|
\Etv1tm2Tmj/\Etv1+
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| increased muscle spindle number
|
J:75311
|
\Etv1tm2Tmj/\Etv1tm2Tmj
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| abnormal muscle spindle morphology
|
J:75311
|
| absent golgi tendon organ
|
J:75311
|
\Etv1tm2Tmj/\Etv1tm2Tmj
\Ntf3tm1Lfr/\Ntf3tm1Lfr
(involves: 129S1/Sv * 129S2/SvPas)
|
absent golgi tendon organ
|
J:75311
|
| absent muscle spindles
|
J:75311
|
\Evlb2b2600Clo/\Evlb2b2600Clo
(C57BL/6J-Evlb2b2600Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\Ewsr1tm1Sblee/\Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
muscular atrophy
|
J:122058
|
\Eya1tm1Rilm/\Eya1tm1Rilm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:172023
|
\Eya1tm1Rilm/\Eya1tm1Rilm
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal extraocular muscle morphology
|
J:172023
|
| abnormal skeletal muscle morphology
|
J:172023
|
| facial muscle hypoplasia
|
J:172023
|
| tongue muscle hypoplasia
|
J:172023
|
\Eya1tm1Rilm/\Eya1tm1Rilm
\Six1tm1Rsd/\Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal epaxial muscle morphology
|
J:86619
|
| absent hypaxial muscle
|
J:86619
|
\Ezh2tm2Sho/\Ezh2tm2Sho
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
myocardial ventricular hypertrabeculation
|
J:179371
|
| thin myocardium compact layer
|
J:179371
|
\F2tm1Jld/\F2tm1Sjd
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
muscle hemorrhage
|
J:144572
|
\F3tm1.1Dwr/\F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal vascular smooth muscle physiology
|
J:111390
|
| increased vascular smooth muscle cell proliferation
|
J:111390
|
\F11tm1Gjb/\F11tm1Gjb
\Proctm1Fjc/\Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myocardial fiber degeneration
|
J:67398
|
| myocardium necrosis
|
J:67398
|
\Faahtm1Crv/\Faahtm1Crv
\Tg(SOD1*G93A)1Gur/0
(involves: 129X1/SvJ * ABH * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
\Fabp3tm1Bin/\Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
increased cardiac muscle cell glucose uptake
|
J:54614
|
\Fabp4tm1Brsp/\Fabp4tm1Brsp
\Fabp5tm1Hota/\Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased skeletal muscle glycogen level
|
J:217245
|
| muscle phenotype
|
J:217245
|
\Fabp4tm1Brsp/\Fabp4tm1Brsp
\Fabp5tm1Hota/\Fabp5tm1Hota
\Lepob/\Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
increased muscle cell glucose uptake
|
J:111878
|
\Faddtm1Mak/\Faddtm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal myocardium layer morphology
|
J:46527
|
| thin myocardium
|
J:46527
|
| trabecula carnea hypoplasia
|
J:46527
|
\Fam120bem1Qqlg/\Fam120bem1Qqlg
(C57BL/6-Fam120bem1Qqlg)
|
decreased fetal cardiomyocyte proliferation
|
J:318650
|
| decreased heart ventricle muscle contractility
|
J:318650
|
| increased myocardial fiber size
|
J:318650
|
| myocardial fiber disarray
|
J:318650
|
\Fam161bem1(IMPC)Ccpcz/\Fam161bem1(IMPC)Ccpcz
(C57BL/6N-Fam161bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Fam227bem1(IMPC)Ccpcz/\Fam227bem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam227bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr/J)
|
abnormal myocardium layer morphology
|
J:14151
|
\Fat1Gt(KST249)Byg/\Fat1Gt(KST249)Byg
\Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| decreased skeletal muscle fiber diameter
|
J:199157
|
| decreased skeletal muscle mass
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
| myositis
|
J:199157
|
| skeletal muscle atrophy
|
J:199157
|
| skeletal muscle fiber necrosis
|
J:199157
|
\Fat1tm1.2Fhel/\Fat1tm1.2Fhel
\Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)
|
abnormal facial muscle morphology
|
J:199157
|
| abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| decreased skeletal muscle fiber diameter
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
| myositis
|
J:199157
|
| skeletal muscle fiber necrosis
|
J:199157
|
\Fat1tm1Fhel/\Fat1tm1Fhel
\Pax3tm1(cre)Joe/\Pax3+
\Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
\Fat1tm1Fhel/\Fat1tm1Fhel
\Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
\Fat3em1(IMPC)Ccpcz/\Fat3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fat3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Fbln1Gt(XST011)Byg/\Fbln1Gt(XST011)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
ventricle myocardium hypoplasia
|
J:137690
|
\Fbln5tm1Eno/\Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:96831
|
\Fbn1tm1.2Lysa/\Fbn1+
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:165897
|
| abnormal tendon morphology
|
J:165897
|
\Fbn1tm1.2Lysa/\Fbn1tm1.2Lysa
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:165897
|
| abnormal tendon morphology
|
J:165897
|
\Fbn1tm2Rmz/\Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ)
|
diaphragmatic hernia
|
J:54081
|
\Fbn1tm3Rmz/\Fbn1tm3Rmz
(Not Specified)
|
abnormal diaphragm morphology
|
J:110586
|
| abnormal intercostal muscle morphology
|
J:110586
|
| diaphragmatic hernia
|
J:110586
|
\Fbn1Tsk \Bloc1s6+/\Fbn1+ \Bloc1s6pa
(B6.Cg-Fbn1Tsk +/+ Bloc1s6pa/J)
|
abnormal vasodilation
|
J:81020
|
\Fbn1Tsk/\Fbn1+
(B10.D2/(58N)Sn)
|
abnormal tendon morphology
|
J:5629
|
| abnormal tendon sheath morphology
|
J:5629
|
\Fbn1Tsk/\Fbn1+
(B6.Cg-Fbn1Tsk)
|
heart right ventricle hypertrophy
|
J:20724
|
\Fbn2fp/\Fbn2fp
(C3Fe(B6)-Fbn2fp/J)
|
muscle weakness
|
J:157998
|
\Fbn2fp/\Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH * C3HeB/FeHu * C57BL/6J)
|
muscle weakness
|
J:157998
|
\Fbn2mz/\Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal muscle electrophysiology
|
J:157998
|
| centrally nucleated skeletal muscle fibers
|
J:157998
|
| decreased skeletal muscle fiber diameter
|
J:157998
|
| increased skeletal muscle mass
|
J:157998
|
| muscle weakness
|
J:157998
|
\Fbxl3em1(IMPC)Ccpcz/\Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Fbxo10tm1b(KOMP)Wtsi/\Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased cardiac muscle contractility
|
J:211773
|
\Fbxo32tm1Glas/\Fbxo32tm1Glas
(involves: 129S1/Sv)
|
decreased susceptibility to induced muscular atrophy
|
J:77660
|
\Fbxw5em1Syli/\Fbxw5em1Syli
(C57BL/6-Fbxw5em1Syli)
|
decreased cardiac muscle contractility
|
J:298305
|
\Fdpstm1Jiy/\Fdpstm1Jiy
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:317808
|
| increased myocardial fiber size
|
J:317808
|
\Fendrrtm1Bgh/\Fendrrtm2Bgh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:191565
|
| ventricle myocardium hypoplasia
|
J:191565
|
\Fendrrtm1Vlcg/\Fendrrtm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N)
|
abnormal esophageal smooth muscle morphology
|
J:204277
|
\Festm2Mcs/\Fes+
(chimera involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:76509
|
| thin myocardium compact layer
|
J:76509
|
\Fgf2tm1Doe/\Fgf2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
| decreased cardiac muscle contractility
|
J:119652
|
| decreased vasoconstriction
|
J:45775
|
| increased cardiomyocyte apoptosis
|
J:119652
|
\Fgf2tm1Zllr/\Fgf2tm1Zllr
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:85088
|
\Fgf2tm1Zllr/\Fgf2tm1Zllr
\Fgf6tm1Thbr/\Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal myoblast migration
|
J:85088
|
| muscle phenotype
|
J:85088
|
\Fgf2tm2Doe/\Fgf2tm2Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
| decreased cardiac muscle contractility
|
J:119652
|
| increased cardiomyocyte apoptosis
|
J:119652
|
\Fgf6tm1Thbr/\Fgf6tm1Thbr
(either: (involves: 129S4/SvJae-Fgf6tm1Thbr) or (involves: 129S4/SvJae * C57BL/6))
|
impaired skeletal muscle regeneration
|
J:42574
|
| increased satellite cell number
|
J:42574
|
\Fgf8tm1.3Mrt/\Fgf8tm1.4Mrt
\Tg(Tbx1-cre)1Joe/0
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:88814
|
\Fgf9tm1Dor/\Fgf9tm1Dor
(involves: C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:95803
|
\Fgf10tm1Ska/\Fgf10tm1Ska
(involves: C57BL/6 * CBA)
|
abnormal limb muscle morphology
|
J:80685
|
| diaphragmatic hernia
|
J:80685
|
| muscle phenotype
|
J:80685
|
\Fgf16tm1Nit/Y
(C57BL/6-Fgf16tm1Nit)
|
decreased fetal cardiomyocyte proliferation
|
J:139637
|
\Fgf16tm1Paca/Y
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
trabecula carnea hypoplasia
|
J:138004
|
\Fgfr1tm1Upir/\Fgfr1tm1.1Upir
(involves: C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:95803
|
| thin myocardium
|
J:95803
|
\Fgfr2tm1.1Dsn/\Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
absent hypodermis muscle layer
|
J:59285
|
\Fgfr2tm1Ewj/\Fgfr2+
\Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal vasodilation
|
J:101174
|
\Fgfr2tm3Dsn/\Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:111148
|
| thin left ventricle myocardium compact layer
|
J:111148
|
\Fgfrl1tm1.1Ptew/\Fgfrl1tm1.1Ptew
(B6.129-Fgfrl1tm1.1Ptew)
|
abnormal diaphragm development
|
J:149673
|
| thin myocardium
|
J:149673
|
\Fgfrl1tm1True/\Fgfrl1tm1True
(B6.129S6-Fgfrl1tm1True)
|
abnormal diaphragm development
|
J:130254
|
| diaphragmatic hernia
|
J:130254
|
| muscle hypoplasia
|
J:130254
|
| thin diaphragm muscle
|
J:130254,
J:218981
|
\Fgfrl1tm2.1True/\Fgfrl1tm2.1True
(B6.Cg-Fgfrl1tm2.1True)
|
muscle phenotype
|
J:218981
|
\Fhl1tm1.1Mihi/Y
(involves: 129S/SvEv * C57BL/6J * C57BL/6NJ)
|
centrally nucleated skeletal muscle fibers
|
J:218097
|
| decreased skeletal muscle fiber diameter
|
J:218097
|
| myopathy
|
J:218097
|
\Fhod3tm1Hsum/\Fhod3+
\Tg(Myh6-Fhod3*I1127A)#Hsum/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardium layer morphology
|
J:187358
|
\Fhod3tm1Hsum/\Fhod3tm1Hsum
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardial trabeculae morphology
|
J:187358
|
| decreased heart ventricle muscle contractility
|
J:187358
|
\Fig4plt1/\Fig4plt1
(involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)
|
muscle weakness
|
J:122737
|
\Fis1tm1.1Itl/\Fis1tm1.1Itl
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NTac * FVB)
|
abnormal skeletal muscle morphology
|
J:290485
|
| abnormal Z line morphology
|
J:290485
|
\Fkbp1atm1.1Shou/\Fkbp1atm1Zuk
\Tg(Tek-cre)1Ywa/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
thin ventricle myocardium compact layer
|
J:195489
|
\Fkbp1atm1Slh/\Fkbp1atm1Slh
\Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:176731
|
| abnormal muscle physiology
|
J:176731
|
| abnormal skeletal muscle morphology
|
J:176731
|
\Fkbp1atm1Zuk/\Fkbp1atm1Slh
\Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:94747
|
| abnormal muscle physiology
|
J:94747
|
| abnormal skeletal muscle fiber morphology
|
J:94747
|
| abnormal skeletal muscle fiber type ratio
|
J:94747
|
| centrally nucleated skeletal muscle fibers
|
J:94747
|
\Fkbp1atm1Zuk/\Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal muscle physiology
|
J:45536
|
| abnormal myocardium layer morphology
|
J:45536
|
| abnormal trabecula carnea morphology
|
J:45536
|
| decreased heart ventricle muscle contractility
|
J:45536
|
| dilated cardiomyopathy
|
J:45536
|
\Fkrptm1.1Pg/\Fkrptm1.1Pg
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle fiber morphology
|
J:285924
|
| abnormal skeletal muscle fiber type ratio
|
J:285924
|
| increased skeletal muscle fiber diameter
|
J:285924
|
| increased skeletal muscle fiber size
|
J:285924
|
| myopathy
|
J:285924
|
| skeletal muscle fibrosis
|
J:285924
|
\Fkrptm1.1Pg/\Fkrptm1.2Pg
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:285924
|
\Fkrptm1Itl/\Fkrptm1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:164448
|
| centrally nucleated skeletal muscle fibers
|
J:164448
|
| dystrophic muscle
|
J:164448
|
| increased variability of skeletal muscle fiber size
|
J:164448
|
| muscle weakness
|
J:164448
|
| skeletal muscle fiber degeneration
|
J:164448
|
| skeletal muscle fiber necrosis
|
J:164448
|
| skeletal muscle fibrosis
|
J:164448
|
\Fkrptm1Scbr/\Fkrptm1Scbr
(involves: C57BL/6)
|
abnormal extensor digitorum longus morphology
|
J:164634
|
| abnormal tibialis anterior morphology
|
J:164634
|
| centrally nucleated skeletal muscle fibers
|
J:164634
|
| decreased skeletal muscle fiber number
|
J:164634
|
\Fkrptm1Scbr/\Fkrptm1Scbr
\Sox1tm1(cre)Take/\Sox1+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
centrally nucleated skeletal muscle fibers
|
J:207119
|
| dystrophic muscle
|
J:207119
|
| muscle degeneration
|
J:207119
|
| myositis
|
J:207119
|
\Fkrptm1Scbr/\Fkrptm1Scbr
\Sox1tm1(cre)Take/\Sox1+
\Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
abnormal muscle morphology
|
J:207119
|
| abnormal muscle physiology
|
J:207119
|
| calcified muscle
|
J:207119
|
| centrally nucleated skeletal muscle fibers
|
J:207119
|
| dystrophic muscle
|
J:207119
|
| myositis
|
J:207119
|
| skeletal muscle fibrosis
|
J:207119
|
| skeletal muscle hypertrophy
|
J:207119
|
\Fkrptvrm53/\Fkrptvrm53
(C57BL/6J-Fkrptvrm53/Pjn)
|
centrally nucleated skeletal muscle fibers
|
J:243745
|
| dystrophic muscle
|
J:243745
|
\Fktntm1Kcam/\Fktntm1Kcam
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
dystrophic muscle
|
J:187144
|
\Fktntm1Kcam/\Fktntm1Kcam
\Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S/SvEv * C57BL/6 * CBA)
|
dystrophic muscle
|
J:187144
|
\Fktntm1Kcam/\Fktntm1Kcam
\Tg(Ckmm-cre)5Khn/?
(involves: 129S/SvEv * FVB)
|
dystrophic muscle
|
J:187144
|
\Fktntm1Ttd/\Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:144746
|
\Fktntm2(FCMD)Ttd/\Fktntm2(FCMD)Ttd
(Not Specified)
|
muscle phenotype
|
J:144746
|
\Fktntm3.1Ttd/\Fktntm3.1Ttd
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:198535
|
| abnormal muscle precursor cell physiology
|
J:198535
|
| centrally nucleated skeletal muscle fibers
|
J:198535
|
| decreased satellite cell number
|
J:198535
|
| decreased skeletal muscle weight
|
J:198535
|
| impaired skeletal muscle regeneration
|
J:198535
|
| increased collagen deposition in the muscles
|
J:198535
|
| increased variability of skeletal muscle fiber size
|
J:198535
|
| skeletal muscle atrophy
|
J:198535
|
| skeletal muscle fibrosis
|
J:198535
|
| skeletal muscle necrosis
|
J:198535
|
\Fktntm3.1Ttd/\Fktntm3.1Ttd
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal skeletal muscle fiber morphology
|
J:198535
|
| centrally nucleated skeletal muscle fibers
|
J:198535
|
| dystrophic muscle
|
J:198535
|
| skeletal muscle necrosis
|
J:198535
|
\Fli1tm1Matr/\Fli1tm1Matr
\Tg(Tek-cre)12Flv/0
(B6.Cg-Fli1tm1Matr Tg(Tek-cre)12Flv)
|
abnormal vascular smooth muscle morphology
|
J:158658
|
\Flnctm1.1Rsdf/\Flnc+
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:226976
|
| abnormal sarcomere morphology
|
J:226976
|
| abnormal Z line morphology
|
J:226976
|
| muscle phenotype
|
J:226976
|
| skeletal muscle fiber degeneration
|
J:226976
|
\Flnctm1Lmk/\Flnctm1Lmk
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:112170
|
| abnormal extensor digitorum longus morphology
|
J:112170
|
| abnormal intercostal muscle morphology
|
J:112170
|
| abnormal myogenesis
|
J:112170
|
| abnormal skeletal muscle fiber morphology
|
J:112170
|
| abnormal skeletal muscle morphology
|
J:112170
|
| abnormal soleus morphology
|
J:112170
|
| abnormal tibialis anterior morphology
|
J:112170
|
| centrally nucleated skeletal muscle fibers
|
J:112170
|
| decreased skeletal muscle fiber number
|
J:112170
|
| decreased skeletal muscle mass
|
J:112170
|
| increased variability of skeletal muscle fiber size
|
J:112170
|
\Flrt2tm1Rob/\Flrt2tm1Rob
(involves: 129S/SvEv * C57BL/6J)
|
thin ventricle myocardium compact layer
|
J:171515
|
\Flt3em1(IMPC)Ccpcz/\Flt3em1(IMPC)Ccpcz
(C57BL/6NCrl-Flt3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Flt4tm1Ali/\Flt4+
\Tmem204tm1.1Ali/\Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
\Fmodtm1Aol/\Fmod+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:54069
|
\Fmodtm1Aol/\Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal tendon morphology
|
J:65867
|
| decreased tendon stiffness
|
J:79115
|
\Fmodtm1Aol/\Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:54069
|
\Fmodtm1Aol/\Fmodtm1Aol
\Lumtm1Chak/\Lum+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased tendon stiffness
|
J:83544
|
\Fmodtm1Aol/\Fmodtm1Aol
\Lumtm1Chak/\Lumtm1Chak
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:79115
|
| abnormal tendon morphology
|
J:79115
|
| decreased tendon stiffness
|
J:83544
|
| muscle weakness
|
J:79115
|
\Fn1tm1Hyn/\Fn1tm1Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
thick myocardium
|
J:16247
|
\Fn1tm4Hyn/\Fn1tm4Hyn
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:126737
|
\Fnip1em1(IMPC)Ccpcz/\Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
| increased cardiac muscle contractility
|
J:211773
|
\Fnip1LPAB.1/\Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
abnormal skeletal muscle morphology
|
J:187318
|
| cardiomyopathy
|
J:187318
|
\Fnip1m1Btlr/\Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
abnormal skeletal muscle morphology
|
J:234285
|
| increased cardiac muscle glycogen level
|
J:234285
|
\Fnip1tm1.1Baba/\Fnip1tm1.1Baba
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal muscle morphology
|
J:220672
|
| abnormal muscle physiology
|
J:220672
|
\Fostm1Wag/\Fostm1Wag
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:89283
|
\Fostm1Wag/\Fostm1Wag
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:89283
|
\Foxc1tm1Blh/\Foxc1+
\Foxc2tm1Blh/\Foxc2+
(involves: 129S6/SvEvTac * Black Swiss)
|
trabecula carnea hypoplasia
|
J:57677
|
| ventricle myocardium hypoplasia
|
J:57677
|
\Foxc1tm1Blh/\Foxc1tm1Blh
\Foxc2tm1Blh/\Foxc2tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
disorganized myocardium
|
J:71693
|
\Foxc2tm1.2Tsku/\Foxc2tm1.2Tsku
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL * Tac:NIHBS)
|
thin myocardium
|
J:188816
|
\Foxc2tm1Miu/\Foxc2tm1Miu
\Pax1tm2Neu/\Pax1tm2Neu
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal dermomyotome development
|
J:55575
|
| abnormal muscle development
|
J:55575
|
\Foxe3tm1Mjam/\Foxe3tm1Mjam
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:232427
|
\Foxf1tm2Rhc/\Foxf1+
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:203847
|
| impaired contractility of intestinal smooth muscle
|
J:203847
|
\Foxf1tm2Rhc/\Foxf1tm2Rhc
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * DBA/2)
|
abnormal esophageal smooth muscle morphology
|
J:203847
|
\Foxf2W174R/\Foxf2+
(involves: BALB/c * C3H/HeH)
|
abnormal ciliary muscle morphology
|
J:178103
|
\Foxh1b2b2662Clo/\Foxh1b2b2662Clo
(C57BL/6J-Foxh1b2b2662Clo)
|
diaphragmatic hernia
|
J:175213
|
\Foxh1tm1Jlw/\Foxh1tm1Jlw
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
disorganized myocardium
|
J:93034
|
| trabecula carnea hypoplasia
|
J:93034
|
\Foxj1b2b774Clo/\Foxj1b2b774Clo
(C57BL/6J-Foxj1b2b774Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Foxj3Gt(XL913)Byg/\Foxj3Gt(XL913)Byg
(either: 129P2/OlaHsd-Foxj3Gt(XL913)Byg or B6.129P2-Foxj3 |
abnormal extensor digitorum longus morphology
|
J:157260
|
| abnormal muscle physiology
|
J:157260
|
| abnormal skeletal muscle fiber type ratio
|
J:157260
|
| abnormal skeletal muscle satellite cell proliferation
|
J:157260
|
| abnormal soleus morphology
|
J:157260
|
| impaired skeletal muscle contractility
|
J:157260
|
| impaired skeletal muscle regeneration
|
J:157260
|
| skeletal muscle necrosis
|
J:157260
|
\Foxk1tm1Djg/\Foxk1tm1Djg
(involves: 129S4/SvJae)
|
abnormal muscle precursor cell morphology
|
J:81688
|
| abnormal myogenesis
|
J:81688
|
| impaired skeletal muscle regeneration
|
J:62225
|
\Foxk2tm1.2Sven/\Foxk2tm1.2Sven
(B6.Cg-Foxk2tm1.2Sven)
|
decreased skeletal muscle cell glucose uptake
|
J:273343
|
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(involves: 129X1/SvJ)
|
increased myocardial fiber size
|
J:94883
|
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(involves: 129X1/SvJ * C57BL/6)
|
vascular smooth muscle hypertrophy
|
J:100263
|
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(B6.129X1-Foxm1tm1.1Rhc)
|
abnormal ventricle myocardium morphology
|
J:119481
|
| decreased fetal cardiomyocyte proliferation
|
J:119481
|
\Foxm1tm1Cle/\Foxm1tm1Cle
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:95612
|
| myocardial fiber disarray
|
J:95612
|
| thin myocardium
|
J:95612
|
\Foxn1nu/\Foxn1nu
(involves: C57BL/10)
|
abnormal muscle morphology
|
J:95776
|
| decreased skeletal muscle fiber size
|
J:95776
|
| decreased skeletal muscle mass
|
J:95776
|
\Foxo1tm1.1Dac/\Foxo1tm1.1Dac
(Not Specified)
|
abnormal myocardial trabeculae morphology
|
J:179687
|
\Foxp1Gt(S17-4A1)Sor/\Foxp1+
\Ncor2tm1Rsd/\Ncor2+
(involves: 129/Sv * 129S4/SvJaeSor)
|
thin myocardium
|
J:132982
|
\Foxp1tm1Eem/\Foxp1+
\Foxp2tm1Bux/\Foxp2tm1Bux
(involves: 129X1/SvJ * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:121421
|
\Foxp1tm1Eem/\Foxp1tm1Eem
(involves: 129S6/SvEvTac * C57BL/6)
|
disorganized myocardium
|
J:93182
|
| thin ventricle myocardium compact layer
|
J:93182
|
\Foxp1tm2.1Eem/\Foxp1tm2.1Eem
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129 * C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:163662
|
| increased fetal cardiomyocyte proliferation
|
J:163662
|
\Foxp1tm2.1Eem/\Foxp1tm2.1Eem
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:163662
|
\Frem1eyes2/\Frem1eyes2
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal diaphragm development
|
J:192553
|
| diaphragmatic hernia
|
J:192553
|
\Frem1eyes2/\Frem1eyes2
(C57BL/6J-Frem1eyes2)
|
diaphragmatic hernia
|
J:192553
|
\Frem2b2b3270Clo/\Frem2b2b3270Clo
(C57BL/6J-Frem2b2b3270Clo)
|
diaphragmatic hernia
|
J:175213
|
\fsq/\fsq
(KK(Cg)-fsq/J)
|
muscle hypertonia
|
J:137888
|
| muscle phenotype
|
J:137888
|
\Fsttm1Zuk/\Fst+
(B6.129S7-Fsttm1Zuk)
|
abnormal extensor digitorum longus morphology
|
J:182827
|
| abnormal gastrocnemius morphology
|
J:182827
|
| abnormal muscle physiology
|
J:182827
|
| abnormal pectoral muscle morphology
|
J:182827
|
| abnormal skeletal muscle fiber morphology
|
J:182827
|
| decreased gastrocnemius weight
|
J:182827
|
| decreased quadriceps weight
|
J:182827
|
| decreased skeletal muscle weight
|
J:182827
|
\Fsttm1Zuk/\Fst+
\Fstl3tm1.1Sjl/\Fstl3tm1.1Sjl
(B6.129-Fsttm1Zuk Fstl3tm1.1Sjl)
|
decreased skeletal muscle weight
|
J:182827
|
\Fsttm1Zuk/\Fst+
\Mstntm1Sjl/\Mstn+
(B6.129-Mstntm1Sjl Fsttm1Zuk)
|
decreased skeletal muscle weight
|
J:182827
|
\Fsttm1Zuk/\Fst+
\Mstntm1Sjl/\Mstntm1Sjl
(B6.129-Mstntm1Sjl Fsttm1Zuk)
|
decreased skeletal muscle weight
|
J:182827
|
\Fsttm1Zuk/\Fsttm1Zuk
(involves: 129S7/SvEvBrd)
|
decreased skeletal muscle mass
|
J:23925
|
\Fsttm1Zuk/\Fsttm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:23925
|
\Fstl1tm1.1Mvdh/\Fstl1tm1.1Mvdh
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:177416
|
| increased myocardial fiber size
|
J:177416
|
\Fuzb2b1273Clo/\Fuzb2b1273Clo
(C57BL/6J-Fuzb2b1273Clo)
|
diaphragmatic hernia
|
J:175213
|
\Fxnem2Lutzy/\Fxnem2.1Lutzy
\Tg(Ckmm-cre)5Khn/?
(B6.Cg-Fxnem2Lutzy Fxnem2.1Lutzy Tg(Ckmm-cre)5Khn/J)
|
cardiomyopathy
|
J:101977
|
| decreased cardiac muscle contractility
|
J:101977
|
\Fxntm1Mkn/\Fxntm1Mkn
\Tg(FXN)YG8Pook/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:114840
|
\Fxntm2Mkn/\Fxntm2.1Mkn
\Tg(Ckmm-cre)1Lrsn/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:75420
|
| abnormal myocardial fiber morphology
|
J:75420,
J:90401
|
| decreased heart ventricle muscle contractility
|
J:90401
|
| dilated cardiomyopathy
|
J:75420,
J:90401
|
| heart left ventricle hypertrophy
|
J:75420
|
| myocardium necrosis
|
J:75420
|
\Fxntm2Mkn/\Fxntm2.1Mkn
\Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:75420
|
| dilated cardiomyopathy
|
J:75420
|
| muscle phenotype
|
J:75420
|
| myocardium necrosis
|
J:75420
|
\Fxr1tm1.2Dln/\Fxr1tm1.2Dln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:91191
|
| abnormal myocardial fiber morphology
|
J:91191
|
\Fxr1tm1Dln/\Fxr1tm1Dln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:91191
|
| disorganized myocardium
|
J:91191
|
\Fxyd1tm1Atck/\Fxyd1tm1Atck
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased cardiac muscle contractility
|
J:97365
|
\Fzd4tm1Nat/\Fzd4tm1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:70078
|
\Fzd8em1(IMPC)Bay/\Fzd8em1(IMPC)Bay
(C57BL/6N-Fzd8em1(IMPC)Bay/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
\Gaatm1.1Rabn/\Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased cardiac muscle glycogen level
|
J:76435,
J:48839
|
| increased skeletal muscle glycogen level
|
J:76435,
J:48839
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435
|
\Gaatm1Rabn/\Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle fiber morphology
|
J:48839
|
| abnormal sarcomere morphology
|
J:48839
|
| abnormal Z line morphology
|
J:48839
|
| cardiomyopathy
|
J:76435,
J:48839
|
| increased cardiac muscle glycogen level
|
J:235790,
J:76435,
J:48839
|
| increased skeletal muscle glycogen level
|
J:235790,
J:48839,
J:73924
|
| muscle weakness
|
J:48839
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435,
J:48839
|
\Gaatm1Rabn/\Gaatm1Rabn
\Stbd1tm1Bsn/\Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6)
|
increased cardiac muscle glycogen level
|
J:235790
|
| increased skeletal muscle glycogen level
|
J:235790
|
\Gaatm1Rabn/\Gaatm1Rabn
\Tg(CMV-GAA*P545L)#Kjv/0
(involves: 129X1/SvJ * C57BL/6)
|
increased skeletal muscle glycogen level
|
J:219022
|
\Gaatm1Vdp/\Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
abnormal myocardial fiber morphology
|
J:45386
|
| abnormal skeletal muscle fiber morphology
|
J:45386
|
| cardiomyopathy
|
J:45386
|
| heart left ventricle hypertrophy
|
J:45386
|
| heart right ventricle hypertrophy
|
J:45386
|
\Gaatm1Vdp/\Gaatm1Vdp
(B6.129P2-Gaatm1Vdp)
|
abnormal muscle physiology
|
J:105167
|
| decreased skeletal muscle mass
|
J:105167
|
| muscular atrophy
|
J:105167
|
| progressive muscle weakness
|
J:105167
|
\Gaatm2Rabn/\Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:76435
|
| increased cardiac muscle glycogen level
|
J:76435
|
| increased skeletal muscle glycogen level
|
J:76435
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435
|
\Gab1tm1Nmoc/\Gab1tm1Nmoc
\Gab2tm1Thir/\Gab2tm1Thir
\Tg(Myh6-cre)2182Mds/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:124033
|
| decreased cardiac muscle contractility
|
J:124033
|
\Gab1tm1Wbm/\Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:68751
|
| abnormal muscle precursor cell migration
|
J:68751
|
| hypaxial muscle hypoplasia
|
J:68751
|
\Gab1tm1Wbm/\Gab1tm1Wbm
(involves: 129P2/OlaHsd)
|
abnormal intrinsic tongue muscle morphology
|
J:100909
|
| abnormal muscle precursor cell migration
|
J:100909
|
| hypaxial muscle hypoplasia
|
J:100909
|
\Gab1tm1Wbm/\Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal skeletal muscle morphology
|
J:125303
|
| decreased skeletal muscle mass
|
J:125303
|
\Gab1tm1Wbm/\Gab1tm1Wbm
\Mettm1Cbm/\Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:68751
|
\Gab1tm2Wbm/\Gab1tm2Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
muscle phenotype
|
J:125303
|
\Gab1tm3Wbm/\Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
muscle phenotype
|
J:125303
|
\Gab1tm5Wbm/\Gab1tm5Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
abnormal muscle precursor cell morphology
|
J:125303
|
| abnormal myogenesis
|
J:125303
|
\Gabpatm1Pjh/\Gabpatm1Pjh
\Tg(ACTA1-cre)79Jme/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
muscle phenotype
|
J:121356
|
\Gabpb1tm1Hhx/\Gabpb1tm1Hhx
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:137300
|
\Gabra1tm1.1Geh/\Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh)
|
myoclonus
|
J:227437
|
\Gabra1tm1.1Mjga/\Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga)
|
myoclonus
|
J:227437
|
\Gabrg2tm1.2Rmac/\Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL)
|
myoclonus
|
J:306976
|
\Gad2tm1Oba/\Gad2tm1Oba
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:62320
|
\Galctwi/\Galctwi
(B6.CE-Galctwi/J)
|
muscle twitch
|
J:170081
|
\Galctwi/\Galctwi
(involves: C57BL/6J * CE/J)
|
progressive muscle weakness
|
J:6390
|
\Galnt1tm1.1Jxm/\Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased heart left ventricle muscle contractility
|
J:242253
|
\Galnt3tcal/\Galnt3tcal
(involves: C3H * C57BL/6J)
|
calcified muscle
|
J:187064
|
\Gantm1Jpj/\Gantm1Jpj
(involves: C57BL/6)
|
muscular atrophy
|
J:140136
|
\Gantm1Yany/\Gantm1Yany
(Not Specified)
|
muscle spasm
|
J:108239
|
| muscular atrophy
|
J:108239
|
| progressive muscle weakness
|
J:108239
|
\Gars1C201R/\Gars1+
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
abnormal tibialis anterior morphology
|
J:149830
|
| decreased skeletal muscle fiber number
|
J:149830
|
| decreased tibialis anterior weight
|
J:149830
|
| muscle weakness
|
J:149830
|
\Gars1C201R/\Gars1+
\Nrcamm1J/\Nrcamm1J
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
muscle hypoplasia
|
J:240096
|
\Gars1em1Rwb/\Gars1em2Rwb
(involves: C57BL/6NJ * FVB/NJ)
|
muscular atrophy
|
J:284948
|
\Gars1Nmf249/\Gars1+
(C57BL/6J-Gars1Nmf249/J)
|
decreased muscle weight
|
J:112221
|
| muscular atrophy
|
J:112221
|
\Gars1Nmf249/\Gars1+
\Scn8am10J/\Scn8a+
(involves: C57BL/6J * FVB/NJ)
|
skeletal muscle atrophy
|
J:240096
|
\Gas2l2tm1a(KOMP)Wtsi/\Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Gas2l3tm1c(EUCOMM)Hmgu/\Gas2l3tm1c(EUCOMM)Hmgu
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
\Gas2l3tm1c(EUCOMM)Hmgu/\Gas2l3tm1c(EUCOMM)Hmgu
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6N)
|
dilated cardiomyopathy
|
J:244087
|
\Gas2l3tm1d(EUCOMM)Hmgu/\Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:244087
|
| decreased cardiac muscle contractility
|
J:244087
|
| decreased fetal cardiomyocyte proliferation
|
J:244087
|
| decreased myocardial fiber number
|
J:244087
|
| dilated cardiomyopathy
|
J:244087
|
| increased myocardial fiber size
|
J:244087
|
\Gas7tm1Slch/\Gas7tm1Slch
(B6.129-Gas7tm1Slch)
|
abnormal skeletal muscle fiber type ratio
|
J:227375
|
| abnormal soleus morphology
|
J:227375
|
| increased skeletal muscle fiber diameter
|
J:227375
|
| progressive muscle weakness
|
J:227375
|
\Gata3tm1Gsv/\Gata3tm1Gsv
(involves: 129)
|
abnormal pyloric sphincter morphology
|
J:228275
|
| abnormal stomach smooth muscle circular layer morphology
|
J:228275
|
| abnormal stomach smooth muscle outer longitudinal layer morphology
|
J:228275
|
\Gata4tm1.1Sad/\Gata4tm1.1Sad
\Gata6tm2.1Sad/\Gata6tm2.1Sad
\Tg(Wt1-cre)1Jbeb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:206877
|
| thin myocardium
|
J:206877
|
\Gata4tm1.1Sad/\Gata4tm1.1Sad
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased cardiomyocyte apoptosis
|
J:121367
|
\Gata4tm1.1Sad/\Gata4tm1.1Sad
\Tg(Myh6-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:121367
|
| decreased cardiac muscle contractility
|
J:121367
|
\Gata4tm1.1Sad/\Gata4tm1.1Sad
\Tg(Myh7-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:121367
|
| decreased cardiac muscle contractility
|
J:121367
|
| increased myocardial fiber apoptosis
|
J:121367
|
\Gata4tm1.1Sad/\Gata4tm1.2Sad
\Pax3Sp-d/\Pax3Sp-d
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
muscle phenotype
|
J:231793
|
\Gata4tm1.1Sad/\Gata4tm1.2Sad
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle phenotype
|
J:231793
|
\Gata4tm1.1Sad/\Gata4tm1.2Sad
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal diaphragm development
|
J:231793
|
| abnormal muscle precursor cell morphology
|
J:231793
|
| abnormal muscle precursor cell physiology
|
J:231793
|
| diaphragmatic hernia
|
J:231793
|
\Gata4tm1.1Wtp/\Gata4tm1.1Wtp
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd)
|
decreased fetal cardiomyocyte proliferation
|
J:99203
|
\Gata4tm1.1Wtp/\Gata4tm1.1Wtp
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
decreased fetal cardiomyocyte proliferation
|
J:99203
|
\Gata4tm1.2Wtp/\Gata4+
(B6.Cg-Gata4tm1.2Wtp)
|
abnormal diaphragm central tendon morphology
|
J:117367
|
| diaphragmatic hernia
|
J:117367
|
\Gata4tm1Eno/\Gata4+
(B6.129S7-Gata4tm1Eno)
|
diaphragmatic hernia
|
J:187416
|
\Gata4tm1Eno/\Gata4+
\Gata6tm1Eno/\Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:111824
|
| abnormal vascular smooth muscle morphology
|
J:111824
|
| decreased fetal cardiomyocyte proliferation
|
J:111824
|
| thin myocardium
|
J:111824
|
| thin myocardium compact layer
|
J:111824
|
\Gata4tm1Grg/\Gata4+
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
| thin ventricle myocardium compact layer
|
J:185124
|
\Gata4tm1Grg/\Gata4tm1.1Wtp
\Tg(Nkx2-5-cre)9Eno/0
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:185124
|
\Gata4tm1Grg/\Gata4tm1Grg
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
| thin myocardium
|
J:185124
|
\Gata4tm1Jml/\Gata4+
\Gata5tm1Eem/\Gata5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin myocardium compact layer
|
J:155855
|
| thin ventricle myocardium compact layer
|
J:155855
|
\Gata4tm1Jml/\Gata4+
\Gata5tm1Eem/\Gata5tm1Eem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:155855
|
| decreased fetal cardiomyocyte proliferation
|
J:155855
|
| thin ventricle myocardium compact layer
|
J:155855
|
| ventricular myocardium compact layer hypoplasia
|
J:155855
|
\Gata4tm1Sho/\Gata4tm1.1Wtp
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
\Gata4tm1Sho/\Gata4tm1Sho
(involves: 129S6/SvEvTac)
|
thin myocardium
|
J:77392
|
\Gata4tm1Wtp/\Gata4tm1Wtp
(involves: 129 * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:94637
|
| decreased fetal cardiomyocyte proliferation
|
J:94637
|
| myocardial trabeculae hypoplasia
|
J:94637
|
\Gata5tm1.2Nemr/\Gata5tm1.2Nemr
(involves: 129 * C57BL/6)
|
decreased myocardial fiber number
|
J:175663
|
| increased heart ventricle muscle contractility
|
J:175663
|
| increased myocardial fiber size
|
J:175663
|
| myocardial trabeculae hypoplasia
|
J:175663
|
\Gata5tm1.2Nemr/\Gata5tm1.2Nemr
(Not Specified)
|
abnormal vasodilation
|
J:227997
|
\Gatmtm1.1Isb/\Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
hypotonia
|
J:191142
|
| increased muscle cell glucose uptake
|
J:191142
|
\Gbe1m1Yty/\Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
|
decreased cardiac muscle glycogen level
|
J:167233
|
| increased fetal cardiomyocyte proliferation
|
J:167233
|
| thin myocardium
|
J:167233
|
\Gbe1tm1.1Hoa/\Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:176889
|
| decreased skeletal muscle glycogen level
|
J:176889
|
\Gbe1tm1Hoa/\Gbe1tm1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal skeletal muscle morphology
|
J:176889
|
| increased skeletal muscle glycogen level
|
J:176889
|
\Gbe1tm2.1Hoa/\Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle glycogen level
|
J:226481
|
\Gbe1tm2Hoa/\Gbe1tm2Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle glycogen level
|
J:226481
|
\Gdf11tm1Sjl/\Gdf11tm2.1Sjl
\Tg(Myl1-cre)1Sjl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * FVB * SJL/J)
|
muscle phenotype
|
J:158173
|
\Gdnftm1.1Neas/\Gdnftm1.1Neas
\Egr3tm1(cre)Mod/\Egr3tm1(cre)Mod
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * SJL)
|
muscle phenotype
|
J:160727
|
\Gdnftm1Lmgd/\Gdnf+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * CD-1))
|
intestinal hypoperistalsis
|
J:73922
|
\Gdnftm1Lmgd/\Gdnftm1Lmgd
(either: (involves: 129S4/SvJae) or (involves: 129S1/Sv * 129X1/SvJ))
|
intestinal hypoperistalsis
|
J:33810
|
\Gdnftm1Rosl/\Gdnf+
(involves: 129S2/SvPas * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
\Gdnftm1Rosl/\Gdnf+
\Nrtntm1Jmi/\Nrtntm1Jmi
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
\Gdnftm1Rosl/\Gdnftm1Rosl
(involves: 129S2/SvPas)
|
abnormal muscle spindle morphology
|
J:132854
|
\Gena26/\Gena26+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
\Gena323/\Gena323+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
\Gfaptm1Pkny/\Gfaptm1Pkny
\Vimtm1Cba/\Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased vasodilation
|
J:124385
|
\Gfpt1tm1c(EUCOMM)Wtsi/\Gfpt1tm1c(EUCOMM)Wtsi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle electrophysiology
|
J:265013
|
| abnormal sarcolemma morphology
|
J:265013
|
| abnormal sarcoplasmic reticulum morphology
|
J:265013
|
| abnormal skeletal muscle fiber morphology
|
J:265013
|
| centrally nucleated skeletal muscle fibers
|
J:265013
|
| decreased skeletal muscle fiber size
|
J:265013
|
| impaired skeletal muscle contractility
|
J:265013
|
| increased muscle fatigability
|
J:265013
|
| increased skeletal muscle fiber size
|
J:265013
|
| increased variability of skeletal muscle fiber size
|
J:265013
|
| muscle phenotype
|
J:265013
|
| muscle weakness
|
J:265013
|
| myopathy
|
J:265013
|
| skeletal muscle fiber atrophy
|
J:265013
|
| skeletal muscle fiber necrosis
|
J:265013
|
\Gfra1tm1Jmi/\Gfra1+
(involves: 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
\Gfra1tm3Jmi/\Gfra1tm3Jmi
(involves: 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:132854
|
\Gfra2tm1Msa/\Gfra2tm1Msa
(either: B6.129-Gfra2tm1Msa or 129S2.129-Gfra2tm1Msa)
|
intestinal hypoperistalsis
|
J:93911
|
\Ghitmem1Ltk/\Ghitmem1Ltk
(C57BL6J-Ghitmem1Ltk)
|
abnormal skeletal muscle fiber morphology
|
J:327550
|
\Ghrtm1c(KOMP)Wtsi/\Ghrtm1c(KOMP)Wtsi
\Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6N)
|
increased soleus weight
|
J:206358
|
\Gipc1Gt(OST93079)Lex/\Gipc1Gt(OST93079)Lex
(B6.129S-Gipc1Gt(OST93079)Lex)
|
decreased heart ventricle muscle contractility
|
J:122652
|
\Gja1M1Jrt/\Gja1+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:101733
|
| abnormal myocardium layer morphology
|
J:101733
|
| decreased heart left ventricle muscle contractility
|
J:101733
|
| decreased heart right ventricle muscle contractility
|
J:101733
|
\Gja1tm1.1Gfi/\Gja1tm1.1Gfi
(Not Specified)
|
abnormal trabecula carnea morphology
|
J:108525
|
\Gja1tm1Gfi/\Gja1tm1.1Gfi
\Tg(Pax3-cre)1Joe/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:108525
|
\Gja1tm1Kdr/\Gja1tm1Kdr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal trabecula carnea morphology
|
J:24121
|
| abnormal vascular smooth muscle physiology
|
J:212895
|
\Gja1tm1Kdr/\Gja1tm1Kdr
\Tg(CMV-Gja1)BClo/0
(involves: 129S1/Sv * 129X1/SvJ * SJL/J * SWR/J)
|
heart right ventricle hypertrophy
|
J:40388
|
\Gja1tm1Kwi/\Gja1tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal muscle regeneration
|
J:94694
|
\Gja1tm2(Gjb1)Kwi/\Gja1tm2(Gjb1)Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:65112
|
\Gja1tm3.1Clo/\Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo)
|
abnormal vascular smooth muscle cell proliferation
|
J:212895
|
\Gja1tm5Gfi/\Gja1tm5Gfi
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal cardiac muscle contractility
|
J:185692
|
\Gja1tm6.1(Gjb3)Kwi/\Gja1tm6.1(Gjb3)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:106509
|
\Gja1tm10Kwi/\Gja1tm10Kwi
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myocardial trabeculae morphology
|
J:194957
|
\Gja1W45X/\Gja1W45X
(C57BL/6J-Gja1W45X)
|
thin myocardium compact layer
|
J:94456
|
| thin right ventricle myocardium compact layer
|
J:94456
|
\Gja4tm1Paul/\Gja4tm1Paul
\Gja5tm1Paul/\Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
increased vasodilation
|
J:80178
|
\Gja5tm1Paul/\Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
dilated cardiomyopathy
|
J:109301
|
\Gjc1tm1.1(Gjd2)Kwi/\Gjc1tm1.1(Gjd2)Kwi
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
\Gjc1tm1.1Kni/\Gjc1tm1.1Kni
(involves: 129S/SvEv * C57BL/6)
|
absent trabeculae carneae
|
J:63214
|
| decreased cardiac muscle contractility
|
J:63214
|
\Gjc1tm1.2(Gjd2)Kwi/\Gjc1tm1.2(Gjd2)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
\Gjc1tm1Kni/\Gjc1tm1Kni
(involves: 129S/SvEv * C57BL/6)
|
absent trabeculae carneae
|
J:63214
|
| decreased cardiac muscle contractility
|
J:63214
|
\Gjc1tm2.1Kni/\Gjc1tm2.1Kni
(Not Specified)
|
thin myocardium
|
J:103078
|
\Gjc1tm2Kni/\Gjc1tm2Kni
\Tg(ACTC1-cre)1Miwa/0
(involves: C57BL/6 * DBA)
|
thin myocardium
|
J:103078
|
\Gjd4tm1.1Malt/\Gjd4tm1.1Malt
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
enhanced skeletal muscle regeneration
|
J:172698
|
| increased satellite cell number
|
J:172698
|
| muscle phenotype
|
J:172698
|
\Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6)
|
cardiomyopathy
|
J:187258
|
| heart left ventricle hypertrophy
|
J:187258
|
\Gli2tm1Alj/\Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal esophageal smooth muscle morphology
|
J:49603
|
\Glra1m1Cpai/\Glra1m1Cpai
(involves: 129 * C57BL/6)
|
muscle spasm
|
J:248717
|
\Glra1spd-ot/\Glra1spd-ot
(involves: C57BL/6J)
|
muscle spasm
|
J:107942
|
\Glra1spd/\Glra1spd
(B6C3Fe a/a-Glra1spd/J)
|
muscle hypertonia
|
J:20373
|
\Glra1tm1Betz/\Glra1tm1Betz
(B6.129P2-Glra1tm1Betz)
|
muscle hypertonia
|
J:117236
|
\Glrbspa-Alb/\Glrbspa-Alb
(C57BL/6Fla-H2-T18a)
|
muscle hypertonia
|
J:64454
|
\Glrbspa/\Glrbspa
(Not Specified)
|
muscle spasm
|
J:13079,
J:5196
|
\Glrbspa/\Glrbspa
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
\Glrbspa/\Glrbspa
\Tg(Eno2-Glrb)456Wha/0
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
\Glrx3Gt(RRF094)Byg/\Glrx3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:143577
|
| decreased cardiac muscle contractility
|
J:143577
|
\Gm5544tm1a(KOMP)Wtsi/\Gm5544tm1a(KOMP)Wtsi
(C57BL/6N-Gm5544tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Gmppatm1d(EUCOMM)Wtsi/\Gmppatm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:305791
|
| abnormal skeletal muscle morphology
|
J:305791
|
| abnormal Z line morphology
|
J:305791
|
| centrally nucleated skeletal muscle fibers
|
J:305791
|
| decreased skeletal muscle fiber diameter
|
J:305791
|
| decreased skeletal muscle mass
|
J:305791
|
| increased skeletal muscle cell apoptosis
|
J:305791
|
| myopathy
|
J:305791
|
| progressive muscle weakness
|
J:305791
|
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm1Soff/\Gnaqtm1Soff
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:49140
|
| ventricular myocardium compact layer hypoplasia
|
J:49140
|
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm2Soff/\Gnaqtm2Soff
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm2Soff/\Gnaqtm2Soff
\Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-Gna11tm1Soff Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: 129S1/Sv * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
\Gnastm1Lsw/\Gnas+
(involves: 129S4/SvJae * CD-1)
|
increased muscle cell glucose uptake
|
J:106729
|
\Gnastm5.1Lsw/\Gnastm5.1Lsw
\Tg(Fabp4-cre)1Abel/0
(involves: FVB)
|
decreased skeletal muscle triglyceride level
|
J:159612
|
\Gnb5flr/\Gnb5flr
\Myo5aflr/\Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca)
|
opisthotonus
|
J:61324
|
\Gnetm1Dar/\Gnetm1Dar
(involves: C57BL/6J)
|
muscle phenotype
|
J:122172
|
\Gnetm1Sngi/\Gnetm1Sngi
\Tg(ACTB-GNE*D176V)9Sngi/0
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:117854
|
| abnormal muscle physiology
|
J:117854
|
| abnormal myocardium layer morphology
|
J:117854
|
| abnormal skeletal muscle fiber morphology
|
J:117854
|
| abnormal skeletal muscle morphology
|
J:117854
|
| increased variability of skeletal muscle fiber size
|
J:117854
|
| muscle weakness
|
J:117854
|
| muscular atrophy
|
J:117854
|
| skeletal muscle fiber atrophy
|
J:117854
|
\Gng5tm1.1Rbs/\Gng5tm1.1Rbs
(B6J.Cg-Gng5tm1.1Rbs)
|
decreased fetal cardiomyocyte proliferation
|
J:215128
|
\Gnptabnym/\Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
progressive muscle weakness
|
J:218156
|
\Gpcpd1tm1c(EUCOMM)Hmgu/\Gpcpd1tm1c(EUCOMM)Hmgu
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
abnormal muscle glycogen level
|
J:345630
|
| increased cardiac muscle cell glucose uptake
|
J:345630
|
| increased muscle cell glucose uptake
|
J:345630
|
| muscle phenotype
|
J:345630
|
\Gpm6btm1Kan\Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle hypertonia
|
J:193310
|
| muscle spasm
|
J:193310
|
\Gpr4tm1Witt/\Gpr4tm1Witt
(either: B6.129X1-Gpr4tm1Witt or (involves: 129X1/SvJ * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:118276
|
\Gpsm1tm1.1Lajb/\Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased vasodilation
|
J:138126
|
\Grb10Gt(XC302)Byg/\Grb10Gt(XC302)Byg
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
increased muscle weight
|
J:125128
|
\Grem2tm1Akh/\Grem2tm1Akh
(involves: 129/Sv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:250034
|
\Grid2ho-8J/\Grid2ho-8J
(B10.D2/nSnJ)
|
muscle spasm
|
J:155927
|
\Grid2ho-16J/\Grid2ho-16J
(C57BL/6J-Grid2ho-16J/J)
|
muscle spasm
|
J:87349
|
\Grk2tm1Mca/\Grk2tm1Mca
(involves: 129)
|
abnormal myocardial trabeculae morphology
|
J:36567
|
| decreased heart left ventricle muscle contractility
|
J:36567
|
| disorganized myocardium
|
J:36567
|
| thin myocardium
|
J:36567
|
| thin myocardium compact layer
|
J:36567
|
| trabecula carnea hypoplasia
|
J:36567
|
\Grk5tm1Rjl/\Grk5tm1Rjl
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle contractility
|
J:96208
|
\Grm1crv4/\Grm1crv4
(BALB/cPas-Grm1crv4)
|
muscle spasm
|
J:112290
|
\Grpel1tm1c(EUCOMM)Wtsi/\Grpel1tm1c(EUCOMM)Wtsi
\Tg(ACTA1-cre/ERT2)97.16Mtz/0
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:330869
|
| abnormal skeletal muscle morphology
|
J:330869
|
| decreased skeletal muscle fiber diameter
|
J:330869
|
| skeletal muscle atrophy
|
J:330869
|
| skeletal muscle fibrosis
|
J:330869
|
\Gsctm1Bhr/\Gsctm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal extrinsic tongue muscle morphology
|
J:28702
|
| abnormal genioglossus muscle morphology
|
J:28702
|
\Gsctm1Pgr/\Gsctm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intrinsic tongue muscle morphology
|
J:29421
|
| abnormal masticatory muscle morphology
|
J:29421
|
\Gt(ROSA)26Sorem1(CAG-Zfas1)Cya/\Gt(ROSA)26Sor+
\Tg(Myh6-cre)#Cya/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:294533
|
| increased cardiomyocyte apoptosis
|
J:294533
|
\Gt(ROSA)26Sortm1(Akt1/EGFP)Glas/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle weight
|
J:94134
|
| increased skeletal muscle fiber size
|
J:94134
|
| increased skeletal muscle size
|
J:94134
|
\Gt(ROSA)26Sortm1(CAG-GCaMP5)Ryba/\Gt(ROSA)26Sor+
\Hnrnputm1.1Tman/\Hnrnputm1.1Tman
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
decreased cardiac muscle contractility
|
J:223139
|
\Gt(ROSA)26Sortm1(CAG-LMNA*)Cyh/\Gt(ROSA)26Sor+
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6JNarl * FVB)
|
abnormal skeletal muscle morphology
|
J:284048
|
| centrally nucleated skeletal muscle fibers
|
J:284048
|
| decreased skeletal muscle fiber diameter
|
J:284048
|
| decreased skeletal muscle mass
|
J:284048
|
| dystrophic muscle
|
J:284048
|
\Gt(ROSA)26Sortm1(CAG-Lmx1b,ALPP)Rjo/\Gt(ROSA)26Sor+
\Sox9tm3(cre)Crm/\Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
abnormal tendon morphology
|
J:158676
|
| decreased skeletal muscle mass
|
J:158676
|
\Gt(ROSA)26Sortm1(CAG-Lmx1b,ALPP)Rjo/\Gt(ROSA)26Sor+
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:158676
|
| decreased skeletal muscle mass
|
J:158676
|
\Gt(ROSA)26Sortm1(CAG-MFN2*T105M)Dple/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:251584
|
| abnormal skeletal muscle fiber type ratio
|
J:251584
|
| abnormal soleus morphology
|
J:251584
|
| decreased skeletal muscle fiber diameter
|
J:251584
|
| skeletal muscle fiber atrophy
|
J:251584
|
\Gt(ROSA)26Sortm1(CAG-Nr2f2)Tsa/\Gt(ROSA)26Sor+
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:227012
|
| dilated cardiomyopathy
|
J:227012
|
\Gt(ROSA)26Sortm1(CAG-PLS3,-GFP)Bwir/\Gt(ROSA)26Sor+
\Mnx1tm4(cre)Tmj/\Mnx1+
(involves: 129S1/Sv * 129S4/SvJae * BALB/cJ * C57BL/6)
|
muscle phenotype
|
J:193844
|
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
\Rdh10tm1c(KOMP)Wtsi/\Rdh10tm1d(KOMP)Wtsi
(involves: 129S4/SvJae * C57BL/6N * FVB/NJ)
|
abnormal tongue muscle morphology
|
J:278485
|
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Pdgfratm12Sor/\Pdgfra+
(involves: 129 * C57BL/6)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Pdgfratm13Sor/\Pdgfra+
(involves: 129S4/SvJaeSor * C57BL/6)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
\Gt(ROSA)26Sortm1(DTA)Jpmb/\Gt(ROSA)26Sor+
\Hcn4tm1(cre/ERT2)Anlu/\Hcn4+
(involves: 129S/SvEv)
|
abnormal sinoatrial node morphology
|
J:186021
|
\Gt(ROSA)26Sortm1(DTA)Jpmb/\Gt(ROSA)26Sor+
\Kittm1(cre/ERT2)Dsa/\Kit+
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
\Gt(ROSA)26Sortm1(DTA)Lky/\Gt(ROSA)26Sor+
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor)
|
abnormal levator veli palatini muscle morphology
|
J:310908
|
| abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal soft palate muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| abnormal tensor veli palatini muscle morphology
|
J:310908
|
\Gt(ROSA)26Sortm1(DTA)Mrc/\Gt(ROSA)26Sor+
\Myf5tm1.1(cre)Mrc/\Myf5+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:133338
|
\Gt(ROSA)26Sortm1(DTA)Mrc/\Gt(ROSA)26Sor+
\Myf6tm1(cre)Mrc/\Myf6+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:133338
|
| abnormal skeletal muscle fiber morphology
|
J:133338
|
\Gt(ROSA)26Sortm1(DUX4)Sqh/\Gt(ROSA)26Sor+
\Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:268959
|
| decreased skeletal muscle fiber diameter
|
J:268959
|
| decreased skeletal muscle mass
|
J:268959
|
| muscle weakness
|
J:268959
|
| skeletal muscle fiber degeneration
|
J:268959
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sortm1(EYFP)Cos
\Pax7tm1(cre/ERT2)Gaka/\Pax7tm1(cre/ERT2)Gaka
\Paxbp1tm1.1Nju/\Paxbp1tm1.1Nju
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr)
|
impaired skeletal muscle regeneration
|
J:304562
|
\Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg/\Gt(ROSA)26Sor+
(B6.129-Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg)
|
abnormal myocardial fiber morphology
|
J:254962
|
| abnormal sarcomere morphology
|
J:254962
|
| cardiomyopathy
|
J:254962
|
\Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
muscle weakness
|
J:162008
|
\Gt(ROSA)26Sortm1(Mib1*V943F)Jlp/\Gt(ROSA)26Sor+
\Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:338889
|
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Wt1-cre)#Jbeb/0
(involves: 129S4/SvJaeSor)
|
thin myocardium compact layer
|
J:178290
|
\Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu/\Gt(ROSA)26Sor+
(involves: 129 * C57BL/6J)
|
vascular smooth muscle hypoplasia
|
J:145514
|
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:166283
|
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/\Hprt1+
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:166283
|
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/?
\Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:114992
|
\Gt(ROSA)26Sortm1(Tgfbr1*)Crm/\Gt(ROSA)26Sor+
\Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
vascular smooth muscle hypertrophy
|
J:134135
|
\Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/\Gt(ROSA)26Sor+
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:233994
|
| decreased cardiomyocyte apoptosis
|
J:233994
|
| decreased myocardial fiber size
|
J:233994
|
| increased myocardial fiber number
|
J:233994
|
\Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/\Gt(ROSA)26Sor+
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:233994
|
| decreased cardiac muscle contractility
|
J:233994
|
| decreased myocardial fiber size
|
J:233994
|
| increased fetal cardiomyocyte proliferation
|
J:233994
|
| increased myocardial fiber apoptosis
|
J:233994
|
\Gt(ROSA)26Sortm1.1(CAG-PLS3,-GFP)Bwir/\Gt(ROSA)26Sor+
\Smn1tm1Hung/\Smn1tm1Hung
\Tg(SMN2)2Hung/0
(B6N.Cg-Gt(ROSA)26Sortm1.1(CAG-PLS3,-GFP)Bwir Smn1tm1Hung Tg(SMN2)2Hung)
|
increased skeletal muscle fiber size
|
J:193844
|
\Gt(ROSA)26Sortm1.1(DUX4*)Plj/\Gt(ROSA)26Sor+
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj)
|
muscle phenotype
|
J:256652
|
\Gt(ROSA)26Sortm1.1(DUX4*)Plj/\Gt(ROSA)26Sor+
\Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:256652
|
| decreased skeletal muscle fiber size
|
J:256652
|
| dystrophic muscle
|
J:256652
|
| increased variability of skeletal muscle fiber size
|
J:256652
|
| myopathy
|
J:256652
|
| skeletal muscle fibrosis
|
J:256652
|
| skeletal muscle necrosis
|
J:256652
|
\Gt(ROSA)26Sortm1.1(DUX4*)Plj/\Gt(ROSA)26Sortm1.1(DUX4*)Plj
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj)
|
muscle phenotype
|
J:256652
|
\Gt(ROSA)26Sortm1Lrsn/\Gt(ROSA)26Sor+
\Slc6a3tm1(cre)Lrsn/\Slc6a3+
\Tfamtm1Lrsn/\Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:176022
|
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Meis2tm1.1Zkoz/\Meis2tm1.1Zkoz
\Tfap2atm1(cre)Moon/\Tfap2a+
(involves: 129 * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:229604
|
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Pax3Sp-d/\Pax3Sp-d
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S4/SvJaeSor * C57BL/6J * SJL/J)
|
abnormal diaphragm morphology
|
J:231793
|
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Pax7tm1.1Fan/\Pax7tm2.1(cre/ERT2)Fan
(involves: 129 * C57BL/6 * SJL)
|
abnormal muscle regeneration
|
J:150962
|
| abnormal myogenesis
|
J:150962
|
| muscle phenotype
|
J:150962
|
\Gt(ROSA)26Sortm2(ATF4)Myz/\Gt(ROSA)26Sortm2(ATF4)Myz
\Tg(Myh11-icre/ERT2)1Soff/?
(either: D2.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff or B6.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff)
|
increased cardiomyocyte apoptosis
|
J:237331
|
\Gt(ROSA)26Sortm2(NOTCH3*C455R)Sat/\Gt(ROSA)26Sor+
\Notch3Gt(PST033)Byg/\Notch3Gt(PST033)Byg
\Tg(Tagln-cre)1Her/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:171887
|
\Gt(ROSA)26Sortm2(Pax3)Joe/\Gt(ROSA)26Sor+
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:137730
|
\Gt(ROSA)26Sortm2(Pax3)Joe/\Gt(ROSA)26Sortm2(Pax3)Joe
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:137730
|
| muscle phenotype
|
J:137730
|
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
muscle degeneration
|
J:153656
|
\Gt(ROSA)26Sortm2(SS18)Mrc/\Gt(ROSA)26Sortm2(SS18)Mrc
\Myf6tm1(cre)Mrc/\Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:120967
|
| centrally nucleated skeletal muscle fibers
|
J:120967
|
| myopathy
|
J:120967
|
\Gt(ROSA)26Sortm3(CAG-EYFP)Hze/\Gt(ROSA)26Sor+
\Hiratm1c(EUCOMM)Wtsi/\Hiratm1d(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds)
|
abnormal cardiac muscle contractility
|
J:231593
|
| abnormal myocardial fiber morphology
|
J:231593
|
| abnormal sarcolemma morphology
|
J:231593
|
| myocardial fiber degeneration
|
J:231593
|
\Gt(ROSA)26Sortm3(NOTCH3*R1031C)Sat/\Gt(ROSA)26Sor+
\Tg(Tagln-cre)1Her/0
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:171887
|
\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
\Myf5tm1(cre)Mrc/\Myf5tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:120967
|
\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
\Myf6tm1(cre)Mrc/\Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:120967
|
\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/\Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
\Pax7tm1(cre)Mrc/\Pax7tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:120967
|
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Kdm6atm1.1Kaig/Y
\Pax7tm2.1(cre/ERT2)Fan/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
\Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/\Gt(ROSA)26Sor+
\Myf5tm1(cre)Mrc/\Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:194308
|
\Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/\Gt(ROSA)26Sor+
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
(involves: 129S6/SvEvTac * C57BL/6)
|
myopathy
|
J:194308
|
\Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/\Gt(ROSA)26Sor+
\Tg(Prrx1-cre/ERT2)1Mlgn/?
(involves: C57BL/6)
|
myopathy
|
J:194308
|
\Gt(ROSA)26Sortm4(HIF2A*)Kael/\Gt(ROSA)26Sor+
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:179490
|
| dilated cardiomyopathy
|
J:179490
|
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sor+
\Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc)
|
skeletal muscle hypertrophy
|
J:264410
|
\Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/?
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:176041
|
| impaired skeletal muscle contractility
|
J:176041
|
\Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/\Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:167527
|
| abnormal sarcomere morphology
|
J:167527
|
| abnormal skeletal muscle fiber morphology
|
J:167527
|
| decreased cardiac muscle contractility
|
J:167527
|
\Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte/\Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte)
|
centrally nucleated skeletal muscle fibers
|
J:206057
|
| dystrophic muscle
|
J:206057
|
| enhanced skeletal muscle regeneration
|
J:206057
|
| muscle phenotype
|
J:206057
|
| skeletal muscle endomysial fibrosis
|
J:206057
|
| skeletal muscle necrosis
|
J:206057
|
\Gtf2ird1tm1Hrd/\Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal laryngeal muscle morphology
|
J:182346
|
\Gucy1a1tm1.1Brou/\Gucy1a1tm1.1Brou
(involves: 129S1/Sv * 129X1/SvJ)
|
heart right ventricle hypertrophy
|
J:139850
|
\Gucy1a1tm1.1Dko/\Gucy1a1tm1.1Dko
(involves: C57BL/6)
|
abnormal vasodilation
|
J:110362
|
\Gucy1b1tm1.1Frb/\Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:121321
|
| intestinal hypoperistalsis
|
J:121321
|
\Gucy1b1tm1.2Frb/\Gucy1b1tm1.2Frb
X/\Tg(Myh11-icre/ERT2)1Soff
(B6.Cg-Gucy1b1tm1.2Frb Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:186053
|
\Gulotm1Mae/\Gulotm1Mae
(involves: 129 * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:59931
|
\Gyg1tm1a(KOMP)Wtsi/\Gyg1+
(involves: C57BL/6N)
|
increased cardiac muscle glycogen level
|
J:244440
|
| increased skeletal muscle glycogen level
|
J:244440
|
\Gyg1tm1a(KOMP)Wtsi/\Gyg1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:244440
|
| increased cardiac muscle glycogen level
|
J:244440
|
| increased skeletal muscle glycogen level
|
J:244440
|
\Gys1Gt(OST33395)Lex/\Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:92245
|
| trabecula carnea hypoplasia
|
J:92245
|
\Gys1tm1.1Arte/\Gys1+
(involves: C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:167911
|
\Gys1tm1.1Arte/\Gys1tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle cell glucose uptake
|
J:167911
|
| decreased skeletal muscle glycogen level
|
J:167911
|
\Gys2tm1.1Pro/\Gys2tm1.1Pro
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
decreased cardiac muscle cell glucose uptake
|
J:162043
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
decreased heart ventricle muscle contractility
|
J:86540
|
| dilated cardiomyopathy
|
J:86540
|
| myocardium necrosis
|
J:86540
|
| myositis
|
J:86540
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl)
|
myocardium necrosis
|
J:88055
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
|
abnormal myocardial fiber morphology
|
J:88055
|
| myocardial fiber degeneration
|
J:88055
|
| myocardium necrosis
|
J:88055
|
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
\Meis2tm1.1Zkoz/\Meis2tm1.1Zkoz
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal tongue muscle morphology
|
J:286823
|
\H6pdtm1Pmst/\H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:189132
|
| centrally nucleated skeletal muscle fibers
|
J:189132
|
| decreased quadriceps weight
|
J:189132
|
| decreased tibialis anterior weight
|
J:189132
|
| increased skeletal muscle glycogen level
|
J:189132
|
| skeletal muscle atrophy
|
J:189132
|
\H6pdtm1Pmst/\H6pdtm1Pmst
\Hsd11b1tm1.1Ggla/\Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:189132
|
| centrally nucleated skeletal muscle fibers
|
J:189132
|
| decreased quadriceps weight
|
J:189132
|
| decreased tibialis anterior weight
|
J:189132
|
| increased skeletal muscle glycogen level
|
J:189132
|
| skeletal muscle atrophy
|
J:189132
|
\H13tm1b(KOMP)Wtsi/\H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
\Hacd1tm1Akih/\Hacd1tm1Akih
(B6.129P2-Hacd1tm1Akih/Akih)
|
decreased gastrocnemius weight
|
J:247117
|
\Hacd2tm1b(EUCOMM)Hmgu/\Hacd2tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
thin myocardium
|
J:333944
|
\Hadhatm1Jib/\Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss)
|
abnormal diaphragm morphology
|
J:69846
|
| abnormal myocardium layer morphology
|
J:69846
|
\Hadhbm1Ytc/\Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan)
|
abnormal myocardial fiber morphology
|
J:117738
|
| abnormal skeletal muscle morphology
|
J:117738
|
| cardiomyopathy
|
J:117738
|
\Hand1tm1(tTA)Prri/\Hand1+
\Tg(tetO-Hand1)1Prri/0
(involves: 129/Sv * C57BL/6)
|
increased fetal cardiomyocyte proliferation
|
J:116090
|
\Hand1tm1Eno/\Hand1+
\Rr133tm1Eno/\Rr133tm1Eno
(Not Specified)
|
abnormal myocardium layer morphology
|
J:94514
|
\Hand1tm1Eno/\Hand1tm2Eno
\Rr133tm1Eno/\Rr133+
\Tg(Nkx2-5-cre)9Eno/0
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myocardial trabeculae morphology
|
J:94514
|
| thin myocardium
|
J:94514
|
\Hand1tm1Eno/\Hand1tm2Eno
\Rr133tm1Eno/\Rr133tm1Eno
\Tg(Nkx2-5-cre)9Eno/0
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myocardium layer morphology
|
J:94514
|
| trabecula carnea hypoplasia
|
J:94514
|
\Hand1tm2(Hand1)Abfi/\Hand1tm2(Hand1)Abfi
(Not Specified)
|
abnormal myocardial trabeculae morphology
|
J:164028
|
\Hand1tm5Abfi/\Hand1+
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:311466
|
| thin left ventricle myocardium compact layer
|
J:311466
|
| thin myocardium
|
J:311466
|
\Hand2tm1Cse/\Hand2+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal myocardial trabeculae morphology
|
J:155265
|
| heart right ventricle hypertrophy
|
J:155265
|
| increased fetal cardiomyocyte proliferation
|
J:155265
|
\Hand2tm1Dsr/\Hand2tm1Dsr
(involves: 129S7/SvEvBrd)
|
absent myocardial trabeculae
|
J:40768
|
| absent trabeculae carneae
|
J:40768
|
| decreased cardiac muscle contractility
|
J:40768
|
| thin myocardium
|
J:40768
|
\Hand2tm1Dsr/\Hand2tm1Dsr
\Nkx2-5tm1Wehi/\Nkx2-5tm1Wehi
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:72600
|
\Hand2tm1Dsr/\Hand2tm2.1Dsr
\Tg(Mef2c-cre)#Blk/0
(involves: 129 * 129S7/SvEvBrd * C57BL/6)
|
thin myocardium
|
J:169213
|
\Has2tm1Jam/\Has2tm1Jam
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent trabeculae carneae
|
J:63748
|
\Hat1tm1.1Mrpa/\Hat1+
(B6.Cg-Hat1tm1.1Mrpa)
|
decreased skeletal muscle mass
|
J:296531
|
| muscle degeneration
|
J:296531
|
| muscular atrophy
|
J:296531
|
| skeletal muscle atrophy
|
J:296531
|
| skeletal muscle degeneration
|
J:296531
|
\Hba-a1tm1Shs/\Hba-a1+
(involves: C57BL/6CrSlc)
|
abnormal skeletal muscle fiber type ratio
|
J:81902
|
\Hbb-b1tm1Shs/\Hbb-b1+
(involves: C57BL/6CrSlc)
|
abnormal skeletal muscle fiber type ratio
|
J:81902
|
\Hbegftm1.1Mek/\Hbegftm1.1Mek
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased heart ventricle muscle contractility
|
J:82728
|
| increased myocardial fiber size
|
J:82728
|
\Hbegftm1Dcl/\Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:83820
|
\Hbegftm2Mek/\Hbegftm2Mek
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:86547
|
| decreased heart left ventricle muscle contractility
|
J:86547
|
| dilated cardiomyopathy
|
J:86547
|
| thin myocardium
|
J:86547
|
\Hbegftm3Mek/\Hbegf+
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:86547
|
\Hccstm1Tcc/Y
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129S1/Sv)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:143285
|
| decreased cardiac muscle glycogen level
|
J:143285
|
| decreased fetal cardiomyocyte proliferation
|
J:143285
|
\Hccstm1Tcc/\Hccs+
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129S1/Sv)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:143285
|
| abnormal myocardium layer morphology
|
J:143285
|
| dilated cardiomyopathy
|
J:143285
|
\Hccstm1Tcc/\Hccs+
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
\Tg(CAG-EGFP)D4Nagy/0
\Tg(Hmgcr-lacZ)H253Sest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal fetal cardiomyocyte proliferation
|
J:143285
|
\Hcfc1em1Poche/Y
(C57BL/6J-Hcfc1em1Poche)
|
abnormal ventricle myocardium morphology
|
J:317822
|
\Hcn4tm1Rsei/\Hcn4tm1Rsei
(B6.Cg-Hcn4tm1Rsei)
|
decreased cardiac muscle contractility
|
J:131820
|
\Hcrttm1Ywa/\Hcrttm1Ywa
(involves: 129S6/SvEvTac)
|
abnormal muscle tone
|
J:170824
|
\Hcrtr2tm1Tesc/\Hcrtr2tm1Tesc
(B6.Cg-Hcrtr2tm1Tesc)
|
abnormal muscle tone
|
J:170824
|
\Hdac1tm1.1Eno/\Hdac1tm1.1Eno
\Hdac2tm1.1Eno/\Hdac2tm1.1Eno
\Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * CD-1 * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:123173
|
\Hdac2Gt(W035F03)Joe/\Hdac2Gt(W035F03)Joe
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:121697
|
| abnormal myocardial trabeculae morphology
|
J:121697
|
| abnormal myocardium layer morphology
|
J:121697
|
| diffuse Z line
|
J:121697
|
| increased fetal cardiomyocyte proliferation
|
J:121697
|
| thick myocardium compact layer
|
J:121697
|
\Hdac2tm1.2Eno/\Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1)
|
increased fetal cardiomyocyte apoptosis
|
J:123173
|
| increased fetal cardiomyocyte proliferation
|
J:123173
|
\Hdac3tm1.1Eno/\Hdac3tm1.1Eno
\Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:144604
|
| decreased heart left ventricle muscle contractility
|
J:144604
|
| increased cardiac muscle triglyceride level
|
J:144604
|
\Hdac4tm1Eno/\Hdac4+
\Hdac5tm1Eno/\Hdac5tm1Eno
\Hdac9tm1Eno/\Hdac9+
(involves: 129 * 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Hdac4tm1Eno/\Hdac4tm1Eno
(involves: 129)
|
muscle phenotype
|
J:127416
|
\Hdac4tm1Eno/\Hdac4tm2.1Eno
\Hdac5tm1Eno/\Hdac5tm1Eno
\Tg(Myog-cre)1Eno/0
(involves: 129 * 129S/SvEv * 129S2/SvPas)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Hdac4tm2.1Eno/\Hdac4tm2.1Eno
(involves: 129S/SvEv)
|
muscle phenotype
|
J:127416
|
\Hdac5tm1Eno/\Hdac5tm1Eno
(involves: 129S2/SvPas)
|
muscle phenotype
|
J:127416
|
\Hdac5tm1Eno/\Hdac5tm1Eno
\Hdac9tm1Eno/\Hdac9tm1Eno
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Hdac7tm1Eno/\Hdac7tm2Eno
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:116008
|
\Hdac9tm1Eno/\Hdac9tm1Eno
(involves: 129S1/Sv * 129X1/SvJ)
|
heart left ventricle hypertrophy
|
J:78734
|
| muscle phenotype
|
J:127416
|
\Hdac9tm1Eno/\Hdac9tm1Eno
\Tg(Myh6-Ppp3ca)37Eno/?
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal myocardium layer morphology
|
J:78734
|
\Hdnrem1Bbr/\Hdnrem1Bbr
(C57BL/6J-Hdnrem1Bbr)
|
increased cardiac muscle contractility
|
J:284183
|
\Hectd3tm1(NCOM)Cmhd/\Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju)
|
increased cardiac muscle contractility
|
J:211773
|
\Hexbtm1Grv/\Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))
|
muscle weakness
|
J:30899
|
\Hexbtm1Rlp/\Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
muscular atrophy
|
J:29268
|
\Hexbtm1Rlp/\Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
muscular atrophy
|
J:87617
|
\Hexbtm1Rlp/\Hexbtm1Rlp
\Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
\Hexbtm1Rlp/\Hexbtm1Rlp
\Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
\Hexim1Gt(XB322)Byg/\Hexim1Gt(XB322)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
dilated cardiomyopathy
|
J:141643
|
| thin myocardium compact layer
|
J:141643
|
\Hexim1tm1Maqs/\Hexim1tm1Maqs
(involves: 129S/SvEv * Black Swiss)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:92209
|
| increased fetal cardiomyocyte apoptosis
|
J:92209
|
\Hey1tm1Gess/\Hey1tm1Gess
\Hey2tm1Gess/\Hey2tm1Gess
(involves: 129 * C57BL/6)
|
absent myocardial trabeculae
|
J:89444
|
| thin myocardium
|
J:89444
|
\Hey1tm1Kkb/\Hey1tm1Kkb
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:178310
|
\Hey1tm1Kkb/\Hey1tm1Kkb
\Hey2tm1Kkb/\Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:96337
|
| trabecula carnea hypoplasia
|
J:96337
|
\Hey1tm1Kkb/\Hey1tm1Kkb
\Heyltm1Kkb/\Heyltm1Kkb
(B6.Cg-Hey1tm1Kkb Heyltm1Kkb)
|
abnormal skeletal muscle morphology
|
J:178310
|
| abnormal skeletal muscle satellite cell proliferation
|
J:178310
|
| decreased muscle weight
|
J:178310
|
| decreased satellite cell number
|
J:178310
|
| decreased skeletal muscle fiber number
|
J:178310
|
| decreased skeletal muscle fiber size
|
J:178310
|
| impaired skeletal muscle regeneration
|
J:178310
|
\Hey1tm1Kkb/\Hey1tm1Kkb
\Mesp1tm2(cre)Ysa/\Mesp1+
\Tg(CAG-cat,-Notch1)1Ysa/0
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:108444
|
\Hey2tm1Eno/\Hey2tm2Eno
\Tg(Nkx2-5-cre)9Eno/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
\Hey2tm1Eno/\Hey2tm2Eno
\Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
\Hey2tm1Gess/\Hey2tm1Gess
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:79024
|
| heart right ventricle hypertrophy
|
J:79024
|
| myocardial fiber disarray
|
J:79024
|
\Hey2tm1Kkb/\Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:97120,
J:216895
|
| abnormal myocardium layer morphology
|
J:216895
|
| abnormal ventricle myocardium morphology
|
J:216895
|
| abnormal Z line morphology
|
J:216895
|
| decreased heart left ventricle muscle contractility
|
J:97120,
J:216895
|
\Hey2tm1Mtc/\Hey2tm1Mtc
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:80681
|
| decreased cardiac muscle contractility
|
J:80681
|
\Hey2tm1Uts/\Hey2tm1Uts
(either: (involves: 129X1/SvJ) or (involves: C57BL/6))
|
heart left ventricle hypertrophy
|
J:79025
|
| heart right ventricle hypertrophy
|
J:79025
|
\Hey2tm2.1Mtc/\Hey2tm2.1Mtc
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:186570
|
\Heyltm1Kkb/\Heyltm1Kkb
(Not Specified)
|
muscle phenotype
|
J:178310
|
\Hgstn/\Hgstn
(B6.C3-Hgstn)
|
muscular atrophy
|
J:5025
|
| opisthotonus
|
J:5025
|
\Hgsnattm1a(EUCOMM)Wtsi/\Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal ventricle myocardium morphology
|
J:235361
|
\Hhextm1Cwb/\Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:93580
|
| thin myocardium compact layer
|
J:93580
|
| vascular smooth muscle hypoplasia
|
J:93580
|
\Hhipl1tm1a(KOMP)Wtsi/\Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi)
|
abnormal vascular smooth muscle physiology
|
J:280707
|
| decreased vascular smooth muscle cell proliferation
|
J:280707
|
\Hic2Gt(E225A08)1.1Wrst/\Hic2Gt(E225A08)1.1Wrst
\Mesp1tm2(cre)Ysa/\Mesp1+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
thin myocardium
|
J:225226
|
\Hic2Gt(E225A08)1.1Wrst/\Hic2Gt(E225A08)1.1Wrst
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
thin myocardium
|
J:225226
|
\Hic2Gt(RRN127)Byg/\Hic2+
(B6.129P2-Hic2Gt(RRN127)Byg)
|
abnormal myocardial trabeculae morphology
|
J:225226
|
| abnormal myocardium layer morphology
|
J:225226
|
| thin myocardium
|
J:225226
|
\Hif1atm1Jhu/\Hif1atm1Jhu
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardium layer morphology
|
J:45554
|
| disorganized myocardium
|
J:45554
|
\Hif1atm1Pec/\Hif1atm1Pec
(involves: 129X1/SvJ * Swiss)
|
abnormal myocardial trabeculae morphology
|
J:102537
|
| absent myocardial trabeculae
|
J:102537
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Hprt1tm1(Pck1-cre)Vhh/Y
\Vhltm1Jae/\Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:118455
|
| decreased cardiac muscle contractility
|
J:118455
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:97761
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
\Hif1antm1.2Rsjo/\Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo)
|
decreased quadriceps weight
|
J:160941
|
\Hif3atm1Mym/\Hif3atm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:132655
|
| myocardial fiber degeneration
|
J:132655
|
\Hilpdaem1(IMPC)Mhzh/\Hilpdaem1(IMPC)Mhzh
(C57BL/6N-Hilpdaem1(IMPC)Mhzh/Mhzh)
|
decreased cardiac muscle contractility
|
J:211773
|
\Hip1tm1Hay/\Hip1tm1Hay
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle morphology
|
J:84278
|
\Hipk2tm1Ejh/\Hipk2tm1Ejh
(involves: 129X1/SvJ * C57BL/6)
|
dystonia
|
J:117465
|
\hle/\hle
(involves: C3H/HeH * C57BL/6J)
|
abnormal smooth muscle morphology
|
J:171107
|
\Hlxtm1Rph/\Hlxtm1Rph
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:31553
|
| diaphragmatic hernia
|
J:31553
|
\Hmbstm2Uam/\Hmbstm3Uam
(C57BL/6-Hmbstm2Uam/Hmbstm3Uam)
|
skeletal muscle degeneration
|
J:31572
|
\Hmga1tm1Afus/\Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:106702
|
| heart left ventricle hypertrophy
|
J:106702
|
\Hmgxb3tm1a(EUCOMM)Wtsi/\Hmgxb3tm1a(EUCOMM)Wtsi
(C57BL/6N-Hmgxb3tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Hmox1tm1Mlee/\Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c)
|
increased cardiomyocyte apoptosis
|
J:54684
|
| myocardium necrosis
|
J:54684
|
\Hmox1tm1Mlee/\Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee)
|
abnormal vascular smooth muscle physiology
|
J:106600
|
| increased vascular smooth muscle cell proliferation
|
J:106600
|
\Hmox1tm1Ysh/\Hmox1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:95461
|
| myocardium necrosis
|
J:95461
|
\Hmox2tm1Poss/\Hmox2tm1Poss
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:89581
|
\Hmox2tm1Poss/\Hmox2tm1Poss
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:89581
|
\Hnf1atm1Mya/\Hnf1atm1Mya
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:31627
|
\Hnf1atm2Mya/\Hnf1atm2Mya
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:31627
|
\Hnf1btm1Mya/\Hnf1btm3Mya
\Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
muscular atrophy
|
J:75935
|
\Hnrnpa1tm1.1Cyf/\Hnrnpa1tm1.1Cyf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)
|
abnormal intercostal muscle morphology
|
J:238260
|
| abnormal tongue muscle morphology
|
J:238260
|
| dilated cardiomyopathy
|
J:238260
|
| tongue muscle hypoplasia
|
J:238260
|
\Hnrnputm1.1Tman/\Hnrnputm1.1Tman
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
abnormal I band morphology
|
J:223139
|
| abnormal myocardial fiber morphology
|
J:223139
|
| abnormal sarcomere morphology
|
J:223139
|
| decreased cardiac muscle relaxation
|
J:223139
|
| decreased heart ventricle muscle contractility
|
J:223139
|
| decreased myocardial fiber number
|
J:223139
|
| dilated cardiomyopathy
|
J:223139
|
| increased cardiomyocyte apoptosis
|
J:223139
|
| increased myocardial fiber size
|
J:223139
|
\Hnrnputm1.1Tman/\Hnrnputm1.1Tman
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * FVB/N)
|
dilated cardiomyopathy
|
J:223139
|
\Hopxtm1.1Joe/\Hopxtm1.1Joe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:79153
|
| thin myocardium
|
J:79153
|
| thin myocardium compact layer
|
J:79153
|
\Hopxtm1.1Joe/\Hopxtm1.1Joe
(involves: 129S6/SvEvTac)
|
abnormal myocardium layer morphology
|
J:121995
|
| increased myocardial fiber number
|
J:121995
|
\Hopxtm1Eno/\Hopxtm1Eno
(involves: 129S6/SvEvTac)
|
abnormal fetal cardiomyocyte proliferation
|
J:79152
|
| abnormal muscle physiology
|
J:79152
|
| decreased cardiac muscle contractility
|
J:79152
|
| thin myocardium
|
J:79152
|
\Hottiptm1Vlcg/\Hottiptm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal gastrocnemius morphology
|
J:233815
|
| decreased gastrocnemius weight
|
J:233815
|
| decreased skeletal muscle fiber number
|
J:233815
|
| muscle weakness
|
J:233815
|
\Hoxa1tm1Ipc/\Hoxa1tm1Ipc
(involves: 129S2/SvPas * C57BL/6)
|
muscle spasm
|
J:23837
|
\Hoxa1tm1Ipc/\Hoxa1tm1Ipc
\Hoxb1tm1Ipc/\Hoxb1tm1Ipc
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
muscle phenotype
|
J:124278
|
\Hoxa1tm3.1Mrc/\Hoxa1tm3.1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
heart right ventricle hypertrophy
|
J:178887
|
\Hoxa1tm3.1Mrc/\Hoxa1tm3.1Mrc
\Hoxb1tm3Mrc/\Hoxb1tm3Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal digastric posterior belly morphology
|
J:41540
|
| abnormal stylohyoid muscle morphology
|
J:41540
|
| absent facial muscle
|
J:41540
|
| absent levator labii superioris muscle
|
J:41540
|
| absent orbicularis oculi muscle
|
J:41540
|
| absent zygomaticus muscle
|
J:41540
|
\Hoxa2tm1(tetO)Mllo/\Hoxa2tm1(tetO)Mllo
(involves: 129S1/Sv * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:71951
|
\Hoxa2tm1(tetO)Mllo/\Hoxa2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:71951
|
\Hoxa2tm1Ipc/\Hoxa2tm1Ipc
(involves: 129S2/SvPas)
|
abnormal tensor tympani muscle morphology
|
J:16388
|
| absent stapedius muscle
|
J:16388
|
| absent stylohyoid muscle
|
J:16388
|
\Hoxa2tm1Mrc/\Hoxa2tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal styloglossus muscle morphology
|
J:58093
|
| abnormal tongue muscle morphology
|
J:58093
|
\Hoxa3tm1Mrc/\Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd)
|
abnormal muscle morphology
|
J:17753
|
| abnormal tongue muscle morphology
|
J:17753
|
\Hoxb1tm1Mrc/\Hoxb1tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal buccinator muscle morphology
|
J:36235
|
| abnormal depressor anguli oris muscle morphology
|
J:36235
|
| abnormal digastric posterior belly morphology
|
J:36235
|
| abnormal masseter muscle morphology
|
J:36235
|
| abnormal temporalis muscle morphology
|
J:36235
|
| abnormal zygomaticus muscle morphology
|
J:36235
|
| absent facial muscle
|
J:36235
|
| absent levator nasolabialis muscle
|
J:36235
|
| facial muscle degeneration
|
J:36235
|
\Hoxb1tm2Mrc/\Hoxb1tm2Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal buccinator muscle morphology
|
J:36235
|
| abnormal depressor anguli oris muscle morphology
|
J:36235
|
| abnormal digastric posterior belly morphology
|
J:36235
|
| abnormal masseter muscle morphology
|
J:36235
|
| abnormal temporalis muscle morphology
|
J:36235
|
| abnormal zygomaticus muscle morphology
|
J:36235
|
| absent facial muscle
|
J:36235
|
| absent levator nasolabialis muscle
|
J:36235
|
| facial muscle degeneration
|
J:36235
|
\Hoxb2tm1Mrc/\Hoxb2tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
absent levator nasolabialis muscle
|
J:37682
|
| facial muscle atrophy
|
J:37682
|
\Hoxb4tm1Bay/\Hoxb4tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
diaphragmatic hernia
|
J:4612
|
\Hoxb4tm1Nrm/\Hoxb4tm1Nrm
(involves: 129S7/SvEvBrd * C57BL/6)
|
diaphragmatic hernia
|
J:71389
|
\Hoxb4tm2Bay/\Hoxb4tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
muscle phenotype
|
J:4612
|
\Hoxc4tm1Mrc/\Hoxc4tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:34198
|
\Hoxc8tm1Phb/\Hoxc8tm1Phb
(either: (involves: 129) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))
|
muscle spasm
|
J:590
|
\Hoxc10tm1Emca/\Hoxc10tm1Emca
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased skeletal muscle size
|
J:161095
|
| decreased skeletal muscle weight
|
J:161095
|
| skeletal muscle atrophy
|
J:161095
|
\Hoxc13N/\Hoxc13N
(Not Specified)
|
muscle degeneration
|
J:30359
|
\Hoxd9tm1Emca/\Hoxd9tm1Emca
\Hoxd10tm1Emca/\Hoxd10tm1Emca
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:59070
|
| abnormal tendon morphology
|
J:59070
|
\Hoxd12tm2Ddu/\Hoxd12tm2Ddu
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
| abnormal smooth muscle morphology
|
J:36770
|
\Hoxd13tm1Ddu/\Hoxd13+
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
\Hoxd13tm1Ddu/\Hoxd13tm1Ddu
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
| abnormal smooth muscle morphology
|
J:36770
|
\hph1/\hph1
(involves: C57BL/6 * CBA/Ca)
|
abnormal smooth muscle morphology
|
J:101792
|
\hpld/\hpld
(Not Specified)
|
abnormal diaphragm morphology
|
J:75360
|
\Hprt1tm1(CAG-Gys1*)Jjg/?
\Myl1tm1(cre)Sjb/\Myl1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased skeletal muscle glycogen level
|
J:244440
|
\Hprt1tm1(MAPT)Dph/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:263643
|
| skeletal muscle fiber degeneration
|
J:263643
|
\Hprt1tm1(Pck1-cre)Vhh/Y
\Vhltm1Jae/\Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
\Hprt1tm1Dhm/Y
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| decreased cardiac muscle contractility
|
J:106044
|
| decreased heart ventricle muscle contractility
|
J:91410
|
\Hprt1tm1Dhm/Y
\Plntm1Egk/\Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
\Hprt1tm1Dhm/\Hprt1tm1Dhm
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| decreased cardiac muscle contractility
|
J:106044
|
| decreased heart ventricle muscle contractility
|
J:91410
|
\Hprt1tm1Dhm/\Hprt1tm1Dhm
\Plntm1Egk/\Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
\Hprt1tm2(CAG-Myof)Isrd/Y
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:187293
|
\Hprt1tm2(CAG-Myof)Isrd/\Hprt1tm2(CAG-Myof)Isrd
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:187293
|
\Hprt1tm4(CAG-Tbx18*,-Venus)Akis/Y
\Tbx18tm4(cre)Akis/\Tbx18+
(involves: 129S1/SvImJ * NMRI)
|
decreased fetal cardiomyocyte proliferation
|
J:210076
|
| thin ventricle myocardium compact layer
|
J:210076
|
\Hprt1tm4(Tek-IGF1R)Geno/Y
(B6.129P2-Hprt1tm4(Tek-IGF1R)Geno)
|
increased vasoconstriction
|
J:208523
|
\Hrastm2Xbr/\Hrastm2Xbr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
heart left ventricle hypertrophy
|
J:137729
|
| heart right ventricle hypertrophy
|
J:137729
|
\Hrctm1.1Desa/\Hrctm1.1Desa
(Not Specified)
|
decreased cardiac muscle contractility
|
J:243733
|
| decreased cardiac muscle relaxation
|
J:243733
|
\Hrctm1Blk/\Hrctm1Blk
(B6.129S6-Hrctm1Blk)
|
decreased skeletal muscle mass
|
J:117648
|
\Hrh1tm1Wtn/\Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
increased skeletal muscle triglyceride level
|
J:107191
|
\Hrtfm2DBA/2J/\Hrtfm2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
\Hrtfm4AKR/J/\Hrtfm4AKR/J
\Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
\Hrtfm5AKR/J/?
\Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
\Hrtfm6AKR/J/?
\Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
\Hrtfm7AKR/J/\Hrtfm7DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
\Hsd11b1tm1.1Ggla/\Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:189132
|
\Hsd11b2tm1Yko/\Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
increased myocardial fiber size
|
J:53391
|
\Hsd17b3tm1.2Mpo/\Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)
|
abnormal muscle morphology
|
J:301756
|
\Hsd17b7tm1Mpo/\Hsd17b7tm1Mpo
(involves: 129S7/SvEvBrd)
|
decreased myocardial fiber number
|
J:160004
|
| thick myocardium
|
J:160004
|
\Hspb7tm1.1Yty/\Hspb7tm1.1Yty
\Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal diaphragm morphology
|
J:246267
|
| abnormal sarcomere morphology
|
J:246267
|
| abnormal Z line morphology
|
J:246267
|
| centrally nucleated skeletal muscle fibers
|
J:246267
|
| myopathy
|
J:246267
|
| skeletal muscle fibrosis
|
J:246267
|
\Hspb7tm1.2Chen/\Hspb7tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal sarcomere morphology
|
J:256653
|
| abnormal trabecula carnea morphology
|
J:256653
|
| abnormal Z line morphology
|
J:256653
|
| decreased fetal cardiomyocyte proliferation
|
J:256653
|
\Hspb7tm1.2Chen/\Hspb7tm1.2Chen
\Lmod2tm1(KOMP)Vlcg/\Lmod2tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac * CBA)
|
abnormal sarcomere morphology
|
J:256653
|
\Hspb7tm1.2Chen/\Hspb7tm1.2Chen
\Tg(Myh6-Tmod1)65Msus/\Tg(Myh6-Tmod1)65Msus
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
abnormal sarcomere morphology
|
J:256653
|
\Hspb8tm1.1Depr/\Hspb8tm1.1Depr
(B.129-Hspb8tm1.1Depr)
|
abnormal myocardium layer morphology
|
J:186292
|
| decreased heart ventricle muscle contractility
|
J:186292
|
\Hspb8tm1.1Vti/\Hspb8tm1.1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal skeletal muscle morphology
|
J:284796
|
\Hspb8tm1Vti/\Hspb8+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal muscle fiber morphology
|
J:284796
|
| abnormal Z line morphology
|
J:284796
|
\Hspb8tm1Vti/\Hspb8tm1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal skeletal muscle fiber morphology
|
J:284796
|
| abnormal Z line morphology
|
J:284796
|
| muscular atrophy
|
J:284796
|
| myopathy
|
J:284796
|
| skeletal muscle fiber degeneration
|
J:284796
|
\Hspd1Gt(OST171441)Lex/\Hspd1+
(B6.129S5-Hspd1Gt(OST171441)Lex)
|
decreased skeletal muscle fiber size
|
J:197946
|
\Hspd1tm1c(EUCOMM)Hmgu/\Hspd1tm1c(EUCOMM)Hmgu
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: Black Swiss * C57BL/6 * C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:283049
|
| dilated cardiomyopathy
|
J:283049
|
\Hspg2tm1.1Soni/\Hspg2tm1.1Soni
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle electrophysiology
|
J:139975
|
| abnormal skeletal muscle fiber morphology
|
J:139975
|
| abnormal skeletal muscle fiber type ratio
|
J:139975
|
| centrally nucleated skeletal muscle fibers
|
J:139975
|
| increased variability of skeletal muscle fiber size
|
J:139975
|
\Hspg2tm1Rdgr/\Hspg2tm1Rdgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:121855
|
| skeletal muscle hyperplasia
|
J:121855
|
\Hspg2tm1Ref/\Hspg2tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardium compact layer morphology
|
J:58700
|
| abnormal myocardium layer morphology
|
J:80720
|
\Htatip2tm1Hx/\Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased uterus leiomyoma incidence
|
J:87066
|
\Htr1btm1Rhn/\Htr1btm1Rhn
\Slc6a4tm1Kpl/\Slc6a4tm1Kpl
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:121505
|
| dilated cardiomyopathy
|
J:121505
|
\Htr2atm1Rhn/\Htr2atm1Rhn
(involves: 129S1/Sv * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:108058
|
\Htr2btm1Lum/\Htr2btm1Lum
(129S2/SvPas-Htr2btm1Lum)
|
absent trabeculae carneae
|
J:64067
|
| decreased fetal cardiomyocyte proliferation
|
J:64067
|
| disorganized myocardium
|
J:64067
|
\Htr2ctm1.1Eme/Y
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
hypotonia
|
J:163043
|
\Htr3atm1Ckn/\Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:90942
|
\Htra2mnd2/\Htra2mnd2
(involves: C3H/He * C57BL/6J)
|
dystrophic muscle
|
J:12780
|
\Htra2mnd2/\Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
|
muscular atrophy
|
J:50420
|
\Htra2mnd2/\Htra2mnd2
(B6.Cg-Htra2mnd2)
|
dystonia
|
J:76481
|
| muscle spasm
|
J:76481
|
\Htra2tm1.1Hohj/\Htra2tm1.1Hohj
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6J)
|
muscle weakness
|
J:225666
|
\Htra2tm1.2Hohj/\Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
muscle weakness
|
J:225666
|
\Htttm1Mem/\Htttm6Mem
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster)
|
muscular atrophy
|
J:260244
|
\Hydinhy3/\Hydinhy3
(involves: CBA)
|
muscle spasm
|
J:13103
|
\Icam1tm1Jcgr/\Icam1tm1Jcgr
(B6.129S4-Icam1tm1Jcgr/J)
|
abnormal cardiac muscle contractility
|
J:114093
|
\Id1tm1Zhu/\Id1tm1Zhu
(either: 129/Sv-Id1tm1Zhu or (involves: 129S1/Sv * C57BL/6))
|
muscle phenotype
|
J:44278
|
\Ido1tm1.1Mkks/\Ido1tm1.1Mkks
(B6.Cg-Ido1tm1.1Mkks)
|
abnormal vasodilation
|
J:229059
|
\Idstm1Muen/Y
(involves: C57BL/6)
|
abnormal tendon morphology
|
J:259752
|
| calcified calcaneal tendon
|
J:259752
|
\Iduatm1Efn/\Iduatm1Efn
(involves: C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:101932
|
| abnormal cardiac muscle relaxation
|
J:101932
|
| abnormal myocardial fiber morphology
|
J:101932
|
| abnormal myocardium layer morphology
|
J:101932
|
| decreased heart ventricle muscle contractility
|
J:101932
|
| increased collagen deposition in the muscles
|
J:101932
|
\Ier3tm1Mxw/\Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased vasodilation
|
J:157504
|
\Ier3tm1Raku/\Ier3tm1Raku
(involves: 129S6/SvEvTac)
|
decreased heart left ventricle muscle contractility
|
J:131099
|
| heart left ventricle hypertrophy
|
J:131099
|
| increased myocardial fiber size
|
J:131099
|
\Ifngtm1Ts/\Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
impaired skeletal muscle regeneration
|
J:136628
|
| skeletal muscle fibrosis
|
J:136628
|
\Ifrd1tm1Lah/\Ifrd1tm1Lah
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle regeneration
|
J:89917
|
| abnormal skeletal muscle morphology
|
J:89917
|
| decreased soleus weight
|
J:89917
|
\Igf1tm1Arge/\Igf1tm1Arge
(involves: 129S/SvEv * MF1)
|
muscle hypoplasia
|
J:82113
|
\Igf1tm1Arge/\Igf1tm1Arge
\Liftm1Stw/\Liftm1Stw
(involves: 129S/SvEv * 129S1/Sv * BALB/c * C57BL/6J * MF1)
|
muscle hypoplasia
|
J:82113
|
\Igf1tm1Ts/\Igf1tm1Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal muscle morphology
|
J:16214
|
\Igf1tm2Ts/\Igf1tm2Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased heart left ventricle muscle contractility
|
J:37969
|
\Igf1rtm1.1Mhz/\Igf1r+
\Insrtm1Khn/\Insrtm1Khn
\Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:118987
|
\Igf1rtm1.1Mhz/\Igf1rtm1.1Mhz
\Insrtm1Khn/\Insrtm1Khn
\Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:118987
|
| decreased heart left ventricle muscle contractility
|
J:118987
|
| decreased myocardial fiber size
|
J:118987
|
| dilated cardiomyopathy
|
J:118987
|
\Igf1rtm1.2Mhz/\Igf1rtm1.2Mhz
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal muscle morphology
|
J:63460
|
\Igf1rtm1Arge/\Igf1rtm1Arge
(involves: 129S/SvEv)
|
muscle hypoplasia
|
J:15108
|
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
increased fetal cardiomyocyte proliferation
|
J:77413
|
\Igf2bp1Gt(OST33739)Lex/\Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:89882
|
\Igf2rtm1Stw/\Igf2r+
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:22124
|
\Igf2rtm1Wag/\Igf2r+
(involves: 129S2/SvPas)
|
disorganized myocardium
|
J:20763
|
\Igf2rtm1Wag/\Igf2rtm1Wag
(involves: 129S2/SvPas)
|
disorganized myocardium
|
J:20763
|
\Igfbp3tm1Jep/\Igfbp3tm1Jep
\Igfbp4tm1Jep/\Igfbp4tm1Jep
\Igfbp5tm1Jep/\Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
decreased quadriceps weight
|
J:112029
|
\Igfbp3tm1Lex/\Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased quadriceps weight
|
J:168345
|
| increased tibialis anterior weight
|
J:168345
|
\Igh-Jtm1Aigl/\Igh-J+
\Mogtm1Dpd/\Mogtm1Dpd
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
\Igh-Jtm1Aigl/\Igh-J+
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
\Ighmbp2em1Cll/\Ighmbp2em1Cll
(FVB/NJ-Ighmbp2em1Cll)
|
decreased skeletal muscle fiber size
|
J:326540
|
| muscular atrophy
|
J:326540
|
\Ighmbp2em1Cx/\Ighmbp2em1Cx
(C57BL/6J-Ighmbp2em1Cx/Cx)
|
decreased skeletal muscle weight
|
J:337488
|
| muscular atrophy
|
J:337488
|
| skeletal muscle fiber atrophy
|
J:337488
|
\Ighmbp2em5Cx/\Ighmbp2em5Cx
(C57BL/6J-Ighmbp2em5Cx/Cx)
|
muscular atrophy
|
J:337488
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
(BKS.Cg Dock7m +/+ Leprdb-Ighmbp2nmd-2J)
|
abnormal masseter muscle morphology
|
J:23584
|
| abnormal skeletal muscle fiber morphology
|
J:23584
|
| abnormal temporalis muscle morphology
|
J:23584
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
(B6.BKS-Ighmbp2nmd-2J/J)
|
abnormal diaphragm morphology
|
J:92862
|
| abnormal intercalated disk morphology
|
J:90418
|
| abnormal myocardial fiber morphology
|
J:90418
|
| centrally nucleated skeletal muscle fibers
|
J:90418
|
| dilated cardiomyopathy
|
J:90418
|
| increased variability of skeletal muscle fiber size
|
J:90418
|
| muscle degeneration
|
J:90418
|
| myocardial fiber degeneration
|
J:90418
|
| myocardium necrosis
|
J:90418
|
| skeletal muscle fiber atrophy
|
J:90418
|
| skeletal muscle interstitial fibrosis
|
J:90418
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\MnmC/\MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscular atrophy
|
J:51890
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\Tg(Eno2-Ighmbp2)17Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscle phenotype
|
J:90418
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\Tg(Eno2-Ighmbp2)90Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscle phenotype
|
J:90418
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\Tg(Ttn-Ighmbp2)45Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
muscle degeneration
|
J:102748
|
\Ighmbp2nmd-2J/\Ighmbp2nmd-2J
\Tg(Ttn-Ighmbp2)108Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
muscle degeneration
|
J:102748
|
\Ighmbp2nmd/\Ighmbp2nmd
(CBA/J-Ighmbp2nmd)
|
muscle degeneration
|
J:23584
|
\Igs1tm2(CAG-Bgeo,-Ndp,-EGFP)Nat/\Igs1tm2(CAG-Bgeo,-Ndp,-EGFP)Nat
\Edil3Tg(Sox2-cre)1Amc/?
(involves: 129 * C57BL/6 * CBA)
|
abnormal aorta smooth muscle morphology
|
J:154020
|
\Igs2em53(Myh6-cre/ERT2)Gpt/\Igs2+
\Stx17em1Gpt/\Stx17em1Gpt
(involves: C57BL/6JGpt)
|
abnormal cardiac muscle contractility
|
J:345305
|
| abnormal myocardial fiber morphology
|
J:345305
|
\Igsf3em1Laap/\Igsf3em1Laap
(FVB/NRj-Igsf3em1Laap)
|
abnormal intestinal smooth muscle morphology
|
J:341537
|
\Ihhtm1Amc/\Ihhtm1Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal smooth muscle morphology
|
J:62158
|
\Ikbkbtm2Mka/\Ikbkbtm2Mka
\Tg(Ckmm-cre)1Lrsn/0
(involves: 129)
|
abnormal myotube morphology
|
J:135692
|
| increased skeletal muscle fiber number
|
J:135692
|
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myoblast migration
|
J:131016
|
| abnormal skeletal muscle fiber morphology
|
J:131016
|
| abnormal skeletal muscle satellite cell proliferation
|
J:131016
|
| decreased cardiac muscle contractility
|
J:150895
|
\Il10tm1Cgn/\Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
decreased vasoconstriction
|
J:59742
|
| increased vasoconstriction
|
J:146372
|
\Il10tm1Cgn/\Il10tm1Cgn
(129S.Cg-Il10tm1Cgn)
|
decreased vasoconstriction
|
J:59742
|
\Il13tm2Anjm/\Il13tm2Anjm
\Tg(SFTPC-Il18)AThos/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * DBA/2)
|
decreased skeletal muscle weight
|
J:219136
|
\Il18tm1Aki/\Il18tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:118183
|
\Ilf3tm1Pnk/\Ilf3tm1Pnk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercostal muscle morphology
|
J:99935
|
| abnormal skeletal muscle fiber morphology
|
J:99935
|
| abnormal skeletal muscle morphology
|
J:99935
|
| thin diaphragm muscle
|
J:99935
|
\Ilktm1Star/\Ilktm1Star
\Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:112174
|
| dilated cardiomyopathy
|
J:112174
|
\ImmtGt(AW0256)Wtsi/\Immt+
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber mitochondrial morphology
|
J:344896
|
\In(7Oca2;7Sox6)100H/\In(7Oca2;7Sox6)100H
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:61682
|
| abnormal skeletal muscle morphology
|
J:61682
|
\Inhbatm1Zuk/\Inhba+
(B6.129S7-Inhbatm1Zuk)
|
abnormal pectoral muscle morphology
|
J:182827
|
| increased gastrocnemius weight
|
J:182827
|
| increased quadriceps weight
|
J:182827
|
| increased skeletal muscle weight
|
J:182827
|
\Inhbbtm1Jae/\Inhbbtm1Jae
(B6.129S4-Inhbbtm1Jae)
|
abnormal pectoral muscle morphology
|
J:182827
|
| increased skeletal muscle weight
|
J:182827
|
\Ino80tm1.1Jland/\Ino80tm1.1Jland
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:306156
|
\Inpp4atm1Tsak/\Inpp4atm1Tsak
(involves: 129P2/OlaHsd * C57BL/6)
|
dystonia
|
J:161963
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:173301
|
\Inpp5fGt(XL571)Byg/\Inpp5fGt(XL571)Byg
(involves: 129P2/OlaHsd)
|
increased cardiomyocyte apoptosis
|
J:170072
|
\Inpp5ktm1Brd/\Inpp5k+
(B6.Cg-Inpp5ktm1Brd)
|
increased skeletal muscle cell glucose uptake
|
J:139745
|
| increased skeletal muscle mass
|
J:139745
|
\Ins2Akita/?
(involves: C57BL/6NSlc)
|
abnormal cardiac muscle contractility
|
J:130021
|
| decreased skeletal muscle cell glucose uptake
|
J:130021
|
| decreased skeletal muscle triglyceride level
|
J:130021
|
| heart left ventricle hypertrophy
|
J:130021
|
\Insrtm1Jja/\Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
skeletal muscle hypotrophy
|
J:32538
|
\Insrtm1Khn/\Insrtm1Khn
\Tg(Myhca-cre)1Abel/0
(involves: 129S4/SvJae * FVB)
|
abnormal cardiac muscle cell glucose uptake
|
J:75348
|
| decreased cardiac muscle cell glucose uptake
|
J:75348
|
| decreased heart left ventricle muscle contractility
|
J:75348
|
| decreased myocardial fiber size
|
J:75348
|
| increased cardiac muscle cell glucose uptake
|
J:75348
|
| increased cardiac muscle glycogen level
|
J:75348
|
\Irag1tm1Jens/\Irag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
\Irag1tm1Jens/\Irag1tm1Jens
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
\Irag1tm2.1Jens/\Irag1tm2.1Jens
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:175887
|
| impaired muscle relaxation
|
J:175887
|
\Irag1tm2.1Jens/\Irag1tm2.1Jens
\Taglntm2(PRKG1*)Hfm/\Taglntm2(PRKG1*)Hfm
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired muscle relaxation
|
J:175887
|
\Irak1tm1Jth/Y
\Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocardial fiber degeneration
|
J:84829
|
\Irak1tm1Jth/\Irak1tm1Jth
\Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocardial fiber degeneration
|
J:84829
|
\Irs1smla/\Irs1smla
\Serpinb2tm2Dgi/\Serpinb2tm2Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
muscular atrophy
|
J:164568
|
\Irs1tm1Tka/\Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:74303
|
\Irs2tm1Tka/\Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
\Irx4tm1Jse/\Irx4+
(involves: 129X1/SvJ * Black Swiss)
|
heart left ventricle hypertrophy
|
J:67359
|
\Irx4tm1Jse/\Irx4tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
cardiomyopathy
|
J:67359
|
| decreased heart ventricle muscle contractility
|
J:67359
|
| dilated cardiomyopathy
|
J:67359
|
| heart left ventricle hypertrophy
|
J:67359
|
\Isl1tm1(cre)Tmj/\Isl1+
\Mapttm1(Ewsr1/Etv4)Arbr/\Mapt+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased muscle spindle number
|
J:100886
|
\Itga7tm1Burk/\Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:100236
|
| myopathy
|
J:100236
|
| vascular smooth muscle hyperplasia
|
J:100236
|
| vascular smooth muscle hypertrophy
|
J:100236
|
\Itga7tm1Burk/\Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:187752
|
| abnormal muscle physiology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| centrally nucleated skeletal muscle fibers
|
J:187752
|
| myopathy
|
J:187752
|
| skeletal muscle necrosis
|
J:187752
|
\Itga7tm1Burk/\Itga7tm1Burk
\Sspntm1Kcam/\Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:187752
|
| abnormal muscle physiology
|
J:187752
|
| abnormal quadriceps morphology
|
J:187752
|
| abnormal sarcolemma morphology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| centrally nucleated skeletal muscle fibers
|
J:187752
|
| decreased quadriceps weight
|
J:187752
|
| decreased skeletal muscle mass
|
J:187752
|
| enhanced skeletal muscle regeneration
|
J:187752
|
| myopathy
|
J:187752
|
| skeletal muscle atrophy
|
J:187752
|
| skeletal muscle fibrosis
|
J:187752
|
\Itga7tm1Umr/\Itga7tm1Umr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:43840
|
| abnormal skeletal muscle morphology
|
J:43840,
J:82116
|
| abnormal soleus morphology
|
J:43840
|
| centrally nucleated skeletal muscle fibers
|
J:43840
|
| dystrophic muscle
|
J:43840
|
| increased skeletal muscle fiber size
|
J:43840
|
| increased variability of skeletal muscle fiber size
|
J:43840
|
| muscle degeneration
|
J:43840
|
| skeletal muscle fiber atrophy
|
J:43840
|
\Itga7tm1Umr/\Itga7tm1Umr
\Sgcgtm1Mcn/\Sgcgtm1Mcn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle degeneration
|
J:91880
|
\Itgavtm1Hyn/\Itgavtm1Hyn
(either: (involves: 129/Sv * 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
thin myocardium
|
J:50951
|
| trabecula carnea hypoplasia
|
J:50951
|
\Itgavtm2Hyn/\Itgavtm2.1Hyn
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)
|
muscle hypertonia
|
J:94376
|
| muscle phenotype
|
J:94376
|
\Itgb1tm1Lscd/\Itgb1tm1Ref
\Tg(PLAT-cre)116Sdu/0
(Not Specified)
|
muscular atrophy
|
J:92060
|
| progressive muscle weakness
|
J:92060
|
\Itgb1tm1Ross/\Itgb1tm1Ross
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle cell glucose uptake
|
J:82534
|
| abnormal cardiac muscle relaxation
|
J:82534
|
| abnormal myocardial fiber morphology
|
J:82534
|
| abnormal myocardium layer morphology
|
J:82534
|
| decreased heart left ventricle muscle contractility
|
J:82534
|
| dilated cardiomyopathy
|
J:82534
|
\Itgb1tm1Son/\Itgb1tm1Son
(either: 129P2/OlaHsd-Itgb1tm1Son or (involves: 129P2/OlaHsd * FVB))
|
muscle phenotype
|
J:47279
|
\Itgb1tm2Son/\Itgb1tm2Son
(FVB.129P2-Itgb1tm2Son)
|
abnormal myogenesis
|
J:82463
|
| abnormal myotube morphology
|
J:82463
|
| abnormal skeletal muscle morphology
|
J:82463
|
| decreased skeletal muscle fiber number
|
J:82463
|
| decreased skeletal muscle mass
|
J:82463
|
\Itgb3tm1Hyn/\Itgb3+
(involves: 129S2/SvPas * C57BL/6)
|
heart left ventricle hypertrophy
|
J:119666
|
\Itgb3tm1Hyn/\Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:119666
|
| decreased cardiac muscle contractility
|
J:119666
|
| heart left ventricle hypertrophy
|
J:119666
|
| myositis
|
J:119666
|
\Itpatm1Skmi/\Itpatm1Skmi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:169285
|
| abnormal sarcomere morphology
|
J:169285
|
| absent Z line
|
J:169285
|
\Itpr1opt/\Itpr1opt
(involves: C57BLKS)
|
opisthotonus
|
J:13536
|
\Itpr3tf/\Itpr3tf
\Prkralear-5J/\Prkralear-5J
(BTBR-Prkralear-5J Itpr3tf/GrsrJ)
|
dystonia
|
J:223062
|
\Itprid2tm1Sawa/\Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
|
decreased skeletal muscle triglyceride level
|
J:144968
|
\Ivns1abptm1Htno/\Ivns1abptm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:162743
|
| increased cardiomyocyte apoptosis
|
J:162743
|
\Izumo2em1(IMPC)Bay/\Izumo2em1(IMPC)Bay
(C57BL/6N-Izumo2em1(IMPC)Bay/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
\Jag1tm1Frad/\Jag1tm1Frad
\Tg(Cdh5-cre)7Mlia/0
(B6.Cg-Jag1tm1Frad Tg(Cdh5-cre)7Mlia)
|
heart right ventricle hypertrophy
|
J:189213
|
\Jag1tm1Grid/\Jag1tm2Grid
\Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:166769
|
\Jag1tm2Grid/\Jag1tm2Grid
\Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:166769
|
\Jam3tm1.1(KOMP)Vlcg/\Jam3+
(C57BL/6N-Jam3tm1.1(KOMP)Vlcg/J)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Jarid2Gt(ROSA)1Gel/\Jarid2Gt(ROSA)1Gel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:63359
|
| abnormal myocardium layer morphology
|
J:63359
|
| increased fetal cardiomyocyte proliferation
|
J:100923
|
| thin myocardium
|
J:63359
|
| trabecula carnea hypoplasia
|
J:63359
|
\Jarid2jumonji/\Jarid2jumonji
(C3.129P2-Jarid2jumonji)
|
abnormal myocardial fiber morphology
|
J:57069
|
| abnormal myocardial trabeculae morphology
|
J:57069
|
\Jmjd6tm1Gbf/\Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf)
|
myocardial trabeculae hypoplasia
|
J:102098
|
| thin myocardium compact layer
|
J:102098
|
\Jph1tm1Hta/\Jph1tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal sarcoplasmic reticulum morphology
|
J:77652
|
| abnormal skeletal muscle fiber triad morphology
|
J:77652
|
| impaired skeletal muscle contractility
|
J:77652
|
\Jph2tm1Hta/\Jph2tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:63879
|
\Jsrp1tm1Zor/\Jsrp1tm1Zor
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:128603
|
| muscle weakness
|
J:128603
|
\Juntm4Wag/\Juntm4Wag
\Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
thin right ventricle myocardium compact layer
|
J:199412
|
\Jundtm1Mya/\Jundtm1Mya
\Tg(H2-K-Fosl1)1Wag/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:95691
|
| dilated cardiomyopathy
|
J:95691
|
\Juptm1.1Glr/\Juptm1.1Glr
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
abnormal intercalated disk morphology
|
J:170618
|
| abnormal myocardial fiber morphology
|
J:170618
|
| abnormal sarcomere morphology
|
J:170618
|
| decreased heart left ventricle muscle contractility
|
J:170618
|
| diffuse Z line
|
J:170618
|
| heart left ventricle hypertrophy
|
J:170618
|
| increased myocardial fiber size
|
J:170618
|
\Juptm1.1Shou/\Juptm1.1Shou
\Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:177567
|
| calcified myocardium
|
J:177567
|
| cardiac muscle necrosis
|
J:177567
|
| cardiomyopathy
|
J:177567
|
| decreased cardiac muscle contractility
|
J:177567
|
| increased cardiomyocyte apoptosis
|
J:177567
|
\Juptm1Kem/\Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ)
|
absent cardiac desmosomes
|
J:38047
|
| thin myocardium
|
J:38047
|
| trabecula carnea hypoplasia
|
J:38047
|
\Juptm1Kem/\Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent cardiac desmosomes
|
J:38047
|
| thin myocardium
|
J:38047
|
| trabecula carnea hypoplasia
|
J:38047
|
\Juptm1Ruiz/\Jup+
\Tg(Myh6-Jup*)1Ajm/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:192719
|
\Juptm1Ruiz/\Juptm1Ruiz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:64280
|
| abnormal intercalated disk morphology
|
J:64280
|
| absent cardiac desmosomes
|
J:64280
|
\Kalrntm2.1Npl/\Kalrntm2.1Npl
(B6.Cg-Kalrntm2.1Npl)
|
abnormal I band morphology
|
J:206512
|
| abnormal sarcomere morphology
|
J:206512
|
| abnormal Z line morphology
|
J:206512
|
\Kansl1em1.1Cya/\Kansl1+
(B6(FVB)-Kansl1em1.1Cya)
|
decreased cardiac muscle contractility
|
J:327464
|
\Kat6bGt(pKC199)1Pgr/\Kat6bGt(pKC199)1Pgr
(involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:178264
|
\Kbtbd13em1Coeo/\Kbtbd13em1Coeo
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:295442
|
| abnormal soleus morphology
|
J:295442
|
| impaired muscle relaxation
|
J:295442
|
| increased soleus weight
|
J:295442
|
| thick diaphragm muscle
|
J:295442
|
\Kbtbd13tm1.1Coeo/\Kbtbd13tm1.1Coeo
(involves: C57BL/6J)
|
decreased soleus weight
|
J:295442
|
| increased quadriceps weight
|
J:295442
|
| muscle phenotype
|
J:295442
|
\Kcna1tm1Tem/\Kcna1tm1Tem
(involves: 129S7/SvEvBrd)
|
myoclonus
|
J:164091
|
\Kcna3tm1Gvd/\Kcna3tm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:88651
|
\Kcna5tm1(Kcna1)Lndn/\Kcna5tm1(Kcna1)Lndn
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:70694
|
| decreased vasoconstriction
|
J:70694
|
\Kcnc1tm1Joho/\Kcnc1tm1Joho
\Kcnc3tm1Echa/\Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71179
|
\Kcnc2tm1Rudy/\Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy)
|
myoclonus
|
J:66730
|
\Kcne1tm1Rdn/\Kcne1+
\Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal atrioventricular bundle morphology
|
J:328713
|
| abnormal atrioventricular node morphology
|
J:328713
|
\Kcne4tm1Gwab/\Kcne4tm1Gwab
(B6.129-Kcne4tm1Gwab)
|
increased cardiac muscle relaxation
|
J:227222
|
\Kcng2em1(IMPC)Bay/\Kcng2em1(IMPC)Bay
(C57BL/6N-Kcng2em1(IMPC)Bay/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
\Kcnh2tm1.1Hjd/\Kcnh2tm1.1Hjd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle electrophysiology
|
J:155273
|
\Kcnj2tm1Swz/\Kcnj2tm1Swz
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal vasodilation
|
J:78077
|
\Kcnj6wv/\Kcnj6wv
(involves: C57BL/6 * CBA/CaGnLe)
|
hypotonia
|
J:18348
|
\Kcnj8em1Nich/\Kcnj8+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
| increased myocardial fiber size
|
J:281903
|
| increased vasodilation
|
J:281903
|
\Kcnj8tm1Sse/\Kcnj8tm1Sse
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
\Kcnj11tm1Sse/\Kcnj11tm1Sse
(involves: 129P2/OlaHsd)
|
abnormal muscle relaxation
|
J:105244
|
| impaired skeletal muscle contractility
|
J:105244,
J:140833
|
| increased muscle fatigability
|
J:140833
|
| myoclonus
|
J:69832
|
\Kcnk6tm1Tigm/\Kcnk6tm1Tigm
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:194443
|
| abnormal vasoconstriction
|
J:194443
|
\Kcnma1tm1Ruth/\Kcnma1tm1Ruth
(involves: 129/Sv * C57BL/6)
|
abnormal muscle contractility
|
J:148424
|
| increased muscle relaxation
|
J:148424
|
\Kcnma1tm1Ruth/\Kcnma1tm2.1Ruth
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal muscle contractility
|
J:148424
|
\Kcnmb1tm1Ltor/\Kcnmb1tm1Ltor
(Not Specified)
|
increased vasoconstriction
|
J:195657
|
\Kcnmb1tm1Pong/\Kcnmb1tm1Pong
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:82471
|
| increased vasoconstriction
|
J:82471
|
\Kcnmb1tm1Rwa/\Kcnmb1tm1Rwa
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle contractility
|
J:106302
|
| abnormal vasoconstriction
|
J:65415
|
\Kcnn4tm1Rklr/\Kcnn4tm1Rklr
(involves: 129S/SvEv * C57BL/6)
|
decreased vasodilation
|
J:124858
|
\Kcnq1m1Anu/?
(involves: BALB/c * C57BL/6 * DBA/2)
|
opisthotonus
|
J:196547
|
\Kcnv1vibe/\Kcnv1vibe
(C57BL/6JSfdAnu-Kcnv1vibe/Anu)
|
muscle spasm
|
J:104190
|
\Kctd10tm1.2Zji/\Kctd10tm1.2Zji
(involves: 129S * 129X1/SvJ * C57BL/6J * FVB/N)
|
thin myocardium
|
J:225134
|
\Kdm1atm1.1Tche/\Kdm1atm1.1Tche
(Not Specified)
|
cardiac muscle degeneration
|
J:270116
|
\Kdm3atm1.1Yzha/\Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha)
|
abnormal muscle morphology
|
J:147295
|
| abnormal muscle physiology
|
J:147295
|
\Kdm4atm1Zpl/\Kdm4atm1Zpl
\Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEv * C57BL/6)
|
decreased myocardial fiber size
|
J:173908
|
| increased cardiac muscle contractility
|
J:173908
|
\Kdm6aGt(RRA094)Byg/Y
X/\UtyGt(XS0378)Wtsi
(either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
\Kdm6aGt(RRA094)Byg/\Kdm6aGt(RRA094)Byg
(either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
\Kdm6atm1.1Kaig/Y
\Pax7tm2.1(cre/ERT2)Fan/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
\Kdm6atm1.1Kaig/\Kdm6atm1.1Kaig
\Pax7tm2.1(cre/ERT2)Fan/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
\Kdm6atm1b(EUCOMM)Wtsi/\Kdm6atm1b(EUCOMM)Wtsi
(either: (involves: C57BL/6 * CD-1) or (involves: 129 * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
\Kdm6atm2.1Kaig/Y
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
| muscle phenotype
|
J:232700
|
\Kdm6atm2.1Kaig/\Kdm6atm2.1Kaig
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
| muscle phenotype
|
J:232700
|
\Kdm6btm1.1Rbo/\Kdm6btm1.1Rbo
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal soft palate muscle morphology
|
J:323190
|
\Kdrtm1Jrt/\Kdr+
\Tmem204tm1.1Ali/\Tmem204tm1.1Ali
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
\Keltm1Slee/\Keltm1Slee
\Xktm1Ariv/\Xktm1Ariv
(B6.Cg-Keltm1Slee Xktm1Ariv)
|
abnormal skeletal muscle fiber morphology
|
J:206464
|
| centrally nucleated skeletal muscle fibers
|
J:206464
|
| increased variability of skeletal muscle fiber size
|
J:206464
|
| muscle phenotype
|
J:206464
|
\Kif1btm1Noh/\Kif1b+
(involves: 129S4/SvJae * C57BL/6J)
|
progressive muscle weakness
|
J:69772
|
\Kif3atm1Noh/\Kif3atm1Noh
(involves: 129S4/SvJae * C57BL/6J)
|
myocardium hypoplasia
|
J:55332
|
\Kif7dda/\Kif7dda
(FVB.A-Kif7dda)
|
abnormal diaphragm central tendon morphology
|
J:197449
|
| abnormal diaphragm development
|
J:197449
|
| diaphragm muscle hyperplasia
|
J:197449
|
| diaphragmatic hernia
|
J:197449
|
| thick diaphragm muscle
|
J:197449
|
\Kif7maki/\Kif7maki
(involves: C57BL/6J)
|
abnormal diaphragm central tendon morphology
|
J:197449
|
| diaphragmatic hernia
|
J:197449
|
\Kif16bem1(IMPC)Ccpcz/\Kif16bem1(IMPC)Ccpcz
(C57BL/6NCrl-Kif16bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Kif21atm1.1Ece/\Kif21atm1.1Ece
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal extraocular muscle morphology
|
J:213171
|
\Kif21atm1.1Ece/\Kif21atm1.1Ece
\Tg(Isl1-EGFP*)1Slp/0
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal extraocular muscle morphology
|
J:213171
|
\Kif21atm1.1Ece/\Kif21atm3Ece
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal extraocular muscle morphology
|
J:213171
|
\Kif26atm1.1Noh/\Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:154859
|
\Kifbptm1a(KOMP)Wtsi/\Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Kittm1(cre/ERT2)Dsa/\Kit+
\Prkg1tm2Naw/\Prkg1tm2Naw
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
\KitW/\KitW-v
(involves: C57BL)
|
abnormal muscle physiology
|
J:70182
|
\Klkl/\Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
calcified muscle
|
J:44109
|
\Klm1Anu/\Klm1Anu
(C57BL/6NCrlAnu-Klm1Anu)
|
abnormal smooth muscle morphology
|
J:104190
|
| diaphragmatic hernia
|
J:104190
|
\Klf2tm1Jml/\Klf2tm1Jml
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * CD-1))
|
abnormal vascular smooth muscle morphology
|
J:44352
|
\Klf2tm1Mlkn/\Klf2tm1Mlkn
\Tg(Tek-cre)12Flv/?
(involves: C3H * C57BL/6)
|
thin myocardium
|
J:127228
|
\Klf3m1Cmhd/\Klf3+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal ventricle myocardium morphology
|
J:206507
|
| increased cardiac muscle contractility
|
J:206507
|
\Klf3m1Cmhd/\Klf3m1Cmhd
(involves: C3H/HeJ * C57BL/6J)
|
abnormal ventricle myocardium morphology
|
J:206507
|
\Klf5tm1Jaw/\Klf5tm1Jaw
\Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB)
|
abnormal extraocular muscle morphology
|
J:175263
|
\Klf5tm1Rng/\Klf5+
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:78275
|
\Klf5tm2.1Rng/\Klf5tm2.1Rng
\Tg(Postn-cre)1Sjc/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:156696
|
\Klf15tm1Jain/\Klf15tm1Jain
(B6.129X1-Klf15tm1Jain)
|
cardiomyopathy
|
J:167880
|
| decreased heart left ventricle muscle contractility
|
J:121109
|
| heart left ventricle hypertrophy
|
J:167880
|
| increased myocardial fiber size
|
J:121109
|
\Klhl29tm1b(EUCOMM)Hmgu/\Klhl29tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl29tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
\Klhl31em1Eno/\Klhl31em1Eno
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:247651
|
| abnormal quadriceps morphology
|
J:247651
|
| abnormal sarcomere morphology
|
J:247651
|
| abnormal Z line morphology
|
J:247651
|
| centrally nucleated skeletal muscle fibers
|
J:247651
|
| decreased muscle weight
|
J:247651
|
| dilated sarcoplasmic reticulum
|
J:247651
|
| myopathy
|
J:247651
|
| skeletal muscle fiber degeneration
|
J:247651
|
\Klhl40tm1(KOMP)Vlcg/\Klhl40tm1(KOMP)Vlcg
(C57BL/6-Klhl40tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:213780
|
| abnormal sarcomere morphology
|
J:213780
|
| abnormal skeletal muscle morphology
|
J:213780
|
| abnormal Z line morphology
|
J:213780
|
| impaired skeletal muscle contractility
|
J:213780
|
| muscle weakness
|
J:213780
|
| myopathy
|
J:213780
|
\Klhl40tm1.1Itl/\Klhl40tm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal sarcomere morphology
|
J:227534
|
| decreased skeletal muscle fiber size
|
J:227534
|
| increased skeletal muscle cell apoptosis
|
J:227534
|
\Klhl41tm1a(KOMP)Wtsi/\Klhl41tm1a(KOMP)Wtsi
(C57BL/6-Klhl41tm1a(KOMP)Wtsi)
|
abnormal diaphragm morphology
|
J:255305
|
| myopathy
|
J:255305
|
\Klk1tm1Pmtn/\Klk1tm1Pmtn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:67868
|
| decreased vasodilation
|
J:67868
|
\Klk1tm1Pmtn/\Klk1tm1Pmtn
(involves: 129/Sv * C57BL/6)
|
decreased vasodilation
|
J:103928
|
\Kmt2atm1Sjk/\Kmt2atm1Sjk
(involves: 129S2/SvPas * CD-1)
|
abnormal myoblast differentiation
|
J:201612
|
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle morphology
|
J:207891
|
| decreased muscle weight
|
J:207891
|
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Tg(Tnnt2-cre)5Blh/0
(B6.Cg-Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh)
|
decreased fetal cardiomyocyte proliferation
|
J:229890
|
| thin myocardium compact layer
|
J:229890
|
\Knk/\Knk+
(involves: C57BL/6J * FVB/N)
|
abnormal myotome development
|
J:154368
|
\Krastm1(Hras)Rdl/\Krastm1(Hras)Rdl
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased heart left ventricle muscle contractility
|
J:98940
|
| dilated cardiomyopathy
|
J:98940
|
| increased myocardial fiber size
|
J:98940
|
\Krastm1Mok/\Krastm1Mok
(involves: 129S/SvEv * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:42943
|
| thin myocardium
|
J:42943
|
\Krastm4.1Bbd/\Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased cardiac muscle contractility
|
J:223433
|
| increased myocardial fiber number
|
J:223433
|
\Krit1tm1Kwhi/\Krit1tm1.1Kwhi
\Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
telangiectasia
|
J:215458
|
\Krit1tm1Kwhi/\Krit1tm1Kwhi
\Nfatc1tm1.1(cre)Bz/\Nfatc1+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl)
|
abnormal myocardial trabeculae morphology
|
J:238897
|
| thin myocardium
|
J:238897
|
\Kyky/\Kyky
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:116344
|
| decreased extensor digitorum longus weight
|
J:22972
|
| decreased soleus weight
|
J:22972
|
| impaired skeletal muscle contractility
|
J:22972
|
| muscle degeneration
|
J:116344
|
| muscular atrophy
|
J:116344
|
| skeletal muscle necrosis
|
J:116344
|
\Lama2dy-2J/\Lama2dy-2J
(involves: C57BL/6 * FVB/N)
|
dystrophic muscle
|
J:49435
|
\Lama2dy-2J/\Lama2dy-2J
(B6.WK-Lama2dy-2J/J)
|
enhanced skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367
|
\Lama2dy-2J/\Lama2dy-2J
(involves: WK/ReJ)
|
dystrophic muscle
|
J:5151
|
| opisthotonus
|
J:5151
|
\Lama2dy-6J/\Lama2dy-6J
(involves: C57BL/6JEi * DBA/2J)
|
dystrophic muscle
|
J:56803
|
| progressive muscle weakness
|
J:56803
|
\Lama2dy-7J/\Lama2dy-7J
(C57BL/6J-Lama2dy-7J/J)
|
dystrophic muscle
|
J:134367
|
| enhanced skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367
|
| muscle spasm
|
J:82238
|
| myopathy
|
J:134367,
J:82238
|
| skeletal muscle endomysial fibrosis
|
J:134367
|
\Lama2dy-8J/\Lama2dy-8J
(C57BL/6J-Lama2dy-8J/GrsrJ)
|
myopathy
|
J:149729
|
\Lama2dy-Pas/\Lama2dy-Pas
(involves: non-inbred stock)
|
abnormal skeletal muscle morphology
|
J:102806
|
| centrally nucleated skeletal muscle fibers
|
J:102806
|
| dystrophic muscle
|
J:102806
|
| increased variability of skeletal muscle fiber size
|
J:102806
|
| skeletal muscle fiber necrosis
|
J:102806
|
\Lama2dy/\Lama2dy
(involves: 129P1/Re * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:152525
|
| centrally nucleated skeletal muscle fibers
|
J:152525
|
| decreased skeletal muscle fiber number
|
J:152525
|
| impaired skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367,
J:152525
|
| myopathy
|
J:134367
|
| skeletal muscle fiber necrosis
|
J:152525
|
| skeletal muscle interstitial fibrosis
|
J:134367,
J:152525
|
\Lama2dy/\Lama2dy
(involves: 129P1/Re)
|
abnormal sarcolemma morphology
|
J:13125
|
| abnormal skeletal muscle fiber morphology
|
J:13125
|
| centrally nucleated skeletal muscle fibers
|
J:13125
|
| dystrophic muscle
|
J:13125
|
| increased variability of skeletal muscle fiber size
|
J:13125
|
| progressive muscle weakness
|
J:13125
|
\Lama2dy/\Lama2dy
(B6.129P1-Lama2dy/J)
|
muscle weakness
|
J:101670
|
\Lama2dy/\Lama2dy
(involves: 129P1/ReJ)
|
abnormal muscle physiology
|
J:102959
|
| dystrophic muscle
|
J:102959
|
| muscle weakness
|
J:102959
|
| skeletal muscle interstitial fibrosis
|
J:102959
|
\Lama2tm1Eeng/\Lama2tm1Eeng
(involves: 129S1/Sv * Black Swiss)
|
dystrophic muscle
|
J:59089
|
| impaired skeletal muscle regeneration
|
J:59089
|
\Lama2tm1Eeng/\Lama2tm1Eeng
(involves: 129S1/Sv * Black Swiss * FVB/N)
|
dystrophic muscle
|
J:49435
|
\Lama2tm1Eeng/\Lama2tm1Eeng
(involves: 129S1/Sv)
|
dystrophic muscle
|
J:170192
|
| muscle degeneration
|
J:170192
|
| muscle weakness
|
J:170192
|
| myositis
|
J:170192
|
\Lama2tm1Stk/\Lama2tm1Stk
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * ICR)
|
abnormal skeletal muscle fiber morphology
|
J:43145
|
| abnormal skeletal muscle morphology
|
J:43145
|
| dystrophic muscle
|
J:43145
|
| increased variability of skeletal muscle fiber size
|
J:43145
|
| muscle spasm
|
J:43145
|
| myopathy
|
J:43145
|
\Lama4tm1Ktry/\Lama4tm1Ktry
(B6.129X1-Lama4tm1Ktry)
|
abnormal myocardial fiber morphology
|
J:105789
|
| cardiomyopathy
|
J:105789
|
| decreased heart ventricle muscle contractility
|
J:105789
|
| heart left ventricle hypertrophy
|
J:105789
|
| increased myocardial fiber size
|
J:105789
|
| myocardial fiber degeneration
|
J:105789
|
\Lamb1Lt/\Lamb1+
(B6N.Cg-Lamb1Lt)
|
dystonia
|
J:247484
|
\Lamc1tm1Strl/\Lamc1tm1.2Strl
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * CBA))
|
abnormal quadriceps morphology
|
J:199683
|
| centrally nucleated skeletal muscle fibers
|
J:199683
|
| decreased skeletal muscle fiber diameter
|
J:199683
|
| decreased skeletal muscle mass
|
J:199683
|
| skeletal muscle fiber atrophy
|
J:199683
|
\Lamc1tm1Strl/\Lamc1tm1Strl
\Tg(Camk2a-cre)2Szi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscular atrophy
|
J:86714
|
\Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:328713
|
| cardiomyopathy
|
J:328713
|
| decreased cardiac muscle contractility
|
J:328713
|
| heart left ventricle hypertrophy
|
J:328713
|
| increased cardiac muscle glycogen level
|
J:328713
|
\Lamp2tm1Psa/\Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))
|
decreased cardiac muscle contractility
|
J:64151
|
\Lamp2tm1Psa/\Lamp2tm1Psa
(involves: 129P2/OlaHsd)
|
increased myocardial fiber size
|
J:253728
|
\Large1enr-Tg(MbpReg)36Pop/\Large1enr-Tg(MbpReg)36Pop
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber morphology
|
J:16281
|
| abnormal skeletal muscle morphology
|
J:16281
|
| skeletal muscle endomysial fibrosis
|
J:16281
|
| skeletal muscle fiber necrosis
|
J:16281
|
\Large1myd-3J/\Large1myd-3J
(STOCK Large1myd-3J/GrsrJ)
|
muscle phenotype
|
J:160357
|
| myopathy
|
J:160357
|
| skeletal muscle degeneration
|
J:160357
|
\Large1myd/\Large1myd
(MYD/Le-Os +/+ Largemyd/J)
|
abnormal muscle morphology
|
J:5670
|
| abnormal muscle physiology
|
J:5670
|
| abnormal skeletal muscle fiber morphology
|
J:5670
|
| calcified muscle
|
J:12034
|
| dystrophic muscle
|
J:5670
|
| increased variability of skeletal muscle fiber size
|
J:5670
|
| muscle degeneration
|
J:5670
|
| myopathy
|
J:5670
|
| myositis
|
J:5670
|
\Large1myd/\Large1myd
(B6.Cg-Large1myd/Pjn)
|
abnormal diaphragm morphology
|
J:100214
|
| abnormal myocardium layer morphology
|
J:100214
|
| abnormal soleus morphology
|
J:100214
|
| dilated cardiomyopathy
|
J:100214
|
\Large1myd/\Large1myd
(B6C3Fe a/a-Large1myd/J)
|
abnormal myocardial fiber morphology
|
J:169951
|
| abnormal myocardium layer morphology
|
J:169951
|
| abnormal skeletal muscle fiber morphology
|
J:27793
|
| calcified muscle
|
J:27793
|
| centrally nucleated skeletal muscle fibers
|
J:27793
|
| dystrophic muscle
|
J:144746
|
| increased variability of skeletal muscle fiber size
|
J:27793
|
| myositis
|
J:27793
|
| skeletal muscle fiber degeneration
|
J:27793
|
| skeletal muscle fiber necrosis
|
J:27793
|
\Large1vls/\Large1vls
(B6.CAST(Cg)-Large1vls/Pjn)
|
abnormal diaphragm morphology
|
J:100214
|
| abnormal myocardium layer morphology
|
J:100214
|
| abnormal soleus morphology
|
J:100214
|
| dilated cardiomyopathy
|
J:100214
|
\Lats2tm1Noj/\Lats2tm1Noj
(involves: 129S2/SvPas * C57BL/6)
|
delayed muscle development
|
J:123480
|
\Lats2tm1Raz/\Lats2tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:93191
|
\Lbx1tm1.1Khan/\Lbx1tm1.1Khan
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal muscle precursor cell migration
|
J:178868
|
| abnormal skeletal muscle morphology
|
J:178868
|
\Lbx1tm1.1Khan/\Lbx1tm1.1Khan
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
abnormal skeletal muscle morphology
|
J:178868
|
\Lbx1tm1Gld/\Lbx1tm1Gld
(involves: 129S1/Sv * C57BL/6)
|
abnormal limb muscle morphology
|
J:56498
|
| abnormal muscle precursor cell migration
|
J:56498
|
| abnormal myogenesis
|
J:56498
|
| absent hypaxial muscle
|
J:56498
|
| decreased skeletal muscle mass
|
J:56498
|
| muscle phenotype
|
J:56498
|
\Lbx1tm1Gld/\Lbx1tm1Gld
(involves: 129S1/Sv)
|
abnormal skeletal muscle morphology
|
J:98439
|
| muscle phenotype
|
J:98439
|
\Lbx1tm1Thbr/\Lbx1tm1Thbr
(involves: 129S4/SvJae)
|
abnormal limb muscle morphology
|
J:57891
|
| abnormal muscle precursor cell migration
|
J:57891
|
| muscle phenotype
|
J:57891
|
\Ldb3tm1Chen/\Ldb3tm1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal myocardium layer morphology
|
J:72799
|
| abnormal skeletal muscle morphology
|
J:72799
|
| muscle weakness
|
J:72799
|
| myopathy
|
J:72799
|
\Ldb3tm2Chen/\Ldb3tm2Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:82141
|
| increased variability of skeletal muscle fiber size
|
J:82141
|
| myopathy
|
J:82141
|
| skeletal muscle fiber atrophy
|
J:82141
|
\Ldb3tm3Chen/\Ldb3tm3Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:82141
|
| increased variability of skeletal muscle fiber size
|
J:82141
|
| myopathy
|
J:82141
|
| skeletal muscle fiber atrophy
|
J:82141
|
\Ldb3tm4Chen/\Ldb3tm4Chen
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * FVB/N)
|
dilated cardiomyopathy
|
J:144739
|
\Ldb3tm4Chen/\Ldb3tm4Chen
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:144739
|
| dilated cardiomyopathy
|
J:144739
|
\Ldb3tm6.2Chen/\Ldb3tm6.2Chen
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
abnormal Z line morphology
|
J:170494
|
| decreased cardiac muscle contractility
|
J:170494
|
| dilated cardiomyopathy
|
J:170494
|
\Ldlrtm1Her/\Ldlrtm1Her
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:82871
|
\Ldlrtm1Her/\Ldlrtm1Her
\Wnt16tm2a(EUCOMM)Wtsi/\Wnt16tm2a(EUCOMM)Wtsi
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
abnormal aorta smooth muscle morphology
|
J:344215
|
| abnormal muscle fiber mitochondrial morphology
|
J:344215
|
| abnormal vascular smooth muscle physiology
|
J:344215
|
| decreased vasoconstriction
|
J:344215
|
\Lemd2em1Eno/\Lemd2em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:331716
|
| decreased cardiac muscle contractility
|
J:331716
|
| dilated cardiomyopathy
|
J:331716
|
| increased myocardial fiber size
|
J:331716
|
| muscle phenotype
|
J:331716
|
\Lemd2em2Eno/\Lemd2em2Eno
\Tg(Myh6-cre)2182Mds/0
(involves: C3H * C57BL/6 * C57BL/6N * FVB/N)
|
abnormal myocardial fiber morphology
|
J:331716
|
| dilated cardiomyopathy
|
J:331716
|
\Lemd2Gt(DD0639)Wtsi/\Lemd2+
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
delayed skeletal muscle regeneration
|
J:221495
|
| muscle phenotype
|
J:221495
|
\Lemd2Gt(DD0639)Wtsi/\Lemd2Gt(DD0639)Wtsi
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
myocardial trabeculae hypoplasia
|
J:221495
|
| thin myocardium
|
J:221495
|
\Lepob/\Lepob
(involves: C57BL/6J)
|
abnormal muscle contractility
|
J:106205
|
\Lepob/\Lepob
(B6.Cg-Lepob/J)
|
abnormal muscle morphology
|
J:151518
|
| abnormal myocardial fiber morphology
|
J:103063,
J:111488,
J:104171
|
| abnormal skeletal muscle fiber type ratio
|
J:151518
|
| decreased cardiac muscle contractility
|
J:111488,
J:104171
|
| decreased skeletal muscle fiber size
|
J:151518
|
| decreased skeletal muscle mass
|
J:151518
|
| heart left ventricle hypertrophy
|
J:103063
|
| increased myocardial fiber size
|
J:104171
|
\Lepob/\Lepob
\Plin4tm1Vlcg/\Plin4tm1Vlcg
(involves: C57BL/6J)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
\Lepob/\Lepob
\Ppargtm1Avp/\Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:116568
|
\Lepob/\Lepob
\Ppargtm2Avp/\Ppargtm2Avp
(involves: 129 * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:121534
|
\Leprdb-Pas/\Leprdb-Pas
(involves: DW/Pas)
|
decreased muscle weight
|
J:174584
|
\Leprdb/\Leprdb
(involves: C57BLKS/J)
|
abnormal myocardium layer morphology
|
J:107138
|
| decreased cardiac muscle contractility
|
J:106871
|
| increased vasoconstriction
|
J:106597
|
\Leprdb/\Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal myocardial fiber morphology
|
J:103063
|
| heart left ventricle hypertrophy
|
J:103063
|
\Leprdb/\Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
abnormal myocardial fiber morphology
|
J:6115
|
\Leprotl1tm1b(EUCOMM)Hmgu/\Leprotl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Leprotl1tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
\Lfngtm1Rjo/\Lfngtm1Rjo
(B6.129S7-Lfngtm1Rjo)
|
abnormal multifidus muscle morphology
|
J:324821
|
\Lgals1tm1Rob/\Lgals1tm1Rob
(involves: 129S/SvEv)
|
delayed muscle development
|
J:119480
|
\Lgals1tm1Rob/\Lgals1tm1Rob
\Myf5tm2Pas/\Myf5+
(involves: 129S/SvEv * 129S2/SvPas)
|
abnormal skeletal muscle fiber morphology
|
J:119480
|
| decreased skeletal muscle fiber diameter
|
J:119480
|
| delayed muscle development
|
J:119480
|
| delayed skeletal muscle regeneration
|
J:119480
|
\Lgi4clp/\Lgi4clp
(C57BL/6J-Lgi4clp/J)
|
muscle phenotype
|
J:11392
|
\Lig3tm1.1Pmc/\Lig3tm1.1Pmc
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:170077
|
| decreased cardiac muscle contractility
|
J:170077
|
\Limch1em1Coop/\Limch1em1Coop
(FVB-Limch1em1Coop)
|
abnormal skeletal muscle fiber morphology
|
J:336773
|
| impaired muscle relaxation
|
J:336773
|
| impaired skeletal muscle contractility
|
J:336773
|
| muscle phenotype
|
J:336773
|
| muscle weakness
|
J:336773
|
\Lims1tm1.1Chen/\Lims1tm1.1Chen
\Lims2tm1.1Chen/\Lims2tm1.1Chen
\Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal pectinate muscle morphology
|
J:167114
|
| abnormal ventricle myocardium morphology
|
J:167114
|
| decreased myocardial fiber size
|
J:167114
|
| thin myocardium compact layer
|
J:167114
|
\Lims1tm1.1Chen/\Lims1tm1.1Chen
\Tg(Tnnt2-cre)5Blh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:167114
|
\Lims2tm1.1Chen/\Lims2tm1.1Chen
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:167114
|
\Lin28atm1.1Gqda/\Lin28atm1.1Gqda
(involves: 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:199720
|
\Lin28btm1Gqda/\Lin28btm1Gqda
\Myf5tm1(cre)Mrc/\Myf5+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:199720
|
\Lipetm1Land/\Lipetm1Land
(involves: 129 * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:85540
|
\Lipetm1Land/\Lipetm1Land
(involves: 129)
|
decreased skeletal muscle glycogen level
|
J:106148
|
\Lipetm1Rze/\Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cardiac muscle triglyceride level
|
J:74644
|
\Litchiem1Jnch/\Litchiem1Jnch
(involves: C57BL/6J)
|
muscle weakness
|
J:345795
|
\Lmbrd1tm1.1Ntum/\Lmbrd1+
(B6.Cg-Lmbrd1tm1.1Ntum)
|
abnormal cardiac muscle cell glucose uptake
|
J:204994
|
| increased cardiac muscle cell glucose uptake
|
J:204994
|
\LmnaGt(S7-1F1)Sor/\LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased myocardial fiber size
|
J:221850
|
| decreased quadriceps weight
|
J:221850
|
| decreased skeletal muscle fiber diameter
|
J:221850
|
| decreased skeletal muscle fiber size
|
J:221850
|
| muscle weakness
|
J:221850
|
\Lmnatm1.1Bliu/\Lmna+
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
\Lmnatm1.1Bliu/\Lmnatm1.1Bliu
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
\Lmnatm1.1Otin/\Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:211388
|
\Lmnatm1.1Otin/\Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:177632
|
\Lmnatm1.1Vde/\Lmnatm1.1Vde
(B6.129(Cg)-Lmnatm1.1Vde)
|
abnormal muscle tone
|
J:322912
|
\Lmnatm1.2Yxz/\Lmnatm1.2Yxz
(involves: 129S * BALB/cJ * C57BL/6 * CD-1 * SJL)
|
decreased skeletal muscle fiber size
|
J:211369
|
\Lmnatm1Bliu/\Lmnatm1Bliu
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vasodilation
|
J:287256
|
| decreased heart left ventricle muscle contractility
|
J:287256
|
| dilated cardiomyopathy
|
J:287256
|
\Lmnatm1Gbon/\Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6)
|
abnormal diaphragm morphology
|
J:95528
|
| abnormal gastrocnemius morphology
|
J:95528
|
| abnormal hypaxial muscle morphology
|
J:95528
|
| abnormal myocardial fiber morphology
|
J:95528
|
| abnormal soleus morphology
|
J:95528
|
| abnormal tibialis anterior morphology
|
J:95528
|
| decreased cardiac muscle contractility
|
J:187399
|
| decreased heart left ventricle muscle contractility
|
J:95528
|
| dilated cardiomyopathy
|
J:187399
|
| dystrophic muscle
|
J:95528
|
| myocardium necrosis
|
J:95528
|
| progressive muscle weakness
|
J:95528
|
| skeletal muscle fibrosis
|
J:95528
|
\Lmnatm1Stw/\Lmna+
\Mliptm1.1(cre)Dzw/\Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
| dilated cardiomyopathy
|
J:227485
|
\Lmnatm1Stw/\Lmna+
\Zmpste24tm1Sgy/\Zmpste24tm1Sgy
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:95274
|
\Lmnatm1Stw/\Lmnatm1Stw
(involves: 129S1/Sv)
|
dystrophic muscle
|
J:58702
|
| muscle degeneration
|
J:58702
|
\Lmnatm1Stw/\Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6)
|
muscle weakness
|
J:95274
|
\Lmnatm1Stw/\Lmnatm1Stw
\Mliptm1.1(cre)Dzw/\Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
\Lmnatm1Stw/\Lmnatm1Stw
\Zmpste24tm1Sgy/\Zmpste24+
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
\Lmnatm1Stw/\Lmnatm1Stw
\Zmpste24tm1Sgy/\Zmpste24tm1Sgy
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
\Lmnatm2.1Gbon/\Lmna+
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:198526
|
| cardiac muscle degeneration
|
J:198526
|
| decreased cardiac muscle contractility
|
J:198526
|
| dilated cardiomyopathy
|
J:198526
|
| muscle phenotype
|
J:198526
|
\Lmnatm2.1Gbon/\Lmnatm2.1Gbon
(involves: 129 * C57BL/6)
|
abnormal muscle development
|
J:180603
|
| abnormal myocardial fiber morphology
|
J:180603
|
| centrally nucleated skeletal muscle fibers
|
J:180603
|
| decreased skeletal muscle fiber size
|
J:180603
|
\Lmnatm2Lgf/\Lmna+
\Zmpste24tm1Sgy/\Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:106473
|
\Lmnatm2Stw/\Lmnatm2Stw
(involves: 129S1/Sv)
|
abnormal esophageal smooth muscle morphology
|
J:83382
|
| cardiac muscle degeneration
|
J:83382
|
| decreased myocardial fiber number
|
J:83382
|
| decreased myocardial fiber size
|
J:83382
|
| muscular atrophy
|
J:83382
|
| skeletal muscle degeneration
|
J:83382
|
\Lmnatm3Stw/\Lmnatm3Stw
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL)
|
abnormal myocardial fiber morphology
|
J:100393
|
| cardiac muscle degeneration
|
J:100393
|
| decreased heart left ventricle muscle contractility
|
J:100393
|
| dilated cardiomyopathy
|
J:100393
|
| myocardial fiber degeneration
|
J:100393
|
| thin myocardium
|
J:100393
|
\Lmnatm4Stw/\Lmnatm4Stw
\Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:220874
|
| decreased skeletal muscle fiber diameter
|
J:220874
|
| dystrophic muscle
|
J:220874
|
\Lmnatm5Lgf/\Lmnatm5Lgf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:160705
|
| dilated cardiomyopathy
|
J:160705
|
\Lmnatm8Lgf/\Lmnatm8Lgf
(involves: 129P2/OlaHsd)
|
decreased heart ventricle muscle contractility
|
J:167229
|
\Lmnatm10Lgf/\Lmnatm10Lgf
\Zmpste24tm1Sgy/\Zmpste24tm1Sgy
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
esophageal achalasia
|
J:220988
|
\Lmnatm11Lgf/\Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:220988
|
| esophageal achalasia
|
J:220988
|
\Lmnatm12Lgf/\Lmnatm12Lgf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:234711
|
\Lmnb1tm1Yxz/\Lmnb1tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin diaphragm muscle
|
J:178993
|
\Lmnb1tm1Yxz/\Lmnb1tm1Yxz
\Lmnb2tm1Yxz/\Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin diaphragm muscle
|
J:178993
|
\Lmo7tm1Tilg/\Lmo7tm1Tilg
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:83810
|
\Lmod1em1Jomm/\Lmod1em1Jomm
(Not Specified)
|
abnormal muscle physiology
|
J:241933
|
| abnormal smooth muscle morphology
|
J:241933
|
| abnormal urinary bladder detrusor smooth muscle morphology
|
J:241933
|
| impaired contractility of jejunal smooth muscle
|
J:241933
|
| impaired ureteric peristalsis
|
J:241933
|
| intestinal hypoperistalsis
|
J:241933
|
\Lmod2tm1(KOMP)Vlcg/\Lmod2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal intercalated disk morphology
|
J:227272
|
| abnormal myocardial fiber morphology
|
J:227272
|
| abnormal sarcomere morphology
|
J:227272
|
| abnormal Z line morphology
|
J:227272
|
| decreased cardiac muscle contractility
|
J:227272
|
| dilated cardiomyopathy
|
J:227272
|
\Lmod2Tn(pb-Act-RFP)1.1Zhu/\Lmod2Tn(pb-Act-RFP)1.1Zhu
(involves: FVB/N)
|
abnormal intercalated disk morphology
|
J:233669
|
| abnormal myocardial fiber morphology
|
J:233669
|
| abnormal sarcomere morphology
|
J:233669
|
| abnormal Z line morphology
|
J:233669
|
| absent M line
|
J:233669
|
| decreased cardiac muscle contractility
|
J:233669
|
| dilated cardiomyopathy
|
J:233669
|
\Lmod3em1(IMPC)Mbp/\Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Lmod3em1Eno/\Lmod3em1Eno
(involves: C3H * C57BL/6)
|
abnormal sarcomere morphology
|
J:222174
|
| abnormal Z line morphology
|
J:222174
|
| centrally nucleated skeletal muscle fibers
|
J:222174
|
| decreased cardiac muscle contractility
|
J:222174
|
| decreased skeletal muscle fiber size
|
J:222174
|
| decreased skeletal muscle size
|
J:222174
|
| increased skeletal muscle glycogen level
|
J:222174
|
\Lmod3Tn(pb-Act-RFP)1.1Zhu/\Lmod3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6J)
|
abnormal sarcomere morphology
|
J:223382
|
| abnormal skeletal muscle fiber morphology
|
J:223382
|
| abnormal Z line morphology
|
J:223382
|
| muscle weakness
|
J:223382
|
| skeletal muscle fiber atrophy
|
J:223382
|
\Lmx1btm1Rjo/\Lmx1btm1Zfc
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:158676
|
\Lmx1btm1Rjo/\Lmx1btm4.1Rjo
\Pitx2tm4(cre)Jfm/\Pitx2+
(involves: 129S7/SvEvBrd)
|
abnormal intraocular muscle morphology
|
J:161793
|
\Lncpinttm1Vlcg/\Lncpinttm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
decreased gastrocnemius weight
|
J:233815
|
| decreased skeletal muscle mass
|
J:233815
|
| decreased tibialis anterior weight
|
J:233815
|
| progressive muscle weakness
|
J:233815
|
\Lnhrttm1.1Koho/\Lnhrttm1.1Koho
(involves: C57BL/6 * DBA/2)
|
decreased heart ventricle muscle contractility
|
J:293789
|
| decreased myocardial fiber size
|
J:293789
|
| decreased susceptibility to induced muscular atrophy
|
J:293789
|
\Loxb2b370.2Clo/\Loxb2b370.2Clo
(C57BL/6J-Loxb2b370.2Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Loxtm1Ikh/\Loxtm1Ikh
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:82926
|
| abnormal diaphragm central tendon morphology
|
J:82926
|
| abnormal diaphragm development
|
J:82926
|
| diaphragmatic hernia
|
J:82926
|
\Loxtm1Soin/\Loxtm1Soin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:103389
|
| abnormal diaphragm morphology
|
J:101687
|
| diaphragmatic hernia
|
J:101687
|
\Lpar4tm1Sati/Y
(involves: C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:167262
|
\Lpar4tm1Sati/\Lpar4tm1Sati
(involves: C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:167262
|
\Lpin120884/\Lpin120884
\Nrcam20884/\Nrcam20884
(involves: C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:153042
|
\Lpin1fld/\Lpin1fld
\Nrcam20884/\Nrcam20884
(involves: BALB/cByJ * C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:153042
|
\Lpltm1Bres/\Lpl+
\Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae)
|
abnormal cardiac muscle tissue morphology
|
J:134550
|
| abnormal myocardial fiber morphology
|
J:134550
|
| cardiomyopathy
|
J:134550
|
| decreased heart left ventricle muscle contractility
|
J:134550
|
\Lpltm1Bres/\Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:30062
|
\Lpltm1Ijg/\Lpltm1Ijg
\Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6)
|
decreased cardiac muscle triglyceride level
|
J:90737
|
| increased cardiac muscle cell glucose uptake
|
J:90737
|
\Lpltm1Ijg/\Lpltm1Ijg
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:110484
|
| increased cardiac muscle cell glucose uptake
|
J:110484
|
\Lpoem1Zlu/\Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
dilated cardiomyopathy
|
J:307289
|
| myositis
|
J:307289
|
\Lrig3em1(IMPC)Ccpcz/\Lrig3em1(IMPC)Ccpcz
(C57BL/6NCrl-Lrig3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Lrp1b2b1554Clo/\Lrp1b2b1554Clo
(C57BL/6J-Lrp1b2b1554Clo)
|
diaphragmatic hernia
|
J:175213
|
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:127398
|
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Tagln-cre)1Her/0
(B6.Cg-Lrp1tm2Her Tg(Tagln-cre)1Her)
|
abnormal aorta smooth muscle morphology
|
J:167799
|
| abnormal vascular smooth muscle physiology
|
J:167799
|
| decreased vasoconstriction
|
J:167799
|
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:209752
|
| decreased cardiac muscle contractility
|
J:209752
|
| dilated cardiomyopathy
|
J:209752
|
\Lrp2b2b2671Clo/\Lrp2b2b2671Clo
(C57BL/6J-Lrp2b2b2671Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Lrp4tm1.1Pg/\Lrp4tm1.1Pg
(involves: C57BL/6N)
|
muscle phenotype
|
J:277372
|
\Lrrc8atm1.1Geha/\Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal skeletal muscle morphology
|
J:211308
|
\Lrrc10tm1Sgt/\Lrrc10tm1Sgt
(B6.129P2-Lrrc10tm1Sgt)
|
abnormal myocardial fiber morphology
|
J:195548
|
| decreased cardiac muscle contractility
|
J:195548
|
| dilated cardiomyopathy
|
J:195548
|
\Lrrc25em1Cya/\Lrrc25em1Cya
(C57BL/6J-Lrrc25em1Cya/Cya)
|
decreased heart left ventricle muscle contractility
|
J:270157
|
\Lsq1BALB/cJ/\Lsq1C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
skeletal muscle necrosis
|
J:135427
|
\Lsq1C57BL/6J/\Lsq1C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
skeletal muscle necrosis
|
J:135427
|
\Ltbp1tm1Veto/\Ltbp1tm1Veto
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128012
|
\Ltbp1tm2Veto/\Ltbp1tm2Veto
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128012
|
\Ltbp4dmod1-r/\Ltbp4dmod1-r
\Sgcgtm1Mcn/\Sgcgtm1Mcn
(129T2.Cg-Ltbp4dmod1-r Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
| skeletal muscle fibrosis
|
J:155107
|
\Ltbp4dmod1-s/\Ltbp4dmod1-s
\Sgcgtm1Mcn/\Sgcgtm1Mcn
(D2.Cg-Ltbp4dmod1-s Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
| skeletal muscle fibrosis
|
J:155107
|
\Ltbp4Gt(E301B04)Wrst/\Ltbp4Gt(E301B04)Wrst
(B6N.129P2-Ltbp4Gt(E301B04)Wrst)
|
heart right ventricle hypertrophy
|
J:221200
|
\Ltbp4Gt(U3Cre)1Vmel/\Ltbp4Gt(U3Cre)1Vmel
(involves: 129S2/SvPas * C57BL/6)
|
cardiomyopathy
|
J:85162
|
\Ltbp4Gt(U3Cre)1Vmel/\Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel)
|
increased myocardial fiber size
|
J:78819
|
| ventricular cardiomyopathy
|
J:78819
|
\Ltn1lister/\Ltn1lister
(C57BL/6-Ltn1lister)
|
abnormal muscle regeneration
|
J:146493
|
| decreased skeletal muscle fiber size
|
J:146493
|
| muscular atrophy
|
J:146493
|
\Lumtm1Chak/\Lumtm1Chak
(involves: 129S/Sv * CD-1)
|
abnormal tendon morphology
|
J:65867
|
\Ly6etm1Zmt/\Ly6etm1Zmt
(involves: 129S1/Sv)
|
dilated cardiomyopathy
|
J:73972
|
\Lztr1tm1a(EUCOMM)Wtsi/\Lztr1+
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:268690
|
| increased myocardial fiber size
|
J:268690
|
\Mad1l1tm1.1Ktj/\Mad1l1+
(involves: BALB/c * C57BL/6J)
|
increased rhabdomyosarcoma incidence
|
J:117337
|
\Mad2l1bptm1.2Itl/\Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
muscle phenotype
|
J:234643
|
\Mafgtm1Jeng/\Mafgtm1Jeng
\Mafktm1Jeng/\Mafk+
(involves: 129S1/Sv * 129X1/SvJ)
|
myoclonus
|
J:81813
|
\Magel2tm1Stw/\Magel2tm1Stw
(C57BL/6-Magel2tm1Stw/J)
|
decreased skeletal muscle fiber size
|
J:233299
|
| decreased skeletal muscle weight
|
J:233299
|
| increased skeletal muscle fiber size
|
J:233299
|
| skeletal muscle atrophy
|
J:233299
|
\Maml1tm1Lizw/\Maml1tm1Lizw
(involves: 129)
|
increased variability of skeletal muscle fiber size
|
J:106711
|
| skeletal muscle fiber necrosis
|
J:106711
|
\Maml1tm1Mkit/\Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
dystrophic muscle
|
J:122286
|
\Mamstrtm1.1Eno/\Mamstrtm1.1Eno
\Pax7tm2.1(cre/ERT2)Fan/\Pax7+
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
\Mamstrtm1.2Eno/\Mamstrtm1.2Eno
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
\Mamstrtm1.2Eno/\Mamstrtm1.2Eno
\Mrtfatm1Eno/\Mrtfatm1Eno
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:179880
|
| abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
| decreased skeletal muscle weight
|
J:179880
|
| impaired skeletal muscle regeneration
|
J:179880
|
| muscular atrophy
|
J:179880
|
\Man2b1tm1Psa/\Man2b1tm1Psa
(involves: 129 * C57BL/6J)
|
abnormal eye muscle morphology
|
J:56659
|
\Map1stm1.1Lliu/\Map1stm1.1Lliu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:170757
|
\Map2k5tm1Ctr/\Map2k5tm1Ctr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:95388
|
\Map3k1tm1Glj/\Map3k1tm1Glj
(involves: 129S/SvEv)
|
abnormal vascular smooth muscle physiology
|
J:108989
|
| decreased heart ventricle muscle contractility
|
J:78068
|
| increased cardiomyocyte apoptosis
|
J:78068
|
\Map3k3tm1.1Mlkn/\Map3k3tm1.2Mlkn
\Nfatc1tm1.1(cre)Bz/\Nfatc1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
thin myocardium
|
J:238897
|
\Map3k3tm1Bisu/\Map3k3tm1Bisu
(Not Specified)
|
abnormal myocardium layer morphology
|
J:60748
|
| trabecula carnea hypoplasia
|
J:60748
|
\Map3k7Gt(XB444)Byg/\Map3k7Gt(XB444)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:107401
|
| abnormal vascular smooth muscle morphology
|
J:107401
|
| thin myocardium compact layer
|
J:107401
|
\Map3k10tm1Lex/\Map3k10tm1Lex
\Map3k9tm1Lex/\Map3k9tm1Lex
(either: 129S-Map3k10tm1Lex Map3k9tm1Lex or B6.129S-Map3k10tm1Lex Map3k9tm1Lex)
|
muscle phenotype
|
J:137358
|
\Map4em1Coop/\Map4em1Coop
(FVB/NJ-Map4em1Coop)
|
abnormal skeletal muscle fiber morphology
|
J:358165
|
| impaired skeletal muscle contractility
|
J:358165
|
| muscle phenotype
|
J:358165
|
\Map4em2Coop/\Map4em2Coop
(FVB/NJ-Map4em2Coop)
|
muscle phenotype
|
J:358165
|
\Mapk1tm1Gela/\Mapk1tm1Gela
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal extrinsic tongue muscle morphology
|
J:239772
|
| abnormal tongue muscle morphology
|
J:239772
|
\Mapk1tm1Melo/\Mapk1+
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:127872
|
| increased cardiomyocyte apoptosis
|
J:127872
|
\Mapk1tm1Melo/\Mapk1+
(involves: 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:124903
|
\Mapk1tm1Moga/\Mapk1tm1Moga
(involves: 129P2/OlaHsd * C57BL/6)
|
thin myocardium
|
J:89903
|
\Mapk3tm1Gpg/\Mapk3tm1Gpg
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:190460
|
\Mapk7b2b2346Clo/\Mapk7b2b2346Clo
(C57BL/6J-Mapk7b2b2346Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\Mapk7tm1Jdl/\Mapk7tm1Jdl
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
myocardial fiber degeneration
|
J:89215
|
\Mapk7tm1Jdl/\Mapk7tm1Jdl
\Tg(Tek-cre)12Flv/0
(Not Specified)
|
trabecula carnea hypoplasia
|
J:89215
|
\Mapk7tm1Jsca/\Mapk7tm1Jsca
(either: (involves: BALB/c) or (involves: C57BL/6))
|
thin myocardium
|
J:107620
|
\Mapk7tm1Kda/\Mapk7tm1Kda
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle morphology
|
J:77725
|
| trabecula carnea hypoplasia
|
J:77725
|
\Mapk7tm1Wnt/\Mapk7tm1Wnt
(involves: C57BL/6)
|
heart left ventricle hypertrophy
|
J:80044
|
| thin myocardium
|
J:80044
|
| trabecula carnea hypoplasia
|
J:80044
|
\Mapk8tm1Flv/\Mapk8tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
\Mapk8tm1Flv/\Mapk8tm1Flv
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:108253
|
| increased cardiomyocyte apoptosis
|
J:108253
|
\Mapk9tm1Mka/\Mapk9tm1Mka
(involves: 129/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
\Mapk11tm1Jsca/\Mapk11tm1Jsca
(involves: 129P2/OlaHsd)
|
increased fetal cardiomyocyte proliferation
|
J:176023
|
| thin right ventricle myocardium compact layer
|
J:176023
|
\Mapk11tm1Jsca/\Mapk11tm1Jsca
\Mapk14tm2Nbr/\Mapk14tm2Nbr
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased fetal cardiomyocyte proliferation
|
J:176023
|
\Mapk11tm2.1Lex/\Mapk11tm2.1Lex
(involves: 129 * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
\Mapk11tm2Lex/\Mapk11tm2Lex
\Tg(Myog-cre)1Eno/0
(involves: 129S/SvEvBrd)
|
muscle phenotype
|
J:155408
|
\Mapk12tm1.1Lex/\Mapk12tm1.1Lex
(involves: 129S/SvEvBrd * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
\Mapk12tm1Lex/\Mapk12tm1Lex
\Tg(Myog-cre)1Eno/0
(involves: 129S/SvEvBrd)
|
muscle phenotype
|
J:155408
|
\Mapk13tm2.1Lex/\Mapk13tm2.1Lex
(involves: 129S5/SvEvBrd * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
\Mapk14tm1.1Lex/\Mapk14tm1.1Lex
(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:119724
|
| abnormal myoblast differentiation
|
J:119724
|
| abnormal myoblast fusion
|
J:119724
|
| increased myoblast proliferation
|
J:119724
|
\Mapk14tm1.2Otsu/\Mapk14tm1.2Otsu
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:95116
|
| decreased heart left ventricle muscle contractility
|
J:95116
|
| increased cardiomyocyte apoptosis
|
J:95116
|
\Mapk14tm1Lex/\Mapk14tm1Lex
\Tg(Myog-cre)1Eno/0
(involves: 129S5/SvEvBrd)
|
muscle phenotype
|
J:155408
|
\Mapk14tm1Nbr/\Mapk14tm1Nbr
(either: (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
absent myocardial trabeculae
|
J:63877
|
| decreased cardiac muscle contractility
|
J:63877
|
| thin myocardium
|
J:63877
|
\Mapkapk2tm1Mgl/\Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:101888
|
\Mapttm3.1(FUS)Neas/\Mapt+
(B6J.129P2(129S)-Mapttm3.1(FUS)Neas)
|
abnormal sarcomere morphology
|
J:232167
|
| abnormal tibialis anterior morphology
|
J:232167
|
\Marveld2tm1.1Sria/\Marveld2+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:201580
|
\Marveld2tm1.1Sria/\Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:201580
|
\Matr3em1Tcp/\Matr3em1Tcp
(C57BL/6J-Matr3em1Tcp)
|
decreased skeletal muscle fiber size
|
J:298091
|
\Mavstm1Itl/\Mavstm1Itl
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
\Mbem1Shad/\Mbem1Shad
(B6N-Mbem1Shad)
|
muscle phenotype
|
J:307655
|
\Mbtm1Wlm/\Mbtm1Wlm
(Not Specified)
|
abnormal myocardium layer morphology
|
J:50584
|
| abnormal skeletal muscle fiber type ratio
|
J:72560
|
| abnormal soleus morphology
|
J:72560,
J:50584
|
| increased muscle fatigability
|
J:72560
|
| muscle phenotype
|
J:50584
|
\Mbtm1Wlm/\Mbtm1Wlm
(either: (involves: 129/Sv) or (involves: C57BL/6))
|
thin myocardium
|
J:74121
|
\Mbtm1Wlm/\Mbtm1Wlm
(B6.Cg-Mbtm1Wlm)
|
decreased heart ventricle muscle contractility
|
J:86546
|
| heart left ventricle hypertrophy
|
J:86546
|
\Mbnl1tm1Sws/\Mbnl1tm1Sws
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle physiology
|
J:86903
|
| abnormal skeletal muscle fiber morphology
|
J:86903
|
| centrally nucleated skeletal muscle fibers
|
J:86903
|
\Mbnl1tm1Sws/\Mbnl1tm1Sws
\Mbnl2tm1.1Sws/\Mbnl2+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL)
|
heart left ventricle hypertrophy
|
J:218011
|
| impaired muscle relaxation
|
J:218011
|
| muscle degeneration
|
J:218011
|
| progressive muscle weakness
|
J:218011
|
\Mbnl1tm1Sws/\Mbnl1tm1Sws
\Mbnl2tm1Sws/\Mbnl2tm1Sws
\Tg(Myog-cre)1Eno/0
(involves: 129S1/Sv * 129S1/SvImJ * C57BL)
|
centrally nucleated skeletal muscle fibers
|
J:218011
|
| decreased skeletal muscle fiber size
|
J:218011
|
| increased variability of skeletal muscle fiber size
|
J:218011
|
| skeletal muscle degeneration
|
J:218011
|
\Mbnl2Gt(RRK149)Byg/\Mbnl2Gt(RRK149)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:130160
|
| centrally nucleated skeletal muscle fibers
|
J:130160
|
| decreased skeletal muscle fiber size
|
J:130160
|
| impaired muscle relaxation
|
J:130160
|
| skeletal muscle interstitial fibrosis
|
J:130160
|
\Mbnl2Gt(XB595)Byg/\Mbnl2Gt(XB595)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:112061
|
\Mbnl2tm1.1Sws/\Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
muscle phenotype
|
J:218010
|
\Mbnl3tm1.1Sws/Y
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
decreased skeletal muscle fiber number
|
J:199127
|
| decreased skeletal muscle fiber size
|
J:199127
|
| impaired skeletal muscle regeneration
|
J:199127
|
\Mbnl3tm1.1Sws/\Mbnl3tm1.1Sws
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
decreased skeletal muscle fiber number
|
J:199127
|
| decreased skeletal muscle fiber size
|
J:199127
|
| impaired skeletal muscle regeneration
|
J:199127
|
\Mcattm1.1Ssmi/\Mcattm1.1Ssmi
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal muscle physiology
|
J:192213
|
| increased skeletal muscle glycogen level
|
J:192213
|
\Mcm2tm1(cre/ERT2)Scpr/\Mcm2tm1(cre/ERT2)Scpr
(involves: 129S6/SvEvTac)
|
muscle weakness
|
J:141493
|
\Mcoln1tm1Sasl/\Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle mass
|
J:135368
|
| dilated cardiomyopathy
|
J:135368
|
\Mcrip2em1Eno/\Mcrip2em1Eno
(C57BL/6N-Mcrip2em1Eno)
|
muscle phenotype
|
J:316902
|
\Mcutm1.1Jmol/\Mcutm1.1Jmol
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:224853
|
| decreased cardiomyocyte apoptosis
|
J:224853
|
| decreased heart ventricle muscle contractility
|
J:224853
|
\Mdga2Tg(Prnp-PFN1*G118V)838Kiaei/\Mdga2+
(involves: C57BL/6N)
|
progressive muscle weakness
|
J:241428
|
| skeletal muscle atrophy
|
J:241428
|
\Mdm2tm1Glo/\Mdm2tm2.1Glo
\Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:104114
|
| thin myocardium
|
J:104114
|
\Mdm2tm3.1Glo/\Mdm2tm3.1Glo
\Trp53tm3.1Glo/\Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo)
|
increased leiomyosarcoma incidence
|
J:164201
|
\Mdm4tm2Glo/\Mdm4tm2.1Glo
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased myocardial fiber number
|
J:137114
|
| dilated cardiomyopathy
|
J:137114
|
| increased cardiomyocyte apoptosis
|
J:137114
|
| increased myocardial fiber size
|
J:137114
|
\Mdmsc1Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mdmsc2Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mdmsc3Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mdmsc4Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mdmsc5Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mdmsc6Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
\Mecomtm1Aspe/\Mecomtm1Aspe
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:207915
|
\Mecomtm1Mmor/\Mecomtm1Mmor
(involves: 129S2/SvPas * CF-1)
|
abnormal myotome development
|
J:42030
|
| absent myotome
|
J:42030
|
| trabecula carnea hypoplasia
|
J:42030
|
\Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * CD-1)
|
increased muscle fatigability
|
J:268051
|
\Mecp2tm1Nlnd/Y
(involves: 129 * CD-1)
|
increased muscle fatigability
|
J:268051
|
\Med1tm1.1Mpk/\Med1tm1.1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:86857
|
\Med1tm1Jkr/\Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6)
|
myocardial trabeculae hypoplasia
|
J:74328
|
| myocardium hypoplasia
|
J:74328
|
| thin myocardium
|
J:62272
|
| trabecula carnea hypoplasia
|
J:74328
|
\Med1tm1Mpk/\Med1tm1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:86857
|
\Med1tm1Rgr/\Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ))
|
abnormal myocardial trabeculae morphology
|
J:61840
|
| thin myocardium compact layer
|
J:61840
|
| trabecula carnea hypoplasia
|
J:61840
|
\Med1tm2Jkr/\Med1tm2Jkr
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:243730
|
| dilated cardiomyopathy
|
J:243730
|
| increased cardiomyocyte apoptosis
|
J:243730
|
\Med1tm2Jkr/\Med1tm2Jkr
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:243730
|
| abnormal Z line morphology
|
J:243730
|
| decreased cardiac muscle contractility
|
J:243730
|
| decreased myocardial fiber mitochondrial DNA content
|
J:243730
|
| dilated cardiomyopathy
|
J:243730
|
| increased cardiomyocyte apoptosis
|
J:243730
|
\Med24tm1Rgr/\Med24tm1Rgr
(involves: 129X1/SvJ * C57BL/6 * CD-1)
|
trabecula carnea hypoplasia
|
J:77765
|
\Med30m1Btlr/\Med30m1Btlr
(involves: C57BL/6J)
|
abnormal I band morphology
|
J:180728
|
| abnormal myocardial fiber morphology
|
J:180728
|
| abnormal sarcomere morphology
|
J:180728
|
| abnormal Z line morphology
|
J:180728
|
| cardiomyopathy
|
J:180728
|
| decreased cardiac muscle contractility
|
J:180728
|
| myocardium necrosis
|
J:180728
|
\Mef2atm1Eno/\Mef2atm1Eno
(involves: 129S6/SvEvTac)
|
muscle phenotype
|
J:127416
|
\Mef2ctm1.1Jjs/\Mef2ctm1.1Jjs
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
increased sinoatrial node size
|
J:100949
|
\Mef2ctm1Eno/\Mef2ctm1Eno
(involves: 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:40724
|
| decreased heart ventricle muscle contractility
|
J:40724
|
| trabecula carnea hypoplasia
|
J:40724
|
\Mef2ctm1Eno/\Mef2ctm2Eno
\Tg(Myog-cre)1Eno/0
(involves: 129S/SvEv * 129S7/SvEvBrd)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Mef2dtm1Eno/\Mef2dtm1Eno
\Tg(Myog-cre)1Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Mef2dtm3Eno/\Mef2dtm3Eno
\Meox2tm1(cre)Sor/\Meox2+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:130825
|
| decreased cardiac muscle contractility
|
J:130825
|
\Meg3tm1Itl/\Meg3+
(B6.129S6-Meg3tm1Itl)
|
abnormal muscle development
|
J:166176
|
| abnormal skeletal muscle fiber morphology
|
J:166176
|
\Megf8hlb611/\Megf8hlb611
(involves: C57BL/6J * C3H/HeJ)
|
trabecula carnea hypoplasia
|
J:146957
|
\Men1tm1Zqw/\Men1tm1Zqw
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
trabecula carnea hypoplasia
|
J:83882
|
\Meox1Tg(Mx1-TAX)2627Arnh/\Meox1Tg(Mx1-TAX)2627Arnh
\Meox2tm1Vpa/\Meox2tm1Vpa
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:84754
|
\Meox1tm1Bmk/\Meox1tm1Bmk
\Meox2tm1Vpa/\Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dermomyotome development
|
J:84754
|
| abnormal epaxial muscle morphology
|
J:84754
|
| abnormal hypaxial muscle morphology
|
J:84754
|
| abnormal myotome development
|
J:84754
|
| abnormal skeletal muscle morphology
|
J:84754
|
\Meox2fla/\Meox2fla
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:123197
|
| abnormal skeletal muscle morphology
|
J:123197
|
| thin myocardium
|
J:123197
|
\Meox2tm1(cre)Sor/\Meox2+
\Ptpn11tm6Bgn/\Ptpn11+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:147154
|
\Meox2tm1(cre)Sor/\Meox2+
\Ptrh2tm1Eruo/\Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor)
|
abnormal muscle fiber morphology
|
J:220518
|
| muscle weakness
|
J:220518
|
\Meox2tm1(cre)Sor/\Meox2+
\Smad1tm2Rob/\Smad1tm2Sor
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal stomach muscularis externa morphology
|
J:90769
|
\Meox2tm1(cre)Sor/\Meox2+
\Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
muscular atrophy
|
J:216672
|
\Meox2tm1(cre)Sor/\Meox2+
\Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
muscular atrophy
|
J:216672
|
\Meox2tm1Vpa/\Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:56172
|
| abnormal myogenesis
|
J:56172
|
| centrally nucleated skeletal muscle fibers
|
J:56172
|
| decreased skeletal muscle mass
|
J:56172
|
| increased variability of skeletal muscle fiber size
|
J:56172
|
\Meox2tm1Vpa/\Meox2tm1Vpa
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle morphology
|
J:98439
|
| muscle phenotype
|
J:98439
|
\Mesp1tm2(cre)Ysa/\Mesp1+
\Pofut1tm1Ysa/\Pofut1tm1Ysa
(involves: C57BL/6 * CBA * SJL)
|
myocardial trabeculae hypoplasia
|
J:139209
|
\Mesp1tm2(cre)Ysa/\Mesp1+
\Tg(CAG-cat,-Notch1)1Ysa/0
(involves: C3H * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:108444
|
| abnormal myocardium layer morphology
|
J:108444
|
| abnormal sarcomere morphology
|
J:108444
|
| abnormal trabecula carnea morphology
|
J:108444
|
\Mesp2tm1Ysa/\Mesp2tm1Ysa
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * ICR))
|
abnormal dermomyotome development
|
J:42014
|
| muscle phenotype
|
J:42014
|
\Mesttm1Masu/\Mest+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:79223
|
| abnormal myocardium layer morphology
|
J:79223
|
\Mettm1Cbm/\Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:28570
|
| abnormal intrinsic tongue muscle morphology
|
J:28570
|
| abnormal muscle precursor cell migration
|
J:28570
|
| abnormal myogenesis
|
J:28570
|
| hypaxial muscle hypoplasia
|
J:28570
|
\Mettm1Cbm/\Mettm1Cbm
(involves: ICR)
|
abnormal diaphragm morphology
|
J:80685
|
| abnormal muscle precursor cell migration
|
J:80685
|
| diaphragmatic hernia
|
J:80685
|
| hypaxial muscle hypoplasia
|
J:80685
|
| thin diaphragm muscle
|
J:80685
|
\Mettm1Cpo/\Mettm1Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle development
|
J:36244
|
| abnormal tongue muscle morphology
|
J:36244
|
| absent diaphragm
|
J:36244
|
\Mettm1Cpo/\Mettm1Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent skeletal muscle
|
J:98439
|
| muscle phenotype
|
J:98439
|
\Mettm1Cpo/\Mettm2Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:36244
|
\Mettm1Kln/\Mettm1Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal myoblast migration
|
J:94030
|
| abnormal myogenesis
|
J:94030
|
| decreased skeletal muscle mass
|
J:94030
|
\Mettm2Cpo/\Mettm2Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:36244
|
\Mettm2Kln/\Mettm2Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal diaphragm morphology
|
J:94030
|
| abnormal myoblast migration
|
J:94030
|
| abnormal myogenesis
|
J:94030
|
| decreased skeletal muscle mass
|
J:94030
|
\Mettl21ctm1.1Krug/\Mettl21ctm1.1Krug
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:270838
|
| muscle weakness
|
J:270838
|
\Mfn2tm1.1Mzhe/\Mfn2tm1.1Mzhe
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:188865
|
| abnormal myocardial fiber morphology
|
J:188865
|
| decreased heart ventricle muscle contractility
|
J:188865
|
| increased myocardial fiber apoptosis
|
J:188865
|
\Mfsd8tm1a(EUCOMM)Hmgu/\Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:211608
|
\Mgat2tm1.1Jxm/\Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:80661
|
\mgb/\mgb
(involves: FVB/N)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:283803
|
\Mgptm1Kry/\Mgptm1Kry
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:38867
|
\Mgrn1md-2J/\Mgrn1md-2J
(involves: 129S1/SvImJ * C3H/HeJ)
|
thin myocardium
|
J:116645
|
\Mgrn1md-nc/\Mgrn1md-nc
(involves: 101/H * C3H/HeH)
|
muscle weakness
|
J:81466
|
| thin myocardium
|
J:116645
|
\Mib1em1Jlp/\Mib1tm2Kong
\Tg(Tnnt2-cre)5Blh/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal trabecula carnea morphology
|
J:338889
|
| decreased cardiac muscle contractility
|
J:338889
|
| thin left ventricle myocardium compact layer
|
J:338889
|
\Micu1em#Fink/\Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
abnormal muscle physiology
|
J:238984
|
| decreased skeletal muscle fiber number
|
J:238984
|
\Micu1em#Fink/\Micu1em#Fink
\Smdt1em1Fink/\Smdt1+
(involves: C57BL/6J * C57BL/6N * CBA)
|
muscle phenotype
|
J:238984
|
\Micu2Gt(OST409343)Lex/\Micu2Gt(OST409343)Lex
(B6.129S5-Micu2Gt(OST409343)Lex)
|
abnormal myocardial fiber mitochondrial morphology
|
J:249367
|
| decreased cardiac muscle contractility
|
J:249367
|
| decreased cardiac muscle relaxation
|
J:249367
|
\Mid1tm1Mero/Y
(B6.Cg-Mid1tm1Mero)
|
muscle phenotype
|
J:157828
|
\Mir1a-1tm1Dsr/\Mir1a-1tm1Dsr
\Mir1a-2tm1Dsr/\Mir1a-2tm1Dsr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal sarcomere morphology
|
J:207845
|
| decreased cardiac muscle contractility
|
J:207845
|
\Mir1a-2tm1Dsr/\Mir1a-2tm1Dsr
(involves: 129/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:211548
|
\Mir21atm1.1Zqy/\Mir21atm1.1Zqy
\Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * C3H * C57BL/6 * SJL)
|
decreased vasodilation
|
J:199907
|
\Mir22tm1.1Arod/\Mir22tm1.1Arod
(involves: 129S1/SvImJ * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:183005
|
\Mir22tm1Boet/\Mir22tm1Boet
(B6.129S2-Mir22tm1Boet)
|
muscle phenotype
|
J:266382
|
\Mir92bem22Gpt/\Mir92bem22Gpt
(involves: C57BL/6JGpt)
|
abnormal skeletal muscle morphology
|
J:346344
|
| increased skeletal muscle glycogen level
|
J:346344
|
| increased skeletal muscle weight
|
J:346344
|
| muscle phenotype
|
J:346344
|
\Mir133a-1tm1.1Eno/\Mir133a-1tm1.1Eno
\Mir133a-2tm1.1Eno/\Mir133a-2tm1.1Eno
(involves: 129S/SvEv * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:142220
|
| decreased cardiac muscle contractility
|
J:142220
|
| decreased heart ventricle muscle contractility
|
J:142220
|
| dilated cardiomyopathy
|
J:142220
|
| increased cardiomyocyte apoptosis
|
J:142220
|
\Mir133a-1tm1Eno/\Mir133a-1tm1Eno
\Mir133a-2tm1Eno/\Mir133a-2tm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:142220
|
| decreased cardiac muscle contractility
|
J:142220
|
| decreased heart left ventricle muscle contractility
|
J:142220
|
| dilated cardiomyopathy
|
J:142220
|
| increased cardiomyocyte apoptosis
|
J:142220
|
\Mir145atm1Eno/\Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152458
|
| vascular smooth muscle hypotrophy
|
J:152458
|
\Mir206tm1Eno/\Mir206tm1Eno
\Tg(SOD1*G93A)dl1Gur/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
skeletal muscle atrophy
|
J:155806
|
\Mir208atm1.1Eno/\Mir208atm1.1Eno
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:120908
|
| abnormal sarcomere morphology
|
J:120908
|
| decreased cardiac muscle contractility
|
J:120908
|
\Mir208btm1.1Eno/\Mir208btm1.1Eno
\Mir499tm1.1Eno/\Mir499tm1.1Eno
(involves: C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
\Mir214tm1.1Eno/\Mir214tm1.1Eno
(involves: C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:184550
|
| increased myocardial fiber size
|
J:184550
|
\Mir503hgem1Jina/\Mir503hgem1Jina
(C57BL/6J-Mir503hgem1Jina)
|
increased myocardial fiber size
|
J:336590
|
\Mirc6tm1.1Mzhu/\Mirc6+
(B6.129(Cg)-Mirc6tm1.1Mzhu)
|
abnormal muscle fiber morphology
|
J:227271
|
| skeletal muscle hypertrophy
|
J:227271
|
\Mirc32tm1.2Eno/\Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152458
|
| vascular smooth muscle hypotrophy
|
J:152458
|
\Mirc32tm1Gcon/\Mirc32tm1Gcon
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal aorta smooth muscle morphology
|
J:159593
|
| abnormal vascular smooth muscle physiology
|
J:159593
|
\Mirc32tm1Thbr/\Mirc32tm1Thbr
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152702
|
| decreased vasoconstriction
|
J:152702
|
| vascular smooth muscle hypotrophy
|
J:152702
|
\Mkxtm1.1Asah/\Mkxtm1.1Asah
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal tendon morphology
|
J:161299
|
\Mkxtm1.2Jian/\Mkxtm1.2Jian
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal tendon morphology
|
J:175747
|
| abnormal tendon sheath morphology
|
J:175747
|
\Mkxtm1Asah/\Mkxtm1Asah
(involves: C57BL/6 * CBA)
|
abnormal tendon morphology
|
J:161299
|
\Mkxtm1Miu/\Mkxtm1Miu
(involves: 129 * C57BL/6)
|
abnormal tendon morphology
|
J:167977
|
\Mliptm1.1(cre)Dzw/\Mliptm1.1(cre)Dzw
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
| increased myocardial fiber size
|
J:227485
|
\Mliptm1.1(cre)Dzw/\Mliptm1.1(cre)Dzw
\Tg(Myh6-Ppp3ca)37Eno/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:227485
|
\Mlxtm1.2Rne/\Mlxtm1.2Rne
(Not Specified)
|
impaired skeletal muscle regeneration
|
J:227117
|
\Mlxiptm1.2Lchan/\Mlxiptm1.2Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:217834
|
\Mmp2tm1Ito/\Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:109006
|
| decreased cardiac muscle contractility
|
J:148442
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
increased heart ventricle muscle contractility
|
J:104786
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(FVB.129S6(Cg)-Mmp9tm1Tvu/J)
|
increased tibialis anterior weight
|
J:147593
|
\Mmp14tm1Hbh/\Mmp14tm1Hbh
(involves: 129P2/OlaHsd * Black Swiss)
|
skeletal muscle fibrosis
|
J:57969
|
\Mmp14tm1Noda/\Mmp14tm1Noda
\Mmp2tm1Ito/\Mmp2tm1Ito
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:91198
|
| delayed muscle development
|
J:91198
|
| thin diaphragm muscle
|
J:91198
|
\Mmp14tm1Ski/\Mmp14tm1Ski
(B6.Cg-Mmp14tm1Ski)
|
abnormal skeletal muscle fiber morphology
|
J:113113,
J:165029
|
| centrally nucleated skeletal muscle fibers
|
J:113113
|
| increased skeletal muscle fiber size
|
J:113113
|
| skeletal muscle interstitial fibrosis
|
J:113113
|
\Mnx1tm1Tmj/\Mnx1tm1Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
\Mnx1tm2Tmj/\Mnx1tm2Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
\Mnx1tm3Tmj/\Mnx1tm3Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
\Mnx1tm4(cre)Tmj/\Mnx1+
(involves: 129S1/Sv)
|
decreased skeletal muscle fiber size
|
J:193844
|
\Mnx1tm4(cre)Tmj/\Mnx1+
\Tardbptm1.1Ckjs/\Tardbptm1.2Cjks
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:190254
|
| muscular atrophy
|
J:190254
|
\Mocs2tm1(KOMP)Vlcg/\Mocs2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
muscle weakness
|
J:242197
|
\Mogtm1Dpd/\Mogtm1Dpd
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
muscle hypertonia
|
J:151335
|
\Morc2aem1(IMPC)Wtsi/\Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal masticatory muscle morphology
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
| absent digastric muscle
|
J:239583
|
| absent eye muscles
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
\Morc2aem1Snupy/\Morc2a+
(involves: C57BL/6)
|
muscle phenotype
|
J:341847
|
| skeletal muscle atrophy
|
J:341847
|
| skeletal muscle fiber atrophy
|
J:341847
|
\Morf4l1tm1Kto/\Morf4l1tm1Kto
(involves: 129S7/SvEvBrd)
|
myocardial fiber disarray
|
J:97640
|
\Mospd3Gt(PT1-ATG)124Wrst/\Mospd3Gt(PT1-ATG)124Wrst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal ventricle myocardium morphology
|
J:93956
|
| papillary muscle hypoplasia
|
J:93956
|
| trabecula carnea hypoplasia
|
J:93956
|
\Mpotm1Lus/\Mpotm1Lus
(B6.129X1-Mpotm1Lus)
|
abnormal muscle fiber morphology
|
J:112488
|
\Mpp3tm1b(EUCOMM)Wtsi/\Mpp3tm1b(EUCOMM)Wtsi
(C57BL/6N-Mpp3tm1b(EUCOMM)Wtsi/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
\Mpv17/\Mpv17
(CFW-Mpv17/J)
|
abnormal hypodermis muscle layer morphology
|
J:143355
|
| decreased muscle fiber mitochondrial DNA content
|
J:143355
|
\Mpzl3rc/\Mpzl3rc
(C57BL/6J-Mpzl3rc/J)
|
abnormal myocardial fiber morphology
|
J:93038
|
| myocardial fiber degeneration
|
J:93038
|
\Mpzl3tm1Tacz/\Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz)
|
abnormal muscle contractility
|
J:199257
|
| abnormal muscle morphology
|
J:199257
|
| abnormal muscle physiology
|
J:199257
|
\Mregdsu/\Mregdsu
\Myo5ad-l20J/\Myo5ad-l20J
(involves: C57BL/6J)
|
opisthotonus
|
J:20299
|
\Mrgprdtm5Mjz/\Mrgprdtm5Mjz
(B6.129S1-Mrgprdtm5Mjz/Mmnc)
|
abnormal myocardial fiber morphology
|
J:269603
|
| decreased cardiac muscle contractility
|
J:269603
|
| dilated cardiomyopathy
|
J:269603
|
| increased vasodilation
|
J:269603
|
\Mrlnem1Eno/\Mrlnem1Eno
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:217579
|
\Mrlntm1.1Nju/\Mrlntm1.1Nju
(involves: C57BL/6)
|
decreased skeletal muscle fiber number
|
J:243999
|
| impaired skeletal muscle regeneration
|
J:243999
|
\Mrps12em2.2Afi/\Mrps12em2.2Afi
(B6N(Cg)-Mrps12em2.2Afi)
|
decreased cardiac muscle contractility
|
J:284101
|
| dilated cardiomyopathy
|
J:284101
|
\Mrps34m1Anu/\Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu)
|
centrally nucleated skeletal muscle fibers
|
J:222643
|
| increased cardiac muscle contractility
|
J:222643
|
\Mrtfatm1Swm/\Mrtfatm1Swm
(involves: 129/Sv * C57BL/6)
|
abnormal muscle fiber mitochondrial morphology
|
J:111560
|
| myocardium necrosis
|
J:111560
|
\Mrtfbem1Dsr/\Mrtfb+
\Myh7em1Dsr/\Myh7+
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
\Mrtfbem1Dsr/\Mrtfb+
\Myh7em1Dsr/\Myh7+
\Nkx2-5em1Dsr/\Nkx2-5+
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
\MrtfbGt(RRJ478)Byg/\MrtfbGt(RRJ478)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
thin myocardium
|
J:117226
|
\Mrtfbtm1Eno/\Mrtfbtm1Eno
(involves: 129S/SvEv * C57BL/6)
|
thin myocardium
|
J:102475
|
| vascular smooth muscle hypoplasia
|
J:102475
|
\Msctm1Eno/\Msc+
\Tcf21tm2Eno/\Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
muscle phenotype
|
J:111337
|
\Msctm1Eno/\Msctm1Eno
\Tcf21tm2Eno/\Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
abnormal masticatory muscle morphology
|
J:111337
|
| abnormal myogenesis
|
J:111337
|
| abnormal pterygoid muscle morphology
|
J:111337
|
| absent masseter muscle
|
J:111337
|
| absent pterygoid muscle
|
J:111337
|
| absent temporalis muscle
|
J:111337
|
| diaphragmatic hernia
|
J:111337
|
\Msgn1tm1Wb/\Msgn1tm1Wb
(involves: 129S1/Sv * C57BL/6)
|
abnormal myotome development
|
J:66514
|
\Mskt2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:111262
|
\Mskt4C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal tibialis anterior morphology
|
J:111262
|
| increased gastrocnemius weight
|
J:111262
|
\Mskt5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal tibialis anterior morphology
|
J:111262
|
\Mss51tm1(KOMP)Vlcg/\Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal muscle morphology
|
J:280597
|
| increased skeletal muscle glycogen level
|
J:280597
|
\MstnCmpt/\Mstn+
(either: HCI or HCR)
|
abnormal muscle morphology
|
J:43299
|
| increased skeletal muscle mass
|
J:43299
|
\MstnCmpt/\MstnCmpt
(BEH)
|
impaired skeletal muscle contractility
|
J:119757
|
| increased skeletal muscle mass
|
J:119757
|
\Mstnem1(IMPC)Hmgu/\Mstnem1(IMPC)Hmgu
(C57BL/6NCrl-Mstnem1(IMPC)Hmgu/Ieg)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Mstnlean/\Mstnlean
(C57BL/6J-Mstnlean)
|
increased gastrocnemius weight
|
J:146513
|
| increased quadriceps weight
|
J:146513
|
\Mstntm1.1Mgs/\Mstntm1.1Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL * FVB/N)
|
abnormal muscle physiology
|
J:184622
|
| abnormal skeletal muscle morphology
|
J:184622
|
| increased skeletal muscle weight
|
J:184622
|
| skeletal muscle hypertrophy
|
J:184622
|
\Mstntm1.1Swel/\Mstntm1.1Swel
(involves: 129S7/SvEvBrd-Hprt1 * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:106054
|
| increased muscle weight
|
J:106054
|
\Mstntm1Mgs/\Mstntm1Mgs
\Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB)
|
abnormal muscle morphology
|
J:83122
|
| increased muscle weight
|
J:83122
|
| increased skeletal muscle fiber size
|
J:83122
|
| skeletal muscle hypertrophy
|
J:83122
|
\Mstntm1Sjl/\Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle weight
|
J:40054
|
| increased skeletal muscle fiber number
|
J:40054
|
| increased skeletal muscle fiber size
|
J:40054
|
| increased skeletal muscle mass
|
J:40054
|
| increased skeletal muscle size
|
J:75178
|
\Mstntm1Sjl/\Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased quadriceps weight
|
J:105955
|
\Mstntm1Sjl/\Mstntm1Sjl
(B6N.129-Mstntm1Sjl)
|
increased skeletal muscle fiber diameter
|
J:132807
|
| increased skeletal muscle fiber number
|
J:132807
|
| increased skeletal muscle mass
|
J:132807
|
\Mstntm1Sjl/\Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal skeletal muscle fiber morphology
|
J:158173
|
| increased skeletal muscle fiber number
|
J:158173
|
\Mstntm1Swel/\Mstntm1Swel
\Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S7/SvEvBrd-Hprt1 * C57BL/6 * CBA)
|
increased skeletal muscle fiber diameter
|
J:121233
|
| increased skeletal muscle mass
|
J:121233
|
\Mstntm2Sjl/\Mstn+
(B6.129-Mstntm2Sjl)
|
increased skeletal muscle mass
|
J:132807
|
\Mstntm2Sjl/\Mstntm2Sjl
(B6.129-Mstntm2Sjl)
|
increased skeletal muscle fiber diameter
|
J:132807
|
| increased skeletal muscle fiber number
|
J:132807
|
| increased skeletal muscle mass
|
J:132807
|
\Mstntm3.1Sjl/\Mstntm3.1Sjl
(B6N.129S6(FVB)-Mstntm3.1Sjl/Sjl)
|
muscle phenotype
|
J:240862
|
\Mstntm3.1Sjl/\Mstntm3.1Sjl
\Tg(CDX2-cre)101Erf/0
(B6.Cg-Mstntm3.1Sjl Tg(CDX2-cre)101Erf/Sjl)
|
abnormal skeletal muscle morphology
|
J:240862
|
| increased skeletal muscle weight
|
J:240862
|
| skeletal muscle hyperplasia
|
J:240862
|
| skeletal muscle hypertrophy
|
J:240862
|
\Mswtq1NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
decreased muscle weight
|
J:122125
|
\Msx1tm1Bero/\Msx1tm1Bero
\Msx2tm1Bero/\Msx2tm1Yvla
\Taglntm2(cre)Yec/\Tagln+
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
\Msx1tm1Bero/\Msx1tm2.1(cre/ERT2)Bero
\Msx2tm1Yvla/\Msx2tm1Yvla
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
\Msx1tm1Rem/\Msx1tm1Rem
\Msx2tm1Yvla/\Msx2tm1Yvla
\Taglntm2(cre)Yec/\Tagln+
(involves: 129S2/SvPas * 129S6/SvEvTac * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
\mt-Co1m1Jiha
(involves: C57BL/6J * M. m. domesticus)
|
abnormal myocardial fiber morphology
|
J:132659
|
| cardiomyopathy
|
J:132659
|
| myocardial fiber degeneration
|
J:132659
|
| myopathy
|
J:132659
|
\mt-Nd6m1Jbst
\mt-Tam1Jbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
cardiomyopathy
|
J:238994
|
\mt-Rnr2m1Dwa
(C3H/An-mt-Rnr2m1Dwa)
|
abnormal myocardial fiber morphology
|
J:133576
|
| abnormal skeletal muscle fiber morphology
|
J:133576
|
| dilated cardiomyopathy
|
J:133576
|
| myopathy
|
J:133576
|
\mt-Tkm1
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
muscle weakness
|
J:206827
|
\mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal muscle fiber morphology
|
J:344247
|
\Mta1em1(IMPC)Ccpcz/\Mta1+
(C57BL/6NCrl-Mta1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Mtbcq2NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
\Mtbcq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
\Mtbcq7NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
decreased muscle weight
|
J:122125
|
\Mterf2Gt(OST453159)Lex/\Mterf2Gt(OST453159)Lex
(B6.129S5-Mterf2Gt(OST453159)Lex)
|
increased skeletal muscle fiber mitochondrial DNA content
|
J:149828
|
| muscle weakness
|
J:149828
|
\Mterf3tm1.1Lrsn/\Mterf3tm1.1Lrsn
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL)
|
abnormal myocardial fiber morphology
|
J:145125
|
| cardiomyopathy
|
J:145125
|
\Mterf4tm1.1Lrsn/\Mterf4tm1.1Lrsn
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:175816
|
| cardiomyopathy
|
J:175816
|
\Mtfp1tm1.2Wait/\Mtfp1tm1.2Wait
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:330965
|
| dilated cardiomyopathy
|
J:330965
|
| increased cardiomyocyte apoptosis
|
J:330965
|
\Mtg1em1Ywxu/\Mtg1em1Ywxu
(Not Specified)
|
increased cardiac muscle contractility
|
J:271147
|
| increased myocardial fiber number
|
J:271147
|
\Mtgq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
\Mtif3tm1c(EUCOMM)Wtsi/\Mtif3tm1c(EUCOMM)Wtsi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N)
|
cardiomyopathy
|
J:287609
|
| centrally nucleated skeletal muscle fibers
|
J:287609
|
| decreased cardiac muscle contractility
|
J:287609
|
| decreased skeletal muscle fiber size
|
J:287609
|
\Mtlnem1Rlbd/\Mtlnem1Rlbd
(involves: C57BL/6J * SJL/J)
|
abnormal cardiac muscle tissue morphology
|
J:263464
|
\Mtm1Gt(OST290577)Lex/Y
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal Z line morphology
|
J:192845
|
| centrally nucleated skeletal muscle fibers
|
J:192845
|
| decreased muscle weight
|
J:192845
|
| decreased skeletal muscle fiber size
|
J:192845
|
| myopathy
|
J:192845
|
\Mtm1tm1.1Jman/Y
(involves: 129T1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:81791
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:81791
|
| abnormal skeletal muscle fiber morphology
|
J:81791
|
| decreased gastrocnemius weight
|
J:179741
|
| muscular atrophy
|
J:81791
|
| myopathy
|
J:81791
|
| progressive muscle weakness
|
J:81791,
J:179741
|
| skeletal muscle atrophy
|
J:179741
|
\Mtm1tm1.2Jman/Y
\Tg(ACTA1-cre)79Jme/?
(involves: 129T1/Sv * C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:81791
|
| myopathy
|
J:81791
|
| skeletal muscle fiber atrophy
|
J:81791
|
\Mtm1tm1Itl/Y
(B6.Cg-Mtm1tm1Itl)
|
abnormal gastrocnemius morphology
|
J:179741
|
| centrally nucleated skeletal muscle fibers
|
J:179741
|
| decreased gastrocnemius weight
|
J:179741
|
| decreased quadriceps weight
|
J:179741
|
| decreased skeletal muscle fiber size
|
J:179741
|
| decreased skeletal muscle mass
|
J:179741
|
| decreased tibialis anterior weight
|
J:179741
|
| increased variability of skeletal muscle fiber size
|
J:179741
|
| progressive muscle weakness
|
J:179741
|
| skeletal muscle atrophy
|
J:179741
|
\Mtmr14tm1Ckq/\Mtmr14tm1Ckq
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:155068
|
| abnormal muscle contractility
|
J:155068
|
| abnormal muscle physiology
|
J:155068
|
| abnormal muscle relaxation
|
J:155068
|
| dilated sarcoplasmic reticulum
|
J:155068
|
| impaired skeletal muscle contractility
|
J:155068
|
| impaired smooth muscle contractility
|
J:267733
|
| increased muscle fatigability
|
J:155068
|
| muscular atrophy
|
J:155068
|
\Mto1Gt(G019A03)Wrst/\Mto1Gt(G019A03)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
cardiac muscle necrosis
|
J:223246
|
| cardiomyopathy
|
J:223246
|
| decreased myocardial fiber mitochondrial DNA content
|
J:223246
|
| dilated sarcoplasmic reticulum
|
J:223246
|
| myocardial fiber degeneration
|
J:223246
|
\Mtortm1.1Clyn/\Mtor+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle physiology
|
J:162945
|
| decreased skeletal muscle weight
|
J:162945
|
\Mtortm1.1Gcon/\Mtortm1.1Gcon
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:163763
|
| abnormal sarcomere morphology
|
J:163763
|
| decreased cardiac muscle contractility
|
J:163763
|
| decreased heart ventricle muscle contractility
|
J:163763
|
| decreased myocardial fiber size
|
J:163763
|
| dilated cardiomyopathy
|
J:163763
|
| increased cardiomyocyte apoptosis
|
J:163763
|
\Mtortm1.2Koz/\Mtortm1.2Koz
\Tg(ACTA1-cre)79Jme/?
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
abnormal diaphragm morphology
|
J:162918
|
| abnormal gastrocnemius morphology
|
J:162918
|
| abnormal limb muscle morphology
|
J:162918
|
| abnormal muscle contractility
|
J:162918
|
| abnormal muscle morphology
|
J:162918
|
| abnormal muscle physiology
|
J:162918
|
| abnormal muscle relaxation
|
J:162918
|
| abnormal skeletal muscle fiber morphology
|
J:162918
|
| abnormal soleus morphology
|
J:162918
|
| abnormal tibialis anterior morphology
|
J:162918
|
| centrally nucleated skeletal muscle fibers
|
J:162918
|
| increased muscle fatigability
|
J:162918
|
| increased skeletal muscle glycogen level
|
J:162918
|
| skeletal muscle degeneration
|
J:162918
|
| skeletal muscle fiber degeneration
|
J:162918
|
\Mus81tm1Esse/\Mus81tm1Esse
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:133703
|
\Musktm1.1Vwi/\Musktm2Vwi
(Not Specified)
|
abnormal muscle electrophysiology
|
J:141024
|
| decreased skeletal muscle mass
|
J:141024
|
| muscle weakness
|
J:141024
|
| thin diaphragm muscle
|
J:141024
|
\Musktm1.2Ics/\Musktm1.2Ics
(involves: BALB/cN * C57BL/6NTac)
|
increased muscle fatigability
|
J:221340
|
| progressive muscle weakness
|
J:221340
|
\Musktm1Vwi/\Musktm1.1Vwi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
\Musktm1Vwi/\Musktm1Vwi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
\Musktm2Vwi/\Musktm2Vwi
(Not Specified)
|
muscle phenotype
|
J:141024
|
\Mustn1tm1d(EUCOMM)Wtsi/\Mustn1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * SJL)
|
skeletal muscle fibrosis
|
J:346460
|
\Musz2MRL/MpJ/\Musz2MRL/MpJ
\Musz3SJL/J/\Musz3SJL/J
(involves: MRL/MpJ * SJL/J)
|
abnormal muscle morphology
|
J:81605
|
\Musz2SJL/J/\Musz2SJL/J
\Musz3SJL/J/\Musz3SJL/J
(involves: MRL/MpJ * SJL/J)
|
abnormal muscle morphology
|
J:81605
|
\Mwq1DBA/2J/\Mwq1DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq1DU6i/\Mwq1DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq2DBA/2J/\Mwq2DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq2DU6i/\Mwq2DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq3DBA/2J/\Mwq3DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq3DU6i/\Mwq3DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq4DBA/2J/\Mwq4DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq4DU6i/\Mwq4DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq5DBA/2J/\Mwq5DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mwq5DU6i/\Mwq5DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
\Mybpc1em1Lbmc/\Mybpc1+
(C57BL/6NTac-Mybpc1em1Lbmc/Lmcb)
|
abnormal sarcomere morphology
|
J:322115
|
| decreased skeletal muscle mass
|
J:322115
|
\Mybpc2tm1Ssad/\Mybpc2tm1Ssad
(involves: C57BL/6 * FVB/N)
|
abnormal extensor digitorum longus morphology
|
J:309473
|
| abnormal muscle contractility
|
J:309473
|
| abnormal muscle physiology
|
J:309473
|
| abnormal skeletal muscle fiber morphology
|
J:309473
|
| centrally nucleated skeletal muscle fibers
|
J:309473
|
| hypotonia
|
J:309473
|
| impaired muscle relaxation
|
J:309473
|
| impaired skeletal muscle contractility
|
J:309473
|
| muscle weakness
|
J:309473
|
\Mybpc3DBA/2J/\Mybpc3DBA/2J
\Myh7DBA/2J/\Myh7DBA/2J
(DBA/2J)
|
increased myocardial fiber size
|
J:225492
|
\Mybpc3tm1.1Jse/\Mybpc3tm1.1Jse
(Not Specified)
|
abnormal M line morphology
|
J:58295
|
| abnormal myocardial fiber morphology
|
J:58295
|
| abnormal ventricle papillary muscle morphology
|
J:58295
|
| decreased heart ventricle muscle contractility
|
J:58295
|
| dilated cardiomyopathy
|
J:58295
|
| disorganized myocardium
|
J:58295
|
| heart left ventricle hypertrophy
|
J:58295
|
\Mybpc3tm1Jse/\Mybpc3tm1Jse
(Not Specified)
|
abnormal M line morphology
|
J:58295
|
| abnormal myocardial fiber morphology
|
J:58295
|
| abnormal ventricle papillary muscle morphology
|
J:58295
|
| decreased heart left ventricle muscle contractility
|
J:58295
|
| dilated cardiomyopathy
|
J:58295
|
| heart left ventricle hypertrophy
|
J:58295
|
| myocardial fiber disarray
|
J:58295
|
\Mybpc3tm1Jse/\Mybpc3tm1Jse
(involves: 129S/SvEv)
|
abnormal cardiac muscle contractility
|
J:98868
|
| abnormal cardiac muscle relaxation
|
J:98868
|
| dilated cardiomyopathy
|
J:98868
|
| increased cardiac muscle contractility
|
J:98868
|
\Mybpc3tm1Lcrr/\Mybpc3+
(involves: 129S4/SvJae * Black Swiss)
|
heart left ventricle hypertrophy
|
J:101903
|
\Mybpc3tm1Lcrr/\Mybpc3tm1Lcrr
(involves: 129S4/SvJae * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:105732
|
| decreased cardiac muscle contractility
|
J:101903
|
| heart left ventricle hypertrophy
|
J:101903
|
| impaired muscle relaxation
|
J:101903
|
\Mybpc3tm1Rmos/\Mybpc3tm1Rmos
(either: (involves: 129) or (involves: 129 * C57BL/6))
|
cardiomyopathy
|
J:95725
|
| decreased cardiac muscle contractility
|
J:95725
|
| decreased heart left ventricle muscle contractility
|
J:95725
|
| myocardial fiber disarray
|
J:95725
|
\Mybpc3tm1Rmos/\Mybpc3tm1Rmos
(involves: 129)
|
decreased heart ventricle muscle contractility
|
J:202199
|
\Mybpc3tm2.1Lcrr/\Mybpc3+
(involves: 129S2/SvPasCrl * Black Swiss * C57BL/6 * CD-1 * DBA/2)
|
increased myocardial fiber size
|
J:164934
|
\Mybpc3tm2.1Lcrr/\Mybpc3+
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
\Mybpc3tm2.1Lcrr/\Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss * C57BL/6 * CD-1 * DBA/2)
|
decreased cardiac muscle contractility
|
J:164934
|
| heart left ventricle hypertrophy
|
J:164934
|
| increased myocardial fiber size
|
J:164934
|
\Mybpc3tm2.1Lcrr/\Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
| decreased cardiac muscle contractility
|
J:185726
|
| heart left ventricle hypertrophy
|
J:185726
|
\Mybpc3tm2.1Rmos/\Mybpc3tm2.1Rmos
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:202199
|
| increased myocardial fiber size
|
J:202199
|
| myocardial fiber disarray
|
J:202199
|
\Mybphltm1a(KOMP)Wtsi/\Mybphltm1a(KOMP)Wtsi
(C57BL/6N-Mybphltm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Mybphltm1b(KOMP)Wtsi/\Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
\Myctm1.1(Nmyc1)Fwa/\Myctm1.1(Nmyc1)Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:62573
|
\Mycbp2tm1.1Adia/\Mycbp2tm1.1Adia
(involves: C57BL/6 * FVB/N)
|
abnormal diaphragm morphology
|
J:125702
|
\Mycntm1Fwa/\Mycntm1Fwa
(involves: 129S/SvEv * MF1)
|
trabecula carnea hypoplasia
|
J:3413
|
\Mycntm1Jrt/\Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:15281
|
| thin myocardium
|
J:15281
|
| thin myocardium compact layer
|
J:15281
|
\Mycntm1Knd/\Mycntm1Knd
(involves: 129P2/OlaHsd * BALB/c)
|
thin myocardium
|
J:11859
|
| trabecula carnea hypoplasia
|
J:11859
|
\Mycntm1Nagy/\Mycntm2.1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:67930
|
\Mycntm1Par/\Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
thin myocardium
|
J:3432
|
\Myf5tm1(cre)Mrc/\Myf5+
\Myod1tm1Jae/\Myod1tm1Jae
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased satellite cell number
|
J:202693
|
\Myf5tm1Jae/\Myf5+
\Myf6tm1Eno/\Myf6+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal myotome development
|
J:42453
|
\Myf5tm1Jae/\Myf5+
\Myf6tm1Wb/\Myf6+
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal myotome development
|
J:42453
|
\Myf5tm1Jae/\Myf5tm1Jae
(involves: 129S4/SvJae)
|
absent myotome
|
J:42453
|
\Myf5tm1Jae/\Myf5tm1Jae
(either: 129-Myf5tm1Jae or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal muscle morphology
|
J:3013
|
| abnormal myotome development
|
J:3013
|
\Myf5tm1Jae/\Myf5tm1Jae
\Myod1tm1.1Glh/\Myod1+
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
\Myf5tm1Jae/\Myf5tm1Jae
\Myod1tm1.1Glh/\Myod1tm1.1Glh
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
\Myf5tm1Pas/\Myf5tm1Pas
(Not Specified)
|
abnormal eye muscle development
|
J:150130
|
| absent extraocular muscles
|
J:150130
|
\Myf5tm1Pas/\Myf5tm1Pas
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
\Myf5tm1Pas/\Myf5tm1Pas
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
\Myf5tm1Tajb/\Myf5tm1Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
\Myf5tm1Tajb/\Myf5tm1Tajb
(involves: 129S2/SvPas)
|
abnormal eye muscle development
|
J:150130
|
\Myf5tm1Tajb/\Myf5tm1Tajb
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
\Myf5tm1Tajb/\Myf5tm1Tajb
\Pax7tm1.1Tajb/\Pax7tm1.1Tajb
(involves: 129S2/SvPas)
|
abnormal extraocular muscle morphology
|
J:150130
|
| muscle phenotype
|
J:150130
|
\Myf5tm2(Myog)Jae/\Myf5tm2(Myog)Jae
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myotome development
|
J:65301
|
\Myf5tm2(Pdgfa)Sor/\Myf5tm2(Pdgfa)Sor
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myotome development
|
J:65301
|
\Myf5tm2Pas/\Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:128921
|
\Myf5tm2Tajb/\Myf5+
\Tbx1tm1Pa/\Tbx1tm1Pa
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal pharyngeal muscle morphology
|
J:150130
|
\Myf5tm2Tajb/\Myf5tm2Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
\Myf5tm2Tajb/\Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal eye muscle development
|
J:150130
|
| abnormal muscle regeneration
|
J:128921
|
| abnormal skeletal muscle morphology
|
J:128921
|
| abnormal skeletal muscle satellite cell proliferation
|
J:128921
|
| centrally nucleated skeletal muscle fibers
|
J:128921
|
| increased skeletal muscle fiber diameter
|
J:128921
|
| increased variability of skeletal muscle fiber size
|
J:128921
|
| muscle phenotype
|
J:168843
|
| skeletal muscle fibrosis
|
J:128921
|
\Myf5tm2Tajb/\Myf5tm2Tajb
\Myf6tm1Tajb/\Myf6+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal muscle development
|
J:92799
|
\Myf5tm2Tajb/\Myf5tm2Tajb
\Myf6tm1Tajb/\Myf6tm1Tajb
(involves: 129S2/SvPas)
|
abnormal extraocular muscle morphology
|
J:150130
|
| abnormal eye muscle development
|
J:150130
|
\Myf5tm2Tajb/\Myf5tm2Tajb
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
\Myf5tm2Tajb/\Myf5tm2Tajb
\Tbx1tm1Pa/\Tbx1tm1Pa
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal pharyngeal muscle morphology
|
J:150130
|
\Myf5tm3(cre)Sor/\Myf5+
\Sik1tm1.1Berd/\Sik1tm1.1Berd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased skeletal muscle cell glucose uptake
|
J:236223
|
| muscle phenotype
|
J:236223
|
\Myf5tm3(cre)Sor/\Myf5+
\Spin1tm1.1Rosc/\Spin1tm1.1Rosc
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NTac)
|
abnormal diaphragm morphology
|
J:302851
|
| abnormal M line morphology
|
J:302851
|
| abnormal myogenesis
|
J:302851
|
| abnormal skeletal muscle fiber morphology
|
J:302851
|
| abnormal skeletal muscle fiber type ratio
|
J:302851
|
| abnormal skeletal muscle morphology
|
J:302851
|
| abnormal soleus morphology
|
J:302851
|
| abnormal tibialis anterior morphology
|
J:302851
|
| decreased skeletal muscle fiber number
|
J:302851
|
| decreased skeletal muscle mass
|
J:302851
|
| increased skeletal muscle fiber size
|
J:302851
|
| skeletal muscle degeneration
|
J:302851
|
| skeletal muscle fiber degeneration
|
J:302851
|
| skeletal muscle fiber necrosis
|
J:302851
|
| skeletal muscle fibrosis
|
J:302851
|
\Myf5tm3(cre)Sor/\Myf5+
\Styxl2tm1Nju/\Styxl2tm1Nju
(involves: 129S4/SvJaeSor)
|
abnormal sarcomere morphology
|
J:351096
|
\Myf5tm3(cre)Sor/\Myf5+
\Tg(CAG-Nog)1Ych/0
(involves: 129S4/SvJaeSor)
|
abnormal levator veli palatini muscle morphology
|
J:310908
|
| abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal soft palate muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| abnormal tensor veli palatini muscle morphology
|
J:310908
|
\Myf5tm3(cre)Sor/\Myf5tm3(cre)Sor
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myogenesis
|
J:65301
|
| abnormal myotube morphology
|
J:65301
|
\Myf5tm3.1Thbr/\Myf5tm3.1Thbr
(Not Specified)
|
abnormal myotome development
|
J:63517
|
\Myf5tm4(Myod1)Sor/\Myf5tm4(Myod1)Sor
(involves: 129S4/SvJae * C57BL/6J)
|
muscle phenotype
|
J:65301
|
\Myf6tm1(cre)Mrc/\Myf6+
\Pax3tm1Mrc/\Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
\Myf6tm1(cre)Mrc/\Myf6+
\Pax3tm1Mrc/\Pax3tm1Mrc
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
\Myf6tm1(cre)Mrc/\Myf6+
\Pax3tm1Mrc/\Pax3tm1Mrc
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
\Myf6tm1Eno/\Myf6tm1Eno
(involves: 129S7/SvEvBrd)
|
abnormal extraocular muscle morphology
|
J:150130
|
| abnormal myotome development
|
J:42453
|
| muscle phenotype
|
J:26105
|
\Myf6tm1Eno/\Myf6tm1Eno
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
absent skeletal muscle
|
J:48809
|
| centrally nucleated skeletal muscle fibers
|
J:48809
|
| decreased skeletal muscle fiber number
|
J:48809
|
\Myf6tm1Eno/\Myf6tm1Eno
\Myod1tm1Jae/\Myod1tm1Jae
\Myogtm1Whk/\Myog+
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal myogenesis
|
J:48809
|
\Myf6tm1Eno/\Myf6tm1Eno
\Myod1tm1Jae/\Myod1tm1Jae
\Myogtm1Whk/\Myogtm1Whk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle development
|
J:61155
|
| muscle hypoplasia
|
J:61155
|
\Myf6tm1Eno/\Myf6tm1Eno
\Myogtm1Whk/\Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:48809
|
| muscle hypoplasia
|
J:48809
|
\Myf6tm1Thbr/\Myf6tm1Thbr
(either: (involves: 129S4/SvJae-Myf6tm1Thbr) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal muscle morphology
|
J:24360
|
\Myf6tm1Wb/\Myf6tm1Wb
(involves: 129S1/Sv * C57BL/6)
|
abnormal intercostal muscle morphology
|
J:29279
|
| abnormal myotome development
|
J:29279
|
| abnormal myotome morphology
|
J:29279
|
\Myh1tm1Lnwd/\Myh1tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:48228
|
| abnormal skeletal muscle morphology
|
J:44448,
J:78284
|
| decreased skeletal muscle mass
|
J:44448
|
| impaired skeletal muscle contractility
|
J:44448
|
| muscle weakness
|
J:44448
|
\Myh3tm1.2Sajm/\Myh3tm1.1Sajm
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
\Myh3tm1.2Sajm/\Myh3tm1.1Sajm
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
\Myh3tm1.2Sajm/\Myh3tm1.2Sajm
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
| abnormal skeletal muscle fiber type ratio
|
J:287755
|
| decreased skeletal muscle fiber diameter
|
J:287755
|
| decreased skeletal muscle weight
|
J:287755
|
| increased myoblast apoptosis
|
J:287755
|
| increased skeletal muscle fiber number
|
J:287755
|
\Myh4arl/\Myh4arl
(involves: C3H/HeH * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:181892
|
| centrally nucleated skeletal muscle fibers
|
J:181892
|
| increased variability of skeletal muscle fiber size
|
J:181892
|
| muscular atrophy
|
J:181892
|
| myositis
|
J:181892
|
| skeletal muscle fiber degeneration
|
J:181892
|
\Myh4tm1Lnwd/\Myh4tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:78886
|
| abnormal skeletal muscle fiber type ratio
|
J:78886
|
| abnormal skeletal muscle morphology
|
J:44448
|
| decreased skeletal muscle fiber number
|
J:78886
|
| decreased skeletal muscle mass
|
J:78886,
J:44448,
J:78284
|
| impaired skeletal muscle contractility
|
J:44448
|
| increased skeletal muscle fiber size
|
J:78886,
J:44448
|
| muscle weakness
|
J:44448
|
| skeletal muscle fiber atrophy
|
J:78886
|
\Myh6em1(MYH7*R403Q)Eno/\Myh6+
(involves: C57BL/6)
|
cardiomyopathy
|
J:362301
|
| myocardial fiber disarray
|
J:362301
|
\Myh6tm1.1Jpsc/\Myh6tm2Jse
(involves: 129)
|
abnormal cardiac muscle relaxation
|
J:247162
|
| decreased heart ventricle muscle contractility
|
J:247162
|
| increased myocardial fiber size
|
J:247162
|
| myocardium hypertrophy
|
J:247162
|
\Myh6tm1Ces/\Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:114549
|
| decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
\Myh6tm1Ces/\Myh6tm1Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
\Myh6tm1Jse/\Myh6+
(involves: 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:32960
|
| myocardial fiber disarray
|
J:32960,
J:95600
|
\Myh6tm1Jse/\Myh6+
(129S.129X1-Myh6tm1Jse)
|
increased heart left ventricle muscle contractility
|
J:104363
|
| myocardial fiber disarray
|
J:104363
|
\Myh6tm1Jse/\Myh6+
\Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle tissue morphology
|
J:153302
|
| abnormal myocardial fiber morphology
|
J:153302
|
| cardiac muscle necrosis
|
J:153302
|
| decreased cardiac muscle contractility
|
J:153302
|
| dilated cardiomyopathy
|
J:153302
|
| increased myocardial fiber size
|
J:153302
|
| myocardial fiber degeneration
|
J:153302
|
\Myh6tm1Jse/\Myh6+
\Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
\Tg(Myh6-tTA)55Rbns/0
(involves: 129X1/SvJ * FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
\Myh6tm1Jse/\Myh6tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:51939
|
| decreased heart ventricle muscle contractility
|
J:51939
|
| dilated cardiomyopathy
|
J:51939
|
| disorganized myocardium
|
J:51939
|
| myocardial fiber disarray
|
J:51939
|
| myocardium necrosis
|
J:51939
|
\Myh6tm1Rbns/\Myh6+
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:36089
|
| abnormal myocardium layer morphology
|
J:36089
|
| decreased cardiac muscle contractility
|
J:36089
|
\Myh6tm2Ces/\Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
\Myh6tm2Ces/\Myh6tm2Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
\Myh6tm2Jse/\Myh6+
(involves: 129S1/Sv)
|
myocardial fiber disarray
|
J:95600
|
\Myh6tm2Jse/\Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
\Myh6tm2Jse/\Myh6tm2Jse
(involves: 129)
|
calcified myocardium
|
J:247162
|
| increased cardiomyocyte apoptosis
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
\Myh6tm3.1Jse/\Myh6+
(involves: 129X1/SvJ)
|
cardiomyopathy
|
J:165269
|
| heart left ventricle hypertrophy
|
J:165269
|
\Myh6tm3.1Jse/\Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
\Myh6tm3.1Jse/\Myh6tm3.1Jse
(involves: 129)
|
calcified myocardium
|
J:247162
|
| increased cardiomyocyte apoptosis
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
\Myh10b2b2437Clo/\Myh10b2b2437Clo
(C57BL/6J-Myh10b2b2437Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\Myh10ehc/\Myh10ehc
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:248868
|
| abnormal ventricle myocardium morphology
|
J:248868
|
| myocardial trabeculae hypoplasia
|
J:248868
|
\Myh10ehc/\Myh10tm2Rsad
(involves: 129S4/SvJae * 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:248868
|
\Myh10tm2Rsad/\Myh10tm2Rsad
(involves: 129S4/SvJae)
|
abnormal myocardium compact layer morphology
|
J:248868
|
| decreased fetal cardiomyocyte proliferation
|
J:92230
|
| increased fetal cardiomyocyte apoptosis
|
J:248868
|
\Myh10tm2Rsad/\Myh10tm2Rsad
\Myh14tm1Rsad/\Myh14tm1Rsad
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
\Myh10tm3.1Rsad/\Myh10+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal diaphragm development
|
J:245570
|
| diaphragmatic hernia
|
J:245570
|
| thin diaphragm muscle
|
J:245570
|
\Myh10tm3.1Rsad/\Myh10tm3.1Rsad
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal diaphragm development
|
J:245570
|
| decreased cardiac muscle contractility
|
J:245570
|
| diaphragmatic hernia
|
J:245570
|
\Myh10tm4Rsad/\Myh10tm4Rsad
\Myh14tm1Rsad/\Myh14tm1Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
\Myh10tm6(Myh9/GFP)Rsad/\Myh10tm6(Myh9/GFP)Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124610
|
| dilated cardiomyopathy
|
J:124610
|
| increased myocardial fiber size
|
J:124610
|
\Myh10tm7Rsad/\Myh10tm7Rsad
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:170148
|
| cardiomyopathy
|
J:170148
|
| decreased cardiac muscle contractility
|
J:170148
|
| increased cardiomyocyte apoptosis
|
J:170148
|
| increased myocardial fiber size
|
J:170148
|
\Myh11tm1.1Dmmz/\Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:212664
|
| decreased vasoconstriction
|
J:212664
|
| increased vascular smooth muscle cell proliferation
|
J:212664
|
\Myh11tm1Bdr/\Myh11tm1Bdr
(Not Specified)
|
dilated cardiomyopathy
|
J:82859
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:82859
|
| intestinal hypoperistalsis
|
J:82859
|
\Myh11tm1Peri/\Myh11+
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
\Myh11tm1Peri/\Myh11tm1Peri
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
\Myh11tm2Peri/\Myh11tm2Peri
(involves: 129 * C57BL/6)
|
abnormal muscle contractility
|
J:142230
|
| abnormal sarcomere morphology
|
J:142230
|
\Myhastm1Bcgen/\Myhastm1Bcgen
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
decreased extensor digitorum longus weight
|
J:240240
|
| decreased gastrocnemius weight
|
J:240240
|
| decreased skeletal muscle fiber diameter
|
J:240240
|
| decreased tibialis anterior weight
|
J:240240
|
| muscle weakness
|
J:240240
|
| skeletal muscle atrophy
|
J:240240
|
\Myl1tm1(cre)Sjb/0
\Ndufab1tm1Xiwa/\Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:293657
|
| muscle phenotype
|
J:293657
|
\Myl1tm1(cre)Sjb/\Myl1+
\Shc1tm3Paw/\Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
\Myl1tm1(cre)Sjb/\Myl1+
\Shc1tm4Paw/\Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
\Myl1tm1(cre)Sjb/\Myl1+
\Shc1tm7Paw/\Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
\Myl1tm1(cre)Sjb/\Myl1+
\Shc1tm9Paw/\Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
\Myl1tm1(cre)Sjb/\Myl1+
\Smarcd3tm1Jddl/\Smarcd3tm1Jddl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:256788
|
\Myl1tm1(cre)Sjb/\Myl1+
\Tfamtm1Lrsn/\Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle contractility
|
J:81561
|
| increased skeletal muscle fiber size
|
J:81561
|
\Myl2tm1(cre)Krc/\Myl2+
\Nkx2-5tm1Krc/\Nkx2-5tm1Krc
(either: (involves: 129/Sv * Black Swiss) or (involves: 129/Sv * C57BL/6))
|
abnormal atrioventricular bundle morphology
|
J:89404
|
| abnormal impulse conducting system morphology
|
J:89404
|
| abnormal myocardial fiber morphology
|
J:89404
|
| atrioventricular node hypoplasia
|
J:89404
|
| dilated cardiomyopathy
|
J:89404
|
| myocardial ventricular hypertrabeculation
|
J:89404
|
\Myl2tm1(cre)Krc/\Myl2+
\Ptk2tm1.1Guan/\Ptk2tm1.1Guan
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:105371
|
| abnormal myocardium layer morphology
|
J:105371
|
| disorganized myocardium
|
J:105371
|
\Myl2tm1(cre)Krc/\Myl2+
\Slc8a1tm1Kdp/\Slc8a1tm1Kdp
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:101484
|
\Myl2tm1(cre)Krc/\Myl2+
\Srsf1tm1Xdfu/\Srsf1tm1Xdfu
(involves: 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:96039
|
| abnormal myocardial fiber morphology
|
J:96039
|
| dilated cardiomyopathy
|
J:96039
|
\Myl2tm1(cre)Krc/\Myl2+
\Srsf2tm1Xdfu/\Srsf2tm1Xdfu
(involves: 129S4/SvJae)
|
decreased heart left ventricle muscle contractility
|
J:88432
|
| decreased heart ventricle muscle contractility
|
J:88432
|
| dilated cardiomyopathy
|
J:88432
|
\Myl2tm1(cre)Krc/\Myl2+
\Tsc1tm1Djk/\Tsc1tm1Djk
(involves: 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:96138
|
| decreased cardiac muscle contractility
|
J:96138
|
| dilated cardiomyopathy
|
J:96138
|
| increased myocardial fiber size
|
J:96138
|
\Myl2tm1(cre)Krc/\Myl2+
\Txnrd2tm1Marc/\Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:94136
|
\Myl2tm1(cre)Krc/\Myl2+
\Vcltm1Ross/\Vcltm1Ross
(involves: 129S4/SvJae * Black Swiss * C57BL/6 * SJL)
|
abnormal cardiac muscle relaxation
|
J:129075
|
| abnormal intercalated disk morphology
|
J:129075
|
| abnormal myocardial fiber morphology
|
J:129075
|
| decreased cardiac muscle contractility
|
J:129075
|
| dilated cardiomyopathy
|
J:129075
|
\Myl2tm1(Hand1)Tana/\Myl2+
(involves: 129X1/SvJ * C57BL/6J)
|
thin myocardium compact layer
|
J:91082
|
\Myl2tm2.1Chen/\Myl2tm2.1Chen
(B6.129-Myl2tm2.1Chen)
|
abnormal Z line morphology
|
J:184548
|
| decreased heart ventricle muscle contractility
|
J:184548
|
| dilated cardiomyopathy
|
J:184548
|
| increased myocardial fiber size
|
J:184548
|
\Myl7tm1(cre)Krc/\Myl7+
\Prkg1tm2Naw/\Prkg1tm2Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
\Myl7tm1(cre)Krc/\Myl7tm1(cre)Krc
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:87043
|
| trabecula carnea hypoplasia
|
J:87043
|
| ventricle myocardium hypoplasia
|
J:87043
|
\Myl9tm1Mzhu/\Myl9tm1Mzhu
\Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA)
|
abnormal aorta smooth muscle morphology
|
J:308237
|
| abnormal intestinal peristalsis
|
J:308237
|
| abnormal vascular smooth muscle physiology
|
J:308237
|
| impaired contractility of jejunal smooth muscle
|
J:308237
|
| impaired smooth muscle contractility
|
J:308237
|
\Mylk2tm1Jtst/\Mylk2tm1Jtst
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired skeletal muscle contractility
|
J:104384
|
\Mylk3tm1.1Hkas/\Mylk3tm1.1Hkas
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:210147
|
| increased myocardial fiber size
|
J:210147
|
\Mylk3tm1Jtst/\Mylk3+
(involves: 129S/SvEv * C57BL/6)
|
cardiac muscle necrosis
|
J:167590
|
| decreased cardiac muscle contractility
|
J:167590
|
| increased myocardial fiber size
|
J:167590
|
\Mylk3tm1Jtst/\Mylk3tm1Jtst
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:167590
|
| heart left ventricle hypertrophy
|
J:167590
|
| heart right ventricle hypertrophy
|
J:167590
|
| increased myocardial fiber size
|
J:167590
|
\Mylk4em1Yima/\Mylk4em1Yima
(Not Specified)
|
abnormal muscle physiology
|
J:316008
|
\Mylk4em2Yima/\Mylk4em2Yima
(Not Specified)
|
abnormal muscle physiology
|
J:316008
|
\Mylktm1.1Bph/\Mylktm1.1Bph
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
\Mylktm1.1Bph/\Mylktm1.2Bph
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
\Mylktm1Avs/\Mylktm1Avs
(B6.129-Mylktm1Avs)
|
abnormal muscle contractility
|
J:106058
|
| abnormal muscle relaxation
|
J:106058
|
\Mylktm1Mzhu/\Mylktm1Mzhu
\Taglntm1(cre/ERT2)Feil/?
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:141907
|
| abnormal intestinal smooth muscle morphology
|
J:141907
|
\Mylpftm1Jdp/\Mylpftm1Jdp
(involves: 129S6/SvEvTac * C57BL/6)
|
absent skeletal muscle
|
J:131461
|
\Mymktm1e(KOMP)Wtsi/\Mymktm1e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
abnormal muscle development
|
J:200444
|
| abnormal myoblast differentiation
|
J:200444
|
| abnormal myoblast fusion
|
J:200444
|
\Mymxem1Shcs/\Mymxem1Shcs
(involves: C57BL/6J)
|
abnormal intercostal muscle morphology
|
J:241564
|
| abnormal limb muscle morphology
|
J:241564
|
| abnormal muscle morphology
|
J:241564
|
| abnormal myoblast fusion
|
J:241564
|
| abnormal skeletal muscle morphology
|
J:241564
|
| muscle weakness
|
J:241564
|
\Myo1eGt(ROSA)74Sor/\Myo1eGt(ROSA)74Sor
\Pdgfrbtm1Sor/\Pdgfrb+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal smooth muscle morphology
|
J:117491
|
\Myo5ad-15H/\Myo5ad-15H
(Not Specified)
|
opisthotonus
|
J:13409
|
\Myo5ad-50H/\Myo5ad-50H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-51H/\Myo5ad-51H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-53H/\Myo5ad-53H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-80H/\Myo5ad-80H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-82H/\Myo5ad-82H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-83H/\Myo5ad-83H
(involves: C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-84H/\Myo5ad-84H
(involves: 101/H)
|
opisthotonus
|
J:178968
|
\Myo5ad-85H/\Myo5ad-85H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:169366
|
\Myo5ad-86H/\Myo5ad-86H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-86H/\Myo5ad-97H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
\Myo5ad-90H/\Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
\Myo5ad-93H/\Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
\Myo5ad-l20J/\Myo5ad-l20J
(involves: C57BL/6J * DBA/2J)
|
opisthotonus
|
J:20299
|
\Myo5ad-l32J/\Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ)
|
opisthotonus
|
J:169210
|
\Myo5ad-l34J/\Myo5ad-l34J
(BALB/cJ-Myo5ad-l34J/GrsrJ)
|
opisthotonus
|
J:216055
|
\Myo5ad-l/\d-100H
(involves: C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:181531
|
\Myo5ad-l/\Myo5ad-l
(involves: C57BL)
|
opisthotonus
|
J:12978
|
\Myo5ad-n2Btlr/\Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr)
|
myoclonus
|
J:133120
|
| opisthotonus
|
J:133120
|
\Myo5ad-n3Btlr/\Myo5ad-n3Btlr
(C57BL/6J-Myo5ad-n3Btlr)
|
opisthotonus
|
J:201726
|
\Myo5ad-nBtlr/\Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr)
|
myoclonus
|
J:133119
|
| opisthotonus
|
J:133119
|
\Myo6chl/\Myo6chl
(involves: C57BL/6JAnu)
|
cardiomyopathy
|
J:196601
|
\Myo18atm1b(KOMP)Wtsi/\Myo18atm1b(KOMP)Wtsi
(C57BL/6N-Myo18atm1b(KOMP)Wtsi)
|
abnormal A band morphology
|
J:277320
|
| abnormal muscle fiber morphology
|
J:277320
|
| abnormal sarcomere morphology
|
J:277320
|
\Myo18btm1Jyo/\Myo18btm1Jyo
(involves: C57BL/6J)
|
abnormal myocardium layer morphology
|
J:142442
|
\Myocdem1Blk/\Myocdtm1.1Msp
(involves: 129)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:283803
|
\Myocdtm1Eno/\Myocdtm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:84789
|
\Myocdtm1Msp/\Myocdtm1Msp
(involves: 129)
|
abnormal myocardial fiber morphology
|
J:154666
|
| increased cardiomyocyte apoptosis
|
J:154666
|
\Myocdtm1Msp/\Myocdtm1Msp
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129/Sv * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:154666
|
| abnormal myocardial fiber morphology
|
J:154666
|
| abnormal sarcomere morphology
|
J:154666
|
| decreased cardiac muscle contractility
|
J:154666
|
| dilated cardiomyopathy
|
J:154666
|
| increased cardiomyocyte apoptosis
|
J:154666
|
| myocardial fiber degeneration
|
J:154666
|
| myocardial fiber disarray
|
J:154666
|
\Myocdtm1Msp/\Myocdtm1Msp
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal vascular smooth muscle morphology
|
J:131288
|
\Myocdtm1Msp/\Myocdtm1Msp
\Tg(Myh6-cre)2182Mds/0
(involves: 129/Sv * FVB/N)
|
abnormal intercalated disk morphology
|
J:154666
|
| abnormal myocardial fiber morphology
|
J:154666
|
| abnormal sarcomere morphology
|
J:154666
|
| decreased cardiac muscle contractility
|
J:154666
|
| dilated cardiomyopathy
|
J:154666
|
| myocardial fiber degeneration
|
J:154666
|
\Myod1tm1.1Glh/\Myod1tm1.1Glh
(involves: 129 * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
\Myod1tm1Ahb/\Myod1tm1Ahb
(Not Specified)
|
abnormal muscle morphology
|
J:116060
|
| abnormal muscle physiology
|
J:116060
|
| delayed skeletal muscle regeneration
|
J:116060
|
\Myod1tm1Jae/\Myod1tm1Jae
(involves: 129S4/SvJae)
|
abnormal myogenesis
|
J:168843
|
| increased satellite cell number
|
J:128921
|
\Myoftm1Mcn/\Myoftm1Mcn
(involves: 129X1/SvJ)
|
abnormal myogenesis
|
J:163585
|
| abnormal soleus morphology
|
J:163585
|
| decreased skeletal muscle fiber density
|
J:163585
|
| skeletal muscle fiber degeneration
|
J:163585
|
\Myogtm1Sjb/\Myogtm1Sjb
(involves: 129)
|
muscle phenotype
|
J:88178
|
\Myogtm1Whk/\Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased skeletal muscle fiber density
|
J:14208
|
| decreased skeletal muscle mass
|
J:14208
|
| muscle hypoplasia
|
J:14208
|
| thin diaphragm muscle
|
J:14208
|
\Myogtm1Whk/\Myogtm1Whk
(involves: 129S7/SvEvBrd)
|
abnormal laryngeal muscle morphology
|
J:110733
|
| abnormal muscle development
|
J:22984
|
| abnormal myoblast differentiation
|
J:22984
|
| abnormal myogenesis
|
J:22984
|
| muscle hypoplasia
|
J:110733,
J:22984
|
| thin diaphragm muscle
|
J:110733
|
\Myogtm1Whk/\Myogtm2Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle hypoplasia
|
J:54065
|
\Myogtm1Yin/\Myogtm1Yin
(involves: 129P2/OlaHsd * BALB/c)
|
muscle hypoplasia
|
J:14059
|
\Myogtm2Whk/\Myogtm2Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle hypoplasia
|
J:54065
|
\Myogtm3Whk/\Myogtm3Whk
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
thin diaphragm muscle
|
J:105925
|
\myol/\myol
(C3.Cg-myol/GrsrJ)
|
impaired muscle relaxation
|
J:234691
|
\Myoz1tm1Eno/\Myoz1tm1Eno
(involves: 129 * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:144597
|
| abnormal muscle physiology
|
J:144597
|
| abnormal muscle tone
|
J:144597
|
| abnormal skeletal muscle fiber type ratio
|
J:144597
|
| abnormal skeletal muscle morphology
|
J:144597
|
| decreased gastrocnemius weight
|
J:144597
|
| decreased skeletal muscle fiber size
|
J:144597
|
| enhanced skeletal muscle regeneration
|
J:144597
|
| increased skeletal muscle fiber diameter
|
J:144597
|
| muscle degeneration
|
J:144597
|
\Myoz2tm1Eno/\Myoz2+
\Tg(Myh6-MYOZ2*I246M)#Ajm/0
(involves: 129/Sv * FVB/N)
|
abnormal Z line morphology
|
J:210073
|
| heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
\Myoz2tm1Eno/\Myoz2tm1Eno
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:94665
|
| abnormal skeletal muscle fiber type ratio
|
J:94665
|
| abnormal skeletal muscle morphology
|
J:94665
|
| cardiomyopathy
|
J:94665
|
| decreased cardiac muscle contractility
|
J:94665
|
| decreased myocardial fiber size
|
J:94665
|
| decreased skeletal muscle fiber size
|
J:94665
|
\Myoz2tm1Eno/\Myoz2tm1Eno
\Tg(Myh6-Ppp3ca)37Eno/0
(involves: 129 * C57BL/6J)
|
increased myocardial fiber size
|
J:94665
|
\Mypntm1.1Epu/\Mypn+
(either: (involves: 129S6/SvEv) or (involves: 129S6/SvEv * C57BL/6NCrl))
|
abnormal cardiac muscle relaxation
|
J:243710
|
| abnormal intercalated disk morphology
|
J:243710
|
| abnormal myocardial fiber morphology
|
J:243710
|
\Mypntm1.1Epu/\Mypntm1.1Epu
(involves: 129S6/SvEvTac)
|
abnormal Z line morphology
|
J:248575
|
| myopathy
|
J:248575
|
\Myt1tm1.1Ggu/\Myt1tm1.1Ggu
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL)
|
abnormal diaphragm morphology
|
J:127471
|
\Myzaptm1Norf/\Myzaptm1Norf
(involves: C57BL/6J)
|
abnormal cardiac muscle tissue morphology
|
J:231032
|
| decreased cardiac muscle contractility
|
J:231032
|
\Nacatm1Dsr/\Nacatm1Dsr
(129S6/SvEvTac-Nacatm1Dsr)
|
abnormal muscle physiology
|
J:167169
|
| abnormal myocardial trabeculae morphology
|
J:167169
|
| abnormal myocardium layer morphology
|
J:167169
|
| decreased fetal cardiomyocyte proliferation
|
J:167169
|
| decreased skeletal muscle mass
|
J:167169
|
| impaired skeletal muscle regeneration
|
J:167169
|
| thin myocardium
|
J:167169
|
\nad/\nad
(C(D2)-nad)
|
skeletal muscle atrophy
|
J:156089
|
\Nae1tm1c(EUCOMM)Wtsi/\Nae1tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
abnormal myocardium layer morphology
|
J:261328
|
| decreased fetal cardiomyocyte proliferation
|
J:261328
|
| decreased heart ventricle muscle contractility
|
J:261328
|
| increased myocardial fiber size
|
J:261328
|
| myocardial hypertrabeculation
|
J:261328
|
| myocardial ventricular hypertrabeculation
|
J:261328
|
| myocardium hypoplasia
|
J:261328
|
| thin left ventricle myocardium compact layer
|
J:261328
|
| thin ventricle myocardium compact layer
|
J:261328
|
\NbeaTg(GH1)240BNec/\NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL)
|
impaired muscle contractility
|
J:128767
|
\Nbnem3Jpt/\Nbnem3Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased leiomyosarcoma incidence
|
J:251434
|
| increased rhabdomyosarcoma incidence
|
J:251434
|
\Nbnem4Jpt/\Nbnem4Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased leiomyosarcoma incidence
|
J:251434
|
| increased rhabdomyosarcoma incidence
|
J:251434
|
\Ncam2tm1b(EUCOMM)Hmgu/\Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
\Ncf1tm1Shl/\Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
decreased vasoconstriction
|
J:120187
|
\Ncf1tm1Shl/\Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
abnormal cardiac muscle contractility
|
J:133916
|
| abnormal vascular smooth muscle physiology
|
J:111142
|
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:144060
|
\Ncoa6tm1.1Jkr/\Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:81217
|
| decreased fetal cardiomyocyte proliferation
|
J:81217
|
| thin myocardium compact layer
|
J:81217
|
| trabecula carnea hypoplasia
|
J:81217
|
\Ncoa6tm1Jkr/\Ncoa6+
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
\Ncoa6tm1Jkr/\Ncoa6tm1Jkr
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal sarcomere morphology
|
J:269856
|
| decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
\Ncoa6tm1Jxu/\Ncoa6tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:80175
|
| disorganized myocardium
|
J:80175
|
| trabecula carnea hypoplasia
|
J:80175
|
\Ncoa6tm1Pera/\Ncoa6tm1Pera
(involves: 129X1/SvJ * C57BL/6)
|
disorganized myocardium
|
J:81818
|
| thin myocardium
|
J:81818
|
| trabecula carnea hypoplasia
|
J:81818
|
\Ncor1tm1.1Ics/\Ncor1tm1.1Ics
\Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal gastrocnemius morphology
|
J:178827
|
| abnormal muscle physiology
|
J:178827
|
| abnormal quadriceps morphology
|
J:178827
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:178827
|
| abnormal skeletal muscle morphology
|
J:178827
|
| abnormal soleus morphology
|
J:178827
|
| increased skeletal muscle fiber diameter
|
J:178827
|
| increased skeletal muscle fiber mitochondrial size
|
J:178827
|
\nd/\nd
(129/Sv-nd)
|
muscle hypertonia
|
J:24834
|
\Ndntm1Stw/\Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
\Ndntm2Stw/\Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
\Ndnfem1Nou/\Ndnfem1Nou
(C57BL/6J-Ndnfem1Nou)
|
skeletal muscle atrophy
|
J:322617
|
\Ndrg1str/\Ndrg1str
(involves: BALB/c * C57BL/6 * NOD/ShiLtWtsi)
|
skeletal muscle atrophy
|
J:172770
|
\Ndrg1tm1Myta/\Ndrg1tm1Myta
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
skeletal muscle atrophy
|
J:172770
|
\Ndrg4tm1b(KOMP)Wtsi/\Ndrg4tm1b(KOMP)Wtsi
(C57BL/6N-Ndrg4tm1b(KOMP)Wtsi/H)
|
decreased cardiac muscle contractility
|
J:211773
|
\Ndst1b2b2230Clo/\Ndst1b2b2230Clo
(C57BL/6J-Ndst1b2b2230Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Ndst1tm1Je/\Ndst1tm1Je
\Robo4tm1Kzh/\Robo4+
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
\Ndst1tm1Je/\Ndst1tm1Je
\Robo4tm1Kzh/\Robo4tm1Kzh
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
\Ndst1tm1Je/\Ndst1tm1Je
\Slit3tm1.1Dor/\Slit3+
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
diaphragmatic hernia
|
J:208012
|
\Ndst1tm1Je/\Ndst1tm1Je
\Slit3tm1.1Dor/\Slit3tm1.1Dor
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
diaphragmatic hernia
|
J:208012
|
\Ndst1tm1Je/\Ndst1tm1Je
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm central tendon morphology
|
J:208012
|
| abnormal diaphragm morphology
|
J:208012
|
| abnormal tendon cell morphology
|
J:208012
|
| abnormal tendon collagen fibril morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
| thin diaphragm muscle
|
J:208012
|
\Ndufs4tm1.1Rpa/\Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor)
|
abnormal muscle tone
|
J:161393
|
\Ndufs4tm1.1Rpa/\Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
hypotonia
|
J:190475
|
\Ndufs4tm1Rpa/\Ndufs4tm1Rpa
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal muscle tone
|
J:161393
|
\Ndufs4tm1Rpa/\Ndufs4tm1Rpa
\Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
hypotonia
|
J:190475
|
\Ndufs6Gt(AR0138)Wtsi/\Ndufs6Gt(AR0138)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:183619
|
| decreased heart ventricle muscle contractility
|
J:183619
|
\Nebm1Anu/\Nebm2Anu
(C57BL/6J-Nebm1Anu Nebm2Anu)
|
abnormal muscle fiber morphology
|
J:285564
|
| abnormal muscle physiology
|
J:285564
|
| abnormal skeletal muscle fiber type ratio
|
J:285564
|
| decreased skeletal muscle fiber diameter
|
J:285564
|
| decreased skeletal muscle fiber size
|
J:285564
|
| impaired skeletal muscle contractility
|
J:285564
|
| increased variability of skeletal muscle fiber size
|
J:285564
|
\Nebtm1(cre)Chen/\Nebtm1(cre)Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal A band morphology
|
J:111470
|
| abnormal I band morphology
|
J:111470
|
| abnormal muscle fiber morphology
|
J:111470
|
| abnormal sarcomere morphology
|
J:111470
|
| abnormal Z line morphology
|
J:111470
|
| muscle phenotype
|
J:111470
|
\Nebtm1.1Hgra/\Nebtm1.1Hgra
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:206854
|
| abnormal sarcomere morphology
|
J:206854
|
| abnormal skeletal muscle fiber morphology
|
J:206854
|
| abnormal Z line morphology
|
J:206854
|
| decreased skeletal muscle fiber size
|
J:206854
|
| muscle weakness
|
J:206854
|
\Nebtm1Slbt/\Nebtm1Slbt
(involves: 129P2/OlaHsd)
|
abnormal H zone morphology
|
J:119578
|
| abnormal muscle contractility
|
J:119578
|
| abnormal sarcomere morphology
|
J:119578
|
| progressive muscle weakness
|
J:119578
|
\Nebtm2.1Chen/\Nebtm2.1Chen
(involves: 129 * Black Swiss)
|
abnormal muscle electrophysiology
|
J:211217
|
| muscle phenotype
|
J:211217
|
\Nebtm2Hgra/\Nebtm2Hgra
\Tg(Ckmm-cre)5Khn/0
(involves: 129S6/SvEvTac * FVB)
|
abnormal A band morphology
|
J:225840
|
| abnormal H zone morphology
|
J:225840
|
| abnormal muscle fiber morphology
|
J:225840
|
| abnormal sarcomere morphology
|
J:225840
|
| abnormal skeletal muscle fiber size
|
J:225840
|
| abnormal skeletal muscle fiber type ratio
|
J:225840
|
| abnormal Z line morphology
|
J:225840
|
| decreased quadriceps weight
|
J:225840
|
| decreased skeletal muscle weight
|
J:225840
|
| impaired skeletal muscle contractility
|
J:225840
|
| increased skeletal muscle fiber number
|
J:225840
|
\Nebltm1.1Epu/\Nebltm1.1Epu
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:304786
|
| abnormal sarcomere morphology
|
J:304786
|
| decreased cardiac muscle relaxation
|
J:304786
|
| increased myocardial fiber size
|
J:304786
|
\Nedd4Gt(XA209)Byg/\Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
centrally nucleated skeletal muscle fibers
|
J:207675
|
| delayed muscle development
|
J:207675
|
| increased variability of skeletal muscle fiber size
|
J:207675
|
\Nedd4ltm1.2Blyg/\Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:148641
|
\Nek6tm1Dgen/\Nek6tm1Dgen
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart left ventricle muscle contractility
|
J:215160
|
| increased myocardial fiber size
|
J:215160
|
\Nemfem8Cx/\Nemfem8Cx
(C57BL/6J-Nemfem8Cx/Cx)
|
muscular atrophy
|
J:296528
|
\Nemfpdft/\Nemfpdft
(B6(C3)-Nemfpdft/Cx)
|
muscular atrophy
|
J:296528
|
\Nemftvrm116/\Nemftvrm116
(C57BL/6J-Nemftvrm116/PjnCx)
|
muscular atrophy
|
J:296528
|
\Neu1tm1Adz/\Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
myoclonus
|
J:76937
|
\Neu2em1Kyp/\Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp)
|
abnormal muscle morphology
|
J:321653
|
| decreased skeletal muscle fiber number
|
J:321653
|
| increased muscle free fatty acids level
|
J:321653
|
\Neurl2tm1Adz/\Neurl2tm1Adz
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:90054
|
\Nexnem1Chen/\Nexnem1Chen
(C57BL/6J-Nexnem1Chen)
|
abnormal myocardial fiber morphology
|
J:301807
|
| decreased cardiac muscle contractility
|
J:301807
|
| dilated cardiomyopathy
|
J:301807
|
\Nexntm1.1Chen/\Nexntm1.1Chen
(Not Specified)
|
decreased cardiac muscle contractility
|
J:290931
|
| dilated cardiomyopathy
|
J:290931
|
\Nexntm1.1Zhh/\Nexn+
(involves: C57BL/6NTac)
|
dilated cardiomyopathy
|
J:228046
|
\Nexntm1.1Zhh/\Nexntm1.1Zhh
(involves: C57BL/6NTac)
|
decreased cardiac muscle contractility
|
J:228046
|
| dilated cardiomyopathy
|
J:228046
|
\Nexntm1Chen/\Nexntm1Chen
\Tg(myl7.L-cre)1118Tmhn/0
(involves: MF1)
|
abnormal myocardial fiber morphology
|
J:290931
|
| dilated cardiomyopathy
|
J:290931
|
\Nexntm1Chen/\Nexntm1Chen
\Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2)
|
dilated cardiomyopathy
|
J:290931
|
\Nf1tm1Fcr/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:58877
|
| increased rhabdomyosarcoma incidence
|
J:58877
|
\Nf1tm1Fcr/\Nf1tm1Fcr
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J))
|
abnormal muscle morphology
|
J:18048
|
| delayed muscle development
|
J:18048
|
| disorganized myocardium
|
J:18048
|
| skeletal muscle hypoplasia
|
J:18048
|
\Nf1tm1Par/\Nf1tm1Par
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal muscle development
|
J:173779
|
| abnormal muscle fiber morphology
|
J:173779
|
| abnormal muscle morphology
|
J:173779
|
| abnormal muscle physiology
|
J:173779
|
| abnormal myoblast differentiation
|
J:173779
|
| abnormal myogenesis
|
J:173779
|
| decreased muscle weight
|
J:173779
|
| decreased skeletal muscle fiber number
|
J:173779
|
| decreased skeletal muscle mass
|
J:173779
|
| increased myoblast proliferation
|
J:173779
|
| skeletal muscle fibrosis
|
J:173779
|
\Nf1tm1Par/\Nf1tm1Par
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
thin myocardium
|
J:80323
|
| thin myocardium compact layer
|
J:80323
|
\Nf1tm1Tyj/\Nf1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myocardium layer morphology
|
J:18542
|
\Nf1tm1Tyj/\Nf1tm2Tyj
(chimera involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:58876
|
\Nf2tm2Gth/\Nf2+
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased uterus leiomyoma incidence
|
J:132943
|
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brd/\Trp53+
\Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased leiomyosarcoma incidence
|
J:92413
|
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased rhabdomyosarcoma incidence
|
J:92413
|
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased uterus leiomyoma incidence
|
J:132943
|
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
| increased uterus leiomyoma incidence
|
J:132943
|
\Nfat5tm1Skc/\Nfat5tm1Skc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:175527
|
| abnormal myocardium compact layer morphology
|
J:175527
|
| decreased fetal cardiomyocyte proliferation
|
J:175527
|
\Nfatc1tm1(cre)Bz/\Nfatc1+
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
cardiomyopathy
|
J:226941
|
\Nfatc1tm1.1(cre)Bz/\Nfatc1+
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
thick myocardium
|
J:226941
|
\Nfatc2tm1Glm/\Nfatc2tm1Glm
\Nfatc3tm1Glm/\Nfatc3tm1Glm
\Nfatc4tm1Grc/\Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
\Nfatc2tm1Glm/\Nfatc2tm1Glm
\Nfatc4tm1Grc/\Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
\Nfatc3tm1Glm/\Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
abnormal skeletal muscle morphology
|
J:68675
|
| decreased extensor digitorum longus weight
|
J:68675
|
| decreased skeletal muscle fiber number
|
J:68675
|
| decreased soleus weight
|
J:68675
|
| muscle weakness
|
J:68675
|
\Nfatc3tm1Glm/\Nfatc3tm1Glm
\Nfatc4tm1Grc/\Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
trabecula carnea hypoplasia
|
J:84138
|
\Nfatc3tm1Glm/\Nfatc3tm1Glm
\Nfatc4tm1Jmk/\Nfatc4tm1Jmk
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:84138
|
| abnormal myocardium compact layer morphology
|
J:84138
|
| abnormal myocardium layer morphology
|
J:84138
|
| abnormal trabecula carnea morphology
|
J:84138
|
\Nfatc4tm1Jmk/\Nfatc4tm1Jmk
\Tg(Myh6-Ppp3ca)37Eno/?
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal myocardium layer morphology
|
J:79608
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J)
|
muscle phenotype
|
J:135692
|
\Ngftm1.1Blhe/\Ngf+
(B6.Cg-Ngftm1.1Blhe)
|
abnormal myocardial fiber morphology
|
J:190893
|
| abnormal myocardium layer morphology
|
J:190893
|
| decreased cardiac muscle contractility
|
J:190893
|
| dilated cardiomyopathy
|
J:190893
|
| thin myocardium
|
J:190893
|
\Ngftm1.1Blhe/\Ngf+
\Sort1tm1Tew/\Sort1tm1Tew
(B6.Cg-Ngftm1.1Blhe Sort1tm1Tew)
|
dilated cardiomyopathy
|
J:190893
|
\Ngfrtm1Jae/\Ngfrtm1Jae
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825
|
| decreased muscle spindle number
|
J:53825
|
\Ngfrtm1Jae/\Ngfrtm1Jae
\Ntf3tm1Jae/\Ntf3+
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825
|
| absent muscle spindles
|
J:53825
|
| decreased muscle spindle number
|
J:53825
|
| dystonia
|
J:53825
|
| muscle spasm
|
J:53825
|
\Nhlrc1tm1(KOMP)Vlcg/\Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased cardiac muscle glycogen level
|
J:165994
|
| increased skeletal muscle glycogen level
|
J:165994,
J:218959
|
\Nhlrc1tm1.2Geno/\Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J)
|
myoclonus
|
J:181559
|
\Nhlrc1tm1Bmin/\Nhlrc1tm1Bmin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)
|
increased skeletal muscle glycogen level
|
J:181674
|
\Nid1tm1Dong/\Nid1tm1Dong
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:80843
|
\Ninj2em1Cqxu/\Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu)
|
increased skeletal muscle triglyceride level
|
J:332575
|
\NipblGt(RRS564)Byg/\Nipbl+
(involves: 129P2/OlaHsd * CD-1)
|
abnormal myocardium compact layer morphology
|
J:154117
|
| abnormal ventricle myocardium morphology
|
J:154117
|
\Nkx2-3tm1Rph/\Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:64018
|
\Nkx2-5em1Dsr/\Nkx2-5em1Dsr
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
| thin myocardium
|
J:277399
|
\Nkx2-5tm1.1Burg/\Nkx2-5tm1.1Burg
(involves: 129S1/Sv * 129S2/SvPasCrl * 129X1/SvJ)
|
abnormal trabecula carnea morphology
|
J:251389
|
| thin myocardium
|
J:251389
|
\Nkx2-5tm1.1Gum/\Nkx2-5tm1.1Gum
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J)
|
abnormal pyloric sphincter morphology
|
J:228275
|
| abnormal stomach smooth muscle circular layer morphology
|
J:228275
|
| abnormal stomach smooth muscle outer longitudinal layer morphology
|
J:228275
|
\Nkx2-5tm1.1Hkas/\Nkx2-5+
(129S2.Cg-Nkx2-5tm1.1Hkas)
|
abnormal atrioventricular node morphology
|
J:273097
|
| abnormal left posterior bundle morphology
|
J:273097
|
| cardiomyopathy
|
J:273096
|
\Nkx2-5tm1Krc/\Nkx2-5tm1Krc
\Isl1tm1(cre)Tmj/\Isl1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:214093
|
\Nkx2-5tm1Siz/\Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal Purkinje fiber morphology
|
J:89216
|
| decreased heart ventricle muscle contractility
|
J:174208
|
\Nkx2-5tm1Siz/\Nkx2-5tm1Siz
(involves: 129S4/SvJaeSor * C57BL/6J)
|
absent myocardial trabeculae
|
J:52597
|
\Nkx2-5tm1Wehi/\Nkx2-5tm1Wehi
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/10)
|
abnormal myocardium layer morphology
|
J:27443
|
| abnormal myogenesis
|
J:27443
|
| absent trabeculae carneae
|
J:27443
|
| disorganized myocardium
|
J:27443
|
\Nkx2-5tm2.1Mwc/\Nkx2-5+
(B6J.Cg-Nkx2-5tm2.1Mwc/Mwc)
|
atrioventricular node hypoplasia
|
J:239808
|
| decreased heart left ventricle muscle contractility
|
J:239808
|
| decreased heart right ventricle muscle contractility
|
J:239808
|
| decreased heart ventricle muscle contractility
|
J:239808
|
\Nkx2-5tm2Siz/\Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal atrioventricular node morphology
|
J:89216
|
| abnormal impulse conducting system morphology
|
J:89216
|
| abnormal Purkinje fiber morphology
|
J:89216
|
\Nkx2-5tm2Siz/\Nkx2-5tm2Siz
(involves: 129S4/SvJaeSor)
|
absent atrioventricular node
|
J:89216
|
\Nkx2-5tm3.1Mwc/\Nkx2-5+
(B6J.Cg-Nkx2-5tm3.1Mwc/Mwc)
|
abnormal atrioventricular node morphology
|
J:239808
|
| decreased heart right ventricle muscle contractility
|
J:239808
|
\Nkx2-5tm4Rph/\Nkx2-5+
(involves: 129S1/Sv)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
\Nkx2-5tm4Rph/\Nkx2-5+
\Tbx20tm1.1Rph/\Tbx20+
(involves: 129S1/Sv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
| dilated cardiomyopathy
|
J:98489
|
| myocardial fiber disarray
|
J:98489
|
\Nkx2-5tm4Rph/\Nkx2-5tm4Rph
(either: (involves: 129S1/Sv * 129T2/SvEms) or (involves: 129S1/Sv * C57BL/6J))
|
abnormal myocardium layer morphology
|
J:81343
|
\Nkx2-5tm6Rph/\Nkx2-5+
\Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
\Nkx2-5tm6Rph/\Nkx2-5+
\Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/\Tg(DMPK/tetO-EGFP/DMPK)5-313Masm
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
\Nkx3-2tm1(cre)Tsa/\Nkx3-2+
\Nr2f2tm2.1Tsa/\Nr2f2tm2.1Tsa
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal stomach smooth muscle circular layer morphology
|
J:98520
|
\nm3/\nm3
(involves: RIIIS/J)
|
muscle phenotype
|
J:88298
|
\nma/\nma
(B6C3Fe a/a-nma/J)
|
muscle phenotype
|
J:60439
|
\Nmf31/\Nmf31
(BALB/cByJ-Nmf31/J)
|
myoclonus
|
J:87349
|
\nmf67/\nmf67
(C57BL/6J-nmf67/J)
|
muscle weakness
|
J:82238
|
\nmf118/\nmf118
(C57BL/6J-nmf118/J)
|
muscle degeneration
|
J:87349
|
\nmf161/\nmf161
(C57BL/6J-nmf161/J)
|
muscle spasm
|
J:82238
|
\nmf242/\nmf242
(C57BL/6J-nmf242/J)
|
muscle spasm
|
J:82238
|
\nmf347/\nmf347
(C57BL/6J-nmf347/J)
|
muscle spasm
|
J:87349
|
\nmf356/\nmf356
(C57BL/6J-nmf356/J)
|
muscle spasm
|
J:87349
|
| muscle weakness
|
J:87349
|
\nmf391/\nmf391
(C57BL/6J-nmf391/J)
|
dystrophic muscle
|
J:87349
|
| muscle weakness
|
J:87349
|
| myoclonus
|
J:87349
|
\nmf418/\nmf418
(B6;CByJ-nmf418/J)
|
muscle phenotype
|
J:87349
|
| muscle spasm
|
J:87349
|
| muscle weakness
|
J:87349
|
\Nmnat2Gt(EUCE0262a08)Hmgu/\Nmnat2Gt(EUCE0262a08)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal diaphragm development
|
J:200901
|
| decreased muscle weight
|
J:200901
|
| decreased skeletal muscle mass
|
J:192196
|
\Nmnat2Gt(EUCE0262a08)Hmgu/\Nmnat2Gt(EUCE0262a08)Hmgu
\Wlds/\+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6Ola)
|
muscle phenotype
|
J:200901
|
\Nmnat2Tn(sb-Tyr)2172.P9KK4BOve/\Nmnat2Tn(sb-Tyr)2172.P9KK4BOve
(involves: FVB/N)
|
abnormal diaphragm development
|
J:192196
|
| decreased skeletal muscle mass
|
J:192196
|
\NodalTgR(MPSVNeo)413.dRob/\Nodaltm6Rob
(involves: 129S/SvEv * C57BL/6)
|
thin myocardium compact layer
|
J:94418
|
| trabecula carnea hypoplasia
|
J:94418
|
\Nogtm1Amc/\Nogtm1Amc
(involves: 129S1/Sv * CD-1)
|
abnormal muscle fiber morphology
|
J:108573
|
| abnormal muscle morphology
|
J:108573
|
\Nol3tm1Rvh/\Nol3tm1Rvh
(involves: C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:121501
|
| increased cardiomyocyte apoptosis
|
J:121501
|
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:103346
|
| abnormal muscle physiology
|
J:104916
|
| decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased heart ventricle muscle contractility
|
J:103346
|
| pyloric sphincter hypertrophy
|
J:16390
|
| stomach smooth muscle circular layer hypertrophy
|
J:16390
|
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal gastroesophageal sphincter physiology
|
J:70182,
J:56948
|
| abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:56948,
J:89581
|
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6J)
|
pyloric sphincter hypertrophy
|
J:64225
|
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
muscle phenotype
|
J:48851
|
\Nos1tm1Plh/\Nos1tm1Plh
(B6.129S4-Nos1tm1Plh/J)
|
decreased skeletal muscle weight
|
J:144588
|
| impaired skeletal muscle contractility
|
J:144588
|
| increased muscle fatigability
|
J:144588
|
\Nos1tm1Plh/\Nos1tm1Plh
\Nos2tm1Mrl/\Nos2tm1Mrl
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
pyloric sphincter hypertrophy
|
J:100308
|
\Nos1tm1Plh/\Nos1tm1Plh
\Nos3tm1Plh/\Nos3tm1Plh
(B6.129S4-Nos3tm1Plh Nos1tm1Plh)
|
abnormal cardiac muscle relaxation
|
J:129064
|
| heart left ventricle hypertrophy
|
J:129064
|
| increased cardiac muscle contractility
|
J:129064
|
\Nos1tm1Plh/\Nos1tm1Plh
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:75645
|
| decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased cardiac muscle contractility
|
J:75645
|
\Nos1aptm1Tsso/\Nos1aptm1Tsso
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:268528
|
\Nos2tm1Lau/\Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
abnormal myocardium layer morphology
|
J:71505
|
\Nos2tm1Mrl/\Nos2tm1Mrl
\Tg(Myh6-Tnf)1.6Amf/?
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal cardiac muscle contractility
|
J:109732
|
| decreased cardiac muscle contractility
|
J:109732
|
\Nos3tm1Gdk/\Nos3tm1Gdk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:46061
|
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae)
|
abnormal vasodilation
|
J:112419
|
| decreased vasodilation
|
J:28778
|
| increased vasoconstriction
|
J:57624
|
| muscle phenotype
|
J:56948
|
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased cardiac muscle contractility
|
J:75645
|
\Nos3tm1Unc/\Nos3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasodilation
|
J:54772
|
\Nos3tm1Unc/\Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
decreased cardiac muscle contractility
|
J:103270
|
| increased fetal cardiomyocyte apoptosis
|
J:103270
|
| increased heart ventricle muscle contractility
|
J:98094
|
\Nos3tm1Unc/\Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:102136
|
| decreased vasodilation
|
J:103153
|
\Nos3tm1Unc/\Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasodilation
|
J:54772
|
| increased vasoconstriction
|
J:54772
|
\Nos3tm1Weo/\Nos3tm1Weo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:51563
|
\Nos3tm2.1Plh/\Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased vasodilation
|
J:198075
|
\Notch1tm1Agt/\Notch1tm1Agt
\Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * SJL)
|
thin myocardium
|
J:100449
|
\Notch1tm1Agt/\Notch1tm1Agt
\Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
thin myocardium
|
J:100449
|
\Notch1tm1Agt/\Notch1tm1Agt
\Tg(Wt1-cre)#Jbeb/0
(involves: 129)
|
myocardium hypoplasia
|
J:178290
|
| thin myocardium compact layer
|
J:178290
|
\Notch1tm1Con/\Notch1tm1Con
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardium layer morphology
|
J:119151
|
| disorganized myocardium
|
J:119151
|
| trabecula carnea hypoplasia
|
J:119151
|
\Notch1tm1Grid/\Notch1+
\Notch3tm1Grid/\Notch3tm1Grid
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:227333
|
\Notch2tm1Grid/\Notch2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:67157
|
\Notch2tm3Grid/\Notch2tm3.1Grid
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:132939
|
\Notch3hpbk/\Notch3hpbk
(C57BL/6J-Notch3hpbk/GrsrJ)
|
myopathy
|
J:157222
|
| skeletal muscle atrophy
|
J:157222
|
\Notch3tm1Grid/\Notch3tm1Grid
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle morphology
|
J:94047
|
\Notch3tm1Grid/\Notch3tm1Grid
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:227333
|
\Notumem150Sinn/\Notumem150Sinn
(Not Specified)
|
abnormal tracheal smooth muscle morphology
|
J:260471
|
\Nox1tm1Cyn/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vasodilation
|
J:116837
|
\Nox4tm1.1Jusa/\Nox4tm1.1Jusa
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB)
|
decreased cardiomyocyte apoptosis
|
J:163751
|
| decreased heart left ventricle muscle contractility
|
J:163751
|
| decreased heart ventricle muscle contractility
|
J:163751
|
| heart left ventricle hypertrophy
|
J:163751
|
\Npas4tm1Ooe/\Npas4tm1Ooe
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:145569
|
\Npattm1b(EUCOMM)Wtsi/\Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal digastric muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
\Nplem1Avps/\Nplem1Avps
(C57BL/6-Nplem1Avps)
|
decreased skeletal muscle fiber size
|
J:342764
|
| muscle phenotype
|
J:342764
|
| muscle weakness
|
J:342764
|
\Nplem2Avps/\Nplem2Avps
(C57BL/6-Nplem2Avps)
|
muscle phenotype
|
J:342764
|
| muscle weakness
|
J:342764
|
\Nppatm1Unc/\Nppa+
(involves: 129P2/OlaHsd * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:64898
|
\Nppatm1Unc/\Nppatm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:54986
|
| heart left ventricle hypertrophy
|
J:54986
|
| heart right ventricle hypertrophy
|
J:54986,
J:64898
|
\Nppbtm1Yog/\Nppbtm1Yog
(either: 129X1/SvJ or (involves: 129 * C57BL/6J))
|
abnormal myocardial fiber morphology
|
J:61680
|
\Npr1tm1Gar/\Npr1tm1Gar
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:42893
|
\Npr1tm1Kuhn/\Npr1tm1Kuhn
\Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:83298
|
| abnormal myocardial fiber morphology
|
J:83298
|
\Npr1tm1Kuhn/\Npr1tm1Kuhn
\Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vasodilation
|
J:76460
|
\Npr1tm1Mae/\Npr1tm1Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:74420
|
| myocardium necrosis
|
J:74420
|
\Npr2slw/\Npr2slw
(involves: C57BL/6 * DDY)
|
abnormal pyloric sphincter morphology
|
J:163374
|
| impaired muscle relaxation
|
J:163374
|
\Nprl3tm1.1Drhi/\Nprl3tm1.1Drhi
(involves: 129P2/OlaHsd)
|
abnormal ventricle myocardium morphology
|
J:183988
|
| myocardial ventricular hypertrabeculation
|
J:183988
|
| thin ventricle myocardium compact layer
|
J:183988
|
\Npy1rtm1Tped/\Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vasoconstriction
|
J:47972
|
\Nr1d1tm1Ven/\Nr1d1tm1Ven
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:95758
|
| increased skeletal muscle fiber size
|
J:95758
|
\Nr1h2tm1.1Nph/\Nr1h2tm1.1Nph
(B6.129-Nr1h2tm1.1Nph)
|
increased muscle cell glucose uptake
|
J:169945
|
\Nr1h2tm1Djm/\Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
\Nr1h2tm1Djm/\Nr1h2tm1Djm
\Nr1h3tm1Djm/\Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
\Nr2f1tm1Mjts/\Nr2f1+
(involves: 129S7/SvEvBrd)
|
hypotonia
|
J:286647
|
\Nr2f2tm1Tsa/\Nr2f2tm1Tsa
(either: 129S7/SvEvBrd or C57BL/6 or (involves: 129S7/SvEvBrd * C57BL/6 * ICR))
|
absent trabeculae carneae
|
J:54469
|
\Nr3c1tm1.1Jaci/\Nr3c1tm1.1Jaci
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:201995
|
| increased myocardial fiber size
|
J:201995
|
\Nr3c2tm1.1Ics/\Nr3c2tm1.1Ics
\Tg(Acta2-cre/ERT2)#Pcn/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal muscle tone
|
J:193438
|
| abnormal vasoconstriction
|
J:193438
|
| abnormal vasodilation
|
J:193438
|
| decreased vasoconstriction
|
J:193438
|
| increased vasoconstriction
|
J:193438
|
| increased vasodilation
|
J:193438
|
\Nrastm1Tyj/\Nras+
\Meox2tm1(cre)Sor/\Meox2+
(B6.Cg-Nrastm1Tyj Meox2tm1(cre)Sor)
|
myocardial hypertrabeculation
|
J:305401
|
| thin myocardium
|
J:305401
|
| thin ventricle myocardium compact layer
|
J:305401
|
\Nrastm1Tyj/\Nras+
\Tg(Tek-cre)1Ywa/0
(B6.Cg-Nrastm1Tyj Tg(Tek-cre)1Ywa)
|
myocardial hypertrabeculation
|
J:305401
|
| thin ventricle myocardium compact layer
|
J:305401
|
\Nrcamm1J/\Nrcamm1J
\Sh3tc2m1J/\Sh3tc2m1J
(B6.Cg-Nrcamm1J Sh3tc2m1J/GrsrRwb)
|
muscular atrophy
|
J:240096
|
\Nrg1tm1Cbm/\Nrg1+
(involves: 129P2/OlaHsd)
|
decreased heart left ventricle muscle contractility
|
J:100313
|
\Nrg1tm1Cbm/\Nrg1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:29971
|
\Nrg1tm1Cbm/\Nrg1tm1Cbm
(involves: 129P2/OlaHsd)
|
abnormal myocardium layer morphology
|
J:119151
|
\Nrg1tm1Cbm/\Nrg1tm3Cbm
\Isl1tm1(cre)Tmj/\Isl1+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:80793
|
\Nrg1tm1Gne/\Nrg1tm1Gne
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6J))
|
absent trabeculae carneae
|
J:45302
|
\Nrg1tm1Leth/\Nrg1tm1Leth
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:33038
|
| trabecula carnea hypoplasia
|
J:33038
|
\Nrg1tm1Lwr/\Nrg1tm1Lwr
(129/Sv-Nrg1tm1Lwr)
|
abnormal intercostal muscle morphology
|
J:60159
|
| centrally nucleated skeletal muscle fibers
|
J:60159
|
| thin diaphragm muscle
|
J:60159
|
\Nrg1tm1Lwr/\Nrg1tm1Lwr
(involves: 129)
|
muscle phenotype
|
J:80793
|
\Nrg1tm1Zhou/\Nrg1tm1Zhou
(involves: 129S1/Sv * C57BL/6)
|
trabecula carnea hypoplasia
|
J:50592
|
\Nrg1tm2Cbm/\Nrg1tm2Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:29971
|
\Nrg1tm3Cbm/\Nrg1tm3Cbm
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
\Nrg1tm4.1Cbm/\Nrg1+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
\Nrg1tm4Cbm/\Nrg1tm4.1Cbm
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * CBA/J)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
\Nrp1tm1.1Izac/\Nrp1tm1.1Izac
(involves: 129S2/SvPas * C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:208348
|
\Nrp2tm1.2Mom/\Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
\Nrp2tm1.2Mom/\Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
\Nrtntm1Jmi/\Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:53261
|
| intestinal hypoperistalsis
|
J:82456
|
\Nsun2tm1a(EUCOMM)Wtsi/\Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
\Nsun3tm1.1Tomik/\Nsun3tm1.1Tomik
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
abnormal myocardial fiber mitochondrial morphology
|
J:336777
|
| increased cardiac muscle contractility
|
J:336777
|
\Ntf3tm1(Bdnf)Tes/\Ntf3tm1(Bdnf)Tes
(involves: 129S1/Sv)
|
absent muscle spindles
|
J:72304
|
\Ntf3tm1Jae/\Ntf3+
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825,
J:23882
|
\Ntf3tm1Jae/\Ntf3tm1Jae
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:23882
|
| absent golgi tendon organ
|
J:23882
|
| absent muscle spindles
|
J:23882
|
\Ntf3tm1Jae/\Ntf3tm1Jae
(involves: 129S4/SvJae)
|
absent muscle spindles
|
J:43444
|
\Ntf3tm1Jae/\Ntf3tm1Jae
(involves: 129S4/SvJae * C57BL/6)
|
absent muscle spindles
|
J:83461
|
\Ntf3tm1Jae/\Ntf3tm1Jae
\Tg(Myog-Ntf3)5160Wds/0
(involves: C57BL/6 * CBA * CF-1)
|
abnormal muscle spindle morphology
|
J:43444
|
\Ntf3tm1Lfr/\Ntf3tm1Lfr
(involves: 129S2/SvPas)
|
abnormal muscle spindle morphology
|
J:132854
|
| absent muscle spindles
|
J:18984
|
\Ntf3tm1Par/\Ntf3tm1Par
(involves: 129S1/Sv)
|
abnormal atrium myocardial trabeculae morphology
|
J:35639
|
| atrium myocardium hypoplasia
|
J:35639
|
| vascular smooth muscle hypotrophy
|
J:35639
|
\Ntf3tm1Tojo/\Ntf3tm1Tojo
(involves: C57BL/6 * DBA/2 * ICR)
|
muscular atrophy
|
J:22369
|
\Ntrk1tm2(Ntrk3)Apat/\Ntrk1tm2(Ntrk3)Apat
(involves: 129S1/Sv)
|
increased muscle spindle number
|
J:92099
|
\Ntsr1tm2Dgen/\Ntsr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
\Ntsr1tm2Dgen/\Ntsr1tm2Dgen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
\Nuak1tm1Esu/\Nuak1tm1Esu
\Tg(Ckmm-cre)5Khn/0
(B6.Cg-Nuak1tm1Esu Tg(Ckmm-cre)5Khn)
|
abnormal skeletal muscle cell glucose uptake
|
J:185463
|
| increased skeletal muscle glycogen level
|
J:185463
|
| muscle phenotype
|
J:185463
|
\Nuggcem1(IMPC)Ccpcz/\Nuggcem1(IMPC)Ccpcz
(C57BL/6NCrl-Nuggcem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Nup35m1Apb/\Nup35m1Apb
(involves: C57BL/6N)
|
abnormal intestinal smooth muscle morphology
|
J:235141
|
| muscle phenotype
|
J:235141
|
\nur15/\nur15
(Not Specified)
|
opisthotonus
|
J:85113
|
\nur16/\nur16
(Not Specified)
|
opisthotonus
|
J:85113
|
\nur33/\nur33
(Not Specified)
|
muscle weakness
|
J:89098
|
| myoclonus
|
J:89098
|
\Nxntm1a(EUCOMM)Wtsi/\Nxn+
(C57BL/6N-Nxntm1a(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
\Nxnl2em1(IMPC)Ccpcz/\Nxnl2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
| increased cardiac muscle contractility
|
J:211773
|
\Obscntm1.1Geno/\Obscntm1.1Geno
(B6.129-Obscntm1.1Geno)
|
increased heart left ventricle muscle contractility
|
J:243723
|
\Obscntm1Chen/\Obscntm1Chen
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal sarcoplasmic reticulum morphology
|
J:153150
|
| centrally nucleated skeletal muscle fibers
|
J:153150
|
| muscle phenotype
|
J:153150
|
| myopathy
|
J:153150
|
\Obscntm1Chen/\Obscntm1Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
| abnormal sarcolemma morphology
|
J:283623
|
| abnormal sarcoplasmic reticulum morphology
|
J:283623
|
| increased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
\Obscntm1Chen/\Obscntm1Chen
\Obsl1tm1.1Slan/\Obsl1tm1.1Slan
\Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
| abnormal sarcolemma morphology
|
J:283623
|
| abnormal sarcoplasmic reticulum morphology
|
J:283623
|
| decreased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
\Obsl1tm1.1Slan/\Obsl1tm1.1Slan
\Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
increased extensor digitorum longus weight
|
J:283623
|
| increased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
\OclnGt(ROSA)39Tshi/\OclnGt(ROSA)39Tshi
(involves: DBA/2)
|
abnormal stomach muscularis externa morphology
|
J:110222
|
\Oclntm1Tshi/\Oclntm1Tshi
(involves: C57BL/6 * DBA/2)
|
abnormal muscle morphology
|
J:110222
|
| abnormal stomach muscularis externa morphology
|
J:110222
|
\Odad2b2b227.1Clo/\Odad2b2b227.1Clo
(C57BL/6J-Odad2b2b227.1Clo)
|
cardiomyopathy
|
J:175213
|
\Olig2tm1(cre)Tmj/\Olig2+
\Smn1tm1Jme/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
abnormal muscle morphology
|
J:164292
|
| decreased skeletal muscle fiber number
|
J:164292
|
| increased skeletal muscle fiber size
|
J:164292
|
| muscle weakness
|
J:164292
|
| muscular atrophy
|
J:164292
|
| skeletal muscle fiber degeneration
|
J:164292
|
\Olig2tm1(cre/Esr1*)Htak/\Olig2tm1(cre/Esr1*)Htak
(involves: BALB/c * C57BL/6 * C57BL/6NCrj * CBA)
|
hypotonia
|
J:77821
|
\Olr1tm1Meht/\Olr1tm1Meht
(B6.129X1-Olr1tm1Meht/Meht)
|
increased muscle relaxation
|
J:130794
|
\Opa1M1Bewi/\Opa1+
(involves: C3HeB/FeJ)
|
muscle phenotype
|
J:154865
|
\Opa1tm1.1Geno/\Opa1+
(involves: 129S2/SvPas)
|
abnormal cardiac muscle tissue morphology
|
J:237963
|
| abnormal muscle fiber morphology
|
J:237963
|
| abnormal sarcomere morphology
|
J:237963
|
| decreased muscle fiber mitochondrial DNA content
|
J:237963
|
\Opa3m1Votr/\Opa3m1Votr
(involves: C3H * C57BL/6JCrl)
|
abnormal ventricle myocardium morphology
|
J:181670
|
| dilated cardiomyopathy
|
J:181670
|
\Or51e1tm1Jplu/\Or51e1tm1Jplu
(C57BL/6N-Or51e1tm1Jplu/J)
|
abnormal vascular smooth muscle physiology
|
J:346436
|
| decreased vasoconstriction
|
J:346436
|
| increased vasoconstriction
|
J:346436
|
| increased vasodilation
|
J:346436
|
\Orm1tm1Smoc/\Orm1tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:264446
|
\Osr2tm5(cre)Jian/\Osr2+
\Tg(CAG-Nog)1Ych/0
(Not Specified)
|
abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| small levator veli palatini muscle
|
J:310908
|
| small tensor veli palatini muscle
|
J:310908
|
\Ostes/\Ostes
(involves: 101/H * C3H/HeH)
|
dystrophic muscle
|
J:124220
|
| muscular atrophy
|
J:124220
|
\Ostntm1.1Geno/\Ostntm1.1Geno
(involves: C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:228285
|
\Otx2tm1Sia/\Otx2+
(involves: C57BL/6 * CBA)
|
abnormal extraocular muscle morphology
|
J:29682
|
\Ovol2tm1Sito/\Ovol2tm1Sito
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent myocardial trabeculae
|
J:132526
|
\Oxct1tm1a(KOMP)Wtsi/\Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi)
|
abnormal muscle physiology
|
J:170537
|
\Oxtrtm1.2Wsy/\Oxtrtm1.2Wsy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
muscle phenotype
|
J:137445
|
\P2rx4tm1Ando/\P2rx4tm1Ando
(Not Specified)
|
abnormal vasodilation
|
J:104459
|
\P2ry2tm1c(EUCOMM)Hmgu/\P2ry2tm1c(EUCOMM)Hmgu
\Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
\P2ry6tm1.1Brob/\P2ry6tm1.1Brob
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased vasoconstriction
|
J:169742
|
| decreased vasodilation
|
J:169742
|
\P2ry14tm1Gbtm/\P2ry14tm1Gbtm
(B6.129P2-P2ry14tm1Gbtm)
|
abnormal muscle physiology
|
J:149708
|
\P3h1tm1b(EUCOMM)Wtsi/\P3h1tm1b(EUCOMM)Wtsi
(C57BL/6N-P3h1tm1b(EUCOMM)Wtsi/Ucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
\P3h1tm1Dgen/\P3h1tm1Dgen
(involves: C57BL/6)
|
abnormal tendon morphology
|
J:163884
|
\P3h4tm1.2Rmr/\P3h4tm1.2Rmr
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle morphology
|
J:232567
|
\Pabir1em1.1Yhua/\Pabir1em1.1Yhua
\Myh6em2(cre)Smoc/\Myh6+
(involves: C57BL/6 * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:337007
|
\Pabir1em2Yhua/\Pabir1+
(involves: 129/SvJ * C57BL/6)
|
abnormal atrium myocardium morphology
|
J:337007
|
| abnormal ventricle myocardium morphology
|
J:337007
|
| thin myocardium
|
J:337007
|
\Pabpn1tm1.2Gpvl/\Pabpn1+
(involves: C57BL/6 * FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:243638
|
| decreased skeletal muscle fiber diameter
|
J:243638
|
| increased skeletal muscle fiber diameter
|
J:243638
|
| skeletal muscle atrophy
|
J:243638
|
| skeletal muscle hypertrophy
|
J:243638
|
\Pabpn1tm2.2Gpvl/\Pabpn1+
(involves: C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber diameter
|
J:243638
|
| increased skeletal muscle fiber diameter
|
J:243638
|
| muscle phenotype
|
J:243638
|
| skeletal muscle atrophy
|
J:243638
|
| skeletal muscle hypertrophy
|
J:243638
|
\Pacsin3tm1.2Bqu/\Pacsin3tm1.2Bqu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:255013
|
| centrally nucleated skeletal muscle fibers
|
J:255013
|
| decreased skeletal muscle fiber diameter
|
J:255013
|
| increased skeletal muscle fiber diameter
|
J:255013
|
| muscle phenotype
|
J:255013
|
| myositis
|
J:255013
|
| skeletal muscle fiber degeneration
|
J:255013
|
| skeletal muscle fiber necrosis
|
J:255013
|
\Pak1tm1.1Xwg/\Pak1tm1.1Xwg
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:193804
|
| increased cardiomyocyte apoptosis
|
J:193804
|
| increased myocardial fiber size
|
J:193804
|
\Pak1ip1mray/\Pak1ip1mray
(involves: C57BL/6J * FVB/NJ)
|
abnormal masseter muscle morphology
|
J:204457
|
\Pak4tm1Amin/\Pak4tm1Amin
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
thin myocardium
|
J:85954
|
\Pank1tm1.1Suja/\Pank1tm1.1Suja
\Pank2tm1.1Suja/\Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
dystonia
|
J:189609
|
\Pard3btm1b(EUCOMM)Wtsi/\Pard3btm1b(EUCOMM)Wtsi
(C57BL/6N-Pard3btm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle fiber diameter
|
J:116017
|
| decreased skeletal muscle mass
|
J:116017
|
| muscular atrophy
|
J:116017
|
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
muscular atrophy
|
J:269785
|
\Parltm1Bdes/\Parltm1Bdes
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
muscular atrophy
|
J:269785
|
\Parms1BALB/cByJ/\Parms1C57BL/6NCrl
\Ptch1tm1Zim/\Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl)
|
increased rhabdomyosarcoma incidence
|
J:93364
|
\Parms1C57BL/6NCrl/\Parms1C57BL/6NCrl
\Ptch1tm1Zim/\Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl)
|
increased rhabdomyosarcoma incidence
|
J:93364
|
\Parvatm1Ref/\Parvatm1Ref
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:154437
|
\Pasktm1Weng/\Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
abnormal muscle physiology
|
J:125307
|
\Pax1un-i/\Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
abnormal myotome development
|
J:100951
|
\Pax3Sp-2H/\Pax3Sp-2H
(involves: C57BL/6)
|
abnormal dermomyotome development
|
J:32016
|
| abnormal muscle precursor cell migration
|
J:32016
|
| abnormal myogenesis
|
J:18227,
J:32016
|
\Pax3Sp-2H/\Pax3Sp-2H
(involves: 101 * C3H/He * CBA/Ca)
|
decreased heart left ventricle muscle contractility
|
J:46341
|
\Pax3Sp-2H/\Pax3Sp-2H
(involves: 101 * C3H/He)
|
decreased heart left ventricle muscle contractility
|
J:46341
|
\Pax3Sp/\Pax3Sp
(involves: C57BL)
|
abnormal dermomyotome development
|
J:112275,
J:32016
|
| abnormal hypoglossal cord morphology
|
J:112275
|
| abnormal muscle precursor cell migration
|
J:32016
|
| abnormal myogenesis
|
J:18227,
J:112275,
J:32016
|
\Pax3tm1(cre)Joe/\Pax3+
\Rbpjtm1Hon/\Rbpjtm1Hon
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:120053
|
| abnormal epaxial muscle morphology
|
J:120053
|
| abnormal intercostal muscle morphology
|
J:120053
|
| abnormal myogenesis
|
J:120053
|
| decreased satellite cell number
|
J:120053
|
| hypaxial muscle hypoplasia
|
J:120053
|
\Pax3tm1(cre)Joe/\Pax3tm1(cre)Joe
(Not Specified)
|
abnormal diaphragm development
|
J:137730
|
| thin diaphragm muscle
|
J:137730
|
\Pax3tm1(FOXO1A)Gcg/\Pax3+
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))
|
abnormal diaphragm development
|
J:79365
|
| abnormal skeletal muscle morphology
|
J:79365
|
| abnormal tongue muscle morphology
|
J:79365
|
\Pax3tm1.1Sjc/\Pax3tm1.1Sjc
\Pax7tm1.2Fan/\Pax7tm1.2Fan
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
muscle phenotype
|
J:150962
|
\Pax3tm1Buck/\Pax3Sp
(involves: 129P2/OlaHsd * C57BL)
|
abnormal dermomyotome development
|
J:86911
|
| abnormal myogenesis
|
J:86911
|
\Pax3tm1Buck/\Pax3tm1Buck
(involves: 129P2/OlaHsd)
|
abnormal dermomyotome development
|
J:176192
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:176192
|
| abnormal myogenesis
|
J:86911
|
| abnormal myotome development
|
J:176192
|
\Pax3tm1Buck/\Pax3tm1Buck
\Pax7tm2Pgr/\Pax7tm2Pgr
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) or (involves: 129P2/OlaHsd * 129S2/SvPas))
|
abnormal myotome development
|
J:99365
|
\Pax3tm1Mrc/\Pax3+
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased satellite cell number
|
J:93443
|
| decreased skeletal muscle fiber diameter
|
J:93443
|
| decreased skeletal muscle mass
|
J:93443
|
| increased skeletal muscle fiber density
|
J:93443
|
| muscle hypoplasia
|
J:93443
|
\Pax3tm1Mrc/\Pax3+
\Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:93443
|
| thin diaphragm muscle
|
J:93443
|
\Pax3tm2.1(PAX3/FOXO1A)Buck/\Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:86911
|
| abnormal intercostal muscle morphology
|
J:86911
|
| abnormal muscle development
|
J:86911
|
| abnormal myogenesis
|
J:86911
|
| abnormal myotome morphology
|
J:86911
|
| abnormal skeletal muscle morphology
|
J:86911
|
\Pax3tm2.1(PAX3/FOXO1A)Buck/\Pax3Sp
(involves: 129S2/SvPas * BALB/c * C57BL * C57BL/6)
|
abnormal muscle development
|
J:86911
|
\Pax3tm2Joe/\Pax3tm2Joe
(involves: 129S1/Sv * 129X1/SvJ)
|
absent hypaxial muscle
|
J:159124
|
\Pax3tm2Joe/\Pax3tm2Joe
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
hypaxial muscle hypoplasia
|
J:159124
|
\Pax3tm3(Pax7)Buck/\Pax3tm3(Pax7)Buck
(involves: 129S2/SvPas)
|
abnormal muscle development
|
J:90568
|
\Pax3tm3.1(Pax7)Buck/\Pax3Sp
(involves: 129S2/SvPas)
|
abnormal diaphragm development
|
J:90568
|
| abnormal myogenesis
|
J:90568
|
\Pax3tm3.1(Pax7)Buck/\Pax3tm3.1(Pax7)Buck
(involves: 129S2/SvPas)
|
abnormal diaphragm development
|
J:90568
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:90568
|
| abnormal myogenesis
|
J:90568
|
\Pax3tm5.1Buck/\Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:112275
|
| abnormal myogenesis
|
J:112275
|
\Pax3tm6(Pax8)Buck/\Pax3+
(involves: 129S2/SvPas)
|
abnormal muscle development
|
J:176192
|
| abnormal myotome development
|
J:176192
|
\Pax3tm6(Pax8)Buck/\Pax3tm6(Pax8)Buck
(involves: 129S2/SvPas)
|
absent skeletal muscle
|
J:176192
|
\Pax3tm6.1(Pax8)Buck/\Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal muscle development
|
J:176192
|
| abnormal myotome development
|
J:176192
|
\Pax3tm6.1(Pax8)Buck/\Pax3tm6.1(Pax8)Buck
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:176192
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:176192
|
| abnormal myotome development
|
J:176192
|
| absent skeletal muscle
|
J:176192
|
\Pax3tm6.1(Pax8)Buck/\Pax3tm6.2Buck
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal muscle development
|
J:176192
|
\Pax6tm2Pgr/\Pax6+
\Tg(Dct-cre)1Apdn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intraocular muscle morphology
|
J:152253
|
\Pax7tm1(cre)Mrc/\Pax7+
\Styxl2tm1Nju/\Styxl2tm1Nju
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal sarcomere morphology
|
J:351096
|
| abnormal skeletal muscle morphology
|
J:351096
|
\Pax7tm1(cre/ERT2)Gaka/0
\Snhg15tm1.1Nju/\Snhg15tm1.1Nju
(involves: C57BL/6J * SJL/J)
|
delayed skeletal muscle regeneration
|
J:291983
|
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
\Gt(ROSA)26Sortm1(DTA)Mrc/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
decreased satellite cell number
|
J:174914
|
| impaired skeletal muscle regeneration
|
J:174914
|
| skeletal muscle fibrosis
|
J:174914
|
\Pax7tm1(cre/ERT2)Gaka/\Pax7tm1(cre/ERT2)Gaka
\Styxl2tm1Nju/\Styxl2tm1Nju
(involves: 129S * C57BL/6)
|
abnormal sarcomere morphology
|
J:351096
|
| impaired skeletal muscle contractility
|
J:351096
|
| impaired skeletal muscle regeneration
|
J:351096
|
\Pax7tm1.1(HBEGF,-EYFP)Mal/\Pax7+
(involves: C57BL/6)
|
decreased skeletal muscle mass
|
J:180899
|
| impaired skeletal muscle regeneration
|
J:180899
|
| muscle phenotype
|
J:180899
|
| myositis
|
J:180899
|
\Pax7tm1.1(HBEGF,-EYFP)Mal/\Pax7+
\Tg(Pax7-EGFP)15Tajb/0
(involves: C57BL/6 * SJL/J)
|
abnormal muscle regeneration
|
J:180899
|
| decreased satellite cell number
|
J:180899
|
\Pax7tm1.1(rtTA)Sjl/\Pax7tm1.1(rtTA)Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle weight
|
J:188599
|
\Pax7tm1.1(rtTA)Sjl/\Pax7tm1.1(rtTA)Sjl
\Tg(Myl1-FST)F66Sjl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
(Not Specified)
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
\Myf5tm1(cre)Mrc/\Myf5+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased satellite cell number
|
J:202693
|
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor)
|
decreased satellite cell number
|
J:202693
|
| decreased skeletal muscle fiber diameter
|
J:202693
|
| decreased skeletal muscle fiber number
|
J:202693
|
| impaired skeletal muscle regeneration
|
J:202693
|
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
\Tg(CMV-cre)1Cgn/0
(involves: BALB/cJ)
|
abnormal muscle morphology
|
J:202693
|
| decreased satellite cell number
|
J:202693
|
\Pax7tm1.1Thbr/\Pax7tm2.1(cre/ERT2)Fan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle regeneration
|
J:202693
|
| abnormal skeletal muscle morphology
|
J:202693
|
| abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
| decreased satellite cell number
|
J:202693
|
| decreased skeletal muscle size
|
J:202693
|
| muscle phenotype
|
J:202693
|
| skeletal muscle fibrosis
|
J:202693
|
| skeletal muscle necrosis
|
J:202693
|
\Pax7tm1.2Fan/\Pax7tm1.2Fan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
impaired skeletal muscle regeneration
|
J:150962
|
| skeletal muscle fibrosis
|
J:150962
|
\Pax7tm1Pgr/\Pax7tm1Pgr
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:64793
|
| decreased skeletal muscle fiber diameter
|
J:64793
|
| muscle phenotype
|
J:32018
|
| muscle weakness
|
J:64793
|
| thin diaphragm muscle
|
J:64793
|
\Pax7tm2Pgr/\Pax7tm2Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal muscle regeneration
|
J:92280
|
| decreased satellite cell number
|
J:92280
|
\Pax9tm1Rbal/\Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal autopod muscle morphology
|
J:49857
|
| abnormal tendon morphology
|
J:49857
|
\Pbx1tm1Mlc/\Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
diaphragmatic hernia
|
J:182007
|
\Pbx4em2Hncs/\Pbx4em2Hncs
(involves: C57BL/6J * DBA * ICR)
|
abnormal quadriceps morphology
|
J:349843
|
\Pccatm1Tmiy/\Pccatm1Tmiy
\Tg(CAG-PCCA*A138T,-EGFP)#Miab/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:282292
|
\Pcdh15m2Btlr/\Pcdh15m2Btlr
(involves: C57BL/6J)
|
dystonia
|
J:198553
|
\Pcdha9em1Zhxu/\Pcdha9em1Zhxu
(C57BL/6-Pcdha9em1Zhxu)
|
abnormal muscle electrophysiology
|
J:360856
|
| muscular atrophy
|
J:360856
|
\Pcdha9em2Zhxu/\Pcdha9em2Zhxu
(C57BL/6-Pcdha9em2Zhxu)
|
muscular atrophy
|
J:360856
|
\Pcdhgtm1.1Tman/\Pcdhgtm1.1Tman
(involves: 129S4/SvJae * C57BL/6)
|
muscle hypertonia
|
J:188341
|
\Pcmt1tm1Shs/\Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:46228
|
\Pcolcetm1Dgr/\Pcolcetm1Dgr
(involves: 129X1/SvJ * Black Swiss)
|
abnormal tendon morphology
|
J:104148
|
\Pcsk1N222D/\Pcsk1N222D
(C57BL/6-Pcsk1N222D)
|
decreased skeletal muscle mass
|
J:109531
|
| increased skeletal muscle mass
|
J:109531
|
\Pdctm1Luhe/\Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
decreased vasodilation
|
J:155373
|
| increased heart ventricle muscle contractility
|
J:155373
|
| increased vasoconstriction
|
J:155373
|
| vascular smooth muscle hypertrophy
|
J:155373
|
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon)
|
abnormal cardiac muscle contractility
|
J:66979
|
\Pdcd10tm1.1Wami/\Pdcd10tm1.1Wami
(involves: 129 * C57BL/6)
|
myocardial trabeculae hypoplasia
|
J:171969
|
| thin myocardium
|
J:171969
|
\Pdcd10tm1Kwhi/\Pdcd10tm1Kwhi
\Nfatc1tm1.1(cre)Bz/\Nfatc1+
(involves: 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:238897
|
\Pdcd10tm1Wami/\Pdcd10tm1Wami
\Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
abnormal myocardium layer morphology
|
J:171969
|
| myocardial trabeculae hypoplasia
|
J:171969
|
| thin myocardium
|
J:171969
|
\Pde1aem1Cjwa/\Pde1aem1Cjwa
(C57BL/6J-Pde1aem1Cjwa)
|
increased heart left ventricle muscle contractility
|
J:246596
|
\Pde1aem2Cjwa/\Pde1aem2Cjwa
(C57BL/6J-Pde1aem2Cjwa)
|
increased heart left ventricle muscle contractility
|
J:246596
|
\Pde4dtm1Mct/\Pde4dtm1Mct
(involves: 129P2/OlaHsd)
|
increased cardiac muscle contractility
|
J:96125
|
\Pdgfatm1Cbet/\Pdgfatm1Cbet
(involves: 129P2/OlaHsd * C57BL)
|
heart right ventricle hypertrophy
|
J:33629
|
\Pdgfatm1Cbet/\Pdgfatm1Cbet
\Pdgfctm1Nagy/\Pdgfctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myotome development
|
J:93954
|
\Pdgfbtm1Cbet/\Pdgfbtm1Cbet
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:20017
|
\Pdgfbtm1Cbet/\Pdgfbtm2Cbet
\Tg(Tie1-cre)9Ref/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
thin myocardium
|
J:89186
|
\Pdgfbtm3.1Cbet/\Pdgfbtm3.1Cbet
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle morphology
|
J:84701
|
\Pdgfratm1Sor/\Pdgfra+
\Plekha1Gt(ROSA)82Sor/\Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
\Pdgfratm1Sor/\Pdgfra+
\Schip1Gt(ROSA)77Sor/\Schip1Gt(ROSA)77Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
\Pdgfratm1Sor/\Pdgfratm1Sor
(either: 129S4/SvJaeSor-Pdgfratm1Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myotome development
|
J:41814
|
| abnormal myotome morphology
|
J:41814
|
\Pdgfratm2Sor/\Pdgfratm2Sor
(either: 129S4/SvJaeSor-Pdgfratm2Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myotome development
|
J:41814
|
| abnormal myotome morphology
|
J:41814
|
\Pdgfratm2Sor/\Pdgfratm2Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal diaphragm development
|
J:160875
|
| diaphragmatic hernia
|
J:160875
|
\Pdgfrbtm1Sor/\Pdgfrb+
\Schip1Gt(ROSA)77Sor/\Schip1Gt(ROSA)77Sor
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal smooth muscle morphology
|
J:117491
|
\Pdgfrbtm1Sor/\Pdgfrbtm5Sor
(either: (involves: 129S4/SvJaeSor * 129S7/SvEvBrd) or (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6))
|
myocardial fiber disarray
|
J:67735
|
\Pdgfrbtm14(Pdgfrb)Sor/\Pdgfrb+
\Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:173602
|
| vascular smooth muscle hyperplasia
|
J:173602
|
\Pdha1tm1Ptl/Y
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
| heart left ventricle hypertrophy
|
J:141289
|
| increased myocardial fiber size
|
J:141289
|
\Pdha1tm1Ptl/\Pdha1+
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
| increased myocardial fiber size
|
J:141289
|
\Pdk2tm1Rhar/\Pdk2tm1Rhar
(B6.129-Pdk2tm1Rhar)
|
impaired skeletal muscle contractility
|
J:172411
|
\Pdlim3tm1Krc/\Pdlim3tm1Krc
(either: (involves: 129S) or (involves: C57BL/6) or (involves: Black Swiss))
|
decreased heart right ventricle muscle contractility
|
J:69097
|
| dilated cardiomyopathy
|
J:69097
|
| trabecula carnea hypoplasia
|
J:69097
|
\Pdlim5tm1.1Chen/\Pdlim5tm1.1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:175042
|
| abnormal Z line morphology
|
J:175042
|
| dilated cardiomyopathy
|
J:175042
|
\Pdlim5tm1Chen/\Pdlim5tm1Chen
\Tg(Tnnt2-cre)5Blh/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA/2)
|
decreased heart left ventricle muscle contractility
|
J:175042
|
| dilated cardiomyopathy
|
J:175042
|
\Pdpk1tm1.1Mlw/\Pdpk1tm1.1Mlw
\Tg(Ckmm-cre)5Khn/?
(involves: BALB/c)
|
abnormal myocardial fiber morphology
|
J:85498
|
| abnormal Z line morphology
|
J:85498
|
| decreased cardiac muscle contractility
|
J:85498
|
| dilated cardiomyopathy
|
J:85498
|
| heart right ventricle hypertrophy
|
J:85498
|
| myocardium hypoplasia
|
J:85498
|
\Pdpntm1Acgg/\Pdpntm1Acgg
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal myocardial trabeculae morphology
|
J:132132
|
| abnormal myocardium compact layer morphology
|
J:132132
|
| abnormal myocardium layer morphology
|
J:132132
|
| thin myocardium
|
J:132132
|
\Pds5aGt(RRM243)Byg/\Pds5a+
\Pds5btm1Jmi/\Pds5btm1Jmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:148890
|
\Pds5aGt(RRM243)Byg/\Pds5aGt(RRM243)Byg
\Pds5btm1Jmi/\Pds5b+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:148890
|
\Pdss2kd/\Pdss2kd
(CBA/H-Pdss2kd)
|
myopathy
|
J:197578
|
\Pdss2tm1.1Jdhu/\Pdss2tm1.2Jdhu
\Tg(Pax2-cre)1Akg/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal skeletal muscle morphology
|
J:179845
|
\Pdx1tm1Cvw/\Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pyloric sphincter morphology
|
J:32017
|
\Pdx1tm2Cvw/\Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pyloric sphincter morphology
|
J:32017
|
\Pdxptm1.2Ango/\Pdxptm1.2Ango
(involves: C57BL/6J)
|
muscle weakness
|
J:270551
|
\Pdzk1tm2b(EUCOMM)Wtsi/\Pdzk1tm2b(EUCOMM)Wtsi
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
\Pecam1Gt(OST16303)Lex/\Pecam1Gt(OST16303)Lex
(B6.129S5-Pecam1Gt(OST16303)Lex)
|
decreased vasodilation
|
J:104082
|
\Pecam1Gt(OST16303)Lex/\Pecam1Gt(OST16303)Lex
(B6.129S-Pecam1Gt(OST16303)Lex/J)
|
abnormal vasodilation
|
J:114343
|
| decreased vasodilation
|
J:114343
|
\Pepddal/\Pepddal
(involves: C3H/HeJ * CBA/J)
|
abnormal cardiac muscle tissue morphology
|
J:215150
|
| abnormal myocardial fiber morphology
|
J:215150
|
| myocardium hypertrophy
|
J:215150
|
\Perm1em1Jswn/\Perm1em1Jswn
(C57BL/6-Perm1em1Jswn)
|
decreased cardiac muscle contractility
|
J:334191
|
\Pex1tm1e.1(EUCOMM)Hmgu/\Pex1+
(C57BL/6NCrl-Pex1tm1e.1(EUCOMM)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Pex5tm1Baes/\Pex5tm1Baes
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:42719
|
\Pex7tm1Rjaw/\Pex7tm1Rjaw
(Swiss)
|
dystonia
|
J:92346
|
\Pex13tm1.1Crne/\Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J)
|
hypotonia
|
J:84795
|
\Pfkfb3tm1.1Pec/\Pfkfb3tm1.1Pec
\Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
decreased skeletal muscle fiber diameter
|
J:296552
|
| skeletal muscle necrosis
|
J:296552
|
\Pfkmtm1Fbos/\Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal muscle physiology
|
J:152153
|
| abnormal skeletal muscle fiber morphology
|
J:152153
|
| centrally nucleated skeletal muscle fibers
|
J:152153
|
| enhanced skeletal muscle regeneration
|
J:152153
|
| heart left ventricle hypertrophy
|
J:152153
|
| increased cardiac muscle glycogen level
|
J:152153
|
| increased skeletal muscle glycogen level
|
J:152153
|
| skeletal muscle fiber degeneration
|
J:152153
|
| skeletal muscle fiber necrosis
|
J:152153
|
\Pgap2clpex/\Pgap2tm1a(EUCOMM)Wtsi
(involves: A/J * C57BL/6N)
|
myocardium hypoplasia
|
J:277316
|
\Pgrtm1Bwo/\Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
vascular smooth muscle hyperplasia
|
J:118403
|
\Phc1tm1Os/\Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
heart right ventricle hypertrophy
|
J:43764
|
\PhipGt(RRJ571)Byg/\PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased myocardial fiber size
|
J:164354
|
\Phka1I/FnLn/Y
((I/FnLn x C57BL/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
\Phka1I/FnLn/Y
(I/FnLn)
|
increased skeletal muscle glycogen level
|
J:5156
|
\Phka1I/FnLn/\Phka1+
((C57BL/FnLn x I/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
\Phka1I/FnLn/\Phka1+
((I/FnLn x C57BL/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
\Phka1I/FnLn/\Phka1I/FnLn
(I/FnLn)
|
increased skeletal muscle glycogen level
|
J:5156
|
\Pik3c3tm1c(EUCOMM)Wtsi/\Pik3c3tm1c(EUCOMM)Wtsi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:182628
|
\Pik3catm1.1Rzl/\Pik3catm1.1Rzl
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:166421
|
\Pik3catm1.1Waph/\Pik3ca+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal diaphragm morphology
|
J:184382
|
\Pik3catm1Bvan/\Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:109024
|
\Pik3cgtm1Ehi/\Pik3cgtm1Ehi
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:91945
|
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:79151
|
| increased cardiac muscle contractility
|
J:79151
|
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
\Ptentm2Mak/\Ptentm2Mak
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased cardiac muscle contractility
|
J:79151
|
\Pik3cgtm1Wym/\Pik3cgtm1Wym
(involves: 129S1/Sv * 129X1/SvJ)
|
increased cardiac muscle contractility
|
J:79151
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
increased skeletal muscle fiber size
|
J:65523
|
\Pik3r1tm1Lca/\Pik3r1tm1Lca
\Pik3r2tm1Lca/\Pik3r2tm1Lca
\Tg(Ckmm-cre)5Khn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
decreased myocardial fiber size
|
J:102176
|
\Pik3r1tm1Tka/\Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
increased skeletal muscle cell glucose uptake
|
J:52576
|
\Pik3r1tm2Dfr/\Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
increased skeletal muscle fiber size
|
J:94077
|
\Pik3r4tm1.1Mpnd/\Pik3r4tm1.1Mpnd
\Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)
|
abnormal sarcolemma morphology
|
J:198770
|
| centrally nucleated skeletal muscle fibers
|
J:198770
|
| increased skeletal muscle glycogen level
|
J:198770
|
| muscle weakness
|
J:198770
|
| myopathy
|
J:198770
|
| myositis
|
J:198770
|
| skeletal muscle degeneration
|
J:198770
|
| skeletal muscle fiber necrosis
|
J:198770
|
\PikfyveGt(AT0926)Wtsi/\PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal atrium myocardium morphology
|
J:190368
|
| abnormal ventricle myocardium morphology
|
J:190368
|
\Pikfyvetm1.1Ashi/\Pikfyvetm1.1Ashi
\Tg(Ckm-cre)28Arte/0
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:199213
|
| muscle phenotype
|
J:199213
|
\Pitx1tm1Rsd/\Pitx1+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle hypoplasia
|
J:175799
|
\Pitx2tm1.1Sac/\Pitx2tm2Sac
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
\Gt(ROSA)26Sortm1Sor/?
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal eye muscle development
|
J:104125
|
\Pitx2tm1Jfm/\Pitx2tm1Jfm
(involves: 129S4/SvJaeSor)
|
absent extraocular muscles
|
J:57674
|
\Pitx2tm1Kki/\Pitx2tm1Kki
(involves: 129P2/OlaHsd * C57BL)
|
absent extraocular muscles
|
J:55455
|
\Pitx2tm1Rsd/\Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal extraocular muscle morphology
|
J:57673
|
| abnormal facial muscle morphology
|
J:57673
|
\Pitx2tm1Sac/\Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal eye muscle morphology
|
J:51160
|
\Pitx2tm2Sac/\Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal eye muscle development
|
J:51160
|
\Pkd1b2b1585Clo/\Pkd1b2b1585Clo
(C57BL/6J-Pkd1b2b1585Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Pkd1tm1Rsa/\Pkd1tm1Rsa
(involves: 129S4/SvJaeSor)
|
abnormal myocardial trabeculae morphology
|
J:72238
|
| thin myocardium
|
J:72238
|
\Pkd1tm1Shh/\Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:193544
|
| thick myocardium
|
J:193544
|
\Pkn1tm1Ajmc/\Pkn1tm1Ajmc
(B6.129P2-Pkn1tm1Ajmc)
|
decreased cardiac muscle contractility
|
J:258572
|
| decreased cardiac muscle relaxation
|
J:258572
|
\Pkp2tm1Wbm/\Pkp2tm1Wbm
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:93314
|
| trabecula carnea hypoplasia
|
J:93314
|
\pl/\pl
(involves: PERU-COPPOCK)
|
abnormal muscle tone
|
J:14122
|
\Pla2g4atm1Jvb/\Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
increased myocardial fiber size
|
J:99600
|
| increased skeletal muscle fiber diameter
|
J:99600
|
\Pla2g5tm1.1Kiku/\Pla2g5tm1.1Kiku
(involves: 129 * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:186024
|
| abnormal cardiomyocyte apoptosis
|
J:186024
|
\Pla2g6m1Sein/\Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
muscular atrophy
|
J:153195
|
| skeletal muscle atrophy
|
J:155328
|
\Pla2g10tm1Kiku/\Pla2g10tm1Kiku
(B6.129P2-Pla2g10tm1Kiku)
|
abnormal cardiac muscle contractility
|
J:155082
|
\Plaaem1Pmi/\Plaaem1Pmi
(C57BL/6J-Plaaem1Pmi)
|
decreased skeletal muscle fiber diameter
|
J:240526
|
| skeletal muscle fiber atrophy
|
J:240526
|
| skeletal muscle necrosis
|
J:240526
|
\Plaat1em1Ueda/\Plaat1em1Ueda
(C57BL/6NCrSlc-Plaat1em1Ueda)
|
decreased gastrocnemius weight
|
J:343807
|
| decreased skeletal muscle weight
|
J:343807
|
\Plaat3em1Ueda/\Plaat3em1Ueda
(C57BL/6NCrSlc-Plaat3em1Ueda)
|
decreased gastrocnemius weight
|
J:343807
|
| decreased skeletal muscle weight
|
J:343807
|
\Plattm1Mlg/\Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:95236
|
| heart left ventricle hypertrophy
|
J:95236
|
\Plattm1Mlg/\Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
muscle phenotype
|
J:68083
|
\Platr4em#Dlsp/\Platr4em#Dlsp
(B6.Cg-Platr4em#Dlsp)
|
abnormal myocardium layer morphology
|
J:331476
|
| decreased cardiac muscle contractility
|
J:331476
|
| heart left ventricle hypertrophy
|
J:331476
|
\Plautm1Mlg/\Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased heart left ventricle muscle contractility
|
J:95236
|
\Plautm1Mlg/\Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
impaired skeletal muscle regeneration
|
J:68083
|
| myopathy
|
J:73613
|
\Plaurtm1Mlg/\Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg)
|
myoclonus
|
J:81735
|
\Plcb4tm1Hssh/\Plcb4tm1Hssh
(Not Specified)
|
muscle phenotype
|
J:43077
|
\Plce1tm1Avsm/\Plce1tm1Avsm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:117556
|
\Plce1tm1Tkat/\Plce1tm1Tkat
(involves: 129/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:97661
|
| decreased heart ventricle muscle contractility
|
J:97661
|
\Plectm1Gwi/\Plectm1Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercalated disk morphology
|
J:59000
|
| abnormal myocardial fiber morphology
|
J:59000
|
| abnormal skeletal muscle fiber morphology
|
J:59000
|
| muscle degeneration
|
J:59000
|
| myopathy
|
J:59000
|
\Plectm1Gwi/\Plectm4Gwi
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:137067
|
| abnormal myocardial fiber morphology
|
J:137067
|
| abnormal sarcolemma morphology
|
J:137067
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal soleus morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| decreased skeletal muscle mass
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| muscle phenotype
|
J:137067
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
\Plectm2Gwi/\Plectm2Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercalated disk morphology
|
J:59000
|
| abnormal myocardial fiber morphology
|
J:59000
|
| abnormal skeletal muscle fiber morphology
|
J:59000
|
| muscle degeneration
|
J:59000
|
| myopathy
|
J:59000
|
\Plectm3Gwi/\Plectm3Gwi
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:137067
|
\Plectm4Gwi/\Plectm4Gwi
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:137067
|
| abnormal myocardial fiber morphology
|
J:137067
|
| abnormal sarcolemma morphology
|
J:137067
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal soleus morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| decreased skeletal muscle mass
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| muscle phenotype
|
J:137067
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
\Plectm5Gwi/\Plectm5Gwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber diameter
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
\Plectm6Gwi/\Plectm6Gwi
(Not Specified)
|
muscle phenotype
|
J:137067
|
\Plekha1Gt(ROSA)82Sor/\Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
\Plekha1tm1.1Arte/\Plekha1tm1.1Arte
\Plekha2tm1.1Arte/\Plekha2tm1.1Arte
(C57BL/6J-Plekha1tm1.1Arte Plekha2tm1.1Arte)
|
increased cardiac muscle cell glucose uptake
|
J:169475
|
| increased skeletal muscle cell glucose uptake
|
J:169475
|
\Plekhg5tm1Jbar/\Plekhg5tm1Jbar
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased heart ventricle muscle contractility
|
J:195233
|
\Plin1tm1Chan/\Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased gastrocnemius weight
|
J:66267
|
\Plin4tm1Vlcg/\Plin4tm1Vlcg
(B6.Cg-Plin4tm1Vlcg)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
\Plin5tm1e(KOMP)Wtsi/\Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased cardiac muscle triglyceride level
|
J:221539
|
| decreased skeletal muscle glycogen level
|
J:221539
|
| decreased skeletal muscle triglyceride level
|
J:221539
|
\Plin5tm1Macl/\Plin5tm1Macl
(involves: 129S6/SvEvTac * C57BL/6JBomTac)
|
decreased cardiac muscle contractility
|
J:286482
|
| decreased cardiac muscle triglyceride level
|
J:286482
|
| increased cardiac muscle cell glucose uptake
|
J:286482
|
\Plin5tm1Tosu/\Plin5tm1Tosu
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:188390
|
| decreased cardiac muscle triglyceride level
|
J:188390
|
\Plk3tm1Dai/\Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:136425
|
\Plntm1Egk/\Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:39745,
J:59967
|
\Plntm1Egk/\Plntm1Egk
(involves: 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
\Plntm1Egk/\Plntm1Egk
\Tg(Myh6-Pln)11Egk/?
(involves: 129S2/SvPas)
|
abnormal cardiac muscle contractility
|
J:66084
|
\Plntm1Egk/\Plntm1Egk
\Tnnt2tm2.1Feah/\Tnnt2+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
| dilated cardiomyopathy
|
J:243725
|
\Plod1tm1Soin/\Plod1tm1Soin
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:120891
|
| hypotonia
|
J:120891
|
\Plod2tm1.1Krako/\Plod2tm1.1Krako
(C3H.B6(Cg)-Plod2tm1.1Krako)
|
abnormal tendon morphology
|
J:358139
|
\Plod2tm1.1Krako/\Plod2tm1.1Krako
\Tg(Scx-GFP)1Stzr/0
(involves: C3H/HeJ * C57BL/6)
|
abnormal tendon morphology
|
J:358139
|
\Plod3tm1Rmyl/\Plod3tm1Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
\Plod3tm2Rmyl/\Plod3tm2Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
\Plpp7em1Eno/\Plpp7em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal cardiac muscle tissue morphology
|
J:302139
|
| abnormal muscle physiology
|
J:302139
|
| abnormal sarcomere morphology
|
J:302139
|
| abnormal skeletal muscle fiber morphology
|
J:302139
|
| decreased skeletal muscle fiber diameter
|
J:302139
|
| muscle phenotype
|
J:302139
|
| muscle weakness
|
J:302139
|
\Plrg1tm2Jcbr/\Plrg1tm2Jcbr
\Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:149153
|
| dilated cardiomyopathy
|
J:149153
|
| increased cardiomyocyte apoptosis
|
J:149153
|
\Pls3em1Bult/Y
(C57BL/6J-Pls3em1Bult/BultJ)
|
abnormal abdominal muscle morphology
|
J:341714
|
| abnormal diaphragm morphology
|
J:341714
|
| diaphragmatic hernia
|
J:341714
|
| thin diaphragm muscle
|
J:341714
|
\Pls3em1Bult/\Pls3em1Bult
(C57BL/6J-Pls3em1Bult/BultJ)
|
abnormal abdominal muscle morphology
|
J:341714
|
| abnormal diaphragm development
|
J:341714
|
| abnormal diaphragm morphology
|
J:341714
|
| diaphragmatic hernia
|
J:341714
|
| thin diaphragm muscle
|
J:341714
|
\Plxnd1em1Zho/\Plxnd1+
(C57BL/6-Plxnd1em1Zho)
|
abnormal ventricle myocardium morphology
|
J:326461
|
| thin myocardium
|
J:326461
|
\Plxnd1em1Zho/\Plxnd1em1Zho
(C57BL/6-Plxnd1em1Zho)
|
abnormal ventricle myocardium morphology
|
J:326461
|
| thin myocardium
|
J:326461
|
\Plxnd1tm1.1Tmj/\Plxnd1tm1.1Tmj
\Tg(Tek-cre)1Ywa/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:143763
|
\Plxnd1tm1Joe/\Plxnd1tm1Joe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:91658
|
\pma/\pma
(involves: CF-1)
|
abnormal muscle fiber morphology
|
J:4723,
J:4724,
J:8195
|
| muscle degeneration
|
J:4723
|
| muscular atrophy
|
J:86652,
J:4723,
J:4724,
J:6590,
J:8195
|
| myopathy
|
J:8195
|
\Pmm2tm1.1Cknr/\Pmm2tm2.1Cknr
(involves: C57BL/6J)
|
abnormal myocardium layer morphology
|
J:180794
|
\Pmm2tm1.1Jins/\Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:236704
|
| abnormal myocardium layer morphology
|
J:236704
|
| hypotonia
|
J:236704
|
\Pmp22tm1Lnot/\Pmp22tm1Lnot
(Not Specified)
|
muscle weakness
|
J:104989
|
\Pmp22Tr-J/\Pmp22+
(involves: C57BL/6)
|
muscle degeneration
|
J:39953
|
\Pnpla2tm1Eek/\Pnpla2tm1Eek
\Tg(Ckmm-cre)5Khn/0
(involves: 129S * FVB/N)
|
increased cardiac muscle triglyceride level
|
J:176252
|
\Pnpla2tm1Eek/\Pnpla2tm1Eek
\Tg(Myog-cre)1Eno/0
(involves: 129S * C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:207007
|
\Pnpla2tm1Rze/\Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:108546
|
| abnormal myocardial fiber morphology
|
J:108546
|
| abnormal myocardium layer morphology
|
J:108546
|
| decreased heart left ventricle muscle contractility
|
J:108546
|
| increased cardiac muscle triglyceride level
|
J:108546
|
\Pnpla2tm1Rze/\Pnpla2tm1Rze
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber mitochondrial morphology
|
J:176252
|
| abnormal myocardial fiber morphology
|
J:176252
|
| decreased heart ventricle muscle contractility
|
J:176252
|
| increased cardiac muscle glycogen level
|
J:176252
|
\Pnpla7tm1.2Murm/\Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm)
|
abnormal skeletal muscle fiber morphology
|
J:333442
|
\Poglut2tm2d(EUCOMM)Hmgu/\Poglut2tm2d(EUCOMM)Hmgu
\Poglut3tm1.3Rsh/\Poglut3tm1.3Rsh
(B6.Cg-Poglut2tm2d(EUCOMM)Hmgu Poglut3tm1.3Rsh)
|
abnormal vascular smooth muscle morphology
|
J:350484
|
\Pogzem1Tnkw/\Pogz+
(involves: C57BL/6NJcl)
|
muscle phenotype
|
J:286398
|
\Polbtm1a(KOMP)Wtsi/\Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Pold1tm1Loeb/\Pold1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:129046
|
\Poldip2Gt(IST12080D9)Tigm/\Poldip2+
(involves: C57BL/6N)
|
abnormal vasoconstriction
|
J:211022
|
| abnormal vasodilation
|
J:211022
|
\Polgtm1.1Lrsn/\Polgtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:91077
|
\Polgtm1Prol/\Polgtm1Prol
(involves: 129S7/SvEvBrd * C57BL/6J * ICR)
|
decreased skeletal muscle mass
|
J:99764
|
\Polrmttm1.1Arte/\Polrmttm1.1Arte
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
dilated cardiomyopathy
|
J:258184
|
\Pomgnt1Gt(OST179231)Lex/\Pomgnt1Gt(OST179231)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:107697
|
| abnormal tongue muscle morphology
|
J:107697
|
| centrally nucleated skeletal muscle fibers
|
J:107697
|
| dystrophic muscle
|
J:107697
|
| increased variability of skeletal muscle fiber size
|
J:107697
|
\Pomgnt1tm1Stk/\Pomgnt1tm1Stk
(involves: 129S/SvEv)
|
abnormal muscle physiology
|
J:144928
|
| abnormal muscle regeneration
|
J:144928
|
| abnormal skeletal muscle satellite cell proliferation
|
J:144928
|
| decreased skeletal muscle fiber number
|
J:144928
|
| decreased skeletal muscle fiber size
|
J:144928
|
| dystrophic muscle
|
J:144928
|
\Pomt1Gt(OST194127)Lex/\Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased vasodilation
|
J:103485
|
\Popdc1tm1Tbd/\Popdc1tm1Tbd
(involves: 129S4/SvJae)
|
abnormal sinoatrial node morphology
|
J:184566
|
| delayed skeletal muscle regeneration
|
J:74656
|
\Popdc2tm1Tbd/\Popdc2tm1Tbd
(B6.129S2(FVB)-Popdc2tm1Tbd)
|
abnormal sinoatrial node morphology
|
J:184566
|
\Portm1Cbk/\Portm1Cbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:74666
|
| absent trabeculae carneae
|
J:74666
|
\Postntm1Sjc/\Postntm1Sjc
(involves: C57BL/6)
|
muscle phenotype
|
J:103753
|
\Pparatm1Gonz/\Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:50024
|
| cardiomyopathy
|
J:81834
|
\Pparatm1Gonz/\Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz)
|
abnormal myocardium layer morphology
|
J:56056
|
\Pparatm1Gonz/\Pparatm1Gonz
(involves: 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:63801
|
| cardiomyopathy
|
J:63801
|
| myocardial fiber degeneration
|
J:63801
|
| myocardium necrosis
|
J:63801
|
\Pparatm1Gonz/\Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J)
|
increased muscle cell glucose uptake
|
J:129848
|
| increased skeletal muscle triglyceride level
|
J:129848
|
\Ppardtm1Dsvg/\Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle mass
|
J:219677
|
| muscle weakness
|
J:219677
|
\Ppargtm1.1Gonz/\Ppargtm1.1Gonz
(involves: 129X1/SvJ * FVB)
|
increased myocardial fiber size
|
J:112034
|
\Ppargtm1Lja/\Pparg+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased skeletal muscle cell glucose uptake
|
J:98786
|
\Ppargtm1Rev/\Ppargtm1Rev
(involves: 129S4/SvJae)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:58223
|
| abnormal myocardial trabeculae morphology
|
J:58223
|
| thin myocardium
|
J:58223
|
| thin ventricle myocardium compact layer
|
J:58223
|
\Ppargtm1Tka/\Ppargtm1Tka
(involves: C57BL/6 * CBA)
|
thin myocardium
|
J:58222
|
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Tagln-cre)1Her/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
heart right ventricle hypertrophy
|
J:136168
|
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
heart right ventricle hypertrophy
|
J:155909
|
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Tek-cre)12Flv/?
(B6.Cg-Ppargtm2Rev Tg(Tek-cre)12Flv)
|
abnormal vasodilation
|
J:154216
|
| impaired muscle relaxation
|
J:154216
|
\Ppargc1atm1Brsp/\Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
dystonia
|
J:93896
|
| myoclonus
|
J:93896
|
\Ppargc1atm1Dpk/\Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:96306
|
| decreased gastrocnemius weight
|
J:96306
|
| decreased heart left ventricle muscle contractility
|
J:96306
|
| decreased skeletal muscle weight
|
J:96306
|
| decreased soleus weight
|
J:96306
|
| increased muscle fatigability
|
J:96306
|
\Ppargc1atm1Dpk/\Ppargc1atm1Dpk
\Ppargc1btm1.1Dpk/\Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
abnormal myocardium layer morphology
|
J:137598
|
\Ppargc1atm1Dpk/\Ppargc1atm1Dpk
\Ppargc1btm1Dpk/\Ppargc1btm1Dpk
\Tg(Myh6-cre)2182Mds/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal myocardium layer morphology
|
J:137598
|
\Ppargc1btm1.1Avp/\Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:116167
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:116167
|
\Ppargc1btm1.1Dpk/\Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
abnormal muscle physiology
|
J:137598
|
| muscle phenotype
|
J:137598
|
\Ppp1r3atm1Adpr/\Ppp1r3atm1Adpr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J))
|
decreased skeletal muscle glycogen level
|
J:68370
|
\Ppp1r3atm1Ptwc/\Ppp1r3atm1Ptwc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:82422
|
| decreased skeletal muscle glycogen level
|
J:82422
|
\Ppp1r3atm2Adpr/\Ppp1r3a+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:134157
|
\Ppp1r3atm2Adpr/\Ppp1r3atm2Adpr
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:134157
|
\Ppp1r3ctm1Adpr/\Ppp1r3ctm1Adpr
(B6.Cg-Ppp1r3ctm1Adpr)
|
increased muscle cell glucose uptake
|
J:242758
|
\Ppp1r3ctm1Ars/\Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars)
|
decreased cardiac muscle glycogen level
|
J:83297
|
| decreased skeletal muscle cell glucose uptake
|
J:83297
|
| decreased skeletal muscle glycogen level
|
J:83297
|
| increased skeletal muscle triglyceride level
|
J:83297
|
\Ppp1r12atm1Mzhu/\Ppp1r12atm1Mzhu
\Tg(Acta2-cre)#Xya/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal muscle contractility
|
J:207752
|
| abnormal muscle electrophysiology
|
J:207752
|
| abnormal smooth muscle morphology
|
J:207752
|
| intestinal hypoperistalsis
|
J:207752
|
\Ppp1r12bem1(IMPC)J/\Ppp1r12bem1(IMPC)J
(C57BL/6NJ-Ppp1r12bem1(IMPC)J/Mmjax)
|
increased cardiac muscle contractility
|
J:335272
|
\Ppp1r12bem1Chana/\Ppp1r12bem1Chana
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:346986
|
\Ppp1r13ltm1.1Xlu/\Ppp1r13ltm1.1Xlu
(involves: 129 * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:220162
|
| abnormal myocardial fiber morphology
|
J:220162
|
| abnormal myocardium layer morphology
|
J:220162
|
| cardiac muscle degeneration
|
J:220162
|
| decreased heart ventricle muscle contractility
|
J:220162
|
| disorganized myocardium
|
J:220162
|
| ventricular cardiomyopathy
|
J:220162
|
\Ppp1r13lwa3-J/\Ppp1r13lwa3-J
(BALB/cJ-Ppp1r13lwa3-J/J)
|
cardiomyopathy
|
J:146206
|
| dilated cardiomyopathy
|
J:264272
|
\Ppp1r13lwa3/\Ppp1r13lwa3
(either: C57BL/6-Ppp1r13lwa3 or (involves: C57BL/6 * DBA/2J))
|
decreased cardiac muscle contractility
|
J:96392
|
| dilated cardiomyopathy
|
J:96392
|
| myocardium necrosis
|
J:96392
|
\Ppp1r13lwoe2/\Ppp1r13lwoe2
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:190557
|
\Ppp1r14aem1Gpt/\Ppp1r14a+
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
\Ppp1r14aem1Gpt/\Ppp1r14aem1Gpt
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
\Ppp2r5cGt(XP0444)Wtsi/\Ppp2r5cGt(XP0444)Wtsi
(B6.129P2-Ppp2r5cGt(XP0444)Wtsi)
|
abnormal Z line morphology
|
J:210365
|
| increased fetal cardiomyocyte apoptosis
|
J:210365
|
| thin myocardium
|
J:210365
|
\Ppp2r5cGt(XP0444)Wtsi/\Ppp2r5cGt(XP0444)Wtsi
\Ppp2r5dGt(RRT114)Byg/\Ppp2r5dGt(RRT114)Byg
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased fetal cardiomyocyte apoptosis
|
J:348684
|
\Ppp3catm1Jse/\Ppp3catm1Jse
(involves: 129S4/SvJae)
|
abnormal skeletal muscle fiber type ratio
|
J:110822
|
| decreased skeletal muscle fiber number
|
J:110822
|
| increased skeletal muscle fiber diameter
|
J:110822
|
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac)
|
abnormal skeletal muscle fiber type ratio
|
J:110822
|
| decreased skeletal muscle fiber diameter
|
J:110822
|
| increased skeletal muscle fiber number
|
J:110822
|
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
\Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
\Tg(Myh6-tTA)55Rbns/0
(involves: 129S6/SvEvTac * FVB)
|
decreased cardiac muscle contractility
|
J:234490
|
\Ppp3r1tm1.1Jhon/\Ppp3r1tm1.1Jhon
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal myocardial fiber morphology
|
J:298603
|
| decreased heart left ventricle muscle contractility
|
J:298603
|
| dilated cardiomyopathy
|
J:298603
|
| increased cardiomyocyte apoptosis
|
J:298603
|
\Ppp3r1tm2Grc/\Ppp3r1tm2.1Grc
\Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
\Ppp3r1tm2Grc/\Ppp3r1tm2Grc
\Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
\Ppt1tm1Aj/\Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6)
|
myoclonus
|
J:95522
|
\Ppt1tm1Hof/\Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
myoclonus
|
J:72931
|
\Ppt2tm1Hof/\Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
muscle spasm
|
J:86202
|
\Pptc7em1Pagd/\Pptc7em1Pagd
(C57BL/6J-Pptc7em1Pagd)
|
abnormal myocardial fiber mitochondrial morphology
|
J:277086
|
\Pptc7em2Pagd/\Pptc7em2Pagd
(C57BL/6J-Pptc7em2Pagd)
|
abnormal myocardial fiber mitochondrial morphology
|
J:277086
|
\Prdm1tm1.1Clme/\Prdm1tm1.1Clme
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)
|
abnormal dermomyotome development
|
J:101718
|
\Prdm1tm1.1Clme/\Prdm1tm2Rob
(involves: 129S/Sv * 129X1/Sv * C57BL/6 * FVB/N * ICR)
|
abnormal dermomyotome development
|
J:101718
|
\Prdm1tm1Rob/\Prdm1tm1Rob
(involves: 129S/SvEv * C57BL/6)
|
abnormal myotome development
|
J:101718
|
\Prdm1tm2Rob/\Prdm1tm2Rob
(involves: 129S/SvEv * C57BL/6)
|
abnormal myotome development
|
J:101718
|
\Prdm4tm1b(EUCOMM)Hmgu/\Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
\Prdm6tm1.2Jrld/\Prdm6tm1.2Jrld
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
thin myocardium
|
J:209773
|
\Prdm16tm1.1Brsp/\Prdm16tm1.1Brsp
\Tg(myl7.L-cre)1118Tmhn/0
(involves: 129 * C57BL/6J * MF1)
|
cardiomyopathy
|
J:326525
|
| decreased cardiac muscle contractility
|
J:326525
|
| decreased fetal cardiomyocyte proliferation
|
J:326525
|
| thin left ventricle myocardium compact layer
|
J:326525
|
\Prepltm1.2Sagh/\Prepltm1.2Sagh
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * Swiss Webster)
|
hypotonia
|
J:213429
|
\Prickle1tm1.2Asw/\Prickle1tm1.2Asw
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:213772
|
\Prkaa1tm1Sbj/\Prkaa1tm1Sbj
(involves: 129S2/SvPas * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:87719
|
\Prkaa2tm1.1Vio/\Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:81120
|
\Prkaa2tm1.1Vio/\Prkaa2tm1.1Vio
(involves: 129S2/SvPas)
|
decreased skeletal muscle cell glucose uptake
|
J:87719
|
| decreased skeletal muscle glycogen level
|
J:87719
|
| increased skeletal muscle cell glucose uptake
|
J:87719
|
\Prkab1tm1Grst/\Prkab1tm1Grst
\Prkab2tm1Grst/\Prkab2tm1Grst
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal skeletal muscle morphology
|
J:176578
|
| decreased muscle cell glucose uptake
|
J:176578
|
| increased muscle fatigability
|
J:176578
|
\Prkab2Gt(AL0483)Wtsi/\Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi)
|
decreased muscle cell glucose uptake
|
J:186658
|
| decreased skeletal muscle glycogen level
|
J:186658
|
\Prkab2tm1.1Grst/\Prkab2tm1.1Grst
(involves: C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:167339
|
| decreased skeletal muscle fiber size
|
J:167339
|
| decreased skeletal muscle glycogen level
|
J:167339
|
| increased muscle cell glucose uptake
|
J:167339
|
| muscle weakness
|
J:167339
|
\Prkag2tm1.1Geno/\Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
abnormal sinoatrial node morphology
|
J:256296
|
| decreased cardiac muscle contractility
|
J:256296
|
| increased cardiac muscle glycogen level
|
J:256296
|
\Prkag2tm2.1Mrl/?
(C57BL/6-Prkag2tm2.1Mrl/Tac)
|
increased skeletal muscle glycogen level
|
J:237375
|
\Prkag2tm3.1Mrl/?
(C57BL/6-Prkag2tm3.1Mrl/Tac)
|
increased cardiac muscle glycogen level
|
J:237375
|
| increased skeletal muscle glycogen level
|
J:237375
|
\Prkag3tm1Sson/\Prkag3tm1Sson
(involves: C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:92821
|
\Prkar1atm2Gsm/\Prkar1atm2Gsm
\Tg(Plp1-cre)1Bzal/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2)
|
muscular atrophy
|
J:148464
|
\Prkar1atm2Gsm/\Prkar1atm2Gsm
\Tlx2tm1.1(cre)Rpk/\Tlx2+
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2)
|
intestinal hypoperistalsis
|
J:148464
|
\Prkcatm1Far/\Prkcatm1Far
(involves: 129/Sv * 129P2/OlaHsd)
|
increased skeletal muscle cell glucose uptake
|
J:85923
|
\Prkcatm1Jmk/\Prkcatm1Jmk
(involves: 129)
|
abnormal cardiac muscle contractility
|
J:132098
|
| abnormal myocardium layer morphology
|
J:132098
|
\Prkcdtm1Qxu/\Prkcdtm1Qxu
(involves: 129P2/OlaHsd)
|
vascular smooth muscle hyperplasia
|
J:78680
|
\Prkcitm1Rfar/\Prkci+
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
| decreased muscle cell glucose uptake
|
J:123964
|
| decreased skeletal muscle cell glucose uptake
|
J:123964
|
\Prkcitm1Rfar/\Prkcitm1Rfar
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
| decreased skeletal muscle cell glucose uptake
|
J:123964
|
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle cell glucose uptake
|
J:92834
|
\Prkd1tm1Eno/\Prkd1tm1Eno
\Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased cardiac muscle contractility
|
J:132803
|
\Prkdcscid/\Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
muscle phenotype
|
J:125527
|
\Prkg1tm1.1Arte/\Prkg1tm1.1Arte
(C57BL/6-Prkg1tm1.1Arte)
|
decreased vasodilation
|
J:181180
|
\Prkg1tm1Hfm/\Prkg1tm1Hfm
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:48058
|
| abnormal intestinal peristalsis
|
J:48058
|
| abnormal vascular smooth muscle physiology
|
J:48058
|
| impaired muscle relaxation
|
J:60928,
J:48058
|
| impaired smooth muscle contractility
|
J:94387
|
| pyloric sphincter hypertrophy
|
J:48058
|
\Prkg1tm1Meme/\Prkg1tm1Meme
(involves: 129S/SvEv)
|
decreased vasodilation
|
J:134634
|
\Prkg1tm1Naw/\Prkg1tm1Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
\Prkg1tm2.1Naw/\Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:134928
|
\Prkntm1Roo/\Prkntm1Roo
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
muscle phenotype
|
J:85561
|
\Prmt7tm1.1Rchd/\Prmt7tm1.1Rchd
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal muscle physiology
|
J:271361
|
| impaired skeletal muscle regeneration
|
J:271361
|
\Prmt7tm1.2Rchd/\Prmt7tm1.2Rchd
(involves: 129S4/SvJaeSor * FVB/N)
|
abnormal muscle physiology
|
J:271361
|
| abnormal myoblast differentiation
|
J:271361
|
| decreased satellite cell number
|
J:271361
|
| decreased skeletal muscle weight
|
J:271361
|
| impaired skeletal muscle regeneration
|
J:271361
|
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
muscular atrophy
|
J:183170
|
| myoclonus
|
J:183170
|
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Prnp*S170N*N174T)1020Aag/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:143528
|
| muscle degeneration
|
J:143528
|
\Prnptm2.1Cwe/\Prnptm2.1Cwe
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:67593
|
\Prorptm1.1Afi/\Prorptm1.1Afi
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
cardiomyopathy
|
J:238964
|
| myocardium necrosis
|
J:238964
|
\Pros1tm1.2Grl/\Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N)
|
vascular smooth muscle hypoplasia
|
J:198769
|
\Prox1tm2Gco/\Prox1tm2Gco
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212185
|
\Prox1tm2Gco/\Prox1tm2Gco
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:212185
|
| decreased heart ventricle muscle contractility
|
J:212185
|
| dilated cardiomyopathy
|
J:212185
|
| thin myocardium
|
J:212185
|
\Prrc2btm1a(EUCOMM)Wtsi/\Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal skeletal muscle morphology
|
J:239583
|
| absent skeletal muscle
|
J:239583
|
\Prrt2tm1d(KOMP)Wtsi/\Prrt2+
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
\Prrt2tm1d(KOMP)Wtsi/\Prrt2tm1d(KOMP)Wtsi
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
\Prss48em1(IMPC)Ccpcz/\Prss48em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss48em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Psaptm1Suz/\Psaptm1Suz
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber morphology
|
J:113052
|
| muscular atrophy
|
J:113052
|
| progressive muscle weakness
|
J:33477
|
\Psaptm2Suz/\Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:78223
|
| muscle weakness
|
J:78223
|
| muscular atrophy
|
J:78223
|
\Psen1tm1Hko/\Psen1tm1Hko
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:84418
|
\Psmb9tm1Stl/\Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:73945
|
\Psmf1tm1c(EUCOMM)Hmgu/\Psmf1tm1c(EUCOMM)Hmgu
\Mnx1tm4(cre)Tmj/\Mnx1+
(involves: 129S1/Sv * C57BL/6J * C57BL/6N)
|
muscular atrophy
|
J:282431
|
\Psmf1tm1c(EUCOMM)Hmgu/\Psmf1tm1c(EUCOMM)Hmgu
\Tg(CDX2-cre)101Erf/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle tone
|
J:282431
|
\Psphtm1a(EUCOMM)Hmgu/\Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| absent eye muscles
|
J:239583
|
\Ptcd1tm1(KOMP)Vlcg/\Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:256004
|
\Ptcd2Gt(RRF537)Byg/\Ptcd2Gt(RRF537)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:143946
|
| abnormal sarcolemma morphology
|
J:143946
|
| myocardial fiber degeneration
|
J:143946
|
\Ptch1mes/\Ptch1mes
(B6C3Fe a/a-Ptch1mes)
|
abnormal tendon morphology
|
J:23861
|
\Ptch1tm1.1Hahn/\Ptch1+
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
increased rhabdomyosarcoma incidence
|
J:149148
|
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased rhabdomyosarcoma incidence
|
J:114992
|
\Ptch1tm1Mps/\Ptch1+
\Ptch2tm1Pmc/\Ptch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:112118
|
| telangiectasia
|
J:112118
|
\Ptch1tm1Mps/\Ptch1+
\Ptch2tm1Pmc/\Ptch2tm1Pmc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:112118
|
\Ptch1tm1Mps/\Ptch1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:125534
|
\Ptch1tm1Zim/\Ptch1+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))
|
increased rhabdomyosarcoma incidence
|
J:47421
|
\Ptchd1tm2.2Gfng/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:232709
|
\Ptentm1.1Yxy/\Ptentm1.1Yxy
(involves: C57BL/6)
|
increased myocardial fiber mitochondrial DNA content
|
J:308567
|
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129S4/SvJae)
|
abnormal muscle fiber morphology
|
J:169364
|
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Ckmm-cre)5Khn/?
(involves: 129S4/SvJae * FVB)
|
enhanced skeletal muscle regeneration
|
J:169364
|
\Ptentm2Mak/\Ptentm2Mak
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
| increased myocardial fiber size
|
J:79151
|
\Ptentm2Mak/\Ptentm2Mak
\Tg(Ckmm-cre)5Khn/0
\Tg(Myh6-Pik3ca)1Siz/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
\Ptgdrtm1Dgen/\Ptgdr+
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
| increased vasodilation
|
J:109107
|
\Ptgdrtm1Dgen/\Ptgdrtm1Dgen
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
\Ptger2tm1Brey/\Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:53646
|
\Ptger2tm1Brey/\Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
abnormal vasodilation
|
J:78902
|
| increased vasoconstriction
|
J:78902
|
\Ptger3tm1Cof/\Ptger3tm1Cof
(involves: 129P2/OlaHsd)
|
increased vasodilation
|
J:77409
|
\Ptger4tm1.1Matb/\Ptger4tm1.1Matb
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal cardiac muscle tissue morphology
|
J:158439
|
| abnormal myocardial fiber morphology
|
J:158439
|
| decreased cardiac muscle contractility
|
J:158439
|
| dilated cardiomyopathy
|
J:158439
|
\Ptgs1tm1Unc/\Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:146321
|
\Ptgs1tm1Unc/\Ptgs1tm1Unc
(B6;129P2-Ptgs1tm1Unc/Tac)
|
muscle phenotype
|
J:107751
|
\Ptgs2tm1Gaf/\Ptgs2tm1Gaf
\A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:148331
|
| increased myocardial fiber size
|
J:148331
|
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:146321
|
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
impaired skeletal muscle regeneration
|
J:107751
|
\Ptk2tm1.1Jtpa/\Ptk2tm1.1Jtpa
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:142495
|
\Ptk2tm1Imeg/\Ptk2tm1Imeg
(involves: C57BL/6 * CBA)
|
thick myocardium
|
J:29978
|
\Ptk2btm1Okig/\Ptk2btm1Okig
(involves: C57BL/6)
|
decreased vasodilation
|
J:139849
|
\Ptpn11tm1.1Ics/\Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:216593
|
| decreased skeletal muscle triglyceride level
|
J:216593
|
| dilated cardiomyopathy
|
J:216593
|
| heart left ventricle hypertrophy
|
J:216593
|
\Ptpn11tm1Bgn/\Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
\Ptpn11tm1Bgn/\Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
| thin myocardium
|
J:91609
|
| thin myocardium compact layer
|
J:91609
|
\Ptpn11tm1Gsf/\Ptpn11tm1Gsf
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:144767
|
| decreased heart left ventricle muscle contractility
|
J:144767
|
| decreased skeletal muscle cell glucose uptake
|
J:144767
|
| dilated cardiomyopathy
|
J:144767
|
| increased cardiac muscle triglyceride level
|
J:144767
|
| increased myocardial fiber size
|
J:144767
|
| increased skeletal muscle triglyceride level
|
J:144767
|
\Ptpn11tm1Yan/\Ptpn11tm1Yan
\Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * C57BL/6 * FVB)
|
decreased skeletal muscle fiber number
|
J:114499
|
| decreased skeletal muscle fiber size
|
J:114499
|
\Ptpn11tm4.2Bgn/\Ptpn11+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:172033
|
| dilated cardiomyopathy
|
J:172033
|
| heart left ventricle hypertrophy
|
J:172033
|
| increased myocardial fiber size
|
J:172033
|
\Ptpn11tm6Bgn/\Ptpn11+
\Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
thin myocardium
|
J:147154
|
\Ptpn11tm7Bgn/\Ptpn11tm7Bgn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:147154
|
\Ptprbtm1Dgen/\Ptprbtm1Dgen
(B6.Cg-Ptprbtm1Dgen)
|
abnormal myocardial trabeculae morphology
|
J:125783
|
\Ptprdtm1Yiw/\Ptprdtm1Yiw
\Ptprstm1Mtr/\Ptprstm1Mtr
(B6.Cg-Ptprdtm1Yiw Ptprstm1Mtr)
|
centrally nucleated skeletal muscle fibers
|
J:109122
|
| hypaxial muscle hypoplasia
|
J:109122
|
| thin diaphragm muscle
|
J:109122
|
\Ptprjtm1Taka/\Ptprjtm1Taka
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:82356
|
| abnormal vascular smooth muscle morphology
|
J:82356
|
| thin myocardium
|
J:82356
|
| vascular smooth muscle hypoplasia
|
J:82356
|
\Ptprmtm1Mfbg/\Ptprmtm1Mfbg
(FVB.129P2-Ptprmtm1Mfbg)
|
decreased vasodilation
|
J:97057
|
\Ptprvtm1Kry/\Ptprvtm1Kry
\Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:126780
|
| increased muscle cell glucose uptake
|
J:126780
|
\Ptrh2tm1.1Eruo/\Ptrh2tm1.1Eruo
(C57BL/6-Ptrh2tm1.1Eruo)
|
abnormal epaxial muscle morphology
|
J:131853
|
| abnormal sarcolemma morphology
|
J:241883
|
| centrally nucleated skeletal muscle fibers
|
J:241883
|
| dystrophic muscle
|
J:241883
|
| increased variability of skeletal muscle fiber size
|
J:241883
|
| myopathy
|
J:241883
|
| progressive muscle weakness
|
J:241883,
J:131853
|
| skeletal muscle degeneration
|
J:241883
|
| skeletal muscle endomysial fibrosis
|
J:241883
|
\Ptstm1Ich/\Ptstm1Ich
\Tg(DBH-PTS)6Csic/0
(involves: 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:138968
|
\Ptstm1Thny/\Ptstm1Thny
(involves: 129/Sv * C57BL/6)
|
dystonia
|
J:84533
|
\Pus1tm1.1Mdf/\Pus1tm1.1Mdf
(B6.129S7(C)-Pus1tm1.1Mdf)
|
abnormal muscle physiology
|
J:237107
|
| decreased skeletal muscle fiber size
|
J:237107
|
| decreased skeletal muscle mass
|
J:237107
|
\Pvalbtm1Swal/\Pvalbtm1Swal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:53121
|
\Pygmtm1.1Adru/\Pygmtm1.1Adru
(involves: 129 * C57BL/6J)
|
increased skeletal muscle glycogen level
|
J:226312
|
| increased variability of skeletal muscle fiber size
|
J:226312
|
\Qars1em1(IMPC)Mbp/\Qars1+
(C57BL/6NCrl-Qars1em1(IMPC)Mbp/MbpMmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Qkitm1Imeg/\Qkitm1Imeg
(involves: 129P2/OlaHsd)
|
abnormal myocardium layer morphology
|
J:88215
|
\Qprttm1Kshib/\Qprttm1Kshib
(B6.129X1-Qprttm1Kshib)
|
abnormal intestinal smooth muscle morphology
|
J:361891
|
\Qrich1b2b2404Clo/\Qrich1b2b2404Clo
(C57BL/6J-Qrich1b2b2404Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\R3hdmltm1Mita/\R3hdmltm1Mita
(B6.Cg-R3hdmltm1Mita)
|
abnormal muscle development
|
J:282737
|
| abnormal quadriceps morphology
|
J:282737
|
| abnormal sarcomere morphology
|
J:282737
|
| abnormal skeletal muscle fiber morphology
|
J:282737
|
| abnormal skeletal muscle satellite cell proliferation
|
J:282737
|
| decreased skeletal muscle fiber diameter
|
J:282737
|
| decreased skeletal muscle weight
|
J:282737
|
| diffuse Z line
|
J:282737
|
| impaired skeletal muscle regeneration
|
J:282737
|
\Rac1tm1Djk/\Rac1tm1.1Djk
\Tg(Myh6-cre/Esr1*)1Liao/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:109582
|
| abnormal myocardium layer morphology
|
J:109582
|
\Rac1tm1Djk/\Rac1tm1Djk
\Tg(Mef2c-cre)2Blk/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal ventricle myocardium morphology
|
J:315097
|
| thin right ventricle myocardium compact layer
|
J:315097
|
| trabecula carnea hypoplasia
|
J:315097
|
\Rac1tm1Djk/\Rac1tm1Djk
\Tg(Nkx2-5-cre)9Eno/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:321017
|
| abnormal trabecula carnea morphology
|
J:321017
|
| abnormal ventricle myocardium morphology
|
J:321017
|
| decreased fetal cardiomyocyte proliferation
|
J:321017
|
| thin myocardium compact layer
|
J:321017
|
| thin ventricle myocardium compact layer
|
J:321017
|
\Rad18tm1a(EUCOMM)Wtsi/\Rad18tm1a(EUCOMM)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Rad18tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal arrector pilli muscle morphology
|
J:232539
|
\Raf1tm1.1Bgn/\Raf1+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
decreased cardiac muscle contractility
|
J:172034
|
| dilated cardiomyopathy
|
J:172034
|
| increased cardiac muscle contractility
|
J:189143,
J:172034
|
| increased myocardial fiber size
|
J:172034
|
\Raf1tm2.1Ara/\Raf1tm2.1Ara
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased cardiac muscle contractility
|
J:189143
|
| increased myocardial fiber size
|
J:189143
|
\Raf1tm2Bacc/\Raf1tm2Bacc
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:93418
|
| decreased heart left ventricle muscle contractility
|
J:93418
|
| increased cardiomyocyte apoptosis
|
J:93418
|
| thin myocardium
|
J:93418
|
\Ralatm1a(EUCOMM)Wtsi/\Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Ralgapa1tm1.1Schen/\Ralgapa1tm1.1Schen
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:287672
|
| decreased muscle cell glucose uptake
|
J:287672
|
\Ralgapa1tm2c(KOMP)Wtsi/\Ralgapa1tm2c(KOMP)Wtsi
\Myl1tm1(cre)Sjb/\Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
increased muscle cell glucose uptake
|
J:287672
|
\Ramp1tm1.1Tsuj/\Ramp1tm1.1Tsuj
(involves: 129S2/SvPas * C57BL/6)
|
decreased vasodilation
|
J:125974
|
\Ramp2tm1Kmca/\Ramp2tm1Kmca
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:130930
|
\Rangrftm1.1Tke/\Rangrftm1.1Tke
(involves: C57BL/6)
|
abnormal cardiac muscle tissue morphology
|
J:325055
|
| abnormal I band morphology
|
J:325055
|
| abnormal myocardial fiber morphology
|
J:325055
|
| abnormal sarcomere morphology
|
J:325055
|
| decreased cardiac muscle contractility
|
J:325055
|
\Rap1gds1tm1Ytk/\Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal myocardial trabeculae morphology
|
J:62244
|
| abnormal myocardium layer morphology
|
J:62244
|
| increased cardiomyocyte apoptosis
|
J:62244
|
\Rapgef1Gt(pGT1.8geo)5Pgr/\Rapgef1Gt(pGT1.8geo)5Pgr
(involves: 129/Sv * C57BL/6 * Swiss)
|
abnormal vascular smooth muscle morphology
|
J:80219
|
| vascular smooth muscle hypoplasia
|
J:80219
|
\Rapgef3tm1.2Chen/\Rapgef3tm1.2Chen
\Rapgef4tm1.2Chen/\Rapgef4tm1.2Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
\Rapgef4tm1.2Chen/\Rapgef4tm1.2Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
\Rapsntm1Jrs/\Rapsntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:28777
|
\Raratm1Ipc/\Raratm1Ipc
\Rarbtm1Mma/\Rarbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
diaphragmatic hernia
|
J:43344
|
\Raratm1Ipc/\Raratm1Ipc
\Rargtm1Ipc/\Rargtm1Ipc
(involves: 129S2/SvPas)
|
ventricle myocardium hypoplasia
|
J:21034
|
\Rarres2tm1Yktk/\Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
increased muscle cell glucose uptake
|
J:206120
|
\Rasa1tm1Wid/\Rasa1tm1Wid
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N)
|
increased cardiomyocyte apoptosis
|
J:189241
|
\Rb1tm1Tyj/\Rb1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:19542
|
\Rb1tm1Tyj/\Rb1tm1Tyj
\Rbl1tm1Tyj/\Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
muscle phenotype
|
J:34058
|
\Rb1tm1Tyj/\Rb1tm1Tyj
\Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myogenesis
|
J:37145
|
| abnormal skeletal muscle fiber morphology
|
J:37145
|
| abnormal skeletal muscle morphology
|
J:37145
|
| decreased skeletal muscle fiber density
|
J:37145
|
| decreased skeletal muscle mass
|
J:37145
|
\Rb1tm1Tyj/\Rb1tm1Tyj
\Tg(Rb1)1Blg/0
(involves: 129S2/SvPas)
|
abnormal myogenesis
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
\Rb1tm1Tyj/\Rb1tm1Tyj
\Tg(Rb1)1Blg/0
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
\Rb1tm2.1Fad/\Rb1tm2.1Fad
(involves: 129 * C57BL/6)
|
skeletal muscle atrophy
|
J:215358
|
\Rb1tm2Brn/\Rb1tm2Brn
\Rbl2tm1Tyj/\Rbl2tm1Tyj
\Tg(Myh6-cre)2182Mds/\Tg(Myh6-cre)2182Mds
(involves: 129 * 129S2/SvPas * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:97589
|
| increased myocardial fiber size
|
J:97589
|
\Rb1tm3Tyj/\Rb1tm3.1Tyj
\Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N)
|
abnormal myogenesis
|
J:81643
|
\Rb1cc1tm1.2Guan/\Rb1cc1tm1.2Guan
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:114498
|
| abnormal myocardium compact layer morphology
|
J:114498
|
| abnormal myocardium layer morphology
|
J:114498
|
| abnormal trabecula carnea morphology
|
J:114498
|
| thin myocardium
|
J:114498
|
\Rbfox2tm1.1Dblk/\Rbfox2tm1.1Dblk
\Pax3tm1(cre)Joe/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)
|
muscle phenotype
|
J:279139
|
\Rbkstm1d(EUCOMM)Wtsi/\Rbkstm1d(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
interstinal hyperperistalsis
|
J:236053
|
\Rbl1tm1Mru/\Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal muscle physiology
|
J:51060
|
\Rbl2tm1Mru/\Rbl2tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal myotome development
|
J:50516
|
| muscle phenotype
|
J:50516
|
| thin myocardium
|
J:50516
|
\Rbm20em1Hide/\Rbm20+
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
\Rbm20em1Hide/\Rbm20em1Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
| dilated cardiomyopathy
|
J:297234
|
\Rbm20em2Wguo/\Rbm20em2Wguo
(C57BL/6J-Rbm20em2Wguo)
|
dilated cardiomyopathy
|
J:324125
|
\Rbm20em3Hide/\Rbm20em3Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
\Rbm20em3Wguo/\Rbm20+
(C57BL/6-Rbm20em3Wguo)
|
abnormal sarcomere morphology
|
J:324088
|
| decreased heart left ventricle muscle contractility
|
J:324088
|
| dilated cardiomyopathy
|
J:324088
|
| thin myocardium
|
J:324088
|
\Rbm20em3Wguo/\Rbm20em3Wguo
(C57BL/6-Rbm20em3Wguo)
|
decreased heart left ventricle muscle contractility
|
J:324088
|
| dilated cardiomyopathy
|
J:324088
|
| thin myocardium
|
J:324088
|
\Rbm20tm1Hgra/\Rbm20+
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:208676
|
\Rbm20tm1Hgra/\Rbm20tm1Hgra
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:208676
|
| abnormal sarcomere morphology
|
J:208676
|
| decreased cardiac muscle contractility
|
J:208676
|
\Rbm20tm2.1Hgra/\Rbm20+
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:208676
|
\Rbm24tm1.1Xch/\Rbm24tm1.1Xch
(involves: FVB/N)
|
myocardial trabeculae hypoplasia
|
J:259290
|
\Rbm24tm1.1Xixu/\Rbm24tm1.1Xixu
\Tg(Myh6-cre)1Xya/0
(involves: C57BL/6NTac)
|
abnormal M line morphology
|
J:302917
|
| abnormal sarcomere morphology
|
J:302917
|
| abnormal Z line morphology
|
J:302917
|
| decreased heart left ventricle muscle contractility
|
J:302917
|
| dilated cardiomyopathy
|
J:302917
|
\Rbm39em1(IMPC)Hmgu/\Rbm39+
(C57BL/6NCrl-Rbm39em1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Rbp4tm1Gott/\Rbp4tm1Gott
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:82903
|
| abnormal myocardium compact layer morphology
|
J:82903
|
| trabecula carnea hypoplasia
|
J:82903
|
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Lbx1-cre)3Cbm/0
(involves: 129P2/OlaHsd)
|
abnormal myogenesis
|
J:120053
|
| decreased satellite cell number
|
J:120053
|
| decreased skeletal muscle fiber density
|
J:120053
|
| hypaxial muscle hypoplasia
|
J:120053
|
\Rbpjtm1Kyo/\Rbpj+
(involves: 129S2/SvPas * CD-1)
|
decreased cardiac muscle contractility
|
J:187551
|
\Rbpjtm1Kyo/\Rbpjtm1Kyo
(involves: 129S2/SvPas)
|
abnormal myocardium layer morphology
|
J:119151
|
| decreased fetal cardiomyocyte proliferation
|
J:119151
|
| disorganized myocardium
|
J:119151
|
| trabecula carnea hypoplasia
|
J:119151
|
\Rbpmsem1Eno/\Rbpmsem1Eno
(involves: C3H * C57BL/6)
|
cardiomyopathy
|
J:324468
|
| decreased cardiac muscle contractility
|
J:324468
|
| myocardial ventricular hypertrabeculation
|
J:324468
|
| thin ventricle myocardium compact layer
|
J:324468
|
\Rcan1tm1Jmol/\Rcan1tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal myocardium layer morphology
|
J:109586
|
\Rcan1tm1Jmol/\Rcan1tm1Jmol
\Rcan2tm1Jmol/\Rcan2tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal myocardium layer morphology
|
J:109586
|
\Rce1tm2Kim/\Rce1tm2.1Kim
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6)
|
dilated cardiomyopathy
|
J:87958
|
| thin myocardium
|
J:87958
|
\Relatm1Yuo/\Relatm1Yuo
(involves: 129S/SvEv)
|
abnormal myogenesis
|
J:135692
|
\Relatm1Yuo/\Relatm1Yuo
\Tnftm1Ljo/\Tnftm1Ljo
(involves: 129S/SvEv * 129S1/Sv)
|
abnormal myogenesis
|
J:135692
|
| decreased skeletal muscle fiber diameter
|
J:135692
|
| increased skeletal muscle fiber number
|
J:135692
|
\Relatm2.1Gho/\Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
myositis
|
J:163663
|
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
myositis
|
J:22675
|
\Relnrl-6J/\Relnrl-6J
(C57BL/6J-Relnrl-6J/J)
|
muscle spasm
|
J:87349
|
\Ren1tm1.2Sig/\Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:169129
|
\Ren1tm1Afu/\Ren1tm1Afu
(involves: C57BL/6 * CBA)
|
vascular smooth muscle hyperplasia
|
J:59299
|
\Rer1Gt(RRN159)Byg/\Rer1+
(involves: 129P2/OlaHsd)
|
decreased skeletal muscle fiber diameter
|
J:169417
|
\Rettm1Cos/\Ret+
(involves: 129S/SvEv * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
\Rettm1Cos/\Rettm1Cos
(involves: 129S/SvEv * MF1)
|
intestinal hypoperistalsis
|
J:23852,
J:30389
|
\Rettm1Heno/\Rettm1Heno
(Not Specified)
|
abnormal gastrocnemius morphology
|
J:132854
|
| abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
\Rettm2.1Heno/\Rettm2.1Heno
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal gastrocnemius morphology
|
J:132854
|
| abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
\Rettm2Cos/\Rettm2Cos
(involves: 129S1/Sv)
|
abnormal intestinal peristalsis
|
J:60659
|
\Rettm3(RET)Vpa/\Rettm3(RET)Vpa
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:102170
|
\Rettm11(RET)Jmi/\Rettm12(RET)Jmi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
\Rettm12(RET)Jmi/\Rettm12(RET)Jmi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
\Retntm1Laz/\Retntm1Laz
\Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:171262
|
\Rfx3b2b1213Clo/\Rfx3b2b1213Clo
(C57BL/6J-Rfx3b2b1213Clo)
|
cardiomyopathy
|
J:175213
|
\Rgs2tm1.1Kjb/\Rgs2tm1.1Kjb
\Tg(Tek-cre/ERT2)1Arnd/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:184284
|
\Rgs2tm1Pngr/\Rgs2tm1Pngr
(B6.129P2-Rgs2tm1Pngr)
|
decreased vasodilation
|
J:184284
|
| increased vasoconstriction
|
J:184284
|
\Rhebtm1.1Otsu/\Rhebtm1.1Otsu
\Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal sarcomere morphology
|
J:197831
|
| cardiomyopathy
|
J:197831
|
| decreased cardiac muscle contractility
|
J:197831
|
| decreased myocardial fiber size
|
J:197831
|
\Rictortm1Rueg/\Rictortm1Rueg
\Rptortm1Rueg/\Rptortm1Rueg
\Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle morphology
|
J:143748
|
| abnormal muscle physiology
|
J:143748
|
\Rictortm1Rueg/\Rictortm1Rueg
\Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle phenotype
|
J:143748
|
\Rint1tm1Whl/\Rint1+
(Not Specified)
|
increased uterus leiomyoma incidence
|
J:122805
|
\Ripply2tm1.1Ysa/\Ripply2tm1.1Ysa
(involves: C57BL/6 * CBA * ICR)
|
abnormal myotome morphology
|
J:123846
|
\Rnd3Gt(OST364657)Lex/\Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal hypaxial muscle morphology
|
J:172361
|
| abnormal tibialis anterior morphology
|
J:172361
|
\Rnf5tm1Zron/\Rnf5tm1Zron
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle regeneration
|
J:132185
|
\Rnf170Gt(OST104375)Lex/\Rnf170Gt(OST104375)Lex
(B6.129S-Rnf170Gt(OST104375)Lex)
|
abnormal muscle physiology
|
J:226836
|
\Rnlstm1Gvd/\Rnlstm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:186878
|
\Rnu2-8nmf291/\Rnu2-8nmf291
(B6;129-Rnu2-8nmf291/J)
|
progressive muscle weakness
|
J:87349
|
\Robo1b2b872Clo/\Robo1b2b872Clo
(C57BL/6J-Robo1b2b872Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Robo1tm1Matl/\Robo1tm1Matl
\Robo2tm1Mrt/\Robo2tm1Mrt
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:193400
|
\Robo1tm1Matl/\Robo1tm1Matl
\Robo2tm1Rilm/\Robo2tm1Rilm
\Twist2tm1(cre)Dor/\Twist2+
(involves: 129 * 129X1/SvJ)
|
diaphragmatic hernia
|
J:193400
|
\Robo4tm1Kzh/\Robo4tm1Kzh
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:208012
|
\Robo4tm1Kzh/\Robo4tm1Kzh
(Not Specified)
|
increased vasodilation
|
J:294754
|
\Rock1tm1Liao/\Rock1+
(C57BL/6-Rock1tm1Liao)
|
abnormal vascular smooth muscle morphology
|
J:135152
|
\Rock2tm1.1Itl/\Rock2+
\Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:222206
|
| decreased vascular smooth muscle cell proliferation
|
J:222206
|
\Rorasg/\Rorasg
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:109735
|
| abnormal vasodilation
|
J:109735
|
\RpgrRd9/Y
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
\RpgrRd9/\RpgrRd9
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
\Rpgrip1ltm1a(EUCOMM)Wtsi/\Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Rpl3lem1Jmol/\Rpl3lem1Jmol
(C57BL/6NTac-Rpl3lem1Jmol)
|
muscle phenotype
|
J:333030
|
\Rpl3lem1Kei/\Rpl3lem1Kei
(C57BL/6J-Rpl3em1Kei)
|
abnormal cardiac muscle contractility
|
J:335523
|
\Rps6ka2tm1.1Mskf/\Rps6ka2tm1.1Mskf
(B6.129(C)-Rps6ka2tm1.1Mskf)
|
abnormal myocardial fiber morphology
|
J:205403
|
\Rps6ka3tm1.1Kry/\Rps6ka3+
(involves: 129X1/SvJ)
|
muscle phenotype
|
J:89403
|
\Rps6ka3tm1.1Kry/\Rps6ka3tm1.1Kry
(involves: 129X1/SvJ)
|
muscle phenotype
|
J:89403
|
\Rps6ka3tm1Ljg/Y
(involves: 129 * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:67575
|
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd)
|
decreased skeletal muscle fiber diameter
|
J:129852
|
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
\Rps6kb2tm1Gtho/\Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:129852
|
| abnormal skeletal muscle morphology
|
J:129852
|
| decreased skeletal muscle fiber diameter
|
J:129852
|
| increased skeletal muscle glycogen level
|
J:129852
|
\Rps6kb1tm1Nte/\Rps6kb1tm1Nte
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle regeneration
|
J:155912
|
| abnormal tibialis anterior morphology
|
J:155912
|
| decreased skeletal muscle weight
|
J:155912
|
\Rptortm1Rueg/\Rptortm1Rueg
\Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle cell glucose uptake
|
J:143748
|
| abnormal muscle morphology
|
J:143748
|
| abnormal muscle physiology
|
J:143748
|
| decreased muscle weight
|
J:143748
|
| dystrophic muscle
|
J:143748
|
| increased skeletal muscle glycogen level
|
J:143748
|
| skeletal muscle interstitial fibrosis
|
J:143748
|
\Rr28tm1Tilg/\Rr28+
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:77413
|
| increased fetal cardiomyocyte proliferation
|
J:77413
|
\Rr34tm1.1Lap/\Rr34tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:252154
|
| decreased cardiac muscle contractility
|
J:252154
|
\Rr35tm1.1Lap/\Rr35tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:252154
|
| decreased cardiac muscle contractility
|
J:252154
|
\Rr133tm1Eno/\Rr133tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal tongue muscle morphology
|
J:81764
|
\Rr143tm1.1Sson/\Rr143+
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
\Rr143tm1.1Sson/\Rr143+
\Zbed6tm1.2Sson/\Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
\Rr277em1Flc/\Rr277em1Flc
(C57BL/6J-Rr277em1Flc)
|
thick myocardium compact layer
|
J:324708
|
| thin ventricle myocardium compact layer
|
J:324708
|
\Rr278em1Flc/\Rr278em1Flc
(C57BL/6J-Rr278em1Flc)
|
thick myocardium compact layer
|
J:324708
|
\Rr303em1Vave/\Rr303em1Vave
(Not Specified)
|
abnormal sinoatrial node morphology
|
J:308878
|
\Rr593em1Emta/\Rr593+
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:358600
|
| decreased heart left ventricle muscle contractility
|
J:358600
|
| myocardium hypertrophy
|
J:358600
|
\Rr593em1Emta/\Rr593em1Emta
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:358600
|
| decreased heart left ventricle muscle contractility
|
J:358600
|
| myocardium hypertrophy
|
J:358600
|
\Rradtm1Yec/\Rradtm1Yec
(B6.129X1-Rradtm1Yec)
|
abnormal cardiac muscle contractility
|
J:143140
|
\Rreb1em1Rtpl/\Rreb1+
(C57BL/6J-Rreb1em1Rtpl)
|
cardiomyopathy
|
J:296982
|
| decreased cardiac muscle contractility
|
J:296982
|
| heart left ventricle hypertrophy
|
J:296982
|
| increased myocardial fiber size
|
J:296982
|
\Rrm2bGt(OST85254)Lex/\Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
muscular atrophy
|
J:186071
|
\Rrm2btm1Ynak/\Rrm2btm1Ynak
(involves: 129 * C57BL/6J)
|
skeletal muscle atrophy
|
J:84841
|
\Rsph9em1Jwji/\Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
muscle weakness
|
J:294184
|
\Rspo3tm1Arte/\Rspo3tm1Arte
\Isl1tm1(cre)Sev/\Isl1+
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:214093
|
\Rtel1tm1Pml/\Rtel1tm1Pml
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal dermomyotome development
|
J:91351
|
| abnormal myotome development
|
J:91351
|
\Rtf1tm1c(KOMP)Wtsi/\Rtf1tm1c(KOMP)Wtsi
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: C57BL/6N * FVB/N)
|
abnormal intercalated disk morphology
|
J:338311
|
| decreased heart left ventricle muscle contractility
|
J:338311
|
| decreased heart ventricle muscle contractility
|
J:338311
|
| dilated cardiomyopathy
|
J:338311
|
| myocardial fiber disarray
|
J:338311
|
\Rtn2tm1Lex/\Rtn2+
(involves: 129S/SvEvBrd)
|
decreased skeletal muscle cell glucose uptake
|
J:158249
|
\Rtn2tm1Lex/\Rtn2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased skeletal muscle cell glucose uptake
|
J:158249
|
| muscle phenotype
|
J:158249
|
\Rundc1tm1b(EUCOMM)Wtsi/\Rundc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Rundc1tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Runx2tm1Kish/\Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:40783
|
\Runx3tm1Yg/\Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal muscle tone
|
J:77764
|
| absent muscle spindles
|
J:77764
|
\Runx3tm1Yg/\Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle tone
|
J:77764
|
\Runx3tm1Yg/\Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased skeletal muscle fiber size
|
J:243559
|
\Rxratm1.1Pcn/\Rxratm1.1Pcn
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
ventricular myocardium compact layer hypoplasia
|
J:146761
|
\Rxratm1Ipc/\Rxratm1Ipc
\Rxrbtm1Mma/\Rxrbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
ventricular myocardium compact layer hypoplasia
|
J:146761
|
\Rxratm1Rev/\Rxra+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:35363
|
| abnormal myocardium compact layer morphology
|
J:35363
|
| abnormal myocardium layer morphology
|
J:35363
|
| abnormal ventricle papillary muscle morphology
|
J:35363
|
\Rxratm1Rev/\Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:35363
|
| abnormal myocardium compact layer morphology
|
J:18047
|
| abnormal myocardium layer morphology
|
J:35363,
J:18047
|
| abnormal ventricle papillary muscle morphology
|
J:35363
|
| decreased heart left ventricle muscle contractility
|
J:65904
|
| trabecula carnea hypoplasia
|
J:18047
|
| ventricular myocardium compact layer hypoplasia
|
J:35363
|
\Rxrgtm1Ysa/\Rxrgtm1Ysa
(B6.129S2-Rxrgtm1Ysa)
|
increased muscle relaxation
|
J:77613
|
\Ryr1em1Tmur/\Ryr1+
(Not Specified)
|
abnormal muscle physiology
|
J:322211
|
\Ryr1em1Zor/\Ryr1+
(C57BL/6J-Ryr1em1Zor)
|
abnormal skeletal muscle fiber triad morphology
|
J:275501
|
| muscle phenotype
|
J:275501,
J:291685
|
| muscle weakness
|
J:275501
|
| skeletal muscle fiber degeneration
|
J:275501
|
\Ryr1em1Zor/\Ryr1em2Zor
(C57BL/6J-Ryr1em1Zor Ryr1em2Zor)
|
abnormal extraocular muscle morphology
|
J:291685
|
| abnormal muscle fiber morphology
|
J:291685
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:292405
|
| abnormal skeletal muscle fiber morphology
|
J:292405
|
| abnormal skeletal muscle fiber triad morphology
|
J:292405
|
| decreased skeletal muscle weight
|
J:292405
|
| muscle weakness
|
J:292405
|
| skeletal muscle fiber degeneration
|
J:292405
|
\Ryr1em2Zor/\Ryr1+
(C57BL/6J-Ryr1em2Zor)
|
muscle phenotype
|
J:291685
|
\Ryr1em2Zor/\Ryr1em2Zor
(C57BL/6J-Ryr1em2Zor)
|
muscle phenotype
|
J:291685
|
\Ryr1m1Bei/\Ryr1m1Bei
(involves: A/J * FVB/N)
|
abnormal skeletal muscle morphology
|
J:75360
|
\Ryr1m1Nisw/\Ryr1+
(129S1.B6-Ryr1m1Nisw)
|
abnormal sarcomere morphology
|
J:219285
|
| abnormal sarcoplasmic reticulum morphology
|
J:219285
|
| abnormal skeletal muscle fiber morphology
|
J:219285
|
| abnormal Z line morphology
|
J:219285
|
| centrally nucleated skeletal muscle fibers
|
J:219285
|
| muscle weakness
|
J:219285
|
| myopathy
|
J:219285
|
\Ryr1tm1.1Dhm/\Ryr1+
(involves: 129S2/SvPasCrl * 129S6/SvEvTac)
|
abnormal muscle fiber morphology
|
J:155825
|
| abnormal sarcomere morphology
|
J:155825
|
| abnormal skeletal muscle fiber morphology
|
J:155825
|
| abnormal Z line morphology
|
J:155825
|
| decreased skeletal muscle fiber diameter
|
J:155825
|
| impaired muscle contractility
|
J:155825
|
| increased variability of skeletal muscle fiber size
|
J:155825
|
| muscle weakness
|
J:155825
|
| myopathy
|
J:155825
|
\Ryr1tm1.1Dhm/\Ryr1tm1.1Dhm
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:127629
|
| abnormal muscle development
|
J:127629
|
| abnormal muscle physiology
|
J:127629
|
| decreased skeletal muscle mass
|
J:127629
|
| impaired skeletal muscle contractility
|
J:127629
|
| skeletal muscle degeneration
|
J:127629
|
\Ryr1tm1.1Inp/\Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
\Ryr1tm1.1Inp/\Ryr1tm1.1Inp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
| abnormal soleus morphology
|
J:181523
|
| impaired muscle relaxation
|
J:181523
|
\Ryr1tm1.1Itl/?
(B6.Cg-Ryr1tm1.1Itl)
|
abnormal muscle contractility
|
J:176731
|
| abnormal muscle physiology
|
J:176731
|
| abnormal skeletal muscle morphology
|
J:176731
|
\Ryr1tm1.1Msnr/\Ryr1tm1.1Msnr
(129S.129P2-Ryr1tm1.1Msnr)
|
abnormal muscle contractility
|
J:195542
|
| abnormal muscle electrophysiology
|
J:195542
|
| muscle tetany
|
J:195542
|
| muscle twitch
|
J:195542
|
\Ryr1tm1Slh/\Ryr1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:105738
|
| abnormal muscle physiology
|
J:105738
|
\Ryr1tm1Slh/\Ryr1tm1Slh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:105738
|
| abnormal skeletal muscle fiber morphology
|
J:105738
|
| abnormal skeletal muscle morphology
|
J:105738
|
| increased variability of skeletal muscle fiber size
|
J:105738
|
\Ryr1tm1Tno/\Ryr1tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:18895
|
| centrally nucleated skeletal muscle fibers
|
J:18895
|
| decreased skeletal muscle fiber number
|
J:18895
|
| decreased skeletal muscle fiber size
|
J:18895
|
| impaired skeletal muscle contractility
|
J:18895
|
| increased variability of skeletal muscle fiber size
|
J:18895
|
\Ryr1tm2.1Itl/?
(B6.Cg-Ryr1tm2.1Itl)
|
abnormal muscle physiology
|
J:205099
|
| abnormal skeletal muscle fiber morphology
|
J:205099
|
| muscle phenotype
|
J:205099
|
\Ryr1tm3.1Alle/\Ryr1+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
\Ryr1tm3.1Alle/\Ryr1tm3.1Alle
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
\Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/\Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
\Trp53tm1Sia/\Trp53+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:117828
|
\Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/\Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
\Trp53tm1Sia/\Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:117828
|
| myositis
|
J:117828
|
\Ryr2tm1.1Hta/\Ryr2tm1.1Hta
(involves: 129S4/SvJae)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:48277
|
| abnormal myocardial trabeculae morphology
|
J:48277
|
| disorganized myocardium
|
J:48277
|
\Ryr2tm1.1Msnr/\Ryr2tm1.1Msnr
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:122033
|
| decreased heart ventricle muscle contractility
|
J:122033
|
| heart left ventricle hypertrophy
|
J:122033
|
\Ryr2tm1Hhv/\Ryr2tm1Hhv
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal myocardial fiber morphology
|
J:141342
|
\Ryr2tm1Krbr/\Ryr2tm1Krbr
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:210083
|
\Ryr2tm1Slh/\Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6)
|
cardiomyopathy
|
J:111780
|
| decreased cardiac muscle contractility
|
J:111780
|
| decreased heart right ventricle muscle contractility
|
J:111780
|
\Ryr2tm2.1Swch/\Ryr2+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:214434
|
\Ryr2tm2.1Wex/\Ryr2tm2.1Wex
(B6.129S7-Ryr2tm2.1Wex)
|
abnormal myocardial fiber morphology
|
J:179475
|
| decreased cardiac muscle contractility
|
J:179475
|
\Ryr2tm2.1Wex/\Ryr2tm2.1Wex
(involves: 129S7/SvEvBrd)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
\Ryr2tm2Amks/\Ryr2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
\Ryr2tm3.1Amks/\Ryr2+
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
\Ryr2tm4.1Amks/\Ryr2+
(involves: 129 * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
\Ryr3tm1Vso/\Ryr3tm1Vso
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:45244
|
| impaired muscle contractility
|
J:45244
|
\Ryr3tm1Vso/\Ryr3tm1Vso
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:106292
|
\S1pr1tm1Rlp/\S1pr1tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:71961
|
| vascular smooth muscle hypoplasia
|
J:71961
|
\S1pr1tm1Rlp/\S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal aorta smooth muscle morphology
|
J:189010
|
\S1pr1tm1Rlp/\S1pr1tm2Rlp
\Tg(Tek-cre)1Ywa/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:106055
|
\S100a1tm1Jhh/\S100a1+
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
\S100a1tm1Jhh/\S100a1tm1Jhh
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
| decreased vasodilation
|
J:230300
|
\S100a1tm1Mfs/\S100a1tm1Mfs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal muscle physiology
|
J:132177
|
\Sacstm2Bebr/\Sacstm2Bebr
(involves: C57BL/6)
|
abnormal gastrocnemius morphology
|
J:217753
|
| abnormal skeletal muscle fiber morphology
|
J:217753
|
| decreased gastrocnemius weight
|
J:217753
|
| decreased soleus weight
|
J:217753
|
| muscle weakness
|
J:217753
|
\Sall3tm1.1(KOMP)Mbp/\Sall3+
(C57BL/6NCrl-Sall3tm1.1(KOMP)Mbp/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\Sall4Gt(XE027)Byg/\Sall4+
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
disorganized myocardium
|
J:105332
|
| thin myocardium
|
J:105332
|
\Samd1tm1Pfi/\Samd1tm1Pfi
(involves: C57BL/6J * C57BL/6N)
|
skeletal muscle degeneration
|
J:333561
|
\Samd4m1Btlr/\Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
abnormal muscle fiber morphology
|
J:208616
|
| abnormal skeletal muscle morphology
|
J:208616
|
| centrally nucleated skeletal muscle fibers
|
J:208616
|
| decreased skeletal muscle glycogen level
|
J:208616
|
| muscle hypoplasia
|
J:208616
|
| myopathy
|
J:208616
|
\Sbno2tm1.1Aki/\Sbno2tm1.1Aki
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:202853
|
\Scamp5tm1Smoc/\Scamp5tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288324
|
\Scn1aem1Anord/\Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord)
|
muscle phenotype
|
J:333350
|
\Scn3btm1a(KOMP)Wtsi/\Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi)
|
abnormal hypodermis muscle layer morphology
|
J:232539
|
| myositis
|
J:232539
|
\Scn4am1Aaa/\Scn4a+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:217522
|
| abnormal muscle fiber morphology
|
J:217522
|
| abnormal muscle morphology
|
J:217522
|
| abnormal muscle physiology
|
J:217522
|
| centrally nucleated skeletal muscle fibers
|
J:217522
|
| impaired muscle relaxation
|
J:217522
|
| impaired skeletal muscle contractility
|
J:217522
|
| increased muscle fatigability
|
J:217522
|
| increased skeletal muscle fiber size
|
J:217522
|
| muscle twitch
|
J:217522
|
\Scn4am1Aaa/\Scn4am1Aaa
(involves: BALB/c * C57BL/6J)
|
muscle phenotype
|
J:217522
|
\Scn4am1Aaa/\Scn4atm1.1Ljh
(involves: 129S4/SvJae * BALB/c * C57BL/6J)
|
muscle phenotype
|
J:217522
|
\Scn4atm1.1Cann/\Scn4a+
(involves: 129)
|
muscle weakness
|
J:178228
|
\Scn4atm1.1Cann/\Scn4atm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:178228
|
| abnormal muscle fiber morphology
|
J:178228
|
| muscle weakness
|
J:178228
|
\Scn4atm1.1Ljh/\Scn4a+
(B6.129S4-Scn4atm1.1Ljh)
|
abnormal muscle physiology
|
J:135831
|
| abnormal skeletal muscle fiber morphology
|
J:135831
|
| impaired muscle relaxation
|
J:135831
|
| impaired skeletal muscle contractility
|
J:135831
|
| increased muscle fatigability
|
J:135831
|
| increased muscle relaxation
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
\Scn4atm1.1Ljh/\Scn4atm1.1Ljh
(B6.129S4-Scn4atm1.1Ljh)
|
abnormal skeletal muscle fiber morphology
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
| skeletal muscle atrophy
|
J:135831
|
\Scn4atm1Ljh/\Scn4a+
(B6.129S4-Scn4atm1Ljh)
|
abnormal muscle physiology
|
J:135831
|
| abnormal skeletal muscle fiber morphology
|
J:135831
|
| impaired muscle relaxation
|
J:135831
|
| impaired skeletal muscle contractility
|
J:135831
|
| increased muscle fatigability
|
J:135831
|
| increased muscle relaxation
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
\Scn4atm1Ljh/\Scn4atm1Ljh
(B6.129S4-Scn4atm1Ljh)
|
abnormal skeletal muscle fiber morphology
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
| skeletal muscle atrophy
|
J:135831
|
\Scn5atm1(SCN5A)Rdn/\Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
| dilated cardiomyopathy
|
J:189389
|
\Scn5atm1.1Iba/\Scn5a+
(involves: 129 * C57BL/6)
|
increased myocardial fiber size
|
J:266290
|
\Scn5atm1Agrc/\Scn5atm1Agrc
(involves: 129 * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:76331
|
| abnormal trabecula carnea morphology
|
J:76331
|
| decreased myocardial fiber number
|
J:76331
|
\Scn5atm3(SCN5A*)Rdn/\Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
| dilated cardiomyopathy
|
J:189389
|
\Scn8a6J/\Scn8a6J
(C57BL/6J-Scn8a6J/J)
|
muscular atrophy
|
J:90095
|
\Scn8a7J/\Scn8a7J
(involves: BALB/cByJ * C57BL/6J)
|
decreased skeletal muscle fiber size
|
J:87349
|
| myoclonus
|
J:87349
|
| myopathy
|
J:87349
|
\Scn8a9J/\Scn8a9J
(B6J.C-Scn8a9J/Mm)
|
dystonia
|
J:230867
|
| muscle weakness
|
J:230867
|
\Scn8admu/\Scn8admu
(involves: C3H * C57BL/6)
|
dystrophic muscle
|
J:71615
|
| muscle degeneration
|
J:71615
|
| myocardial fiber degeneration
|
J:71615
|
| skeletal muscle necrosis
|
J:71615
|
\Scn8admu/\Scn8amed
(involves: C3H * C3HeB/Fe * C57BL/6)
|
dystrophic muscle
|
J:71615
|
\Scn8am11J/\Scn8am11J
(B6.Cg-Scn8am11J/GrsrJ)
|
impaired muscle relaxation
|
J:231578
|
\Scn8amed-J/\Scn8amed-J
(involves: STOCK Krt71Ca)
|
dystonia
|
J:141236
|
\Scn8amed-J/\Scn8amed-J
\Scnm1s/\Scnm1s
(involves: C57BL/6J)
|
dystonia
|
J:79617
|
| muscular atrophy
|
J:79617
|
\Scn8amed-J/\Scn8amed-J
\Scnm1s/\Scnm1s
(involves: C57BL/6J * STOCK Krt71Ca)
|
muscle weakness
|
J:141236
|
\Scn8amed-jo/\Scn8amed-jo
(DBA/2WyDi-Scn8amed-jo)
|
muscle phenotype
|
J:24907
|
\Scn8amed-TgA4Bs/\Scn8amed-TgA4Bs
(involves: C3H * C57BL/6J)
|
muscular atrophy
|
J:24228
|
\Scn8amed/\Scn8amed
(PCT)
|
abnormal muscle physiology
|
J:5192
|
| abnormal muscle tone
|
J:28679
|
| muscular atrophy
|
J:5153
|
| progressive muscle weakness
|
J:28678,
J:5153
|
\Sco2tm1.1Easc/\Sco2tm2.1Easc
(129X1/SvJ-Sco2tm1.1Easc/Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
\Sco2tm2.1Easc/\Sco2tm2.1Easc
(129X1/SvJ-Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
\scrny/\scrny
(C57BL/6J-scrny/GrsrJ)
|
abnormal muscle fiber morphology
|
J:217859
|
\Scxtm1.1Stzr/\Scxtm1.1Stzr
(Not Specified)
|
abnormal tendon morphology
|
J:122742
|
| abnormal tendon stiffness
|
J:122742
|
\Scxtm1.1Stzr/\Scxtm1.1Stzr
\Tg(Scx-GFP)1Stzr/0
(Not Specified)
|
abnormal tendon morphology
|
J:122742
|
\Scyl1mdf/\Scyl1mdf
(B6C3Fe a/a-Scyl1mdf/J)
|
abnormal muscle electrophysiology
|
J:30384
|
| abnormal muscle regeneration
|
J:30384
|
| muscular atrophy
|
J:30384
|
| skeletal muscle fiber necrosis
|
J:30384
|
\Scyl1mdf/\Scyl1mdf
(involves: CFW * C57BL/6J * C57BR)
|
decreased skeletal muscle mass
|
J:28676
|
| muscular atrophy
|
J:4479,
J:28676
|
\Scyl1tm1.1Spel/\Scyl1tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber type ratio
|
J:192445
|
| centrally nucleated skeletal muscle fibers
|
J:192445
|
| dystrophic muscle
|
J:192445
|
| increased variability of skeletal muscle fiber size
|
J:192445
|
| muscular atrophy
|
J:192445
|
\Scyl1tm1.1Spel/\Scyl1tm1.1Spel
(involves: 129S6/SvEvTac)
|
decreased skeletal muscle fiber diameter
|
J:262629
|
| skeletal muscle atrophy
|
J:262629
|
\Scyl1tm1.1Spel/\Scyl1tm1.1Spel
\Scyl3tm1.1Spel/\Scyl3tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle fiber diameter
|
J:262629
|
\Scyl1tm1Spel/\Scyl1tm1Spel
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
muscle phenotype
|
J:192445
|
\Scyl1tm1Spel/\Scyl1tm1Spel
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:192445
|
| decreased myocardial fiber size
|
J:192445
|
| muscle phenotype
|
J:192445
|
\Scyl3tm1.1Spel/\Scyl3tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:262629
|
\Sdc4tm1Goe/\Sdc4tm1Goe
\Tg(Myl1-FST)F66Sjl/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased skeletal muscle fiber diameter
|
J:188599
|
| increased skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle mass
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
\Sdhaf4em1Bcgen/\Sdhaf4em1Bcgen
\Tg(Ckmm-cre)5Khn/0
(B6.Cg-Sdhaf4em1Bcgen Tg(Ckmm-cre)5Khn)
|
abnormal cardiac muscle contractility
|
J:345348
|
| abnormal myocardial fiber mitochondrial morphology
|
J:345348
|
| abnormal myocardial fiber morphology
|
J:345348
|
| decreased heart left ventricle muscle contractility
|
J:345348
|
| decreased myocardial fiber mitochondrial DNA content
|
J:345348
|
| dilated cardiomyopathy
|
J:345348
|
| thick myocardium
|
J:345348
|
\Sdhctm1c(EUCOMM)Wtsi/\Sdhctm1c(EUCOMM)Wtsi
\Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal muscle physiology
|
J:284745
|
\Sec61a1m1Gek/\Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
decreased skeletal muscle mass
|
J:164159
|
\Sectm1aem1Gcfa/\Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
decreased cardiac muscle contractility
|
J:317204
|
\Selenontm1.2Mred/\Selenontm1.2Mred
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:168699
|
| abnormal muscle regeneration
|
J:168699
|
| decreased satellite cell number
|
J:168699
|
| skeletal muscle atrophy
|
J:168699
|
\Selenontm1.2Mred/\Selenontm1.2Mred
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:176499
|
| abnormal skeletal muscle fiber type ratio
|
J:176499
|
| abnormal skeletal muscle morphology
|
J:176499
|
| centrally nucleated skeletal muscle fibers
|
J:176499
|
| decreased extensor digitorum longus weight
|
J:176499
|
| decreased gastrocnemius weight
|
J:176499
|
| decreased quadriceps weight
|
J:176499
|
| decreased skeletal muscle fiber diameter
|
J:176499
|
| decreased skeletal muscle fiber size
|
J:176499
|
| decreased skeletal muscle mass
|
J:176499
|
| decreased soleus weight
|
J:176499
|
| decreased tibialis anterior weight
|
J:176499
|
| skeletal muscle atrophy
|
J:176499
|
\Selenontm1Begg/\Selenontm1Begg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal skeletal muscle morphology
|
J:197753
|
| skeletal muscle hypertrophy
|
J:197753
|
\Selenostm1.1Sfa/\Selenos+
(involves: C57BL/6)
|
muscle phenotype
|
J:264254
|
| muscle weakness
|
J:264254
|
\Selenostm1.1Sfa/\Selenostm1.1Sfa
(involves: C57BL/6)
|
muscle phenotype
|
J:264254
|
| muscle weakness
|
J:264254
|
\Sema3atm1Mcf/\Sema3atm1Mcf
(involves: 129S4/SvJae)
|
heart right ventricle hypertrophy
|
J:35824
|
\Senp2Gt(AN0727)Wtsi/\Senp2Gt(AN0727)Wtsi
(involves: 129P2/OlaHsd)
|
thin myocardium
|
J:162938
|
\Serac1em1Bcgen/\Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
abnormal muscle fiber morphology
|
J:326672
|
| cardiomyopathy
|
J:326672
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:326672
|
| muscle weakness
|
J:326672
|
\Serp1tm1Hori/\Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:109619
|
\Serpinc1tm1Sai/\Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J)
|
myocardial fiber degeneration
|
J:65092
|
\Serpind1tm1Moto/\Serpind1+
(B6.Cg-Serpind1tm1Moto)
|
vascular smooth muscle hyperplasia
|
J:122173
|
\Serpine1tm1Mlg/\Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle triglyceride level
|
J:87982
|
\Setd3tm1.1(NCOM)Mfgc/\Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
muscle phenotype
|
J:270048
|
\Setd5tm1.1Mgn/\Setd5tm1.1Mgn
(involves: 129S6/SvEvTac * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:237500
|
| abnormal myocardium layer morphology
|
J:237500
|
\Setd5tm1a(EUCOMM)Wtsi/\Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
\Sfrp2tm1Sato/\Sfrp2tm1Sato
(Not Specified)
|
increased cardiac muscle contractility
|
J:146963
|
\Sgcatm1Eeng/\Sgcatm1Eeng
(involves: 129S/SvEv * 129X1/SvJ)
|
impaired skeletal muscle contractility
|
J:83034
|
\Sgcatm1Isrd/\Sgcatm1Isrd
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
muscle phenotype
|
J:133929
|
\Sgcatm1Kcam/\Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:49992
|
| abnormal muscle fiber morphology
|
J:49992
|
| abnormal sarcolemma morphology
|
J:49992
|
| abnormal skeletal muscle fiber morphology
|
J:133929
|
| calcified muscle
|
J:49992
|
| cardiac muscle necrosis
|
J:177563
|
| cardiomyopathy
|
J:177563
|
| centrally nucleated skeletal muscle fibers
|
J:49992
|
| dystrophic muscle
|
J:49992
|
| increased extensor digitorum longus weight
|
J:49992
|
| increased soleus weight
|
J:49992
|
| muscle phenotype
|
J:177563
|
\Sgcatm1Kcam/\Sgcatm1Kcam
\Sgcetm1Vinni/\Sgcetm1Vinni
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cardiac muscle necrosis
|
J:177563
|
| cardiomyopathy
|
J:177563
|
| decreased cardiac muscle contractility
|
J:177563
|
| muscle phenotype
|
J:177563
|
\Sgcatm1Kcam/\Sgcatm1Kcam
\Tg(Ckm-SGCE)1Kcam/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
cardiomyopathy
|
J:177563
|
\Sgcatm2.1Kcam/\Sgcatm2.1Kcam
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N))
|
muscle phenotype
|
J:130252
|
\Sgcatm2Kcam/\Sgcatm2Kcam
(either: (129S6/SvEvTac-Sgcatm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal muscle contractility
|
J:130252
|
| abnormal muscle fiber morphology
|
J:130252
|
| abnormal sarcolemma morphology
|
J:130252
|
| calcified muscle
|
J:130252
|
| dystrophic muscle
|
J:130252
|
| increased muscle weight
|
J:130252
|
\Sgcatm2Kcam/\Sgcatm2Kcam
(B6.129S6-Sgcatm2Kcam/J)
|
abnormal muscle physiology
|
J:250485
|
| abnormal skeletal muscle morphology
|
J:250485
|
| dystrophic muscle
|
J:250485
|
| skeletal muscle fibrosis
|
J:250485
|
\Sgcatm2Kcam/\Sgcatm2Kcam
\Tg(Ckmm-cre)5Khn/0
(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6J * FVB))
|
muscle phenotype
|
J:130252
|
\Sgcbtm1Kcam/\Sgcbtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:60154
|
| abnormal sarcolemma morphology
|
J:60154
|
| abnormal vascular smooth muscle morphology
|
J:60154
|
| calcified muscle
|
J:60154
|
| cardiomyopathy
|
J:60154
|
| dystrophic muscle
|
J:60154
|
| muscular atrophy
|
J:60154
|
| myocardium necrosis
|
J:60154
|
\Sgcbtm1Oza/\Sgcbtm1Oza
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:57590
|
| centrally nucleated skeletal muscle fibers
|
J:57590
|
| dystrophic muscle
|
J:57590
|
| increased gastrocnemius weight
|
J:57590
|
| increased tibialis anterior weight
|
J:57590
|
| myositis
|
J:57590
|
| skeletal muscle fiber degeneration
|
J:57590
|
| skeletal muscle fiber necrosis
|
J:57590
|
\Sgcdtm1Kcam/\Sgcdtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:57107
|
| dilated cardiomyopathy
|
J:57107
|
| dystrophic muscle
|
J:57107
|
| myocardium necrosis
|
J:57107
|
| skeletal muscle necrosis
|
J:57107
|
\Sgcdtm1Mcn/\Sgcdtm1Mcn
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
abnormal muscle contractility
|
J:76730
|
| abnormal muscle physiology
|
J:76730
|
| cardiomyopathy
|
J:76730
|
| dystrophic muscle
|
J:76730
|
| muscle degeneration
|
J:76730
|
\Sgcdtm1Mcn/\Sgcdtm1Mcn
(B6.129-Sgcdtm1Mcn/J)
|
abnormal muscle physiology
|
J:250485
|
| abnormal skeletal muscle morphology
|
J:250485
|
| cardiac muscle degeneration
|
J:234761
|
| cardiac muscle necrosis
|
J:234761
|
| decreased cardiac muscle contractility
|
J:234761
|
| dilated cardiomyopathy
|
J:234761
|
| dystrophic muscle
|
J:250485
|
| skeletal muscle fibrosis
|
J:250485
|
\Sgcdtm1Ojml/\Sgcd+
(B6.129-Sgcdtm1Ojml)
|
dilated cardiomyopathy
|
J:234761
|
\Sgcetm1Ygl/\Sgce+
(involves: 129S2/SvPas)
|
myoclonus
|
J:180682
|
\Sgcetm1Ygl/\Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6)
|
myoclonus
|
J:101332
|
\Sgcgtm1Mcn/\Sgcgtm1Mcn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:49871
|
| dystrophic muscle
|
J:49871
|
| muscle phenotype
|
J:57664
|
| thick diaphragm muscle
|
J:49871
|
\Sgcgtm1Oza/\Sgcgtm1Oza
(involves: 129S4/SvJae * C57BL/6)
|
abnormal diaphragm morphology
|
J:102780
|
| abnormal muscle regeneration
|
J:102780
|
| abnormal tibialis anterior morphology
|
J:102780
|
| dystrophic muscle
|
J:102780
|
| increased skeletal muscle fiber size
|
J:102780
|
| increased skeletal muscle mass
|
J:102780
|
| muscle degeneration
|
J:102780
|
| myocardium necrosis
|
J:102780
|
| progressive muscle weakness
|
J:102780
|
| skeletal muscle hypertrophy
|
J:102780
|
| skeletal muscle interstitial fibrosis
|
J:102780
|
| skeletal muscle necrosis
|
J:102780
|
\Sgpl1Gt(OST58278)Lex/\Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:145159
|
\Sgpl1Gt(ROSA)78Sor/\Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
\Sgpl1Gt(ROSA)78Sor/\Sgpl1Gt(ROSA)78Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
\Sgshmps3a/\Sgshmps3a
(involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:72142
|
\Sh3bp2tm1Bjro/\Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
myositis
|
J:117880
|
\Sh3pxd2atm1b(EUCOMM)Wtsi/\Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal digastric muscle connection
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal eye muscle topology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal muscle morphology
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
\Sh3pxd2bGt(GST_1527_E5)Lex/\Sh3pxd2bGt(GST_1527_E5)Lex
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:158635
|
\Sh3tc1tm1b(EUCOMM)Hmgu/\Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
\Shc1tm1Paw/\Shc1tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
abnormal vascular smooth muscle morphology
|
J:62182
|
| decreased cardiac muscle contractility
|
J:62182
|
| thin myocardium
|
J:62182
|
| trabecula carnea hypoplasia
|
J:62182
|
| vascular smooth muscle hypoplasia
|
J:62182
|
\Shc1tm1Pgp/\Shc1tm1Pgp
(involves: 129)
|
increased vasodilation
|
J:81977
|
\Shc1tm3Paw/\Shc1tm4Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
\Shc1tm3Paw/\Shc1tm7Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
\Shc1tm4Paw/\Shc1tm4Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
| abnormal myocardial trabeculae morphology
|
J:122927
|
\Shc1tm7Paw/\Shc1tm7Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
\Shhtm1(EGFP/cre)Cjt/\Shh+
\Sox17tm1Ysk/\Sox17+
(involves: 129S1/Sv * C57BL/6)
|
abnormal gallbladder smooth muscle morphology
|
J:241569
|
\Shhtm1(EGFP/cre)Cjt/\Shhtm1(EGFP/cre)Cjt
(Not Specified)
|
abnormal atrium myocardium morphology
|
J:204743
|
| abnormal gallbladder smooth muscle morphology
|
J:241569
|
| abnormal vascular smooth muscle morphology
|
J:204743
|
\Shhtm1Amc/\Shhtm1Amc
(involves: 129/Sv * C57BL/6J * CBA/J)
|
abnormal smooth muscle morphology
|
J:62158
|
| abnormal tracheal smooth muscle morphology
|
J:50051
|
\Shox2tm1Ddu/\Shox2tm3.1(cre)Ypc
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
sinoatrial node hypoplasia
|
J:199319
|
\Shox2tm1Ypc/\Shox2tm1Ypc
(involves: 129X1/SvJ)
|
sinoatrial node hypoplasia
|
J:199319
|
\Shox2tm3.1(cre)Ypc/\Shox2tm4.1Ypc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
sinoatrial node hypoplasia
|
J:199319
|
\Shroom3Gt(ROSA53)Sor/\Shroom3Gt(ROSA53)Sor
(B6.129S4-Shroom3Gt(ROSA53)Sor/J)
|
increased fetal cardiomyocyte proliferation
|
J:293794
|
| thin left ventricle myocardium compact layer
|
J:293794
|
\Sik2tm1Lex/\Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased muscle cell glucose uptake
|
J:229999
|
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129)
|
heart right ventricle hypertrophy
|
J:81010
|
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
heart right ventricle hypertrophy
|
J:81010
|
\Sirt7tm1Evbo/\Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6)
|
cardiomyopathy
|
J:147652
|
| increased cardiomyocyte apoptosis
|
J:147652
|
| increased myocardial fiber size
|
J:147652
|
\Six1tm1Kwk/\Six1tm1Kwk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:104488
|
\Six1tm1Mair/\Six1tm1Mair
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal genioglossus muscle morphology
|
J:82459
|
| abnormal hypaxial muscle morphology
|
J:82459
|
| abnormal intercostal muscle morphology
|
J:82459
|
| abnormal muscle fiber morphology
|
J:82459
|
| abnormal myogenesis
|
J:82459
|
| decreased skeletal muscle mass
|
J:82459
|
| muscle hypoplasia
|
J:82459
|
| thin diaphragm muscle
|
J:82459
|
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:172023
|
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S2/SvPas)
|
abnormal epaxial muscle morphology
|
J:84417
|
| abnormal hypaxial muscle morphology
|
J:84417
|
| absent diaphragm
|
J:84417
|
\Six1tm1Mair/\Six1tm1Mair
\Six4tm1Mair/\Six4tm1Mair
(either: 129/Sv-Six1tm1Mair Six4tm1Mair or B6N.129-Six1tm1Mair Six4tm1Mair)
|
abnormal genioglossus muscle morphology
|
J:98519
|
| abnormal intrinsic tongue muscle morphology
|
J:98519
|
| abnormal muscle development
|
J:98519
|
| abnormal muscle precursor cell migration
|
J:98519
|
| abnormal skeletal muscle morphology
|
J:98519
|
| absent eye muscles
|
J:98519
|
| absent hypaxial muscle
|
J:98519
|
| absent tongue muscles
|
J:98519
|
| muscle hypoplasia
|
J:98519
|
\Six1tm1Rsd/\Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:86619
|
| abnormal muscle precursor cell migration
|
J:86619
|
\Six1tm2.1Mair/\Six1tm2.1Mair
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac)
|
abnormal muscle physiology
|
J:190460
|
| abnormal muscle regeneration
|
J:190460
|
| muscle phenotype
|
J:190460
|
| skeletal muscle fibrosis
|
J:190460
|
\Six1tm2.2Mair/\Six1tm2.2Mair
(involves: C57BL/6NTac)
|
abnormal myogenesis
|
J:190460
|
\Six5tm1Tap/\Six5tm1Tap
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:61882
|
\Skitm1Cco/\Skitm1Cco
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle hypoplasia
|
J:42573
|
\Skitm1Cco/\Skitm1Cco
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal skeletal muscle fiber morphology
|
J:42573
|
| abnormal skeletal muscle morphology
|
J:42573
|
| decreased skeletal muscle fiber diameter
|
J:42573
|
| decreased skeletal muscle mass
|
J:42573
|
| muscle hypoplasia
|
J:42573
|
\skimp/\skimp
(involves: C3H/HeH)
|
opisthotonus
|
J:77535
|
\Skmw1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
\Skmw1C57BL/6J/\Skmw1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
\Skmw1C57BL/6J/\Skmw1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
\Skmw2C57BL/6J/\Skmw2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
\Skmw2DBA/2J/\Skmw2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw3DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
\Skmw4C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
\Skmw5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
\Skmw6C57BL/6J/\Skmw6DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:99478,
J:110033
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
\Skmw6DBA/2J/\Skmw6DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:99478,
J:110033
|
| increased tibialis anterior weight
|
J:99478
|
\Skmw7C57BL/6J/\Skmw7C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
\Skmw7C57BL/6J/\Skmw7DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
\Skmw8C57BL/6J/\Skmw8C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
\Skmw8C57BL/6J/\Skmw8DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw9C57BL/6J/\Skmw9C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478,
J:110033
|
\Skmw9C57BL/6J/\Skmw9DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478,
J:110033
|
\Skmw10C57BL/6J/\Skmw10C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal gastrocnemius morphology
|
J:99478,
J:110033
|
| increased muscle weight
|
J:110033
|
\Skmw10C57BL/6J/\Skmw10DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478
|
\Skmw11C57BL/6J/\Skmw11C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
| increased soleus weight
|
J:99478
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
\Skmw11C57BL/6J/\Skmw11DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
| increased soleus weight
|
J:99478
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
\Skmw12C57BL/6J/\Skmw12C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
\Skmw12C57BL/6J/\Skmw12DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
\Skmw13C57BL/6J/\Skmw13C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw13C57BL/6J/\Skmw13DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw14C57BL/6J/\Skmw14C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
\Skmw15C57BL/6J/\Skmw15C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal gastrocnemius morphology
|
J:110033
|
| increased muscle weight
|
J:110033
|
\Skmw16C57BL/6J/\Skmw16DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
\Skmw17C57BL/6J/\Skmw17DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw17DBA/2J/\Skmw17DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
\Skmw18C57BL/6J/\Skmw18C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
\Skmw18C57BL/6J/\Skmw18DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
\sky/\sky
(DBA/2J-sky/J)
|
abnormal muscle morphology
|
J:136875
|
\Slc2a4tm1Abel/\Slc2a4+
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased muscle cell glucose uptake
|
J:110773
|
\Slc2a4tm1Abel/\Slc2a4tm1Abel
\Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:75418
|
| decreased skeletal muscle cell glucose uptake
|
J:75418
|
| muscle phenotype
|
J:75418
|
\Slc2a4tm1Abel/\Slc2a4tm1Abel
\Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:110773
|
\Slc2a4tm1Abel/\Slc2a4tm1Abel
\Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * FVB)
|
abnormal myocardium layer morphology
|
J:59054
|
| decreased cardiac muscle cell glucose uptake
|
J:59054
|
\Slc2a4tm1Abel/\Slc2a4tm1Abel
\Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:108830
|
| increased cardiac muscle cell glucose uptake
|
J:108830
|
| increased cardiac muscle glycogen level
|
J:108830
|
\Slc2a4tm1Jdz/\Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:123335
|
\Slc2a4tm1Jdz/\Slc2a4tm1Jdz
\Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased skeletal muscle cell glucose uptake
|
J:123335
|
| increased cardiac muscle cell glucose uptake
|
J:123335
|
| increased skeletal muscle cell glucose uptake
|
J:123335
|
\Slc2a4tm1Mch/\Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL)
|
decreased muscle cell glucose uptake
|
J:43935
|
| decreased skeletal muscle cell glucose uptake
|
J:43650
|
| myocardium necrosis
|
J:43650
|
\Slc2a4tm1Mch/\Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)
|
abnormal muscle physiology
|
J:49328
|
\Slc2a4tm1Mch/\Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
abnormal skeletal muscle fiber type ratio
|
J:75600
|
| decreased skeletal muscle glycogen level
|
J:75600
|
| decreased skeletal muscle mass
|
J:75600
|
| impaired skeletal muscle contractility
|
J:75600
|
| increased muscle fatigability
|
J:75600
|
\Slc3a1tm1Jat/\Slc3a1tm1Jat
(involves: 129 * C57BL/6)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:254981
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:254981
|
\Slc4a1tm1Llp/\Slc4a1tm1Llp
(B6;129S4-Slc4a1tm1Llp/J)
|
decreased heart ventricle muscle contractility
|
J:120610
|
\Slc4a3tm1Ges/\Slc4a3tm1Ges
\Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:171021
|
| decreased cardiac muscle contractility
|
J:171021
|
\Slc4a4tm1.1Slin/\Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased gastrocnemius weight
|
J:186877
|
\Slc4a7Gt(40G1)Cmhd/\Slc4a7Gt(40G1)Cmhd
(B6.129-Slc4a7Gt(40G1)Cmhd)
|
abnormal vascular smooth muscle physiology
|
J:189470
|
| abnormal vasoconstriction
|
J:189470
|
| decreased vasodilation
|
J:189470
|
\Slc6a3tm1(cre)Lrsn/\Slc6a3+
\Tfamtm1Lrsn/\Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle spasm
|
J:119515
|
\Slc6a4tm1Kpl/\Slc6a4tm1Kpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:62768
|
\Slc6a4tm1Kpl/\Slc6a4tm1Kpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:237081
|
| decreased cardiac muscle contractility
|
J:121505
|
| dilated cardiomyopathy
|
J:121505
|
\Slc6a4tm2.1Rbl/\Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
intestinal hypoperistalsis
|
J:237081
|
\Slc6a5m1J/\Slc6a5m1J
(involves: 129S2/SvPas * NOD)
|
muscle hypertonia
|
J:184306
|
| muscle spasm
|
J:184306
|
\Slc6a5tm1Betz/\Slc6a5tm1Betz
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:86625
|
\Slc6a6tm1Jaz/\Slc6a6tm1Jaz
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle fiber morphology
|
J:135159
|
| abnormal myocardial fiber morphology
|
J:135159
|
| decreased cardiac muscle contractility
|
J:135159
|
| decreased myocardial fiber size
|
J:135159
|
| decreased skeletal muscle fiber diameter
|
J:135159
|
| decreased skeletal muscle weight
|
J:135159
|
| dilated cardiomyopathy
|
J:135159
|
| muscular atrophy
|
J:135159
|
\Slc6a8tm1e(KOMP)Wtsi/Y
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle morphology
|
J:264220
|
| abnormal muscle physiology
|
J:264220
|
| hypotonia
|
J:264220
|
| muscle weakness
|
J:264220
|
| skeletal muscle fiber atrophy
|
J:264220
|
\Slc6a9tm1Betz/\Slc6a9tm1Betz
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:86624
|
\Slc6a9tm1Veul/\Slc6a9tm1Veul
\Tg(EIIa-cre)C5379Lmgd/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
\Slc6a9tm1Veul/\Slc6a9tm1Veul
\Tg(Gfap-cre)2Brn/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
\Slc6a9tm1Veul/\Slc6a9tm1Veul
\Tg(Syn1-cre)671Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscle phenotype
|
J:161993
|
\Slc7a7Gt(OST41878)Lex/\Slc7a7Gt(OST41878)Lex
(B6.129S-Slc7a7Gt(OST41878)Lex)
|
hypotonia
|
J:125847
|
\Slc7a10tm1Dgen/\Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:100127
|
\Slc8a1tm1Hssh/\Slc8a1tm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:74096
|
\Slc8a1tm1Hssh/\Slc8a1tm1Hssh
(involves: 129S4/SvJae * C3H * C57BL/6)
|
abnormal myocardium layer morphology
|
J:106177
|
\Slc8a1tm1Yin/\Slc8a1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:75050
|
| heart left ventricle hypertrophy
|
J:75050
|
| impaired smooth muscle contractility
|
J:65985
|
| increased heart left ventricle muscle contractility
|
J:75050
|
\Slc8a1tm1Yin/\Slc8a1tm1Yin
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte mitochondrial morphology
|
J:102564
|
| absent Z line
|
J:102564
|
| increased fetal cardiomyocyte apoptosis
|
J:65985
|
\Slc8a3tm1Sso/\Slc8a3tm1Sso
(Not Specified)
|
skeletal muscle fiber necrosis
|
J:87615
|
\Slc8b1tm1c(EUCOMM)Wtsi/\Slc8b1tm1c(EUCOMM)Wtsi
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:325413
|
| decreased heart left ventricle muscle contractility
|
J:325413
|
| increased myocardial fiber size
|
J:325413
|
\Slc12a6tm1Tjj/\Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6)
|
muscle hypertonia
|
J:86183
|
\Slc13a5tm1.2Helf/\Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf)
|
abnormal muscle physiology
|
J:176732
|
| increased skeletal muscle cell glucose uptake
|
J:176732
|
\Slc16a3tm1Tac/\Slc16a3tm1Tac
(B6NTac.Cg-Slc16a3tm1Tac/Tac)
|
muscle phenotype
|
J:288233
|
\Slc16a13em1Tac/\Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac)
|
muscle phenotype
|
J:309785
|
\Slc18a2tm2Kmo/\Slc18a2tm2Kmo
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:150414
|
\Slc25a3tm1.1Jmol/\Slc25a3tm1.1Jmol
\A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal cardiac muscle tissue morphology
|
J:229795
|
| abnormal sarcomere morphology
|
J:229795
|
| cardiomyopathy
|
J:229795
|
| decreased heart left ventricle muscle contractility
|
J:229795
|
\Slc25a4tm2Dwa/\Slc25a4tm2Dwa
(involves: 129S4/SvJae * C57BL/6J)
|
myopathy
|
J:41256
|
\Slc25a25tm1.1Kz/\Slc25a25tm1.1Kz
(involves: C57BL/6J * FVB/N)
|
muscle phenotype
|
J:170924
|
\Slc26a4em1Jgao/\Slc26a4em1Jgao
(involves: CBA/CaJ)
|
torticollis
|
J:291230
|
\Slc27a1tm1Jkk/\Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J)
|
abnormal skeletal muscle cell glucose uptake
|
J:88657
|
| abnormal skeletal muscle triglyceride level
|
J:88657
|
\Slc32a1tm1Bros/\Slc32a1tm1Bros
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:122318
|
\Slc34a1tm1Hten/\Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J)
|
muscle weakness
|
J:47637
|
\Slc39a4tm2Gka/\Slc39a4tm2Gka
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased muscle weight
|
J:187178
|
\Slc39a8tm1.2Mrl/\Slc39a8tm1.2Mrl
(B6(Cg)-Slc39a8tm1.2Mrl)
|
abnormal myocardial trabeculae morphology
|
J:258360
|
| increased fetal cardiomyocyte proliferation
|
J:258360
|
| thin myocardium compact layer
|
J:258360
|
\Slc39a14tm1Thir/\Slc39a14tm1Thir
(involves: 129 * C57BL/6)
|
torticollis
|
J:171670
|
\Slit3b2b2362.1Clo/\Slit3b2b2362.1Clo
(C57BL/6J-Slit3b2b2362.1Clo)
|
myocardial hypertrabeculation
|
J:175213
|
\Slit3Gt(OST106158)Lex/\Slit3Gt(OST106158)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
diaphragmatic hernia
|
J:86149
|
| heart right ventricle hypertrophy
|
J:86149
|
\Slit3tm1.1Dor/\Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6J)
|
abnormal diaphragm morphology
|
J:83292
|
| diaphragmatic hernia
|
J:83292
|
| thin diaphragm muscle
|
J:83292
|
\Slit3tm1.1Dor/\Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6)
|
abnormal diaphragm central tendon morphology
|
J:208012
|
| abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
\Slit3tm1Dor/\Slit3tm1Dor
(involves: 129S1/Sv * C57BL/6J)
|
abnormal diaphragm central tendon morphology
|
J:83292
|
| abnormal diaphragm development
|
J:83292
|
| diaphragmatic hernia
|
J:83292
|
| thin diaphragm muscle
|
J:83292
|
\SlkGt(BC0415)Wtsi/\SlkGt(BC0415)Wtsi
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myogenesis
|
J:211339
|
\Slntm1Peri/\Slntm1Peri
(involves: Black Swiss * C57BL/6)
|
increased cardiac muscle contractility
|
J:127150
|
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Kdrtm1(cre)Sato/\Kdr+
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal trabecula carnea morphology
|
J:112269
|
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Tg(ACTA1-cre)AMcle/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:164492
|
| thin ventricle myocardium compact layer
|
J:164492
|
\Smad5tm1Cxd/\Smad5tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
vascular smooth muscle hypotrophy
|
J:53289
|
\Smad5tm1Huy/\Smad5tm1.1Huy
\Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
decreased cardiac muscle contractility
|
J:121072
|
\Smad6tm1Glvn/\Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ)
|
decreased vasodilation
|
J:60214
|
\Smad7Gt(YHC053)Byg/\Smad7+
\Tbx1tm1Bld/\Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
| vascular smooth muscle hypoplasia
|
J:212881
|
\Smad7tm1.1Shou/\Smad7tm1.1Shou
(involves: C57BL/6 * FVB)
|
abnormal trabecula carnea morphology
|
J:145777
|
| decreased cardiac muscle contractility
|
J:145777
|
\Smad7tm1Shou/\Smad7tm1Shou
\Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:145777
|
| decreased cardiac muscle contractility
|
J:145777
|
\Smarca2tm1Mya/\Smarca2tm1Mya
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:172661
|
\Smarca2tm1Mya/\Smarca2tm1Mya
\Smarca4tm1.1Pcn/\Smarca4+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:172661
|
\Smarca2tm1Mya/\Smarca2tm1Mya
\Smarca4tm1.2Pcn/\Smarca4tm1.1Pcn
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:172661
|
| abnormal muscle physiology
|
J:172661
|
| impaired smooth muscle contractility
|
J:172661
|
\Smarca4tm1.2Pcn/\Smarca4tm1.1Pcn
\Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:172661
|
| abnormal muscle physiology
|
J:172661
|
| impaired smooth muscle contractility
|
J:172661
|
\Smarcb1tm1Sho/\Smarcb1tm3Sho
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased rhabdomyoma incidence
|
J:80224
|
\Smarcb1tm2Sho/\Smarcb1tm2Sho
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA)
|
dystonia
|
J:226786
|
\Smarcd3tm1.1Bbr/\Smarcd3tm1.1Bbr
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(either: (involves: 129 * C57BL/6 * SJL) or (involves: 129 * C57BL/6 * ICR * SJL))
|
abnormal myocardial trabeculae morphology
|
J:257963
|
| thin myocardium
|
J:257963
|
\Smarcd3tm1.1Bbr/\Smarcd3tm1.1Bbr
\Tg(Myh6-cre)2182Mds/0
(either: (involves: 129 * C57BL/6 * FVB/N * SJL) or (involves: 129 * C57BL/6 * FVB/N * ICR * SJL))
|
abnormal intercalated disk morphology
|
J:257963
|
| abnormal sarcomere morphology
|
J:257963
|
| decreased cardiac muscle contractility
|
J:257963
|
| increased cardiomyocyte apoptosis
|
J:257963
|
\Smarcd3tm1.2Bbr/\Smarcd3tm1.2Bbr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR * SJL))
|
abnormal cardiac muscle relaxation
|
J:257963
|
| abnormal I band morphology
|
J:257963
|
| abnormal M line morphology
|
J:257963
|
| abnormal sarcomere morphology
|
J:257963
|
| abnormal Z line morphology
|
J:257963
|
| decreased fetal cardiomyocyte proliferation
|
J:257963
|
| decreased heart left ventricle muscle contractility
|
J:257963
|
\Smarcd3tm1.2Bbr/\Smarcd3tm1.2Bbr
(B6.129(Cg)-Smarcd3tm1.2Bbr)
|
abnormal myocardial trabeculae morphology
|
J:257963
|
| thin myocardium compact layer
|
J:257963
|
\Smg9em1(IMPC)J/\Smg9em1(IMPC)J
(involves: C57BL/6NJ)
|
thin myocardium
|
J:231968
|
\Smg9tm1b(EUCOMM)Wtsi/\Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Smn1tm1.1Dscd/\Smn1tm1.1Dscd
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
increased skeletal muscle fiber size
|
J:164889
|
\Smn1tm1Hung/\Smn1tm1Hung
\Tg(SMN2)2Hung/0
(B6N.Cg-Smn1tm1Hung Tg(SMN2)2Hung)
|
decreased skeletal muscle fiber size
|
J:193844
|
\Smn1tm1Hung/\Smn1tm1Hung
\Tg(SMN2)2Hung/0
(FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J)
|
decreased skeletal muscle fiber size
|
J:193844
|
\Smn1tm1Hung/\Smn1tm1Hung
\Tg(SMN2)2Hung/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/N)
|
increased skeletal muscle fiber size
|
J:193844
|
\Smn1tm1Hung/\Smn1tm1Hung
\Tg(SMN2)2Hung/\Tg(SMN2)2Hung
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:59313
|
| decreased skeletal muscle fiber diameter
|
J:59313
|
| decreased skeletal muscle fiber number
|
J:59313
|
| increased skeletal muscle fiber size
|
J:59313
|
| muscular atrophy
|
J:59313
|
\Smn1tm1Jme/\Smn1tm1.1Jme
\Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:67884
|
| abnormal skeletal muscle fiber morphology
|
J:67884
|
| centrally nucleated skeletal muscle fibers
|
J:67884
|
| increased variability of skeletal muscle fiber size
|
J:67884
|
| skeletal muscle necrosis
|
J:67884
|
\Smn1tm1Jme/\Smn1tm1.1Jme
\Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:61396
|
| hypotonia
|
J:61396
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
muscle phenotype
|
J:60592
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd/J)
|
decreased skeletal muscle fiber diameter
|
J:132467
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
\Tg(SMN2*A111G)588Ahmb/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal gastrocnemius morphology
|
J:148541
|
| abnormal skeletal muscle morphology
|
J:148541
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
\Tg(SMN2*delta7)4299Ahmb/0
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb/J)
|
decreased skeletal muscle fiber size
|
J:194969
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
\Tg(SMN2*delta7)4299Ahmb/\Tg(SMN2*delta7)4299Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb/J)
|
decreased skeletal muscle fiber diameter
|
J:132467
|
| dilated cardiomyopathy
|
J:164446
|
\Smn1tm1Msd/\Smn1tm1Msd
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
\Tg(SMN2*delta7)4299Ahmb/\Tg(SMN2*delta7)4299Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb)
|
skeletal muscle fiber atrophy
|
J:97103
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(ACTA1-SMN)63Ahmb/\Tg(ACTA1-SMN)63Ahmb
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * FVB/N)
|
decreased skeletal muscle fiber size
|
J:131663
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(Prnp-SMN)92Ahmb/\Tg(Prnp-SMN)92Ahmb
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * FVB/N)
|
decreased skeletal muscle fiber size
|
J:131663
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(SMN1*A2G)2023Ahmb/0
\Grm7Tg(SMN2)89Ahmb/\Grm7+
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal muscle electrophysiology
|
J:81238
|
| muscular atrophy
|
J:81238
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(SMN1-SMN2*)16Cll/0
\Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber size
|
J:194969
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(SMN2)11Tro/0
\Tg(SMN2)46Tro/0
(B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J)
|
abnormal muscle electrophysiology
|
J:159930
|
| abnormal skeletal muscle fiber morphology
|
J:159930
|
| muscular atrophy
|
J:159930
|
| progressive muscle weakness
|
J:159930
|
\Smn1tm1Msd/\Smn1tm1Msd
\Tg(SMN2)566Ahmb/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
muscle phenotype
|
J:60592
|
\Smn1tm5(Smn1/SMN2)Mrph/\Smn1tm5(Smn1/SMN2)Mrph
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
decreased skeletal muscle fiber size
|
J:186987
|
\Smotm2Amc/\Smotm2Amc
\Nkx3-2tm1(cre)Wez/\Nkx3-2+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal intestinal smooth muscle morphology
|
J:199664
|
\Smstm1a(EUCOMM)Wtsi/Y
(involves: C57BL/6N)
|
muscle weakness
|
J:200082
|
\Smtntm1Gve/\Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
decreased vasoconstriction
|
J:158046
|
| impaired contractility of jejunal smooth muscle
|
J:104648
|
| intestinal hypoperistalsis
|
J:104648
|
\Smtntm2Gve/\Smtntm2Gve
(B6.129-Smtntm2Gve)
|
decreased vasoconstriction
|
J:158046
|
\Smtnl1tm1Tajh/\Smtnl1tm1Tajh
(129S6.129P2-Smtnl1tm1Tajh)
|
abnormal skeletal muscle fiber type ratio
|
J:136573
|
| decreased vasoconstriction
|
J:136573
|
| increased vasodilation
|
J:136573
|
\Smyd1tm1Dsr/\Smyd1tm1Dsr
(involves: 129S6/SvEvTac)
|
trabecula carnea hypoplasia
|
J:76212
|
\Smyd3em1Yzzh/\Smyd3em1Yzzh
(C57BL/6-Smyd3em1Yzzh)
|
abnormal vasodilation
|
J:296379
|
\Snap25tm1Mcw/\Snap25tm1Mcw
(involves: C57BL/6)
|
abnormal intercostal muscle morphology
|
J:73755
|
| thin diaphragm muscle
|
J:73755
|
\Snap25tm2Mcw/\Snap25tm2Mcw
(involves: C57BL/6J)
|
myoclonus
|
J:94005
|
\Snhg15tm1Nju/\Snhg15tm1Nju
(involves: C57BL/6J)
|
delayed skeletal muscle regeneration
|
J:291983
|
| muscle phenotype
|
J:291983
|
\Snrktm2Rra/\Snrktm2Rra
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:218247
|
\Snta1tm1Scf/\Snta1tm1Scf
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:76455
|
\Snta1tm1Stk/\Snta1tm1Stk
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:52275
|
\Socs1tm2Wehi/\Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
myositis
|
J:72528
|
\Socs2tm1Wehi/\Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
increased skeletal muscle triglyceride level
|
J:186227
|
\Sod1m1H/\Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:219360
|
| progressive muscle weakness
|
J:219360
|
\Sod1tm1Dkd/\Sod1tm1Dkd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:60470
|
| myocardium necrosis
|
J:89952,
J:60470
|
\Sod1tm1Svb/\Sod1tm1Svb
\Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:201098
|
| abnormal muscle regeneration
|
J:201098
|
| centrally nucleated skeletal muscle fibers
|
J:201098
|
| increased extensor digitorum longus weight
|
J:201098
|
| increased gastrocnemius weight
|
J:201098
|
| increased quadriceps weight
|
J:201098
|
| increased skeletal muscle mass
|
J:201098
|
| increased soleus weight
|
J:201098
|
| increased tibialis anterior weight
|
J:201098
|
| muscle phenotype
|
J:201098
|
| muscle weakness
|
J:201098
|
\Sod2tm1(tetO-Sod2)Evbo/\Sod2+
(involves: 129S4/SvJae * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:162190
|
| increased cardiomyocyte apoptosis
|
J:162190
|
| increased myocardial fiber size
|
J:162190
|
| myocardium necrosis
|
J:162190
|
\Sod2tm1(tetO-Sod2)Evbo/\Sod2tm1(tetO-Sod2)Evbo
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:162190
|
\Sod2tm1.1Kskk/\Sod2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98289
|
| increased cardiomyocyte apoptosis
|
J:98289
|
\Sod2tm1.1Kskk/\Sod2tm1.1Kskk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98289
|
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J * CD-1)
|
abnormal skeletal muscle morphology
|
J:29899
|
| dilated cardiomyopathy
|
J:29899
|
| hypotonia
|
J:29899
|
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J)
|
dilated cardiomyopathy
|
J:45913
|
\Sod2tm1Cje/\Sod2tm1Cje
(B6.Cg-Sod2tm1Cje/Mmmh)
|
dilated cardiomyopathy
|
J:73998
|
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber morphology
|
J:98007
|
| decreased skeletal muscle fiber size
|
J:98007
|
\Sod2tm1Leb/\Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J)
|
decreased skeletal muscle mass
|
J:36148
|
| dilated cardiomyopathy
|
J:36148
|
\Sod2tm1Shs/\Sod2tm1Shs
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6CrSlc * FVB)
|
abnormal cardiac muscle tissue morphology
|
J:117386
|
| abnormal myocardium layer morphology
|
J:117386
|
| abnormal skeletal muscle morphology
|
J:117386
|
| cardiac muscle necrosis
|
J:117386
|
| decreased cardiac muscle contractility
|
J:117386
|
| dilated cardiomyopathy
|
J:117386
|
| increased cardiac muscle glycogen level
|
J:117386
|
| myocardial fiber degeneration
|
J:117386
|
\Sod2tm1Shs/\Sod2tm1Shs
\Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:171017
|
| myocardial fiber degeneration
|
J:171017
|
| myocardial fiber disarray
|
J:171017
|
\Sod2tm1Shs/\Sod2tm1Shs
\Tg(TNNI2-icre)1Vrmn/0
(involves: C57BL/6)
|
abnormal muscle contractility
|
J:155917
|
| abnormal muscle physiology
|
J:155917
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:155917
|
| abnormal skeletal muscle morphology
|
J:155917
|
| abnormal tibialis anterior morphology
|
J:155917
|
| increased muscle cell glucose uptake
|
J:155917
|
| increased muscle fatigability
|
J:155917
|
| muscle phenotype
|
J:155917
|
\Sod3tm1Svp/\Sod3tm1Svp
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
heart right ventricle hypertrophy
|
J:285340
|
\Sorl1tm1Bujo/\Sorl1tm1Bujo
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:140878
|
\Sos1tm1.2Rak/\Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal myocardial fiber morphology
|
J:171873
|
| decreased fetal cardiomyocyte apoptosis
|
J:171873
|
| heart left ventricle hypertrophy
|
J:171873
|
| increased cardiomyocyte apoptosis
|
J:171873
|
| increased fetal cardiomyocyte proliferation
|
J:171873
|
| increased myocardial fiber size
|
J:171873
|
\Sos1tm1.2Rak/\Sos1tm1.2Rak
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
decreased fetal cardiomyocyte apoptosis
|
J:171873
|
| heart right ventricle hypertrophy
|
J:171873
|
| increased fetal cardiomyocyte proliferation
|
J:171873
|
| myocardial fiber degeneration
|
J:171873
|
\Sos1tm1Dlb/\Sos1tm1Dlb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:38321
|
\Sos1tm1Dlb/\Sos1tm1Dlb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:38321
|
\Sox2tm2Skn/\Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
dystonia
|
J:92063
|
\Sox7tm1.1Dsco/\Sox7+
(involves: 129S/SvEv * C57BL/6)
|
abnormal diaphragm morphology
|
J:187416
|
| diaphragmatic hernia
|
J:187416
|
\Sox7tm1.1Dsco/\Sox7+
(B6.129-Sox7tm1.1Dsco)
|
muscle phenotype
|
J:187416
|
\Sox9tm1Gsr/\Sox9tm1Gsr
\Tg(Pax3-cre)1Joe/0
(involves: 129P2/OlaHsd * C57BL/6 * NMRI * SJL)
|
impaired ureteric peristalsis
|
J:166547
|
\Sox11tm1.2Vlf/\Sox11tm1.2Vlf
\Sox4tm1.1Vlf/\Sox4+
(involves: 129 * C57BL/6 * FVB/N)
|
myocardium hypoplasia
|
J:175338
|
\Sox15tm1Imad/\Sox15tm1Imad
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal myoblast differentiation
|
J:93031
|
| impaired skeletal muscle regeneration
|
J:93031
|
| increased satellite cell number
|
J:93031
|
\Sox17tm1Ysk/\Sox17+
(B6.129S1-Sox17tm1Ysk)
|
abnormal gallbladder smooth muscle morphology
|
J:241569
|
\Sox17tm2Sjm/\Sox17tm2Sjm
\Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:234137
|
\Sp4tm1Krc/\Sp4tm1Krc
(involves: 129S4/SvJae * Black Swiss)
|
abnormal Purkinje fiber morphology
|
J:77375
|
\Sp4tm2Krc/\Sp4tm2Krc
\Tg(Pax3-cre)1Joe/0
(involves: C57BL/6 * SJL)
|
abnormal impulse conducting system morphology
|
J:107057
|
\Spaarem1Ppp/\Spaarem1Ppp
(C57BL/6J-Spaarem1Ppp)
|
abnormal muscle physiology
|
J:238474
|
| enhanced muscle regeneration
|
J:238474
|
\Spegtm1Mkap/\Spegtm1Mkap
(either: B6.129S2-Spegtm1Mkap or (involves: 129S2/SvPas * C57BL/6))
|
decreased heart left ventricle muscle contractility
|
J:163968
|
\Sphk1tm1Rlp/\Sphk1tm1Rlp
\Sphk2tm1Rlp/\Sphk2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:103755
|
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal vasodilation
|
J:103050
|
\Spp1tm1Rit/\Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:95591
|
\Sprtntm1Yjm/\Sprtntm1Yjm
(involves: 129S/SvEv * C57BL/6)
|
muscle phenotype
|
J:225198
|
\Spta1sph/\Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
myocardium necrosis
|
J:44313
|
\Sptan1Gt(RRQ171)Byg/\Sptan1Gt(RRQ171)Byg
(B6.129P2-Sptan1Gt(RRQ171)Byg)
|
thin myocardium compact layer
|
J:186305
|
\Sptbja/\Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1)
|
abnormal myocardium layer morphology
|
J:44313
|
\Sptbn1tm1a(EUCOMM)Wtsi/\Sptbn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
| increased fetal cardiomyocyte apoptosis
|
J:219548
|
| myocardial trabeculae hypoplasia
|
J:219548
|
| thin left ventricle myocardium compact layer
|
J:219548
|
\Sptbn1tm1c(EUCOMM)Wtsi/\Sptbn1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
| increased fetal cardiomyocyte apoptosis
|
J:219548
|
\Sptbn1tm1Mish/\Sptbn1tm1Mish
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal myocardial fiber morphology
|
J:81747
|
\Sptbn4Gt(ROSABetageo)62Sor/\Sptbn4Gt(ROSABetageo)62Sor
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle contractility
|
J:120916,
J:77228
|
\Sptbn4Gt(ROSABetageo)62Sor/\Sptbn4Gt(ROSABetageo)62Sor
(129S4/SvJaeSor-Spnb4Gt(ROSABetageo)62Sor)
|
abnormal muscle contractility
|
J:77228
|
\Sptbn4Gt(ROSABetageo)62Sor/\Sptbn4Gt(ROSABetageo)62Sor
(B6.129S4-Sptbn4Gt(ROSABetageo)62Sor/Mmucd)
|
abnormal muscle contractility
|
J:77228
|
\Sptbn4qv-7J/\Sptbn4qv-7J
(A.B6 Tyr+-Sptbn4qv-7J/J)
|
muscle phenotype
|
J:82238
|
\Sptbn4qv-J/\Sptbn4qv-J
(C3FeB6 A/Aw-J-Sptbn4qv-J/J)
|
muscle phenotype
|
J:37678
|
\Srftm1Rjs/\Srftm2.1Nor
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:101311
|
| increased cardiomyocyte apoptosis
|
J:101311
|
\Srftm1Rmn/\Srftm1Rmn
\Tg(Tagln-cre)1Jomm/0
(involves: CD-1)
|
abnormal myocardial fiber morphology
|
J:94725
|
| vascular smooth muscle hypotrophy
|
J:94725
|
\Srftm1Zli/\Srftm1Zli
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:135043
|
| abnormal intercalated disk morphology
|
J:135043
|
| abnormal myocardial fiber morphology
|
J:135043
|
| abnormal myocardium layer morphology
|
J:135043
|
| abnormal Z line morphology
|
J:135043
|
| decreased heart left ventricle muscle contractility
|
J:135043
|
| dilated cardiomyopathy
|
J:135043
|
\Srftm1Zli/\Srftm1Zli
\Tg(Myh7-cre)1Zli/0
(involves: 129/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:91025
|
| disorganized myocardium
|
J:91025
|
| thin myocardium
|
J:91025
|
| trabecula carnea hypoplasia
|
J:91025
|
\Srftm2.1Nor/\Srftm2.1Nor
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:96122
|
\Srftm2.1Nor/\Srftm2.1Nor
\Tg(Myog-cre)1Eno/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm morphology
|
J:96122
|
| abnormal skeletal muscle fiber morphology
|
J:96122
|
| decreased skeletal muscle mass
|
J:96122
|
\Srltm1Hta/\Srltm1Hta
(B6.129S4-Srltm1Hta)
|
abnormal muscle physiology
|
J:101569
|
\Srltm1Hta/\Srltm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:96983
|
| abnormal muscle contractility
|
J:96983
|
| abnormal sarcoplasmic reticulum morphology
|
J:96983
|
| decreased cardiac muscle contractility
|
J:96983
|
| impaired skeletal muscle contractility
|
J:96983
|
\Srpk3tm1Eno/Y
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:100494
|
| centrally nucleated skeletal muscle fibers
|
J:100494
|
| decreased skeletal muscle mass
|
J:100494
|
\Srpk3tm1Eno/\Srpk3tm1Eno
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:100494
|
| centrally nucleated skeletal muscle fibers
|
J:100494
|
| decreased skeletal muscle mass
|
J:100494
|
\Srsf4tm1c(EUCOMM)Wtsi/\Srsf4tm1c(EUCOMM)Wtsi
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129S1/Sv * C57BL/6 * C57BL/6N)
|
heart left ventricle hypertrophy
|
J:344969
|
| increased myocardial fiber size
|
J:344969
|
\Srsf5em1Nju/\Srsf5em1Nju
(C57BL/6JGpt-Srsf5em1Nju)
|
abnormal trabecula carnea morphology
|
J:311867
|
| abnormal ventricle myocardium morphology
|
J:311867
|
| decreased cardiac muscle contractility
|
J:311867
|
| decreased fetal cardiomyocyte proliferation
|
J:311867
|
| thin ventricle myocardium compact layer
|
J:311867
|
\Srsf10tm1Jalm/\Srsf10tm1Jalm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:149480
|
| disorganized myocardium
|
J:149480
|
| thin myocardium
|
J:149480
|
\Sspntm1Kcam/\Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:60294
|
\Sspntm1Kcam/\Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| increased quadriceps weight
|
J:187752
|
\Ssr2tm1b(EUCOMM)Wtsi/\Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal digastric muscle morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
\Ssu2em1(IMPC)Ccpcz/\Ssu2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ssu2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Stab1tm1.1Cger/\Stab1tm1.1Cger
\Stab2tm1.1Cger/\Stab2tm1.1Cger
(C.129S2-Stab2tm1.1Cger Stab1tm1.1Cger)
|
dilated cardiomyopathy
|
J:171818
|
\Stac3tm1a(KOMP)Wtsi/\Stac3tm1a(KOMP)Wtsi
(B6(Cg)-Stac3tm1a(KOMP)Wtsi)
|
abnormal extensor digitorum longus morphology
|
J:200631
|
| abnormal skeletal muscle fiber morphology
|
J:200631
|
| abnormal Z line morphology
|
J:200631
|
| centrally nucleated skeletal muscle fibers
|
J:200631
|
| decreased skeletal muscle fiber number
|
J:200631
|
| increased skeletal muscle fiber diameter
|
J:200631
|
| thin diaphragm muscle
|
J:200631
|
\Stac3tm1a(KOMP)Wtsi/\Stac3tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal diaphragm morphology
|
J:222015
|
| abnormal muscle electrophysiology
|
J:222015
|
| abnormal sarcomere morphology
|
J:222015
|
| abnormal skeletal muscle fiber morphology
|
J:222015
|
| abnormal skeletal muscle morphology
|
J:222015
|
| abnormal tongue muscle morphology
|
J:222015
|
| centrally nucleated skeletal muscle fibers
|
J:222015
|
| decreased skeletal muscle mass
|
J:222015
|
| impaired skeletal muscle contractility
|
J:222015
|
| thin diaphragm muscle
|
J:222015
|
\Stag1Gt(P099A04)Wrst/\Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:184719
|
\Stat1tm1Rds/\Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
increased cardiomyocyte apoptosis
|
J:120449
|
\Stat3tm1Vpo/\Stat3+
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
cardiomyopathy
|
J:141591
|
\Stat3tm1Vpo/\Stat3tm1Vpo
\Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:141591
|
| cardiomyopathy
|
J:141591
|
| decreased cardiac muscle contractility
|
J:141591
|
| increased cardiomyocyte apoptosis
|
J:141591
|
\Stat3tm1Xyfu/\Stat3tm1.1Xyfu
\Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
decreased cardiac muscle contractility
|
J:86400
|
| increased cardiomyocyte apoptosis
|
J:86400
|
\Steap4tm1Dgen/\Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
decreased muscle cell glucose uptake
|
J:187736
|
\Stim1tm1.1Pg/\Stim1+
(involves: C57BL/6)
|
abnormal muscle physiology
|
J:285187
|
| abnormal skeletal muscle fiber morphology
|
J:285187
|
| abnormal skeletal muscle morphology
|
J:285187
|
| centrally nucleated skeletal muscle fibers
|
J:285187
|
| decreased gastrocnemius weight
|
J:285187
|
| decreased quadriceps weight
|
J:285187
|
| decreased skeletal muscle fiber diameter
|
J:285187
|
| decreased skeletal muscle weight
|
J:285187
|
| increased soleus weight
|
J:285187
|
| increased variability of skeletal muscle fiber size
|
J:285187
|
| myopathy
|
J:285187
|
| skeletal muscle endomysial fibrosis
|
J:285187
|
| skeletal muscle necrosis
|
J:285187
|
\Stim1tm3Ics/\Stim1+
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:277842,
J:327797
|
| abnormal muscle weight
|
J:277842
|
| abnormal skeletal muscle fiber morphology
|
J:277842,
J:327797
|
| abnormal skeletal muscle morphology
|
J:277842
|
| centrally nucleated skeletal muscle fibers
|
J:277842
|
| decreased gastrocnemius weight
|
J:277842
|
| decreased muscle fatigability
|
J:277842
|
| enhanced skeletal muscle regeneration
|
J:327797
|
| impaired muscle relaxation
|
J:277842
|
| increased skeletal muscle cell apoptosis
|
J:327797
|
| increased skeletal muscle fiber mitochondrial size
|
J:277842
|
| increased soleus weight
|
J:277842
|
| muscle weakness
|
J:277842
|
| myositis
|
J:277842
|
| skeletal muscle fibrosis
|
J:277842
|
\Stk11tm1.1Arte/\Stk11tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:208379
|
\Stk11tm1Keis/\Stk11tm1Keis
\Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:98513
|
\Stk11tm1Tpm/\Stk11tm1Tpm
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:70892
|
\Stk11tm2.1Tpm/\Stk11tm2.1Tpm
(involves: BALB/c * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:70892
|
\Stk39tm2.1Arte/\Stk39tm2.1Arte
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:224087
|
\Stmn1tm1Wed/\Stmn1tm1Wed
(involves: 129P2/OlaHsd * C57BL/6)
|
myopathy
|
J:74496
|
\Stradaem1Pbcr/\Stradaem1Pbcr
(C57BL/6N-Stradaem1Pbcr)
|
hypotonia
|
J:308972
|
\Strip2tm1.2Tac/\Strip2tm1.2Tac
(Not Specified)
|
decreased cardiac muscle contractility
|
J:306481
|
\Strit1em1Eno/\Strit1em1Eno
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:229305
|
\Stub1tm1Cpat/\Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle fiber morphology
|
J:245069
|
| abnormal sarcoplasmic reticulum morphology
|
J:245069
|
| abnormal skeletal muscle fiber type ratio
|
J:245069
|
\Styxl2tm1.1Nju/\Styxl2tm1.1Nju
(involves: C57BL/6 * FVB/N)
|
abnormal sarcomere morphology
|
J:351096
|
\Styxl2tm1Nju/\Styxl2tm1Nju
\Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6)
|
muscle phenotype
|
J:351096
|
\Sucla2Gt(IST10208H1)Tigm/\Sucla2+
(involves: 129S/SvEv * C57BL/6N)
|
decreased myocardial fiber mitochondrial DNA content
|
J:241325
|
\SufuGt(XB699)Byg/\Sufu+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:125534
|
\Sufutm1Aeb/\Sufutm1Aeb
(either: 129S1/Sv-Sufutm1Aeb or (involves: 129S1/Sv * C57BL/6))
|
abnormal myocardium layer morphology
|
J:101731
|
\Sulf1tm1.1Cpe/\Sulf1tm1.1Cpe
\Sulf2tm1.1Cpe/\Sulf2tm1.1Cpe
(involves: 129S/SvEv * C57BL/6)
|
impaired smooth muscle contractility
|
J:124898
|
\Sulf1tm1b(KOMP)Mbp/\Sulf1tm1b(KOMP)Mbp
(C57BL/6NCrl-Sulf1tm1b(KOMP)Mbp/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Sult1a1em1(IMPC)Ccpcz/\Sult1a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Sult1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Sun1tm1Mhan/\Sun1+
\Sun2tm1Mhan/\Sun2tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
\Sun1tm1Mhan/\Sun1tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
\Sun1tm1Mhan/\Sun1tm1Mhan
\Sun2tm1Mhan/\Sun2+
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
\Sun1tm1Mhan/\Sun1tm1Mhan
\Sun2tm1Mhan/\Sun2tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
\Supv3l1tm2.1Jkl/\Supv3l1tm2.2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased skeletal muscle mass
|
J:144991
|
| dystrophic muscle
|
J:144991
|
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:144991
|
| dystrophic muscle
|
J:144991
|
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscular atrophy
|
J:144991
|
\Syislem1Bzuo/\Syislem1Bzuo
(involves: C57BL/6)
|
abnormal myoblast differentiation
|
J:266240
|
| abnormal myoblast fusion
|
J:266240
|
| abnormal skeletal muscle fiber morphology
|
J:266240
|
| decreased myoblast proliferation
|
J:266240
|
| enhanced muscle regeneration
|
J:266240
|
| increased gastrocnemius weight
|
J:266240
|
| increased quadriceps weight
|
J:266240
|
| increased skeletal muscle fiber number
|
J:266240
|
| increased tibialis anterior weight
|
J:266240
|
\Synctm1.1Ked/\Synctm1.1Ked
(involves: 129/Sv * C57BL/6)
|
impaired skeletal muscle contractility
|
J:138552
|
| muscle phenotype
|
J:138552
|
\Synctm1Chen/\Synctm1Chen
(involves: 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:136645
|
| muscle phenotype
|
J:136645
|
\Syne1tm1.1Chen/\Syne1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:155342
|
| abnormal skeletal muscle fiber morphology
|
J:155342
|
| centrally nucleated skeletal muscle fibers
|
J:155342
|
\Syne1tm1.1Mcn/\Syne1tm1.1Mcn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)
|
dystrophic muscle
|
J:144757
|
\Syne1tm1Chen/\Syne1tm1Chen
\Syne2tm1.1Chen/\Syne2tm1.1Chen
\Tg(Nkx2-5-cre)9Eno/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:211007
|
| increased myocardial fiber apoptosis
|
J:211007
|
\Syne1tm1Rexu/\Syne1tm1Rexu
(involves: 129 * C57BL/6)
|
abnormal muscle fiber morphology
|
J:118671
|
\Syne2tm1Rexu/\Syne2tm1Rexu
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:118671
|
\Syngr1em1(IMPC)Ccpcz/\Syngr1em1(IMPC)Ccpcz
(C57BL/6NCrl-Syngr1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Synmtm1.1(KOMP)Vlcg/\Synmtm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal muscle fiber morphology
|
J:224030
|
| abnormal muscle morphology
|
J:224030
|
| abnormal muscle physiology
|
J:224030
|
| abnormal sarcolemma morphology
|
J:224030
|
| abnormal skeletal muscle morphology
|
J:224030
|
| cardiomyopathy
|
J:257039
|
| decreased heart left ventricle muscle contractility
|
J:257039
|
| decreased skeletal muscle mass
|
J:224030
|
| decreased skeletal muscle size
|
J:224030
|
| heart left ventricle hypertrophy
|
J:257039
|
| increased muscle fatigability
|
J:224030
|
| increased myocardial fiber size
|
J:257039
|
| muscle twitch
|
J:224030
|
| myocardium hypertrophy
|
J:257039
|
| skeletal muscle necrosis
|
J:224030
|
\Synmtm1.1Ics/\Synmtm1.1Ics
(involves: 129S2/SvPas * C57BL/6 * FVB/N * SJL)
|
abnormal muscle electrophysiology
|
J:268425
|
| abnormal sarcolemma morphology
|
J:268425
|
| abnormal sarcomere morphology
|
J:268425
|
| abnormal skeletal muscle fiber morphology
|
J:268425
|
| abnormal skeletal muscle fiber type ratio
|
J:268425
|
| abnormal skeletal muscle regeneration
|
J:268425
|
| centrally nucleated skeletal muscle fibers
|
J:268425
|
| increased satellite cell number
|
J:268425
|
| increased skeletal muscle fiber diameter
|
J:268425
|
| increased skeletal muscle mass
|
J:268425
|
| myopathy
|
J:268425
|
| skeletal muscle fiber degeneration
|
J:268425
|
\Sypl2tm1Hta/\Sypl2tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal sarcoplasmic reticulum morphology
|
J:59188
|
| abnormal skeletal muscle fiber morphology
|
J:59188
|
| abnormal skeletal muscle fiber triad morphology
|
J:59188
|
| decreased skeletal muscle fiber size
|
J:59188
|
| impaired skeletal muscle contractility
|
J:59188
|
\Syt1tm1a(EUCOMM)Wtsi/\Syt1tm1a(EUCOMM)Wtsi
(C57BL/6N-Syt1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
\Syt7tm1Nan/\Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:85201
|
| myositis
|
J:85201
|
| skeletal muscle interstitial fibrosis
|
J:85201
|
\Taar8bem1(IMPC)Mbp/\Taar8bem1(IMPC)Mbp
(C57BL/6N-Taar8bem1(IMPC)Mbp/MbpMmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Tab1tm1Geny/\Tab1tm1Geny
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:80766
|
| abnormal myocardial trabeculae morphology
|
J:80766
|
| thin myocardium
|
J:80766
|
\Taf7ltm1.1Jw/Y
(B6J.Cg-Taf7ltm1.1Jw)
|
abnormal muscle development
|
J:228546
|
| abnormal muscle physiology
|
J:228546
|
\Tafazzinem1Xfa/Y
\Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased heart left ventricle muscle contractility
|
J:339058
|
| dilated cardiomyopathy
|
J:339058
|
\Tafazzinem1Xfa/\Tafazzinem1Xfa
\Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased heart left ventricle muscle contractility
|
J:339058
|
| dilated cardiomyopathy
|
J:339058
|
\Taglntm1Liw/\Tagln+
\Tbx18tm1.1Mwmy/\Tbx18tm1.1Mwmy
(involves: 129 * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:203805
|
\Tal1Hpt/\Tal1+
(HPT/Le)
|
heart left ventricle hypertrophy
|
J:1780
|
\Taok1em1Bcgen/\Taok1+
(C57BL/6N-Taok1em1Bcgen)
|
hypotonia
|
J:341142
|
\Tarbp2tm1.1Dzw/\Tarbp2tm1.1Dzw
\Tg(Tnnt2-cre)5Blh/0
(involves: 129 * C57BL/6 * DBA/2J)
|
decreased heart left ventricle muscle contractility
|
J:222613
|
| dilated cardiomyopathy
|
J:222613
|
\Tardbpm1H/\Tardbp+
(involves: C3H/HeH * C57BL/6J)
|
abnormal muscle tone
|
J:211620
|
| impaired muscle relaxation
|
J:211620
|
\Tardbpm1H/\Tardbp+
\Tg(SOD1*G93A)dl1Gur/0
(involves: C3H/HeH * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle tone
|
J:211620
|
| decreased extensor digitorum longus weight
|
J:211620
|
| impaired muscle relaxation
|
J:211620
|
\Tardbptm1.1Sobue/\Tardbptm1.1Sobue
\Tg(SLC18A3-cre)Misa/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
muscular atrophy
|
J:324570
|
\Tardbptm3.1Ckjs/\Tardbp+
(involves: C57BL/6J)
|
skeletal muscle atrophy
|
J:285792
|
\Tars3em1Smoc/\Tars3em1Smoc
(C57BL/6-Tars3em1Smoc)
|
abnormal soleus morphology
|
J:341137
|
| abnormal tibialis anterior morphology
|
J:341137
|
| decreased skeletal muscle fiber size
|
J:341137
|
\Tatdn1tm1.2Csaag/\Tatdn1tm1.2Csaag
(involves: 129S4/SvJaeSor * C57BL/6J * DBA/2)
|
decreased myocardial fiber size
|
J:365556
|
| dilated cardiomyopathy
|
J:365556
|
\Tbc1d1Gt(E140H06)Wrst/\Tbc1d1Gt(E140H06)Wrst
(B6.129P2-Tbc1d1Gt(E140H06)Wrst)
|
abnormal muscle cell glucose uptake
|
J:203285
|
\Tbc1d4tm1.1Arte/\Tbc1d4tm1.1Arte
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:169477
|
| increased muscle cell glucose uptake
|
J:169477
|
\Tbc1d4tm1.1Arte/\Tbc1d4tm1.1Arte
(Not Specified)
|
muscle phenotype
|
J:186867
|
\Tbc1d4tm1.2Arte/\Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA)
|
decreased skeletal muscle cell glucose uptake
|
J:194026
|
\Tbc1d4tm1Lex/\Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased skeletal muscle cell glucose uptake
|
J:191749
|
\Tbc1d7em1Hms/\Tbc1d7em1Hms
(C57BL/6J-Tbc1d7em1Hms)
|
increased skeletal muscle fiber size
|
J:325096
|
\Tbc1d20em1Djsi/\Tbc1d20em1Djsi
(involves: C57BL/6 * DBA/2)
|
abnormal eye muscle morphology
|
J:315009
|
\Tbc1d25Gt(IST10205D5)Tigm/Y
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:295960
|
| decreased heart ventricle muscle contractility
|
J:295960
|
| increased myocardial fiber size
|
J:295960
|
\Tbcepmn/\Tbcepmn
(NMRI/Pan)
|
muscular atrophy
|
J:30914
|
| progressive muscle weakness
|
J:1717
|
\Tbl1xr1tm1.1Arte/\Tbl1xr1tm1.1Arte
\Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:198124
|
\Tbx1tm1Bem/\Tbx1tm1Bem
(FVB.Cg-Tbx1tm1Bem)
|
absent masseter muscle
|
J:91664
|
| absent pterygoid muscle
|
J:91664
|
\Tbx1tm1Bld/\Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
| vascular smooth muscle hypoplasia
|
J:212881
|
\Tbx1tm1Pa/\Tbx1tm1Pa
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypoglossal cord morphology
|
J:94411
|
| abnormal laryngeal muscle morphology
|
J:94411
|
| abnormal myogenesis
|
J:94411
|
| abnormal pharyngeal muscle morphology
|
J:150130
|
\Tbx1tm2.1Bem/\Tbx1tm2.2Bem
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129 * C57BL/6J * SJL * Swiss Webster)
|
absent masseter muscle
|
J:105980
|
| absent pterygoid muscle
|
J:105980
|
\Tbx1tm2.2Bem/\Tbx1tm2.2Bem
(involves: 129/Sv * C57BL/6J * SJL * Swiss Webster)
|
absent facial muscle
|
J:105980
|
\Tbx3tm1.1(cre)Vmc/\Tbx3tm1.1(cre)Vmc
(involves: 129P2/OlaHsd * FVB)
|
abnormal sinoatrial node morphology
|
J:121230
|
| decreased sinoatrial node size
|
J:121230
|
\Tbx3tm1.1Moon/\Tbx3tm2Moon
(involves: 129 * C57BL/6 * SJL)
|
sinoatrial node hypoplasia
|
J:179977
|
\Tbx3tm2.1Moon/\Tbx3tm2.1Moon
(involves: 129 * BALB/cJ * C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:179977
|
| sinoatrial node hypoplasia
|
J:179977
|
\Tbx5tm1.1Jse/\Tbx5+
(either: (involves: 129/Sv) or (involves: Black Swiss))
|
abnormal atrioventricular bundle morphology
|
J:92050
|
| abnormal impulse conducting system morphology
|
J:92050
|
| abnormal left posterior bundle morphology
|
J:92050
|
| abnormal right bundle morphology
|
J:92050
|
\Tbx5tm1Jse/\Tbx5tm1Jse
\Tg(Prrx1-cre/ERT2)1Mlgn/0
\Tg(Scx-GFP)1Stzr/0
(Not Specified)
|
abnormal tendon morphology
|
J:157917
|
\Tbx15tm1Akis/\Tbx15tm1Akis
(involves: 129P2/OlaHsd * NMRI)
|
decreased skeletal muscle mass
|
J:96466
|
\Tbx18tm1.1Mwmy/\Tbx18tm1.1Mwmy
(involves: 129 * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:203805
|
\Tbx20tm1.1Rph/\Tbx20+
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
| dilated cardiomyopathy
|
J:98489
|
\Tbx20tm1.1Rph/\Tbx20tm1.1Rph
(involves: C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:98489
|
\Tbx20tm1.1Sev/\Tbx20tm1.1Sev
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:98516
|
\Tbx20tm1Akis/\Tbx20tm1Akis
(involves: 129S1/SvImJ * NMRI)
|
decreased fetal cardiomyocyte proliferation
|
J:98806
|
\Tcaf2em1(IMPC)Ccpcz/\Tcaf2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tcaf2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Tcaptm1Mkc/\Tcaptm1Mkc
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:159687
|
| centrally nucleated skeletal muscle fibers
|
J:159687
|
| decreased skeletal muscle fiber diameter
|
J:159687
|
| muscle phenotype
|
J:159687
|
| myopathy
|
J:159687
|
| skeletal muscle fiber atrophy
|
J:159687
|
\Tcaptm1Rnk/\Tcaptm1Rnk
(Not Specified)
|
abnormal sarcomere morphology
|
J:188832
|
| increased cardiomyocyte apoptosis
|
J:188832
|
\Tcf7l2tm1a(EUCOMM)Wtsi/\Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
\Tcf7l2tm3.1(cre/ERT2)Mrc/\Tcf7l2+
\Gt(ROSA)26Sortm1(DTA)Mrc/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle morphology
|
J:174914
|
| abnormal muscle regeneration
|
J:174914
|
| decreased satellite cell number
|
J:174914
|
\Tcf15tm1Eno/\Tcf15tm1Eno
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal intercostal muscle morphology
|
J:37117
|
| abnormal skeletal muscle morphology
|
J:37117
|
| absent myotome
|
J:37117
|
| skeletal muscle hypertrophy
|
J:37117
|
\Tcf21tm2Eno/\Tcf21tm2Eno
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:185552
|
\Tcratm1Mom/\Tcratm1Mom
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
myositis
|
J:181257
|
\Tdgtm1.1Abc/\Tdgtm1.1Abc
(B6.129-Tdgtm1.1Abc)
|
myocardium hypoplasia
|
J:174772
|
| thin myocardium
|
J:174772
|
\Tead1Gt(ROSA5)Sor/\Tead1Gt(ROSA5)Sor
(Not Specified)
|
trabecula carnea hypoplasia
|
J:20882
|
\Tead1tm1Hssk/\Tead1tm1Hssk
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1))
|
abnormal myocardial trabeculae morphology
|
J:131426
|
\Tecrlem1Bcgen/\Tecrlem1Bcgen
(C57BL/6-Tecrlem1Bcgen)
|
abnormal myocardial fiber mitochondrial morphology
|
J:325991
|
| decreased heart left ventricle muscle contractility
|
J:325991
|
\Tefmtm1.1Lrsn/\Tefmtm1.1Lrsn
\Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
abnormal myocardial fiber morphology
|
J:276874
|
\Tektm1Ber/\Tektm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent myocardial trabeculae
|
J:99096
|
\Tektm1Dmt/\Tektm1Dmt
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent myocardial trabeculae
|
J:99096
|
\Tektm1Dmt/\Tektm1Dmt
\Tie1tm1Jpa/\Tie1tm1Jpa
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:54983
|
\Tektm1Sato/\Tektm1Sato
(involves: 129S1/Sv * C57BL/6J)
|
absent trabeculae carneae
|
J:79305
|
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal cardiac muscle contractility
|
J:110900
|
| abnormal cardiac muscle relaxation
|
J:110900
|
| abnormal fetal cardiomyocyte proliferation
|
J:110900
|
| abnormal myocardial fiber morphology
|
J:110900
|
| decreased myocardial fiber number
|
J:110900
|
| dilated cardiomyopathy
|
J:110900
|
| heart left ventricle hypertrophy
|
J:110900
|
| increased cardiomyocyte apoptosis
|
J:110900
|
\Tfamtm1Lrsn/\Tfamtm1Lrsn
\Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
dilated cardiomyopathy
|
J:51964
|
| increased cardiomyocyte apoptosis
|
J:125471
|
\Tfap2bem1Fenli/\Tfap2bem1Fenli
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:278067
|
\Tfap2btm1Rbu/\Tfap2btm1Rbu
(129P2.129-Tfap2btm1Rbu)
|
muscle spasm
|
J:83000
|
\Tfb1mtm1.1Lrsn/\Tfb1mtm1.1Lrsn
\Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL)
|
abnormal myocardial fiber morphology
|
J:148166
|
\Tg(ACTA1*D286G)#Kjno/\Tg(ACTA1*D286G)#Kjno
(involves: C57BL/6 * CBA)
|
abnormal sarcomere morphology
|
J:209273
|
| abnormal skeletal muscle morphology
|
J:209273
|
| abnormal Z line morphology
|
J:209273
|
| impaired skeletal muscle contractility
|
J:209273
|
| muscle weakness
|
J:209273
|
\Tg(ACTA1*D286G/EGFP)#Kjno/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal skeletal muscle morphology
|
J:182255
|
| abnormal Z line morphology
|
J:182255
|
| impaired skeletal muscle contractility
|
J:182255
|
| muscle weakness
|
J:182255
|
\Tg(ACTA1-Ar)78Kyjo/0
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:127205
|
\Tg(ACTA1-Ar)141Kyjo/0
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:127205
|
| decreased skeletal muscle fiber number
|
J:127205
|
| increased skeletal muscle fiber size
|
J:127205
|
| muscle weakness
|
J:127205
|
| muscular atrophy
|
J:127205
|
\Tg(ACTA1-Capn3)7.2Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| muscle phenotype
|
J:77348
|
\Tg(ACTA1-Capn3*)10.3Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
\Tg(ACTA1-Capn3*)27.10Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-Capn3*)37.3Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-Capn3*)37.9Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-Capn3*)39.1Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-Capn3*)41.1Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-Capn3*)42Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
\Tg(ACTA1-cre/ERT2)97.16Mtz/0
\Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal skeletal muscle fiber morphology
|
J:132154
|
| decreased skeletal muscle size
|
J:132154
|
| impaired muscle relaxation
|
J:132154
|
| skeletal muscle degeneration
|
J:132154
|
| skeletal muscle fibrosis
|
J:132154
|
\Tg(ACTA1-Ctss)1Jmol/?
(FVB/N-Tg(ACTA1-Ctss)1Jmol)
|
centrally nucleated skeletal muscle fibers
|
J:230788
|
| dystrophic muscle
|
J:230788
|
| skeletal muscle fibrosis
|
J:230788
|
\Tg(ACTA1-FRG1)highRotu/0
(C57BL/6-Tg(ACTA1-FRG1)highRotu)
|
abnormal skeletal muscle fiber morphology
|
J:106896
|
| centrally nucleated skeletal muscle fibers
|
J:106896
|
| decreased skeletal muscle mass
|
J:106896
|
| dystrophic muscle
|
J:106896
|
\Tg(ACTA1-FRG1)lowRotu/0
(C57BL/6-Tg(ACTA1-FRG1)lowRotu)
|
muscle phenotype
|
J:106896
|
\Tg(ACTA1-FRG1)medRotu/0
(C57BL/6-Tg(ACTA1-FRG1)medRotu)
|
abnormal skeletal muscle fiber morphology
|
J:106896
|
| centrally nucleated skeletal muscle fibers
|
J:106896
|
| decreased skeletal muscle mass
|
J:106896
|
| dystrophic muscle
|
J:106896
|
\Tg(ACTA1-IGF1)1Rjs/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:58354
|
| abnormal myocardial fiber morphology
|
J:58354
|
| increased skeletal muscle fiber size
|
J:25522
|
\Tg(ACTA1-Il15*)11650Lsq/0
(involves: C3H * C57BL/6)
|
decreased extensor digitorum longus weight
|
J:145611
|
\Tg(ACTA1-MYOT)12Mah/?
(involves: C57BL/6 * SJL)
|
abnormal sarcolemma morphology
|
J:110377
|
| abnormal skeletal muscle morphology
|
J:110377
|
\Tg(ACTA1-MYOT*T57I)71Mah/?
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:110377
|
| abnormal skeletal muscle morphology
|
J:110377
|
| diffuse Z line
|
J:110377
|
| dystrophic muscle
|
J:110377
|
| impaired skeletal muscle contractility
|
J:110377
|
| muscle weakness
|
J:110377
|
| skeletal muscle interstitial fibrosis
|
J:110377
|
\Tg(ACTA1-PABPN1*A17)1Drub/0
(involves: FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:115642
|
| centrally nucleated skeletal muscle fibers
|
J:115642
|
| muscle weakness
|
J:115642
|
| progressive muscle weakness
|
J:115642
|
\Tg(Acta1-Slmap)#Eno/0
(Not Specified)
|
decreased skeletal muscle fiber size
|
J:247651
|
X/\Tg(ACTA1-STIM1)2Jmol
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:101977
|
| skeletal muscle interstitial fibrosis
|
J:101977
|
\Tg(ACTA1-STIM1)4Jmol/?
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:101977
|
| skeletal muscle interstitial fibrosis
|
J:101977
|
\Tg(ACTA1-TPM3*M9R)4Hrd/0
(FVB/NJ-Tg(ACTA1-TPM3*M9R)4Hrd)
|
abnormal muscle physiology
|
J:67596
|
| abnormal skeletal muscle fiber morphology
|
J:67596
|
| abnormal skeletal muscle morphology
|
J:67596
|
| increased skeletal muscle fiber size
|
J:67596
|
| muscle weakness
|
J:67596
|
| myopathy
|
J:67596
|
\Tg(ACTB-EGFP,-Kcnj8*)1Wco/0
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134852
|
\Tg(ACTB-EGFP,-Kcnj8*G343D)9Nich/0
\Tg(Myh11-icre/ERT2)1Soff/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
| decreased vasoconstriction
|
J:202037
|
\Tg(ACTB-SOD2)66Ysh/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127776
|
| myocardium necrosis
|
J:89952
|
\Tg(ACTB-Twnk*)DSuom/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:104378
|
| muscle phenotype
|
J:104378
|
\Tg(ACTB-Twnk*A360T)HSuom/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:104378
|
| muscle phenotype
|
J:104378
|
\Tg(AGT)2-5Afu/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:194606
|
| myocardium hypertrophy
|
J:130455
|
\Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
cardiomyopathy
|
J:92579
|
| decreased cardiac muscle contractility
|
J:92579
|
| heart right ventricle hypertrophy
|
J:92579
|
| myocardium necrosis
|
J:92579
|
\Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
abnormal muscle morphology
|
J:249664
|
| abnormal skeletal muscle morphology
|
J:249664
|
\Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2)
|
abnormal myocardial fiber morphology
|
J:135124
|
| cardiac muscle atrophy
|
J:135124
|
| cardiac muscle degeneration
|
J:135124
|
| decreased cardiac muscle contractility
|
J:135124
|
| dilated cardiomyopathy
|
J:135124
|
\Tg(AR*100Q)C25Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle morphology
|
J:89772
|
| muscle weakness
|
J:89772
|
| skeletal muscle atrophy
|
J:89772
|
\Tg(AR*100Q)C32Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
skeletal muscle atrophy
|
J:89772
|
\Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr)
|
abnormal muscle morphology
|
J:239579
|
| skeletal muscle atrophy
|
J:239579
|
\Tg(CAG-APPL1)#Ymli/0
(involves: C57BL/6 * CBA)
|
abnormal vasodilation
|
J:189487
|
| decreased vasoconstriction
|
J:189487
|
| increased skeletal muscle cell glucose uptake
|
J:230004
|
| increased vasodilation
|
J:189487
|
\Tg(CAG-AR*97Q)7-8Sobue/?
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
dystrophic muscle
|
J:128619
|
| muscular atrophy
|
J:121559
|
\Tg(CAG-AR*97Q)7-8Sobue/?
\Tg(CAG-STUB1)1Sobue/\Tg(CAG-STUB1)1Sobue
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
muscular atrophy
|
J:121559
|
\Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo)
|
heart left ventricle hypertrophy
|
J:103364
|
| heart right ventricle hypertrophy
|
J:103364
|
\Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo)
|
heart left ventricle hypertrophy
|
J:103364
|
| heart right ventricle hypertrophy
|
J:103364
|
\Tg(CAG-Calr)#Mlk/0
\Tg(Myh6-cre/Esr1*)1Liao/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:199413
|
| dilated cardiomyopathy
|
J:199413
|
\Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
\Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N)
|
ventricular cardiomyopathy
|
J:142212
|
\Tg(CAG-cat,-TBX3)1Vmc/0
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
myocardium hypoplasia
|
J:181526
|
| ventricle myocardium hypoplasia
|
J:181526
|
\Tg(CAG-COL4A3BP)#Jsau/0
(B6.Cg-Tg(CAG-COL4A3BP)#Jsau)
|
abnormal muscle development
|
J:177789
|
\Tg(CAG-cre/Esr1*)5Amc/0
\Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * CBA * DBA/2)
|
muscle phenotype
|
J:142253
|
\Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0
(involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)
|
abnormal muscle morphology
|
J:207750
|
| muscle degeneration
|
J:207750
|
| progressive muscle weakness
|
J:207750
|
| skeletal muscle fiber necrosis
|
J:207750
|
\Tg(CAG-EPM2A*C266S)1Bmin/0
(involves: 129 * C57BL/6 * SJL)
|
increased skeletal muscle glycogen level
|
J:120356
|
\Tg(CAG-GLVP)#Cath/0
\Tg(GAL4-PABPN1*A16)#Cath/0
(involves: C57BL/6 * FVB)
|
abnormal muscle fiber morphology
|
J:178541
|
| dilated cardiomyopathy
|
J:178541
|
| increased variability of skeletal muscle fiber size
|
J:178541
|
| myopathy
|
J:178541
|
| skeletal muscle fiber atrophy
|
J:178541
|
\Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * DBA/2)
|
myositis
|
J:142253
|
\Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
\Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal soft palate muscle morphology
|
J:233662
|
| abnormal tensor veli palatini muscle morphology
|
J:233662
|
\Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
abnormal diaphragm morphology
|
J:158388
|
\Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal muscle physiology
|
J:168339
|
\Tg(CAG-Large)#Kcam/0
(B6J.B6NTac-Tg(CAG-Large)#Kcam)
|
decreased skeletal muscle fiber diameter
|
J:206057
|
\Tg(CAG-Map3k7*K63W)1232Mds/0
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:117108
|
| abnormal ventricle papillary muscle morphology
|
J:117108
|
| cardiomyopathy
|
J:117108
|
| increased cardiac muscle glycogen level
|
J:117108
|
\Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
\Tg(CAG-Ncoa6)84Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
\Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
\Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
\Tg(CAG-NRIP1)51Row/0
(involves: FVB/N)
|
abnormal myocardial fiber mitochondrial morphology
|
J:175885
|
| abnormal myocardial fiber morphology
|
J:175885
|
| cardiomyopathy
|
J:175885
|
| decreased cardiac muscle contractility
|
J:175885
|
| myocardial fiber disarray
|
J:175885
|
\Tg(CAG-OTC/CAT)#Wcl/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:176731
|
\Tg(CAG-Romo1)#Xiwa/0
(involves: C57BL/6J)
|
abnormal muscle morphology
|
J:367536
|
| increased cardiac muscle contractility
|
J:367536
|
\Tg(CAG-rtTA)72Wiek/0
\Tg(tetO-Rnf5)1Zron/0
(involves: C3H * C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:132185
|
| centrally nucleated skeletal muscle fibers
|
J:132185
|
| decreased skeletal muscle weight
|
J:132185
|
| increased variability of skeletal muscle fiber size
|
J:132185
|
| muscle degeneration
|
J:132185
|
\Tg(CAG-STUB1)1Sobue/?
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:121559
|
\Tg(CAG-STUB1)1Sobue/\Tg(CAG-STUB1)1Sobue
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:121559
|
\Tg(CAG-VCP*A232E)93Jpat/0
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:158713
|
| abnormal skeletal muscle fiber morphology
|
J:158713
|
| myopathy
|
J:158713
|
| progressive muscle weakness
|
J:158713
|
| skeletal muscle degeneration
|
J:158713
|
\Tg(CAG-VCP*R155H)55Jpat/0
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:158713
|
| abnormal skeletal muscle fiber morphology
|
J:158713
|
| myopathy
|
J:158713
|
| progressive muscle weakness
|
J:158713
|
| skeletal muscle degeneration
|
J:158713
|
\Tg(CAMalpha1b)7Wjk/?
(Not Specified)
|
abnormal myocardium layer morphology
|
J:82721
|
| decreased heart left ventricle muscle contractility
|
J:134704
|
| dilated cardiomyopathy
|
J:134704
|
| heart right ventricle hypertrophy
|
J:82721
|
| myocardial fiber disarray
|
J:134704
|
\Tg(Camk2a-tTA)1Mmay/0
\Fgf14Tg(tetO-MAPT*P301L)4510Kha/\Fgf14+
(involves: FVB/N)
|
dystonia
|
J:102973
|
\Tg(Camk2a-tTA)1Mmay/0
\Tg(tetO-HTT*94Q,-lacZ)1Rhn/0
(involves: C57BL/6 * CBA)
|
dystonia
|
J:61490
|
\Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro)
|
myositis
|
J:81981
|
\Tg(Ckm*-Mstn)1Nfg/?
(involves: BALB/c * C57BL/6)
|
decreased skeletal muscle mass
|
J:123052
|
\Tg(Ckm-APPSw)A2Lfa/0
(involves: C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:76338
|
| myositis
|
J:76338
|
\Tg(Ckm-APPSw)A6Lfa/0
(involves: C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:76338
|
| myositis
|
J:76338
|
\Tg(Ckm-Cd36)1Naa/0
(involves: FVB)
|
abnormal muscle physiology
|
J:57650
|
\Tg(Ckm-Chrnd*S262T)40Cgz/0
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:31221
|
\Tg(Ckm-Chrne*L269F)5Cgz/?
(involves: FVB/NJ)
|
abnormal skeletal muscle fiber morphology
|
J:193524
|
| muscle weakness
|
J:193524
|
| skeletal muscle fiber degeneration
|
J:193524
|
\Tg(Ckm-CUGBP1)1039Coop/0
(FVB-Tg(Ckm-CUGBP1)1039Coop)
|
abnormal skeletal muscle fiber morphology
|
J:99370
|
| skeletal muscle fiber degeneration
|
J:99370
|
\Tg(Ckm-DGAT2)10Far/0
(involves: C57BL/6NHsd)
|
increased skeletal muscle triglyceride level
|
J:129495
|
\Tg(Ckm-DNAJB6_ib*F93L)#Ccwe/0
(B6.Cg-Tg(Ckm-DNAJB6_ib*F93L)#Ccwe)
|
abnormal muscle fiber morphology
|
J:226488
|
| abnormal Z line morphology
|
J:226488
|
| myopathy
|
J:226488
|
| progressive muscle weakness
|
J:226488
|
\Tg(Ckm-Fstl1)#Mvdh/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:177416
|
| increased myocardial fiber size
|
J:177416
|
\Tg(Ckm-GSN*D187N)AJewe/0
(C57BL/6J-Tg(Ckm-GSN*D187N)AJewe)
|
centrally nucleated skeletal muscle fibers
|
J:150825
|
| increased variability of skeletal muscle fiber size
|
J:150825
|
| muscle degeneration
|
J:150825
|
| progressive muscle weakness
|
J:150825
|
| skeletal muscle fiber atrophy
|
J:150825
|
\Tg(Ckm-GSN*D187N)AJewe/\Tg(Ckm-GSN*D187N)AJewe
(C57BL/6J-Tg(Ckm-GSN*D187N)AJewe)
|
abnormal skeletal muscle fiber morphology
|
J:150825
|
| muscular atrophy
|
J:150825
|
| skeletal muscle fiber atrophy
|
J:150825
|
\Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
decreased muscle cell glucose uptake
|
J:71205
|
\Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal muscle fiber morphology
|
J:101818
|
| abnormal myocardial fiber morphology
|
J:101818
|
| abnormal skeletal muscle morphology
|
J:101818
|
| decreased skeletal muscle mass
|
J:101818
|
| increased muscle free fatty acids level
|
J:101818
|
| increased skeletal muscle glycogen level
|
J:101818
|
| myopathy
|
J:101818
|
\Tg(Ckm-LPL)LRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal skeletal muscle morphology
|
J:101818
|
\Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal muscle fiber morphology
|
J:101818
|
| abnormal myocardial fiber morphology
|
J:101818
|
| abnormal skeletal muscle morphology
|
J:101818
|
| increased muscle free fatty acids level
|
J:101818
|
| increased skeletal muscle glycogen level
|
J:101818
|
| myopathy
|
J:101818
|
\Tg(Ckm-Mir499)#Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
\Tg(Ckm-Mkl1)1Eno/0
(Not Specified)
|
decreased skeletal muscle mass
|
J:96122
|
| myopathy
|
J:96122
|
\Tg(Ckm-Mstn)1Nfg/?
(involves: BALB/c * C57BL/6)
|
abnormal myocardium layer morphology
|
J:123052
|
| abnormal skeletal muscle fiber morphology
|
J:123052
|
| decreased skeletal muscle fiber size
|
J:123052
|
| decreased skeletal muscle mass
|
J:123052
|
\Tg(Ckm-Pnpla2)164Eek/0
(involves: FVB/N)
|
decreased skeletal muscle triglyceride level
|
J:207007
|
\Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased muscle cell glucose uptake
|
J:129848
|
| increased skeletal muscle triglyceride level
|
J:129848
|
\Tg(Ckm-Ppard)MEDpk/0
(involves: C57BL/6 * CBA)
|
abnormal muscle cell glucose uptake
|
J:129848
|
\Tg(Ckm-Ppargc1a)31Brsp/0
(C57BL/6-Tg(Ckm-Ppargc1a)31Brsp)
|
abnormal muscle physiology
|
J:78333
|
| abnormal skeletal muscle morphology
|
J:78333
|
\Tg(Ckm-Ppargc1b)T37Brsp/0
(FVB-Tg(Ckm-Ppargc1b)T37Brsp)
|
abnormal muscle physiology
|
J:118258
|
| abnormal skeletal muscle fiber type ratio
|
J:118258
|
| abnormal skeletal muscle morphology
|
J:118258
|
| decreased skeletal muscle fiber size
|
J:118258
|
| skeletal muscle hypoplasia
|
J:118258
|
\Tg(Ckm-Prkaa2*K45R)1Mbb/0
(involves: C57BL/6J * SJL/J)
|
abnormal muscle physiology
|
J:110092
|
| abnormal myocardial fiber morphology
|
J:91969
|
| decreased heart left ventricle muscle contractility
|
J:91969
|
\Tg(Ckm-PTPN1)45Bbk/0
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
\Tg(Ckm-PTPN1)45Bbk/?
\Tg(Ckm-PTPRF)13Bbk/?
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
\Tg(Ckm-PTPRF)13Bbk/0
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
\Tg(Ckm-Sgcg)4Mcn/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle morphology
|
J:128649
|
| centrally nucleated skeletal muscle fibers
|
J:128649
|
| decreased skeletal muscle mass
|
J:128649
|
| dystrophic muscle
|
J:128649
|
| increased variability of skeletal muscle fiber size
|
J:128649
|
\Tg(Ckm-Sox6)#Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
\Tg(Ckmm-Cav3)1Ysu/0
(involves: C57BL/Slc * DBA/Slc)
|
abnormal muscle physiology
|
J:67174
|
| abnormal myocardial fiber morphology
|
J:87692
|
| centrally nucleated skeletal muscle fibers
|
J:67174
|
| increased heart left ventricle muscle contractility
|
J:87692
|
| increased myocardial fiber size
|
J:87692
|
| increased variability of skeletal muscle fiber size
|
J:67174
|
| myopathy
|
J:67174
|
| skeletal muscle atrophy
|
J:67174
|
| skeletal muscle fiber degeneration
|
J:67174
|
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)
|
abnormal skeletal muscle morphology
|
J:205907
|
| muscle weakness
|
J:205907
|
| myositis
|
J:205907
|
| skeletal muscle fiber atrophy
|
J:205907
|
| skeletal muscle fiber degeneration
|
J:205907
|
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: FVB)
|
abnormal skeletal muscle fiber morphology
|
J:237183
|
| decreased skeletal muscle fiber size
|
J:237183
|
| increased satellite cell number
|
J:237183
|
\Tg(Ckmm-Ucp1)1Boud/0
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber type ratio
|
J:80053
|
| abnormal skeletal muscle morphology
|
J:80053
|
| decreased gastrocnemius weight
|
J:80053
|
| decreased skeletal muscle fiber diameter
|
J:80053
|
| decreased skeletal muscle mass
|
J:80053
|
| decreased skeletal muscle weight
|
J:80053
|
\Tg(Ckmm-Ucp1)1Boud/\Tg(Ckmm-Ucp1)1Boud
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber type ratio
|
J:80053
|
| abnormal skeletal muscle morphology
|
J:80053
|
| decreased gastrocnemius weight
|
J:80053
|
| decreased skeletal muscle fiber diameter
|
J:80053
|
| decreased skeletal muscle mass
|
J:80053
|
| decreased skeletal muscle weight
|
J:80053
|
\Tg(CMV-Abcc9)1Ajo/?
(either: (involves: BALB/c * CBA) or (involves: BALB/c * C57BL/6J * CBA))
|
abnormal sarcolemma morphology
|
J:111456
|
\Tg(CMV-APPL2)1Smoc/0
(Not Specified)
|
decreased skeletal muscle cell glucose uptake
|
J:230004
|
\Tg(CMV-ATXN3*135Q)CPama/0
(C57BL/6-Tg(CMV-ATXN3*135Q)CPama)
|
abnormal muscle tone
|
J:222991
|
\Tg(CMV-cat,-ROCK2*)3-1Koba/0
\Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2 * SJL)
|
abnormal intercalated disk morphology
|
J:242116
|
| decreased fetal cardiomyocyte proliferation
|
J:242116
|
| decreased heart left ventricle muscle contractility
|
J:242116
|
| disorganized myocardium
|
J:242116
|
| myocardium steatosis
|
J:242116
|
| ventricular cardiomyopathy
|
J:242116
|
\Tg(CMV-Gja1)BClo/\Tg(CMV-Gja1)BClo
(involves: SJL/J * SWR/J)
|
abnormal myocardial trabeculae morphology
|
J:40388
|
| abnormal myocardium layer morphology
|
J:40388
|
| thin right ventricle myocardium compact layer
|
J:40388
|
\Tg(CMV-IghvaD11)CCat/0
\Tg(CMV-IgkvaD11)BCat/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:79946
|
| decreased skeletal muscle fiber diameter
|
J:79946
|
| decreased skeletal muscle mass
|
J:79946
|
\Tg(CMV-IghvaD11)DCat/0
\Tg(CMV-IgkvaD11)ACat/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:79946
|
| decreased skeletal muscle fiber diameter
|
J:79946
|
| decreased skeletal muscle mass
|
J:79946
|
\Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:95933
|
\Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
muscular atrophy
|
J:92996
|
\Tg(DM15)26Bew/0
(involves: FVB)
|
abnormal muscle relaxation
|
J:93614
|
| abnormal myocardial fiber morphology
|
J:33711,
J:93614
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:93614
|
| abnormal skeletal muscle fiber morphology
|
J:93614
|
| cardiomyopathy
|
J:33711,
J:93614
|
| centrally nucleated skeletal muscle fibers
|
J:93614
|
| dystrophic muscle
|
J:93614
|
| heart left ventricle hypertrophy
|
J:93614
|
| increased variability of skeletal muscle fiber size
|
J:93614
|
| myopathy
|
J:93614
|
\Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:207560
|
| dystrophic muscle
|
J:207560
|
| impaired muscle relaxation
|
J:131302,
J:207560
|
| increased variability of skeletal muscle fiber size
|
J:207560
|
| skeletal muscle fiber atrophy
|
J:207560
|
\Tg(DMWD,DMPK*,SIX5)328Ggo/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:73187
|
| centrally nucleated skeletal muscle fibers
|
J:73187
|
| impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
| skeletal muscle fibrosis
|
J:73187
|
\Tg(DMWD,DMPK*,SIX5)328Ggo/\Tg(DMWD,DMPK*,SIX5)328Ggo
(involves: C57BL/6 * DBA/2)
|
abnormal diaphragm morphology
|
J:196337
|
| abnormal skeletal muscle fiber type ratio
|
J:196337
|
| impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
\Tg(DMWD,DMPK*,SIX5)1177Ggo/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:73187
|
| centrally nucleated skeletal muscle fibers
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
| muscular atrophy
|
J:73187
|
| skeletal muscle degeneration
|
J:73187
|
| skeletal muscle fibrosis
|
J:73187
|
\Tg(DMWD,DMPK*,SIX5)1177Ggo/\Tg(DMWD,DMPK*,SIX5)1177Ggo
(involves: C57BL/6 * DBA/2)
|
impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
\Tg(DUX4*)1Maar/?
(involves: C57BL/6J * CBA/J)
|
delayed skeletal muscle regeneration
|
J:195481
|
\Tg(Edn1-NOS3)22Yky/0
(involves: C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:81132
|
\Tg(EIF1AX-Aldh2*E487K)101Oht/\Tg(EIF1AX-Aldh2*E487K)101Oht
(C57BL/6-Tg(EIF1AX-Aldh2*E487K)101Oht)
|
muscle weakness
|
J:137374
|
\Tg(Eno2-Bmp4)3Jake/0
(involves: BALB/c * C57BL/6)
|
abnormal muscle fiber morphology
|
J:93682
|
| abnormal muscle morphology
|
J:93682
|
\Tg(Eno2-TOR1A*)13Shas/0
(involves: C3H * C57BL/6J)
|
dystonia
|
J:95447
|
\Tg(Fabp2-Arg1)1Wla/\Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
decreased skeletal muscle fiber diameter
|
J:80556
|
\Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl)
|
decreased muscle cell glucose uptake
|
J:149858
|
| muscle phenotype
|
J:149858
|
\Tg(Fabp4-LMNA*R482Q)17CCdl/0
(FVB/N-Tg(Fabp4-LMNA*R482Q)17CCdl)
|
abnormal muscle cell glucose uptake
|
J:149858
|
\Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:288386
|
\Tg(Gata1-Zfpm1)1Sho/0
\Zfpm1tm1Sho/\Zfpm1tm1Sho
(involves: 129S1/Sv * C57BL/6N * CD-1)
|
thin myocardium
|
J:99745
|
\Tg(Gfap-TGFB1)64Lms/0
\Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: BALB/c * C57BL/6 * DBA/2 * SJL)
|
decreased vasodilation
|
J:167619
|
\Tg(Gpx1)41Dkd/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127782
|
| myocardium necrosis
|
J:89952,
J:127782
|
\Tg(GSK3B*S9A)1Vln/0
\Tg(Thy1-MAPT)1Vln/\Tg(Thy1-MAPT)1Vln
(involves: FVB)
|
muscle phenotype
|
J:100971
|
\Tg(GSK3B*S9A)1Vln/0
\Tg(Thy1-MAPT)2Vln/\Tg(Thy1-MAPT)2Vln
(involves: FVB)
|
muscle phenotype
|
J:100971
|
\Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:95691
|
\Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)
|
vascular smooth muscle hyperplasia
|
J:238723
|
\Tg(H2-K-Hmga1)#Lmsr/0
(involves: C57BL/6 * SJL)
|
increased uterus leiomyoma incidence
|
J:121308
|
\Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J)
|
muscular atrophy
|
J:276641
|
\Tg(HBx-HCV)C5Tto/0
(involves: C57BL/6 * DBA/2)
|
abnormal cardiac muscle tissue morphology
|
J:105313
|
| abnormal myocardial fiber morphology
|
J:105313
|
| abnormal Z line morphology
|
J:105313
|
| cardiomyopathy
|
J:105313
|
| decreased cardiac muscle contractility
|
J:105313
|
| increased myocardial fiber size
|
J:105313
|
\Tg(HCRT-tTA)1Ahky/0
\Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
abnormal muscle physiology
|
J:211045
|
\Tg(HDexon1)61Gpb/?
(involves: C57BL/6 * CBA)
|
decreased myocardial fiber size
|
J:203027
|
\Tg(HDexon1)62Gpb/0
(B6CBA-Tg(HDexon1)62Gpb/1J)
|
abnormal myocardial fiber morphology
|
J:116660
|
| decreased heart left ventricle muscle contractility
|
J:116660
|
\Tg(HIV)26Aln/0
(involves: FVB/N)
|
myocardium degeneration
|
J:90297
|
| myositis
|
J:90297
|
| skeletal muscle degeneration
|
J:90297
|
\Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6)
|
abnormal limb muscle morphology
|
J:135606
|
| abnormal pectoral muscle morphology
|
J:135606
|
| abnormal skeletal muscle fiber morphology
|
J:99371
|
| abnormal skeletal muscle morphology
|
J:99371
|
| centrally nucleated skeletal muscle fibers
|
J:99371
|
| increased variability of skeletal muscle fiber size
|
J:99371
|
| skeletal muscle fiber degeneration
|
J:99371,
J:135606
|
| skeletal muscle fiber necrosis
|
J:99371
|
| skeletal muscle interstitial fibrosis
|
J:135606
|
\Tg(HSA*LR)20aCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*LR)20bCath/?
(involves: FVB/N)
|
abnormal muscle electrophysiology
|
J:125885
|
| abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*LR)21Cath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*LR)32aCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*LR)32bCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*LR)41Cath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
\Tg(HSA*SR)29Cath/?
(involves: FVB/N)
|
muscle phenotype
|
J:64493
|
\Tg(HTT*)AXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
\Tg(HTT*)LXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
\Tg(HTT*)NXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
| skeletal muscle fiber atrophy
|
J:219890
|
\Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA)
|
decreased vasoconstriction
|
J:84652
|
\Tg(Krt14-Angptl2)1Yo/0
(C.Cg-Tg(Krt14-Angptl2)1Yo)
|
muscle phenotype
|
J:181261
|
\Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
heart right ventricle hypertrophy
|
J:194882
|
| increased vasoconstriction
|
J:194882
|
\Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
myositis
|
J:129951
|
\Tg(LMNA*G608G)HClns/?
(C57BL/6-Tg(LMNA*G608G)HClns/J)
|
abnormal vascular smooth muscle morphology
|
J:107176
|
\Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J)
|
muscle spasm
|
J:197168
|
\Tg(LONP1-mt-ND4*,-mCherry*)#Jguy
(B6(D2)-Tg(LONP1-mt-ND4*,-mCherry*)#Jguy)
|
muscle phenotype
|
J:224897
|
\Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:51661
|
\Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased leiomyosarcoma incidence
|
J:93548
|
\Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc/\Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc
(Not Specified)
|
decreased skeletal muscle size
|
J:132035
|
| muscle weakness
|
J:132035
|
\Tg(Mnx1-Zfp106,-EGFP)1Blk/0
\Zfp106tm1b(KOMP)Wtsi/\Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle fiber morphology
|
J:241305
|
\Tg(Mnx1-Zfp106,-EGFP)2Blk/0
\Zfp106tm1b(KOMP)Wtsi/\Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle fiber morphology
|
J:241305
|
\Tg(Mpz)80.2Wra/0
(involves: FVB/N)
|
muscular atrophy
|
J:78758
|
\Tg(Mpz)88.1Mfel/0
(FVB/N-Tg(Mpz)88.1Mfel)
|
muscle weakness
|
J:77658
|
| muscular atrophy
|
J:77658
|
\Tg(Mpz)88.2Mfel/0
(FVB/N-Tg(Mpz)88.2Mfel)
|
muscle weakness
|
J:77658
|
| muscular atrophy
|
J:77658
|
\Tg(Mpz)88.4Mfel/0
(FVB/N-Tg(Mpz)88.4Mfel)
|
muscle weakness
|
J:77658
|
\Tg(Mpz*S63C)32Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
\Tg(Mpz*S63C)33Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
\Tg(Mpz*S63X)30Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
\Tg(Mpz*S63X)31Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
\Tg(Mt1-Hgf)19Lmb/0
(involves: FVB/N)
|
ectopic skeletal muscle
|
J:34022
|
\Tg(Mt1-Hgf)19Lmb/0
(involves: C57BL/6 * FVB/N)
|
ectopic skeletal muscle
|
J:34022
|
\Tg(MT2A-TGFBR2)#Rser/0
(involves: C57BL/6 * DBA)
|
decreased cardiac muscle contractility
|
J:158480
|
| dilated cardiomyopathy
|
J:158480
|
\Tg(Myh6*)1Lnwd/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle relaxation
|
J:55938
|
| disorganized myocardium
|
J:55938
|
| heart left ventricle hypertrophy
|
J:55938
|
\Tg(Myh6*)1Lnwd/\Tg(Myh6*)1Lnwd
(involves: C57BL/6 * FVB/N)
|
heart left ventricle hypertrophy
|
J:55938
|
\Tg(Myh6*)131Lnwd/0
(involves: C57BL/6 * CBA)
|
heart left ventricle hypertrophy
|
J:31537
|
\Tg(Myh6*)140Lnwd/0
(involves: C57BL/6 * CBA)
|
abnormal vascular smooth muscle morphology
|
J:31537,
J:36522
|
| decreased cardiac muscle contractility
|
J:134706
|
| heart left ventricle hypertrophy
|
J:31537,
J:36522,
J:134706
|
| myocardial fiber degeneration
|
J:36522
|
\Tg(Myh6*)140Lnwd/0
\Tg(WTbeta2)4Wjk/0
(involves: C57BL/6 * CBA)
|
abnormal cardiac muscle contractility
|
J:134706
|
\Tg(Myh6*/tetO-BAG3)69Atsa/0
\Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
decreased cardiac muscle contractility
|
J:273465
|
\Tg(Myh6*/tetO-Capn1)L2Gwd/0
(involves: FVB/N)
|
decreased heart ventricle muscle contractility
|
J:133797
|
\Tg(Myh6*/tetO-Capn1)L3Gwd/0
(involves: FVB/N)
|
decreased heart ventricle muscle contractility
|
J:133797
|
| myocardium necrosis
|
J:133797
|
\Tg(Myh6*/tetO-FXYD1*S68E)39Jych/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:182365
|
| increased heart ventricle muscle contractility
|
J:182365
|
\Tg(Myh6*/tetO-Hspb8*K141N)#Atsa/0
\Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
cardiomyopathy
|
J:197853
|
| decreased cardiac muscle contractility
|
J:197853
|
\Tg(Myh6*/tetO-Slc8a1)BJych/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:151091
|
| abnormal myocardial fiber morphology
|
J:151091
|
\Tg(Myh6-1810058I24Rik)#Eno/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:325962
|
| decreased cardiac muscle contractility
|
J:325962
|
\Tg(Myh6-ACE2)1Rbre/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:128793
|
\Tg(Myh6-ACE2)2Rbre/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:128793
|
\Tg(Myh6-Acsl1)J3Jesc/0
(FVB/N-Tg(Myh6-Acsl1)J3Jesc)
|
decreased heart ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
\Tg(Myh6-Acsl1)M13Jesc/0
(FVB/N-Tg(Myh6-Acsl1)M13Jesc)
|
decreased heart ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
\Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc)
|
abnormal myocardial fiber morphology
|
J:68639
|
| cardiomyopathy
|
J:68639
|
| decreased heart ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
| increased cardiac muscle triglyceride level
|
J:68639
|
| increased cardiomyocyte apoptosis
|
J:68639
|
\Tg(Myh6-ACTC1*E99K)#Sbm/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal cardiac muscle relaxation
|
J:175388
|
| decreased cardiac muscle contractility
|
J:175388
|
| dilated cardiomyopathy
|
J:175388
|
| heart left ventricle hypertrophy
|
J:175388
|
| myocardial fiber disarray
|
J:175388
|
\Tg(Myh6-ACTC1*E361G)361.20Sbm/0
(Not Specified)
|
decreased cardiac muscle relaxation
|
J:242344
|
| decreased heart ventricle muscle contractility
|
J:242344
|
| dilated cardiomyopathy
|
J:242344
|
\Tg(Myh6-Actc1*R312H)307Iko/?
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:178587
|
| dilated cardiomyopathy
|
J:178587
|
| increased myocardial fiber apoptosis
|
J:178587
|
| myocardial fiber degeneration
|
J:178587
|
\Tg(Myh6-Actc1dt)2Kwan/0
(involves: C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:297375
|
| decreased myocardial fiber number
|
J:297375
|
| increased myocardial fiber size
|
J:297375
|
\Tg(Myh6-Adra1a)A1A1Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A1Rmgr)
|
abnormal cardiac muscle relaxation
|
J:108879
|
| increased cardiac muscle contractility
|
J:108879
|
| increased heart left ventricle muscle contractility
|
J:108867
|
\Tg(Myh6-Adra1a)A1A4Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A4Rmgr)
|
increased heart left ventricle muscle contractility
|
J:108867,
J:108879
|
| increased myocardial fiber apoptosis
|
J:108867
|
| myocardial fiber degeneration
|
J:108867
|
\Tg(Myh6-ADRB1)4Mjlo/0
(FVB/N-Tg(Myh6-ADRB1)4Mjlo)
|
decreased cardiac muscle contractility
|
J:55719
|
| decreased heart left ventricle muscle contractility
|
J:55719
|
| increased cardiac muscle contractility
|
J:55719
|
| increased myocardial fiber size
|
J:55719
|
\Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:134706
|
\Tg(Myh6-AIP/PLN*)46Jded/0
(FVB/N-Tg(Myh6-AIP/PLN*)46Jded)
|
abnormal cardiac muscle relaxation
|
J:84333
|
\Tg(Myh6-Akt1)20Anr/Y
(involves: C57BL/6)
|
heart left ventricle hypertrophy
|
J:77257
|
\Tg(Myh6-Akt1)20Anr/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:77257
|
| heart left ventricle hypertrophy
|
J:77257
|
\Tg(Myh6-Akt1)564Anr/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:77257
|
\Tg(Myh6-Akt1*T308D*S473D)1Siz/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:75780
|
| decreased heart left ventricle muscle contractility
|
J:75780
|
\Tg(Myh6-ANKRD1)#Camm/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:302922
|
| abnormal fetal cardiomyocyte mitochondrial morphology
|
J:302922
|
| abnormal myocardial fiber mitochondrial morphology
|
J:302922
|
| abnormal myocardial fiber morphology
|
J:302922
|
| decreased cardiac muscle contractility
|
J:302922
|
\Tg(Myh6-Atp1a2)1Jmol/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:223625
|
\Tg(Myh6-BAG3*P209L)#Mswi/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:234278
|
| decreased cardiac muscle relaxation
|
J:234278
|
| increased myocardial fiber size
|
J:234278
|
\Tg(Myh6-Bclaf1)#Cya/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
| increased cardiomyocyte apoptosis
|
J:301260
|
\Tg(Myh6-BRUNOL4*)10Coop/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:99369
|
| dilated cardiomyopathy
|
J:99369
|
| myocardial fiber degeneration
|
J:99369
|
\Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134761,
J:129494
|
| dilated cardiomyopathy
|
J:134761
|
| increased cardiac muscle contractility
|
J:129494
|
| increased cardiac muscle relaxation
|
J:129494
|
| increased myocardial fiber apoptosis
|
J:134761
|
\Tg(Myh6-Camk2d)1Jhb/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:73694
|
| decreased cardiac muscle relaxation
|
J:73694
|
\Tg(Myh6-Camk2d)1Xdfu/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:96039
|
| dilated cardiomyopathy
|
J:96039
|
\Tg(Myh6-Camk2d_ic)LJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
| dilated cardiomyopathy
|
J:130644
|
| increased myocardial fiber size
|
J:130644
|
\Tg(Myh6-Camk2d_ic)MJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
| dilated cardiomyopathy
|
J:130644
|
| increased myocardial fiber size
|
J:130644
|
\Tg(Myh6-Camta2)1Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:115868
|
\Tg(Myh6-CASQ2)1Mord/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:46786
|
| abnormal sarcoplasmic reticulum morphology
|
J:46786
|
| decreased cardiac muscle contractility
|
J:79838
|
| decreased cardiac muscle relaxation
|
J:79838
|
| decreased heart left ventricle muscle contractility
|
J:79838
|
| decreased heart ventricle muscle contractility
|
J:79838
|
| dilated cardiomyopathy
|
J:79838
|
\Tg(Myh6-CASQ2)1Mord/0
\Tg(Myh6-TNNI3K)#Dmar/0
\Tnni3kB/\Tnni3kB
(involves: C57BL/6J * DBA/2J * SJL/J)
|
decreased cardiac muscle contractility
|
J:154116
|
| dilated cardiomyopathy
|
J:154116
|
\Tg(Myh6-CASQ2)1Mord/0
\Tnni3kB/\Tnni3kA
(involves: AKR/J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:154116
|
\Tg(Myh6-Cast)1Gwd/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:133797
|
| decreased heart left ventricle muscle contractility
|
J:133797
|
| decreased heart ventricle muscle contractility
|
J:133797
|
| dilated cardiomyopathy
|
J:133797
|
\Tg(Myh6-Ccna2)58Djw/0
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:92551
|
| decreased cardiac muscle contractility
|
J:92551
|
| decreased myocardial fiber size
|
J:92551
|
\Tg(Myh6-Ccnd1)#Ljf/0
(involves: C3HeB/FeJ * DBA/2J)
|
abnormal myocardial fiber morphology
|
J:40920
|
\Tg(Myh6-cre)TG9Pjay/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:198043
|
| dilated cardiomyopathy
|
J:198043,
J:119070
|
| increased myocardial fiber apoptosis
|
J:198043
|
\Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1)
|
abnormal cardiac muscle contractility
|
J:133881
|
| abnormal myocardial fiber morphology
|
J:133881
|
| cardiac muscle atrophy
|
J:133881
|
| decreased heart left ventricle muscle contractility
|
J:133881
|
| dilated cardiomyopathy
|
J:133881
|
\Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns)
|
abnormal myocardial fiber morphology
|
J:133093
|
| abnormal Z line morphology
|
J:133093
|
| decreased cardiac muscle contractility
|
J:133093
|
| decreased cardiac muscle relaxation
|
J:133093
|
| increased myocardial fiber size
|
J:133093
|
\Tg(Myh6-CRYAB*R120G)7302Ijb/0
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:126781
|
| cardiomyopathy
|
J:126781
|
\Tg(Myh6-Des*)641Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:108730
|
| abnormal myocardial fiber morphology
|
J:108730
|
| abnormal Z line morphology
|
J:108730
|
| decreased heart left ventricle muscle contractility
|
J:108730
|
| increased myocardial fiber size
|
J:108730
|
\Tg(Myh6-Dyrk1b)#Yax/0
(involves: C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:334531
|
| decreased cardiac muscle contractility
|
J:334531
|
| decreased heart left ventricle muscle contractility
|
J:334531
|
\Tg(Myh6-EGFR*)9-12Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:182337
|
| dilated cardiomyopathy
|
J:182337
|
\Tg(Myh6-EP300)21Csk/0
(C57BL/6-Tg(Myh6-EP300)21Csk)
|
abnormal myocardial fiber morphology
|
J:110549
|
| decreased heart left ventricle muscle contractility
|
J:110549
|
\Tg(Myh6-EP300)39Csk/0
(C57BL/6-Tg(Myh6-EP300)39Csk)
|
abnormal myocardial fiber morphology
|
J:110549
|
| decreased heart left ventricle muscle contractility
|
J:110549
|
\Tg(Myh6-Erbb2)6Kaga/0
(involves: C57BL/6J * SJL/J)
|
abnormal myocardium layer morphology
|
J:189979
|
| cardiomyopathy
|
J:189979
|
| decreased cardiac muscle contractility
|
J:189979
|
| increased myocardial fiber size
|
J:189979
|
| myocardium hypertrophy
|
J:189979
|
\Tg(Myh6-GFP,MAP2K3)58Ywa/?
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:72242
|
\Tg(Myh6-GFP,MAP2K6)8Ywa/?
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased myocardial fiber size
|
J:72242
|
\Tg(Myh6-Gnaq)25Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:144736,
J:41949
|
| decreased heart left ventricle muscle contractility
|
J:41949
|
| heart left ventricle hypertrophy
|
J:41949
|
| increased myocardial fiber size
|
J:41949
|
\Tg(Myh6-Gnaq)25Gwd/0
\Tg(Myh6-Gnaq)40Gwd/0
(involves: FVB/N)
|
dilated cardiomyopathy
|
J:41949
|
\Tg(Myh6-Gnaq)#Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
\Tg(Myh6-Gnaq)#Gwd/0
\Tg(Myh6-tTA)55Rbns/0
\Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
\Tg(Myh6-Gnaq*Q209L)44Ejne/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:127756
|
\Tg(Myh6-Gnaq*Q209L)44Ejne/\Tg(Myh6-Gnaq*Q209L)44Ejne
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:127756
|
| decreased cardiac muscle contractility
|
J:127756
|
| dilated cardiomyopathy
|
J:127756
|
| increased myocardial fiber size
|
J:127756
|
\Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB)
|
abnormal atrium myocardial trabeculae morphology
|
J:204274
|
| decreased cardiac muscle contractility
|
J:127756
|
| dilated cardiomyopathy
|
J:204274,
J:127756
|
| increased myocardial fiber size
|
J:204274
|
| myocardial fiber degeneration
|
J:204274
|
| myocardium hypertrophy
|
J:204274
|
\Tg(Myh6-Gnaq*Q209L/Esr1*)7Rzl/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:104100
|
| decreased cardiac muscle contractility
|
J:104100
|
| dilated cardiomyopathy
|
J:104100
|
\Tg(Myh6-Grem2)1Akh/0
(involves: C57BL/6)
|
increased cardiac muscle contractility
|
J:250034
|
\Tg(Myh6-HBEGF)#Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:93335
|
| dilated cardiomyopathy
|
J:93335
|
| increased myocardial fiber size
|
J:93335
|
| myocardial fiber degeneration
|
J:93335
|
\Tg(Myh6-Hod)3Joe/?
(Not Specified)
|
increased myocardial fiber size
|
J:121995
|
\Tg(Myh6-Htr2b)1Lum/0
(involves: CD-1)
|
abnormal myocardial fiber morphology
|
J:128784
|
| increased myocardial fiber number
|
J:128784
|
| increased myocardial fiber size
|
J:128784
|
\Tg(Myh6-IGF1R)7Jmcm/0
(involves: FVB/N)
|
increased heart ventricle muscle contractility
|
J:87944
|
| increased myocardial fiber size
|
J:87944
|
\Tg(Myh6-Jund1)9Wag/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:95691
|
\Tg(Myh6-Jup*)1Ajm/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:192719
|
\Tg(Myh6-JUP*)1Dpju/0
(FVB/N-Tg(Myh6-JUP*)1Dpju)
|
increased cardiomyocyte apoptosis
|
J:235770
|
\Tg(Myh6-KDM4A)BZpl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:173908
|
| increased myocardial fiber size
|
J:173908
|
\Tg(Myh6-LDB3*S196L)93Mva/0
(involves: C57BL/6J)
|
abnormal sarcomere morphology
|
J:243711
|
| abnormal Z line morphology
|
J:243711
|
| decreased cardiac muscle contractility
|
J:243711
|
\Tg(Myh6-Lef1)2Tfo/0
(involves: C57BL/6J * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:109612
|
| dilated cardiomyopathy
|
J:109612
|
\Tg(Myh6-LMNA*E82K)35Lizh/0
(involves: C57BL/6J)
|
abnormal cardiac muscle tissue morphology
|
J:167734
|
| abnormal myocardial fiber morphology
|
J:167734
|
| abnormal sarcomere morphology
|
J:167734
|
| decreased cardiac muscle contractility
|
J:167734
|
| decreased heart left ventricle muscle contractility
|
J:167734
|
| dilated cardiomyopathy
|
J:167734
|
| increased cardiomyocyte apoptosis
|
J:167734
|
\Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB)
|
decreased cardiomyocyte apoptosis
|
J:66102
|
| heart left ventricle hypertrophy
|
J:66102
|
| increased myocardial fiber size
|
J:66102
|
\Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:127872
|
\Tg(Myh6-Map2k1*)1Jmol/0
\Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
increased cardiac muscle contractility
|
J:234490
|
\Tg(Myh6-Map2k3*)1Jmol/0
(FVB-Tg(Myh6-Map2k3*)1Jmol)
|
cardiomyopathy
|
J:83547
|
| decreased cardiac muscle contractility
|
J:83547
|
| decreased heart left ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
\Tg(Myh6-Map2k6*)1Jmol/0
(FVB-Tg(Myh6-Map2k6*)1Jmol)
|
decreased cardiac muscle contractility
|
J:83547
|
| decreased heart ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
\Tg(Myh6-Map2k7)1Jmol/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
\Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0
(involves: FVB/N)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
\Tg(Myh6-Mapk14*)1Jmol/0
(FVB-Tg(Myh6-Mapk14*)1Jmol)
|
cardiomyopathy
|
J:83547
|
| decreased cardiac muscle contractility
|
J:83547
|
| decreased heart left ventricle muscle contractility
|
J:83547
|
| decreased heart ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
\Tg(Myh6-MEF2A)1Jmol/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:111573
|
| increased myocardial fiber size
|
J:111573
|
\Tg(Myh6-Mef2c)2Jmol/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
| dilated cardiomyopathy
|
J:111573
|
\Tg(Myh6-Mef2c)2Jmol/0
\Tg(Myh6-Ppp3ca)37Eno/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
\Tg(Myh6-Mef2c/VP16)1Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
\Tg(Myh6-Mef2d)2Eno/0
(Not Specified)
|
cardiomyopathy
|
J:130825
|
\Tg(Myh6-Mir30c-1)AEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
dilated cardiomyopathy
|
J:216095
|
\Tg(Myh6-Mir30c-1)BEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:216095
|
| dilated cardiomyopathy
|
J:216095
|
\Tg(Myh6-Mmp2*V107G)712Ajb/0
(involves: 129/Sv * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:105703
|
| abnormal myocardium layer morphology
|
J:105703
|
| decreased cardiac muscle contractility
|
J:105703
|
\Tg(Myh6-Mtg1)3Ywxu/0
(involves: C57BL/6J)
|
increased cardiac muscle contractility
|
J:271147
|
| increased myocardial fiber number
|
J:271147
|
\Tg(Myh6-Mtpn)4Ssen/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:89823
|
| increased myocardial fiber size
|
J:89823
|
| myocardial fiber disarray
|
J:89823
|
\Tg(Myh6-Murc)#Tue/0
(Not Specified)
|
increased myocardial fiber size
|
J:136004
|
\Tg(Myh6-Mybpc3*)24Rbns/0
(Not Specified)
|
abnormal myocardial fiber mitochondrial morphology
|
J:59702
|
| abnormal sarcomere morphology
|
J:59702
|
| abnormal Z line morphology
|
J:59702
|
\Tg(Myh6-Mybpc3*)32Rbns/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:50237
|
| abnormal sarcomere morphology
|
J:50237
|
| myocardial fiber degeneration
|
J:50237
|
\Tg(Myh6-Myh7)102Rbns/\Tg(Myh6-Myh7)102Rbns
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
\Tg(Myh6-Myh7)137Rbns/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
\Tg(Myh6-MYH7B)#Lnwd/0
(C57BL/6-Tg(Myh6-MYH7B)#Lnwd)
|
decreased cardiac muscle contractility
|
J:285433
|
\Tg(Myh6-Myl2*)21Rbns/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:114298
|
| abnormal cardiac muscle relaxation
|
J:114298
|
| abnormal intercalated disk morphology
|
J:114298
|
| abnormal myocardial fiber morphology
|
J:114298
|
| abnormal sarcomere morphology
|
J:114298
|
| decreased cardiac muscle contractility
|
J:110993
|
| myocardial fiber degeneration
|
J:114298
|
\Tg(Myh6-MYL2*A13T)L1Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:181028
|
\Tg(Myh6-MYL2*D94A)1Dsc/0
(Not Specified)
|
abnormal myocardium layer morphology
|
J:258888
|
| abnormal sarcomere morphology
|
J:258888
|
| decreased cardiac muscle contractility
|
J:258888
|
| dilated cardiomyopathy
|
J:258888
|
\Tg(Myh6-MYL2*E22K)4Dsc/0
(involves: C57BL/6 * SJL)
|
papillary muscle hypertrophy
|
J:101467
|
\Tg(Myh6-MYL2*K104E)2Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:263776
|
| decreased cardiac muscle relaxation
|
J:263776
|
| increased cardiac muscle contractility
|
J:263776
|
\Tg(Myh6-MYL2*N47K)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:144685
|
\Tg(Myh6-MYL2*R58Q)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:162200
|
| abnormal myocardial fiber morphology
|
J:144685
|
| decreased cardiac muscle relaxation
|
J:162200
|
\Tg(Myh6-MYL3*)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle tissue morphology
|
J:178377
|
| abnormal myocardium layer morphology
|
J:195614
|
\Tg(Myh6-MYL3*A57G)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle tissue morphology
|
J:178377
|
| increased heart left ventricle muscle contractility
|
J:202154
|
| increased myocardial fiber size
|
J:202154
|
\Tg(Myh6-MYL3*E143K)2Dsc/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:258831
|
| abnormal sarcomere morphology
|
J:258831
|
| abnormal Z line morphology
|
J:258831
|
| absent M line
|
J:258831
|
| cardiomyopathy
|
J:258831
|
\Tg(Myh6-MYOZ2*I246M)#Ajm/0
(involves: FVB)
|
heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
\Tg(Myh6-MYOZ2*S48P)114Ajm/0
(involves: FVB)
|
heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
\Tg(Myh6-MYPN*Y20C)#Jato/0
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:181871
|
| abnormal myocardial fiber morphology
|
J:181871
|
| decreased cardiac muscle contractility
|
J:181871
|
| decreased heart left ventricle muscle contractility
|
J:181871
|
| increased myocardial fiber size
|
J:181871
|
\Tg(Myh6-Ncor2*)1Kjep/0
(Not Specified)
|
thin myocardium compact layer
|
J:132982
|
\Tg(Myh6-NEBL*A592E)#Jato/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:242962
|
| abnormal Z line morphology
|
J:242962
|
| decreased cardiac muscle contractility
|
J:242962
|
| dilated cardiomyopathy
|
J:242962
|
\Tg(Myh6-NEBL*G202R)#Jato/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:242962
|
| abnormal intercalated disk morphology
|
J:242962
|
| abnormal myocardial fiber morphology
|
J:242962
|
| decreased cardiac muscle contractility
|
J:242962
|
| dilated cardiomyopathy
|
J:242962
|
\Tg(Myh6-NFATC4)#Eno/0
(involves: FVB)
|
myocardial fiber disarray
|
J:93176
|
\Tg(Myh6-Nox4)#Jusa/0
(FVB-Tg(Myh6-Nox4)#Jusa)
|
abnormal ventricle myocardium morphology
|
J:163751,
J:164275
|
| decreased heart ventricle muscle contractility
|
J:163751,
J:164275
|
| increased cardiomyocyte apoptosis
|
J:163751,
J:164275
|
\Tg(Myh6-Pfkfb3)7Pne/0
(FVB-Tg(Myh6-Pfkfb3)7Pne)
|
decreased cardiac muscle cell glucose uptake
|
J:94475
|
| decreased cardiac muscle contractility
|
J:94475
|
| increased cardiac muscle glycogen level
|
J:94475
|
\Tg(Myh6-Pik3ca)1Siz/0
(involves: FVB/N)
|
decreased myocardial fiber size
|
J:62707
|
\Tg(Myh6-Pik3r1/PIK3CA)BSiz/0
(involves: FVB/N)
|
increased myocardial fiber size
|
J:62707
|
\Tg(Myh6-Pkp2*/mRuby)4Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
\Tg(Myh6-Pkp2*/mRuby)4Rbrug/0
\Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
abnormal intercalated disk morphology
|
J:237859
|
| cardiomyopathy
|
J:237859
|
| decreased heart left ventricle muscle contractility
|
J:237859
|
\Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
\Tg(Myh6-Pln)416Egk/?
(FVB/N-Tg(Myh6-Pln)416Egk)
|
abnormal cardiac muscle contractility
|
J:135899
|
\Tg(Myh6-Pln*)#Egk/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:105976
|
| dilated cardiomyopathy
|
J:105976
|
\Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:82353
|
| dilated cardiomyopathy
|
J:82353
|
| increased myocardial fiber size
|
J:82353
|
\Tg(Myh6-POLG*Y955C)DWcc/0
(Not Specified)
|
abnormal myocardial fiber mitochondrial morphology
|
J:122507
|
| abnormal myocardial fiber morphology
|
J:122507
|
| cardiomyopathy
|
J:122507
|
| decreased myocardial fiber mitochondrial DNA content
|
J:122507
|
| increased myocardial fiber size
|
J:122507
|
\Tg(Myh6-Ppara)402-2Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
| cardiomyopathy
|
J:110580
|
| decreased heart ventricle muscle contractility
|
J:110580
|
\Tg(Myh6-Ppara)404-3Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
| cardiomyopathy
|
J:81834,
J:110580
|
| decreased cardiac muscle cell glucose uptake
|
J:110580
|
| decreased heart ventricle muscle contractility
|
J:110580
|
\Tg(Myh6-Ppara)404-4Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
\Tg(Myh6-Ppard)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:130750
|
| increased cardiac muscle cell glucose uptake
|
J:130750
|
| increased cardiac muscle glycogen level
|
J:130750
|
\Tg(Myh6-Ppif)26.2Jmol/0
(FVB/N-Tg(Myh6-Ppif)26.2Jmol)
|
abnormal myocardial fiber mitochondrial morphology
|
J:97660
|
\Tg(Myh6-Ppp3ca)37Eno/0
(involves: FVB)
|
increased myocardial fiber size
|
J:94665
|
| myocardial fiber disarray
|
J:93176
|
\Tg(Myh6-Prkaa2*D157A)1Rti/0
\Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:123005
|
| increased cardiac muscle glycogen level
|
J:123005
|
\Tg(Myh6-Prkaca)2Eno/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263774
|
| dilated cardiomyopathy
|
J:263774
|
| increased myocardial fiber size
|
J:263774
|
\Tg(Myh6-Prkaca)33Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:263774
|
| increased myocardial fiber size
|
J:263774
|
\Tg(Myh6-PRKAG2)2Dca/0
(involves: C57BL/10 * CBA/Ca)
|
increased cardiac muscle glycogen level
|
J:108517
|
\Tg(Myh6-PRKAG2)#Rro/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:108102
|
| decreased heart ventricle muscle contractility
|
J:108102
|
\Tg(Myh6-PRKAG2*N488I)4623Jse/0
(involves: FVB)
|
decreased heart left ventricle muscle contractility
|
J:128648
|
| increased cardiac muscle glycogen level
|
J:128648
|
| increased myocardial fiber size
|
J:128648
|
\Tg(Myh6-PRKAG2*R302Q)#Rro/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:108102
|
| decreased heart ventricle muscle contractility
|
J:108102
|
| increased cardiac muscle glycogen level
|
J:108102
|
\Tg(Myh6-PRKAG2*R531G)22Dca/0
(involves: C57BL/10 * CBA/Ca)
|
decreased heart left ventricle muscle contractility
|
J:108517
|
| increased cardiac muscle glycogen level
|
J:108517
|
\Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:123005
|
| decreased heart ventricle muscle contractility
|
J:123005
|
| increased cardiac muscle glycogen level
|
J:123005
|
\Tg(Myh6-Prkca)1Jmk/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:88510
|
\Tg(Myh6-PRKCE*A159E)344Robo/?
(involves: FVB)
|
calcified myocardium
|
J:133478
|
| decreased cardiac muscle contractility
|
J:133478
|
| dilated cardiomyopathy
|
J:133478
|
\Tg(Myh6-PROKR1)13Cagn/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal cardiac muscle contractility
|
J:149020
|
\Tg(Myh6-Rab1a)highGwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
\Tg(Myh6-Rab1a)lowGwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
\Tg(Myh6-Rab1a)medGwd/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134581
|
| decreased heart left ventricle muscle contractility
|
J:134581
|
| decreased heart ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
| increased myocardial fiber size
|
J:134581
|
\Tg(Myh6-Rest*)474Ysai/0
(involves: C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:86837
|
| abnormal Z line morphology
|
J:86837
|
| decreased cardiac muscle contractility
|
J:86837
|
| decreased heart left ventricle muscle contractility
|
J:86837
|
| dilated cardiomyopathy
|
J:86837
|
\Tg(Myh6-rtTA)8585Jam/0
\Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0
(involves: C57BL/6 * CBA * FVB/NTac)
|
abnormal myocardial fiber morphology
|
J:229825
|
| cardiomyopathy
|
J:229825
|
| decreased heart left ventricle muscle contractility
|
J:229825
|
| increased cardiac muscle glycogen level
|
J:229825
|
\Tg(Myh6-rtTA)8585Jam/0
\Tg(tetO-CUGBP1)3413Coop/0
(involves: FVB * FVB/N * FVB/NTac)
|
cardiac muscle degeneration
|
J:157646
|
| decreased cardiac muscle contractility
|
J:157646
|
| dilated cardiomyopathy
|
J:157646
|
| myocardium necrosis
|
J:157646
|
\Tg(Myh6-rtTA)8585Jam/0
\Tg(tetO-Fgfr3*R248C/Fgfr1)#Dor/0
(involves: 129 * C57BL/6 * FVB/N * FVB/NTac)
|
abnormal cardiac muscle relaxation
|
J:211151
|
| cardiomyopathy
|
J:211151
|
| increased cardiac muscle contractility
|
J:211151
|
| increased heart left ventricle muscle contractility
|
J:211151
|
| increased myocardial fiber size
|
J:211151
|
| myocardial fiber disarray
|
J:211151
|
\Tg(Myh6-rtTA)8585Jam/0
\Tg(tetO-Ppargc1a)1Dpk/0
(involves: FVB/N * FVB/NTac)
|
abnormal myocardial fiber morphology
|
J:96614
|
| cardiomyopathy
|
J:96614
|
| decreased cardiac muscle contractility
|
J:96614
|
\Tg(Myh6-Rxra)41Pcn/0
(Not Specified)
|
abnormal M line morphology
|
J:60351
|
| abnormal myocardial fiber morphology
|
J:60351
|
| abnormal sarcomere morphology
|
J:60351
|
| abnormal Z line morphology
|
J:60351
|
| dilated cardiomyopathy
|
J:60351
|
| myocardial fiber degeneration
|
J:60351
|
\Tg(Myh6-Sgcd*S151A)5Mcn/0
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:117855
|
| dilated cardiomyopathy
|
J:117855
|
\Tg(Myh6-SLC2A1)54Rti/0
(FVB-Tg(Myh6-SLC2A1)54Rti)
|
increased cardiac muscle cell glucose uptake
|
J:106467
|
| increased cardiac muscle glycogen level
|
J:106467
|
\Tg(Myh6-Sln)26Peri/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:108309
|
| decreased cardiac muscle contractility
|
J:108309
|
\Tg(Myh6-Snai1)B10Jcc/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
| dilated cardiomyopathy
|
J:126850
|
\Tg(Myh6-Snai1)B10Jcc/\Tg(Myh6-Snai1)B10Jcc
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
| dilated cardiomyopathy
|
J:126850
|
\Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:139414
|
| decreased heart left ventricle muscle contractility
|
J:139414
|
| decreased myocardial fiber number
|
J:139414
|
| decreased myocardial fiber size
|
J:139414
|
| dilated cardiomyopathy
|
J:139414
|
| increased cardiomyocyte apoptosis
|
J:139414
|
\Tg(Myh6-STK4*K59R)10Jusa/0
(involves: C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:139414
|
\Tg(Myh6-Sumo2*)9606Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9606Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
| increased cardiomyocyte apoptosis
|
J:230540
|
| increased myocardial fiber size
|
J:230540
|
\Tg(Myh6-Sumo2*)9608Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9608Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
\Tg(Myh6-Sumo2*)9610Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9610Jwang or (involves: C57BL/6 * FVB/N))
|
decreased cardiac muscle contractility
|
J:230540
|
| increased myocardial fiber size
|
J:230540
|
\Tg(Myh6-Tcap)#Rnk/0
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:188832
|
\Tg(Myh6-Tmem11)#Kwan/0
(C57BL/6JGpt-Tg(Myh6-Tmem11)#Kwan)
|
increased myocardial fiber size
|
J:345326
|
\Tg(Myh6-Tmod1)65Msus/\Tg(Myh6-Tmod1)65Msus
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:107823
|
| abnormal myocardial fiber morphology
|
J:107823
|
| decreased cardiac muscle contractility
|
J:107823
|
| decreased heart left ventricle muscle contractility
|
J:107823
|
| dilated cardiomyopathy
|
J:107823
|
| myocardial fiber degeneration
|
J:107823
|
| thin myocardium
|
J:107823
|
\Tg(Myh6-Tmod1)65Msus/\Tg(Myh6-Tmod1)65Msus
(FVB/N-Tg(Myh6-Tmod1)65Msus)
|
abnormal myocardial fiber morphology
|
J:58879
|
| dilated cardiomyopathy
|
J:58879
|
\Tg(Myh6-Tnf)1.6Amf/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:104759
|
| dilated cardiomyopathy
|
J:104759
|
\Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL)
|
decreased heart ventricle muscle contractility
|
J:100006
|
\Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL)
|
decreased heart ventricle muscle contractility
|
J:100006
|
\Tg(Myh6-Tnni3*)1Ammu/0
(involves: A/J * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59433
|
| abnormal myocardium layer morphology
|
J:59433
|
| decreased cardiac muscle contractility
|
J:104770,
J:59433
|
| dilated cardiomyopathy
|
J:104770
|
\Tg(Myh6-TNNI3*G203S)1Chs/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:114537
|
| cardiomyopathy
|
J:114537
|
| heart left ventricle hypertrophy
|
J:114537
|
\Tg(Myh6-TNNI3*G203S)4Chs/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:114537
|
| cardiomyopathy
|
J:114537
|
| heart left ventricle hypertrophy
|
J:114537
|
\Tg(Myh6-Tnni3*R146G)121Rbns/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:243628
|
| decreased cardiac muscle relaxation
|
J:243628
|
| increased cardiac muscle contractility
|
J:243628
|
\Tg(Myh6-Tnni3*R146G)133Rbns/0
(Not Specified)
|
abnormal I band morphology
|
J:243628
|
| abnormal myocardial fiber mitochondrial morphology
|
J:243628
|
| abnormal myocardial fiber morphology
|
J:243628
|
| abnormal sarcomere morphology
|
J:243628
|
| abnormal sarcoplasmic reticulum morphology
|
J:243628
|
| abnormal Z line morphology
|
J:243628
|
\Tg(Myh6-Tnni3*R193H)42Xhu/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:119991
|
| decreased cardiac muscle contractility
|
J:119991
|
| decreased cardiac muscle relaxation
|
J:119991
|
\Tg(Myh6-Tnni3*R193H)594Jmme/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:186721
|
| decreased cardiac muscle relaxation
|
J:186721
|
| increased cardiac muscle contractility
|
J:186721
|
\Tg(Myh6-Tnnt2)117Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
| abnormal myocardial fiber morphology
|
J:56911,
J:48301
|
| abnormal Z line morphology
|
J:56911
|
| decreased cardiac muscle contractility
|
J:48301
|
| decreased myocardial fiber number
|
J:48301
|
| decreased myocardial fiber size
|
J:48301
|
| disorganized myocardium
|
J:48301
|
| myocardial fiber degeneration
|
J:56911,
J:48301
|
\Tg(Myh6-Tnnt2)191Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
| abnormal myocardial fiber morphology
|
J:48301
|
| decreased cardiac muscle contractility
|
J:48301
|
| decreased myocardial fiber number
|
J:48301
|
| decreased myocardial fiber size
|
J:48301
|
| disorganized myocardium
|
J:48301
|
| myocardial fiber degeneration
|
J:48301
|
\Tg(Myh6-Tnnt2*)1Feah/0
(129S.FVB-Tg(Myh6-Tnnt2*)1Feah)
|
dilated cardiomyopathy
|
J:137964
|
\Tg(Myh6-Tnnt2*)1Feah/0
\Tnnt2tm1Feah/\Tnnt2+
(involves: 129S/SvEv * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:137964
|
| dilated cardiomyopathy
|
J:137964
|
\Tg(Myh6-Tnnt2*R92L)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92L)1Jcf)
|
abnormal myocardial fiber morphology
|
J:104369
|
| cardiomyopathy
|
J:104369
|
| decreased cardiac muscle contractility
|
J:104369
|
| decreased cardiac muscle relaxation
|
J:104369
|
| myocardial fiber degeneration
|
J:104369
|
\Tg(Myh6-Tnnt2*R92Q)1Lnwd/0
(involves: C57BL/6)
|
abnormal sarcomere morphology
|
J:56911
|
\Tg(Myh6-Tnnt2*R92Q)2Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:56911
|
| abnormal cardiac muscle relaxation
|
J:56911
|
| abnormal myocardial fiber morphology
|
J:56911
|
| abnormal sarcomere morphology
|
J:56911
|
| decreased myocardial fiber size
|
J:56911
|
| increased cardiac muscle contractility
|
J:56911
|
| myocardial fiber degeneration
|
J:56911
|
\Tg(Myh6-Tnnt2*R92Q)3Lnwd/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:56911
|
| abnormal sarcomere morphology
|
J:56911
|
| myocardial fiber degeneration
|
J:56911
|
| myocardial fiber disarray
|
J:56911
|
\Tg(Myh6-TNNT2*R92Q)#Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:161899,
J:162685
|
\Tg(Myh6-Tnnt2*R92W)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92W)1Jcf)
|
abnormal myocardial fiber morphology
|
J:104369
|
| cardiomyopathy
|
J:104369
|
| decreased cardiac muscle contractility
|
J:104369
|
| decreased cardiac muscle relaxation
|
J:104369
|
| decreased myocardial fiber size
|
J:104369
|
| dilated sarcoplasmic reticulum
|
J:104369
|
| myocardial fiber degeneration
|
J:104369
|
\Tg(Myh6-TNNT2*R141W)#Lian/0
(involves: C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211769
|
| decreased cardiac muscle contractility
|
J:211769
|
| dilated cardiomyopathy
|
J:211769
|
\Tg(Myh6-Tpm1*D175N)#Dfw/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:57365
|
| decreased cardiac muscle relaxation
|
J:57365
|
| disorganized myocardium
|
J:57365
|
| increased myocardial fiber size
|
J:57365
|
| myocardium hypertrophy
|
J:57365
|
\Tg(Myh6-Tpm1*D230N)HJcf/0
(B6.FVB-Tg(Myh6-Tpm1*D230N)HJcf)
|
abnormal intercalated disk morphology
|
J:243724
|
| decreased cardiac muscle contractility
|
J:243724
|
| decreased heart left ventricle muscle contractility
|
J:243724
|
| dilated cardiomyopathy
|
J:243724
|
\Tg(Myh6-Tpm1*E54K)30Dfw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:137813
|
| decreased cardiac muscle contractility
|
J:137813
|
| decreased cardiac muscle relaxation
|
J:137813
|
| decreased heart left ventricle muscle contractility
|
J:137813
|
| dilated cardiomyopathy
|
J:137813
|
| increased myocardial fiber size
|
J:137813
|
\Tg(Myh6-Tpm1*E54K)67Dfw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:137813
|
| decreased cardiac muscle contractility
|
J:137813
|
| decreased cardiac muscle relaxation
|
J:137813
|
| decreased heart left ventricle muscle contractility
|
J:137813
|
| dilated cardiomyopathy
|
J:137813
|
| increased myocardial fiber size
|
J:137813
|
\Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:127507,
J:172340
|
| abnormal cardiac muscle relaxation
|
J:127507,
J:172340
|
| abnormal myocardial fiber morphology
|
J:127507
|
| decreased cardiac muscle contractility
|
J:171021
|
| heart left ventricle hypertrophy
|
J:127507
|
| increased cardiac muscle contractility
|
J:172340
|
\Tg(Myh6-Trim72)1Rpx/0
(C57BL/6-Tg(Myh6-Trim72)1Rpx)
|
cardiomyopathy
|
J:234132
|
| decreased cardiac muscle contractility
|
J:234132
|
| myocardium hypertrophy
|
J:234132
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
decreased myocardial fiber number
|
J:128617
|
| increased cardiomyocyte apoptosis
|
J:128617
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:131245
|
| cardiac muscle necrosis
|
J:131245
|
| increased myocardial fiber size
|
J:131245
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA)
|
myocardium necrosis
|
J:81967
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-Mir208a)#Dzw/0
(involves: C3H * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:152696
|
| decreased cardiac muscle contractility
|
J:152696
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-NOS2,-lacZ)240iMhus/0
(involves: C57BL/6 * CBA)
|
abnormal atrioventricular node morphology
|
J:132082
|
| cardiac muscle necrosis
|
J:132082
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-Spp1)5Gad/0
(involves: C57BL/6 * CBA)
|
decreased heart left ventricle muscle contractility
|
J:194810
|
| dilated cardiomyopathy
|
J:194810
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-TPR/MET,-EGFP)12Tcre/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetO-TPR/MET,-EGFP)12Tcre)
|
decreased skeletal muscle weight
|
J:241276
|
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetORo1-lacZ)3Conk/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetORo1-lacZ)3Conk)
|
abnormal cardiac muscle relaxation
|
J:107363
|
| abnormal myocardium layer morphology
|
J:107363
|
| decreased cardiac muscle contractility
|
J:107363
|
| decreased heart left ventricle muscle contractility
|
J:107363
|
| decreased heart right ventricle muscle contractility
|
J:107363
|
| decreased heart ventricle muscle contractility
|
J:107363
|
| dilated cardiomyopathy
|
J:107363
|
| myocardial fiber disarray
|
J:107363
|
\Tg(Myh6-tTA)55Rbns/?
\Tg(Myh6/tetO-BNIP3)1Gwd/?
(Not Specified)
|
increased cardiomyocyte apoptosis
|
J:127533
|
\Tg(Myh6-tTA)55Rbns/0
\Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:145090
|
| decreased heart left ventricle muscle contractility
|
J:145090
|
| heart left ventricle hypertrophy
|
J:145090
|
| increased cardiac muscle glycogen level
|
J:145090
|
\Tg(Myh6-tTA)55Rbns/0
\Tg(Myh6/tetO-PRKCA*)1Jmk/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:132098
|
| abnormal myocardium layer morphology
|
J:132098
|
| increased heart ventricle muscle contractility
|
J:132098
|
\Tg(Myh6-tTA)55Rbns/0
\Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
\Tg(Myh6-tTA)55Rbns/0
\Tg(tetO-Dusp6)1Jmol/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:124903
|
| increased cardiomyocyte apoptosis
|
J:124903
|
| increased myocardial fiber size
|
J:124903
|
\Tg(Myh6-Yap1*S112A)#Eno/0
(involves: C3H * C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:200670
|
| enhanced cardiac muscle regeneration
|
J:200670
|
| thick myocardium
|
J:200670
|
\Tg(Myh6/tetO-Mybpc3*)#Rbns/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:213370
|
| abnormal sarcomere morphology
|
J:213370
|
| decreased cardiac muscle contractility
|
J:213370
|
\Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:145090
|
\Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
abnormal sarcomere morphology
|
J:234490
|
| decreased cardiac muscle contractility
|
J:234490
|
| increased cardiac muscle relaxation
|
J:234490
|
\Tg(Myh6/tetO-Tnnc1*L48Q)2Jmol/0
\Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
| decreased cardiac muscle relaxation
|
J:234490
|
| increased cardiac muscle contractility
|
J:234490
|
\Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: C3H * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:102279
|
\Tg(Myh7-Phc1)#Yota/0
(involves: C57BL/6)
|
abnormal M line morphology
|
J:75968
|
| abnormal myocardial fiber morphology
|
J:75968
|
| abnormal sarcomere morphology
|
J:75968
|
| abnormal Z line morphology
|
J:75968
|
| decreased heart left ventricle muscle contractility
|
J:75968
|
| dilated cardiomyopathy
|
J:75968
|
| increased myocardial fiber apoptosis
|
J:75968
|
| thin myocardium
|
J:75968
|
\Tg(Myh7-Pln)2Egk/0
(FVB/N-Tg(Myh7-Pln)2Egk)
|
abnormal muscle physiology
|
J:224766
|
| abnormal skeletal muscle fiber morphology
|
J:224766
|
| abnormal skeletal muscle fiber type ratio
|
J:224766
|
| centrally nucleated skeletal muscle fibers
|
J:224766
|
| decreased soleus weight
|
J:224766
|
| impaired skeletal muscle contractility
|
J:94077
|
| muscle weakness
|
J:224766
|
| myopathy
|
J:224766
|
| skeletal muscle atrophy
|
J:94077,
J:224766
|
| skeletal muscle endomysial fibrosis
|
J:224766
|
| skeletal muscle fibrosis
|
J:224766
|
\Tg(Myh7-Pln)2Egk/?
(involves: FVB/N)
|
abnormal skeletal muscle fiber type ratio
|
J:127873
|
| abnormal soleus morphology
|
J:127873
|
| impaired muscle relaxation
|
J:127873
|
| impaired skeletal muscle contractility
|
J:127873
|
\Tg(Myh7-Ptpn11*Q79R)11Rbns/0
(FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns)
|
decreased cardiac muscle contractility
|
J:123963
|
| ventricular cardiomyopathy
|
J:123963
|
\Tg(Myh7-Ptpn11*Q510E)#Krnz/0
(FVB/N-Tg(Myh7-Ptpn11*Q510E)#Krnz)
|
abnormal myocardial fiber morphology
|
J:222124
|
| cardiomyopathy
|
J:181656
|
| decreased heart left ventricle muscle contractility
|
J:181656
|
| increased cardiac muscle contractility
|
J:222124
|
| increased myocardial fiber size
|
J:181656,
J:222124
|
| myocardial fiber disarray
|
J:181656
|
\Tg(Myh7-RARA/lacZ)30Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
| decreased cardiac muscle contractility
|
J:146424
|
| decreased heart left ventricle muscle contractility
|
J:146424
|
| dilated cardiomyopathy
|
J:146424
|
| increased myocardial fiber size
|
J:146424
|
| papillary muscle hypoplasia
|
J:146424
|
| thin myocardium
|
J:146424
|
\Tg(Myh7-RARA/lacZ)32Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
| decreased heart left ventricle muscle contractility
|
J:146424
|
| increased myocardial fiber size
|
J:146424
|
\Tg(MYH7-Yap1*S112A)#Eno/?
(involves: C3H * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:189577
|
| abnormal myocardium layer morphology
|
J:189577
|
| thick myocardium
|
J:189577
|
\Tg(Myhca-Casq2)418Egk/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:50498
|
| decreased cardiac muscle contractility
|
J:50498
|
| decreased heart left ventricle muscle contractility
|
J:50498
|
| increased myocardial fiber size
|
J:50498
|
\Tg(Myl1-cre)13Nros/0
(involves: FVB)
|
muscle phenotype
|
J:140318
|
\Tg(Myl1-FST)F66Sjl/0
(involves: C57BL/6 * SJL)
|
increased skeletal muscle fiber diameter
|
J:188599
|
| increased skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle mass
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
\Tg(Myl1-Igf1)1Nros/0
\Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal skeletal muscle fiber type ratio
|
J:95812
|
| centrally nucleated skeletal muscle fibers
|
J:95812
|
| decreased skeletal muscle fiber diameter
|
J:95812
|
\Tg(Myl1-Prkag3*R225Q)1Sson/0
(involves: C57BL/6J * CBA)
|
increased skeletal muscle glycogen level
|
J:92821
|
\Tg(Myl1-SOD1*G93A)#Amu/0
(FVB/NJ-Tg(Myl1-SOD1*G93A)#Amu)
|
abnormal muscle physiology
|
J:143747
|
| abnormal sarcomere morphology
|
J:143747
|
| abnormal sarcoplasmic reticulum morphology
|
J:143747
|
| abnormal skeletal muscle fiber morphology
|
J:143747
|
| abnormal Z line morphology
|
J:143747
|
| skeletal muscle atrophy
|
J:143747
|
\Tg(Myl1-Trp53inp2)1Azo/0
(involves: C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212763
|
| decreased skeletal muscle fiber diameter
|
J:212763
|
| decreased skeletal muscle mass
|
J:212763
|
| decreased skeletal muscle weight
|
J:212763
|
\Tg(Myl1-Trp53inp2)2Azo/0
(involves: C57BL/6J)
|
decreased skeletal muscle weight
|
J:212763
|
\Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
decreased skeletal muscle triglyceride level
|
J:76323
|
\Tg(Myl2SLC2A1)2Mue/0
(involves: C57BL/6 * SJL)
|
increased skeletal muscle cell glucose uptake
|
J:93868
|
\Tg(Myog-Myhas)#Bcgen/0
(C57BL/6J-Tg(Myog-Myhas)#Bcgen)
|
abnormal muscle physiology
|
J:240240
|
| increased extensor digitorum longus weight
|
J:240240
|
| increased gastrocnemius weight
|
J:240240
|
| increased skeletal muscle fiber diameter
|
J:240240
|
| increased tibialis anterior weight
|
J:240240
|
| skeletal muscle hypertrophy
|
J:240240
|
\Tg(Myog-Ntf3)5160Wds/0
(involves: C57BL/6 * CBA * CF-1)
|
abnormal muscle spindle morphology
|
J:43444
|
\Tg(Myog-tTA)1Eno/0
\Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:127416
|
\Tg(NEFH)200Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
\Tg(NEFH)200Jpj/\Tg(NEFH)200Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
\Tg(NEFH-tTA)8Vle/0
\Tg(tetO-TARDBP*)4Vle/0
(involves: C3H/HeJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:225639
|
\Tg(NEFL*E397K)1Milg/0
(Not Specified)
|
muscular atrophy
|
J:173771
|
\Tg(NFH)120Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
\Tg(NFH)120Jpj/\Tg(NFH)120Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
\Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:220006
|
| decreased vasoconstriction
|
J:156682,
J:220006
|
\Tg(NPPA-Bmp10)1Krc/0
(Not Specified)
|
myocardial hypertrabeculation
|
J:89404
|
\Tg(Pgk1-FGF2)15Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
\Tg(Pgk1-FGF2)16Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
\Tg(Pgk1-FGF2)48Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
\Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
heart left ventricle hypertrophy
|
J:157952
|
| increased cardiac muscle contractility
|
J:157952
|
\Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
abnormal myocardium layer morphology
|
J:157952
|
| heart left ventricle hypertrophy
|
J:157952
|
\Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N)
|
muscular atrophy
|
J:183170
|
| myoclonus
|
J:183170
|
\Tg(Prnp*P101L)2866Sbp/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:136434
|
| abnormal skeletal muscle fiber type ratio
|
J:136434
|
| abnormal skeletal muscle morphology
|
J:136434
|
| myopathy
|
J:136434
|
| skeletal muscle fiber degeneration
|
J:136434
|
\Tg(Prnp-APPSweArc)#Rmni/0
(involves: C57BL/6 * DBA/2)
|
abnormal vasodilation
|
J:239408
|
\Tg(Prnp-CCS)17Jlel/?
\Tg(SOD1*G93A)dl1Gur/?
(involves: C57BL/6 * SJL)
|
muscle hypertonia
|
J:120361
|
\Tg(Prnp-FUS)WT3Cshw/0
(involves: C57BL/6 * Crl:CD-1(ICR))
|
muscle phenotype
|
J:189360
|
\Tg(Prnp-FUS)WT3Cshw/\Tg(Prnp-FUS)WT3Cshw
(involves: C57BL/6 * Crl:CD-1(ICR))
|
abnormal muscle physiology
|
J:189360
|
| abnormal skeletal muscle fiber type ratio
|
J:189360
|
| impaired muscle relaxation
|
J:189360
|
| impaired skeletal muscle contractility
|
J:189360
|
| muscular atrophy
|
J:189360
|
\Tg(Prnp-FUS*R521C)3313Ejh/0
(involves: C57BL/6 * SJL)
|
muscle degeneration
|
J:209419
|
\Tg(Prnp-Immt/SOD1*G93A)7Gmnf/\Tg(Prnp-Immt/SOD1*G93A)7Gmnf
(involves: C57BL/6 * CBA * SJL)
|
decreased heart left ventricle muscle contractility
|
J:177846
|
| decreased skeletal muscle size
|
J:177846
|
| decreased skeletal muscle weight
|
J:177846
|
| muscular atrophy
|
J:177846
|
| skeletal muscle atrophy
|
J:177846
|
\Tg(Prnp-MAPT*)2652Gds/0
(B6.Cg-Tg(Prnp-MAPT*)2652Gds)
|
skeletal muscle fiber atrophy
|
J:244052
|
\Tg(Prnp-MAPT*P301L)#Ruvi/\Tg(Prnp-MAPT*P301L)#Ruvi
(involves: C3HeB/FeJ * C57BL/6)
|
dystonia
|
J:197198
|
\Tg(Prnp-MAPT*P301L)JNPL3Hlmc/?
(involves: C57BL/6 * DBA/2)
|
abnormal sarcomere morphology
|
J:63887
|
| abnormal skeletal muscle fiber morphology
|
J:63887
|
\Tg(Prnp-MAPT*P301S)PS19Vle/0
(involves: C3H * C57BL/6)
|
dystrophic muscle
|
J:119741
|
| progressive muscle weakness
|
J:119741
|
\Tg(Prnp-MAPT*R406W)21807Dwst/?
(FVB/N-Tg(Prnp-MAPT*R406W)21807Dwst)
|
muscle phenotype
|
J:95971
|
\Tg(Prnp-PFN1*C71G)22Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
\Tg(Prnp-PFN1*C71G)22Zxu/0
\Tg(Thy1-PFN1*C71G)67Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
\Tg(Prnp-PFN1*C71G)22Zxu/0
\Tg(Thy1-PFN1*C71G)67Zxu/\Tg(Thy1-PFN1*C71G)67Zxu
(involves: FVB/N)
|
increased variability of skeletal muscle fiber size
|
J:235427
|
| progressive muscle weakness
|
J:235427
|
| skeletal muscle fiber atrophy
|
J:235427
|
\Tg(Prnp-SNCA*A53T)25Mkle/0
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
\Tg(Prnp-SNCA*A53T)83Vle/\Tg(Prnp-SNCA*A53T)83Vle
(involves: C3H * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:76657
|
\Tg(Prnp-TARDBP)4Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
hypotonia
|
J:165985
|
| increased variability of skeletal muscle fiber size
|
J:165985
|
| muscle weakness
|
J:165985
|
| myopathy
|
J:165985
|
\Tg(Prnp-TARDBP)96Dwc/0
\Tg(Prnp-TARDBP*Q331K)31Dwc/0
(involves: C3H * C57BL/6)
|
skeletal muscle fiber degeneration
|
J:239141
|
\Tg(Prnp-TARDBP*A315T)23Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
abnormal quadriceps morphology
|
J:165985
|
| muscle weakness
|
J:165985
|
| skeletal muscle atrophy
|
J:165985
|
\Tg(Prnp-TARDBP*A315T)95Balo/0
(involves: C57BL/6 * CBA)
|
abnormal muscle electrophysiology
|
J:153197
|
| abnormal skeletal muscle fiber morphology
|
J:153197
|
| abnormal skeletal muscle morphology
|
J:153197
|
| muscle weakness
|
J:153197
|
\Tg(Prnp-TARDBP*Q331K)31Dwc/?
(involves: C3H * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:239141
|
\Tg(Prnp-TARDBP*Q331K)103Dwc/?
(involves: C57BL/6 * C3H)
|
abnormal muscle electrophysiology
|
J:191785
|
| abnormal muscle physiology
|
J:191785
|
| abnormal muscle regeneration
|
J:191785
|
| skeletal muscle degeneration
|
J:191785
|
\Tg(RSV-BDKRB2)8905Chao/0
(involves: C57BL/6 * DBA/2)
|
impaired smooth muscle contractility
|
J:128651
|
\Tg(Scgb1a1-IL6)9Flv/0
(involves: C57BL/6 * CBA)
|
heart right ventricle hypertrophy
|
J:156430
|
\Tg(SFTPC-Il18)AThos/0
(B6N.Cg-Tg(SFTPC-Il18)AThos)
|
decreased skeletal muscle weight
|
J:219136
|
| heart right ventricle hypertrophy
|
J:147547
|
\Tg(SFTPC-rtTA)2Jaw/0
\Tg(tetO-CTGF)#Swu/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:171151
|
\Tg(SOD1)2Gur/0
\Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
\Tg(SOD1)3Cje/0
(involves: BALB/c * C57BL/6J * DBA/2)
|
myocardium necrosis
|
J:89952
|
\Tg(SOD1*)DF7Yaw/0
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
| muscular atrophy
|
J:97932
|
\Tg(SOD1*)DF7Yaw/\Tg(SOD1*)DF7Yaw
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
| muscular atrophy
|
J:97932
|
\Tg(SOD1*G37R)9Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
\Tg(SOD1*G37R)29Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
\Tg(SOD1*G37R)42Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
\Tg(SOD1*G37R)106Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
\Tg(SOD1*G85R)74Dwc/?
(Not Specified)
|
muscular atrophy
|
J:77600
|
| progressive muscle weakness
|
J:77600
|
\Tg(SOD1*G85R)148Dwc/?
(Not Specified)
|
muscular atrophy
|
J:77600
|
| progressive muscle weakness
|
J:77600
|
\Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N)
|
abnormal muscle physiology
|
J:91800
|
| muscle degeneration
|
J:22628
|
\Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
| muscle weakness
|
J:109423,
J:84843
|
| skeletal muscle atrophy
|
J:76718
|
\Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tg(SOD1*G93A)1Gur/J)
|
abnormal skeletal muscle fiber type ratio
|
J:95812
|
| decreased skeletal muscle fiber diameter
|
J:95812
|
\Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal muscle physiology
|
J:158298
|
| abnormal skeletal muscle fiber morphology
|
J:158298
|
| muscle weakness
|
J:130811
|
| progressive muscle weakness
|
J:103582,
J:146652
|
\Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tg(SOD1*G93A)1Gur)
|
decreased skeletal muscle size
|
J:155140
|
\Tg(SOD1*G93A)1Gur/0
\Vegfatm2Pec/\Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle weakness
|
J:84843
|
\Tg(SOD1*G93A)2Gur/0
(involves: C57BL/6 * SJL)
|
progressive muscle weakness
|
J:32665
|
\Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * CBA * SJL)
|
muscle weakness
|
J:134095
|
| progressive muscle weakness
|
J:134095
|
\Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * SJL)
|
muscle weakness
|
J:106420
|
\Tg(SOD1*G93A)dl1Gur/0
\Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
| progressive muscle weakness
|
J:134095
|
\Tg(SOD1*H46R)#Maw/0
(involves: C57BL/6 * DBA/2)
|
muscle degeneration
|
J:99701
|
| progressive muscle weakness
|
J:99701
|
\Tg(SOD1*H46R)LAra/0
(involves: C57BL/6 * DBA/2)
|
abnormal tibialis anterior morphology
|
J:221350
|
| decreased tibialis anterior weight
|
J:221350
|
| muscular atrophy
|
J:221350
|
\Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
| decreased vascular smooth muscle cell proliferation
|
J:82620
|
\Tg(Tagln-rtTA)E1Jwst/0
\Tg(tetO-Bmpr2*R899X)#Jwst/0
(involves: FVB/N)
|
heart right ventricle hypertrophy
|
J:164503
|
\Tg(Tagln-rtTA)E1Jwst/0
\Tg(tetO-BMPR2*T504)1Jwst/0
(involves: FVB/N)
|
abnormal vascular smooth muscle morphology
|
J:98898
|
\Tg(Tagln-SLC6A4)#Edd/?
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:144126
|
| heart right ventricle hypertrophy
|
J:144126
|
\Tg(Tagln-tTA)1Mrab/0
\Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:70031
|
| increased vasoconstriction
|
J:70031
|
\Tg(tetO-NEFL)173.2Jpj/0
\Tg(THY1-tTA)177Jpj/0
(involves: C3H * C57BL/6)
|
increased skeletal muscle fiber size
|
J:160704
|
\Tg(tetO-TARDBP*A315T)13Lmit/0
\Tg(Thy1-tTA)6Lmit/0
(involves: C57BL/6)
|
skeletal muscle atrophy
|
J:245760
|
\Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
vascular smooth muscle hypoplasia
|
J:67583
|
\Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
\Tg(Thy1-App*R609D*K612E)4Vln/\Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
\Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
\Tg(Thy1-App*R609D*K612E)6Vln/\Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
\Tg(Thy1-APPDutch)#Jckr/0
(involves: C57BL/6J)
|
vascular smooth muscle hypoplasia
|
J:92796
|
\Tg(Thy1-BSCL2*N88S)1Dit/0
(involves: C57BL/6 * DBA/2)
|
muscular atrophy
|
J:175537
|
\Tg(Thy1-DCTN1*G59S)M2Pcw/?
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:132857
|
| muscular atrophy
|
J:132857
|
| progressive muscle weakness
|
J:132857
|
\Tg(Thy1-FUS*)19Vlb/0
(B6.Cg-Tg(Thy1-FUS*)19Vlb)
|
muscular atrophy
|
J:203550
|
\Tg(Thy1-GLRA1*R271Q)300Wha/0
(involves: C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:173399
|
| abnormal muscle tone
|
J:173399
|
\Tg(Thy1-HSPB1*P182L)#Lvdb/0
(involves: FVB/N)
|
abnormal gastrocnemius morphology
|
J:174508
|
| skeletal muscle fiber atrophy
|
J:174508
|
\Tg(Thy1-HSPB1*S135F)#Lvdb/0
(involves: FVB/N)
|
abnormal gastrocnemius morphology
|
J:174508
|
| skeletal muscle fiber atrophy
|
J:174508
|
\Tg(Thy1-MAPT)1Vln/0
(FVB/N-Tg(Thy1-MAPT)1Vln)
|
muscular atrophy
|
J:96869
|
\Tg(Thy1-MAPT)1Vln/\Tg(Thy1-MAPT)1Vln
(involves: FVB)
|
decreased skeletal muscle mass
|
J:100972
|
| muscle weakness
|
J:100972
|
| muscular atrophy
|
J:100971,
J:100972
|
| skeletal muscle fiber atrophy
|
J:100972
|
\Tg(Thy1-MAPT)2Vln/\Tg(Thy1-MAPT)2Vln
(involves: FVB)
|
muscular atrophy
|
J:100971
|
\Tg(Thy1-MAPT*)1Avil/\Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:201700
|
\Tg(Thy1-MAPT*K369I)K3Gotz/0
(B6.Cg-Tg(Thy1-MAPT*K369I)K3Gotz)
|
muscular atrophy
|
J:143439
|
\Tg(Thy1-MAPT*P301S)2541Godt/\Tg(Thy1-MAPT*P301S)2541Godt
(involves: C57BL/6J * CBA/Ca)
|
muscle weakness
|
J:108870
|
| skeletal muscle fiber atrophy
|
J:108870
|
\Tg(Thy1-Nrg1*I)1Kan/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| increased muscle spindle number
|
J:199150
|
\Tg(Thy1-PFN1*C71G)67Zxu/0
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
\Tg(Thy1-PFN1*C71G)67Zxu/\Tg(Thy1-PFN1*C71G)67Zxu
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
\Tg(Thy1-Snca)1S13Putt/?
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:177661
|
\Tg(Thy1-SNCA*)#Ztzh/0
(involves: C57BL/6J)
|
muscle weakness
|
J:313970
|
\Tg(Thy1-SNCA*A30P)18Pjk/\Tg(Thy1-SNCA*A30P)18Pjk
(involves: C57BL/6)
|
progressive muscle weakness
|
J:80181
|
\Tg(Thy1-SNCA*A53T)9813Putt/0
(involves: C57BL/6)
|
muscular atrophy
|
J:63836
|
\Tg(Thy1-SOD1*G93A)T1Hgrd/0
\Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
\Tg(Thy1-SOD1*G93A)T3Hgrd/\Tg(Thy1-SOD1*G93A)T3Hgrd
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
\Tg(Thy1-TARDBP)4Singh/\Tg(Thy1-TARDBP)4Singh
(involves: C57BL/6J * SJL/J)
|
facial muscle fasciculation
|
J:157550
|
| facial muscle spasm
|
J:157550
|
\Tg(Thy1-UBQLN2*P497S)3Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:239510
|
| decreased skeletal muscle fiber diameter
|
J:239510
|
| muscle degeneration
|
J:239510
|
\Tg(Thy1-UBQLN2*P506T)6Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:239510
|
| decreased skeletal muscle fiber diameter
|
J:239510
|
| muscle degeneration
|
J:239510
|
\Tg(Tnnt2-TNNT2*R92Q)#Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:117554
|
\Tg(Tnnt2-TNNT2*R92Q)M-2Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:117554
|
\Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1)
|
decreased skeletal muscle mass
|
J:73757
|
\Tg(Tuba1-MAPT)14Vle/0
(involves: C57BL/6 * SJL)
|
dystonia
|
J:78400
|
\Tg(UAS-Shh)1Rth/0
\Tg(Wnt1-GAL4)1Rth/0
(involves: C57BL/6J * CBA/J)
|
abnormal epaxial muscle morphology
|
J:57948
|
\Tg(WTbeta2)4Wjk/?
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:17862
|
| abnormal myocardial fiber morphology
|
J:128583
|
| cardiomyopathy
|
J:128583
|
| decreased cardiac muscle contractility
|
J:128583
|
| heart left ventricle hypertrophy
|
J:128583
|
| increased cardiac muscle contractility
|
J:17862
|
| increased heart left ventricle muscle contractility
|
J:17862
|
| increased myocardial fiber size
|
J:128583
|
| myocardial fiber degeneration
|
J:128583
|
\Tg(WTbeta2)4Wjk/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:134706
|
\Tgfatm1Unc/\Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
orbicularis oculi muscle hypoplasia
|
J:4605
|
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1)
|
abnormal diaphragm morphology
|
J:2892
|
| diaphragmitis
|
J:2892
|
| myocardium necrosis
|
J:2892
|
| myositis
|
J:2892
|
\Tgfb1i1tm1.1Knos/\Tgfb1i1tm1.1Knos
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:223628
|
\Tgfb2tm1Doe/\Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal myocardium layer morphology
|
J:41682,
J:103391
|
| trabecula carnea hypoplasia
|
J:41682
|
\Tgfbr1tm1.1Karl/\Tgfbr1tm1.1Karl
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
\Tgfbr1tm1Spo/\Tgfbr1tm1Spo
(either: (involves: 129S4/SvJae) or (involves: 129 * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:104918
|
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal soft palate muscle morphology
|
J:208431
|
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tg(KRT14-cre)52Smr/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:208431
|
| abnormal soft palate muscle morphology
|
J:208431
|
| centrally nucleated skeletal muscle fibers
|
J:208431
|
| small levator veli palatini muscle
|
J:208431
|
| small tensor veli palatini muscle
|
J:208431
|
\Tgfbr2tm1Karl/\Tgfbr2tm1Karl
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal vasodilation
|
J:96359
|
\Tgfbr3tm1.1Jba/\Tgfbr3tm1.1Jba
(involves: 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:141344
|
\Tgfbr3tm1Stv/\Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:83727
|
| decreased myocardial fiber number
|
J:83727
|
| trabecula carnea hypoplasia
|
J:83727
|
| ventricle myocardium hypoplasia
|
J:83727
|
\Tgm2tm1Gml/\Tgm2tm1Gml
(involves: C57BL/6)
|
disorganized myocardium
|
J:131975
|
\Thap11em1Poche/\Thap11em1Poche
(C57BL/6J-Thap11em1Poche)
|
abnormal trabecula carnea morphology
|
J:317822
|
| abnormal ventricle myocardium morphology
|
J:317822
|
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
vascular smooth muscle hyperplasia
|
J:48446
|
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle fiber morphology
|
J:139652
|
| muscle phenotype
|
J:139652
|
\Thbs2tm1Bst/\Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))
|
abnormal tendon collagen fibril morphology
|
J:45509
|
| abnormal tendon morphology
|
J:45509
|
\Thbs4tm1Dgen/\Thbs4tm1Dgen
(B6.129P2-Thbs4tm1Dgen)
|
decreased heart ventricle muscle contractility
|
J:187437
|
\Thratm1Jas/\Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart ventricle muscle contractility
|
J:68577
|
\Thratm1Syc/\Thra+
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle cell glucose uptake
|
J:95397
|
\Thratm2Jas/\Thratm2Jas
(involves: 129)
|
decreased heart ventricle muscle contractility
|
J:68577
|
\Thrbtm1.1Syc/\Thrbtm1.1Syc
(involves: 129S6/SvEvTac)
|
increased cardiac muscle cell glucose uptake
|
J:95397
|
\Thsd4tm1.2Lysa/\Thsd4+
(involves: C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:346290
|
\Tigartm1.2Smat/\Tigartm1.2Smat
\Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JJcl * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
| increased cardiac muscle contractility
|
J:183674
|
\Timp3tm1Osya/\Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased vasodilation
|
J:211441
|
\Timp3tm1Rkho/\Timp3tm1Rkho
(involves: 129 * C57BL/6)
|
decreased cardiac muscle contractility
|
J:112033
|
| dilated cardiomyopathy
|
J:112033
|
\Timp3tm1Rkho/\Timp3tm1Rkho
(B6.129-Timp3tm1Rkho)
|
abnormal cardiac muscle relaxation
|
J:102205
|
| decreased heart ventricle muscle contractility
|
J:102205
|
| dilated cardiomyopathy
|
J:102205
|
\Timp3tm1Rkho/\Timp3tm1Rkho
\Tnftm1Gkl/\Tnftm1Gkl
(involves: 129 * 129S/SvEv * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:112033
|
\Tincrem1(IMPC)Ccpcz/\Tincrem1(IMPC)Ccpcz
(C57BL/6NCrl-Tincrem1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
\TiparpGt(ROSA)79Sor/\TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
\Tk2tm1Anka/\Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:137664
|
\Tk2tm1Mihi/\Tk2tm1Mihi
(involves: 129S6/SvEv * C57BL/6J)
|
decreased muscle fiber mitochondrial DNA content
|
J:166725
|
| decreased myocardial fiber mitochondrial DNA content
|
J:166725
|
| muscle phenotype
|
J:139195
|
\Tll1b2b2476Clo/\Tll1b2b2476Clo
(C57BL/6J-Tll1b2b2476Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
\Tll2tm1.1Sjl/\Tll2tm1.1Sjl
(B6N.129(FVB)-Tll2tm1.1Sjl/Sjl)
|
increased muscle weight
|
J:132807
|
\Tln1tm4.1Crit/\Tln1tm4.1Crit
\Tln2tm1.1Crit/\Tln2tm1.1Crit
\Tg(ACTA1-cre)1Mll/0
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal muscle morphology
|
J:153959
|
| abnormal myoblast fusion
|
J:153959
|
| abnormal myotome morphology
|
J:153959
|
| abnormal sarcomere morphology
|
J:153959
|
| abnormal Z line morphology
|
J:153959
|
| increased variability of skeletal muscle fiber size
|
J:153959
|
\Tln2tm1.1Crit/\Tln2tm1.1Crit
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:152372
|
\Tln2tm1.1Crit/\Tln2tm1.1Crit
(involves: 129P2/OlaHsd * BALB/cJ)
|
centrally nucleated skeletal muscle fibers
|
J:153959
|
| muscle phenotype
|
J:153959
|
\Tln2tm2Crit/\Tln2tm2Crit
(involves: 129P2/OlaHsd * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:190037
|
| dystrophic muscle
|
J:190037
|
\Tlr2tm1Aki/\Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:116310
|
\Tlr3tm1Aki/\Tlr3tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle physiology
|
J:116310
|
\Tlr4Lps-d/\Tlr4Lps-d
(involves: C3H/HeJ)
|
muscle phenotype
|
J:116310
|
\Tlr4Lps-d/\Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal skeletal muscle cell glucose uptake
|
J:126488
|
\Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal muscle morphology
|
J:324448
|
\Tlr7em2Anu/\Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal muscle morphology
|
J:324448
|
\tlss/\tlss
(Not Specified)
|
intestinal hypoperistalsis
|
J:169366
|
\Tmem11em4Gpt/\Tmem11em4Gpt
(C57BL/6JGpt-Tmem11em4Gpt)
|
decreased myocardial fiber size
|
J:345326
|
| increased myocardial fiber number
|
J:345326
|
\Tmem38atm1Hta/\Tmem38a+
\Tmem38btm1Hta/\Tmem38b+
(involves: 129S4/SvJae)
|
abnormal muscle physiology
|
J:122817
|
| decreased myocardial fiber number
|
J:122817
|
\Tmem70tm1a(KOMP)Wtsi/\Tmem70+
(involves: C57BL/6N)
|
decreased heart left ventricle muscle contractility
|
J:238642
|
\Tmem94em1Mcvm/\Tmem94em1Mcvm
(C57BL/6-Tmem94em1Mcvm)
|
abnormal cardiac muscle tissue morphology
|
J:269160
|
\Tmem100tm1.1Ysai/\Tmem100tm1.1Ysai
(C57BL/6-Tmem100tm1.1Ysai)
|
abnormal trabecula carnea morphology
|
J:186473
|
| thin myocardium
|
J:186473
|
\Tmem100tm1.1Ysai/\Tmem100tm2.1Ysai
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal trabecula carnea morphology
|
J:186473
|
\Tmem106bem1Damme/\Tmem106bem1Damme
(C57BL/6-Tmem106bem1Damme)
|
abnormal orbicularis oculi muscle morphology
|
J:288278
|
\Tmem182em1Cya/\Tmem182em1Cya
(C57BL/6J-Tmem182em1Cya)
|
abnormal myoblast differentiation
|
J:314094
|
| abnormal myoblast fusion
|
J:314094
|
| abnormal myoblast migration
|
J:314094
|
| enhanced skeletal muscle regeneration
|
J:314094
|
| increased gastrocnemius weight
|
J:314094
|
| increased quadriceps weight
|
J:314094
|
| increased skeletal muscle fiber diameter
|
J:314094
|
| increased skeletal muscle fiber number
|
J:314094
|
| increased skeletal muscle fiber size
|
J:314094
|
| increased skeletal muscle mass
|
J:314094
|
| increased skeletal muscle weight
|
J:314094
|
| increased tibialis anterior weight
|
J:314094
|
\Tmem184bGt(IST10294F4)Tigm/\Tmem184bGt(IST10294F4)Tigm
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:231818
|
\Tmem204tm1.1Ali/\Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
\Tmem263em1Gww/\Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww)
|
decreased skeletal muscle weight
|
J:345905
|
\Tmlheem1Plaa/\Tmlheem1Plaa
(C57BL/6N-Tmlheem1Plaa)
|
abnormal myocardial fiber morphology
|
J:341247
|
\Tmod1tm1Sung/\Tmod1tm1Sung
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:89956
|
| abnormal myocardial trabeculae morphology
|
J:89956
|
\Tmod1tm1Vmf/\Tmod1tm1Vmf
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:87158
|
| abnormal myocardial fiber morphology
|
J:87158
|
| abnormal sarcomere morphology
|
J:87158
|
| absent myocardial trabeculae
|
J:87158
|
| thin myocardium
|
J:87158
|
\Tmprss2tm2b(EUCOMM)Hmgu/\Tmprss2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmprss2tm2b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
\Tmsb4xtm1Prri/\Tmsb4xtm1Prri
(B6.129-Tmsb4xtm1Prri)
|
abnormal vascular smooth muscle development
|
J:195902
|
| thin myocardium
|
J:195902
|
\Tnftm1Gkl/\Tnftm1Gkl
\Zfp36tm1Pjb/\Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
abnormal vasodilation
|
J:214114
|
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
decreased heart left ventricle muscle contractility
|
J:264147
|
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
\Tnfrsf1btm1Imx/\Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:104990
|
\Tnfsf11gum/\Tnfsf11gum
(STOCK Tnfsf11gum/GrsrJ)
|
dystrophic muscle
|
J:223062
|
\TnksGt(RRC239)Byg/\TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased muscle cell glucose uptake
|
J:154388
|
\Tnmdtm1Ref/\Tnmdtm1Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:96005
|
\Tnnc1tm1.1Jrpi/\Tnnc1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:274007
|
| cardiomyopathy
|
J:274007
|
| heart right ventricle hypertrophy
|
J:274007
|
| papillary muscle hypertrophy
|
J:274007
|
\Tnnc1tm1.1Jrpi/\Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:249978
|
| abnormal cardiac muscle relaxation
|
J:249978
|
| cardiomyopathy
|
J:274007
|
| decreased cardiac muscle relaxation
|
J:274007
|
| heart left ventricle hypertrophy
|
J:274007
|
| heart right ventricle hypertrophy
|
J:274007
|
| increased cardiac muscle contractility
|
J:274007
|
| myocardial fiber disarray
|
J:274007
|
| papillary muscle hypertrophy
|
J:274007
|
\Tnni3tm1Jww/\Tnni3tm1Jww
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:53628
|
| abnormal myocardium layer morphology
|
J:53628
|
| abnormal sarcomere morphology
|
J:53628
|
\Tnni3kB/\Tnni3kB
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:339644
|
\Tnni3ktm1.1Tfo/\Tnni3ktm1.1Tfo
(involves: C57BL/6)
|
increased myocardial fiber number
|
J:249318
|
| muscle phenotype
|
J:249318
|
\Tnni3ktm1Tfo/\Tnni3ktm1Tfo
\A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: C57BL/6 * FVB/N)
|
increased myocardial fiber number
|
J:249318
|
\Tnnt1tm1.2Jin/\Tnnt1tm1.2Jin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:219907
|
| abnormal muscle fiber morphology
|
J:219907
|
| abnormal muscle physiology
|
J:219907
|
| abnormal muscle relaxation
|
J:219907
|
| abnormal skeletal muscle fiber type ratio
|
J:219907
|
| abnormal skeletal muscle size
|
J:219907
|
| centrally nucleated skeletal muscle fibers
|
J:219907
|
| decreased skeletal muscle fiber diameter
|
J:219907
|
| decreased skeletal muscle fiber size
|
J:219907
|
| increased skeletal muscle fiber diameter
|
J:219907
|
| skeletal muscle fiber atrophy
|
J:219907
|
\Tnnt1tm1Jin/\Tnnt1tm1Jin
(B6.129P2-Tnnt1tm1Jin)
|
abnormal muscle contractility
|
J:219907
|
| abnormal muscle fiber morphology
|
J:219907
|
| abnormal muscle physiology
|
J:219907
|
| abnormal muscle relaxation
|
J:219907
|
| abnormal skeletal muscle fiber type ratio
|
J:219907
|
| centrally nucleated skeletal muscle fibers
|
J:219907
|
| decreased skeletal muscle fiber diameter
|
J:219907
|
| decreased skeletal muscle fiber size
|
J:219907
|
| increased skeletal muscle fiber diameter
|
J:219907
|
| skeletal muscle fiber atrophy
|
J:219907
|
\Tnnt2tm1Feah/\Tnnt2tm1Feah
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal myocardial fiber morphology
|
J:137964
|
| decreased cardiac muscle contractility
|
J:137964
|
\Tnnt2tm1Mmto/\Tnnt2tm1Mmto
(involves: 129S/SvEv)
|
abnormal sarcomere morphology
|
J:141967
|
\Tnnt2tm2.1Feah/\Tnnt2+
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
| dilated cardiomyopathy
|
J:243725
|
\Tnnt2tm2Mmto/\Tnnt2+
(involves: 129S/SvEv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:137784
|
\Tnnt2tm2Mmto/\Tnnt2tm2Mmto
(involves: 129S/SvEv * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:137784
|
| decreased heart left ventricle muscle contractility
|
J:137784
|
\Tnnt3tm2a(KOMP)Wtsi/\Tnnt3tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
thin diaphragm muscle
|
J:204474
|
\Tns3em1(IMPC)Bay/\Tns3+
(C57BL/6N-Tns3em1(IMPC)Bay/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
\Tor1atm1Calak/\Tor1atm1Calak
(involves: 129 * C57BL/6)
|
dystonia
|
J:247570
|
\Tor1atm1Wtd/\Tor1atm3.1Wtd
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:288753,
J:213785
|
\Tor1atm2Wtd/\Tor1atm3.1Wtd
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
\Tph1tm1Mlt/\Tph1tm1Mlt
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased cardiac muscle contractility
|
J:99733
|
\Tpm3tm3Pgun/\Tpm3tm3Pgun
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:200893
|
| abnormal muscle morphology
|
J:200893
|
\Tpm3tm4.1Pgun/\Tpm3tm4.1Pgun
(B6JArc.Cg-Tpm3tm4.1Pgun)
|
abnormal muscle contractility
|
J:200893
|
\Tpp1m1J/\Tpp1m1J
(STOCK Tpp1m1J/GrsrJ)
|
myopathy
|
J:201119
|
\Traf2tm1Mak/\Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased skeletal muscle mass
|
J:44360
|
\Traf6tm2a(EUCOMM)Wtsi/\Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal myocardium compact layer morphology
|
J:239583
|
\Trak1hyrt/\Trak1hyrt
(involves: AKR * C3HeB/FeJ * C57BL/6J)
|
abnormal muscle physiology
|
J:105231
|
\Trappc9tm1a(EUCOMM)Wtsi/\Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
\Trappc10b2b2416Clo/\Trappc10b2b2416Clo
(Trappc10b2b2416Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
\Trdntm1.1Cfp/\Trdntm1.1Cfp
(involves: 129X1/SvJ * FVB/N)
|
abnormal skeletal muscle fiber triad morphology
|
J:128951
|
\Trdntm1.2Isma/\Trdntm1.2Isma
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal muscle electrophysiology
|
J:157794
|
| abnormal muscle physiology
|
J:157794
|
| abnormal sarcoplasmic reticulum morphology
|
J:157794
|
| abnormal skeletal muscle fiber triad morphology
|
J:157794
|
| skeletal muscle hypertrophy
|
J:157794
|
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:92264
|
| cardiomyopathy
|
J:92264
|
| myocardial fiber degeneration
|
J:92264
|
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
\Trim29tm1a(EUCOMM)Wtsi/\Trim29tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased fetal cardiomyocyte apoptosis
|
J:349246
|
\Trim29tm1c(EUCOMM)Wtsi/\Trim29tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased fetal cardiomyocyte apoptosis
|
J:349246
|
\Trim32Gt(BGA355)Byg/\Trim32Gt(BGA355)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:146155
|
| abnormal skeletal muscle fiber type ratio
|
J:146155
|
| centrally nucleated skeletal muscle fibers
|
J:146155
|
| decreased muscle weight
|
J:146155
|
| decreased skeletal muscle fiber diameter
|
J:146155
|
| increased variability of skeletal muscle fiber size
|
J:146155
|
| muscle phenotype
|
J:146155
|
| myopathy
|
J:146155
|
\Trim32tm1Hdin/\Trim32tm1Hdin
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:184218
|
| abnormal skeletal muscle morphology
|
J:184218
|
| centrally nucleated skeletal muscle fibers
|
J:184218
|
| delayed skeletal muscle regeneration
|
J:184218
|
| increased satellite cell number
|
J:184218
|
| myopathy
|
J:184218
|
\Trim32tm1Spc/\Trim32tm1Spc
(involves: 129S/SvEvBrd * BALB/cJ * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:175798
|
| centrally nucleated skeletal muscle fibers
|
J:175798
|
| dystrophic muscle
|
J:175798
|
\Trim37Gt(RRO307)Byg/\Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
abnormal trabecula carnea morphology
|
J:232482
|
| cardiomyopathy
|
J:232482
|
\Trim54tm1Eno/\Trim54tm1Eno
(B6.Cg-Trim54tm1Eno)
|
abnormal cardiac muscle contractility
|
J:120068
|
| abnormal sarcomere morphology
|
J:120068
|
| dilated cardiomyopathy
|
J:120068
|
| increased cardiomyocyte apoptosis
|
J:120068
|
| myocardial fiber degeneration
|
J:120068
|
\Trim55tm1Cpat/\Trim55tm1Cpat
\Trim63tm1Glas/\Trim63tm1Glas
(involves: 129S1/Sv * C57BL/6)
|
abnormal M line morphology
|
J:267246
|
| abnormal myocardial fiber morphology
|
J:267246
|
| abnormal sarcomere morphology
|
J:267246
|
| abnormal Z line morphology
|
J:267246
|
| decreased cardiac muscle contractility
|
J:267246
|
\Trim55tm1Slbt/\Trim55tm1Slbt
(involves: 129 * C57BL/6)
|
increased quadriceps weight
|
J:130921
|
| increased skeletal muscle fiber size
|
J:130921
|
| skeletal muscle hypertrophy
|
J:130921
|
\Trim55tm1Slbt/\Trim55tm1Slbt
\Trim63tm1Slbt/\Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:130921
|
| abnormal myocardium layer morphology
|
J:130921
|
| abnormal Z line morphology
|
J:130921
|
| decreased cardiac muscle contractility
|
J:130921
|
| increased quadriceps weight
|
J:130921
|
\Trim63tm1.1Vlcg/\Trim63tm1.1Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:150424
|
\Trim63tm1Glas/\Trim63tm1Glas
(involves: 129S1/Sv)
|
decreased susceptibility to induced muscular atrophy
|
J:150424,
J:77660
|
\Trim63tm1Glas/\Trim63tm1Glas
(involves: 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:133708
|
\Trim63tm1Slbt/\Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
increased quadriceps weight
|
J:130921
|
| increased skeletal muscle fiber size
|
J:130921
|
\Trim63tm2.1Vlcg/\Trim63tm2.1Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to induced muscular atrophy
|
J:150424
|
\Trim72tm1Hta/\Trim72tm1Hta
(Not Specified)
|
abnormal muscle physiology
|
J:146965
|
| abnormal muscle regeneration
|
J:146965
|
| abnormal skeletal muscle morphology
|
J:146965
|
| centrally nucleated skeletal muscle fibers
|
J:146965
|
| decreased skeletal muscle fiber diameter
|
J:146965
|
| impaired skeletal muscle contractility
|
J:146965
|
\Trim72tm1Rpx/\Trim72tm1Rpx
(involves: 129/SvJ * C57BL/6)
|
muscle phenotype
|
J:342778
|
\Trim72tm1Ygko/\Trim72tm1Ygko
(Not Specified)
|
abnormal myogenesis
|
J:186368
|
| centrally nucleated skeletal muscle fibers
|
J:186368
|
\Triotm1Mst/\Triotm1Mst
(involves: 129S4/SvJae * BALB/c)
|
abnormal myogenesis
|
J:65380
|
| abnormal skeletal muscle fiber morphology
|
J:65380
|
| abnormal skeletal muscle morphology
|
J:65380
|
\Trp53tm1.1Thst/\Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased leiomyosarcoma incidence
|
J:198482
|
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:51661
|
\Trp53tm1Ldo/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:73757
|
| muscular atrophy
|
J:73757
|
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:17728
|
| increased rhabdomyosarcoma incidence
|
J:17728
|
\Trp53tm1Tyj/\Trp53+
\Trp63tm1Fmc/\Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:98958
|
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:17728
|
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
| increased cardiac muscle contractility
|
J:183674
|
\Trp53bp2tm1Xlu/\Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased rhabdomyosarcoma incidence
|
J:108701
|
\Trp53inp2tm1Azo/\Trp53inp2tm1Azo
\Myl1tm1(cre)Sjb/\Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212763
|
| increased skeletal muscle fiber diameter
|
J:212763
|
| increased skeletal muscle weight
|
J:212763
|
| skeletal muscle hypertrophy
|
J:212763
|
\Trp63tm2Brd/\Trp63tm2Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:119657
|
\Trp63tm2Brd/\Trp63tm2Brd
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:98439
|
\Trpc4tm1Bni/\Trpc4tm1Bni
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased vasodilation
|
J:68178
|
\Trpc6tm1Lbi/\Trpc6tm1Lbi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:106082
|
| abnormal vasoconstriction
|
J:106082
|
| increased vasoconstriction
|
J:106082
|
\Trpm2tm1.1Jych/\Trpm2tm1.1Jych
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:196475
|
| decreased cardiac muscle contractility
|
J:196475
|
\Trpv4tm1Rck/\Trpv4tm1Rck
(Not Specified)
|
abnormal vasodilation
|
J:129365
|
\Tsc1tm1Hin/\Tsc1+
(involves: 129S4/SvJae * C57BL/6J)
|
increased leiomyosarcoma incidence
|
J:70463
|
| increased uterus leiomyoma incidence
|
J:70463
|
\Tsc2tm1.1Mjg/\Tsc2tm1.1Mjg
\Pgrtm2(cre)Lyd/\Pgr+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased uterus leiomyoma incidence
|
J:221228
|
\Tsc2tm1Tno/\Tsc2tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
thick myocardium
|
J:52464
|
\Tshz3tm1Lafa/\Tshz3tm1Lafa
(involves: 129P2/OlaHsd * CD-1)
|
impaired ureteric peristalsis
|
J:138769
|
X/\Tspy-pstm1(Mlc3-Gdf8)Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased muscle weight
|
J:98460
|
| increased skeletal muscle fiber size
|
J:98460
|
X/\Tspy-pstm2(Mlc3-Gdf8)Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased muscle weight
|
J:98460
|
| increased skeletal muscle fiber size
|
J:98460
|
\Ttnem1Kage/\Ttnem1Kage
(B6J.B6N-Ttnem1Kage)
|
abnormal myocardium layer morphology
|
J:302920
|
| decreased heart left ventricle muscle contractility
|
J:302920
|
| muscle phenotype
|
J:302920
|
\Ttnmdm/\Ttnmdm
(Not Specified)
|
muscle degeneration
|
J:14016
|
| myositis
|
J:14016
|
\Ttnmdm/\Ttnmdm
(involves: C57BL/6J)
|
muscle phenotype
|
J:87870
|
\Ttnshru/\Ttnshru
(B6.BTBR-Ttnshru)
|
decreased cardiac muscle contractility
|
J:92178
|
| trabecula carnea hypoplasia
|
J:92178
|
\Ttntm1.1Her/\Ttntm1.1Her
(involves: 129S4/SvJae * 129T2/SvEms)
|
abnormal myocardial fiber morphology
|
J:111284
|
| abnormal myocardial trabeculae morphology
|
J:111284
|
| abnormal myocardium layer morphology
|
J:111284
|
| thin myocardium
|
J:111284
|
\Ttntm1.1Hgra/\Ttntm1.1Hgra
(B6.Cg-Ttntm1.1Hgra)
|
abnormal myocardial fiber morphology
|
J:206712
|
\Ttntm1.1Hgra/\Ttntm1.1Hgra
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal diaphragm morphology
|
J:206713
|
| abnormal muscle contractility
|
J:206713
|
| decreased soleus weight
|
J:206713
|
| skeletal muscle fiber atrophy
|
J:206713
|
\Ttntm1.1Isrd/\Ttn+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal limb muscle morphology
|
J:165576
|
| abnormal quadriceps morphology
|
J:165576
|
| abnormal tibialis anterior morphology
|
J:165576
|
| dystrophic muscle
|
J:165576
|
\Ttntm1.1Isrd/\Ttntm1.1Isrd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:165576
|
| abnormal limb muscle morphology
|
J:165576
|
| abnormal M line morphology
|
J:165576
|
| abnormal skeletal muscle morphology
|
J:165576
|
| abnormal soleus morphology
|
J:165576
|
| abnormal tibialis anterior morphology
|
J:165576
|
| centrally nucleated skeletal muscle fibers
|
J:165576
|
| decreased heart ventricle muscle contractility
|
J:165576
|
| dilated cardiomyopathy
|
J:165576
|
| dystrophic muscle
|
J:165576
|
| impaired skeletal muscle contractility
|
J:165576
|
| increased variability of skeletal muscle fiber size
|
J:165576
|
| myositis
|
J:165576
|
| skeletal muscle fiber necrosis
|
J:165576
|
\Ttntm1Brge/\Ttn+
(B6.Cg-Ttntm1Brge)
|
decreased cardiac muscle contractility
|
J:152736
|
| dilated cardiomyopathy
|
J:152736
|
\Ttntm1Brge/\Ttntm1Brge
(B6.Cg-Ttntm1Brge)
|
abnormal myocardium layer morphology
|
J:152736
|
\Ttntm1Her/\Ttntm1Her
\Tg(Ckmm-cre)5Khn/0
(Not Specified)
|
abnormal M line morphology
|
J:81993
|
| abnormal sarcomere morphology
|
J:81993
|
| progressive muscle weakness
|
J:81993
|
\Ttntm1Mgot/\Ttntm1Mgot
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:125922
|
\Ttntm2.1Hgra/\Ttntm2.1Hgra
(B6J.Cg-Ttntm2.1Hgra)
|
abnormal myocardial fiber morphology
|
J:216466
|
| abnormal sarcomere morphology
|
J:216466
|
| heart left ventricle hypertrophy
|
J:216466
|
| increased myocardial fiber size
|
J:216466
|
\Ttntm2.1Mgot/\Ttn+
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:169969
|
\Ttntm2.1Mgot/\Ttntm2.1Mgot
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:169969
|
| abnormal muscle physiology
|
J:169969
|
| abnormal sarcomere morphology
|
J:169969
|
| heart left ventricle hypertrophy
|
J:169969
|
| increased myocardial fiber size
|
J:169969
|
\Ttpatm1Hsz/\Ttpatm1Hsz
(involves: 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:90006
|
| increased variability of skeletal muscle fiber size
|
J:90006
|
| skeletal muscle fiber atrophy
|
J:90006
|
\Tubb4aem1Avan/\Tubb4aem1Avan
(involves: C57BL/6)
|
dystonia
|
J:291062
|
\Tulp4tm1a(KOMP)Wtsi/\Tulp4+
(involves: C57BL/6N * C57BL/6NRj)
|
abnormal infrahyoid muscle morphology
|
J:344151
|
| telangiectasia
|
J:344151
|
\Twist1tm1Bhr/\Twist1+
\Twist2tm1(cre)Dor/\Twist2+
(involves: 129/Sv * 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:81485
|
\Twist1tm1Bhr/\Twist1tm1Bhr
(involves: 129S7/SvEvBrd)
|
abnormal muscle development
|
J:124278
|
\Twist2tm1(cre)Dor/\Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:81485
|
| decreased skeletal muscle glycogen level
|
J:81485
|
| dystonia
|
J:81485
|
\Txniptm1.1Rlee/\Txniptm1.1Rlee
(involves: 129S4/SvJae)
|
decreased heart left ventricle muscle contractility
|
J:141487
|
| increased cardiac muscle cell glucose uptake
|
J:141487
|
\Txniptm1.1Road/\Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
increased skeletal muscle cell glucose uptake
|
J:132756
|
\Txniptm1Rlee/\Txniptm1Rlee
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S4/SvJae * FVB/N)
|
increased cardiac muscle cell glucose uptake
|
J:141487
|
\Txnrd2tm1.1Marc/\Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94136
|
| trabecula carnea hypoplasia
|
J:94136
|
\Ube3ctm1b(EUCOMM)Hmgu/\Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
increased cardiac muscle contractility
|
J:211773
|
\Ube4btm1Kei/\Ube4btm1Kei
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:103761
|
| abnormal myocardial trabeculae morphology
|
J:103761
|
| abnormal myocardium layer morphology
|
J:103761
|
| increased cardiomyocyte apoptosis
|
J:103761
|
\Ubp1tm1Jmc/\Ubp1tm1Jmc
(involves: 129S7/SvEvBrd * C57BL/6)
|
thin myocardium
|
J:92266
|
| trabecula carnea hypoplasia
|
J:92266
|
\Ubr1tm1Avar/\Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
decreased skeletal muscle mass
|
J:72859
|
\Ubr1tm1Avar/\Ubr1tm1Avar
\Ubr2tm1Ytkw/\Ubr2tm1Ytkw
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:109036
|
| disorganized myocardium
|
J:109036
|
\Uchl3tm1Tilg/\Uchl3tm1Tilg
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:83810
|
\Ucp3tm1Brnd/\Ucp3tm1Brnd
(Not Specified)
|
decreased skeletal muscle triglyceride level
|
J:106901
|
\Ugt1tm1.1Afmu/\Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL)
|
dystonia
|
J:182805
|
\Ugt1tm1.1Afmu/\Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu)
|
dystonia
|
J:216224
|
\uns/\uns
(involves: C57BL/6J * CD-1)
|
abnormal muscle contractility
|
J:14139
|
| abnormal muscle electrophysiology
|
J:14139
|
| skeletal muscle atrophy
|
J:14139
|
\Usp14ax-J/\Usp14ax-J
(involves: STOCK Mafbkr)
|
muscular atrophy
|
J:12283
|
\Usp14ax-J/\Usp14ax-J
(C.Cg-Usp14ax-J)
|
progressive muscle weakness
|
J:203043
|
\Usp14nmf375/\Usp14nmf375
(B6;CByJ-Usp14nmf375/J)
|
muscle degeneration
|
J:87349
|
| muscle spasm
|
J:87349
|
\Usp14nmf375/\Usp14nmf375
(C.B6-Usp14nmf375)
|
muscle phenotype
|
J:203043
|
| muscle weakness
|
J:203043
|
\Usp19Gt(XG128)Byg/\Usp19Gt(XG128)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:225526
|
| decreased susceptibility to induced muscular atrophy
|
J:225526
|
\Utf1tm1Okud/\Utf1tm1Okud
(B6.129P2-Utf1tm1Okud)
|
thin myocardium
|
J:204409
|
\Utrntm1Ked/\Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
muscle phenotype
|
J:70949
|
\Uts2rtm1Djbe/\Uts2rtm1Djbe
(B6.129P2-Uts2rtm1Djbe)
|
abnormal vasoconstriction
|
J:103118
|
\UvragTn(pb-Act-RFP)1.100107015-HRAZhu/\UvragTn(pb-Act-RFP)1.100107015-HRAZhu
(involves: FVB/NJ)
|
cardiomyopathy
|
J:219546
|
| decreased cardiac muscle contractility
|
J:219546
|
| increased cardiomyocyte apoptosis
|
J:219546
|
| increased myocardial fiber size
|
J:219546
|
\Vamp4em1(IMPC)Ccpcz/\Vamp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Vamp4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Vapbtm1.1Tsud/\Vapbtm1.1Tsud
(involves: 129S7/SvEvBrd)
|
centrally nucleated skeletal muscle fibers
|
J:226459
|
| skeletal muscle fiber atrophy
|
J:226459
|
\Vapbtm1.2Ics/\Vapbtm1.2Ics
(B6N.129S2-Vapbtm1.2Ics)
|
hypotonia
|
J:198145
|
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
heart left ventricle hypertrophy
|
J:124056
|
| increased myocardial fiber size
|
J:124056
|
| vascular smooth muscle hyperplasia
|
J:124056
|
\Vav3tm1Xrb/\Vav3tm1Xrb
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:111973
|
| decreased heart ventricle muscle contractility
|
J:111973
|
| heart left ventricle hypertrophy
|
J:111973
|
\vc/\vc
(DBA/1-vc)
|
muscle weakness
|
J:297
|
\Vcam1tm1Roml/\Vcam1tm1Roml
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:23137
|
| disorganized myocardium
|
J:23137,
J:28110
|
| thin ventricle myocardium compact layer
|
J:23137,
J:28110
|
\Vcltm1Eda/\Vcl+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal intercalated disk morphology
|
J:92398
|
| abnormal myocardial fiber morphology
|
J:92398
|
| decreased heart left ventricle muscle contractility
|
J:92398
|
\Vcltm1Eda/\Vcltm1Eda
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:45781
|
| decreased myocardial fiber number
|
J:45781
|
| thin myocardium
|
J:45781
|
\Vcptm1Itl/\Vcp+
(B6.129S-Vcptm1Itl)
|
abnormal skeletal muscle fiber morphology
|
J:166230
|
| centrally nucleated skeletal muscle fibers
|
J:166230
|
| increased variability of skeletal muscle fiber size
|
J:166230
|
| myopathy
|
J:166230
|
| progressive muscle weakness
|
J:166230
|
\Vcptm1Itl/\Vcptm1Itl
(involves: 129S6/SvEvTac)
|
abnormal sarcomere morphology
|
J:191963
|
| abnormal skeletal muscle fiber morphology
|
J:191963
|
| abnormal skeletal muscle morphology
|
J:191963
|
| centrally nucleated skeletal muscle fibers
|
J:191963
|
| decreased skeletal muscle mass
|
J:191963
|
| increased variability of skeletal muscle fiber size
|
J:191963
|
| muscle weakness
|
J:191963
|
| myopathy
|
J:191963
|
| skeletal muscle endomysial fibrosis
|
J:191963
|
| skeletal muscle fiber necrosis
|
J:191963
|
\Vdac3tm1Wjc/\Vdac3tm1Wjc
(Not Specified)
|
abnormal muscle physiology
|
J:72188
|
| abnormal skeletal muscle fiber mitochondrial shape
|
J:72188
|
\Vdrtm1.1Sgcg/\Vdrtm1.2Sgcg
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased myocardial fiber size
|
J:189471
|
\Vegfatm1.1Nagy/\Vegfatm1.1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:64090
|
| thin ventricle myocardium compact layer
|
J:64090
|
\Vegfatm1Pec/\Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:56003
|
| abnormal myocardial fiber morphology
|
J:56003
|
| abnormal sarcomere morphology
|
J:56003
|
| decreased cardiac muscle contractility
|
J:56003
|
| decreased heart left ventricle muscle contractility
|
J:56003
|
| increased myocardial fiber size
|
J:56003
|
| myocardial fiber degeneration
|
J:56003
|
\Vegfatm2Gne/\Vegfatm2Gne
\Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA)
|
myocardium necrosis
|
J:193198
|
\Vegfatm2Pec/\Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:69797
|
| progressive muscle weakness
|
J:69797
|
| skeletal muscle fiber atrophy
|
J:69797
|
\Vegfbtm1Gfk/\Vegfbtm1Gfk
(involves: 129T2/SvEms)
|
heart right ventricle hypertrophy
|
J:102808
|
\Vgll2tm1Tm/\Vgll2tm1Tm
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal skeletal muscle fiber type ratio
|
J:258195
|
\Vgll4tm1b(EUCOMM)Hmgu/\Vgll4tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * CBA)
|
increased cardiac muscle contractility
|
J:273437
|
\Vgll4tm1b(EUCOMM)Hmgu/\Vgll4tm1c(EUCOMM)Hmgu
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6N * CBA * SJL)
|
decreased cardiac muscle contractility
|
J:273437
|
| increased myocardial fiber size
|
J:273437
|
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
\Vhltm1Jae/\Vhltm1Jae
\Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * FVB/N)
|
cardiomyopathy
|
J:179490
|
| decreased heart ventricle muscle contractility
|
J:179490
|
\Vimtm1Cba/\Vimtm1Cba
(involves: 129S2/SvPas)
|
abnormal vasoconstriction
|
J:43049
|
| abnormal vasodilation
|
J:43049
|
\Viptm1Clw/\Viptm1Clw
(involves: 129S/Sv * C57BL/6)
|
heart right ventricle hypertrophy
|
J:132313
|
\Vipas39tm1c(KOMP)Mbp/\Vipas39tm1c(KOMP)Mbp
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal tendon collagen fibril morphology
|
J:236095
|
\Vkorc1tm1.1Jobg/\Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
muscle hemorrhage
|
J:207884
|
\Vms1A/J/\Vms1A/J
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
\Vms2C57BL/10SnSg/?
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
\Vms3C57BL/10SnSg/?
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
\Vnn3em1(IMPC)Ccpcz/\Vnn3em1(IMPC)Ccpcz
(C57BL/6NCrl-Vnn3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
\Vps16em1Weli/\Vps16em1Weli
(C57BL/6J-Vps16em1Weli)
|
dystonia
|
J:243974
|
\Vps33btm1.1Arte/\Vps33btm1.1Arte
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
abnormal tendon collagen fibril morphology
|
J:236095
|
\Vps54Gt(RRI497)Byg/\Vps54Gt(RRI497)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:104824
|
\Vps54wr/\Vps54wr
(multiple strains)
|
abnormal muscle physiology
|
J:5102
|
| abnormal skeletal muscle fiber morphology
|
J:5102
|
| facial muscle atrophy
|
J:5102
|
| muscle weakness
|
J:5102
|
| muscular atrophy
|
J:6388,
J:5102
|
\Vps54wr/\Vps54wr
(involves: C57BL/6J * C57BL/Fa)
|
progressive muscle weakness
|
J:181019
|
\Vwa1tm1Jfba/\Vwa1tm1Jfba
(C57BL/6-Vwa1tm1Jfba)
|
muscle phenotype
|
J:149746
|
\Wars1tm1b(EUCOMM)Hmgu/\Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Wars2mpc151H/\Wars2mpc151H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
\Wasf1Gt(VICTR37)1Kwak/\Wasf1Gt(VICTR37)1Kwak
(involves: 129S5/SvEvBrd * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:83377
|
\Wasf2tm1Tta/\Wasf2tm1Tta
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:84651
|
\Wdfy3Tn(pb-Act-RFP)1.1Zhu/\Wdfy3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6 * FVB/NJ)
|
abnormal trabecula carnea morphology
|
J:285853
|
\Wdr1tm1.1Zzy/\Wdr1tm1.1Zzy
\A1cfTg(Myh6-cre/Esr1*)1Jmk/\A1cf+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211364
|
| increased myocardial fiber size
|
J:211364
|
\Wdr1tm1.1Zzy/\Wdr1tm1.1Zzy
\Tg(Myh6-cre)1Xya/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211364
|
| abnormal myocardium layer morphology
|
J:211364
|
| decreased heart left ventricle muscle contractility
|
J:211364
|
| increased myocardial fiber size
|
J:211364
|
\Wdr19twto/\Wdr19twto
(involves: FVB/NJ)
|
abnormal dermomyotome development
|
J:181888
|
| abnormal myotome development
|
J:181888
|
\Wdr35yeti/\Wdr35yeti
(Not Specified)
|
diaphragmatic hernia
|
J:171617
|
\Wfikkn1tm1.1Sjl/\Wfikkn1tm1.1Sjl
(involves: 129 * C57BL/6)
|
abnormal limb muscle morphology
|
J:201148
|
| abnormal skeletal muscle fiber type ratio
|
J:201148
|
| decreased quadriceps weight
|
J:201148
|
| decreased skeletal muscle weight
|
J:201148
|
| impaired skeletal muscle regeneration
|
J:201148
|
\Wfikkn1tm1.1Sjl/\Wfikkn1tm1.1Sjl
\Wfikkn2tm1.1Sjl/\Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:201148
|
\Wfikkn2tm1.1Sjl/\Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
abnormal limb muscle morphology
|
J:201148
|
| abnormal skeletal muscle fiber type ratio
|
J:201148
|
| decreased quadriceps weight
|
J:201148
|
| decreased skeletal muscle weight
|
J:201148
|
| impaired skeletal muscle regeneration
|
J:201148
|
\Wlstm1Xzg/\Wlstm1Xzg
\Tg(Msx2-cre)5Rem/0
(Not Specified)
|
abnormal muscle development
|
J:184918
|
| abnormal tendon morphology
|
J:184918
|
\Wnk1Gt(OST38262)Lex/\Wnk1Gt(OST38262)Lex
(involves: 129S5/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:152906
|
| thin myocardium
|
J:152906
|
| trabecula carnea hypoplasia
|
J:152906
|
\Wnk1tm1Clhu/\Wnk1tm1Clhu
\Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:152906
|
| thin myocardium
|
J:152906
|
\Wnt1sw/\Wnt1sw
(Not Specified)
|
muscle hypertonia
|
J:30722
|
\Wnt1tm1Brd/\Wnt1tm1Brd
\Wnt3atm1Amc/\Wnt3atm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal dermomyotome development
|
J:50279
|
| abnormal myotome development
|
J:50279
|
\Wnt10btm1Ptr/\Wnt10btm1Ptr
(involves: FVB)
|
abnormal muscle development
|
J:99298
|
| abnormal muscle regeneration
|
J:99298
|
\Wsb2tm1b(EUCOMM)Hmgu/\Wsb2tm1b(EUCOMM)Hmgu
(C57BL/6N-Wsb2tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased cardiac muscle contractility
|
J:211773
|
\Wt1tm1(EGFP/cre)Wtp/\Wt1+
\Zfpm2tm1Sho/\Zfpm2tm2Sho
(involves: 129S1/Sv * 129S4/SvJae * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
\Wt1tm1.1Ndha/\Wt1tm1.1Ndha
\Tg(Gata4*G2-cre)#Roja/0
(involves: 129P2/OlaHsd)
|
abnormal diaphragm development
|
J:238024
|
| diaphragmatic hernia
|
J:238024
|
| thin ventricle myocardium compact layer
|
J:229936
|
\Wt1tm1Jae/\Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6)
|
diaphragmatic hernia
|
J:14317
|
\Wt1tm1Jae/\Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6 * MF1)
|
abnormal diaphragm development
|
J:114565
|
| diaphragmatic hernia
|
J:114565
|
\Wt1tm1Jae/\Wt1tm1Jae
(involves: 129S4/SvJae)
|
abnormal diaphragm development
|
J:238024
|
\Wt1tm1Mlh/\Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:135449
|
| myocardium hypoplasia
|
J:135449
|
\Wwtr1tm1.1Eno/\Wwtr1+
\Yap1tm1.1Eno/\Yap1tm1.1Eno
\Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:200670
|
| myocardium hypoplasia
|
J:200670
|
| thin myocardium
|
J:200670
|
\Wwtr1tm1.1Eno/\Wwtr1tm1.1Eno
\Yap1tm1.1Eno/\Yap1+
\Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
dilated cardiomyopathy
|
J:200670
|
\Xbp1tm1Nogu/\Xbp1tm1Nogu
(involves: 129S/SvEv * A/J)
|
absent trabeculae carneae
|
J:56678
|
| myocardium necrosis
|
J:56678
|
\Xdhtm1Mrc/\Xdh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:80993
|
\Xiaptm1Vdr/\Xiaptm1Vdr
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:182515
|
\Xirp1tm1Dofr/\Xirp1tm1Dofr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:159352
|
| abnormal myocardium layer morphology
|
J:159352
|
| abnormal sarcomere morphology
|
J:159352
|
| decreased cardiac muscle contractility
|
J:159352
|
\Xirp1tm1Jl/\Xirp1+
(involves: 129)
|
abnormal trabecula carnea morphology
|
J:132079
|
| abnormal ventricle myocardium morphology
|
J:132079
|
| cardiomyopathy
|
J:132079
|
| increased myocardial fiber size
|
J:132079
|
\Xirp1tm1Jl/\Xirp1tm1Jl
(involves: 129)
|
abnormal A band morphology
|
J:132079
|
| abnormal I band morphology
|
J:132079
|
| abnormal intercalated disk morphology
|
J:132079,
J:112201
|
| abnormal myocardial fiber morphology
|
J:132079,
J:112201
|
| abnormal sarcomere morphology
|
J:132079
|
| abnormal trabecula carnea morphology
|
J:132079
|
| abnormal ventricle myocardium morphology
|
J:132079
|
| cardiomyopathy
|
J:132079
|
| diffuse Z line
|
J:132079
|
| increased myocardial fiber size
|
J:132079
|
\Xirp2tm1Itl/\Xirp2tm1Itl
(Not Specified)
|
increased myocardial fiber size
|
J:170869
|
\Xirp2tm1Jl/\Xirp2tm1Jl
(B6.129-Xirp2tm1Jl)
|
abnormal atrioventricular bundle morphology
|
J:255706
|
| abnormal intercalated disk morphology
|
J:158491
|
| abnormal myocardial fiber morphology
|
J:158491
|
| abnormal Purkinje fiber morphology
|
J:255706
|
| abnormal trabecula carnea morphology
|
J:158491
|
| decreased myocardial fiber size
|
J:158491
|
| disorganized myocardium
|
J:158491
|
| increased cardiomyocyte apoptosis
|
J:158491
|
| ventricular myocardium compact layer hypoplasia
|
J:158491
|
\Xktm1Ariv/\Xktm1Ariv
(B6.Cg-Xktm1Ariv)
|
abnormal skeletal muscle fiber morphology
|
J:206464
|
| centrally nucleated skeletal muscle fibers
|
J:206464
|
| increased variability of skeletal muscle fiber size
|
J:206464
|
| muscle phenotype
|
J:206464
|
\Xlch/?
(C57BL/6J-Xlch)
|
abnormal myocardial fiber morphology
|
J:136798
|
| abnormal ventricle papillary muscle morphology
|
J:136798
|
| dilated sarcoplasmic reticulum
|
J:136798
|
| disorganized myocardium
|
J:136798
|
| heart left ventricle hypertrophy
|
J:136798
|
| increased cardiac muscle contractility
|
J:136798
|
\Xpnpep1tm1a(KOMP)Wtsi/\Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
\Yap1tm1.1Eno/\Yap1tm1.1Eno
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S/SvEv)
|
abnormal myocardium layer morphology
|
J:189577
|
| thin myocardium
|
J:189577
|
\Yap1tm1.1Eno/\Yap1tm1.1Eno
\Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
decreased cardiac muscle contractility
|
J:200670
|
| dilated cardiomyopathy
|
J:200670
|
\Yme1l1tm1Tlan/\Yme1l1tm1Tlan
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6NCrl * FVB/N)
|
abnormal muscle physiology
|
J:229455
|
| abnormal myocardial fiber mitochondrial morphology
|
J:229455
|
| cardiac muscle necrosis
|
J:229455
|
| decreased heart left ventricle muscle contractility
|
J:229455
|
| dilated cardiomyopathy
|
J:229455
|
| increased cardiac muscle cell glucose uptake
|
J:229455
|
\Ywhaetm1Awb/\Ywhae+
(involves: 129S6/SvEvTac)
|
thin ventricle myocardium compact layer
|
J:192860
|
\Ywhaetm1Awb/\Ywhaetm1Awb
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:192860
|
| decreased fetal cardiomyocyte proliferation
|
J:192860
|
| thin myocardium compact layer
|
J:192860
|
| thin ventricle myocardium compact layer
|
J:192860
|
\YwhaqGt(RRR746)Byg/\Ywhaq+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:118280
|
\Zbed6tm1.2Sson/\Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
\Zdhhc9tm1Lex/Y
(B6.129S5-Zdhhc9tm1Lex)
|
hypotonia
|
J:268248
|
\Zdhhc13skc4/\Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
muscular atrophy
|
J:161519
|
\Zdhhc16tm1Goff/\Zdhhc16tm1Goff
(involves: 129S1/Sv)
|
abnormal sarcomere morphology
|
J:228307
|
| cardiomyopathy
|
J:228307
|
\Zeb1tm2Yhi/\Zeb1tm2Yhi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:110800
|
\Zfand5Gt(ROSA)72Sor/\Zfand5Gt(ROSA)72Sor
(involves: 129S4/SvJaeSor)
|
vascular smooth muscle hypoplasia
|
J:117491
|
\Zfp36tm1Pjb/\Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
abnormal vasodilation
|
J:214114
|
\Zfp36tm4.1Pjb/\Zfp36tm4.1Pjb
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal myocardium layer morphology
|
J:188677
|
\Zfp36l1tm1Seb/\Zfp36l1tm1Seb
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
trabecula carnea hypoplasia
|
J:113396
|
\Zfp106em1Blk/\Zfp106em1Blk
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:241305
|
| skeletal muscle fiber atrophy
|
J:241305
|
| skeletal muscle fiber degeneration
|
J:241305
|
\Zfp106tm1a(KOMP)Wtsi/\Zfp106tm1a(KOMP)Wtsi
(involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)
|
abnormal gastrocnemius morphology
|
J:229162
|
| abnormal muscle electrophysiology
|
J:229162
|
| abnormal muscle physiology
|
J:229162
|
| abnormal skeletal muscle fiber type ratio
|
J:229162
|
| abnormal soleus morphology
|
J:229162
|
| centrally nucleated skeletal muscle fibers
|
J:229162
|
| decreased gastrocnemius weight
|
J:229162
|
| decreased skeletal muscle fiber number
|
J:229162
|
| decreased soleus weight
|
J:229162
|
| decreased tibialis anterior weight
|
J:229162
|
| increased variability of skeletal muscle fiber size
|
J:229162
|
| skeletal muscle atrophy
|
J:229162
|
| skeletal muscle fiber atrophy
|
J:229162
|
| skeletal muscle fibrosis
|
J:229162
|
\Zfp106tm1b(KOMP)Wtsi/\Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal skeletal muscle morphology
|
J:241305
|
| skeletal muscle fiber atrophy
|
J:241305
|
| skeletal muscle fiber degeneration
|
J:241305
|
\Zfp235tm1b(KOMP)Wtsi/\Zfp235tm1b(KOMP)Wtsi
(C57BL/6N-Zfp235tm1b(KOMP)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
\Zfp280dem1(IMPC)Hmgu/\Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
\Zfp418em#Juli/\Zfp418em#Juli
(Not Specified)
|
heart left ventricle hypertrophy
|
J:251673
|
\Zfp422em1Mode/\Zfp422em1Mode
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal myoblast differentiation
|
J:297035
|
| abnormal skeletal muscle fiber morphology
|
J:297035
|
| decreased skeletal muscle fiber size
|
J:297035
|
\Zfp422em1Mode/\Zfp422em1Mode
\Pax7tm1(cre/ERT2)Gaka/\Pax7+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal myoblast differentiation
|
J:297035
|
| impaired skeletal muscle regeneration
|
J:297035
|
\Zfp697em1Bcgen/\Zfp697em1Bcgen
\Tg(Myog-cre)1Eno/0
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:362025
|
| decreased skeletal muscle weight
|
J:362025
|
| impaired skeletal muscle regeneration
|
J:362025
|
| muscle phenotype
|
J:362025
|
\Zfp950Gt(ROSA)76Sor/\Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
\Zfpm1tm4Sho/\Zfpm1tm4Sho
\Tg(Gata1-Zfpm1)1Sho/0
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * SJL)
|
thin myocardium
|
J:99745
|
\Zfpm2lil/\Zfpm2lil
(involves: A/J)
|
abnormal diaphragm morphology
|
J:100119
|
| thin diaphragm muscle
|
J:100119
|
| thin myocardium
|
J:100119
|
| thin myocardium compact layer
|
J:100119
|
\Zfpm2tm1.1Esv/\Zfpm2tm1.1Esv
(involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:216295
|
| thin myocardium compact layer
|
J:216295
|
\Zfpm2tm1Jml/\Zfpm2tm1Jml
(involves: 129X1/SvJ)
|
thin left ventricle myocardium compact layer
|
J:63121
|
\Zfpm2tm1Sho/\Zfpm2tm1Sho
(involves: 129S1/Sv)
|
thin ventricle myocardium compact layer
|
J:62879
|
| ventricular myocardium compact layer hypoplasia
|
J:62879
|
\Zfpm2tm1Sho/\Zfpm2tm2Sho
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
\Zfpm2tm1Sho/\Zfpm2tm2Sho
\Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
| decreased heart ventricle muscle contractility
|
J:150452
|
| increased myocardial fiber apoptosis
|
J:150452
|
\Zfpm2tm1Sho/\Zfpm2tm2Sho
\Tg(Tnnt2-rtTA,tetO-cre)1Wtp/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
| increased cardiomyocyte apoptosis
|
J:150452
|
\Zic1tm1Jaru/\Zic1+
(B6.129S4-Zic1tm1Jaru)
|
hypotonia
|
J:72342
|
\Zmpste24tm1Otin/\Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
|
dilated cardiomyopathy
|
J:76209
|
| dystrophic muscle
|
J:76209
|
\Zmpste24tm1Sgy/\Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
progressive muscle weakness
|
J:95274,
J:79501
|
\Zmynd11em1(IMPC)Wtsi/\Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| thin myocardium
|
J:239583
|
Analysis Tools